Clustering O 0 0.18941091001033783
of O 0 0.04827357456088066
missense O 0 0.4555322825908661
mutations O 0 0.15846431255340576
in O 0 0.031387101858854294
the O 0 0.04453998804092407
ataxia B-Disease 1 0.9999867677688599
- I-Disease 1 0.9927608966827393
telangiectasia I-Disease 1 0.9995577931404114
gene O 0 0.1276301145553589
in O 0 0.03139964118599892
a O 0 0.04427172988653183
sporadic B-Disease 1 0.5683954358100891
T I-Disease 1 0.9989755153656006
- I-Disease 1 0.9694236516952515
cell I-Disease 1 0.8585034608840942
leukaemia I-Disease 1 0.9997476935386658
. O 0 0.0725984275341034

Ataxia B-Disease 1 0.9999920129776001
- I-Disease 1 0.9976039528846741
telangiectasia I-Disease 1 0.9998588562011719
( O 0 0.0936630442738533
A B-Disease 0 0.0796908438205719
- I-Disease 1 0.8319392204284668
T I-Disease 1 0.9936096668243408
) O 0 0.031083328649401665
is O 0 0.018796440213918686
a O 0 0.030225303024053574
recessive B-Disease 1 0.9970899820327759
multi I-Disease 1 0.9850566983222961
- I-Disease 1 0.9934819340705872
system I-Disease 1 0.6679599285125732
disorder I-Disease 1 0.9999747276306152
caused O 0 0.4957354962825775
by O 0 0.02768569067120552
mutations O 0 0.09856992214918137
in O 0 0.020629413425922394
the O 0 0.025706935673952103
ATM O 0 0.12051834166049957
gene O 0 0.09823210537433624
at O 0 0.04791071638464928
11q22 O 0 0.3354927897453308
- O 0 0.14295479655265808
q23 O 0 0.2580482065677643
( O 0 0.06398716568946838
ref O 0 0.1399649828672409
. O 0 0.02475694753229618
3 O 0 0.03976427763700485
) O 0 0.038994308561086655
. O 0 0.038410577923059464

The O 0 0.05145994573831558
risk O 1 0.7295352220535278
of O 0 0.03271491453051567
cancer B-Disease 1 0.9998363256454468
, O 0 0.026650769636034966
especially O 0 0.045210178941488266
lymphoid B-Disease 1 0.9859896898269653
neoplasias I-Disease 1 0.5536428689956665
, O 0 0.020753121003508568
is O 0 0.016628323122859
substantially O 0 0.04796542599797249
elevated O 0 0.060566190630197525
in O 0 0.023655526340007782
A B-Disease 0 0.08725232630968094
- I-Disease 1 0.9941283464431763
T I-Disease 1 0.9998642206192017
patients O 1 0.9963615536689758
and O 0 0.015397665090858936
has O 0 0.017398230731487274
long O 0 0.027676550671458244
been O 0 0.018334273248910904
associated O 0 0.03294982761144638
with O 0 0.03458631411194801
chromosomal O 1 0.9942334294319153
instability O 1 0.9891504645347595
. O 0 0.06640168279409409

By O 0 0.06493507325649261
analysing O 0 0.15646076202392578
tumour B-Disease 1 0.9992870688438416
DNA O 0 0.10370426625013351
from O 0 0.03895990923047066
patients O 1 0.9938384890556335
with O 0 0.035551730543375015
sporadic B-Disease 1 0.7089255452156067
T I-Disease 1 0.9990468621253967
- I-Disease 1 0.9304388761520386
cell I-Disease 1 0.888011634349823
prolymphocytic I-Disease 1 0.9984917640686035
leukaemia I-Disease 1 0.9999926090240479
( O 1 0.6827930212020874
T B-Disease 1 0.9994947910308838
- I-Disease 1 0.8879961967468262
PLL I-Disease 1 0.9966105818748474
) O 0 0.03482673317193985
, O 0 0.01870013028383255
a O 0 0.02442196011543274
rare O 0 0.07273714244365692
clonal B-Disease 1 0.6806768774986267
malignancy I-Disease 1 0.9933105707168579
with O 0 0.024918682873249054
similarities O 0 0.041031382977962494
to O 0 0.01875651441514492
a O 0 0.03157645836472511
mature B-Disease 0 0.23637518286705017
T I-Disease 1 0.9982917904853821
- I-Disease 1 0.8115952014923096
cell I-Disease 1 0.5800782442092896
leukaemia I-Disease 1 0.9996962547302246
seen O 0 0.04102722182869911
in O 0 0.018523268401622772
A B-Disease 0 0.041697025299072266
- I-Disease 1 0.6868036985397339
T I-Disease 1 0.9894513487815857
, O 0 0.01658490113914013
we O 0 0.011851596646010876
demonstrate O 0 0.025310704484581947
a O 0 0.016927877441048622
high O 0 0.02843189425766468
frequency O 0 0.04599199816584587
of O 0 0.01982184499502182
ATM O 0 0.12712030112743378
mutations O 0 0.14457930624485016
in O 0 0.03846585378050804
T B-Disease 1 0.9909495711326599
- I-Disease 1 0.6934033632278442
PLL I-Disease 1 0.9888534545898438
. O 0 0.07155755162239075

In O 0 0.034842655062675476
marked O 0 0.04522973671555519
contrast O 0 0.038068413734436035
to O 0 0.018093472346663475
the O 0 0.023063594475388527
ATM O 0 0.12654337286949158
mutation O 0 0.14438483119010925
pattern O 0 0.06232002004981041
in O 0 0.022442016750574112
A B-Disease 0 0.04945211485028267
- I-Disease 1 0.7618415951728821
T I-Disease 1 0.9922829270362854
, O 0 0.015505082905292511
the O 0 0.014122008346021175
most O 0 0.018117068335413933
frequent O 0 0.06050572171807289
nucleotide O 0 0.08324415981769562
changes O 0 0.030029835179448128
in O 0 0.019134553149342537
this O 0 0.027785420417785645
leukaemia B-Disease 1 0.9990274906158447
were O 0 0.048213254660367966
missense O 1 0.7081525921821594
mutations O 0 0.32286781072616577
. O 0 0.0627015233039856

These O 0 0.031553830951452255
clustered O 0 0.05973518267273903
in O 0 0.013636616058647633
the O 0 0.01305826660245657
region O 0 0.026785150170326233
corresponding O 0 0.024107646197080612
to O 0 0.013694963417947292
the O 0 0.017683567479252815
kinase O 0 0.11544439941644669
domain O 0 0.0346967875957489
, O 0 0.013760771602392197
which O 0 0.0115579254925251
is O 0 0.014142577536404133
highly O 0 0.0282220970839262
conserved O 0 0.048290181905031204
in O 0 0.023201964795589447
ATM O 0 0.11016816645860672
- O 0 0.07615062594413757
related O 0 0.04167778044939041
proteins O 0 0.04945739358663559
in O 0 0.024845551699399948
mouse O 0 0.09931827336549759
, O 0 0.03627261891961098
yeast O 0 0.11911033093929291
and O 0 0.03479698300361633
Drosophila O 0 0.12954935431480408
. O 0 0.054520294070243835

The O 0 0.05292690172791481
resulting O 0 0.09395426511764526
amino O 0 0.10273107886314392
- O 0 0.1146034523844719
acid O 0 0.12083777785301208
substitutions O 0 0.061099179089069366
are O 0 0.017306283116340637
predicted O 0 0.032315123826265335
to O 0 0.015751291066408157
interfere O 0 0.04545088857412338
with O 0 0.025357559323310852
ATP O 0 0.10883397608995438
binding O 0 0.05575057491660118
or O 0 0.03381716087460518
substrate O 0 0.0941886231303215
recognition O 0 0.0657399594783783
. O 0 0.046283058822155

Two O 0 0.03281062841415405
of O 0 0.032468728721141815
seventeen O 0 0.08420991152524948
mutated O 1 0.6641281247138977
T B-Disease 1 0.994491696357727
- I-Disease 0 0.39771559834480286
PLL I-Disease 1 0.9388242959976196
samples O 0 0.059577733278274536
had O 0 0.02593214437365532
a O 0 0.02142702043056488
previously O 0 0.028476392850279808
reported O 0 0.04341727867722511
A B-Disease 0 0.06006971001625061
- I-Disease 1 0.6454178690910339
T I-Disease 1 0.9953106045722961
allele O 0 0.24067676067352295
. O 0 0.06797455996274948

In O 0 0.03641946241259575
contrast O 0 0.055802058428525925
, O 0 0.024346694350242615
no O 0 0.026965763419866562
mutations O 0 0.09422048181295395
were O 0 0.017198441550135612
detected O 0 0.053519319742918015
in O 0 0.018498331308364868
the O 0 0.024886181578040123
p53 O 0 0.13514117896556854
gene O 0 0.08667165786027908
, O 0 0.020111912861466408
suggesting O 0 0.037409260869026184
that O 0 0.017987055703997612
this O 0 0.024528203532099724
tumour B-Disease 1 0.9998555183410645
suppressor O 1 0.7686226963996887
is O 0 0.01954224705696106
not O 0 0.012879165820777416
frequently O 0 0.026938553899526596
altered O 0 0.03816869482398033
in O 0 0.020506398752331734
this O 0 0.032444339245557785
leukaemia B-Disease 1 0.9992401599884033
. O 0 0.06173746660351753

Occasional O 0 0.1956731677055359
missense O 1 0.5994811654090881
mutations O 0 0.16925717890262604
in O 0 0.03290800750255585
ATM O 0 0.07930036634206772
were O 0 0.014457442797720432
also O 0 0.01259773038327694
found O 0 0.020592227578163147
in O 0 0.02506253495812416
tumour B-Disease 1 0.9992840886116028
DNA O 0 0.07790490984916687
from O 0 0.03414060175418854
patients O 1 0.9725635647773743
with O 0 0.032196760177612305
B B-Disease 0 0.4948015809059143
- I-Disease 0 0.48816436529159546
cell I-Disease 0 0.3200940489768982
non I-Disease 0 0.4339081645011902
- I-Disease 1 0.9979842901229858
Hodgkins I-Disease 1 0.9999983310699463
lymphomas I-Disease 1 0.9998944997787476
( O 0 0.07611581683158875
B B-Disease 0 0.1407703012228012
- I-Disease 0 0.08447682112455368
NHL I-Disease 0 0.07729736715555191
) O 0 0.02283981256186962
and O 0 0.01503999438136816
a O 0 0.02784031815826893
B B-Disease 0 0.09003887325525284
- I-Disease 0 0.0921957939863205
NHL I-Disease 0 0.09888283908367157
cell O 0 0.08974900841712952
line O 0 0.052744969725608826
. O 0 0.04399409890174866

The O 0 0.024342751130461693
evidence O 0 0.02100103162229061
of O 0 0.010647506453096867
a O 0 0.01628170721232891
significant O 0 0.023102162405848503
proportion O 0 0.030261637642979622
of O 0 0.015444653108716011
loss O 0 0.07777851819992065
- O 0 0.06121784448623657
of O 0 0.01927364431321621
- O 0 0.07076975703239441
function O 0 0.04870535060763359
mutations O 0 0.08211404085159302
and O 0 0.01325525064021349
a O 0 0.01503201387822628
complete O 0 0.021839169785380363
absence O 0 0.027884582057595253
of O 0 0.009471504017710686
the O 0 0.01212481688708067
normal O 0 0.030509965494275093
copy O 0 0.02521619200706482
of O 0 0.013320834375917912
ATM O 0 0.057708390057086945
in O 0 0.01221820991486311
the O 0 0.012922528199851513
majority O 0 0.02891472540795803
of O 0 0.025467395782470703
mutated O 1 0.8697395920753479
tumours B-Disease 1 0.9996656179428101
establishes O 1 0.7183041572570801
somatic O 1 0.7310190200805664
inactivation O 0 0.2665477395057678
of O 0 0.01938612386584282
this O 0 0.0165419802069664
gene O 0 0.05473075807094574
in O 0 0.017148315906524658
the O 0 0.023194659501314163
pathogenesis O 1 0.9463173151016235
of O 0 0.031074710190296173
sporadic B-Disease 1 0.6265973448753357
T I-Disease 1 0.9982244372367859
- I-Disease 1 0.7216071486473083
PLL I-Disease 1 0.9923031330108643
and O 0 0.02333388663828373
suggests O 0 0.04057195037603378
that O 0 0.018894916400313377
ATM O 0 0.08440975844860077
acts O 0 0.03128436952829361
as O 0 0.021863548085093498
a O 0 0.04095302149653435
tumour B-Disease 1 0.9997841715812683
suppressor O 1 0.9475730061531067
. O 0 0.0649782046675682

As O 0 0.03293299674987793
constitutional O 0 0.038064781576395035
DNA O 0 0.048527877777814865
was O 0 0.016109563410282135
not O 0 0.009858477860689163
available O 0 0.01336496602743864
, O 0 0.013964781537652016
a O 0 0.026422912254929543
putative O 0 0.12481431663036346
hereditary O 1 0.9610685706138611
predisposition O 1 0.9941317439079285
to O 0 0.04255616292357445
T B-Disease 1 0.9986767172813416
- I-Disease 1 0.8446791172027588
PLL I-Disease 1 0.993553876876831
will O 0 0.026906423270702362
require O 0 0.03332894295454025
further O 0 0.023600656539201736
investigation O 0 0.04188554733991623
. O 0 0.026402128860354424
. O 0 0.03639965131878853

Myotonic B-Disease 1 0.9999936819076538
dystrophy I-Disease 1 0.9999948740005493
protein O 0 0.2820122539997101
kinase O 0 0.35012292861938477
is O 0 0.022557269781827927
involved O 0 0.0213734433054924
in O 0 0.012021840550005436
the O 0 0.015677491202950478
modulation O 0 0.0798095315694809
of O 0 0.01861531473696232
the O 0 0.03493349626660347
Ca2 O 1 0.9835469722747803
+ O 1 0.7504756450653076
homeostasis O 1 0.9214778542518616
in O 0 0.043379735201597214
skeletal O 1 0.9976315498352051
muscle O 1 0.9989967942237854
cells O 1 0.5514023303985596
. O 0 0.055584706366062164

Myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9928887486457825
DM B-Disease 1 0.9999916553497314
) O 0 0.038259148597717285
, O 0 0.015663759782910347
the O 0 0.015788858756422997
most O 0 0.02300298400223255
prevalent O 1 0.9835345149040222
muscular B-Disease 1 0.9999897480010986
disorder I-Disease 1 0.9999788999557495
in O 0 0.026650503277778625
adults O 0 0.07489663362503052
, O 0 0.01586446911096573
is O 0 0.016240188851952553
caused O 0 0.051454365253448486
by O 0 0.022665338590741158
( O 0 0.04551628977060318
CTG O 1 0.8975058197975159
) O 0 0.038040585815906525
n O 0 0.06823092699050903
- O 0 0.06922909617424011
repeat O 0 0.07472892850637436
expansion O 0 0.04408073425292969
in O 0 0.01883802004158497
a O 0 0.03016105480492115
gene O 0 0.08634155243635178
encoding O 0 0.069735087454319
a O 0 0.0459182932972908
protein O 0 0.12800943851470947
kinase O 1 0.8695530891418457
( O 0 0.12106236815452576
DM B-Disease 1 0.9998965263366699
protein O 0 0.1656622439622879
kinase O 1 0.6082848906517029
; O 0 0.05308172106742859
DMPK O 0 0.24229595065116882
) O 0 0.02936272881925106
and O 0 0.016185998916625977
involves O 0 0.040852323174476624
changes O 0 0.02923116646707058
in O 0 0.022910425439476967
cytoarchitecture O 0 0.13062235713005066
and O 0 0.027510883286595345
ion O 0 0.15680085122585297
homeostasis O 1 0.8224843740463257
. O 0 0.05727650970220566

To O 0 0.02973301336169243
obtain O 0 0.03864089027047157
clues O 0 0.04172400012612343
to O 0 0.013312308117747307
the O 0 0.01475860457867384
normal O 0 0.03484106808900833
biological O 0 0.03483470156788826
role O 0 0.02711140364408493
of O 0 0.018112631514668465
DMPK O 0 0.26985445618629456
in O 0 0.02633473463356495
cellular O 0 0.08589335530996323
ion O 0 0.1252336949110031
homeostasis O 0 0.2527156174182892
, O 0 0.017846915870904922
we O 0 0.012042501010000706
have O 0 0.011739930137991905
compared O 0 0.02368512749671936
the O 0 0.02193833701312542
resting O 0 0.1148204579949379
[ O 0 0.11708763986825943
Ca2 O 1 0.9864002466201782
+ O 0 0.25710681080818176
] O 0 0.06697215884923935
i O 0 0.020827176049351692
, O 0 0.012236938811838627
the O 0 0.012801838107407093
amplitude O 0 0.05438407137989998
and O 0 0.018153116106987
shape O 0 0.048903413116931915
of O 0 0.029783910140395164
depolarization O 1 0.9981088638305664
- O 1 0.9862321019172668
induced O 1 0.9984265565872192
Ca2 O 1 0.9950076341629028
+ O 1 0.6486870646476746
transients O 1 0.5108317136764526
, O 0 0.017381446436047554
and O 0 0.010773097164928913
the O 0 0.011803877539932728
content O 0 0.01788686215877533
of O 0 0.016228163614869118
ATP O 0 0.14271026849746704
- O 0 0.0970785990357399
driven O 0 0.0777958407998085
ion O 0 0.12591907382011414
pumps O 0 0.11759845912456512
in O 0 0.03643752634525299
cultured O 0 0.22837942838668823
skeletal O 1 0.9934954643249512
muscle O 1 0.9944086670875549
cells O 0 0.08823486417531967
of O 0 0.02174793742597103
wild O 0 0.05797847732901573
- O 0 0.08145622164011002
type O 0 0.0634835809469223
and O 0 0.03049626015126705
DMPK O 1 0.9871187210083008
[ O 0 0.2328631430864334
- O 1 0.8658453822135925
/ O 1 0.9860739707946777
- O 0 0.3483279049396515
] O 0 0.13134326040744781
knockout O 0 0.1995892971754074
mice O 0 0.31741848587989807
. O 0 0.06203889474272728

In O 0 0.05933872237801552
vitro O 0 0.17544607818126678
- O 0 0.1773119419813156
differentiated O 0 0.20777903497219086
DMPK O 1 0.9926562905311584
[ O 1 0.5659332871437073
- O 1 0.9534507989883423
/ O 1 0.9939423203468323
- O 0 0.2729651927947998
] O 0 0.117185078561306
myotubes O 0 0.15643653273582458
exhibit O 0 0.062039103358983994
a O 0 0.03334316983819008
higher O 0 0.05155176296830177
resting O 0 0.1155392974615097
[ O 0 0.12359374016523361
Ca2 O 1 0.9786398410797119
+ O 0 0.4502808451652527
] O 0 0.07423412054777145
i O 0 0.026061205193400383
than O 0 0.017035283148288727
do O 0 0.023400714620947838
wild O 0 0.04710038751363754
- O 0 0.07296761870384216
type O 0 0.06551927328109741
myotubes O 0 0.0968194231390953
because O 0 0.018055150285363197
of O 0 0.010546726174652576
an O 0 0.013494842685759068
altered O 0 0.03723693639039993
open O 0 0.03457656875252724
probability O 0 0.03893176093697548
of O 0 0.017826667055487633
voltage O 0 0.0798032134771347
- O 0 0.09646067023277283
dependent O 0 0.09649936854839325
l O 1 0.9388325810432434
- O 0 0.3071131706237793
type O 0 0.15193182229995728
Ca2 O 1 0.9681147933006287
+ O 0 0.2082490622997284
and O 0 0.041096076369285583
Na O 1 0.8195574879646301
+ O 0 0.13859279453754425
channels O 0 0.07550015300512314
. O 0 0.04764791205525398

The O 0 0.05796129256486893
mutant O 0 0.15593604743480682
myotubes O 0 0.20449836552143097
exhibit O 0 0.08025241643190384
smaller O 0 0.047557517886161804
and O 0 0.029417507350444794
slower O 0 0.09383050352334976
Ca2 O 1 0.9223916530609131
+ O 0 0.14772121608257294
responses O 0 0.07122432440519333
upon O 0 0.03505522012710571
triggering O 0 0.0976015254855156
by O 0 0.03074415773153305
acetylcholine O 0 0.14760223031044006
or O 0 0.03497668728232384
high O 0 0.045772984623909
external O 0 0.07290644943714142
K O 0 0.1695471853017807
+ O 0 0.14783601462841034
. O 0 0.053488653153181076

In O 0 0.030208999291062355
addition O 0 0.026759542524814606
, O 0 0.015021364204585552
we O 0 0.012452498078346252
observed O 0 0.026174426078796387
that O 0 0.01409669779241085
these O 0 0.02236376516520977
Ca2 O 1 0.9720877408981323
+ O 0 0.4145037531852722
transients O 1 0.7606494426727295
partially O 0 0.07001816481351852
result O 0 0.03421865031123161
from O 0 0.018272025510668755
an O 0 0.019225619733333588
influx O 0 0.06114021688699722
of O 0 0.026360541582107544
extracellular O 0 0.13009406626224518
Ca2 O 1 0.8775957822799683
+ O 0 0.11365819722414017
through O 0 0.030718322843313217
the O 0 0.03016846440732479
l O 1 0.7922828197479248
- O 0 0.16780193150043488
type O 0 0.13286779820919037
Ca2 O 1 0.9117917418479919
+ O 0 0.15703554451465607
channel O 0 0.08868654817342758
. O 0 0.05226563289761543

Neither O 0 0.05437496677041054
the O 0 0.020617805421352386
content O 0 0.026394277811050415
nor O 0 0.028269384056329727
the O 0 0.016836892813444138
activity O 0 0.03911875933408737
of O 0 0.026933416724205017
Na O 1 0.9888486862182617
+ O 1 0.9361433386802673
/ O 1 0.9741168022155762
K O 0 0.2837405502796173
+ O 0 0.3747475743293762
ATPase O 1 0.9233585596084595
and O 0 0.060627445578575134
sarcoplasmic O 1 0.9985230565071106
reticulum O 1 0.996557891368866
Ca2 O 1 0.9957811832427979
+ O 1 0.9251106977462769
- O 0 0.24758480489253998
ATPase O 1 0.7171990871429443
are O 0 0.0313497893512249
affected O 0 0.06320993602275848
by O 0 0.0341218076646328
DMPK O 1 0.7770143151283264
absence O 0 0.08806654065847397
. O 0 0.05424252897500992

In O 0 0.027603207156062126
conclusion O 0 0.034798745065927505
, O 0 0.014588580466806889
our O 0 0.015706636011600494
data O 0 0.01839848980307579
suggest O 0 0.029159685596823692
that O 0 0.015924150124192238
DMPK O 0 0.10934412479400635
is O 0 0.017182618379592896
involved O 0 0.021658752113580704
in O 0 0.014854038134217262
modulating O 0 0.09690479934215546
the O 0 0.01840204745531082
initial O 0 0.03821917623281479
events O 0 0.030729426071047783
of O 0 0.022808855399489403
excitation O 0 0.33821845054626465
- O 0 0.3814208507537842
contraction O 1 0.5651734471321106
coupling O 0 0.13853664696216583
in O 0 0.040660709142684937
skeletal O 1 0.9966796636581421
muscle O 1 0.9958077669143677
. O 0 0.03099541738629341
. O 0 0.03911358118057251

Constitutional O 0 0.14261581003665924
RB1 O 1 0.9988114833831787
- O 1 0.826138436794281
gene O 0 0.21387596428394318
mutations O 0 0.4231214225292206
in O 0 0.03570639342069626
patients O 1 0.994187593460083
with O 0 0.03785518929362297
isolated O 0 0.13418330252170563
unilateral B-Disease 0 0.43706703186035156
retinoblastoma I-Disease 1 0.995400607585907
. O 0 0.06987501680850983

In O 0 0.037118423730134964
most O 0 0.030896930024027824
patients O 1 0.9798656105995178
with O 0 0.033387765288352966
isolated O 0 0.1903337836265564
unilateral B-Disease 1 0.6767951846122742
retinoblastoma I-Disease 1 0.9997513890266418
, O 0 0.04301292821764946
tumor B-Disease 1 0.997108519077301
development O 0 0.031906478106975555
is O 0 0.0216106828302145
initiated O 0 0.050384365022182465
by O 0 0.024840157479047775
somatic O 0 0.14053484797477722
inactivation O 0 0.11999144405126572
of O 0 0.0198935866355896
both O 0 0.02090686932206154
alleles O 0 0.11524257063865662
of O 0 0.027030926197767258
the O 0 0.04633639380335808
RB1 O 1 0.9956896901130676
gene O 0 0.16729013621807098
. O 0 0.061900343745946884

However O 0 0.03072059527039528
, O 0 0.014588623307645321
some O 0 0.010673326440155506
of O 0 0.011273910291492939
these O 0 0.01721321977674961
patients O 1 0.995934247970581
can O 0 0.03542853146791458
transmit O 0 0.12607966363430023
retinoblastoma B-Disease 1 0.9986386895179749
predisposition O 1 0.8224154710769653
to O 0 0.02406308427453041
their O 0 0.026828614994883537
offspring O 0 0.09583640843629837
. O 0 0.051078226417303085

To O 0 0.0223678071051836
determine O 0 0.02509777434170246
the O 0 0.01561450120061636
frequency O 0 0.035288356244564056
and O 0 0.012357299216091633
nature O 0 0.02519083395600319
of O 0 0.015654638409614563
constitutional O 0 0.04591245576739311
RB1 O 1 0.999744713306427
- O 1 0.8706552982330322
gene O 0 0.19909822940826416
mutations O 0 0.42214104533195496
in O 0 0.03593097999691963
patients O 1 0.992070734500885
with O 0 0.032079584896564484
isolated O 0 0.10129722952842712
unilateral B-Disease 0 0.4063566029071808
retinoblastoma I-Disease 1 0.996399998664856
, O 0 0.024936772882938385
we O 0 0.01647590845823288
analyzed O 0 0.037985559552907944
DNA O 0 0.050566013902425766
from O 0 0.02285010926425457
peripheral O 1 0.9432546496391296
blood O 1 0.6542330980300903
and O 0 0.024236928671598434
from O 0 0.03798491135239601
tumor B-Disease 1 0.9996390342712402
tissue O 1 0.9604319930076599
. O 0 0.05234713852405548

The O 0 0.03698790818452835
analysis O 0 0.043864645063877106
of O 0 0.0260159894824028
tumors B-Disease 1 0.9975318908691406
from O 0 0.030042244121432304
54 O 0 0.05640500411391258
( O 0 0.03738245368003845
71 O 0 0.05612878128886223
% O 0 0.027934899553656578
) O 0 0.023811208084225655
of O 0 0.016053728759288788
76 O 0 0.07092735171318054
informative O 0 0.07868340611457825
patients O 1 0.9947149157524109
showed O 0 0.044082581996917725
loss O 0 0.05503233149647713
of O 0 0.021218957379460335
constitutional O 0 0.051937829703092575
heterozygosity O 1 0.9929514527320862
( O 0 0.1238841637969017
LOH O 1 0.9987305998802185
) O 0 0.05463111028075218
at O 0 0.04357380419969559
intragenic O 0 0.2735016644001007
loci O 0 0.19704864919185638
. O 0 0.058665383607149124

Three O 0 0.035092584788799286
of O 0 0.02956232987344265
13 O 0 0.062040768563747406
uninformative O 1 0.9814901947975159
patients O 1 0.9940264225006104
had O 0 0.036490924656391144
constitutional O 0 0.048514388501644135
deletions O 0 0.13226501643657684
. O 0 0.057186026126146317

For O 0 0.03958900645375252
39 O 0 0.060856085270643234
randomly O 0 0.0726807713508606
selected O 0 0.05688990280032158
tumors B-Disease 1 0.9985170960426331
, O 0 0.042849671095609665
SSCP O 1 0.9573363661766052
, O 0 0.0480429008603096
hetero O 1 0.995824933052063
- O 0 0.15032874047756195
duplex O 0 0.2876301109790802
analysis O 0 0.04476294666528702
, O 0 0.018090901896357536
sequencing O 0 0.046237844973802567
, O 0 0.015026316978037357
and O 0 0.013529920019209385
Southern O 0 0.031948525458574295
blot O 0 0.10366212576627731
analysis O 0 0.027246281504631042
were O 0 0.012060975655913353
used O 0 0.016261054202914238
to O 0 0.01735091581940651
identify O 0 0.05438707768917084
mutations O 0 0.13611887395381927
. O 0 0.051055677235126495

Mutations O 0 0.2187163233757019
were O 0 0.037624236196279526
detected O 0 0.08139535039663315
in O 0 0.02379796653985977
21 O 0 0.0363953560590744
( O 0 0.03400048613548279
91 O 0 0.05842290818691254
% O 0 0.028533142060041428
) O 0 0.023208357393741608
of O 0 0.01763567142188549
23 O 0 0.05200069397687912
tumors B-Disease 1 0.9997147917747498
with O 0 0.04784105345606804
LOH O 1 0.998305082321167
. O 0 0.06540609896183014

In O 0 0.03933006897568703
6 O 0 0.04698728024959564
( O 0 0.03708835691213608
38 O 0 0.04253771901130676
% O 0 0.026087524369359016
) O 0 0.023158982396125793
of O 0 0.016187364235520363
16 O 0 0.04196762293577194
tumors B-Disease 1 0.999884843826294
without O 0 0.04480636492371559
LOH O 1 0.9991876482963562
, O 0 0.02253379486501217
one O 0 0.022999132052063942
mutation O 0 0.09820925444364548
was O 0 0.020679796114563942
detected O 0 0.04811883717775345
, O 0 0.01198400929570198
and O 0 0.010024410672485828
in O 0 0.013368235900998116
9 O 0 0.02829139307141304
( O 0 0.024472743272781372
56 O 0 0.03312268108129501
% O 0 0.022958237677812576
) O 0 0.019721517339348793
of O 0 0.013830062001943588
the O 0 0.027657795697450638
tumors B-Disease 1 0.9998743534088135
without O 0 0.041733480989933014
LOH O 1 0.9991937279701233
, O 0 0.02486315183341503
both O 0 0.02374889887869358
mutations O 0 0.0914856418967247
were O 0 0.019156577065587044
found O 0 0.0318509042263031
. O 0 0.041936177760362625

Thus O 0 0.045521482825279236
, O 0 0.016034066677093506
a O 0 0.01653296686708927
total O 0 0.020259035751223564
of O 0 0.015982721000909805
45 O 0 0.04367620870471001
mutations O 0 0.0860433578491211
were O 0 0.01706663891673088
identified O 0 0.031110746785998344
in O 0 0.02667529135942459
tumors B-Disease 1 0.9990000128746033
of O 0 0.02745652198791504
36 O 0 0.07018407434225082
patients O 1 0.9931991696357727
. O 0 0.0484684482216835

Thirty O 0 0.0851624384522438
- O 0 0.061435066163539886
nine O 0 0.026095019653439522
of O 0 0.012797325849533081
the O 0 0.02429567649960518
mutations O 0 0.11637632548809052
- O 0 0.05818242207169533
including O 0 0.021916013211011887
34 O 0 0.045860305428504944
small O 0 0.03455144539475441
mutations O 0 0.10251045227050781
, O 0 0.021319283172488213
2 O 0 0.0287709292024374
large O 0 0.027656564489006996
structural O 0 0.06576528400182724
alterations O 0 0.05917467176914215
, O 0 0.01906478777527809
and O 0 0.02345145121216774
hypermethylation O 1 0.9592171311378479
in O 0 0.030313512310385704
3 O 0 0.05412280932068825
tumors O 1 0.9997981190681458
- O 0 0.06535563617944717
were O 0 0.01664370484650135
not O 0 0.015029634349048138
detected O 0 0.04061344638466835
in O 0 0.01312586572021246
the O 0 0.01830144226551056
corresponding O 0 0.057879067957401276
peripheral O 1 0.8889195919036865
blood O 1 0.5082175135612488
DNA O 0 0.10159137845039368
. O 0 0.05118224397301674

In O 0 0.03811337426304817
6 O 0 0.044323571026325226
( O 0 0.03311336413025856
17 O 0 0.024806998670101166
% O 0 0.021447790786623955
) O 0 0.01586657576262951
of O 0 0.010253923945128918
the O 0 0.01635110005736351
36 O 0 0.04401580989360809
patients O 1 0.9700560569763184
, O 0 0.016820402815937996
a O 0 0.024249929934740067
mutation O 0 0.10003463923931122
was O 0 0.021192781627178192
detected O 0 0.05352194234728813
in O 0 0.013489224947988987
constitutional O 0 0.02169346809387207
DNA O 0 0.0361822247505188
, O 0 0.011031520552933216
and O 0 0.008304375223815441
1 O 0 0.014281101524829865
of O 0 0.009087592363357544
these O 0 0.012916678562760353
mutations O 0 0.0741608515381813
is O 0 0.014229078777134418
known O 0 0.016014443710446358
to O 0 0.010383893735706806
be O 0 0.010016587562859058
associated O 0 0.02345970831811428
with O 0 0.024448847398161888
reduced O 0 0.07760437577962875
expressivity O 1 0.9684247970581055
. O 0 0.06281160563230515

The O 0 0.03357461467385292
presence O 0 0.034650757908821106
of O 0 0.013987716287374496
a O 0 0.0207916758954525
constitutional O 0 0.03218832239508629
mutation O 0 0.09155482798814774
was O 0 0.015483733266592026
not O 0 0.01077952142804861
associated O 0 0.01913798600435257
with O 0 0.01222409401088953
an O 0 0.01524922251701355
early O 0 0.02982712723314762
age O 0 0.033554431051015854
at O 0 0.03491129353642464
treatment O 1 0.8172808289527893
. O 0 0.05028192698955536

In O 0 0.04677145183086395
1 O 0 0.059353820979595184
patient O 1 0.8752560615539551
, O 0 0.039396025240421295
somatic O 0 0.40544769167900085
mosaicism O 1 0.9474027156829834
was O 0 0.025605883449316025
demonstrated O 0 0.039564747363328934
by O 0 0.01640845648944378
molecular O 0 0.04435882344841957
analysis O 0 0.024424122646450996
of O 0 0.013976513408124447
DNA O 0 0.04614606127142906
and O 0 0.021026557311415672
RNA O 0 0.08018746972084045
from O 0 0.03350018709897995
peripheral O 1 0.8942898511886597
blood O 1 0.6505460739135742
. O 0 0.05574489384889603

In O 0 0.04067642614245415
2 O 0 0.05511658638715744
patients O 1 0.9105513095855713
without O 0 0.029269376769661903
a O 0 0.03428780287504196
detectable O 0 0.13784721493721008
mutation O 0 0.20942625403404236
in O 0 0.034846216440200806
peripheral O 1 0.9845027327537537
blood O 1 0.8697067499160767
, O 0 0.03520175814628601
mosaicism O 1 0.9750068783760071
was O 0 0.022788045927882195
suggested O 0 0.027231786400079727
because O 0 0.017126629129052162
1 O 0 0.019122257828712463
of O 0 0.013518418185412884
the O 0 0.023579277098178864
patients O 1 0.9998190999031067
showed O 1 0.7990815043449402
multifocal O 1 0.9999923706054688
tumors B-Disease 1 0.9999066591262817
and O 0 0.014981387183070183
the O 0 0.011864928528666496
other O 0 0.011052379384636879
later O 0 0.018814055249094963
developed O 0 0.04104827716946602
bilateral B-Disease 0 0.06582555174827576
retinoblastoma I-Disease 1 0.9917619228363037
. O 0 0.059806618839502335

In O 0 0.0338265597820282
conclusion O 0 0.038103774189949036
, O 0 0.016173725947737694
our O 0 0.014989825896918774
results O 0 0.02238941565155983
emphasize O 0 0.03207217529416084
that O 0 0.011115532368421555
the O 0 0.01520524825900793
manifestation O 0 0.07434961944818497
and O 0 0.02347421646118164
transmissibility O 1 0.9012441039085388
of O 0 0.024856124073266983
retinoblastoma B-Disease 1 0.9837906956672668
depend O 0 0.030193427577614784
on O 0 0.01135945413261652
the O 0 0.011256888508796692
nature O 0 0.018330343067646027
of O 0 0.009903495199978352
the O 0 0.014336281456053257
first O 0 0.020776497200131416
mutation O 0 0.0779094398021698
, O 0 0.012281318195164204
its O 0 0.010287406854331493
time O 0 0.012242383323609829
in O 0 0.009403382427990437
development O 0 0.016134673729538918
, O 0 0.009130941703915596
and O 0 0.006789279170334339
the O 0 0.008655969984829426
number O 0 0.009630458429455757
and O 0 0.010906025767326355
types O 0 0.022683506831526756
of O 0 0.012811947613954544
cells O 0 0.04842940345406532
that O 0 0.012481014244258404
are O 0 0.012996772304177284
affected O 0 0.04615044966340065
. O 0 0.024730244651436806
. O 0 0.031651079654693604

Hereditary B-Disease 1 0.9985018968582153
deficiency I-Disease 1 0.9998924732208252
of I-Disease 0 0.02288408949971199
the I-Disease 0 0.018502501770853996
fifth I-Disease 0 0.039180804044008255
component I-Disease 0 0.03856775164604187
of I-Disease 0 0.014561488293111324
complement I-Disease 0 0.04502085968852043
in O 0 0.02049732208251953
man O 0 0.04625747352838516
. O 0 0.03979584574699402

I O 0 0.08917314559221268
. O 0 0.052361853420734406

Clinical O 1 0.9096751809120178
, O 0 0.03681965544819832
immunochemical O 0 0.130825012922287
, O 0 0.019704312086105347
and O 0 0.015916449949145317
family O 0 0.03175509721040726
studies O 0 0.04844997823238373
. O 0 0.04261816293001175

The O 0 0.029367372393608093
first O 0 0.02371709607541561
recognized O 0 0.036932069808244705
human O 0 0.03871787339448929
kindred O 1 0.9872592091560364
with O 0 0.03940989077091217
hereditary B-Disease 1 0.9987425208091736
deficiency I-Disease 1 0.9999548196792603
of I-Disease 0 0.019883552566170692
the I-Disease 0 0.018141262233257294
fifth I-Disease 0 0.03683675080537796
component I-Disease 0 0.046451386064291
of I-Disease 0 0.020134083926677704
complement I-Disease 0 0.06416936218738556
( O 0 0.049043748527765274
C5 O 1 0.6678247451782227
) O 0 0.03472260385751724
is O 0 0.022216325625777245
described O 0 0.04203399270772934
. O 0 0.03765532001852989

The O 0 0.045452315360307693
proband O 0 0.13089966773986816
, O 0 0.024519039317965508
a O 0 0.022010788321495056
20 O 0 0.028157174587249756
- O 0 0.05306967347860336
year O 0 0.027540305629372597
- O 0 0.06372345238924026
old O 0 0.03935492783784866
black O 0 0.061640381813049316
female O 0 0.0897379219532013
with O 0 0.4590104818344116
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999998807907104
since O 0 0.07750273495912552
age O 0 0.05285291746258736
11 O 0 0.03914138674736023
, O 0 0.028684299439191818
lacked O 0 0.4402729272842407
serum O 1 0.9994363188743591
hemolytic O 1 0.9999884366989136
complement O 0 0.09300779551267624
activity O 0 0.05369918793439865
, O 0 0.02096441574394703
even O 0 0.023959927260875702
during O 0 0.042347826063632965
remission O 1 0.9887352585792542
. O 0 0.04975699633359909

C5 O 1 0.6615769863128662
was O 0 0.04701772704720497
undetectable O 0 0.17407485842704773
in O 0 0.025358054786920547
her O 0 0.03382687643170357
serum O 0 0.14234782755374908
by O 0 0.02262742817401886
both O 0 0.023547077551484108
immunodiffusion O 1 0.8380339741706848
and O 0 0.0415400005877018
hemolytic O 1 0.999950647354126
assays O 0 0.16509126126766205
. O 0 0.05900562182068825

Other O 0 0.0315449982881546
complement O 0 0.060797687619924545
components O 0 0.038242653012275696
were O 0 0.018600987270474434
normal O 0 0.04936935752630234
during O 0 0.04289133846759796
remission O 1 0.9976282715797424
of O 0 0.03844810277223587
lupus O 1 0.9999966621398926
, O 0 0.03304992988705635
but O 0 0.030310189351439476
C1 O 1 0.9974802136421204
, O 0 0.03592384606599808
C4 O 1 0.6550667881965637
, O 0 0.03274495527148247
C2 O 1 0.9940887689590454
, O 0 0.02469780296087265
and O 0 0.02529904991388321
C3 O 1 0.9884418249130249
levels O 0 0.06896626204252243
fell O 0 0.06753650307655334
during O 0 0.061220377683639526
exacerbations O 1 0.9976795315742493
. O 0 0.06593761593103409

A O 0 0.05254172906279564
younger O 0 0.062242940068244934
half O 0 0.040909167379140854
- O 0 0.0732865184545517
sister O 0 0.046510666608810425
, O 0 0.01664379984140396
who O 0 0.018011977896094322
had O 0 0.01848323456943035
no O 0 0.021022403612732887
underlying O 0 0.49909868836402893
disease O 1 0.9996790885925293
, O 0 0.01686406508088112
was O 0 0.013485481031239033
also O 0 0.01226290874183178
found O 0 0.018225226551294327
to O 0 0.017872795462608337
lack O 0 0.05247468128800392
immunochemically O 1 0.6640743017196655
detectable O 0 0.2859953045845032
C5 O 1 0.8433966636657715
. O 0 0.06899265944957733

By O 0 0.09532211720943451
hemolytic O 1 0.9998400211334229
assay O 0 0.18515165150165558
, O 0 0.03323674947023392
she O 0 0.029788441956043243
exhibited O 0 0.04890652745962143
1 O 0 0.03064003400504589
- O 0 0.05009165033698082
2 O 0 0.025260981172323227
% O 0 0.021380826830863953
of O 0 0.011008299887180328
the O 0 0.018092907965183258
normal O 0 0.06360115110874176
serum O 1 0.8610062003135681
C5 O 1 0.574069082736969
level O 0 0.0374596044421196
and O 0 0.0161318127065897
normal O 0 0.0406636968255043
concentrations O 0 0.05689823254942894
of O 0 0.01273831445723772
other O 0 0.014075109735131264
complement O 0 0.0506497323513031
components O 0 0.04936513677239418
. O 0 0.0450291745364666

C5 O 1 0.7003500461578369
levels O 0 0.056925661861896515
of O 0 0.014357097446918488
other O 0 0.01274641789495945
family O 0 0.019376423209905624
members O 0 0.013543318025767803
were O 0 0.011221088469028473
either O 0 0.018282834440469742
normal O 0 0.030508074909448624
or O 0 0.020859310403466225
approximately O 0 0.028117457404732704
half O 0 0.026537558063864708
- O 0 0.05413580685853958
normal O 0 0.042438652366399765
, O 0 0.01959454081952572
consistent O 0 0.035854488611221313
with O 0 0.028087399899959564
autosomal O 1 0.992950439453125
codominant O 1 0.7842484712600708
inheritance O 0 0.08546075969934464
of O 0 0.021641863510012627
the O 0 0.0330968014895916
gene O 0 0.15573260188102722
determining O 0 0.18321378529071808
C5 B-Disease 1 0.9999526739120483
deficiency I-Disease 1 0.9999953508377075
. O 0 0.08655514568090439

Normal O 1 0.6064009070396423
hemolytic O 1 0.9999442100524902
titers O 1 0.923782229423523
were O 0 0.029545729979872704
restored O 0 0.034649256616830826
to O 0 0.01832411251962185
both O 0 0.028823530301451683
homozygous O 0 0.4584070146083832
C5 B-Disease 1 0.9998213648796082
- I-Disease 1 0.985272228717804
deficient I-Disease 1 0.9991644620895386
( O 0 0.08755338191986084
C5D B-Disease 1 0.9980698227882385
) O 0 0.04260239005088806
sera O 0 0.07546680420637131
by O 0 0.0163677129894495
addition O 0 0.019535686820745468
of O 0 0.01644984446465969
highly O 0 0.04544532671570778
purified O 0 0.11762414127588272
human O 0 0.07945065945386887
C5 O 1 0.7776147723197937
. O 0 0.06590699404478073

In O 0 0.04777778685092926
specific O 0 0.059452131390571594
C5 O 1 0.9803865551948547
titrations O 1 0.9726619124412537
, O 0 0.019573304802179337
however O 0 0.012863626703619957
, O 0 0.009683778509497643
it O 0 0.007974441163241863
was O 0 0.009539770893752575
noted O 0 0.01404163334518671
that O 0 0.009016809985041618
when O 0 0.015190502628684044
limited O 0 0.02256513573229313
amounts O 0 0.025574760511517525
of O 0 0.01720266416668892
C5 O 0 0.1284446120262146
were O 0 0.016042133793234825
assayed O 0 0.06148538365960121
in O 0 0.013942095451056957
the O 0 0.01414332166314125
presence O 0 0.0283568874001503
of O 0 0.017437949776649475
low O 0 0.057610925287008286
dilutions O 1 0.5942384004592896
of O 0 0.024878958240151405
either O 0 0.04347458481788635
C5D B-Disease 1 0.9973917007446289
serum O 1 0.9070687294006348
, O 0 0.029927778989076614
curving O 0 0.08122138679027557
rather O 0 0.028325790539383888
than O 0 0.024599559605121613
linear O 0 0.07760319113731384
dose O 1 0.9808743596076965
- O 0 0.09395560622215271
response O 0 0.0511384941637516
plots O 0 0.03856809064745903
were O 0 0.014731409028172493
consistently O 0 0.028765760362148285
obtained O 0 0.023044230416417122
, O 0 0.017959918826818466
suggesting O 0 0.04397725686430931
some O 0 0.027609026059508324
inhibitory O 0 0.1955704391002655
effect O 0 0.08050090074539185
. O 0 0.04558486491441727

Further O 0 0.05363840609788895
studies O 0 0.052408162504434586
suggested O 0 0.03764067962765694
that O 0 0.020969750359654427
low O 0 0.06962083280086517
dilutions O 1 0.9052225947380066
of O 0 0.04311471804976463
C5D B-Disease 1 0.9969996809959412
serum O 1 0.8676411509513855
contain O 0 0.044891610741615295
a O 0 0.03045656718313694
factor O 0 0.05467481538653374
( O 0 0.029643448069691658
or O 0 0.02251715399324894
factors O 0 0.038443490862846375
) O 0 0.024907195940613747
interfering O 0 0.044612836092710495
at O 0 0.01881694234907627
some O 0 0.012208960019052029
step O 0 0.026339881122112274
in O 0 0.017366109415888786
the O 0 0.03384466469287872
hemolytic O 1 0.9999179840087891
assay O 0 0.13032007217407227
of O 0 0.0299348384141922
C5 O 0 0.4398663640022278
, O 0 0.018142636865377426
rather O 0 0.01750010997056961
than O 0 0.014966487884521484
a O 0 0.021449698135256767
true O 0 0.04680613428354263
C5 O 1 0.9640081524848938
inhibitor O 1 0.9730351567268372
or O 0 0.05742618441581726
inactivator O 0 0.35940995812416077
. O 0 0.056044261902570724

Of O 0 0.036034662276506424
clinical O 0 0.10539275407791138
interest O 0 0.02569144405424595
are O 0 0.011775089427828789
( O 0 0.02080381289124489
a O 0 0.013932951726019382
) O 0 0.015324375592172146
the O 0 0.011966775171458721
documentation O 0 0.034505695104599
of O 0 0.026055125519633293
membranous O 1 0.9999480247497559
glomerulonephritis B-Disease 1 0.9999973773956299
, O 0 0.12998180091381073
vasculitis B-Disease 1 0.9999914169311523
, O 0 0.03158019483089447
and O 0 0.02591758966445923
arthritis B-Disease 1 0.9999985694885254
in O 0 0.01798749901354313
an O 0 0.017652176320552826
individual O 0 0.032544102519750595
lacking O 0 0.07172928750514984
C5 O 1 0.8907128572463989
( O 0 0.027732281014323235
and O 0 0.013606395572423935
its O 0 0.018193159252405167
biologic O 0 0.10657680779695511
functions O 0 0.024365635588765144
) O 0 0.021711422130465508
, O 0 0.012957810424268246
and O 0 0.015139911323785782
( O 0 0.028399504721164703
b O 0 0.05155178904533386
) O 0 0.0226144939661026
a O 0 0.01978934183716774
remarkable O 0 0.04503675177693367
propensity O 1 0.6001373529434204
to O 0 0.036550816148519516
bacterial B-Disease 1 0.9999206066131592
infections I-Disease 1 0.999953031539917
in O 0 0.023868128657341003
the O 0 0.021457510069012642
proband O 0 0.25475597381591797
, O 0 0.0145998140797019
even O 0 0.015375589020550251
during O 0 0.01955643855035305
periods O 0 0.037126995623111725
of O 0 0.016725657507777214
low O 0 0.0541069321334362
- O 0 0.10371870547533035
dose O 1 0.7865056395530701
or O 0 0.03615425154566765
alternate O 0 0.05955415219068527
- O 0 0.22546197474002838
day O 0 0.07085470855236053
corticosteroid O 1 0.9997158646583557
therapy O 1 0.9979116320610046
. O 0 0.05958960950374603

Other O 0 0.0278144683688879
observations O 0 0.04608556628227234
indicate O 0 0.03234288468956947
that O 0 0.013838877901434898
the O 0 0.01799534074962139
C5D B-Disease 1 0.707429051399231
state O 0 0.017302097752690315
is O 0 0.014825497753918171
compatible O 0 0.032229840755462646
with O 0 0.022516852244734764
normal O 0 0.06488919258117676
coagulation O 1 0.5343095064163208
function O 0 0.03604833409190178
and O 0 0.011635960079729557
the O 0 0.01268672663718462
capacity O 0 0.023823294788599014
to O 0 0.02009524777531624
mount O 0 0.06983967125415802
a O 0 0.05794450268149376
neutrophilic O 1 0.9988904595375061
leukocytosis O 1 0.9990465044975281
during O 0 0.30287912487983704
pyogenic B-Disease 1 0.9997227787971497
infection I-Disease 1 0.9997573494911194
. O 0 0.05284867063164711
. O 0 0.051484137773513794

Susceptibility O 1 0.9923227429389954
to O 0 0.10080990940332413
ankylosing B-Disease 1 0.9999921321868896
spondylitis I-Disease 1 0.999995231628418
in O 0 0.045668959617614746
twins O 0 0.1012638509273529
: O 0 0.02294778823852539
the O 0 0.012416660785675049
role O 0 0.021025417372584343
of O 0 0.015761790797114372
genes O 0 0.06334823369979858
, O 0 0.02424801141023636
HLA O 1 0.9934679865837097
, O 0 0.015672193840146065
and O 0 0.012324904091656208
the O 0 0.01654975302517414
environment O 0 0.04370952397584915
. O 0 0.04077528044581413

OBJECTIVE O 0 0.05901492387056351
To O 0 0.017951171845197678
determine O 0 0.025235503911972046
the O 0 0.01790612004697323
relative O 0 0.04488000273704529
effects O 0 0.06209798529744148
of O 0 0.016841484233736992
genetic O 0 0.05936197191476822
and O 0 0.01839202456176281
environmental O 0 0.036722056567668915
factors O 0 0.042617250233888626
in O 0 0.02659674920141697
susceptibility O 1 0.9960241317749023
to O 0 0.05456821620464325
ankylosing B-Disease 1 0.9999983310699463
spondylitis I-Disease 1 0.9999979734420776
( O 0 0.0698070377111435
AS B-Disease 0 0.03573763370513916
) O 0 0.03717629238963127
. O 0 0.035910315811634064

METHODS O 0 0.09101055562496185
Twins O 0 0.10974689573049545
with O 0 0.023962771520018578
AS B-Disease 0 0.020439524203538895
were O 0 0.011915774084627628
identified O 0 0.021685680374503136
from O 0 0.013816099613904953
the O 0 0.014131969772279263
Royal O 0 0.04146655648946762
National O 0 0.039323288947343826
Hospital O 1 0.9969881176948547
for O 0 0.04946890100836754
Rheumatic B-Disease 1 0.9999991655349731
Diseases I-Disease 1 0.999933123588562
database O 0 0.08875308185815811
. O 0 0.05235888063907623

Clinical O 1 0.8365752100944519
and O 0 0.03978414833545685
radiographic O 1 0.8251778483390808
examinations O 0 0.07200886309146881
were O 0 0.017619024962186813
performed O 0 0.02822590433061123
to O 0 0.015877740457654
establish O 0 0.041784923523664474
diagnoses O 1 0.9988571405410767
, O 0 0.028233911842107773
and O 0 0.03362399339675903
disease O 1 0.9999680519104004
severity O 1 0.9834113717079163
was O 0 0.021270200610160828
assessed O 0 0.042532723397016525
using O 0 0.02154165878891945
a O 0 0.021181397140026093
combination O 0 0.05285922810435295
of O 0 0.020535647869110107
validated O 0 0.06488218903541565
scoring O 0 0.05019292235374451
systems O 0 0.05828322097659111
. O 0 0.045563314110040665

HLA O 1 0.9899656772613525
typing O 0 0.18309833109378815
for O 0 0.05518537387251854
HLA O 1 0.9990379810333252
- O 0 0.4651637673377991
B27 O 1 0.7491119503974915
, O 0 0.050876956433057785
HLA O 1 0.9991629123687744
- O 0 0.15137141942977905
B60 O 0 0.17122650146484375
, O 0 0.032830022275447845
and O 0 0.03086872026324272
HLA O 1 0.9990345239639282
- O 0 0.1692735105752945
DR1 O 1 0.8306059241294861
was O 0 0.030668875202536583
performed O 0 0.04105708375573158
by O 0 0.029433464631438255
polymerase O 0 0.13154153525829315
chain O 0 0.08435512334108353
reaction O 0 0.06592956930398941
with O 0 0.02143998257815838
sequence O 0 0.04336218908429146
- O 0 0.05433780699968338
specific O 0 0.03192843869328499
primers O 0 0.09023459255695343
, O 0 0.02141718380153179
and O 0 0.019688863307237625
zygosity O 0 0.11063552647829056
was O 0 0.02549085021018982
assessed O 0 0.058754388242959976
using O 0 0.04206293448805809
microsatellite O 0 0.3823666572570801
markers O 0 0.13388246297836304
. O 0 0.05631692707538605

Genetic O 0 0.13001441955566406
and O 0 0.030504746362566948
environmental O 0 0.04852801561355591
variance O 0 0.05371807515621185
components O 0 0.029686501249670982
were O 0 0.014752283692359924
assessed O 0 0.03194291889667511
with O 0 0.014532559551298618
the O 0 0.01591387204825878
program O 0 0.0396667942404747
Mx O 0 0.19079965353012085
, O 0 0.013940076343715191
using O 0 0.013090211898088455
data O 0 0.01201398205012083
from O 0 0.009310263209044933
this O 0 0.007819173857569695
and O 0 0.008336893282830715
previous O 0 0.015887079760432243
studies O 0 0.02091684564948082
of O 0 0.013071412220597267
twins O 0 0.06696493923664093
with O 0 0.019828462973237038
AS B-Disease 0 0.032218728214502335
. O 0 0.03976287320256233

RESULTS O 0 0.06973912566900253
Six O 0 0.03289295732975006
of O 0 0.024171466007828712
8 O 0 0.0564899668097496
monozygotic O 1 0.9868500232696533
( O 0 0.0847935676574707
MZ O 1 0.9983968138694763
) O 0 0.06335388869047165
twin O 0 0.1258663535118103
pairs O 0 0.08137284964323044
were O 0 0.036176566034555435
disease O 1 0.9990973472595215
concordant O 0 0.23502670228481293
, O 0 0.025663187727332115
compared O 0 0.028252504765987396
with O 0 0.015529805794358253
4 O 0 0.023078108206391335
of O 0 0.01398966833949089
15 O 0 0.03553222119808197
B27 O 0 0.2191978096961975
- O 0 0.1241784319281578
positive O 0 0.0915522426366806
dizygotic O 1 0.9880819320678711
( O 0 0.08227293193340302
DZ O 1 0.9899298548698425
) O 0 0.04835443198680878
twin O 0 0.08942439407110214
pairs O 0 0.05704377219080925
( O 0 0.0367901436984539
27 O 0 0.03387140482664108
% O 0 0.02435532584786415
) O 0 0.017518961802124977
and O 0 0.011599170975387096
4 O 0 0.023138338699936867
of O 0 0.01619640551507473
32 O 0 0.05440085008740425
DZ O 1 0.9804365038871765
twin O 0 0.11240346729755402
pairs O 0 0.0687534511089325
overall O 0 0.05160851031541824
( O 0 0.034594032913446426
12 O 0 0.026425974443554878
. O 0 0.01687496341764927
5 O 0 0.028021641075611115
% O 0 0.03167664632201195
) O 0 0.03127947077155113
. O 0 0.03661457449197769

Nonsignificant O 1 0.6964370608329773
increases O 0 0.07531701773405075
in O 0 0.021691327914595604
similarity O 0 0.043482404202222824
with O 0 0.016148410737514496
regard O 0 0.03084343858063221
to O 0 0.020177166908979416
age O 0 0.04045213386416435
at O 0 0.04599650949239731
disease O 1 0.9999818801879883
onset O 1 0.9986358284950256
and O 0 0.013797959312796593
all O 0 0.009541322477161884
of O 0 0.012067165225744247
the O 0 0.027198543772101402
disease O 1 0.9999265670776367
severity O 1 0.9885106086730957
scores O 0 0.052569542080163956
assessed O 0 0.04518577829003334
were O 0 0.01501850038766861
noted O 0 0.02457762323319912
in O 0 0.02789159305393696
disease O 1 0.9999573230743408
- O 1 0.9374364614486694
concordant O 1 0.9845422506332397
MZ O 1 0.9994888305664062
twins O 1 0.529741644859314
compared O 0 0.07729080319404602
with O 0 0.04626460373401642
concordant O 1 0.9008183479309082
DZ O 1 0.9956026077270508
twins O 0 0.47834697365760803
. O 0 0.06962180137634277

HLA O 1 0.9990758895874023
- O 0 0.25833743810653687
B27 O 0 0.17839086055755615
and O 0 0.027785664424300194
B60 O 0 0.09897039085626602
were O 0 0.01483688224107027
associated O 0 0.0223983284085989
with O 0 0.016319509595632553
the O 0 0.021046578884124756
disease O 1 0.9988344311714172
in O 0 0.01953669637441635
probands O 0 0.12786538898944855
, O 0 0.012961610220372677
and O 0 0.009392368607223034
the O 0 0.012737222947180271
rate O 0 0.034570083022117615
of O 0 0.0208695400506258
disease O 1 0.9996371269226074
concordance O 0 0.15522335469722748
was O 0 0.022899722680449486
significantly O 0 0.046948324888944626
increased O 0 0.03681987524032593
among O 0 0.038082804530858994
DZ O 1 0.9870907068252563
twin O 0 0.09521172940731049
pairs O 0 0.04512261226773262
in O 0 0.015063554979860783
which O 0 0.014899767935276031
the O 0 0.02016986720263958
co O 0 0.07359649986028671
- O 0 0.0732060894370079
twin O 0 0.07702654600143433
was O 0 0.020467016845941544
positive O 0 0.029847323894500732
for O 0 0.01354910247027874
both O 0 0.020924590528011322
B27 O 0 0.11782556027173996
and O 0 0.03830733895301819
DR1 O 1 0.9713597893714905
. O 0 0.05981024354696274

Additive O 0 0.31727081537246704
genetic O 0 0.1561228185892105
effects O 0 0.09451311826705933
were O 0 0.01905248872935772
estimated O 0 0.02739744819700718
to O 0 0.017822977155447006
contribute O 0 0.04552799090743065
97 O 0 0.05448444187641144
% O 0 0.024248817935585976
of O 0 0.012408816255629063
the O 0 0.018641449511051178
population O 0 0.040423229336738586
variance O 0 0.07776704430580139
. O 0 0.04270603507757187

CONCLUSION O 0 0.10559257864952087
Susceptibility O 0 0.2744497060775757
to O 0 0.019228188320994377
AS B-Disease 0 0.02109832875430584
is O 0 0.013577282428741455
largely O 0 0.024246206507086754
genetically O 0 0.038000233471393585
determined O 0 0.028696922585368156
, O 0 0.012532086111605167
and O 0 0.010718110017478466
the O 0 0.014663082547485828
environmental O 0 0.036645691841840744
trigger O 0 0.07750668376684189
for O 0 0.017054138705134392
the O 0 0.025384221225976944
disease O 1 0.9996548891067505
is O 0 0.031002411618828773
probably O 0 0.047460101544857025
ubiquitous O 0 0.08478216081857681
. O 0 0.045433253049850464

HLA O 1 0.998114824295044
- O 0 0.14691944420337677
B27 O 0 0.1295740157365799
accounts O 0 0.030039571225643158
for O 0 0.013488925993442535
a O 0 0.014162096194922924
minority O 0 0.028909433633089066
of O 0 0.01063226256519556
the O 0 0.016964606940746307
overall O 0 0.05352381244301796
genetic O 0 0.0984843298792839
susceptibility O 1 0.6795030236244202
to O 0 0.024762898683547974
AS B-Disease 0 0.035805750638246536
. O 0 0.04203500226140022

Cell O 0 0.23941710591316223
cycle O 0 0.1514054834842682
- O 0 0.10957660526037216
dependent O 0 0.08868531882762909
colocalization O 0 0.13756676018238068
of O 0 0.030311090871691704
BARD1 O 0 0.3663131892681122
and O 0 0.03431013971567154
BRCA1 O 1 0.86534583568573
proteins O 0 0.06278809159994125
in O 0 0.025983601808547974
discrete O 0 0.06621512770652771
nuclear O 0 0.060713332146406174
domains O 0 0.08233187347650528
. O 0 0.05216548219323158

Germ O 1 0.9880288243293762
- O 0 0.1522814780473709
line O 0 0.0644659474492073
mutations O 0 0.12097355723381042
of O 0 0.023245736956596375
the O 0 0.03748230263590813
BRCA1 O 1 0.9935850501060486
gene O 0 0.27435651421546936
predispose O 1 0.8891569375991821
women O 0 0.04836459457874298
to O 0 0.026369059458374977
early O 0 0.06580793112516403
- O 1 0.9994788765907288
onset O 1 0.9999960660934448
breast B-Disease 1 0.9999986886978149
and I-Disease 1 0.9384605288505554
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999932050704956
by O 0 0.029977556318044662
compromising O 0 0.07295940071344376
the O 0 0.030048776417970657
genes O 0 0.09392081201076508
presumptive O 0 0.42489662766456604
function O 0 0.05088535323739052
as O 0 0.02646181359887123
a O 0 0.050359949469566345
tumor B-Disease 1 0.9981415271759033
suppressor O 1 0.880869448184967
. O 0 0.06155196577310562

Although O 0 0.0401979498565197
the O 0 0.02733656018972397
biochemical O 0 0.08935817331075668
properties O 0 0.045453064143657684
of O 0 0.024568285793066025
BRCA1 O 1 0.9306477904319763
polypeptides O 0 0.09763632714748383
are O 0 0.014259174466133118
not O 0 0.012594124302268028
understood O 0 0.02481449395418167
, O 0 0.011446410790085793
their O 0 0.013173647224903107
expression O 0 0.0408698208630085
pattern O 0 0.05430207774043083
and O 0 0.02131113037467003
subcellular O 0 0.09689589589834213
localization O 0 0.07841300964355469
suggest O 0 0.037578035145998
a O 0 0.01903528906404972
role O 0 0.02780524268746376
in O 0 0.021323762834072113
cell O 0 0.09867295622825623
- O 0 0.12465504556894302
cycle O 0 0.11385367065668106
regulation O 0 0.0842769667506218
. O 0 0.0470854714512825

When O 0 0.06397561728954315
resting O 0 0.13493125140666962
cells O 0 0.11803974211215973
are O 0 0.02771376073360443
induced O 1 0.6788235306739807
to O 0 0.023854438215494156
proliferate O 0 0.07853098958730698
, O 0 0.018307415768504143
the O 0 0.01762574538588524
steady O 0 0.04871444031596184
- O 0 0.04887179285287857
state O 0 0.021686004474759102
levels O 0 0.03909098729491234
of O 0 0.02252049930393696
BRCA1 O 1 0.9101417064666748
increase O 0 0.03823108226060867
in O 0 0.01854030415415764
late O 0 0.03837541490793228
G1 O 0 0.15557363629341125
and O 0 0.020178062841296196
reach O 0 0.03248422592878342
a O 0 0.024793250486254692
maximum O 0 0.0448470339179039
during O 0 0.03763556480407715
S O 0 0.14188633859157562
phase O 0 0.099429190158844
. O 0 0.05077911540865898

Moreover O 0 0.07932544499635696
, O 0 0.02753339894115925
in O 0 0.027339020743966103
S O 0 0.498016357421875
phase O 0 0.11993669718503952
cells O 0 0.11219583451747894
, O 0 0.04005506634712219
BRCA1 O 1 0.9624107480049133
polypeptides O 0 0.12398269027471542
are O 0 0.026751719415187836
hyperphosphorylated O 0 0.11514777690172195
and O 0 0.02638290449976921
accumulate O 0 0.09376688301563263
into O 0 0.03561314940452576
discrete O 0 0.1041824147105217
subnuclear O 0 0.48328495025634766
foci O 0 0.4930657148361206
termed O 0 0.12671789526939392
" O 0 0.06412587314844131
BRCA1 O 1 0.9647893309593201
nuclear O 0 0.10264178365468979
dots O 0 0.14806349575519562
. O 0 0.05635715648531914

" O 0 0.097732774913311
BRCA1 O 1 0.9821674823760986
associates O 0 0.3216667175292969
in O 0 0.030168652534484863
vivo O 0 0.10433945059776306
with O 0 0.023563766852021217
a O 0 0.0316833071410656
structurally O 0 0.10069767385721207
related O 0 0.05660141631960869
protein O 0 0.0940343514084816
termed O 0 0.12672850489616394
BARD1 O 1 0.8916136622428894
. O 0 0.052659403532743454

Here O 0 0.03304172307252884
we O 0 0.01671552285552025
show O 0 0.01799103431403637
that O 0 0.010250208899378777
the O 0 0.015913736075162888
steady O 0 0.05179298669099808
- O 0 0.053095389157533646
state O 0 0.01966903917491436
levels O 0 0.03564950451254845
of O 0 0.01682584546506405
BARD1 O 0 0.1783607453107834
, O 0 0.018372703343629837
unlike O 0 0.022370386868715286
those O 0 0.0125892274081707
of O 0 0.015612048096954823
BRCA1 O 1 0.9718605875968933
, O 0 0.021039437502622604
remain O 0 0.02569810301065445
relatively O 0 0.0339406356215477
constant O 0 0.04811682552099228
during O 0 0.046598322689533234
cell O 0 0.1273118406534195
cycle O 0 0.2337927371263504
progression O 1 0.6775889992713928
. O 0 0.049659986048936844

However O 0 0.04505877196788788
, O 0 0.03207451105117798
immunostaining O 0 0.13736332952976227
revealed O 0 0.05458832532167435
that O 0 0.028102872893214226
BARD1 O 0 0.27644214034080505
resides O 0 0.07752653956413269
within O 0 0.04449504241347313
BRCA1 O 1 0.9393648505210876
nuclear O 0 0.06806343048810959
dots O 0 0.10145732015371323
during O 0 0.04102769121527672
S O 0 0.08572886139154434
phase O 0 0.04878994822502136
of O 0 0.01311575248837471
the O 0 0.01894720271229744
cell O 0 0.06636171042919159
cycle O 0 0.05927174538373947
, O 0 0.012268738821148872
but O 0 0.010340666398406029
not O 0 0.00948017742484808
during O 0 0.018033159896731377
the O 0 0.021882055327296257
G1 O 1 0.9494355916976929
phase O 0 0.10643018782138824
. O 0 0.051985204219818115

Nevertheless O 0 0.09270574897527695
, O 0 0.042159292846918106
BARD1 O 0 0.2295258492231369
polypeptides O 0 0.08969172090291977
are O 0 0.013874544762074947
found O 0 0.015339565463364124
exclusively O 0 0.017255712300539017
in O 0 0.010798687115311623
the O 0 0.013136474415659904
nuclear O 0 0.03063693270087242
fractions O 0 0.03448975086212158
of O 0 0.01220669411122799
both O 0 0.020848821848630905
G1 O 1 0.9858603477478027
- O 0 0.08841607719659805
and O 0 0.030516793951392174
S O 1 0.8119920492172241
- O 0 0.169633686542511
phase O 0 0.14249545335769653
cells O 0 0.14739540219306946
. O 0 0.05258240923285484

Therefore O 0 0.06048325449228287
, O 0 0.03297783434391022
progression O 0 0.11096527427434921
to O 0 0.024775728583335876
S O 0 0.1101331114768982
phase O 0 0.06150748208165169
is O 0 0.018234090879559517
accompanied O 0 0.02691670134663582
by O 0 0.01383000984787941
the O 0 0.018804360181093216
aggregation O 0 0.060912031680345535
of O 0 0.020693989470601082
nuclear O 0 0.05622456222772598
BARD1 O 0 0.29099732637405396
polypeptides O 0 0.12093034386634827
into O 0 0.04692468419671059
BRCA1 O 1 0.9415579438209534
nuclear O 0 0.10488516837358475
dots O 0 0.1616000384092331
. O 0 0.060486290603876114

This O 0 0.04667472094297409
cell O 0 0.11421627551317215
cycle O 0 0.1253407746553421
- O 0 0.09583567082881927
dependent O 0 0.07934631407260895
colocalization O 0 0.13694888353347778
of O 0 0.026751669123768806
BARD1 O 1 0.7671405076980591
and O 0 0.03014528378844261
BRCA1 O 1 0.9591437578201294
indicates O 0 0.05423950403928757
a O 0 0.02112327702343464
role O 0 0.02750718593597412
for O 0 0.022572042420506477
BARD1 O 1 0.8186541199684143
in O 0 0.043852921575307846
BRCA1 O 1 0.9993835687637329
- O 1 0.9884054660797119
mediated O 1 0.9957566857337952
tumor B-Disease 1 0.9995829463005066
suppression O 1 0.6324462890625
. O 0 0.06463093310594559

Ethnic O 0 0.05990969389677048
differences O 0 0.05136767402291298
in O 0 0.030726604163646698
the O 0 0.04391602426767349
HFE O 1 0.9627262949943542
codon O 0 0.23098480701446533
282 O 0 0.4250081777572632
( O 0 0.15079312026500702
Cys O 1 0.999452531337738
/ O 1 0.9896366000175476
Tyr O 1 0.9782485961914062
) O 0 0.07685825973749161
polymorphism O 0 0.17067085206508636
. O 0 0.06670188158750534

Recent O 0 0.06697342544794083
studies O 0 0.04795661196112633
have O 0 0.020616434514522552
shown O 0 0.03682954981923103
that O 0 0.03145531192421913
hereditary B-Disease 1 0.9999502897262573
hemochromatosis I-Disease 1 0.9999998807907104
( O 1 0.9042841196060181
HH B-Disease 1 0.9999600648880005
) O 0 0.03330155462026596
is O 0 0.013199850916862488
likely O 0 0.019599933177232742
to O 0 0.009998238645493984
be O 0 0.011551461182534695
caused O 0 0.043316636234521866
by O 0 0.01912783831357956
homozygosity O 0 0.0915675237774849
for O 0 0.017569968476891518
a O 0 0.030817560851573944
Cys282Tyr O 0 0.18627913296222687
mutation O 0 0.13273143768310547
in O 0 0.02838301658630371
the O 0 0.033648692071437836
HFE O 1 0.9537672400474548
gene O 0 0.11770278960466385
located O 0 0.05835491046309471
4 O 0 0.05614980310201645
. O 0 0.048131633549928665

5 O 0 0.11717298626899719
Mb O 1 0.7062816619873047
telomeric O 1 0.8579422831535339
to O 0 0.0564405620098114
HLA O 1 0.9948670864105225
- O 0 0.11326379328966141
A O 0 0.05532675236463547
. O 0 0.051480863243341446

Population O 0 0.05581030994653702
studies O 0 0.03676663339138031
of O 0 0.013784235343337059
this O 0 0.014954873360693455
polymorphism O 0 0.07490292191505432
are O 0 0.014025541953742504
facilitated O 0 0.041583091020584106
by O 0 0.012256008572876453
the O 0 0.011715199798345566
fact O 0 0.016498617827892303
that O 0 0.012487953528761864
the O 0 0.024517681449651718
Cys282Tyr O 1 0.6773945093154907
mutation O 0 0.43122169375419617
creates O 0 0.08664795756340027
a O 0 0.0432291179895401
Rsal O 0 0.2636266350746155
restriction O 0 0.07244431972503662
site O 0 0.04726504161953926
. O 0 0.04169837757945061

We O 0 0.03209715336561203
have O 0 0.02283191680908203
studied O 0 0.034122198820114136
the O 0 0.029104039072990417
codon O 0 0.14185409247875214
282 O 0 0.1988428235054016
( O 0 0.11541271209716797
Cys O 1 0.9995827078819275
/ O 1 0.9892203211784363
Tyr O 1 0.9690806269645691
) O 0 0.045446254312992096
polymorphism O 0 0.08768109977245331
in O 0 0.015897108241915703
different O 0 0.01502610556781292
ethnic O 0 0.030252069234848022
groups O 0 0.03824527561664581
. O 0 0.046386610716581345

In O 0 0.02879704348742962
agreement O 0 0.024781018495559692
with O 0 0.016718322411179543
previous O 0 0.025335241109132767
observations O 0 0.036928992718458176
the O 0 0.024209266528487206
Tyr O 1 0.862980306148529
allele O 0 0.12517282366752625
appeared O 0 0.034487687051296234
to O 0 0.014712899923324585
be O 0 0.014097705483436584
rare O 0 0.036812733858823776
or O 0 0.02211221680045128
absent O 0 0.05226287245750427
in O 0 0.020733589306473732
Asiatic O 1 0.5346216559410095
( O 0 0.0315442755818367
Indian O 0 0.028357528150081635
, O 0 0.01665891334414482
Chinese O 0 0.02695087529718876
) O 0 0.034533992409706116
populations O 0 0.06532316654920578
. O 0 0.04142984747886658

The O 0 0.04364895075559616
highest O 0 0.07668154686689377
allele O 0 0.16803580522537231
frequency O 0 0.0790201872587204
( O 0 0.03806208819150925
7 O 0 0.028723035007715225
. O 0 0.013617259450256824
5 O 0 0.022544866427779198
% O 0 0.021943984553217888
) O 0 0.017487095668911934
was O 0 0.013669289648532867
found O 0 0.019732734188437462
in O 0 0.020018571987748146
Swedes O 0 0.08852888643741608
. O 0 0.046768952161073685

Saamis O 0 0.43621137738227844
( O 0 0.059578534215688705
2 O 0 0.03585873171687126
% O 0 0.030839959159493446
) O 0 0.02566222846508026
and O 0 0.01832296885550022
Mordvinians O 0 0.11642429977655411
( O 0 0.03074992634356022
1 O 0 0.0219059269875288
. O 0 0.01339181512594223
8 O 0 0.02349628135561943
% O 0 0.025914212688803673
) O 0 0.020661594346165657
had O 0 0.017237551510334015
significantly O 0 0.03502774238586426
lower O 0 0.03508539870381355
frequencies O 0 0.03929615393280983
of O 0 0.015651552006602287
the O 0 0.031039301306009293
Tyr O 1 0.8868162035942078
allele O 0 0.2334071546792984
. O 0 0.06740187853574753

Comparisons O 0 0.0785127803683281
with O 0 0.036079246550798416
allele O 0 0.13457174599170685
frequencies O 0 0.05949454382061958
based O 0 0.026384549215435982
on O 0 0.022092171013355255
prevalence O 1 0.5371103882789612
estimates O 0 0.05380801856517792
of O 0 0.028071366250514984
HH B-Disease 1 0.9996263980865479
showed O 0 0.04148150235414505
some O 0 0.01632862724363804
disagreements O 0 0.036031853407621384
with O 0 0.016363106667995453
the O 0 0.019566552713513374
RFLP O 0 0.1349947601556778
data O 0 0.023128973320126534
, O 0 0.016300061717629433
particularly O 0 0.023254863917827606
in O 0 0.02102953940629959
Finns O 0 0.09374377876520157
. O 0 0.04671701416373253

The O 0 0.0411323606967926
newly O 0 0.06482698768377304
described O 0 0.07741835713386536
HFE O 1 0.9308102130889893
marker O 0 0.09787395596504211
provides O 0 0.03489011898636818
a O 0 0.016641223803162575
new O 0 0.016179105266928673
approach O 0 0.02297581359744072
to O 0 0.010624200105667114
the O 0 0.01394077017903328
screening O 0 0.05504828691482544
of O 0 0.018393030390143394
HH B-Disease 1 0.9985646605491638
as O 0 0.01368009950965643
well O 0 0.011525487527251244
as O 0 0.010757466778159142
studies O 0 0.017933126538991928
of O 0 0.008517635054886341
the O 0 0.012695640325546265
relationship O 0 0.02996770292520523
between O 0 0.020870747044682503
the O 0 0.027222909033298492
HFE O 1 0.9975270628929138
Tyr O 1 0.9909160733222961
allele O 0 0.18911679089069366
and O 0 0.029680287465453148
different O 0 0.03863251209259033
disorders O 1 0.9999064207077026
including O 0 0.07265082746744156
cancer B-Disease 1 0.999842643737793

Autosomal B-Disease 1 0.9983555674552917
dominant I-Disease 1 0.9712490439414978
neurohypophyseal I-Disease 1 0.9994469285011292
diabetes I-Disease 1 0.9999974966049194
insipidus I-Disease 1 0.9998383522033691
associated O 0 0.06547003239393234
with O 0 0.03371921554207802
a O 0 0.05198070406913757
missense O 1 0.6082361340522766
mutation O 0 0.382087767124176
encoding O 0 0.13431482017040253
Gly23 O 1 0.9835927486419678
- O 1 0.8907101154327393
- O 1 0.7631031274795532
> O 1 0.7990283370018005
Val O 1 0.8318744897842407
in O 0 0.047606173902750015
neurophysin O 1 0.5649051070213318
II O 0 0.12248790264129639
. O 0 0.054276399314403534

Autosomal B-Disease 1 0.998855710029602
dominant I-Disease 1 0.9621758460998535
neurohypophyseal I-Disease 1 0.9998134970664978
diabetes I-Disease 1 0.9999985694885254
insipidus I-Disease 1 0.9999691247940063
( O 0 0.18235987424850464
ADNDI B-Disease 1 0.9843124747276306
) O 0 0.03650853410363197
is O 0 0.023917516693472862
an O 0 0.034643933176994324
inherited B-Disease 1 0.9999368190765381
disease I-Disease 1 0.9999986886978149
caused O 1 0.9415035247802734
by O 0 0.03729235753417015
progressive O 1 0.8272770047187805
degeneration O 1 0.9995970129966736
of O 0 0.02250351384282112
the O 0 0.03383108228445053
magnocellular O 1 0.9884577393531799
neurons O 0 0.14126813411712646
of O 0 0.019787879660725594
the O 0 0.024442583322525024
hypothalamus O 0 0.1573399305343628
leading O 0 0.0342482291162014
to O 0 0.018395666033029556
decreased O 0 0.04795941337943077
ability O 0 0.02957814745604992
to O 0 0.0161698330193758
produce O 0 0.02976478822529316
the O 0 0.0290821585804224
hormone O 1 0.8355237245559692
arginine O 1 0.575527012348175
vasopressin O 1 0.9786261320114136
( O 0 0.08288802951574326
AVP O 1 0.9843144416809082
) O 0 0.05599566921591759
. O 0 0.04844352975487709

Affected O 0 0.0942721739411354
individuals O 0 0.03701872006058693
are O 0 0.016455870121717453
not O 0 0.019193828105926514
symptomatic O 1 0.9950926303863525
at O 0 0.027365710586309433
birth O 0 0.039459723979234695
, O 0 0.015346206724643707
but O 0 0.017354102805256844
usually O 0 0.03808322176337242
develop O 1 0.6071532368659973
diabetes B-Disease 1 0.9999929666519165
insipidus I-Disease 1 0.9999033212661743
at O 0 0.047569241374731064
1 O 0 0.04503552243113518
- O 0 0.08647569268941879
6 O 0 0.058144886046648026
yr O 0 0.3255419433116913
of O 0 0.02719329111278057
age O 0 0.05178774148225784
. O 0 0.04412643238902092

The O 0 0.04494204744696617
genetic O 0 0.09250352531671524
locus O 0 0.10152807086706161
of O 0 0.01957310363650322
the O 0 0.02534954808652401
disease O 1 0.9990100860595703
is O 0 0.023700037971138954
the O 0 0.0265771746635437
AVP O 1 0.9978183507919312
- O 1 0.8234285116195679
neurophysin O 1 0.9749653935432434
II O 0 0.240618035197258
( O 0 0.05724390223622322
NPII O 1 0.7790579795837402
) O 0 0.03687230870127678
gene O 0 0.061516281217336655
, O 0 0.017216647043824196
and O 0 0.018210912123322487
mutations O 0 0.11697139590978622
that O 0 0.02147490903735161
cause O 0 0.13682425022125244
ADNDI B-Disease 1 0.5405937433242798
have O 0 0.013835045509040356
been O 0 0.009953051805496216
found O 0 0.01170669961720705
in O 0 0.009523961693048477
both O 0 0.009726302698254585
the O 0 0.013234063051640987
signal O 0 0.04412529990077019
peptide O 0 0.07011303305625916
of O 0 0.015631509944796562
the O 0 0.0246408861130476
prepro O 1 0.8262720704078674
- O 1 0.6368595361709595
AVP O 1 0.9943183064460754
- O 0 0.2973199784755707
NPII O 1 0.739356517791748
precursor O 0 0.09764227271080017
and O 0 0.024116473272442818
within O 0 0.033130429685115814
NPII O 0 0.2331114113330841
itself O 0 0.06116580218076706
. O 0 0.051877461373806

An O 0 0.04703209549188614
affected O 0 0.07057058811187744
girl O 0 0.07269871979951859
who O 0 0.024080513045191765
presented O 0 0.02466355822980404
at O 0 0.01901715248823166
9 O 0 0.022694172337651253
months O 0 0.016779227182269096
of O 0 0.010595394298434258
age O 0 0.021156204864382744
and O 0 0.012067073956131935
her O 0 0.02308010682463646
similarly O 0 0.04125441610813141
affected O 0 0.047086603939533234
younger O 0 0.04098636284470558
brother O 0 0.02856839820742607
and O 0 0.011943161487579346
father O 0 0.01823543757200241
were O 0 0.008649932220578194
all O 0 0.0068804072216153145
found O 0 0.011243139393627644
to O 0 0.009105798788368702
have O 0 0.011922590434551239
a O 0 0.021253500133752823
novel O 0 0.05291851609945297
missense O 1 0.5670029520988464
mutation O 1 0.7834891676902771
( O 0 0.07460401952266693
G1758 O 1 0.9548735618591309
- O 1 0.919258177280426
- O 1 0.7806617021560669
> O 1 0.7919431328773499
T O 0 0.33101722598075867
) O 0 0.037163443863391876
encoding O 0 0.051978759467601776
the O 0 0.026967288926243782
amino O 0 0.08124452084302902
acid O 0 0.1573108285665512
substitution O 0 0.12257609516382217
Gly23 O 1 0.9792634844779968
- O 1 0.8103615045547485
- O 1 0.6398775577545166
> O 1 0.7343700528144836
Val O 1 0.7072742581367493
within O 0 0.07503806054592133
NPII O 1 0.5137736797332764
. O 0 0.06330215930938721

The O 0 0.05287583917379379
mutation O 0 0.1484072059392929
was O 0 0.03083527833223343
confirmed O 0 0.04160880669951439
by O 0 0.0250562634319067
restriction O 0 0.07968152314424515
endonuclease O 0 0.24226991832256317
analysis O 0 0.06068778038024902
. O 0 0.04715968295931816

A O 0 0.09698757529258728
T1 O 1 0.9502951502799988
- O 0 0.1351582407951355
weighted O 0 0.0989980399608612
magnetic O 0 0.100343257188797
resonance O 0 0.1078021377325058
imaging O 0 0.09161155670881271
of O 0 0.01809801533818245
the O 0 0.026903575286269188
fathers O 0 0.10838031023740768
pituitary O 1 0.9991732239723206
gland O 1 0.9970411658287048
demonstrates O 0 0.09886443614959717
an O 0 0.04350968822836876
attenuated O 1 0.9798840284347534
posterior O 1 0.9969028830528259
pituitary O 1 0.9996022582054138
bright O 0 0.20864687860012054
spot O 0 0.08113282918930054
. O 0 0.04997369274497032

This O 0 0.0442303866147995
mutation O 0 0.1431993693113327
may O 0 0.030882831662893295
be O 0 0.011816577054560184
valuable O 0 0.019818458706140518
for O 0 0.011532768607139587
developing O 0 0.03465970233082771
models O 0 0.03357209637761116
of O 0 0.02052151970565319
dominantly B-Disease 1 0.8649086356163025
inherited I-Disease 1 0.99583899974823
neurodegeneration I-Disease 1 0.9999008178710938
, O 0 0.022621292620897293
as O 0 0.01187234278768301
the O 0 0.011708956211805344
early O 0 0.023157358169555664
age O 0 0.031094130128622055
of O 0 0.022764034569263458
onset O 1 0.9995754361152649
of O 0 0.030253957957029343
symptoms O 1 0.9999693632125854
suggests O 0 0.050161488354206085
that O 0 0.017381591722369194
this O 0 0.021073516458272934
mutation O 0 0.13207094371318817
may O 0 0.026476848870515823
be O 0 0.013404345139861107
particularly O 0 0.032520901411771774
deleterious O 0 0.1228603646159172
to O 0 0.02713184803724289
the O 0 0.03256151080131531
magnocellular O 1 0.9924494028091431
neuron O 1 0.8539040088653564
. O 0 0.03986189141869545
. O 0 0.046060580760240555

Frequent O 0 0.1935116946697235
inactivation O 1 0.6783445477485657
of O 0 0.060799047350883484
PTEN O 1 0.9992092251777649
/ O 1 0.9957660436630249
MMAC1 O 1 0.9763744473457336
in O 0 0.046591393649578094
primary O 1 0.9265477061271667
prostate B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999912977218628
. O 0 0.06801212579011917

Sporadic B-Disease 1 0.9979713559150696
prostate I-Disease 1 0.9999979734420776
carcinoma I-Disease 1 0.9999959468841553
is O 0 0.0285290889441967
the O 0 0.01544408779591322
most O 0 0.01580171287059784
common O 0 0.03259114548563957
male B-Disease 0 0.08506853878498077
cancer I-Disease 1 0.9993075132369995
in O 0 0.014097101986408234
the O 0 0.012144360691308975
Western O 0 0.020455265417695045
world O 0 0.01599442958831787
, O 0 0.010404405184090137
yet O 0 0.012827867642045021
many O 0 0.007193692959845066
of O 0 0.008181843906641006
the O 0 0.013176140375435352
major O 0 0.02344643883407116
genetic O 0 0.04785596951842308
events O 0 0.024116935208439827
involved O 0 0.01971704140305519
in O 0 0.011739343404769897
the O 0 0.01734260842204094
progression O 0 0.09064169228076935
of O 0 0.015029508620500565
this O 0 0.020516565069556236
often O 0 0.037029191851615906
fatal O 1 0.9998868703842163
cancer B-Disease 1 0.9998177886009216
remain O 0 0.02519918978214264
to O 0 0.015785079449415207
be O 0 0.01724429614841938
elucidated O 0 0.1084456667304039
. O 0 0.042516253888607025

Numerous O 0 0.08183109760284424
cytogenetic O 0 0.42941173911094666
and O 0 0.03475739061832428
allelotype O 0 0.16196288168430328
studies O 0 0.04182983934879303
have O 0 0.021727116778492928
reported O 0 0.041415415704250336
frequent O 0 0.05664386227726936
loss O 0 0.05671132355928421
of O 0 0.02419913560152054
heterozygosity O 1 0.7768663167953491
on O 0 0.03792891651391983
chromosomal O 1 0.6713823676109314
arm O 1 0.634611189365387
10q O 1 0.9315013289451599
in O 0 0.048385005444288254
sporadic B-Disease 1 0.9977335929870605
prostate I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999954700469971
. O 0 0.07669950276613235

Deletion O 0 0.2840452194213867
mapping O 0 0.10576698929071426
studies O 0 0.0532047301530838
have O 0 0.023640554398298264
unambiguously O 0 0.06105227395892143
identified O 0 0.03027018904685974
a O 0 0.022497661411762238
region O 0 0.03234121948480606
of O 0 0.020847080275416374
chromosome O 0 0.11616595089435577
10q23 O 0 0.093866728246212
to O 0 0.014731341041624546
be O 0 0.010067155584692955
the O 0 0.013293418101966381
minimal O 0 0.04264435917139053
area O 0 0.029082968831062317
of O 0 0.01917680911719799
loss O 0 0.07918260991573334
. O 0 0.04810743406414986

A O 0 0.07187239825725555
new O 0 0.07362670451402664
tumor B-Disease 1 0.9980644583702087
suppressor O 1 0.9684757590293884
gene O 0 0.19253665208816528
, O 0 0.06032225862145424
PTEN O 1 0.999686598777771
/ O 1 0.9902759790420532
MMAC1 O 1 0.7949547171592712
, O 0 0.020246347412467003
was O 0 0.018857764080166817
isolated O 0 0.04660253971815109
recently O 0 0.024416044354438782
at O 0 0.01592564582824707
this O 0 0.01014783140271902
region O 0 0.027854466810822487
of O 0 0.017229562625288963
chromosome O 0 0.10982037335634232
10q23 O 0 0.0909423679113388
and O 0 0.015129052102565765
found O 0 0.01574295200407505
to O 0 0.010808797553181648
be O 0 0.012722216546535492
inactivated O 0 0.06817778944969177
by O 0 0.024839134886860847
mutation O 0 0.12431017309427261
in O 0 0.02665325626730919
three O 0 0.04430298134684563
prostate B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999946355819702
cell O 1 0.5846786499023438
lines O 0 0.06662460416555405
. O 0 0.04705439507961273

We O 0 0.057529937475919724
screened O 0 0.13590902090072632
80 O 0 0.15521953999996185
prostate B-Disease 1 0.9999905824661255
tumors I-Disease 1 0.9997702240943909
by O 0 0.03938363119959831
microsatellite O 0 0.2516610622406006
analysis O 0 0.04561624303460121
and O 0 0.020206572487950325
found O 0 0.03198791667819023
chromosome O 0 0.12031864374876022
10q23 O 0 0.08768941462039948
to O 0 0.014287775382399559
be O 0 0.011952945962548256
deleted O 0 0.03882891312241554
in O 0 0.017979154363274574
23 O 0 0.03457146883010864
cases O 0 0.04420459643006325
. O 0 0.04386044293642044

We O 0 0.02902103401720524
then O 0 0.01985332742333412
proceeded O 0 0.035138849169015884
with O 0 0.015044749714434147
sequence O 0 0.03170686587691307
analysis O 0 0.021262845024466515
of O 0 0.012888353317975998
the O 0 0.021424250677227974
entire O 0 0.06049202010035515
PTEN O 1 0.9984418749809265
/ O 1 0.9775656461715698
MMAC1 O 1 0.7548693418502808
coding O 0 0.11468757688999176
region O 0 0.046904515475034714
and O 0 0.01947924867272377
tested O 0 0.04992886260151863
for O 0 0.021205823868513107
homozygous O 0 0.10693807154893875
deletion O 0 0.11478570848703384
with O 0 0.024511193856596947
new O 0 0.030379388481378555
intragenic O 0 0.1215675100684166
markers O 0 0.05375802889466286
in O 0 0.013279896229505539
these O 0 0.011042710393667221
23 O 0 0.02519538439810276
cases O 0 0.030589064583182335
with O 0 0.02394179441034794
10q23 O 0 0.24268223345279694
loss O 0 0.07797401398420334
of O 0 0.037620674818754196
heterozygosity O 1 0.9745336174964905
. O 0 0.06346455961465836

The O 0 0.028134454041719437
identification O 0 0.03399680554866791
of O 0 0.014489940367639065
the O 0 0.01741124503314495
second O 0 0.03738190978765488
mutational O 0 0.4964895248413086
event O 0 0.042134691029787064
in O 0 0.019592082127928734
10 O 0 0.02404828928411007
( O 0 0.032923970371484756
43 O 0 0.04972624406218529
% O 0 0.047591861337423325
) O 0 0.06594130396842957
tumors B-Disease 1 0.9999109506607056
establishes O 1 0.9804727435112
PTEN O 1 0.9997369647026062
/ O 1 0.981307864189148
MMAC1 O 0 0.3156556189060211
as O 0 0.019898714497685432
a O 0 0.02246250957250595
main O 0 0.03128655627369881
inactivation O 0 0.11682510375976562
target O 0 0.04378996789455414
of O 0 0.02199895866215229
10q O 0 0.3922559320926666
loss O 0 0.2437848150730133
in O 0 0.038358744233846664
sporadic B-Disease 1 0.9962397813796997
prostate I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999955892562866
. O 0 0.048189934343099594
. O 0 0.050117239356040955

Risk O 1 0.8877463936805725
reversals O 0 0.16793633997440338
in O 0 0.03757704421877861
predictive O 0 0.13157828152179718
testing O 0 0.08579502254724503
for O 0 0.04304823651909828
Huntington B-Disease 1 0.9999697208404541
disease I-Disease 1 0.9999842643737793
. O 0 0.0701349526643753

The O 0 0.03664169833064079
first O 0 0.034796927124261856
predictive O 0 0.12056925147771835
testing O 0 0.08055230975151062
for O 0 0.04245324060320854
Huntington B-Disease 1 0.9999831914901733
disease I-Disease 1 0.9999891519546509
( O 0 0.062155187129974365
HD B-Disease 0 0.10529723018407822
) O 0 0.022448420524597168
was O 0 0.012457892298698425
based O 0 0.013003833591938019
on O 0 0.010120184160768986
analysis O 0 0.02138073742389679
of O 0 0.017226746305823326
linked O 0 0.07305394858121872
polymorphic O 0 0.2246260941028595
DNA O 0 0.07141274958848953
markers O 0 0.05977090820670128
to O 0 0.01622612401843071
estimate O 0 0.02893570438027382
the O 0 0.017866985872387886
likelihood O 0 0.05319153517484665
of O 0 0.018265141174197197
inheriting O 0 0.09281505644321442
the O 0 0.02887961082160473
mutation O 0 0.12668734788894653
for O 0 0.030768929049372673
HD B-Disease 0 0.14718028903007507
. O 0 0.05022449418902397

Limits O 0 0.05318819731473923
to O 0 0.02254648692905903
accuracy O 0 0.03553749620914459
included O 0 0.02481094002723694
recombination O 0 0.09276391565799713
between O 0 0.02327117510139942
the O 0 0.017152270302176476
DNA O 0 0.05117003619670868
markers O 0 0.05717923864722252
and O 0 0.01787945069372654
the O 0 0.022246386855840683
mutation O 0 0.13547056913375854
, O 0 0.026066269725561142
pedigree O 0 0.07827530056238174
structure O 0 0.03086058981716633
, O 0 0.014372679404914379
and O 0 0.012659871019423008
whether O 0 0.020285485312342644
DNA O 0 0.041264839470386505
samples O 0 0.029623208567500114
were O 0 0.011054687201976776
available O 0 0.012482061982154846
from O 0 0.013395609334111214
family O 0 0.02577754482626915
members O 0 0.025351306423544884
. O 0 0.036006782203912735

With O 0 0.034631431102752686
direct O 0 0.043865084648132324
tests O 0 0.038293637335300446
for O 0 0.01628381386399269
the O 0 0.022113732993602753
HD B-Disease 0 0.1299249529838562
mutation O 0 0.10715498775243759
, O 0 0.015355980955064297
we O 0 0.012161368504166603
have O 0 0.01163184829056263
assessed O 0 0.031194835901260376
the O 0 0.012578467838466167
accuracy O 0 0.0252904761582613
of O 0 0.01067335158586502
results O 0 0.024196922779083252
obtained O 0 0.019903866574168205
by O 0 0.01771639846265316
linkage O 0 0.07806321978569031
approaches O 0 0.042623452842235565
when O 0 0.016182778403162956
requested O 0 0.02077704668045044
to O 0 0.012141519226133823
do O 0 0.013377749361097813
so O 0 0.010061569511890411
by O 0 0.01066211424767971
the O 0 0.015648452565073967
test O 0 0.04181680828332901
individuals O 0 0.03822074085474014
. O 0 0.03991037979722023

For O 0 0.024609310552477837
six O 0 0.024083323776721954
such O 0 0.015392692759633064
individuals O 0 0.0212623979896307
, O 0 0.01190495491027832
there O 0 0.010609583929181099
was O 0 0.014527820982038975
significant O 0 0.02542540617287159
disparity O 0 0.061775755137205124
between O 0 0.019542371854186058
the O 0 0.019479988142848015
tests O 0 0.054862916469573975
. O 0 0.040399521589279175

Three O 0 0.033552754670381546
went O 0 0.03248609974980354
from O 0 0.021162649616599083
a O 0 0.027219045907258987
decreased O 0 0.06329706311225891
risk O 0 0.07023799419403076
to O 0 0.013309727422893047
an O 0 0.015374694019556046
increased O 0 0.03051292523741722
risk O 0 0.06736365705728531
, O 0 0.011625983752310276
while O 0 0.010190833359956741
in O 0 0.008732525631785393
another O 0 0.012009171769022942
three O 0 0.011097376234829426
the O 0 0.015845807269215584
risk O 0 0.08853328973054886
was O 0 0.027156414464116096
decreased O 0 0.08076801151037216
. O 0 0.04718466103076935

Knowledge O 0 0.038716599345207214
of O 0 0.015657972544431686
the O 0 0.01487478893250227
potential O 0 0.030829859897494316
reasons O 0 0.019278673455119133
for O 0 0.00907416082918644
these O 0 0.009138698689639568
changes O 0 0.01669112779200077
in O 0 0.010340305045247078
results O 0 0.020602243021130562
and O 0 0.010885335505008698
impact O 0 0.025053072720766068
of O 0 0.011203056201338768
these O 0 0.015729807317256927
risk O 0 0.22879290580749512
reversals O 0 0.08426950126886368
on O 0 0.01333701517432928
both O 0 0.01661558449268341
patients O 1 0.949985146522522
and O 0 0.01294434629380703
the O 0 0.015391696244478226
counseling O 0 0.1176384761929512
team O 0 0.021611478179693222
can O 0 0.01268334686756134
assist O 0 0.022543545812368393
in O 0 0.008723540231585503
the O 0 0.008687706664204597
development O 0 0.015535813756287098
of O 0 0.010895203799009323
strategies O 0 0.04238046333193779
for O 0 0.012971247546374798
the O 0 0.017136450856924057
prevention O 1 0.596145749092102
and O 0 0.013186381198465824
, O 0 0.012945453636348248
where O 0 0.013743819668889046
necessary O 0 0.016060391440987587
, O 0 0.012762011960148811
management O 0 0.027959955856204033
of O 0 0.012324555777013302
a O 0 0.024688590317964554
risk O 0 0.19290195405483246
reversal O 0 0.07120957225561142
in O 0 0.01855042576789856
any O 0 0.020936718210577965
predictive O 0 0.09305021911859512
testing O 0 0.05978694558143616
program O 0 0.044051993638277054
. O 0 0.02507920004427433
. O 0 0.03785676136612892

A O 0 0.07506028562784195
novel O 0 0.08187060058116913
common O 0 0.08444886654615402
missense O 0 0.4006870985031128
mutation O 0 0.21663455665111542
G301C O 0 0.12918168306350708
in O 0 0.02246846631169319
the O 0 0.025204617530107498
N O 0 0.0924043357372284
- O 0 0.1402757614850998
acetylgalactosamine O 1 0.8501994609832764
- O 1 0.5269506573677063
6 O 0 0.09929277002811432
- O 1 0.9622596502304077
sulfate O 1 0.9989302754402161
sulfatase O 1 0.9989795088768005
gene O 0 0.17970435321331024
in O 0 0.058647073805332184
mucopolysaccharidosis B-Disease 1 0.9662630558013916
IVA I-Disease 1 0.9955475330352783
. O 0 0.07331293076276779

Mucopolysaccharidosis B-Disease 1 0.9907614588737488
IVA I-Disease 1 0.9984367489814758
( O 0 0.11965931951999664
MPS B-Disease 1 0.8441176414489746
IVA I-Disease 1 0.9994082450866699
) O 0 0.056074898689985275
is O 0 0.026685332879424095
an O 0 0.037904370576143265
autosomal B-Disease 1 0.9996989965438843
recessive I-Disease 1 0.9999574422836304
lysosomal I-Disease 1 0.9999572038650513
storage I-Disease 1 0.9937461614608765
disorder I-Disease 1 0.9999861717224121
caused O 0 0.4651012420654297
by O 0 0.026132939383387566
a O 0 0.03513936325907707
genetic B-Disease 0 0.34564244747161865
defect I-Disease 1 0.9910780787467957
in O 0 0.03937336057424545
N O 0 0.14263813197612762
- O 0 0.26754891872406006
acetylgalactosamine O 1 0.9534321427345276
- O 1 0.6688935160636902
6 O 0 0.11361535638570786
- O 1 0.9842416644096375
sulfate O 1 0.9994986057281494
sulfatase O 1 0.9992109537124634
( O 0 0.09380532801151276
GALNS O 1 0.9099400639533997
) O 0 0.055519040673971176
. O 0 0.04348938539624214

In O 0 0.028297755867242813
previous O 0 0.027764560654759407
studies O 0 0.024457231163978577
, O 0 0.011178272776305676
we O 0 0.009168007411062717
have O 0 0.009696390479803085
found O 0 0.01265861839056015
two O 0 0.010965532623231411
common O 0 0.03269908204674721
mutations O 0 0.09054320305585861
in O 0 0.021116938441991806
Caucasians O 0 0.1653861701488495
and O 0 0.018951447680592537
Japanese O 0 0.03244785591959953
, O 0 0.019239060580730438
respectively O 0 0.03765641152858734
. O 0 0.03720996901392937

To O 0 0.04493451118469238
characterize O 0 0.10545332729816437
the O 0 0.03394513949751854
mutational O 1 0.5464388728141785
spectrum O 0 0.05719117447733879
in O 0 0.013653186149895191
various O 0 0.011093368753790855
ethnic O 0 0.02345302328467369
groups O 0 0.02311662584543228
, O 0 0.019826289266347885
mutations O 0 0.07418383657932281
in O 0 0.016408272087574005
the O 0 0.02388853393495083
GALNS O 1 0.6307652592658997
gene O 0 0.09241656959056854
in O 0 0.02860279567539692
Colombian O 0 0.10946273803710938
MPS B-Disease 1 0.9948630928993225
IVA I-Disease 1 0.9999761581420898
patients O 1 0.9976668357849121
were O 0 0.0201974269002676
investigated O 0 0.04395986348390579
, O 0 0.015398476272821426
and O 0 0.01538220327347517
genetic O 0 0.05308884009718895
backgrounds O 0 0.03763257712125778
were O 0 0.012829761952161789
extensively O 0 0.026517517864704132
analyzed O 0 0.031223177909851074
to O 0 0.012257718481123447
identify O 0 0.029172159731388092
racial O 0 0.03742053732275963
origin O 0 0.02545810677111149
, O 0 0.01343344897031784
based O 0 0.01981864497065544
on O 0 0.01965850032866001
mitochondrial O 0 0.09297281503677368
DNA O 0 0.08340111374855042
( O 0 0.055871155112981796
mtDNA O 0 0.1338292509317398
) O 0 0.05087752640247345
lineages O 0 0.11997611820697784
. O 0 0.057180218398571014

Three O 0 0.05949603393673897
novel O 0 0.09166134893894196
missense O 1 0.6877701878547668
mutations O 0 0.16982920467853546
never O 0 0.03299801051616669
identified O 0 0.028010498732328415
previously O 0 0.018056385219097137
in O 0 0.010527804493904114
other O 0 0.010204141959547997
populations O 0 0.032633647322654724
and O 0 0.012042541056871414
found O 0 0.01435596402734518
in O 0 0.012116173282265663
16 O 0 0.018625086173415184
out O 0 0.012186724692583084
of O 0 0.013896919786930084
19 O 0 0.04184504598379135
Colombian O 0 0.09124487638473511
MPS B-Disease 1 0.6955223679542542
IVA I-Disease 1 0.9988710284233093
unrelated O 0 0.11815828830003738
alleles O 0 0.16402490437030792
account O 0 0.03880051523447037
for O 0 0.022904256358742714
84 O 0 0.07684479653835297
. O 0 0.042257361114025116

2 O 0 0.04880897328257561
% O 0 0.028158310800790787
of O 0 0.013339449651539326
the O 0 0.017134595662355423
alleles O 0 0.098627008497715
in O 0 0.0184718519449234
this O 0 0.014869538135826588
study O 0 0.033749815076589584
. O 0 0.03288916498422623

The O 0 0.05401564761996269
G301C O 0 0.15549278259277344
and O 0 0.04100334644317627
S162F O 0 0.17663796246051788
mutations O 0 0.12913736701011658
account O 0 0.03629423677921295
for O 0 0.023033808916807175
68 O 0 0.077569879591465
. O 0 0.04364819452166557

4 O 0 0.0630510076880455
% O 0 0.03884132578969002
and O 0 0.020407624542713165
10 O 0 0.036180078983306885
. O 0 0.03573649004101753

5 O 0 0.059178806841373444
% O 0 0.038829199969768524
of O 0 0.022847702726721764
mutations O 0 0.09707141667604446
, O 0 0.01651342399418354
respectively O 0 0.021840861067175865
, O 0 0.012448440305888653
whereas O 0 0.026587849482893944
the O 0 0.013504773378372192
remaining O 0 0.028144393116235733
F69V O 0 0.10945939272642136
is O 0 0.017947541549801826
limited O 0 0.0197918601334095
to O 0 0.013355663046240807
a O 0 0.019370054826140404
single O 0 0.04301508516073227
allele O 0 0.15650075674057007
. O 0 0.05279262736439705

The O 0 0.0520872101187706
skewed O 0 0.13582539558410645
prevalence O 1 0.508612334728241
of O 0 0.026706364005804062
G301C O 0 0.1039937436580658
in O 0 0.021547045558691025
only O 0 0.018527725711464882
Colombian O 0 0.07573746144771576
patients O 1 0.992115318775177
and O 0 0.029354525730013847
haplotype O 1 0.7286626696586609
analysis O 0 0.03515671566128731
by O 0 0.02336864173412323
restriction O 0 0.06178032234311104
fragment O 0 0.07582297176122665
length O 0 0.05182292312383652
polymorphisms O 0 0.10800117254257202
in O 0 0.020104700699448586
the O 0 0.02488316036760807
GALNS O 1 0.6702679991722107
gene O 0 0.09211792796850204
suggest O 0 0.044240690767765045
that O 0 0.02067825011909008
G301C O 0 0.09027537703514099
originated O 0 0.04354025050997734
from O 0 0.020112397149205208
a O 0 0.024466687813401222
common O 0 0.043160438537597656
ancestor O 0 0.08821907639503479
. O 0 0.052576944231987

Investigation O 0 0.05902465432882309
of O 0 0.018169278278946877
the O 0 0.018677078187465668
genetic O 0 0.06106681376695633
background O 0 0.0351153165102005
by O 0 0.015718374401330948
means O 0 0.02381436713039875
of O 0 0.017277443781495094
mtDNA O 0 0.10253767669200897
lineages O 0 0.0821397677063942
indicate O 0 0.03317166492342949
that O 0 0.011367461644113064
all O 0 0.011370813474059105
our O 0 0.020937485620379448
patients O 1 0.8882910013198853
are O 0 0.012843213975429535
probably O 0 0.024066083133220673
of O 0 0.013153801672160625
native O 0 0.029561633244156837
American O 0 0.052975401282310486
descent O 0 0.14421837031841278

Low O 0 0.11577985435724258
frequency O 0 0.09790533781051636
of O 0 0.045790597796440125
BRCA1 O 1 0.988050639629364
germline O 1 0.9785333275794983
mutations O 0 0.4278939962387085
in O 0 0.0367201566696167
45 O 0 0.07409778237342834
German O 1 0.9955611228942871
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999997615814209
families O 0 0.09838463366031647
. O 0 0.057733792811632156

In O 0 0.029255583882331848
this O 0 0.018687430769205093
study O 0 0.032476309686899185
we O 0 0.02155579999089241
investigated O 0 0.05745893344283104
45 O 0 0.05501790717244148
German O 1 0.9747360944747925
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 0.9999980926513672
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999958276748657
families O 0 0.08075746148824692
for O 0 0.041776519268751144
germline O 1 0.9757388234138489
mutations O 0 0.17153234779834747
in O 0 0.028312906622886658
the O 0 0.03630709648132324
BRCA1 O 1 0.9845059514045715
gene O 0 0.167815700173378
. O 0 0.05955348536372185

We O 0 0.03740176931023598
identified O 0 0.04719935730099678
four O 0 0.04128783196210861
germline O 1 0.8778237104415894
mutations O 0 0.15145832300186157
in O 0 0.028076931834220886
three O 0 0.03875480964779854
breast B-Disease 1 0.9999886751174927
cancer I-Disease 1 0.9999192953109741
families O 0 0.03827802464365959
and O 0 0.017527464777231216
in O 0 0.020972101017832756
one O 0 0.060820505023002625
breast B-Disease 1 0.9999996423721313
- I-Disease 1 0.999988317489624
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
family O 0 0.03889338672161102
. O 0 0.015055635012686253
among O 0 0.013655203394591808
these O 0 0.00964344758540392
were O 0 0.01132809929549694
one O 0 0.02309323474764824
frameshift O 1 0.932813286781311
mutation O 0 0.1527210921049118
, O 0 0.02266775630414486
one O 0 0.024760141968727112
nonsense O 0 0.08302515000104904
mutation O 0 0.12746447324752808
, O 0 0.022514257580041885
one O 0 0.023110901936888695
novel O 0 0.045267265290021896
splice O 0 0.14712956547737122
site O 0 0.05326560512185097
mutation O 0 0.12816041707992554
, O 0 0.022089697420597076
and O 0 0.020949576050043106
one O 0 0.034914202988147736
missense O 0 0.3959580361843109
mutation O 0 0.395974725484848
. O 0 0.07184458523988724

The O 0 0.07290127128362656
missense O 0 0.4235790967941284
mutation O 0 0.15776020288467407
was O 0 0.024186523631215096
also O 0 0.015669237822294235
found O 0 0.01957131177186966
in O 0 0.017082761973142624
2 O 0 0.039922259747982025
. O 0 0.03699314221739769

8 O 0 0.052392229437828064
% O 0 0.028748206794261932
of O 0 0.011474868282675743
the O 0 0.011382326483726501
general O 0 0.017688188701868057
population O 0 0.020758675411343575
, O 0 0.011404099874198437
suggesting O 0 0.02653144858777523
that O 0 0.009330755099654198
it O 0 0.00965120643377304
is O 0 0.014651215635240078
not O 0 0.02039869874715805
disease O 1 0.9993539452552795
associated O 0 0.055189311504364014
. O 0 0.04424745589494705

The O 0 0.03520648553967476
average O 0 0.05319498851895332
age O 0 0.04494447261095047
of O 0 0.03059183619916439
disease O 1 0.9999804496765137
onset O 1 0.9994218349456787
in O 0 0.02560039609670639
those O 0 0.024796105921268463
families O 0 0.057557180523872375
harbouring O 1 0.9944215416908264
causative O 1 0.989841878414154
mutations O 0 0.17262069880962372
was O 0 0.024894902482628822
between O 0 0.03256918117403984
32 O 0 0.05560939759016037
. O 0 0.041208766400814056

3 O 0 0.06110144406557083
and O 0 0.029113026335835457
37 O 0 0.06410427391529083
. O 0 0.04699869453907013

4 O 0 0.05416048690676689
years O 0 0.024045057594776154
, O 0 0.017364196479320526
whereas O 0 0.03126038983464241
the O 0 0.018590161576867104
family O 0 0.04124333709478378
harbouring O 0 0.4690100848674774
the O 0 0.035821493715047836
missense O 0 0.4811318814754486
mutation O 0 0.13565991818904877
had O 0 0.022588569670915604
an O 0 0.017234034836292267
average O 0 0.03307642787694931
age O 0 0.032831672579050064
of O 0 0.019738798961043358
onset O 1 0.9765439033508301
of O 0 0.02652287669479847
51 O 0 0.07111816108226776
. O 0 0.04724094271659851

2 O 0 0.07370437681674957
years O 0 0.04661384969949722
. O 0 0.0482102669775486

These O 0 0.02968914434313774
findings O 0 0.047622937709093094
show O 0 0.03343421220779419
that O 0 0.019925905391573906
BRCA1 O 1 0.6276670694351196
is O 0 0.02073139138519764
implicated O 0 0.061424948275089264
in O 0 0.014601597562432289
a O 0 0.01817290671169758
small O 0 0.025300217792391777
fraction O 0 0.05911367014050484
of O 0 0.04392222315073013
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999974966049194
families O 0 0.05925138294696808
suggesting O 0 0.045297469943761826
the O 0 0.018373902887105942
involvement O 0 0.04846802353858948
of O 0 0.02038811519742012
another O 0 0.0465623214840889
susceptibility O 1 0.967941164970398
gene O 0 0.16516993939876556
( O 0 0.07579026371240616
s O 0 0.1487254947423935
) O 0 0.07568755745887756

Paternal O 1 0.7234770655632019
transmission O 1 0.8146504759788513
of O 0 0.08956699073314667
congenital B-Disease 1 0.9999994039535522
myotonic I-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999995231628418
. O 0 0.11425169557332993

We O 0 0.03296796604990959
report O 0 0.028539616614580154
a O 0 0.022942647337913513
rare O 0 0.04474610835313797
case O 0 0.03401701897382736
of O 0 0.031234899535775185
paternally O 1 0.992708146572113
transmitted O 1 0.9992794394493103
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9972321391105652
DM B-Disease 1 0.999994158744812
) O 0 0.0723416730761528
. O 0 0.049220144748687744

The O 0 0.043994709849357605
proband O 0 0.12902513146400452
is O 0 0.022617002949118614
a O 0 0.020562676712870598
23 O 0 0.031632550060749054
year O 0 0.023998817428946495
old O 0 0.033851299434900284
, O 0 0.03403765708208084
mentally B-Disease 1 0.9991374015808105
retarded I-Disease 1 0.9983912110328674
male O 1 0.6724250912666321
who O 1 0.6292597055435181
suffers O 1 0.9999896287918091
severe O 1 0.9999819993972778
muscular B-Disease 1 0.9999706745147705
weakness I-Disease 1 0.9984958171844482
. O 0 0.06400351226329803

He O 0 0.03329232335090637
presented O 0 0.0382591187953949
with O 0 0.03501492738723755
respiratory O 1 0.9999556541442871
and O 0 0.028279419988393784
feeding O 0 0.07942555844783783
difficulties O 0 0.07824254781007767
at O 0 0.04172229766845703
birth O 0 0.077346570789814
. O 0 0.04572567716240883

His O 0 0.05193689465522766
two O 0 0.04606850817799568
sibs O 1 0.9987599849700928
suffer O 1 0.9987139701843262
from O 0 0.06231074035167694
childhood O 1 0.9990853071212769
onset O 1 0.9999755620956421
DM B-Disease 1 0.9999901056289673
. O 0 0.08708063513040543

Their O 0 0.03294365480542183
late O 0 0.03540092706680298
father O 0 0.02682281658053398
had O 0 0.018284376710653305
the O 0 0.017501143738627434
adult O 0 0.04448511824011803
type O 0 0.056737497448921204
of O 0 0.029366139322519302
DM B-Disease 1 0.9999752044677734
, O 0 0.025870995596051216
with O 0 0.0271857101470232
onset O 1 0.990675151348114
around O 0 0.032176610082387924
30 O 0 0.03506596013903618
years O 0 0.03171490132808685
. O 0 0.04396357387304306

Only O 0 0.02445036731660366
six O 0 0.023137269541621208
other O 0 0.01386320497840643
cases O 0 0.029119761660695076
of O 0 0.020581740885972977
paternal O 0 0.32771676778793335
transmission O 1 0.7632635831832886
of O 0 0.04664800316095352
congenital B-Disease 1 0.9999996423721313
DM I-Disease 1 0.9999978542327881
have O 0 0.02865096926689148
been O 0 0.02342757023870945
reported O 0 0.044711634516716
recently O 0 0.04962515830993652
. O 0 0.042505402117967606

We O 0 0.028402989730238914
review O 0 0.03191066533327103
the O 0 0.017834199592471123
sex O 0 0.04754183813929558
related O 0 0.04467069357633591
effects O 0 0.07249194383621216
on O 0 0.021817229688167572
transmission O 0 0.1580108255147934
of O 0 0.044364046305418015
congenital B-Disease 1 0.9999979734420776
DM I-Disease 1 0.9999963045120239
. O 0 0.07858307659626007

Decreased O 0 0.2716437578201294
fertility O 0 0.2503200173377991
of O 0 0.028553735464811325
males O 0 0.0716807097196579
with O 0 0.03439422324299812
adult O 0 0.3789040446281433
onset O 1 0.999981164932251
DM B-Disease 1 0.9999924898147583
and O 0 0.02881702408194542
contraction O 0 0.07644184678792953
of O 0 0.01373335998505354
the O 0 0.016942689195275307
repeat O 0 0.06386017054319382
upon O 0 0.02381034381687641
male O 0 0.05212238058447838
transmission O 0 0.07151985913515091
contribute O 0 0.043205827474594116
to O 0 0.014676571823656559
the O 0 0.015724919736385345
almost O 0 0.025764793157577515
absent O 0 0.06756811589002609
occurrence O 0 0.08828368782997131
of O 0 0.028459332883358
paternal O 0 0.24750332534313202
transmission O 1 0.5978938341140747
of O 0 0.06103852763772011
congenital B-Disease 1 0.9999982118606567
DM I-Disease 1 0.9999949932098389
. O 0 0.07260163873434067

Also O 0 0.03010462410748005
the O 0 0.022138049826025963
fathers O 0 0.04229889065027237
of O 0 0.014975153841078281
the O 0 0.0198685210198164
reported O 0 0.053409356623888016
congenitally O 1 0.9494863152503967
affected O 0 0.07357568293809891
children O 0 0.03934235870838165
showed O 0 0.032967597246170044
, O 0 0.014836128801107407
on O 0 0.014334632083773613
average O 0 0.03584140166640282
, O 0 0.022850455716252327
shorter O 0 0.07577284425497055
CTG O 1 0.8675687313079834
repeat O 0 0.10161727666854858
lengths O 0 0.07412804663181305
and O 0 0.02306942082941532
hence O 0 0.05298599600791931
less O 0 0.04925807565450668
severe O 1 0.9997726082801819
clinical O 1 0.999273955821991
symptoms O 1 0.9999383687973022
than O 0 0.02032146044075489
the O 0 0.018104253336787224
mothers O 0 0.07292072474956512
of O 0 0.01868215575814247
children O 0 0.047474514693021774
with O 0 0.05575133115053177
congenital B-Disease 1 0.9999991655349731
DM I-Disease 1 0.9999972581863403
. O 0 0.08171652257442474

We O 0 0.039993517100811005
conclude O 0 0.07215865701436996
that O 0 0.02621477283537388
paternal O 0 0.12927605211734772
transmission O 0 0.3006969392299652
of O 0 0.05015737935900688
congenital B-Disease 1 0.9999991655349731
DM I-Disease 1 0.9999985694885254
is O 0 0.034208428114652634
rare O 0 0.04532884806394577
and O 0 0.020472168922424316
preferentially O 0 0.11538228392601013
occurs O 0 0.0734056904911995
with O 0 0.028973720967769623
onset O 1 0.9982075691223145
of O 0 0.031273987144231796
DM B-Disease 1 0.9999635219573975
past O 0 0.035074036568403244
30 O 0 0.023789703845977783
years O 0 0.014290696941316128
in O 0 0.010334650985896587
the O 0 0.012657742016017437
father O 0 0.02870197221636772
. O 0 0.022220512852072716
. O 0 0.03712491691112518

The O 0 0.08472456783056259
RB1 O 1 0.9954822063446045
gene O 0 0.1791585236787796
mutation O 0 0.1544288843870163
in O 0 0.027239469811320305
a O 0 0.028624068945646286
child O 0 0.061501938849687576
with O 0 0.049252137541770935
ectopic B-Disease 1 0.9996353387832642
intracranial I-Disease 1 0.9998824596405029
retinoblastoma I-Disease 1 0.9992402791976929
. O 0 0.08435678482055664

The O 0 0.09393588453531265
RB1 O 1 0.996749758720398
gene O 0 0.19254186749458313
mutation O 0 0.18739815056324005
was O 0 0.02829817868769169
investigated O 0 0.04512079805135727
in O 0 0.016401415690779686
a O 0 0.023236384615302086
child O 0 0.05298037454485893
with O 0 0.039710383862257004
ectopic B-Disease 1 0.9995195865631104
intracranial I-Disease 1 0.9995467066764832
retinoblastoma I-Disease 1 0.9894483089447021
using O 0 0.041047602891922
DNA O 0 0.049368128180503845
obtained O 0 0.021178079769015312
from O 0 0.012080597691237926
both O 0 0.014583948068320751
the O 0 0.024849049746990204
pineal B-Disease 1 0.9986528158187866
and I-Disease 0 0.0407470278441906
retinal I-Disease 1 0.9999690055847168
tumours I-Disease 1 0.9997525811195374
of O 0 0.02637961506843567
the O 0 0.030920159071683884
patient O 1 0.8617529273033142
. O 0 0.05507224425673485

A O 0 0.07667956501245499
nonsense O 0 0.1252453625202179
mutation O 0 0.1561998873949051
in O 0 0.03227241337299347
exon O 0 0.1395808458328247
17 O 0 0.06106075271964073
( O 0 0.057856470346450806
codon O 0 0.12823371589183807
556 O 0 0.12756752967834473
) O 0 0.03509674221277237
of O 0 0.018182335421442986
the O 0 0.029631435871124268
RB1 O 1 0.9935436248779297
gene O 0 0.0807471051812172
was O 0 0.017851999029517174
found O 0 0.014052088372409344
to O 0 0.01005966030061245
be O 0 0.010040991939604282
present O 0 0.01635676808655262
homozygously O 0 0.06986179202795029
in O 0 0.011810832656919956
both O 0 0.012000665999948978
the O 0 0.019406404346227646
retinal B-Disease 1 0.9964596629142761
and I-Disease 0 0.024194883182644844
the I-Disease 0 0.03956737369298935
pineal I-Disease 1 0.9993557333946228
tumours I-Disease 1 0.9997077584266663
. O 0 0.0742984488606453

The O 0 0.043448757380247116
same O 0 0.03865393251180649
mutation O 0 0.1188637837767601
was O 0 0.02171546407043934
present O 0 0.026831690222024918
heterozygously O 0 0.08094202727079391
in O 0 0.014874634332954884
the O 0 0.013532795943319798
DNA O 0 0.03754868730902672
from O 0 0.013632167130708694
the O 0 0.01350889727473259
constitutional O 0 0.023417064920067787
cells O 0 0.04608944430947304
of O 0 0.01241166889667511
the O 0 0.019733872264623642
patient O 0 0.294808566570282
, O 0 0.019402166828513145
proving O 0 0.03713115677237511
it O 0 0.008684832602739334
to O 0 0.009377911686897278
be O 0 0.009404110722243786
of O 0 0.016999367624521255
germline O 0 0.21882249414920807
origin O 0 0.0529194101691246
. O 0 0.045016203075647354

The O 0 0.04436838999390602
initial O 0 0.07572217285633087
mutation O 0 0.12133003771305084
was O 0 0.02033012919127941
shown O 0 0.020509211346507072
to O 0 0.010773828253149986
have O 0 0.012736477889120579
occurred O 0 0.030661100521683693
in O 0 0.01530907116830349
the O 0 0.024380531162023544
paternally O 0 0.18539802730083466
derived O 0 0.10499538481235504
RB1 O 1 0.9927928447723389
allele O 0 0.2623766362667084
. O 0 0.07075440883636475

The O 0 0.041724324226379395
mutation O 0 0.11130066215991974
is O 0 0.01733260042965412
in O 0 0.010556883178651333
an O 0 0.010598957538604736
area O 0 0.016526153311133385
of O 0 0.009526201523840427
the O 0 0.013527706265449524
gene O 0 0.054657600820064545
that O 0 0.01591736637055874
encodes O 0 0.052544478327035904
the O 0 0.02036663144826889
protein O 0 0.053327061235904694
- O 0 0.05735602602362633
binding O 0 0.039396729320287704
region O 0 0.03279350697994232
known O 0 0.021411020308732986
as O 0 0.011868382804095745
the O 0 0.014063705690205097
pocket O 0 0.06357847899198532
region O 0 0.031778134405612946
and O 0 0.012431932613253593
has O 0 0.013445124961435795
been O 0 0.013281634077429771
detected O 0 0.03871943801641464
in O 0 0.011299628764390945
other O 0 0.010473720729351044
cases O 0 0.026239536702632904
of O 0 0.020226484164595604
retinoblastoma B-Disease 1 0.9939583539962769
. O 0 0.03207363560795784
. O 0 0.040128935128450394

Low O 0 0.08172884583473206
levels O 0 0.05677541717886925
of O 0 0.021514378488063812
beta O 0 0.06695350259542465
hexosaminidase O 0 0.10235057026147842
A O 0 0.028075959533452988
in O 0 0.017840122804045677
healthy O 0 0.07067615538835526
individuals O 0 0.02998930960893631
with O 0 0.023936206474900246
apparent O 1 0.9299266338348389
deficiency O 1 0.9999682903289795
of O 0 0.024793777614831924
this O 0 0.027843257412314415
enzyme O 0 0.10892611742019653
. O 0 0.04735735058784485

Appreciable O 0 0.24273955821990967
beta O 0 0.14921823143959045
hexosaminidase O 0 0.16364331543445587
A O 0 0.047767505049705505
( O 0 0.041209518909454346
hex O 0 0.07260700315237045
A O 0 0.029718758538365364
) O 0 0.024372803047299385
activity O 0 0.029746010899543762
has O 0 0.015099354088306427
been O 0 0.01717320829629898
detected O 0 0.05749039724469185
in O 0 0.02646072581410408
cultured O 1 0.961682140827179
skin O 1 0.9999752044677734
fibroblasts O 1 0.9995107650756836
and O 0 0.09215320646762848
melanoma B-Disease 1 0.9999988079071045
tissue O 1 0.9935178756713867
from O 0 0.032858192920684814
healthy O 0 0.08102239668369293
individuals O 0 0.030090050771832466
previously O 0 0.028824951499700546
reported O 0 0.02860085293650627
as O 0 0.016662944108247757
having O 0 0.03932059183716774
deficiency B-Disease 1 0.9998564720153809
of I-Disease 0 0.020036131143569946
hex I-Disease 0 0.07185535877943039
A I-Disease 0 0.02761094644665718
activity O 0 0.03713679313659668
indistinguishable O 0 0.0512847825884819
from O 0 0.016183674335479736
that O 0 0.012456689961254597
of O 0 0.018463121727108955
patients O 1 0.9997321963310242
with O 0 0.4060344099998474
Tay B-Disease 1 0.9999997615814209
- I-Disease 1 0.9998941421508789
Sachs I-Disease 1 0.9999876022338867
disease I-Disease 1 0.9999945163726807
( O 0 0.4780386984348297
TSD B-Disease 1 0.9991883635520935
) O 0 0.06585834175348282
. O 0 0.05126863718032837

Identification O 0 0.07585707306861877
and O 0 0.029523298144340515
quantitation O 0 0.1434263288974762
of O 0 0.02394093945622444
hex O 0 0.07272772490978241
A O 0 0.027508286759257317
, O 0 0.019374489784240723
amounting O 0 0.052143413573503494
to O 0 0.02167629264295101
3 O 0 0.040194734930992126
. O 0 0.03882944583892822

5 O 0 0.0785936713218689
% O 0 0.05884338915348053
- O 0 0.09899510443210602
6 O 0 0.06181907653808594
. O 0 0.046611204743385315

9 O 0 0.060831304639577866
% O 0 0.032424312084913254
of O 0 0.016343455761671066
total O 0 0.03170301765203476
beta O 0 0.07553485035896301
hexosaminidase O 0 0.14303787052631378
activity O 0 0.03590130805969238
, O 0 0.013806046918034554
has O 0 0.012317766435444355
been O 0 0.011970659717917442
obtained O 0 0.020220322534441948
by O 0 0.023777611553668976
cellulose O 0 0.18846626579761505
acetate O 1 0.8917208313941956
gel O 1 0.9445477724075317
electrophoresis O 1 0.5498982667922974
, O 0 0.04882609844207764
DEAE O 1 0.9837755560874939
- O 0 0.3661183714866638
cellulose O 0 0.3164840042591095
ion O 0 0.1898612231016159
- O 0 0.1191226989030838
exchange O 0 0.06614644080400467
chromatography O 0 0.19937889277935028
, O 0 0.03948250040411949
radial O 1 0.8383088707923889
immunodiffusion O 0 0.3941808342933655
, O 0 0.028315763920545578
and O 0 0.027446623891592026
radioimmunoassay O 0 0.1843542903661728
. O 0 0.049117155373096466

Previous O 0 0.05085467919707298
family O 0 0.03659434616565704
studies O 0 0.03542454540729523
suggested O 0 0.02411714754998684
that O 0 0.010340822860598564
these O 0 0.009992999956011772
individuals O 0 0.01903662085533142
may O 0 0.016857000067830086
be O 0 0.011318128556013107
compound O 0 0.04487074166536331
heterozygotes O 0 0.17151738703250885
for O 0 0.015506027266383171
the O 0 0.021865636110305786
common O 0 0.0496021993458271
mutant O 0 0.2232036292552948
TSD B-Disease 1 0.9979352951049805
gene O 0 0.09299495071172714
and O 0 0.020871788263320923
a O 0 0.02892390266060829
rare O 0 0.05700492486357689
( O 0 0.05419056490063667
allelic O 1 0.648028552532196
) O 0 0.06178385019302368
mutant O 0 0.13787421584129333
gene O 0 0.13987092673778534
. O 0 0.06389673799276352

Thus O 0 0.052700500935316086
, O 0 0.02506553940474987
the O 0 0.024040507152676582
postulated O 0 0.09691179543733597
rate O 0 0.07181807607412338
mutant O 0 0.10703638195991516
gene O 0 0.08102826774120331
appears O 0 0.0357569083571434
to O 0 0.01188224833458662
code O 0 0.016534488648176193
for O 0 0.00868129450827837
the O 0 0.010421594604849815
expression O 0 0.025882603600621223
of O 0 0.012803422287106514
low O 0 0.03461424633860588
amounts O 0 0.026611382141709328
of O 0 0.01805834285914898
hex O 0 0.07766570895910263
A O 0 0.04170916602015495
. O 0 0.044324539601802826

Heterozygotes O 0 0.47929105162620544
for O 0 0.028731929138302803
the O 0 0.02693430334329605
rare O 0 0.060135114938020706
mutant O 0 0.09835416078567505
may O 0 0.033617354929447174
be O 0 0.01597628742456436
indistinguishable O 0 0.06262654066085815
from O 0 0.025208106264472008
heterozygotes O 0 0.15820415318012238
for O 0 0.019207309931516647
the O 0 0.023358916863799095
common O 0 0.06206540763378143
TSD B-Disease 1 0.9948541522026062
mutant O 0 0.17282302677631378
. O 0 0.06178806722164154

However O 0 0.03801082819700241
, O 0 0.02441418543457985
direct O 0 0.03840794041752815
visualization O 0 0.0805596187710762
and O 0 0.02163277566432953
quantitation O 0 0.1123899593949318
of O 0 0.019040770828723907
hex O 0 0.058098651468753815
A O 0 0.020600927993655205
by O 0 0.012744558043777943
the O 0 0.013703621923923492
methods O 0 0.027790797874331474
described O 0 0.0352485366165638
may O 0 0.03438396379351616
prevent O 0 0.0626189261674881
false O 0 0.06161193549633026
- O 0 0.3164273202419281
positive O 0 0.09796106815338135
prenatal O 1 0.9975389242172241
diagnosis O 1 0.9989145994186401
of O 0 0.04208839684724808
TSD B-Disease 1 0.9977797865867615
in O 0 0.03150983527302742
fetuses O 0 0.11898741871118546
having O 0 0.0298960879445076
the O 0 0.018723556771874428
incomplete O 0 0.04505395144224167
hex B-Disease 0 0.08557319641113281
A I-Disease 0 0.03982125595211983
deficiency I-Disease 1 0.9998313188552856
of O 0 0.015130345709621906
the O 0 0.013791168108582497
type O 0 0.03720210865139961
described O 0 0.021842898800969124
in O 0 0.011553323827683926
the O 0 0.01459288690239191
four O 0 0.024949589744210243
healthy O 0 0.08898651599884033
individuals O 0 0.07164790481328964

The O 0 0.09263136982917786
tumor B-Disease 1 0.9991040825843811
suppressor O 1 0.9871941208839417
gene O 1 0.6680570840835571
Smad4 O 1 0.9829406142234802
/ O 1 0.9101648330688477
Dpc4 O 0 0.1430077850818634
is O 0 0.021793805062770844
required O 0 0.022091783583164215
for O 0 0.015329757705330849
gastrulation O 0 0.2168509066104889
and O 0 0.01511530950665474
later O 0 0.016184290871024132
for O 0 0.015089250169694424
anterior O 0 0.26672446727752686
development O 0 0.027036545798182487
of O 0 0.01642109639942646
the O 0 0.026912154629826546
mouse O 0 0.12985599040985107
embryo O 0 0.13593405485153198
. O 0 0.049994610249996185

Mutations O 0 0.1881996989250183
in O 0 0.033702682703733444
the O 0 0.042690057307481766
SMAD4 O 1 0.9970888495445251
/ O 1 0.9990584254264832
DPC4 O 1 0.9986005425453186
tumor B-Disease 1 0.9996546506881714
suppressor O 1 0.9345363974571228
gene O 0 0.09814472496509552
, O 0 0.021816058084368706
a O 0 0.019776908680796623
key O 0 0.03019730933010578
signal O 0 0.054439425468444824
transducer O 0 0.10473750531673431
in O 0 0.017914222553372383
most O 0 0.021277613937854767
TGFbeta O 1 0.8252769112586975
- O 0 0.0857580155134201
related O 0 0.048787038773298264
pathways O 0 0.085668183863163
, O 0 0.01560706552118063
are O 0 0.010447048582136631
involved O 0 0.01799492910504341
in O 0 0.012166558764874935
50 O 0 0.024493757635354996
% O 0 0.031061334535479546
of O 0 0.029715485870838165
pancreatic B-Disease 1 0.9999160766601562
cancers I-Disease 1 0.9998923540115356
. O 0 0.06515789031982422

Homozygous O 0 0.4501936733722687
Smad4 O 1 0.8786749839782715
mutant O 0 0.4277259111404419
mice O 1 0.9559671878814697
die O 1 0.5064359307289124
before O 0 0.03536871448159218
day O 0 0.03820780664682388
7 O 0 0.0507289320230484
. O 0 0.03943558409810066

5 O 0 0.08352669328451157
of O 0 0.04123370349407196
embryogenesis O 0 0.23863303661346436
. O 0 0.07295314222574234

Mutant O 0 0.16391690075397491
embryos O 0 0.08748379349708557
have O 0 0.024001428857445717
reduced O 0 0.041752103716135025
size O 0 0.02976398728787899
, O 0 0.020195428282022476
fail O 0 0.06022858992218971
to O 0 0.023396790027618408
gastrulate O 0 0.11210742592811584
or O 0 0.030618514865636826
express O 0 0.060513731092214584
a O 0 0.034730445593595505
mesodermal O 1 0.7777422666549683
marker O 0 0.07847902923822403
, O 0 0.02212623320519924
and O 0 0.01881868951022625
show O 0 0.0466918982565403
abnormal O 1 0.9521255493164062
visceral O 1 0.9117792248725891
endoderm O 1 0.969554603099823
development O 0 0.06855088472366333
. O 0 0.05172949284315109

Growth B-Disease 1 0.9154095649719238
retardation I-Disease 1 0.9980921149253845
of O 0 0.02824998088181019
the O 0 0.03397265821695328
Smad4 O 1 0.9914759397506714
- O 1 0.543192982673645
deficient O 1 0.8407787680625916
embryos O 0 0.07803147286176682
results O 0 0.038974907249212265
from O 0 0.025598708540201187
reduced O 0 0.05164084956049919
cell O 0 0.0864180475473404
proliferation O 0 0.07463010400533676
rather O 0 0.030090752989053726
than O 0 0.02664419449865818
increased O 0 0.05923953279852867
apoptosis O 0 0.2020370066165924
. O 0 0.0496162585914135

Aggregation O 0 0.15127278864383698
of O 0 0.0443262979388237
mutant O 0 0.1762048900127411
Smad4 O 1 0.9694607257843018
ES O 1 0.9715301394462585
cells O 0 0.09686200320720673
with O 0 0.030365437269210815
wild O 0 0.07098547369241714
- O 0 0.12171611189842224
type O 0 0.10882503539323807
tetraploid O 1 0.6782097816467285
morulae O 1 0.8120364546775818
rescues O 0 0.47261059284210205
the O 0 0.057993292808532715
gastrulation B-Disease 1 0.9904884099960327
defect I-Disease 1 0.9645936489105225
. O 0 0.0748368427157402

These O 0 0.0395638681948185
results O 0 0.04497610777616501
indicate O 0 0.0458422414958477
that O 0 0.018277861177921295
Smad4 O 0 0.0923236757516861
is O 0 0.015135654248297215
initially O 0 0.01869851164519787
required O 0 0.014666879549622536
for O 0 0.008684545755386353
the O 0 0.011019467376172543
differentiation O 0 0.045295342803001404
of O 0 0.014133532531559467
the O 0 0.023049242794513702
visceral O 1 0.5971648097038269
endoderm O 1 0.8677589297294617
and O 0 0.01726175844669342
that O 0 0.014393661171197891
the O 0 0.022702597081661224
gastrulation B-Disease 1 0.989988386631012
defect I-Disease 1 0.7591642737388611
in O 0 0.02249417081475258
the O 0 0.024630440399050713
epiblast O 1 0.916934072971344
is O 0 0.022823400795459747
secondary O 0 0.04187598079442978
and O 0 0.01708182692527771
non O 0 0.0443907156586647
- O 0 0.08227954059839249
cell O 0 0.08306512236595154
autonomous O 0 0.06042454019188881
. O 0 0.041694190353155136

Rescued O 0 0.2876887619495392
embryos O 0 0.14857642352581024
show O 0 0.0879255011677742
severe O 1 0.9983729124069214
anterior O 1 0.9978057742118835
truncations O 1 0.8827203512191772
, O 0 0.0259840190410614
indicating O 0 0.04068225622177124
a O 0 0.01675710640847683
second O 0 0.018933964893221855
important O 0 0.013861067593097687
role O 0 0.023469919338822365
for O 0 0.017673688009381294
Smad4 O 0 0.18972007930278778
in O 0 0.03479640558362007
anterior O 1 0.9935528039932251
patterning O 1 0.9792766571044922
during O 0 0.0777786448597908
embryogenesis O 1 0.7315216064453125
. O 0 0.06610658764839172

Prevalence O 1 0.9200764894485474
of O 0 0.05200597271323204
p16 O 1 0.9610835313796997
and O 0 0.046330776065588
CDK4 O 1 0.990813672542572
germline O 1 0.9872531294822693
mutations O 0 0.4795528054237366
in O 0 0.03927724063396454
48 O 0 0.2168739140033722
melanoma B-Disease 1 0.9999974966049194
- O 1 0.8028188943862915
prone O 1 0.6654298305511475
families O 0 0.05100347474217415
in O 0 0.026250500231981277
France O 0 0.07144864648580551
. O 0 0.04898242652416229

The O 0 0.06087854504585266
French O 0 0.18672595918178558
Familial B-Disease 1 0.999932050704956
Melanoma I-Disease 1 0.9999936819076538
Study O 0 0.08720842748880386
Group O 0 0.07265854626893997
. O 0 0.04844588786363602

Germline O 1 0.9292502999305725
mutations O 0 0.16820921003818512
in O 0 0.029668353497982025
the O 0 0.030484722927212715
p16 O 1 0.6826356053352356
and O 0 0.0304415263235569
CDK4 O 1 0.5447148680686951
genes O 0 0.05787090212106705
have O 0 0.0147985415533185
been O 0 0.01334322802722454
reported O 0 0.02393195778131485
in O 0 0.013209582306444645
a O 0 0.020046640187501907
subset O 0 0.05485345795750618
of O 0 0.028962846845388412
melanoma B-Disease 1 0.9999890327453613
pedigrees O 1 0.5376899838447571
, O 0 0.017728183418512344
but O 0 0.013086539693176746
their O 0 0.014850032515823841
prevalence O 0 0.486436128616333
is O 0 0.016791950911283493
not O 0 0.014508092775940895
well O 0 0.017421821132302284
known O 0 0.03305739909410477
. O 0 0.03674977645277977

We O 0 0.032568253576755524
searched O 0 0.048377346247434616
for O 0 0.02129265107214451
such O 0 0.029279153794050217
germline O 1 0.8671759366989136
mutations O 0 0.15311244130134583
in O 0 0.033153463155031204
48 O 0 0.06706426292657852
French O 1 0.5318602919578552
melanoma B-Disease 1 0.9999963045120239
- O 1 0.6954415440559387
prone O 0 0.40744471549987793
families O 0 0.038816049695014954
selected O 0 0.019354525953531265
according O 0 0.012672721408307552
to O 0 0.009224104695022106
two O 0 0.01060953363776207
major O 0 0.018361806869506836
criteria O 0 0.023724064230918884
families O 0 0.020875325426459312
with O 0 0.01323571428656578
at O 0 0.015011136420071125
least O 0 0.01350654661655426
three O 0 0.014148295857012272
affected O 0 0.03636593371629715
members O 0 0.025069139897823334
( O 0 0.03775465115904808
n O 0 0.0663251057267189
= O 0 0.07853588461875916
20 O 0 0.024356871843338013
) O 0 0.016829807311296463
or O 0 0.012630496174097061
families O 0 0.017346445471048355
with O 0 0.011447456665337086
two O 0 0.011230774223804474
affected O 0 0.02919945865869522
members O 0 0.011744046583771706
, O 0 0.009576995857059956
one O 0 0.008391381241381168
of O 0 0.00857054628431797
them O 0 0.010643448680639267
affected O 0 0.03227794170379639
before O 0 0.01462570670992136
the O 0 0.012507244013249874
age O 0 0.023344842717051506
of O 0 0.013864508830010891
50 O 0 0.028858091682195663
( O 0 0.03603057563304901
n O 0 0.06373860687017441
= O 0 0.07697480916976929
28 O 0 0.029740439727902412
) O 0 0.018140053376555443
, O 0 0.010389558970928192
and O 0 0.00949196144938469
one O 0 0.01348399743437767
additional O 0 0.0278497152030468
minor O 0 0.06177171692252159
criterion O 0 0.0885825827717781
. O 0 0.040008146315813065

Sixteen O 0 0.10809101164340973
different O 0 0.06967692822217941
p16 O 1 0.9825756549835205
germline O 1 0.9729804992675781
mutations O 0 0.14772112667560577
were O 0 0.017905183136463165
found O 0 0.01830647699534893
in O 0 0.013160395435988903
21 O 0 0.023413456976413727
families O 0 0.024197140708565712
, O 0 0.014133012853562832
while O 0 0.019572611898183823
one O 0 0.027991367504000664
germline O 1 0.9389507174491882
mutation O 0 0.3226006329059601
, O 0 0.030582772567868233
Arg24His O 0 0.15365350246429443
, O 0 0.01751989684998989
was O 0 0.016893230378627777
detected O 0 0.04865460842847824
in O 0 0.017237341031432152
the O 0 0.025339843705296516
CDK4 O 1 0.82986980676651
gene O 0 0.125211700797081
. O 0 0.0529526062309742

The O 0 0.043910473585128784
frequency O 0 0.08099593222141266
of O 0 0.03222070634365082
p16 O 1 0.8906748294830322
gene O 0 0.139179065823555
mutation O 0 0.12600749731063843
in O 0 0.01978493668138981
our O 0 0.018740475177764893
sample O 0 0.035389550030231476
( O 0 0.029791906476020813
44 O 0 0.030719146132469177
% O 0 0.02354392036795616
) O 0 0.017428696155548096
is O 0 0.010057096369564533
among O 0 0.013075239025056362
the O 0 0.013794442638754845
highest O 0 0.03327072039246559
rates O 0 0.04151616245508194
yet O 0 0.020299630239605904
reported O 0 0.02359258197247982
and O 0 0.01199541985988617
the O 0 0.020729290321469307
CDK4 O 1 0.8563680648803711
mutation O 0 0.10910386592149734
is O 0 0.017728351056575775
the O 0 0.01646498776972294
second O 0 0.03277988359332085
mutation O 0 0.13685980439186096
detected O 0 0.06865314394235611
in O 0 0.01709434576332569
this O 0 0.02053597755730152
gene O 0 0.08803809434175491
worldwide O 0 0.06460021436214447
. O 0 0.045263372361660004

In O 0 0.029810648411512375
summary O 0 0.049938611686229706
, O 0 0.017655326053500175
our O 0 0.019662722945213318
results O 0 0.030491184443235397
show O 0 0.03115442767739296
frequent O 0 0.04948849231004715
involvement O 0 0.044173967093229294
of O 0 0.016710659489035606
the O 0 0.02709946408867836
p16 O 1 0.9767094850540161
gene O 0 0.13284991681575775
in O 0 0.0383622869849205
familial B-Disease 1 0.9999423027038574
melanoma I-Disease 1 0.9999935626983643
and O 0 0.02151739038527012
confirm O 0 0.03218276798725128
the O 0 0.012756154872477055
role O 0 0.01970376819372177
of O 0 0.011438341811299324
the O 0 0.019583242014050484
CDK4 O 1 0.8226170539855957
gene O 0 0.07660500705242157
as O 0 0.020937450230121613
a O 0 0.0437471978366375
melanoma B-Disease 1 0.9999918937683105
- O 1 0.882142961025238
predisposing O 1 0.9106563925743103
gene O 0 0.12995615601539612
. O 0 0.03820207342505455
. O 0 0.04586506262421608

Progression O 0 0.3372812867164612
of O 0 0.04982146993279457
somatic O 0 0.3356498181819916
CTG O 1 0.9524579048156738
repeat O 0 0.12105412036180496
length O 0 0.05163617059588432
heterogeneity O 0 0.09127490967512131
in O 0 0.01856956258416176
the O 0 0.023405568674206734
blood O 1 0.9607462286949158
cells O 1 0.9381617307662964
of O 0 0.0636281967163086
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999580383300781
. O 0 0.06649228185415268

The O 0 0.044274210929870605
genetic O 0 0.08815669268369675
basis O 0 0.040299274027347565
of O 0 0.058816082775592804
myotonic B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 1.0
( O 1 0.987906813621521
DM B-Disease 1 0.999992847442627
) O 0 0.03364541009068489
is O 0 0.014011516235768795
the O 0 0.012234645895659924
expansion O 0 0.025285178795456886
of O 0 0.01406894437968731
an O 0 0.025966480374336243
unstable O 1 0.5025627613067627
CTG O 1 0.9567055106163025
repeat O 0 0.08871283382177353
in O 0 0.02024116925895214
the O 0 0.020399145781993866
34 O 0 0.051636405289173126
UTR O 0 0.14483238756656647
of O 0 0.025570014491677284
the O 0 0.0460391603410244
DM B-Disease 1 0.9998775720596313
protein O 0 0.15074528753757477
kinase O 0 0.2829459607601166
gene O 0 0.10703841596841812
on O 0 0.033545028418302536
chromosome O 0 0.14650386571884155
19 O 0 0.061744559556245804
. O 0 0.04686373099684715

One O 0 0.02167508192360401
of O 0 0.011836817488074303
the O 0 0.014230911619961262
principal O 0 0.030704200267791748
features O 0 0.024474235251545906
of O 0 0.018629958853125572
the O 0 0.03159843385219574
DM B-Disease 1 0.9999747276306152
mutation O 0 0.27555546164512634
is O 0 0.020033694803714752
an O 0 0.01820426434278488
extraordinarily O 0 0.0559798963367939
high O 0 0.030451033264398575
level O 0 0.026074334979057312
of O 0 0.019383622333407402
somatic O 1 0.6121389865875244
mosaicism O 1 0.9847831130027771
, O 0 0.018581584095954895
due O 0 0.020149046555161476
to O 0 0.010459951125085354
an O 0 0.012728243134915829
extremely O 0 0.025673389434814453
high O 0 0.02404973655939102
degree O 0 0.02648073062300682
of O 0 0.015193215571343899
somatic O 0 0.12414418905973434
instability O 0 0.07890429347753525
both O 0 0.01501806266605854
within O 0 0.01453496515750885
and O 0 0.010073286481201649
between O 0 0.016536690294742584
different O 0 0.021244585514068604
tissues O 0 0.11928152292966843
. O 0 0.045043718069791794

This O 0 0.039688628166913986
instability O 0 0.10212066024541855
appears O 0 0.041144706308841705
to O 0 0.014590186066925526
be O 0 0.013343315571546555
biased O 0 0.038535311818122864
towards O 0 0.02297050878405571
further O 0 0.0178715568035841
expansion O 0 0.02618768811225891
and O 0 0.010639980435371399
continuous O 0 0.02691955678164959
throughout O 0 0.015216920524835587
the O 0 0.009043090045452118
life O 0 0.012811186723411083
of O 0 0.007315551396459341
an O 0 0.010038323700428009
individual O 0 0.015247016213834286
, O 0 0.009347403421998024
features O 0 0.013284945860505104
that O 0 0.006898177787661552
could O 0 0.009128320030868053
be O 0 0.0070488168857991695
associated O 0 0.014298200607299805
with O 0 0.010535983368754387
the O 0 0.014258310198783875
progressive O 0 0.051917992532253265
nature O 0 0.02980659157037735
of O 0 0.015877725556492805
the O 0 0.028332918882369995
disease O 1 0.9995357990264893
. O 0 0.055007342249155045

Although O 0 0.052555497735738754
increasing O 0 0.05798257142305374
measured O 0 0.06414911150932312
allele O 0 0.1319180727005005
size O 0 0.04694416746497154
between O 0 0.03776751458644867
patients O 1 0.9911491870880127
clearly O 0 0.041063595563173294
correlates O 0 0.0659085214138031
with O 0 0.016559552401304245
an O 0 0.017517071217298508
increased O 0 0.045642513781785965
severity O 1 0.9774999022483826
of O 0 0.024020977318286896
symptoms O 1 0.9997861981391907
and O 0 0.013351088389754295
an O 0 0.01184377446770668
earlier O 0 0.022403690963983536
age O 0 0.027472883462905884
of O 0 0.017270224168896675
onset O 1 0.9936214089393616
, O 0 0.015980247408151627
this O 0 0.013174261897802353
correlation O 0 0.04509936273097992
is O 0 0.012571942992508411
not O 0 0.011273299343883991
precise O 0 0.02407490834593773
and O 0 0.014372428879141808
measured O 0 0.04103774204850197
allele O 0 0.09524240344762802
length O 0 0.03591189906001091
cannot O 0 0.021709902212023735
be O 0 0.008420084603130817
used O 0 0.01073182001709938
as O 0 0.00946429930627346
an O 0 0.013875086791813374
accurate O 0 0.032451361417770386
predictor O 0 0.09519845992326736
of O 0 0.017694074660539627
age O 0 0.03628181293606758
of O 0 0.025074943900108337
onset O 1 0.996815025806427
. O 0 0.051046110689640045

In O 0 0.030581457540392876
order O 0 0.020833680406212807
to O 0 0.014728848822414875
further O 0 0.022520817816257477
characterize O 0 0.06745244562625885
the O 0 0.024225706234574318
dynamics O 0 0.08595910668373108
of O 0 0.04997434839606285
DM B-Disease 1 0.9999903440475464
CTG O 1 0.9983059167861938
repeat O 1 0.8463473320007324
somatic O 1 0.6840566992759705
instability O 0 0.169380322098732
, O 0 0.020769750699400902
we O 0 0.014838478527963161
have O 0 0.012892565689980984
studied O 0 0.024922139942646027
repeat O 0 0.04882084205746651
length O 0 0.027430012822151184
changes O 0 0.02130172960460186
over O 0 0.016645897179841995
time O 0 0.020455196499824524
in O 0 0.027291471138596535
111 O 1 0.9984539747238159
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999077320098877
with O 0 0.03818279132246971
varying O 0 0.07466409355401993
clinical O 1 0.9954953193664551
severity O 1 0.99007248878479
and O 0 0.038030192255973816
CTG O 1 0.9401026964187622
repeat O 0 0.09022245556116104
size O 0 0.029267070814967155
over O 0 0.01802598126232624
time O 0 0.01799781247973442
intervals O 0 0.04107766970992088
of O 0 0.014532172121107578
1 O 0 0.03428742662072182
- O 0 0.06371306627988815
7 O 0 0.039819370955228806
years O 0 0.029636675491929054
. O 0 0.03767743706703186

We O 0 0.025727752596139908
have O 0 0.01576211489737034
found O 0 0.017451312392950058
a O 0 0.01871367171406746
direct O 0 0.031238466501235962
progression O 0 0.06782582402229309
of O 0 0.010451771318912506
the O 0 0.01406406331807375
size O 0 0.02692844346165657
heterogeneity O 0 0.07334373891353607
over O 0 0.018500512465834618
time O 0 0.01808544620871544
related O 0 0.02663186751306057
to O 0 0.017555199563503265
initial O 0 0.05474851280450821
CTG O 1 0.8342806696891785
repeat O 0 0.08012724667787552
size O 0 0.027125971391797066
and O 0 0.01197834312915802
the O 0 0.012814262881875038
time O 0 0.016862280666828156
interval O 0 0.04265313595533371
and O 0 0.012903103604912758
always O 0 0.022629480808973312
biased O 0 0.04493747279047966
towards O 0 0.028301585465669632
further O 0 0.02799953892827034
expansion O 0 0.05445728078484535
. O 0 0.041498225182294846

Attempts O 0 0.06797198206186295
to O 0 0.02625514194369316
mathematically O 0 0.06286124885082245
model O 0 0.0382298044860363
the O 0 0.021252533420920372
dynamics O 0 0.05998118594288826
have O 0 0.018959155306220055
proved O 0 0.033213917165994644
only O 0 0.015368032269179821
partially O 0 0.046658460050821304
successful O 0 0.03027074970304966
suggesting O 0 0.03515878692269325
that O 0 0.01227258238941431
individual O 0 0.021379318088293076
specific O 0 0.023828303441405296
genetic O 0 0.06350886076688766
and O 0 0.02196192368865013
/ O 1 0.7714967131614685
or O 0 0.02460560016334057
environmental O 0 0.032119374722242355
factors O 0 0.025095444172620773
also O 0 0.010658865794539452
play O 0 0.013466970063745975
a O 0 0.015237998217344284
role O 0 0.027297474443912506
in O 0 0.026199914515018463
somatic O 0 0.31985369324684143
mosaicism O 1 0.9824042916297913
. O 0 0.04041162133216858
. O 0 0.04618291184306145

Aspartylglucosaminuria B-Disease 1 0.9264594912528992
among O 0 0.06004631146788597
Palestinian O 0 0.08173874020576477
Arabs O 0 0.10435710102319717
. O 0 0.05655603110790253

Aspartylglucosaminuria B-Disease 1 0.9980271458625793
( O 0 0.18585096299648285
AGU B-Disease 1 0.9996229410171509
) O 0 0.0435166098177433
is O 0 0.0239451564848423
a O 0 0.029942139983177185
rare O 0 0.12955978512763977
disorder B-Disease 1 0.9997449517250061
of I-Disease 0 0.03456312417984009
glycoprotein I-Disease 1 0.9838459491729736
metabolism I-Disease 1 0.9650819301605225
caused O 0 0.11312010139226913
by O 0 0.023018650710582733
the O 0 0.0259598009288311
deficiency B-Disease 1 0.9998639822006226
of I-Disease 0 0.0223712045699358
the I-Disease 0 0.03405119478702545
lysosomal I-Disease 1 0.9937898516654968
enzyme I-Disease 0 0.42020121216773987
aspartylglucosaminidase I-Disease 1 0.9262502193450928
( O 0 0.0771830677986145
AGA O 0 0.4583190679550171
) O 0 0.053182922303676605
. O 0 0.04609508439898491

AGU B-Disease 1 0.9991564750671387
is O 0 0.05621854215860367
inherited O 0 0.1322699636220932
as O 0 0.028597723692655563
an O 0 0.03706856071949005
autosomal O 1 0.9990144968032837
recessive O 1 0.999476969242096
trait O 1 0.8364893794059753
and O 0 0.026430657133460045
occurs O 0 0.04659118503332138
with O 0 0.015725083649158478
a O 0 0.017909696325659752
high O 0 0.02536126598715782
frequency O 0 0.03447112441062927
in O 0 0.012477683834731579
Finland O 0 0.02942890301346779
because O 0 0.015266123227775097
of O 0 0.010713014751672745
a O 0 0.022605586796998978
founder O 0 0.05790404975414276
effect O 0 0.06434884667396545
. O 0 0.044358957558870316

While O 0 0.03981912508606911
very O 0 0.03235822916030884
few O 0 0.03299403563141823
patients O 1 0.9883600473403931
with O 0 0.03202419728040695
AGU B-Disease 1 0.9998179078102112
have O 0 0.02061057835817337
been O 0 0.015379718504846096
reported O 0 0.02895563468337059
from O 0 0.018391398712992668
non O 0 0.039661768823862076
- O 0 0.069125235080719
Finnish O 0 0.0652347281575203
origin O 0 0.03592394292354584
, O 0 0.020726637914776802
we O 0 0.02373698353767395
diagnosed O 1 0.9999407529830933
the O 0 0.029988111928105354
disorder O 1 0.9998987913131714
in O 0 0.023937255144119263
8 O 0 0.04709688201546669
patients O 1 0.9861319065093994
originating O 0 0.05890417844057083
from O 0 0.022513702511787415
3 O 0 0.027835464105010033
unrelated O 0 0.040824610739946365
families O 0 0.02401675097644329
, O 0 0.0112684965133667
all O 0 0.008524729870259762
Palestinian O 0 0.024316854774951935
Arabs O 0 0.03209266439080238
from O 0 0.012678664177656174
the O 0 0.012554516084492207
region O 0 0.02900688722729683
of O 0 0.016189128160476685
Jerusalem O 0 0.05043845251202583
. O 0 0.04169812798500061

The O 0 0.06440164893865585
clinical O 1 0.9917049407958984
diagnosis O 1 0.9993423819541931
of O 0 0.03510410711169243
AGU B-Disease 1 0.9998642206192017
is O 0 0.023386800661683083
often O 0 0.02096390537917614
difficult O 0 0.02074386365711689
, O 0 0.011250532232224941
in O 0 0.009190362878143787
particular O 0 0.014091715216636658
early O 0 0.014433465898036957
in O 0 0.008417187258601189
the O 0 0.009857947006821632
course O 0 0.022308606654405594
of O 0 0.011628329753875732
the O 0 0.017485883086919785
disease O 1 0.99921715259552
, O 0 0.01225533988326788
and O 0 0.008235598914325237
most O 0 0.008739661425352097
of O 0 0.009036981500685215
the O 0 0.01726653426885605
patients O 1 0.9985686540603638
are O 0 0.021640749648213387
diagnosed O 1 0.9997912049293518
after O 0 0.024064557626843452
the O 0 0.0135575570166111
age O 0 0.02263333834707737
of O 0 0.012970483861863613
5 O 0 0.03250833600759506
years O 0 0.031040187925100327
. O 0 0.03664710372686386

However O 0 0.03465506434440613
, O 0 0.020341863855719566
since O 0 0.027248017489910126
these O 0 0.02110561728477478
patients O 1 0.9894992113113403
excrete O 0 0.34414252638816833
early O 0 0.03309256583452225
large O 0 0.023751884698867798
amounts O 0 0.03385777026414871
of O 0 0.019164230674505234
aspartylglucosamine O 0 0.11224617063999176
in O 0 0.02613573893904686
urine O 0 0.08788732439279556
, O 0 0.028012217953801155
biochemical O 0 0.09455402195453644
screening O 0 0.07130821794271469
is O 0 0.02142048440873623
easy O 0 0.03519219532608986
by O 0 0.024232814088463783
urine O 0 0.10994365811347961
chromatography O 0 0.24958568811416626
. O 0 0.03484732285141945
. O 0 0.04543821141123772

Detection O 0 0.14850188791751862
of O 0 0.03615759685635567
heterozygous O 0 0.12581050395965576
carriers O 0 0.08376494795084
of O 0 0.02475387044250965
the O 0 0.04037799313664436
ataxia B-Disease 1 0.9999923706054688
- I-Disease 1 0.9941049814224243
telangiectasia I-Disease 1 0.9997132420539856
( O 0 0.08679360151290894
ATM O 0 0.18080171942710876
) O 0 0.05197665095329285
gene O 0 0.09598513692617416
by O 0 0.04358711466193199
G2 O 1 0.9922289252281189
phase O 0 0.16654205322265625
chromosomal O 1 0.6057586073875427
radiosensitivity O 0 0.47559884190559387
of O 0 0.04385325312614441
peripheral O 1 0.9934940934181213
blood O 1 0.9903880953788757
lymphocytes O 1 0.9921448826789856
. O 0 0.06637651473283768

In O 0 0.09465232491493225
ataxia B-Disease 1 0.9999935626983643
- I-Disease 1 0.9988885521888733
telangiectasia I-Disease 1 0.9999358654022217
( O 0 0.1725659966468811
A B-Disease 0 0.4247545003890991
- I-Disease 1 0.9938942790031433
T I-Disease 1 0.9996381998062134
) O 0 0.05938367173075676
patients O 1 0.9961270689964294
, O 0 0.023992475122213364
mutations O 0 0.08449915051460266
in O 0 0.015683526173233986
a O 0 0.02142306976020336
single O 0 0.030800562351942062
gene O 0 0.06907764822244644
, O 0 0.021644553169608116
ATM O 0 0.0745021253824234
, O 0 0.016823433339595795
result O 0 0.028250504285097122
in O 0 0.01994754560291767
an O 0 0.04287261888384819
autosomal B-Disease 1 0.9999953508377075
recessive I-Disease 1 0.9999978542327881
syndrome I-Disease 1 0.9999998807907104
that O 0 0.03553388640284538
embraces O 0 0.06652390956878662
a O 0 0.02156515046954155
variety O 0 0.02100289613008499
of O 0 0.015852084383368492
clinical O 0 0.0764821469783783
features O 0 0.025505417957901955
and O 0 0.01877344399690628
manifests O 0 0.10120848566293716
extreme O 0 0.06758497655391693
radiosensitivity O 0 0.10162807255983353
and O 0 0.01578986644744873
a O 0 0.021770527586340904
strong O 0 0.03355003520846367
pre O 0 0.09665106981992722
- O 0 0.12253620475530624
disposition O 0 0.13578715920448303
to O 0 0.042736027389764786
malignancy B-Disease 1 0.9948340654373169
. O 0 0.06534358859062195

Heterozygotes O 0 0.3759501874446869
for O 0 0.03193321079015732
the O 0 0.030124569311738014
ATM O 0 0.1125926598906517
gene O 0 0.07223449647426605
have O 0 0.018808985128998756
no O 0 0.021088222041726112
clinical O 0 0.07639609277248383
expression O 0 0.0340115986764431
of O 0 0.016072390601038933
A B-Disease 0 0.052576303482055664
- I-Disease 1 0.9675312042236328
T I-Disease 1 0.99925297498703
but O 0 0.020885031670331955
may O 0 0.029231151565909386
be O 0 0.02194540947675705
cancer B-Disease 1 0.9994696974754333
prone O 0 0.14027146995067596
with O 0 0.018150610849261284
a O 0 0.020988982170820236
moderate O 0 0.04603128507733345
increase O 0 0.030746091157197952
in O 0 0.016957007348537445
in O 0 0.025669382885098457
vitro O 0 0.12881459295749664
radiosensitivity O 0 0.35009247064590454
. O 0 0.06632060557603836

We O 0 0.034211039543151855
performed O 0 0.03971971198916435
a O 0 0.030884070321917534
blind O 0 0.09840895980596542
chromosomal O 0 0.16112041473388672
analysis O 0 0.04375026002526283
on O 0 0.03193673491477966
G2 O 1 0.9981005787849426
- O 0 0.25631552934646606
phase O 0 0.12514057755470276
lymphocytes O 1 0.6756060123443604
from O 0 0.029074909165501595
7 O 0 0.03760499507188797
unrelated O 0 0.07133746147155762
A B-Disease 0 0.11771316826343536
- I-Disease 1 0.9941601753234863
T I-Disease 1 0.9997965693473816
patients O 1 0.9974895715713501
, O 0 0.02526249550282955
13 O 0 0.0388115793466568
obligate O 0 0.251715749502182
A B-Disease 0 0.09701309353113174
- I-Disease 1 0.9847346544265747
T I-Disease 1 0.9994639754295349
heterozygotes O 1 0.9845845103263855
( O 0 0.04156875237822533
parents O 0 0.029743852093815804
of O 0 0.011851819232106209
the O 0 0.01950342394411564
patients O 1 0.9763641357421875
) O 0 0.02260802499949932
, O 0 0.01155803445726633
and O 0 0.010310416109859943
14 O 0 0.021969309076666832
normal O 0 0.032267969101667404
controls O 0 0.038790877908468246
following O 0 0.029816526919603348
X O 0 0.08449791371822357
- O 0 0.07374683767557144
irradiation O 0 0.08719988912343979
with O 0 0.023650867864489555
1 O 0 0.035283081233501434
Gy O 0 0.17939262092113495
in O 0 0.015113881789147854
order O 0 0.015485266223549843
to O 0 0.014663324691355228
evaluate O 0 0.04676339402794838
this O 0 0.020289426669478416
cytogenetic O 0 0.13980387151241302
method O 0 0.031307391822338104
as O 0 0.013179189525544643
a O 0 0.016765687614679337
tool O 0 0.03275468945503235
for O 0 0.01564115285873413
detection O 0 0.06365272402763367
of O 0 0.022814245894551277
ATM O 0 0.14078564941883087
carriers O 0 0.12180741131305695
. O 0 0.0524434968829155

Both O 0 0.04411201551556587
A B-Disease 0 0.08180589973926544
- I-Disease 1 0.9571747779846191
T I-Disease 1 0.9985268115997314
homozygotes O 1 0.9839419722557068
and O 0 0.03221576288342476
heterozygotes O 1 0.8948396444320679
showed O 0 0.04934502765536308
significantly O 0 0.050642095506191254
increased O 0 0.04098637402057648
levels O 0 0.04626336321234703
of O 0 0.026647310703992844
radiation O 1 0.9986547231674194
- O 1 0.9855835437774658
induced O 1 0.9985955357551575
chromatid O 1 0.99299156665802
damage O 0 0.1712542474269867
relative O 0 0.03805643692612648
to O 0 0.014043751172721386
that O 0 0.010810297913849354
of O 0 0.014462769031524658
normal O 0 0.04839826747775078
controls O 0 0.059029899537563324
. O 0 0.044806353747844696

These O 0 0.028548775240778923
results O 0 0.035282690078020096
show O 0 0.024748846888542175
that O 0 0.016463086009025574
the O 0 0.026046305894851685
G2 O 1 0.9985872507095337
- O 0 0.4409204125404358
phase O 0 0.15936651825904846
chromosomal O 1 0.7001048922538757
radiosensitivity O 0 0.35680896043777466
assay O 0 0.0933106392621994
can O 0 0.01923447847366333
be O 0 0.007900112308561802
used O 0 0.010418614372611046
for O 0 0.009474528022110462
the O 0 0.014893457293510437
detection O 0 0.06082114204764366
of O 0 0.01895417831838131
A B-Disease 0 0.05665000528097153
- I-Disease 1 0.8681490421295166
T I-Disease 1 0.9978480339050293
heterozygotes O 1 0.9669203162193298
. O 0 0.07698319107294083

In O 0 0.04074390232563019
combination O 0 0.07317739725112915
with O 0 0.026129189878702164
molecular O 0 0.07075414806604385
genetic O 0 0.07540375739336014
analyses O 0 0.046290576457977295
, O 0 0.015469498932361603
this O 0 0.012088079005479813
test O 0 0.026997970417141914
may O 0 0.01507265493273735
be O 0 0.006363359279930592
of O 0 0.007413188461214304
value O 0 0.01195632666349411
in O 0 0.010189428925514221
studies O 0 0.0247568991035223
of O 0 0.01786329783499241
familial B-Disease 1 0.995148241519928
and I-Disease 0 0.029328513890504837
sporadic I-Disease 0 0.46786248683929443
cancers I-Disease 1 0.9986563920974731
aimed O 0 0.053512223064899445
at O 0 0.02360212244093418
determination O 0 0.032931603491306305
of O 0 0.010527228936553001
the O 0 0.015474628657102585
potential O 0 0.039614543318748474
involvement O 0 0.05365440621972084
of O 0 0.025652874261140823
ATM O 1 0.562080979347229
mutations O 1 0.6080702543258667
in O 0 0.03905186802148819
tumor B-Disease 1 0.9996104836463928
risk O 1 0.7679719924926758
or O 0 0.026877110823988914
development O 0 0.030424930155277252
. O 0 0.02420087903738022
. O 0 0.03386040776968002

Ataxia B-Disease 1 0.9999949932098389
- I-Disease 1 0.9968926906585693
telangiectasia I-Disease 1 0.9996784925460815
: O 0 0.047572486102581024
identification O 0 0.03775852546095848
and O 0 0.018677620217204094
detection O 0 0.06683401763439178
of O 0 0.01866341196000576
founder O 0 0.06570577621459961
- O 0 0.10385441780090332
effect O 0 0.0721738412976265
mutations O 0 0.09643511474132538
in O 0 0.018522730097174644
the O 0 0.021348439157009125
ATM O 0 0.10219724476337433
gene O 0 0.0693000853061676
in O 0 0.018704790621995926
ethnic O 0 0.038285158574581146
populations O 0 0.08236052095890045
. O 0 0.047940950840711594

To O 0 0.028017906472086906
facilitate O 0 0.04230748862028122
the O 0 0.02164074033498764
evaluation O 0 0.05381740257143974
of O 0 0.02353738434612751
ATM O 0 0.1254817098379135
heterozygotes O 1 0.8494533896446228
for O 0 0.02656099759042263
susceptibility O 1 0.6423574090003967
to O 0 0.018316227942705154
other O 0 0.017247997224330902
diseases O 1 0.9996308088302612
, O 0 0.017909551039338112
such O 0 0.016875984147191048
as O 0 0.025613829493522644
breast B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9999570846557617
, O 0 0.016567543148994446
we O 0 0.010485358536243439
have O 0 0.009838511236011982
attempted O 0 0.021768836304545403
to O 0 0.01041803415864706
define O 0 0.02265515737235546
the O 0 0.011728860437870026
most O 0 0.013841318897902966
common O 0 0.028262509033083916
mutations O 0 0.07041052728891373
and O 0 0.01229261513799429
their O 0 0.01651162840425968
frequencies O 0 0.05023403465747833
in O 0 0.035561803728342056
ataxia B-Disease 1 0.999993085861206
- I-Disease 1 0.9968882203102112
telangiectasia I-Disease 1 0.9999217987060547
( O 0 0.08535444736480713
A B-Disease 0 0.08799521625041962
- I-Disease 1 0.9636905193328857
T I-Disease 1 0.9970160722732544
) O 0 0.049922119826078415
homozygotes O 1 0.6529613137245178
from O 0 0.023078111931681633
10 O 0 0.02642352692782879
ethnic O 0 0.03677735477685928
populations O 0 0.08181452751159668
. O 0 0.056274063885211945

Both O 0 0.06250932812690735
genomic O 0 0.1668166071176529
mutations O 0 0.1417139768600464
and O 0 0.0203549787402153
their O 0 0.020926985889673233
effects O 0 0.0670875832438469
on O 0 0.023049643263220787
cDNA O 0 0.10401970893144608
were O 0 0.02536604553461075
characterized O 0 0.0910387709736824
. O 0 0.0474386140704155

Protein O 0 0.15973177552223206
- O 0 0.12456400692462921
truncation O 0 0.13532902300357819
testing O 0 0.054596271365880966
of O 0 0.016922907903790474
the O 0 0.020695503801107407
entire O 0 0.05482255667448044
ATM O 0 0.1541433185338974
cDNA O 0 0.16293273866176605
detected O 0 0.11922360211610794
92 O 0 0.0881672352552414
( O 0 0.0452294647693634
66 O 0 0.06654582917690277
% O 0 0.04517614468932152
) O 0 0.04773598909378052
truncating O 0 0.2795059382915497
mutations O 0 0.14997437596321106
in O 0 0.03516809269785881
140 O 0 0.0830121636390686
mutant O 0 0.15321193635463715
alleles O 0 0.2404284030199051
screened O 0 0.14535628259181976
. O 0 0.06660185009241104

The O 0 0.04683941975235939
haplotyping O 0 0.1926753669977188
of O 0 0.025020135566592216
patients O 1 0.9777887463569641
with O 0 0.02606121636927128
identical O 0 0.05798952281475067
mutations O 0 0.13426557183265686
indicates O 0 0.038418322801589966
that O 0 0.009934813715517521
almost O 0 0.009931386448442936
all O 0 0.0060967267490923405
of O 0 0.006253570783883333
these O 0 0.0076652574352920055
represent O 0 0.01465552020817995
common O 0 0.022656626999378204
ancestry O 0 0.03856334462761879
and O 0 0.011903440579771996
that O 0 0.011927721090614796
very O 0 0.018399065360426903
few O 0 0.027935488149523735
spontaneously O 0 0.11523503810167313
recurring O 0 0.41775208711624146
ATM O 0 0.4001827538013458
mutations O 0 0.17249655723571777
exist O 0 0.05319131538271904
. O 0 0.04256384074687958

Assays O 0 0.16539978981018066
requiring O 0 0.08221720159053802
minimal O 0 0.072305828332901
amounts O 0 0.042461324483156204
of O 0 0.019005633890628815
genomic O 0 0.0852375328540802
DNA O 0 0.05001728609204292
were O 0 0.013370084576308727
designed O 0 0.025699345394968987
to O 0 0.015000606887042522
allow O 0 0.028577333316206932
rapid O 0 0.06296560168266296
screening O 0 0.06079426407814026
for O 0 0.017783837392926216
common O 0 0.03338633105158806
ethnic O 0 0.05197514593601227
mutations O 0 0.20190583169460297
. O 0 0.057504571974277496

These O 0 0.053736891597509384
rapid O 0 0.1272822916507721
assays O 0 0.1396743655204773
detected O 0 0.12656034529209137
mutations O 0 0.13019481301307678
in O 0 0.028005026280879974
76 O 0 0.058957599103450775
% O 0 0.0295263584703207
of O 0 0.01728226989507675
Costa O 0 0.06569378823041916
Rican O 0 0.08213552832603455
patients O 1 0.9946427345275879
( O 0 0.03613930568099022
3 O 0 0.02803199365735054
) O 0 0.01952170766890049
, O 0 0.013061290606856346
50 O 0 0.019707562401890755
% O 0 0.019944217056035995
of O 0 0.012633784674108028
Norwegian O 0 0.04470214620232582
patients O 1 0.9879245758056641
( O 0 0.033208370208740234
1 O 0 0.023473050445318222
) O 0 0.01888979971408844
, O 0 0.012124418281018734
25 O 0 0.01910591311752796
% O 0 0.022421101108193398
of O 0 0.015560702420771122
Polish O 0 0.06883015483617783
patients O 1 0.9946091175079346
( O 0 0.03285199776291847
4 O 0 0.0252878088504076
) O 0 0.01648569293320179
, O 0 0.009496309794485569
and O 0 0.009946237318217754
14 O 0 0.019236551597714424
% O 0 0.019530490040779114
of O 0 0.01422762032598257
Italian O 0 0.05699305236339569
patients O 1 0.9971684813499451
( O 0 0.03144524246454239
1 O 0 0.023765426129102707
) O 0 0.017621805891394615
, O 0 0.010403226129710674
as O 0 0.008337524719536304
well O 0 0.010769418440759182
as O 0 0.010772365145385265
in O 0 0.01775820180773735
patients O 1 0.9490929245948792
of O 0 0.02371637523174286
Amish O 0 0.34480518102645874
/ O 1 0.692680299282074
Mennonite O 0 0.10141584277153015
and O 0 0.020751023665070534
Irish O 0 0.04812221974134445
English O 0 0.0339118167757988
backgrounds O 0 0.07350098341703415
. O 0 0.04547598212957382

Additional O 0 0.07547497004270554
mutations O 0 0.11995293200016022
were O 0 0.019288552924990654
observed O 0 0.031146584078669548
in O 0 0.013872203417122364
Japanese O 0 0.024985704571008682
, O 0 0.01684424839913845
Utah O 0 0.04275380074977875
Mormon O 0 0.04462171718478203
, O 0 0.016904592514038086
and O 0 0.015213476493954659
African O 0 0.04624864086508751
American O 0 0.048253901302814484
patients O 1 0.9949783682823181
. O 0 0.05063331872224808

These O 0 0.040946733206510544
assays O 0 0.08271750807762146
should O 0 0.02654964290559292
facilitate O 0 0.04238100349903107
screening O 0 0.06910036504268646
for O 0 0.022702252492308617
A B-Disease 0 0.05640066787600517
- I-Disease 1 0.8767914772033691
T I-Disease 1 0.9976819753646851
heterozygotes O 1 0.7431426644325256
in O 0 0.020265894010663033
the O 0 0.020374581217765808
populations O 0 0.0516633614897728
studied O 0 0.03155728429555893
. O 0 0.02397884614765644
. O 0 0.03667343035340309

The O 0 0.07822209596633911
von B-Disease 1 0.9862276911735535
Hippel I-Disease 1 0.9992734789848328
- I-Disease 1 0.9945884943008423
Lindau I-Disease 1 0.9996898174285889
tumor I-Disease 1 0.9996147155761719
suppressor O 1 0.9432679414749146
gene O 0 0.1013256087899208
is O 0 0.02098478376865387
required O 0 0.022602185606956482
for O 0 0.020214712247252464
cell O 0 0.08240065723657608
cycle O 0 0.10303661227226257
exit O 0 0.08835845440626144
upon O 0 0.04831792041659355
serum O 1 0.6415130496025085
withdrawal O 0 0.139067605137825
. O 0 0.059625111520290375

The O 0 0.04260214418172836
inactivation O 0 0.14220626652240753
of O 0 0.02640761248767376
the O 0 0.04033471643924713
von B-Disease 1 0.9832814335823059
Hippel I-Disease 1 0.9994033575057983
- I-Disease 1 0.9907551407814026
Lindau I-Disease 1 0.9992320537567139
( I-Disease 1 0.6333138346672058
VHL I-Disease 1 0.9996973276138306
) I-Disease 0 0.3223199248313904
tumor I-Disease 1 0.9996570348739624
suppressor O 1 0.9885134100914001
gene O 0 0.4006686508655548
predisposes O 1 0.9922532439231873
affected O 0 0.06861276924610138
individuals O 0 0.029230982065200806
to O 0 0.018580740317702293
the O 0 0.025115493685007095
human O 1 0.8156906366348267
VHL B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999997615814209
and O 0 0.022265102714300156
is O 0 0.01931869052350521
associated O 0 0.03028835542500019
with O 0 0.0286113191395998
sporadic B-Disease 1 0.9959563612937927
renal I-Disease 1 0.9999996423721313
cell I-Disease 1 0.9991899132728577
carcinomas I-Disease 1 0.9999862909317017
( O 0 0.4650419056415558
RCC B-Disease 1 0.9995889067649841
) O 0 0.041667260229587555
and O 0 0.03087104670703411
brain B-Disease 1 0.9595539569854736
hemangioblastomas I-Disease 1 0.668161153793335
. O 0 0.06059269607067108

VHL O 1 0.9990038275718689
- O 1 0.6953212022781372
negative O 0 0.14741994440555573
786 O 1 0.9843989610671997
- O 1 0.7636350393295288
0 O 0 0.1339075267314911
RCC B-Disease 1 0.9988344311714172
cells O 0 0.10002203285694122
are O 0 0.021459028124809265
tumorigenic O 0 0.11586909741163254
in O 0 0.024255407974123955
nude O 0 0.08010509610176086
mice O 0 0.09846646338701248
which O 0 0.018841056153178215
is O 0 0.015770187601447105
suppressed O 0 0.04202013462781906
by O 0 0.017987336963415146
the O 0 0.022318614646792412
reintroduction O 0 0.12916024029254913
of O 0 0.04251560941338539
VHL B-Disease 1 0.9917559623718262
. O 0 0.07274968922138214

Remarkably O 0 0.10054656118154526
, O 0 0.026419028639793396
this O 0 0.01833203434944153
occurs O 0 0.04977823793888092
without O 0 0.02139406092464924
affecting O 0 0.048561688512563705
the O 0 0.018042095005512238
growth O 0 0.03945081681013107
rate O 0 0.033910661935806274
and O 0 0.01854446344077587
cell O 0 0.06307616084814072
cycle O 0 0.06834527850151062
profile O 0 0.041244685649871826
of O 0 0.012342853471636772
these O 0 0.015733808279037476
cells O 0 0.0552150160074234
in O 0 0.0218957532197237
culture O 0 0.04422403872013092
. O 0 0.03950674831867218

The O 0 0.06216084957122803
786 O 1 0.9197553992271423
- O 0 0.14100968837738037
0 O 0 0.08057136833667755
cell O 0 0.0697944313287735
line O 0 0.02808707393705845
, O 0 0.016581200063228607
like O 0 0.021773623302578926
many O 0 0.023951292037963867
cancer B-Disease 1 0.9997357726097107
cells O 0 0.12429655343294144
, O 0 0.022006426006555557
fails O 0 0.059275444597005844
to O 0 0.01807926781475544
exit O 0 0.06066524237394333
the O 0 0.02480563335120678
cell O 0 0.08232748508453369
cycle O 0 0.09379827231168747
upon O 0 0.04360652714967728
serum O 1 0.8198650479316711
withdrawal O 0 0.11972223222255707
. O 0 0.05537833645939827

Here O 0 0.030360382050275803
, O 0 0.0159478560090065
it O 0 0.009982655756175518
is O 0 0.010612753219902515
shown O 0 0.01922820694744587
that O 0 0.011307131499052048
reintroduction O 0 0.06674251705408096
of O 0 0.015098998323082924
the O 0 0.021770521998405457
wild O 0 0.06405169516801834
- O 0 0.18830998241901398
type O 0 0.1482931673526764
VHL B-Disease 1 0.9955198764801025
gene O 0 0.12057451903820038
restores O 0 0.10038969665765762
the O 0 0.02351759374141693
ability O 0 0.04775143787264824
of O 0 0.03329503536224365
VHL O 1 0.9998476505279541
- O 1 0.9863250851631165
negative O 1 0.9220477938652039
RCC B-Disease 1 0.9999778270721436
cancer I-Disease 1 0.9999439716339111
cells O 0 0.08867128938436508
to O 0 0.020056171342730522
exit O 0 0.05141786113381386
the O 0 0.021018292754888535
cell O 0 0.07101491093635559
cycle O 0 0.07863122969865799
and O 0 0.025163061916828156
enter O 0 0.07059420645236969
G0 O 1 0.9996076226234436
/ O 1 0.9930416345596313
quiescence O 1 0.9308241009712219
in O 0 0.03911060467362404
low O 0 0.0960543230175972
serum O 1 0.7373701333999634
. O 0 0.05624978616833687

Both O 0 0.07798495888710022
VHL O 1 0.9968305230140686
- O 0 0.19154132902622223
positive O 0 0.07480376213788986
and O 0 0.03938242048025131
VHL O 1 0.9997541308403015
- O 1 0.8219900131225586
negative O 0 0.13278666138648987
RCC B-Disease 1 0.998902440071106
cells O 0 0.14873875677585602
exit O 0 0.08408188074827194
the O 0 0.02880638837814331
cell O 0 0.08056574314832687
cycle O 0 0.07985710352659225
by O 0 0.028214652091264725
contact O 0 0.08778436481952667
inhibition O 0 0.31810033321380615
. O 0 0.052704356610774994

The O 0 0.07597911357879639
cyclin O 1 0.9650339484214783
- O 0 0.3436116874217987
dependent O 0 0.1817539781332016
kinase O 1 0.9716269969940186
inhibitor O 1 0.9864388704299927
, O 0 0.05132446810603142
p27 O 1 0.959757387638092
, O 0 0.03644832223653793
accumulates O 0 0.11151888966560364
upon O 0 0.03892632946372032
serum O 1 0.605606198310852
withdrawal O 0 0.06201472133398056
, O 0 0.014052762649953365
only O 0 0.008953478187322617
in O 0 0.009882439859211445
the O 0 0.011852864176034927
presence O 0 0.02655058167874813
of O 0 0.017405837774276733
VHL B-Disease 1 0.9931417107582092
, O 0 0.015289388597011566
as O 0 0.010293517261743546
a O 0 0.014557793736457825
result O 0 0.019352199509739876
of O 0 0.00928704347461462
the O 0 0.014283692464232445
stabilization O 0 0.07799149304628372
of O 0 0.015037233009934425
the O 0 0.021572427824139595
protein O 0 0.07053674012422562
. O 0 0.0417013093829155

We O 0 0.037095848470926285
propose O 0 0.053348612040281296
that O 0 0.01607437990605831
the O 0 0.01591254398226738
loss O 0 0.04765474051237106
of O 0 0.019786052405834198
wild O 0 0.06719543039798737
- O 0 0.40159088373184204
type O 0 0.2059333473443985
VHL B-Disease 1 0.998094379901886
gene O 0 0.098414346575737
results O 0 0.03340790048241615
in O 0 0.014711759984493256
a O 0 0.01995394006371498
specific O 0 0.027778591960668564
cellular O 0 0.08206351101398468
defect O 1 0.8213499188423157
in O 0 0.031686875969171524
serum O 1 0.9859842658042908
- O 0 0.09233690053224564
dependent O 0 0.06260275840759277
growth O 0 0.039621274918317795
control O 0 0.033932946622371674
, O 0 0.014946255832910538
which O 0 0.018018364906311035
may O 0 0.041658855974674225
initiate O 0 0.1298990398645401
tumor B-Disease 1 0.9952731728553772
formation O 0 0.1130308285355568
. O 0 0.05285365879535675

This O 0 0.02868831716477871
is O 0 0.02126142755150795
corrected O 0 0.05793178826570511
by O 0 0.01638863794505596
the O 0 0.018927879631519318
reintroduction O 0 0.09173449128866196
of O 0 0.02414570190012455
wild O 0 0.06740059703588486
- O 0 0.33996081352233887
type O 0 0.2414100468158722
VHL B-Disease 1 0.9983752965927124
, O 0 0.046501096338033676
implicating O 1 0.5495151877403259
VHL B-Disease 1 0.9923986792564392
as O 0 0.021524161100387573
the O 0 0.02195858396589756
first O 0 0.034003715962171555
tumor B-Disease 1 0.99644535779953
suppressor O 1 0.5374919772148132
involved O 0 0.02914830669760704
in O 0 0.013461839407682419
the O 0 0.014309469610452652
regulation O 0 0.0384235680103302
of O 0 0.0182686485350132
cell O 0 0.07158471643924713
cycle O 0 0.07396053522825241
exit O 0 0.05481365695595741
, O 0 0.014004153199493885
which O 0 0.01108547206968069
is O 0 0.011474987491965294
consistent O 0 0.02282537892460823
with O 0 0.01201571524143219
its O 0 0.017307594418525696
gatekeeper O 0 0.12538278102874756
function O 0 0.030049894005060196
in O 0 0.01564495824277401
the O 0 0.023073438555002213
kidney O 1 0.9991043210029602
. O 0 0.03516078740358353
. O 0 0.03954638913273811

Piebaldism B-Disease 1 0.9966568946838379
with O 0 0.08053214102983475
deafness B-Disease 1 0.9998936653137207
: O 0 0.044275444000959396
molecular O 0 0.05168888717889786
evidence O 0 0.02197248861193657
for O 0 0.014976988546550274
an O 0 0.023423364385962486
expanded O 0 0.06910398602485657
syndrome O 1 0.9999886751174927
. O 0 0.0649736151099205

In O 0 0.02840832807123661
a O 0 0.025993330404162407
South O 0 0.03469438478350639
African O 0 0.0505240373313427
girl O 0 0.07034599781036377
of O 0 0.023615218698978424
Xhosa O 1 0.7862234711647034
stock O 0 0.07901103049516678
with O 0 0.03966200724244118
severe O 1 0.9995111227035522
piebaldism B-Disease 1 0.9957004189491272
and O 0 0.05279383063316345
profound O 1 0.9980428218841553
congenital O 1 0.9999997615814209
sensorineural B-Disease 1 0.9999967813491821
deafness I-Disease 1 0.999993085861206
we O 0 0.03265880420804024
identified O 0 0.03990470990538597
a O 0 0.026642240583896637
novel O 0 0.05848914384841919
missense O 0 0.17173779010772705
substitution O 0 0.07166590541601181
at O 0 0.02935764193534851
a O 0 0.023304283618927002
highly O 0 0.03640970587730408
conserved O 0 0.050983067601919174
residue O 0 0.06692174077033997
in O 0 0.018685080111026764
the O 0 0.025902774184942245
intracellular O 0 0.12949195504188538
kinase O 0 0.13744303584098816
domain O 0 0.04248148202896118
of O 0 0.01803446188569069
the O 0 0.026258883997797966
KIT O 1 0.5046046376228333
proto O 1 0.9127564430236816
- O 1 0.6355116963386536
oncogene O 1 0.9307323694229126
, O 0 0.06015367805957794
R796G O 0 0.17867356538772583
. O 0 0.0654866099357605

Though O 0 0.09494411200284958
auditory B-Disease 1 0.9171788096427917
anomalies I-Disease 0 0.14865529537200928
have O 0 0.020255209878087044
been O 0 0.016777528449892998
observed O 0 0.027503028512001038
in O 0 0.01840653270483017
mice O 0 0.09019926190376282
with O 0 0.023187434300780296
dominant O 0 0.07420151680707932
white O 0 0.09244845807552338
spotting O 1 0.9816531538963318
( O 0 0.06840752065181732
W O 1 0.9227369427680969
) O 0 0.03386704996228218
due O 0 0.03227080777287483
to O 0 0.026640720665454865
KIT O 1 0.8854837417602539
mutations O 1 0.7954294681549072
, O 0 0.03686670958995819
deafness B-Disease 1 0.9998190999031067
is O 0 0.01967989094555378
not O 0 0.014043712988495827
typical O 0 0.03803247585892677
in O 0 0.01900263875722885
human O 0 0.041248176246881485
piebaldism B-Disease 0 0.24677731096744537
. O 0 0.05192546546459198

Thus O 0 0.04934617504477501
, O 0 0.02168617770075798
the O 0 0.025041675195097923
occurrence O 0 0.09596024453639984
of O 0 0.039827410131692886
sensorineural B-Disease 1 0.9999644756317139
deafness I-Disease 1 0.9999723434448242
in O 0 0.029998403042554855
this O 0 0.022264253348112106
patient O 1 0.5748621225357056
extends O 0 0.06680790334939957
considerably O 0 0.047329459339380264
the O 0 0.02108769677579403
phenotypic O 0 0.07853858917951584
range O 0 0.03884528949856758
of O 0 0.020095219835639
piebaldism B-Disease 0 0.12327947467565536
due O 0 0.033872753381729126
to O 0 0.024738889187574387
KIT O 1 0.5669522881507874
gene O 0 0.11780256032943726
mutation O 0 0.1300969272851944
in O 0 0.021939458325505257
humans O 0 0.049391381442546844
and O 0 0.02457195706665516
tightens O 1 0.6566356420516968
the O 0 0.02654539979994297
clinical O 0 0.11332572996616364
similarity O 0 0.05663710832595825
between O 0 0.023323317989706993
piebaldism B-Disease 0 0.07868457585573196
and O 0 0.010970384813845158
the O 0 0.012028258293867111
various O 0 0.013723473995923996
forms O 0 0.03891435265541077
of O 0 0.04259258508682251
Waardenburg B-Disease 1 0.9999946355819702
syndrome I-Disease 1 0.9999983310699463
. O 0 0.047761641442775726
. O 0 0.04632176086306572

Cycloheximide O 0 0.28551748394966125
facilitates O 0 0.1171027198433876
the O 0 0.027073031291365623
identification O 0 0.041103996336460114
of O 0 0.022333867847919464
aberrant O 0 0.1190878227353096
transcripts O 0 0.05528377369046211
resulting O 0 0.04725506901741028
from O 0 0.018896669149398804
a O 0 0.027457239106297493
novel O 0 0.06052747368812561
splice O 0 0.1657136231660843
- O 0 0.1021750271320343
site O 0 0.0528021864593029
mutation O 0 0.11589960753917694
in O 0 0.02818893827497959
COL17A1 O 0 0.17139028012752533
in O 0 0.02266116626560688
a O 0 0.03294296935200691
patient O 1 0.9740183353424072
with O 0 0.04564417153596878
generalized O 1 0.9979523420333862
atrophic B-Disease 1 0.9999868869781494
benign I-Disease 1 0.9999549388885498
epidermolysis I-Disease 1 0.999975323677063
bullosa I-Disease 1 0.9998856782913208
. O 0 0.10874070227146149

Patients O 1 0.9993680119514465
with O 0 0.08175907284021378
generalized O 1 0.9975316524505615
atrophic B-Disease 1 0.9999886751174927
benign I-Disease 1 0.9999606609344482
epidermolysis I-Disease 1 0.9999828338623047
bullosa I-Disease 1 0.9998399019241333
often O 0 0.06842782348394394
show O 0 0.048501159995794296
decreased O 0 0.0789981484413147
expression O 0 0.05130843073129654
of O 0 0.023341523483395576
type O 0 0.3247472047805786
XVII O 1 0.9994978904724121
collagen O 1 0.9876385927200317
, O 0 0.03025275282561779
a O 0 0.03937619924545288
transmembrane O 0 0.15656837821006775
hemidesmosomal O 0 0.17505280673503876
protein O 0 0.08242259174585342
encoded O 0 0.04772017151117325
by O 0 0.03360389545559883
COL17A1 O 0 0.25333282351493835
. O 0 0.05596470460295677

This O 0 0.023769326508045197
report O 0 0.02440796233713627
documents O 0 0.019740670919418335
a O 0 0.02496812306344509
novel O 0 0.05167107284069061
splice O 0 0.17339782416820526
- O 0 0.1050293892621994
site O 0 0.055098433047533035
mutation O 0 0.12172141671180725
in O 0 0.025145867839455605
COL17A1 O 0 0.21366336941719055
in O 0 0.022171251475811005
a O 0 0.03074658289551735
patient O 1 0.8990259766578674
with O 0 0.04991708695888519
generalized O 1 0.9970582723617554
atrophic B-Disease 1 0.9999918937683105
benign I-Disease 1 0.9999620914459229
epidermolysis I-Disease 1 0.9999903440475464
bullosa I-Disease 1 0.9998539686203003
, O 0 0.03913257271051407
and O 0 0.019957464188337326
applies O 0 0.029342256486415863
a O 0 0.01565338298678398
new O 0 0.014936696738004684
methodology O 0 0.03093036822974682
to O 0 0.012988675385713577
define O 0 0.030814526602625847
and O 0 0.017346233129501343
characterize O 0 0.0672287568449974
the O 0 0.026381121948361397
resulting O 0 0.07076248526573181
mRNA O 0 0.1082136407494545
splice O 0 0.19093380868434906
variants O 0 0.12375184148550034
. O 0 0.06407661736011505

Mutational O 1 0.6328620314598083
analysis O 0 0.06431352347135544
of O 0 0.029438741505146027
COL17A1 O 0 0.16470274329185486
identified O 0 0.048088014125823975
a O 0 0.03770697861909866
maternally O 0 0.2036786824464798
inherited O 1 0.7753132581710815
G O 1 0.7738614082336426
- O 0 0.09903763979673386
to O 0 0.027575144544243813
- O 0 0.16715306043624878
T O 1 0.7962040901184082
transversion O 0 0.11759836226701736
at O 0 0.023890718817710876
the O 0 0.01773228868842125
- O 0 0.051520079374313354
1 O 0 0.026383215561509132
position O 0 0.022722208872437477
of O 0 0.02158709429204464
exon O 0 0.12049668282270432
32 O 0 0.06991380453109741
. O 0 0.0509636215865612

This O 0 0.05018969625234604
acceptor O 0 0.20049844682216644
splice O 0 0.289785236120224
- O 0 0.1109505370259285
site O 0 0.04640829190611839
mutation O 0 0.10158833116292953
led O 0 0.029318351298570633
to O 0 0.012686343863606453
the O 0 0.015126151964068413
formation O 0 0.046141061931848526
of O 0 0.021013576537370682
aberrant O 0 0.1195250079035759
transcripts O 0 0.060044918209314346
present O 0 0.028730634599924088
at O 0 0.02768416702747345
extremely O 0 0.047027915716171265
low O 0 0.06357467174530029
levels O 0 0.07448619604110718
. O 0 0.04986909031867981

Based O 0 0.038159098476171494
on O 0 0.01773122325539589
our O 0 0.021741431206464767
recent O 0 0.03375395014882088
finding O 0 0.03985914960503578
that O 0 0.028049973770976067
cycloheximide O 0 0.4546259045600891
stabilized O 1 0.7291073799133301
mutant O 0 0.15535178780555725
COL17A1 O 1 0.5182064771652222
transcripts O 0 0.07450752705335617
in O 0 0.03262093663215637
keratinocytes O 1 0.5008947849273682
homozygous O 0 0.12603749334812164
for O 0 0.025834593921899796
a O 0 0.042750123888254166
frameshift O 1 0.9580127596855164
mutation O 0 0.16451849043369293
, O 0 0.020508192479610443
the O 0 0.017843907698988914
effects O 0 0.05228244140744209
of O 0 0.014670966193079948
the O 0 0.022370316088199615
splice O 0 0.14983119070529938
- O 0 0.09165319055318832
site O 0 0.04642967879772186
mutation O 0 0.11073650419712067
on O 0 0.021770942956209183
splicing O 0 0.07939707487821579
of O 0 0.02181301638484001
COL17A1 O 0 0.13468997180461884
transcripts O 0 0.04633796587586403
were O 0 0.016873035579919815
determined O 0 0.03346205875277519
using O 0 0.03450806066393852
reverse O 0 0.09636256098747253
transcriptase O 1 0.6909795999526978
polymerase O 0 0.21423643827438354
chain O 0 0.09994291514158249
reaction O 0 0.06378655135631561
of O 0 0.017359599471092224
total O 0 0.03145367279648781
RNA O 0 0.08270034193992615
from O 0 0.027264723554253578
keratinocytes O 0 0.32242655754089355
incubated O 0 0.09100848436355591
for O 0 0.023646768182516098
2 O 0 0.03919540345668793
. O 0 0.037344202399253845

5 O 0 0.06410129368305206
h O 0 0.08298265933990479
in O 0 0.016010582447052002
the O 0 0.014388798736035824
presence O 0 0.03304421156644821
or O 0 0.02491030842065811
absence O 0 0.0435049943625927
of O 0 0.019626770168542862
10 O 0 0.038969140499830246
microg O 0 0.25774484872817993
cycloheximide O 0 0.3312681317329407
per O 0 0.06214822083711624
ml O 0 0.4093579649925232
. O 0 0.05902189016342163

Using O 0 0.03609263151884079
this O 0 0.019743872806429863
approach O 0 0.037970878183841705
, O 0 0.020377112552523613
an O 0 0.026132667437195778
abnormally O 0 0.204430490732193
spliced O 0 0.11812102794647217
transcript O 0 0.059090591967105865
was O 0 0.017530931159853935
identified O 0 0.02178373746573925
that O 0 0.010027235373854637
contains O 0 0.015084227547049522
an O 0 0.012773346155881882
extra O 0 0.032415252178907394
264 O 0 0.06464668363332748
bases O 0 0.03921758010983467
upstream O 0 0.05957060679793358
from O 0 0.02218647673726082
exon O 0 0.10020551830530167
32 O 0 0.04147946089506149
, O 0 0.019068114459514618
resulting O 0 0.036653485149145126
in O 0 0.0193561352789402
a O 0 0.03928633779287338
premature O 1 0.896965503692627
termination O 1 0.6849908828735352
codon O 0 0.15907961130142212
27 O 0 0.0638846904039383
bp O 0 0.10113313794136047
downstream O 0 0.07789257913827896
from O 0 0.027969542890787125
the O 0 0.032116349786520004
cryptic O 0 0.12861427664756775
splice O 0 0.19460038840770721
site O 0 0.0637856051325798
. O 0 0.04830504208803177

Three O 0 0.03542201220989227
other O 0 0.02483205497264862
splice O 0 0.12930025160312653
variants O 0 0.060117144137620926
, O 0 0.016346942633390427
including O 0 0.013704590499401093
one O 0 0.013874773867428303
derived O 0 0.02516530267894268
from O 0 0.014577221125364304
the O 0 0.015214318409562111
skipping O 0 0.06307000666856766
of O 0 0.02016467973589897
exon O 0 0.09837370365858078
32 O 0 0.03566843643784523
, O 0 0.013357937335968018
were O 0 0.01149928942322731
also O 0 0.014030752703547478
identified O 0 0.038674261420965195
. O 0 0.037853315472602844

These O 0 0.030375104397535324
results O 0 0.038971275091171265
indicate O 0 0.03502770885825157
the O 0 0.01678171381354332
usefulness O 0 0.058297667652368546
of O 0 0.022271158173680305
cycloheximide O 1 0.8811596632003784
treatment O 1 0.6433430314064026
in O 0 0.016241049394011497
evaluating O 0 0.04116391763091087
the O 0 0.01715884543955326
abnormal O 0 0.11732558906078339
processing O 0 0.03035505674779415
of O 0 0.017063070088624954
mRNA O 0 0.0529765784740448
due O 0 0.03080054745078087
to O 0 0.025265570729970932
splice O 0 0.15137015283107758
- O 0 0.10002593696117401
site O 0 0.047331973910331726
mutations O 0 0.10892734676599503
, O 0 0.019195500761270523
because O 0 0.024665720760822296
( O 0 0.03211754560470581
i O 0 0.029910005629062653
) O 0 0.03488427400588989
aberrant O 0 0.12701812386512756
splicing O 0 0.1204441636800766
often O 0 0.045259129256010056
generates O 0 0.07808443158864975
a O 0 0.04900265857577324
premature O 1 0.7927505970001221
termination O 1 0.7877665162086487
codon O 0 0.14867815375328064
, O 0 0.030698245391249657
( O 0 0.03935612738132477
ii O 0 0.052311524748802185
) O 0 0.030997764319181442
transcripts O 0 0.04917332902550697
with O 0 0.03052689880132675
premature O 1 0.971814751625061
termination O 1 0.9512369632720947
codons O 0 0.12565812468528748
can O 0 0.033059604465961456
occur O 0 0.04916887357831001
at O 0 0.026880040764808655
low O 0 0.04929397627711296
or O 0 0.030932286754250526
undetectable O 1 0.6537289619445801
levels O 0 0.051128488034009933
due O 0 0.02837049961090088
to O 0 0.022520260885357857
nonsense O 0 0.08382133394479752
- O 0 0.09317750483751297
mediated O 0 0.13936848938465118
mRNA O 0 0.0871853232383728
decay O 0 0.05967484414577484
, O 0 0.01667553000152111
and O 0 0.014703971333801746
( O 0 0.02930532395839691
iii O 0 0.050211697816848755
) O 0 0.016854263842105865
the O 0 0.010030213743448257
levels O 0 0.023989388719201088
of O 0 0.008880714885890484
these O 0 0.00953609123826027
transcripts O 0 0.029915114864706993
can O 0 0.01293596439063549
be O 0 0.010617640800774097
increased O 0 0.02528655342757702
by O 0 0.025477195158600807
cycloheximide O 0 0.15787072479724884
. O 0 0.04987507313489914

A O 0 0.09828789532184601
deletion O 0 0.2366536259651184
mutation O 0 0.17291520535945892
in O 0 0.03417520597577095
COL17A1 O 0 0.15167450904846191
in O 0 0.022765330970287323
five O 0 0.02919352799654007
Austrian O 0 0.07972314953804016
families O 0 0.051714714616537094
with O 0 0.04527387395501137
generalized O 1 0.9946538209915161
atrophic B-Disease 1 0.9999831914901733
benign I-Disease 1 0.9999133348464966
epidermolysis I-Disease 1 0.999969482421875
bullosa I-Disease 1 0.9997567534446716
represents O 0 0.09626026451587677
propagation O 0 0.08083298802375793
of O 0 0.020240794867277145
an O 0 0.02470509149134159
ancestral O 0 0.10011609643697739
allele O 0 0.19990818202495575
. O 0 0.06065353378653526

Patients O 1 0.9990096092224121
with O 0 0.07895854860544205
generalized O 1 0.9977174997329712
atrophic B-Disease 1 0.9999878406524658
benign I-Disease 1 0.9999525547027588
epidermolysis I-Disease 1 0.9999866485595703
bullosa I-Disease 1 0.99978107213974
, O 0 0.040268633514642715
a O 0 0.031079880893230438
usually O 0 0.04014512524008751
nonlethal O 0 0.11948752403259277
form O 0 0.04496898502111435
of O 0 0.04212729260325432
junctional B-Disease 1 0.9996411800384521
epidermolysis I-Disease 1 0.999944806098938
bullosa I-Disease 1 0.9998243451118469
, O 0 0.050776585936546326
have O 0 0.04185499623417854
generalized O 1 0.87424236536026
blistering B-Disease 1 0.9819570779800415
, O 0 0.06774318963289261
nail B-Disease 1 0.9998936653137207
dystrophy I-Disease 1 0.9999991655349731
, O 0 0.11441861838102341
patchy B-Disease 1 0.9997016787528992
alopecia I-Disease 1 0.9999977350234985
, O 0 0.044337544590234756
and O 0 0.038569267839193344
dental B-Disease 1 0.9997209906578064
abnormalities I-Disease 1 0.9981536269187927
. O 0 0.05574328824877739

Skin B-Disease 1 0.9998142123222351
fragility I-Disease 1 0.9669820666313171
in O 0 0.026545967906713486
most O 0 0.01743246801197529
cases O 0 0.027098558843135834
is O 0 0.015491621568799019
due O 0 0.022753598168492317
to O 0 0.018521461635828018
mutations O 0 0.08123768866062164
in O 0 0.01698838174343109
the O 0 0.022729171440005302
gene O 0 0.10453052818775177
encoding O 0 0.10884204506874084
type O 0 0.3829194903373718
XVII O 1 0.9993975162506104
collagen O 1 0.9984228610992432
( O 0 0.08225931227207184
COL17A1 O 1 0.8970345854759216
) O 0 0.05910409614443779
. O 0 0.042076826095581055

Recently O 0 0.06516856700181961
, O 0 0.022689903154969215
we O 0 0.017745332792401314
reported O 0 0.028127599507570267
five O 0 0.02391200140118599
Austrian O 0 0.06902257353067398
families O 0 0.046548858284950256
with O 0 0.04824444651603699
generalized O 1 0.9953378438949585
atrophic B-Disease 1 0.9999836683273315
benign I-Disease 1 0.9999266862869263
epidermolysis I-Disease 1 0.9999679327011108
bullosa I-Disease 1 0.9996535778045654
who O 0 0.04904991760849953
share O 0 0.0444728285074234
the O 0 0.027259740978479385
same O 0 0.03954056650400162
COL17A1 O 1 0.8994064927101135
mutation O 0 0.3042631447315216
. O 0 0.06403651088476181

Affected O 0 0.08612668514251709
individuals O 0 0.03419401869177818
in O 0 0.015425506979227066
three O 0 0.015374037437140942
families O 0 0.026336686685681343
are O 0 0.016221510246396065
homozygous O 0 0.0685281828045845
for O 0 0.019497280940413475
4003delTC O 0 0.10477463901042938
, O 0 0.017436226829886436
whereas O 0 0.023425821214914322
those O 0 0.010225396603345871
in O 0 0.009822622872889042
two O 0 0.009934102185070515
others O 0 0.0188154224306345
are O 0 0.01756957359611988
compound O 0 0.08226326107978821
heterozygotes O 1 0.8946847319602966
. O 0 0.056228701025247574

To O 0 0.02746519446372986
determine O 0 0.028488390147686005
if O 0 0.016309482976794243
the O 0 0.015193650498986244
occurrence O 0 0.06446384638547897
of O 0 0.01783697120845318
4003delTC O 0 0.09016194194555283
in O 0 0.016367027536034584
these O 0 0.016238002106547356
unrelated O 0 0.05075652524828911
families O 0 0.04038844257593155
signifies O 0 0.07300429046154022
propagation O 0 0.060878340154886246
of O 0 0.015126749873161316
an O 0 0.021977948024868965
ancestral O 0 0.07448621839284897
allele O 0 0.14172318577766418
or O 0 0.03793501481413841
a O 0 0.038977500051259995
mutational O 1 0.9352250695228577
hot O 0 0.09248390793800354
spot O 0 0.054803065955638885
, O 0 0.02700592391192913
haplotypes O 0 0.1355094164609909
were O 0 0.01698560267686844
determined O 0 0.028790157288312912
for O 0 0.015010179951786995
polymorphisms O 0 0.07811722159385681
both O 0 0.017766522243618965
within O 0 0.02108156494796276
and O 0 0.022787606343626976
flanking O 0 0.1402713507413864
COL17A1 O 1 0.7862643003463745
. O 0 0.05493956804275513

Five O 0 0.07014212757349014
intragenic O 0 0.19456665217876434
polymorphisms O 0 0.12474659830331802
were O 0 0.019588060677051544
chosen O 0 0.023003924638032913
based O 0 0.01733836717903614
on O 0 0.013508452102541924
their O 0 0.022183503955602646
informativeness O 0 0.14514146745204926
. O 0 0.04530424252152443

One O 0 0.02327457256615162
of O 0 0.012515007518231869
these O 0 0.01072615198791027
, O 0 0.0115038538351655
not O 0 0.00956873968243599
previously O 0 0.017548594623804092
reported O 0 0.02472505159676075
, O 0 0.012070734985172749
was O 0 0.013930285349488258
2988 O 0 0.08040133118629456
A O 0 0.0242429468780756
or O 0 0.022006429731845856
C O 0 0.04640712961554527
that O 0 0.011101196520030499
introduces O 0 0.03762008249759674
a O 0 0.01920139044523239
new O 0 0.01817052625119686
restriction O 0 0.04180991277098656
site O 0 0.026119859889149666
for O 0 0.02143705077469349
Eco0109 O 0 0.12464655190706253
I O 0 0.052759379148483276
. O 0 0.03903232514858246

All O 0 0.0285686906427145
the O 0 0.029616056010127068
4003delTC O 0 0.16061203181743622
alleles O 0 0.13583841919898987
showed O 0 0.03936756029725075
the O 0 0.019111892208456993
same O 0 0.025448882952332497
haplotype O 0 0.15062792599201202
for O 0 0.0147477388381958
these O 0 0.014543578960001469
five O 0 0.03276405110955238
polymorphic O 0 0.2495872527360916
markers O 0 0.12570522725582123
. O 0 0.05819888040423393

Fourteen O 0 0.12898831069469452
microsatellite O 0 0.3017812967300415
polymorphisms O 0 0.1439296305179596
were O 0 0.019566113129258156
selected O 0 0.018098149448633194
based O 0 0.015308618545532227
on O 0 0.009828982874751091
their O 0 0.013773700222373009
high O 0 0.030504323542118073
heterozygosity O 0 0.12494513392448425
and O 0 0.013625634834170341
their O 0 0.013304187916219234
location O 0 0.027069810777902603
within O 0 0.02975337579846382
10q23 O 0 0.18187853693962097
- O 0 0.11996137350797653
q25 O 0 0.1875898838043213
near O 0 0.08176901936531067
COL17A1 O 1 0.5718235969543457
. O 0 0.05974078178405762

Three O 0 0.04203760623931885
families O 0 0.059228818863630295
shared O 0 0.0696573331952095
microsatellite O 0 0.41534602642059326
polymorphisms O 0 0.18269023299217224
covering O 0 0.059822529554367065
at O 0 0.030631892383098602
most O 0 0.018399043008685112
19 O 0 0.033094193786382675
cM O 0 0.04679713398218155
, O 0 0.014305784367024899
whereas O 0 0.024149276316165924
the O 0 0.012161088176071644
others O 0 0.01692693866789341
shared O 0 0.022987795993685722
smaller O 0 0.022372780367732048
regions O 0 0.03040553815662861
consistent O 0 0.02729114331305027
with O 0 0.016300534829497337
cross O 0 0.034777265042066574
- O 0 0.0509127713739872
over O 0 0.0200053621083498
events O 0 0.0249317679554224
during O 0 0.02360508404672146
passage O 0 0.028909487649798393
of O 0 0.014518103562295437
this O 0 0.017649689689278603
mutation O 0 0.09417793899774551
through O 0 0.02730288729071617
several O 0 0.023875851184129715
generations O 0 0.062305204570293427
. O 0 0.04333221912384033

These O 0 0.029356399551033974
results O 0 0.04328591376543045
indicate O 0 0.04092960059642792
that O 0 0.019084809347987175
4003delTC O 0 0.11265037208795547
occurs O 0 0.04944079741835594
on O 0 0.013411914929747581
a O 0 0.018407925963401794
single O 0 0.035748522728681564
ancestral O 0 0.07901140302419662
allele O 0 0.13997988402843475
. O 0 0.03382064029574394
. O 0 0.043430689722299576

The O 0 0.0747787207365036
haptoglobin O 1 0.9203928112983704
- O 0 0.24912197887897491
gene O 0 0.16853861510753632
deletion O 0 0.1815151423215866
responsible O 0 0.06974314898252487
for O 0 0.036999352276325226
anhaptoglobinemia B-Disease 0 0.24363932013511658
. O 0 0.05802946165204048

We O 0 0.026817496865987778
have O 0 0.018725743517279625
found O 0 0.023002369329333305
an O 0 0.02617526426911354
allelic O 0 0.1787773072719574
deletion O 0 0.12511003017425537
of O 0 0.0213219802826643
the O 0 0.027385832741856575
haptoglobin O 1 0.8448607325553894
( O 0 0.052700020372867584
Hp O 0 0.10284662991762161
) O 0 0.032059770077466965
gene O 0 0.05190447345376015
from O 0 0.01583687961101532
an O 0 0.014816884882748127
individual O 0 0.028431519865989685
with O 0 0.030185755342245102
anhaptoglobinemia B-Disease 0 0.2721169590950012
. O 0 0.04938970133662224

The O 0 0.05162101984024048
Hp O 0 0.14374710619449615
gene O 0 0.11043494939804077
cluster O 0 0.07142728567123413
consists O 0 0.02725163660943508
of O 0 0.016237027943134308
coding O 0 0.06697164475917816
regions O 0 0.0299359280616045
of O 0 0.012401432730257511
the O 0 0.01630268432199955
alpha O 0 0.05378919467329979
chain O 0 0.055799826979637146
and O 0 0.019710326567292213
beta O 0 0.05618559569120407
chain O 0 0.04522516578435898
of O 0 0.01683683693408966
the O 0 0.028040686622262
haptoglobin O 1 0.8617242574691772
gene O 0 0.11225230246782303
( O 0 0.0429542101919651
Hp O 0 0.07056742161512375
) O 0 0.020659297704696655
and O 0 0.009838477708399296
of O 0 0.010687575675547123
the O 0 0.01599220186471939
alpha O 0 0.05056208372116089
chain O 0 0.05419640243053436
and O 0 0.019370611757040024
beta O 0 0.061038266867399216
chain O 0 0.046040501445531845
of O 0 0.01741853728890419
the O 0 0.030412200838327408
haptoglobin O 1 0.9530595541000366
- O 0 0.14636877179145813
related O 0 0.0771431028842926
gene O 0 0.1264701932668686
( O 0 0.0576430968940258
Hpr O 1 0.8134501576423645
) O 0 0.03075609728693962
, O 0 0.013211796060204506
in O 0 0.012756471522152424
tandem O 0 0.05138295888900757
from O 0 0.01592743769288063
the O 0 0.015208089724183083
5 O 0 0.033620238304138184
side O 0 0.04597785323858261
. O 0 0.034912314265966415

Southern O 0 0.0972306877374649
blot O 0 0.18211965262889862
and O 0 0.03487100824713707
PCR O 0 0.136318638920784
analyses O 0 0.04812946915626526
have O 0 0.017212631180882454
indicated O 0 0.024429157376289368
that O 0 0.008290688507258892
the O 0 0.010466986335814
individual O 0 0.02091405913233757
with O 0 0.017497502267360687
anhaptoglobinemia B-Disease 0 0.10288504511117935
was O 0 0.018697207793593407
homozygous O 0 0.06764253973960876
for O 0 0.014538844116032124
the O 0 0.017382079735398293
gene O 0 0.07664564251899719
deletion O 0 0.08930151164531708
and O 0 0.014368842355906963
that O 0 0.012504887767136097
the O 0 0.017886007204651833
gene O 0 0.0743914470076561
deletion O 0 0.09037422388792038
was O 0 0.018232999369502068
included O 0 0.017661763355135918
at O 0 0.01578911766409874
least O 0 0.013803203590214252
from O 0 0.012445777654647827
the O 0 0.014907903969287872
promoter O 0 0.0727933868765831
region O 0 0.03550588712096214
of O 0 0.017668448388576508
Hp O 0 0.07171422988176346
to O 0 0.02535506710410118
Hpr O 1 0.5189671516418457
alpha O 0 0.06029188632965088
but O 0 0.01554064266383648
not O 0 0.013738313689827919
to O 0 0.022293085232377052
Hpr O 1 0.8829897046089172
beta O 0 0.10357888042926788
( O 0 0.05535776913166046
Hpdel O 0 0.3891753554344177
) O 0 0.04855921119451523
. O 0 0.03687439113855362

In O 0 0.030050620436668396
addition O 0 0.026047833263874054
, O 0 0.01589655689895153
we O 0 0.013234984129667282
found O 0 0.015643471851944923
seven O 0 0.01640591025352478
individuals O 0 0.019783345982432365
with O 0 0.015444117598235607
hypohaptoglobinemia B-Disease 0 0.0721290335059166
in O 0 0.012101763859391212
three O 0 0.010885561816394329
families O 0 0.019548065960407257
, O 0 0.009986408054828644
and O 0 0.009464853443205357
the O 0 0.01306953001767397
genotypes O 0 0.07936226576566696
of O 0 0.010671412572264671
six O 0 0.013109186664223671
of O 0 0.008018863387405872
the O 0 0.009861736558377743
seven O 0 0.01565525494515896
individuals O 0 0.015433781780302525
were O 0 0.009414625354111195
found O 0 0.01481332816183567
to O 0 0.014212634414434433
be O 0 0.020859122276306152
Hp2 O 1 0.8626855611801147
/ O 1 0.9407473206520081
Hpdel O 0 0.45593729615211487
. O 0 0.05427352339029312

The O 0 0.04692859947681427
phenotypes O 0 0.1709740161895752
and O 0 0.03038356453180313
genotypes O 0 0.11610028147697449
in O 0 0.0144053278490901
one O 0 0.010040929540991783
of O 0 0.008241171017289162
these O 0 0.008107856847345829
three O 0 0.00949253048747778
families O 0 0.020969867706298828
showed O 0 0.024373523890972137
the O 0 0.01202638354152441
father O 0 0.022122640162706375
to O 0 0.01406218484044075
be O 0 0.018923083320260048
hypohaptoglobinemic B-Disease 0 0.13904361426830292
( O 0 0.04467470198869705
Hp2 O 0 0.2635993957519531
) O 0 0.030683573335409164
and O 0 0.02340458333492279
Hp2 O 1 0.9737246036529541
/ O 1 0.924983024597168
Hpdel O 0 0.13114327192306519
, O 0 0.01639680378139019
the O 0 0.013456294313073158
mother O 0 0.028615666553378105
to O 0 0.015193535946309566
be O 0 0.01594695635139942
Hp2 O 0 0.20624135434627533
- O 0 0.06850820034742355
1 O 0 0.03601214662194252
and O 0 0.02489929459989071
Hp1 O 1 0.9352844953536987
/ O 1 0.8046320676803589
Hp2 O 0 0.11190704256296158
, O 0 0.014472751878201962
one O 0 0.008968820795416832
of O 0 0.007942380383610725
the O 0 0.008574055507779121
two O 0 0.010740278288722038
children O 0 0.020560285076498985
to O 0 0.01442883163690567
be O 0 0.01747776009142399
hypohaptoglobinemic B-Disease 0 0.24013110995292664
( O 0 0.05162036791443825
Hp2 O 0 0.44586843252182007
) O 0 0.03617926314473152
and O 0 0.026539674028754234
Hp2 O 1 0.9697279930114746
/ O 1 0.9049124121665955
Hpdel O 0 0.13484644889831543
, O 0 0.015006598085165024
and O 0 0.009474528022110462
the O 0 0.008997758850455284
other O 0 0.009807324968278408
child O 0 0.02645646221935749
to O 0 0.014439339749515057
be O 0 0.016276376321911812
Hp1 O 0 0.19087369740009308
and O 0 0.028961582109332085
Hp1 O 1 0.9789608716964722
/ O 1 0.9446619749069214
Hpdel O 0 0.39304542541503906
, O 0 0.019588569179177284
showing O 0 0.03346068784594536
an O 0 0.02201213501393795
anomalous O 0 0.10087842494249344
inheritance O 0 0.07250317186117172
of O 0 0.02635410614311695
Hp O 0 0.11985167115926743
phenotypes O 0 0.1178799420595169
in O 0 0.0191453006118536
the O 0 0.01839376427233219
child O 0 0.04773560166358948
with O 0 0.03044159896671772
Hp1 O 1 0.5735684037208557
. O 0 0.04849347099661827

The O 0 0.0636293962597847
Hp2 O 1 0.98329758644104
/ O 1 0.9734245538711548
Hpdel O 0 0.4103984832763672
individuals O 0 0.03255783021450043
had O 0 0.01900053396821022
an O 0 0.015087400563061237
extremely O 0 0.034478940069675446
low O 0 0.037915848195552826
level O 0 0.02653994783759117
of O 0 0.01986147090792656
Hp O 0 0.11351800709962845
( O 0 0.05080577731132507
mean O 0 0.06416185200214386
+ O 1 0.8057425022125244
/ O 1 0.9612681269645691
- O 0 0.1482684463262558
SD O 0 0.3807086646556854
= O 0 0.15627995133399963
0 O 0 0.08585303276777267
. O 0 0.04569433629512787
049 O 1 0.9905378818511963
+ O 1 0.8814999461174011
/ O 1 0.9064929485321045
- O 0 0.10703898221254349
0 O 0 0.07902301102876663
. O 0 0.04177773371338844
043 O 1 0.9782771468162537
mg O 1 0.990048885345459
/ O 1 0.9840613007545471
ml O 1 0.6671010851860046
; O 0 0.05820506811141968
n O 0 0.08333712071180344
= O 0 0.08777272701263428
6 O 0 0.030396008864045143
) O 0 0.017912721261382103
, O 0 0.01114802248775959
compared O 0 0.017946356907486916
with O 0 0.011392074637115002
the O 0 0.011564944870769978
level O 0 0.02571801468729973
( O 0 0.024048544466495514
1 O 0 0.023239580914378166
. O 0 0.016207989305257797
64 O 0 0.04437817633152008
+ O 0 0.3727322220802307
/ O 1 0.6821688413619995
- O 0 0.0791092962026596
1 O 0 0.040033213794231415
. O 0 0.02858879789710045
07 O 0 0.47062599658966064
mg O 1 0.985348641872406
/ O 1 0.9500860571861267
ml O 0 0.20945638418197632
) O 0 0.03279837593436241
obtained O 0 0.02757403254508972
from O 0 0.023477816954255104
52 O 0 0.05897407978773117
healthy O 0 0.08410362899303436
volunteers O 0 0.07202986627817154
having O 0 0.05202942714095116
phenotype O 1 0.9248546957969666
Hp2 O 0 0.21373377740383148
, O 0 0.02427811361849308
whereas O 0 0.03695596009492874
the O 0 0.022209366783499718
serum O 0 0.40995556116104126
Hp O 0 0.07001194357872009
level O 0 0.02461441606283188
of O 0 0.010244950652122498
an O 0 0.013790966011583805
individual O 0 0.024586275219917297
with O 0 0.0331571064889431
Hp1 O 1 0.9553989171981812
/ O 1 0.8766351938247681
Hpdel O 0 0.21971137821674347
was O 0 0.036526959389448166
0 O 0 0.07384057343006134
. O 0 0.044957492500543594

50 O 0 0.11024671792984009
mg O 1 0.9865812063217163
/ O 1 0.9645007252693176
ml O 0 0.16019561886787415
, O 0 0.017429577186703682
which O 0 0.011062437668442726
was O 0 0.011313263326883316
approximately O 0 0.016033435240387917
half O 0 0.014399304054677486
the O 0 0.01057534758001566
level O 0 0.021262645721435547
of O 0 0.014770876616239548
Hp O 0 0.06363984942436218
in O 0 0.020433975383639336
control O 0 0.04314076155424118
sera O 0 0.09747767448425293
from O 0 0.026372622698545456
the O 0 0.0315605066716671
Hp1 O 1 0.5555172562599182
phenotype O 1 0.6237658858299255
( O 0 0.048071570694446564
1 O 0 0.03240661695599556
. O 0 0.022561082616448402
26 O 0 0.047663379460573196
+ O 0 0.4606646001338959
/ O 1 0.6890388131141663
- O 0 0.09198129177093506
0 O 0 0.06111142411828041
. O 0 0.02437577396631241
33 O 0 0.06094013527035713
mg O 1 0.9836052060127258
/ O 1 0.9798573851585388
ml O 1 0.7488285303115845
; O 0 0.04785259813070297
n O 0 0.07977307587862015
= O 0 0.08692114055156708
9 O 0 0.0340544693171978
) O 0 0.02096998132765293
, O 0 0.013842178508639336
showing O 0 0.031391799449920654
a O 0 0.02925429306924343
gene O 0 0.11860723793506622
- O 0 0.3902471363544464
dosage O 1 0.93878573179245
effect O 0 0.08437641710042953
. O 0 0.04905915632843971

The O 0 0.03646565601229668
other O 0 0.028230706229805946
allele O 0 0.14730392396450043
( O 0 0.05234574154019356
Hp2 O 0 0.14281848073005676
) O 0 0.028742264956235886
of O 0 0.01416053343564272
individuals O 0 0.028043413534760475
with O 0 0.028788765892386436
Hp2 O 1 0.9842758178710938
/ O 1 0.9475486874580383
Hpdel O 0 0.13268235325813293
was O 0 0.016627294942736626
found O 0 0.013627390377223492
to O 0 0.008145231753587723
have O 0 0.008423457853496075
, O 0 0.00881577841937542
in O 0 0.008843968622386456
all O 0 0.010124149732291698
exons O 0 0.06676317006349564
, O 0 0.01833459362387657
no O 0 0.02582327090203762
mutation O 0 0.10193849354982376
, O 0 0.021149978041648865
by O 0 0.023246634751558304
DNA O 0 0.0745515301823616
sequencing O 0 0.10146308690309525
. O 0 0.05087244138121605

On O 0 0.019807906821370125
the O 0 0.012828047387301922
basis O 0 0.012368840165436268
of O 0 0.008319188840687275
the O 0 0.009337138384580612
present O 0 0.015310682356357574
study O 0 0.017071077600121498
, O 0 0.01009870134294033
the O 0 0.01099501270800829
mechanism O 0 0.03651761636137962
of O 0 0.012858014553785324
anhaptoglobinemia B-Disease 0 0.07777231186628342
and O 0 0.012719468213617802
the O 0 0.013833991251885891
mechanism O 0 0.04697364568710327
of O 0 0.019190816208720207
anomalous O 0 0.12236794829368591
inheritance O 0 0.07607736438512802
of O 0 0.028462234884500504
Hp O 0 0.2044709026813507
phenotypes O 0 0.13795647025108337
were O 0 0.020465295761823654
well O 0 0.024507487192749977
explained O 0 0.049552131444215775
. O 0 0.04486694186925888

However O 0 0.03258524835109711
, O 0 0.01759687066078186
the O 0 0.017183970659971237
mechanism O 0 0.055393118411302567
of O 0 0.029761817306280136
hypohaptoglobinemia B-Disease 0 0.2095380276441574
remains O 0 0.06991209834814072
unknown O 0 0.09465403854846954

ATM O 0 0.4732491075992584
mutations O 0 0.19433093070983887
and O 0 0.03917967155575752
phenotypes O 1 0.9304734468460083
in O 0 0.06203274056315422
ataxia B-Disease 1 0.999996542930603
- I-Disease 1 0.9959050416946411
telangiectasia I-Disease 1 0.9995591044425964
families O 0 0.047075822949409485
in O 0 0.01829971745610237
the O 0 0.01888895221054554
British O 0 0.041262950748205185
Isles O 0 0.07782182842493057
: O 0 0.031070377677679062
expression O 0 0.03544801101088524
of O 0 0.016918711364269257
mutant O 0 0.08956513553857803
ATM O 0 0.08872228115797043
and O 0 0.017816860228776932
the O 0 0.022198794409632683
risk O 1 0.913519561290741
of O 0 0.039302900433540344
leukemia B-Disease 1 0.9999998807907104
, O 1 0.845053493976593
lymphoma B-Disease 1 1.0
, O 0 0.044358041137456894
and O 0 0.04946490004658699
breast B-Disease 1 0.9999957084655762
cancer I-Disease 1 0.999970555305481
. O 0 0.06376046687364578

We O 0 0.030104180797934532
report O 0 0.025774961337447166
the O 0 0.01901298575103283
spectrum O 0 0.057940442115068436
of O 0 0.02425200678408146
59 O 0 0.07495900243520737
ATM O 0 0.15784576535224915
mutations O 0 0.16184647381305695
observed O 0 0.0643153190612793
in O 0 0.04329764470458031
ataxia B-Disease 1 0.9999891519546509
- I-Disease 1 0.9973213076591492
telangiectasia I-Disease 1 0.9999105930328369
( O 0 0.12152962386608124
A B-Disease 0 0.21539808809757233
- I-Disease 1 0.9900175929069519
T I-Disease 1 0.9993557333946228
) O 0 0.045916926115751266
patients O 1 0.839186429977417
in O 0 0.018812090158462524
the O 0 0.01919248327612877
British O 0 0.04573073983192444
Isles O 0 0.12579868733882904
. O 0 0.04999005049467087

Of O 0 0.048084381967782974
51 O 0 0.10032898932695389
ATM O 0 0.2141529619693756
mutations O 0 0.11698839068412781
identified O 0 0.03237641975283623
in O 0 0.014595534652471542
families O 0 0.022183436900377274
native O 0 0.017866408452391624
to O 0 0.012418520636856556
the O 0 0.01436305046081543
British O 0 0.03423459455370903
Isles O 0 0.07752127200365067
, O 0 0.01679956540465355
11 O 0 0.02522323653101921
were O 0 0.016380438581109047
founder O 0 0.05268379673361778
mutations O 0 0.08353978395462036
, O 0 0.014599827118217945
and O 0 0.01048855111002922
2 O 0 0.015337576158344746
of O 0 0.008752046152949333
these O 0 0.011225072667002678
11 O 0 0.023855343461036682
conferred O 0 0.052172884345054626
a O 0 0.03382861614227295
milder O 1 0.9330495595932007
clinical O 1 0.8717859983444214
phenotype O 1 0.692525327205658
with O 0 0.02096390537917614
respect O 0 0.02376391552388668
to O 0 0.017719484865665436
both O 0 0.029540657997131348
cerebellar B-Disease 1 0.9998602867126465
degeneration I-Disease 1 0.999836802482605
and O 0 0.0331684835255146
cellular O 0 0.08128011971712112
features O 0 0.047305233776569366
. O 0 0.04259943217039108

We O 0 0.027208415791392326
report O 0 0.021331317722797394
, O 0 0.011712134815752506
in O 0 0.011083453893661499
two O 0 0.0143275186419487
A B-Disease 0 0.03787033259868622
- I-Disease 0 0.41128265857696533
T I-Disease 1 0.9859345555305481
families O 0 0.035231634974479675
, O 0 0.01993696577847004
an O 0 0.02821436896920204
ATM O 0 0.14324557781219482
mutation O 0 0.4113660454750061
( O 0 0.06591254472732544
7271T O 1 0.937759518623352
- O 1 0.9011484384536743
- O 1 0.7013781070709229
> O 1 0.7637694478034973
G O 0 0.1313994824886322
) O 0 0.023801404982805252
that O 0 0.011357077397406101
may O 0 0.01740628480911255
be O 0 0.00867747887969017
associated O 0 0.0169198140501976
with O 0 0.010838674381375313
an O 0 0.014554292894899845
increased O 0 0.03577578440308571
risk O 1 0.8969820141792297
of O 0 0.034086182713508606
breast B-Disease 1 0.9999912977218628
cancer I-Disease 1 0.9998985528945923
in O 0 0.02562728337943554
both O 0 0.026856865733861923
homozygotes O 1 0.9907540082931519
and O 0 0.03063187189400196
heterozygotes O 1 0.9874284863471985
( O 0 0.04809758812189102
relative O 0 0.05613616108894348
risk O 0 0.08660954236984253
12 O 0 0.029630161821842194
. O 0 0.019609767943620682
7 O 0 0.03680884465575218
; O 0 0.03614417836070061
P O 1 0.5696720480918884
= O 0 0.10933887213468552
. O 0 0.029143275693058968
0025 O 1 0.9709713459014893
) O 0 0.02373442053794861
, O 0 0.012515914626419544
although O 0 0.01220706757158041
there O 0 0.009236786514520645
is O 0 0.009963786229491234
a O 0 0.016782421618700027
less O 0 0.02700348198413849
severe O 1 0.9980720281600952
A B-Disease 0 0.0905308797955513
- I-Disease 1 0.9842550754547119
T I-Disease 1 0.9987665414810181
phenotype O 0 0.45038339495658875
in O 0 0.014395608566701412
terms O 0 0.013497045263648033
of O 0 0.0102746756747365
the O 0 0.01542168390005827
degree O 0 0.03662383183836937
of O 0 0.02788395993411541
cerebellar B-Disease 1 0.9998575448989868
degeneration I-Disease 1 0.9999325275421143
. O 0 0.06931939721107483

This O 0 0.059797413647174835
mutation O 0 0.21859560906887054
( O 0 0.07921573519706726
7271T O 1 0.8462240695953369
- O 1 0.7335553765296936
- O 1 0.5276199579238892
> O 0 0.4371441602706909
G O 0 0.11688682436943054
) O 0 0.027445461601018906
also O 0 0.014899893663823605
allows O 0 0.023767633363604546
expression O 0 0.027524041011929512
of O 0 0.011882560327649117
full O 0 0.02506481111049652
- O 0 0.060524940490722656
length O 0 0.04685575142502785
ATM O 0 0.09091059118509293
protein O 0 0.04603049159049988
at O 0 0.018849864602088928
a O 0 0.015326215885579586
level O 0 0.02234800159931183
comparable O 0 0.0312529057264328
with O 0 0.011772903613746166
that O 0 0.01165942195802927
in O 0 0.017914272844791412
unaffected O 0 0.10877010226249695
individuals O 0 0.04617039114236832
. O 0 0.04515451192855835

In O 0 0.026790134608745575
addition O 0 0.021297216415405273
, O 0 0.014778864569962025
we O 0 0.011019748635590076
have O 0 0.011808991432189941
studied O 0 0.022470230236649513
18 O 0 0.02543371543288231
A B-Disease 0 0.06041915342211723
- I-Disease 1 0.9935908317565918
T I-Disease 1 0.9998810291290283
patients O 1 0.9950998425483704
, O 0 0.016509536653757095
in O 0 0.013006702996790409
15 O 0 0.020919768139719963
families O 0 0.02806604467332363
, O 0 0.018716009333729744
who O 0 0.028301702812314034
developed O 1 0.7158603668212891
leukemia B-Disease 1 0.9999995231628418
, O 0 0.49470171332359314
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.06112591177225113
preleukemic O 1 0.9983025789260864
T O 1 0.9996079802513123
- O 1 0.9548847675323486
cell O 1 0.7227086424827576
proliferation O 1 0.8282046318054199
, O 0 0.03442615270614624
or O 1 0.65823894739151
Hodgkin B-Disease 1 0.9999997615814209
lymphoma I-Disease 1 0.9999997615814209
, O 0 0.0309413131326437
mostly O 0 0.023797428235411644
in O 0 0.0223051980137825
childhood O 0 0.26859036087989807
. O 0 0.047481194138526917

A O 0 0.04441501945257187
wide O 0 0.04173581302165985
variety O 0 0.035117484629154205
of O 0 0.027569547295570374
ATM O 0 0.13286425173282623
mutation O 0 0.1558513343334198
types O 0 0.04585302621126175
, O 0 0.020744144916534424
including O 0 0.027731871232390404
missense O 0 0.31199055910110474
mutations O 0 0.1093081384897232
and O 0 0.019831957295536995
in O 0 0.02157486230134964
- O 0 0.0648190975189209
frame O 0 0.05926483869552612
deletions O 0 0.07856238633394241
, O 0 0.015900883823633194
were O 0 0.011410531587898731
seen O 0 0.019513186067342758
in O 0 0.013112944550812244
these O 0 0.018809784203767776
patients O 1 0.9905679821968079
. O 0 0.04332505539059639

We O 0 0.025342578068375587
also O 0 0.013740174472332
show O 0 0.018720068037509918
that O 0 0.009044226258993149
25 O 0 0.014902373775839806
% O 0 0.01631467230618
of O 0 0.009866748005151749
all O 0 0.013468624092638493
A B-Disease 0 0.04532177746295929
- I-Disease 1 0.9855637550354004
T I-Disease 1 0.9997358918190002
patients O 1 0.9948561191558838
carried O 0 0.028320515528321266
in O 0 0.022380784153938293
- O 0 0.07315824925899506
frame O 0 0.06941553205251694
deletions O 0 0.12462084740400314
or O 0 0.05339566245675087
missense O 1 0.7473348379135132
mutations O 0 0.11904317885637283
, O 0 0.015115812420845032
many O 0 0.009834776632487774
of O 0 0.007209013216197491
which O 0 0.009110946208238602
were O 0 0.007539989892393351
also O 0 0.010364756919443607
associated O 0 0.01904655434191227
with O 0 0.015047560445964336
expression O 0 0.039408572018146515
of O 0 0.02309238351881504
mutant O 0 0.11900478601455688
ATM O 0 0.15420140326023102
protein O 0 0.10155200213193893
. O 0 0.042106743901968

The O 0 0.060389354825019836
DMPK O 1 0.8464606404304504
gene O 0 0.129292830824852
of O 0 0.04642827808856964
severely O 1 0.997782289981842
affected O 1 0.9994552731513977
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 1 0.9999349117279053
is O 0 0.041728436946868896
hypermethylated O 1 0.9332034587860107
proximal O 1 0.7665268182754517
to O 0 0.019038187339901924
the O 0 0.017585135996341705
largely O 0 0.03592607006430626
expanded O 0 0.05566170811653137
CTG O 1 0.9401811361312866
repeat O 0 0.1482635736465454
. O 0 0.060683686286211014

Using O 0 0.07395537942647934
methylation O 0 0.13591216504573822
- O 0 0.0991496816277504
sensitive O 0 0.060623202472925186
restriction O 0 0.06313816457986832
enzymes O 0 0.057476744055747986
, O 0 0.016735590994358063
we O 0 0.016021907329559326
characterized O 0 0.052116066217422485
the O 0 0.018761685118079185
methylation O 0 0.07926498353481293
pattern O 0 0.04427783936262131
on O 0 0.010336969047784805
the O 0 0.012019122950732708
5 O 0 0.02005831152200699
side O 0 0.01981775090098381
of O 0 0.011186699382960796
the O 0 0.019386542961001396
CTG O 1 0.7677960991859436
repeat O 0 0.06623878329992294
in O 0 0.01846456341445446
the O 0 0.02228342369198799
DMPK O 0 0.18308217823505402
gene O 0 0.06525006890296936
of O 0 0.015010340139269829
normal O 0 0.03567199409008026
individuals O 0 0.023657893761992455
and O 0 0.014460988342761993
of O 0 0.019940027967095375
patients O 1 0.9998041987419128
affected O 1 0.8558222651481628
with O 0 0.10788010060787201
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999996423721313
, O 0 0.03600398451089859
showing O 0 0.04139002412557602
expansions O 0 0.0548565611243248
of O 0 0.017271339893341064
the O 0 0.02540629543364048
repetitive O 0 0.14447125792503357
sequence O 0 0.0731857568025589
. O 0 0.049039870500564575

The O 0 0.04982820153236389
gene O 0 0.10900697112083435
segment O 0 0.07173488289117813
analyzed O 0 0.043974947184324265
corresponds O 0 0.04118198901414871
to O 0 0.01718095876276493
the O 0 0.026658302173018456
genomic O 0 0.14603523910045624
SacI O 1 0.8650521636009216
- O 0 0.1389239877462387
HindIII O 0 0.2096535861492157
fragment O 0 0.10466962307691574
carrying O 0 0.058038484305143356
exons O 0 0.11806029081344604
11 O 0 0.0518081970512867
- O 0 0.08103682100772858
15 O 0 0.046826668083667755
. O 0 0.04874369502067566

There O 0 0.038553331047296524
is O 0 0.03349959850311279
constitutive O 0 0.13218265771865845
methylation O 0 0.11939136683940887
in O 0 0.03234130144119263
intron O 0 0.2908168435096741
12 O 0 0.04104737564921379
at O 0 0.024412276223301888
restriction O 0 0.03801368921995163
sites O 0 0.024065522477030754
of O 0 0.018683504313230515
SacII O 0 0.1254631131887436
and O 0 0.022051535546779633
HhaI O 0 0.16900351643562317
, O 0 0.022427186369895935
localized O 0 0.08367204666137695
1 O 0 0.030894016847014427
, O 0 0.02056965045630932
159 O 0 0.07852626591920853
- O 0 0.07408963888883591
1 O 0 0.030679870396852493
, O 0 0.024602103978395462
232 O 0 0.08470896631479263
bp O 0 0.08102485537528992
upstream O 0 0.052664753049612045
of O 0 0.015371828339993954
the O 0 0.02322617545723915
CTG O 1 0.9514957070350647
repeat O 0 0.08239598572254181
, O 0 0.017596986144781113
whereas O 0 0.024310624226927757
most O 0 0.010866673663258553
, O 0 0.009074649773538113
if O 0 0.00901789776980877
not O 0 0.005733436439186335
all O 0 0.005127002019435167
, O 0 0.005940055008977652
of O 0 0.005299360956996679
the O 0 0.008305343799293041
other O 0 0.009093905799090862
sites O 0 0.016502493992447853
of O 0 0.01430661790072918
SacII O 0 0.24943339824676514
, O 0 0.02389286458492279
HhaI O 0 0.13329052925109863
, O 0 0.014918874017894268
and O 0 0.013670665211975574
HpaII O 0 0.07784426212310791
in O 0 0.013509748503565788
this O 0 0.011838402599096298
region O 0 0.027446459978818893
are O 0 0.014405355788767338
unmethylated O 0 0.13669507205486298
, O 0 0.015188992023468018
in O 0 0.01347949355840683
normal O 0 0.031170306727290154
individuals O 0 0.019909333437681198
and O 0 0.00901350099593401
most O 0 0.010519552044570446
of O 0 0.012111459858715534
the O 0 0.024288909509778023
patients O 1 0.9918965697288513
. O 0 0.04825178161263466

In O 0 0.025920704007148743
a O 0 0.01881776563823223
number O 0 0.012812814675271511
of O 0 0.012513629160821438
young O 0 0.033009935170412064
and O 0 0.022726070135831833
severely O 1 0.8829352259635925
affected O 1 0.5236865878105164
patients O 1 0.9967530369758606
, O 0 0.01654534600675106
however O 0 0.01464542094618082
, O 0 0.012641292996704578
complete O 0 0.023120136931538582
methylation O 0 0.04578452184796333
of O 0 0.011354325339198112
these O 0 0.012647325173020363
restriction O 0 0.03338923305273056
sites O 0 0.020408200100064278
was O 0 0.012691015377640724
found O 0 0.014957675710320473
in O 0 0.014713356271386147
the O 0 0.026842547580599785
mutated O 0 0.16257482767105103
allele O 0 0.22414694726467133
. O 0 0.07809600979089737

In O 0 0.023153457790613174
most O 0 0.01386707741767168
of O 0 0.011373106390237808
these O 0 0.015632541850209236
patients O 1 0.9805760979652405
, O 0 0.015812959522008896
the O 0 0.01818670891225338
onset O 1 0.9972182512283325
of O 0 0.01887543313205242
the O 0 0.030499354004859924
disease O 1 0.9999510049819946
was O 0 0.059245165437459946
congenital O 1 0.9999754428863525
. O 0 0.07254418730735779

Preliminary O 0 0.0775824710726738
in O 0 0.04267032444477081
vivo O 0 0.21071700751781464
footprinting O 1 0.93570476770401
data O 0 0.027547836303710938
gave O 0 0.024769514799118042
evidence O 0 0.022041594609618187
for O 0 0.01973804458975792
protein O 0 0.06244490668177605
- O 0 0.07210936397314072
DNA O 0 0.06763328611850739
contact O 0 0.050429705530405045
in O 0 0.02059493027627468
normal O 0 0.04431134834885597
genes O 0 0.05558626726269722
at O 0 0.024301737546920776
an O 0 0.02270650304853916
Sp1 O 1 0.7274155020713806
consensus O 0 0.04467345029115677
binding O 0 0.04685921221971512
site O 0 0.02823016047477722
upstream O 0 0.045468199998140335
of O 0 0.016891252249479294
the O 0 0.0265826229006052
CTG O 1 0.7586981058120728
repeat O 0 0.06765998899936676
and O 0 0.012139853090047836
for O 0 0.010474812239408493
a O 0 0.01594178006052971
significant O 0 0.021383611485362053
reduction O 0 0.038014501333236694
of O 0 0.009753065183758736
this O 0 0.01166439987719059
interaction O 0 0.029600288718938828
in O 0 0.017078783363103867
cells O 0 0.05309370905160904
with O 0 0.01951533369719982
a O 0 0.03615891933441162
hypermethylated O 1 0.8522725105285645
DMPK O 1 0.9456876516342163
gene O 0 0.11795761436223984
. O 0 0.036719147115945816
. O 0 0.04138937219977379

The O 0 0.08875031024217606
hemochromatosis B-Disease 1 0.9999116659164429
gene O 0 0.16613024473190308
product O 0 0.05537973344326019
complexes O 0 0.07991987466812134
with O 0 0.02381950616836548
the O 0 0.028746364638209343
transferrin O 1 0.8822974562644958
receptor O 0 0.1504952758550644
and O 0 0.028372427448630333
lowers O 0 0.15189291536808014
its O 0 0.02599978633224964
affinity O 0 0.07777614146471024
for O 0 0.027396587654948235
ligand O 0 0.12282219529151917
binding O 0 0.07425964623689651
. O 0 0.04438108578324318

We O 0 0.03397153690457344
recently O 0 0.03853774443268776
reported O 0 0.033916935324668884
the O 0 0.020057549700140953
positional O 0 0.0853426456451416
cloning O 0 0.06387593597173691
of O 0 0.01704004406929016
a O 0 0.02641601487994194
candidate O 0 0.050583235919475555
gene O 0 0.10256935656070709
for O 0 0.0439206026494503
hereditary B-Disease 1 0.9997723698616028
hemochromatosis I-Disease 1 0.9999980926513672
called O 0 0.14009989798069
HFE O 1 0.9961508512496948
. O 0 0.08005694299936295

The O 0 0.0390363410115242
gene O 0 0.08058889955282211
product O 0 0.027805235236883163
, O 0 0.010978939943015575
a O 0 0.011230435222387314
member O 0 0.012114410288631916
of O 0 0.009402715601027012
the O 0 0.01789708249270916
major O 0 0.037938397377729416
histocompatibility O 1 0.9851572513580322
complex O 0 0.05234283208847046
class O 0 0.05355275422334671
I O 0 0.03288216516375542
- O 0 0.044043321162462234
like O 0 0.021236391738057137
family O 0 0.019889751449227333
, O 0 0.011349696666002274
was O 0 0.012186381965875626
found O 0 0.014113792218267918
to O 0 0.011214001104235649
have O 0 0.012424487620592117
a O 0 0.0236500333994627
mutation O 0 0.14064975082874298
, O 0 0.03769867494702339
Cys O 1 0.9981129169464111
- O 1 0.5692836046218872
282 O 1 0.749421238899231
- O 1 0.9432075619697571
- O 1 0.8389613628387451
> O 1 0.8695633411407471
Tyr O 1 0.983327329158783
( O 0 0.06670074909925461
C282Y O 0 0.1293657273054123
) O 0 0.025149986147880554
, O 0 0.014142251573503017
in O 0 0.015640079975128174
85 O 0 0.046249859035015106
% O 0 0.03154255449771881
of O 0 0.02370464615523815
patient O 1 0.5308485627174377
chromosomes O 0 0.12598927319049835
. O 0 0.052345044910907745

This O 0 0.05191629007458687
mutation O 0 0.16998474299907684
eliminates O 0 0.11500133574008942
the O 0 0.025200748816132545
ability O 0 0.04332176595926285
of O 0 0.023104960098862648
HFE O 1 0.6877811551094055
to O 0 0.023799000307917595
associate O 0 0.04680539667606354
with O 0 0.030981656163930893
beta2 O 1 0.8646141290664673
- O 0 0.23949812352657318
microglobulin O 1 0.7836307883262634
( O 0 0.05789119750261307
beta2m O 0 0.2744118869304657
) O 0 0.03339025005698204
and O 0 0.02082221955060959
prevents O 0 0.09379616379737854
cell O 0 0.09780940413475037
- O 0 0.08744131028652191
surface O 0 0.06954390555620193
expression O 0 0.07288600504398346
. O 0 0.04490378126502037

A O 0 0.056270211935043335
second O 0 0.04740532860159874
mutation O 0 0.11198844760656357
that O 0 0.015117673203349113
has O 0 0.0158429816365242
no O 0 0.0162335392087698
effect O 0 0.03153584152460098
on O 0 0.017308026552200317
beta2m O 0 0.46394577622413635
association O 0 0.04470786079764366
, O 0 0.021652836352586746
H63D O 0 0.30774009227752686
, O 0 0.015121792443096638
was O 0 0.010836159810423851
found O 0 0.010388711467385292
in O 0 0.007703238632529974
eight O 0 0.011739996261894703
out O 0 0.010976511053740978
of O 0 0.012006920762360096
nine O 0 0.033246491104364395
patients O 1 0.9224410653114319
heterozygous O 0 0.1021367609500885
for O 0 0.02175426483154297
the O 0 0.02960902824997902
C282Y O 0 0.16003909707069397
mutant O 0 0.15244728326797485
. O 0 0.06117468327283859

In O 0 0.02935619466006756
this O 0 0.016753017902374268
report O 0 0.018886767327785492
, O 0 0.012898506596684456
we O 0 0.012597214430570602
demonstrate O 0 0.032926980406045914
in O 0 0.02421427331864834
cultured O 0 0.12184786051511765
293 O 1 0.73504638671875
cells O 1 0.6046513915061951
overexpressing O 1 0.990740180015564
wild O 0 0.09197928011417389
- O 0 0.11607226729393005
type O 0 0.07254239171743393
or O 0 0.03902773559093475
mutant O 0 0.12291751056909561
HFE O 1 0.9091690182685852
proteins O 0 0.04879837855696678
that O 0 0.014522845856845379
both O 0 0.0136597640812397
the O 0 0.016880756244063377
wild O 0 0.05188417807221413
- O 0 0.07922345399856567
type O 0 0.06274625658988953
and O 0 0.03126766160130501
H63D O 1 0.9455751180648804
HFE O 1 0.9861457943916321
proteins O 0 0.07442662119865417
form O 0 0.0446748249232769
stable O 0 0.07359298318624496
complexes O 0 0.07511688023805618
with O 0 0.024506213143467903
the O 0 0.031703703105449677
transferrin O 1 0.9840707778930664
receptor O 1 0.7950438857078552
( O 0 0.08033635467290878
TfR O 1 0.9890598058700562
) O 0 0.04902871698141098
. O 0 0.039942268282175064

The O 0 0.060361724346876144
C282Y O 0 0.301008015871048
mutation O 0 0.17251060903072357
nearly O 0 0.04232809692621231
completely O 0 0.04131525382399559
prevents O 0 0.05517738312482834
the O 0 0.015098104253411293
association O 0 0.03077615797519684
of O 0 0.012157565914094448
the O 0 0.021652260795235634
mutant O 0 0.11771265417337418
HFE O 1 0.9687220454216003
protein O 0 0.07366617023944855
with O 0 0.025398632511496544
the O 0 0.030630262568593025
TfR O 1 0.9815353155136108
. O 0 0.06843481212854385

Studies O 0 0.06582020223140717
on O 0 0.028489170596003532
cell O 0 0.08977413177490234
- O 0 0.08964516222476959
associated O 0 0.05423452705144882
transferrin O 0 0.1771487146615982
at O 0 0.031899433583021164
37 O 0 0.049779243767261505
degrees O 0 0.043536100536584854
C O 0 0.06712634861469269
suggest O 0 0.03516485542058945
that O 0 0.01505100354552269
the O 0 0.023523861542344093
overexpressed O 0 0.372055321931839
wild O 0 0.08488728106021881
- O 0 0.13606612384319305
type O 0 0.11648312956094742
HFE O 1 0.9851505160331726
protein O 0 0.10162115097045898
decreases O 0 0.07475325465202332
the O 0 0.022677913308143616
affinity O 0 0.06383485347032547
of O 0 0.01595618575811386
the O 0 0.025750985369086266
TfR O 1 0.9504079818725586
for O 0 0.03710758686065674
transferrin O 1 0.812272310256958
. O 0 0.05576806142926216

The O 0 0.07809334993362427
overexpressed O 0 0.4870229959487915
H63D O 1 0.7165751457214355
protein O 0 0.07134779542684555
does O 0 0.023578327149152756
not O 0 0.010644594207406044
have O 0 0.009300469420850277
this O 0 0.009454983286559582
effect O 0 0.024938330054283142
, O 0 0.01031414419412613
providing O 0 0.01710636541247368
the O 0 0.009500418789684772
first O 0 0.01298519130796194
direct O 0 0.019493380561470985
evidence O 0 0.014793661423027515
for O 0 0.01108675729483366
a O 0 0.01905481331050396
functional O 0 0.042271461337804794
consequence O 0 0.04657571390271187
of O 0 0.015461592935025692
the O 0 0.031557705253362656
H63D O 1 0.9540241956710815
mutation O 0 0.4808124005794525
. O 0 0.061127111315727234

Addition O 0 0.05575255677103996
of O 0 0.032356761395931244
soluble O 0 0.13112372159957886
wild O 0 0.09417471289634705
- O 1 0.5758582949638367
type O 0 0.4603872001171112
HFE O 1 0.9989631175994873
/ O 1 0.994077205657959
beta2m O 1 0.8793485760688782
heterodimers O 1 0.8959364295005798
to O 0 0.036532431840896606
cultured O 0 0.10477422177791595
cells O 0 0.07635278254747391
also O 0 0.02164505049586296
decreased O 0 0.04660501703619957
the O 0 0.020062092691659927
apparent O 0 0.05621802806854248
affinity O 0 0.05845768749713898
of O 0 0.014602002687752247
the O 0 0.021641485393047333
TfR O 1 0.6732305884361267
for O 0 0.017280567437410355
its O 0 0.01716524176299572
ligand O 0 0.07975999265909195
under O 0 0.024490155279636383
steady O 0 0.050398893654346466
- O 0 0.05058016628026962
state O 0 0.018236301839351654
conditions O 0 0.03015008755028248
, O 0 0.012392791919410229
both O 0 0.011429529637098312
in O 0 0.017315326258540154
293 O 0 0.10245378315448761
cells O 0 0.07469875365495682
and O 0 0.020109055563807487
in O 0 0.028652895241975784
HeLa O 1 0.9786484837532043
cells O 0 0.14223192632198334
. O 0 0.050930559635162354

Furthermore O 0 0.07602714747190475
, O 0 0.024758070707321167
at O 0 0.02548672817647457
4 O 0 0.029166027903556824
degrees O 0 0.03533574566245079
C O 0 0.049559928476810455
, O 0 0.012623664923012257
the O 0 0.014246277511119843
added O 0 0.025212746113538742
soluble O 0 0.08167823404073715
complex O 0 0.044088877737522125
of O 0 0.03155270963907242
HFE O 1 0.9983928799629211
/ O 1 0.9822561740875244
beta2m O 0 0.4995976686477661
inhibited O 0 0.15409180521965027
binding O 0 0.06118733435869217
of O 0 0.02687380649149418
transferrin O 0 0.3167774975299835
to O 0 0.04195999726653099
HeLa O 1 0.9759348630905151
cell O 0 0.14661268889904022
TfR O 1 0.9237962961196899
in O 0 0.028070669621229172
a O 0 0.03443115949630737
concentration O 0 0.08874441683292389
- O 0 0.08284524083137512
dependent O 0 0.07299299538135529
manner O 0 0.05727682262659073
. O 0 0.04711224138736725

Scatchard O 0 0.18869955837726593
plots O 0 0.05419186130166054
of O 0 0.014245408587157726
these O 0 0.012269651517271996
data O 0 0.015106195583939552
indicate O 0 0.022807156667113304
that O 0 0.010080937296152115
the O 0 0.016046348959207535
added O 0 0.02907106839120388
heterodimer O 0 0.25643688440322876
substantially O 0 0.056024663150310516
reduced O 0 0.04443328455090523
the O 0 0.02194652520120144
affinity O 0 0.07582925260066986
of O 0 0.029291825369000435
TfR O 1 0.9750488996505737
for O 0 0.04288072884082794
transferrin O 1 0.6609560251235962
. O 0 0.06094605103135109

These O 0 0.02780274860560894
results O 0 0.03673302009701729
establish O 0 0.03582014515995979
a O 0 0.027269767597317696
molecular O 0 0.05286228284239769
link O 0 0.054739054292440414
between O 0 0.03015015833079815
HFE O 1 0.8911398649215698
and O 0 0.019918616861104965
a O 0 0.01809866726398468
key O 0 0.028000356629490852
protein O 0 0.044116050004959106
involved O 0 0.024950992316007614
in O 0 0.01364619005471468
iron O 0 0.045097820460796356
transport O 0 0.03286159411072731
, O 0 0.015257474035024643
the O 0 0.017776893451809883
TfR O 1 0.9592565894126892
, O 0 0.014360133558511734
and O 0 0.011729925870895386
raise O 0 0.02709989622235298
the O 0 0.013658126816153526
possibility O 0 0.027608156204223633
that O 0 0.010907393880188465
alterations O 0 0.033833932131528854
in O 0 0.013185616582632065
this O 0 0.013117356225848198
regulatory O 0 0.04792499914765358
mechanism O 0 0.0470832884311676
may O 0 0.020885678008198738
play O 0 0.013010303489863873
a O 0 0.012067415751516819
role O 0 0.018081557005643845
in O 0 0.012415965087711811
the O 0 0.02010822668671608
pathogenesis O 1 0.9953049421310425
of O 0 0.04188232496380806
hereditary B-Disease 1 0.9998500347137451
hemochromatosis I-Disease 1 0.9999983310699463
. O 0 0.05210700258612633
. O 0 0.04790622740983963

Genomic O 0 0.15768542885780334
organization O 0 0.048104360699653625
of O 0 0.024968598037958145
the O 0 0.04247787222266197
UBE3A O 1 0.9971705079078674
/ O 1 0.9946370720863342
E6 O 1 0.9947222471237183
- O 0 0.2577468156814575
AP O 0 0.10306836664676666
gene O 0 0.08805269747972488
and O 0 0.022893710061907768
related O 0 0.05291946977376938
pseudogenes O 0 0.16179761290550232
. O 0 0.05596422031521797

The O 0 0.07541690021753311
UBE3A O 1 0.8733463883399963
gene O 0 0.14258763194084167
encodes O 0 0.10235411673784256
the O 0 0.04191797599196434
E6 O 1 0.9649990200996399
- O 0 0.13835430145263672
AP O 0 0.12454068660736084
ubiquitin O 0 0.1630931794643402
- O 0 0.11036421358585358
protein O 0 0.087668776512146
ligase O 0 0.07966858893632889
and O 0 0.014824259094893932
has O 0 0.013766461052000523
recently O 0 0.01991000771522522
been O 0 0.011271237395703793
shown O 0 0.019123423844575882
to O 0 0.012613952159881592
be O 0 0.019936691969633102
mutated O 1 0.9083110094070435
in O 1 0.5787076354026794
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999474287033081
who O 0 0.05409756302833557
lack O 0 0.08712785691022873
15q11 O 1 0.9521002769470215
- O 0 0.42598968744277954
q13 O 0 0.41259336471557617
deletions O 0 0.15283972024917603
or O 0 0.05946546792984009
chromosome O 0 0.18415504693984985
15 O 0 0.07034742832183838
paternal O 0 0.28447142243385315
uniparental B-Disease 1 0.9974246025085449
disomy I-Disease 1 0.86771160364151
. O 0 0.07209103554487228

Previous O 0 0.10579490661621094
UBE3A O 1 0.7754003405570984
cDNA O 0 0.1498759239912033
analysis O 0 0.04591061547398567
has O 0 0.02225804515182972
shown O 0 0.03274388983845711
a O 0 0.0261882022023201
coding O 0 0.0800001323223114
region O 0 0.04121992364525795
of O 0 0.018272537738084793
approximately O 0 0.03817218914628029
2 O 0 0.04551078751683235
. O 0 0.041574567556381226

6 O 0 0.08093330264091492
kb O 0 0.10747959464788437
and O 0 0.022042186930775642
a O 0 0.02782757766544819
3 O 0 0.04313933104276657
- O 0 0.08598259836435318
untranslated O 0 0.19464224576950073
region O 0 0.07573815435171127
( O 0 0.05903860181570053
UTR O 0 0.33516231179237366
) O 0 0.0306266900151968
of O 0 0.01905236206948757
< O 0 0.10891442745923996
50 O 0 0.03801631182432175
bp O 0 0.06909449398517609
, O 0 0.01941762864589691
whereas O 0 0.03923250734806061
Northern O 0 0.03365997225046158
analysis O 0 0.03207181394100189
has O 0 0.019231295213103294
indicated O 0 0.038839612156152725
mRNA O 0 0.052591968327760696
sizes O 0 0.03217020630836487
of O 0 0.015705205500125885
5 O 0 0.037653446197509766
- O 0 0.07517830282449722
8 O 0 0.05460472032427788
kb O 0 0.14509320259094238
. O 0 0.056275203824043274

We O 0 0.030266493558883667
have O 0 0.02004162408411503
analyzed O 0 0.04175923019647598
additional O 0 0.03155992552638054
cDNA O 0 0.10657162964344025
clones O 0 0.0758049488067627
and O 0 0.015596034936606884
provide O 0 0.019324634224176407
evidence O 0 0.016632970422506332
for O 0 0.00982028990983963
an O 0 0.013172711245715618
additional O 0 0.029118742793798447
0 O 0 0.06134906783699989
. O 0 0.03766956925392151

5 O 0 0.07135910540819168
kb O 0 0.11123297363519669
of O 0 0.026551194489002228
5 O 0 0.04658358171582222
- O 0 0.09974828362464905
UTR O 0 0.22953426837921143
and O 0 0.03293469920754433
> O 0 0.11795105785131454
2 O 0 0.03914192318916321
kb O 0 0.07980243116617203
of O 0 0.024705782532691956
3 O 0 0.054383352398872375
- O 0 0.1261940449476242
UTR O 0 0.4474274218082428
. O 0 0.06377654522657394

We O 0 0.02598309889435768
have O 0 0.01603042520582676
established O 0 0.02046387270092964
the O 0 0.01652984321117401
genomic O 0 0.08203483372926712
organization O 0 0.03408701345324516
of O 0 0.021776802837848663
UBE3A O 0 0.3027937114238739
and O 0 0.016930747777223587
the O 0 0.016513967886567116
sequence O 0 0.039334557950496674
of O 0 0.023689081892371178
intron O 1 0.8825814127922058
- O 0 0.12259035557508469
exon O 0 0.16205202043056488
borders O 0 0.08072120696306229
. O 0 0.057494182139635086

We O 0 0.027806241065263748
have O 0 0.01763123646378517
also O 0 0.014165053144097328
mapped O 0 0.04221975430846214
two O 0 0.018280375748872757
highly O 0 0.038304753601551056
homologous O 0 0.11196901649236679
processed O 0 0.05279417708516121
pseudogenes O 0 0.1312849074602127
, O 0 0.032627005130052567
UBE3AP1 O 0 0.3282901346683502
and O 0 0.022896986454725266
UBE3AP2 O 0 0.11944665014743805
, O 0 0.017497239634394646
to O 0 0.015001848340034485
chromosomes O 0 0.04928842931985855
2 O 0 0.0225775595754385
and O 0 0.012087168172001839
21 O 0 0.01980229653418064
, O 0 0.010776938870549202
respectively O 0 0.015473262406885624
, O 0 0.010455035604536533
and O 0 0.009966589510440826
determined O 0 0.02519810013473034
their O 0 0.016209479421377182
genomic O 0 0.0928523987531662
organization O 0 0.0584336556494236
. O 0 0.04446641728281975

These O 0 0.02407948672771454
results O 0 0.027301575988531113
will O 0 0.012644889764487743
form O 0 0.015703869983553886
the O 0 0.009881991893053055
basis O 0 0.013419577851891518
for O 0 0.011384580284357071
studies O 0 0.027036553248763084
of O 0 0.01771291345357895
mutation O 0 0.11540394276380539
and O 0 0.02850930392742157
imprinting O 0 0.24835920333862305
of O 0 0.03949330747127533
UBE3A O 1 0.9715244174003601
. O 0 0.06889872252941132

Mutation O 0 0.3804691433906555
spectrum O 0 0.11803577840328217
and O 0 0.04411681368947029
genotype O 1 0.9754079580307007
- O 1 0.6152100563049316
phenotype O 1 0.9482941031455994
analyses O 0 0.10263919830322266
in O 0 0.058635320514440536
Cowden B-Disease 1 0.9999841451644897
disease I-Disease 1 0.9999876022338867
and O 0 0.07241366058588028
Bannayan B-Disease 1 0.9998514652252197
- I-Disease 1 0.9997748732566833
Zonana I-Disease 1 0.9999798536300659
syndrome I-Disease 1 0.999998927116394
, O 0 0.04867056757211685
two O 0 0.05305349454283714
hamartoma B-Disease 1 0.9999655485153198
syndromes I-Disease 1 0.9999849796295166
with O 0 0.09193409234285355
germline O 1 0.9973130822181702
PTEN O 1 0.9985244870185852
mutation O 1 0.9292151927947998
. O 0 0.07633262127637863

The O 0 0.09661206603050232
tumour B-Disease 1 0.9999613761901855
suppressor O 1 0.9915697574615479
gene O 0 0.2902514934539795
PTEN O 1 0.9835222959518433
, O 0 0.025091446936130524
which O 0 0.0169536042958498
maps O 0 0.031762734055519104
to O 0 0.02011406049132347
10q23 O 0 0.12589479982852936
. O 0 0.04522122070193291

3 O 0 0.05988961085677147
and O 0 0.028361443430185318
encodes O 0 0.07595779001712799
a O 0 0.038279514759778976
403 O 0 0.13498231768608093
amino O 0 0.09701776504516602
acid O 0 0.14554016292095184
dual O 0 0.1079263910651207
specificity O 0 0.16015625
phosphatase O 1 0.9371541142463684
( O 0 0.08334032446146011
protein O 0 0.12451699376106262
tyrosine O 0 0.2685467004776001
phosphatase O 1 0.9657154679298401
; O 0 0.052827782928943634
PTPase O 0 0.15698665380477905
) O 0 0.02655686065554619
, O 0 0.01316049974411726
was O 0 0.012855212204158306
shown O 0 0.018675299361348152
recently O 0 0.017535818740725517
to O 0 0.01044359803199768
play O 0 0.015501466579735279
a O 0 0.015610494650900364
broad O 0 0.035724371671676636
role O 0 0.028372393921017647
in O 0 0.02205316163599491
human O 0 0.054067157208919525
malignancy B-Disease 1 0.9984517097473145
. O 0 0.05337545648217201

Somatic O 1 0.9268038272857666
PTEN O 1 0.9938061237335205
deletions O 0 0.17422281205654144
and O 0 0.03914869949221611
mutations O 0 0.1086544543504715
were O 0 0.02073596604168415
observed O 0 0.03856523707509041
in O 0 0.026432758197188377
sporadic B-Disease 1 0.8345767259597778
breast I-Disease 1 0.9999798536300659
, I-Disease 0 0.0569472536444664
brain I-Disease 1 0.9997187256813049
, I-Disease 0 0.1380641907453537
prostate I-Disease 1 0.9999983310699463
and I-Disease 0 0.2896766662597656
kidney I-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999901056289673
cell O 0 0.13717816770076752
lines O 0 0.02992650680243969
and O 0 0.011268156580626965
in O 0 0.011424751952290535
several O 0 0.01640797220170498
primary O 0 0.05372822657227516
tumours B-Disease 1 0.9997743964195251
such O 0 0.03155934810638428
as O 0 0.04551967233419418
endometrial B-Disease 1 0.9999979734420776
carcinomas I-Disease 1 0.9999994039535522
, O 1 0.997984766960144
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9089922904968262
thyroid B-Disease 1 0.9999991655349731
tumours I-Disease 1 0.9999827146530151
. O 0 0.08042468875646591

In O 0 0.033315397799015045
addition O 0 0.03863364830613136
, O 0 0.032396867871284485
PTEN O 1 0.8984882831573486
was O 0 0.021344520151615143
identified O 0 0.02568250522017479
as O 0 0.014180628582835197
the O 0 0.02151568979024887
susceptibility O 1 0.6022078990936279
gene O 0 0.08864730596542358
for O 0 0.02937239222228527
two O 0 0.05473873391747475
hamartoma B-Disease 1 0.999996542930603
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999927282333374
( O 0 0.07759976387023926
CD B-Disease 0 0.07995589077472687
; O 0 0.050243981182575226
MIM O 1 0.995733916759491
158350 O 0 0.3337945342063904
) O 0 0.03523371368646622
and O 0 0.026424800977110863
Bannayan B-Disease 1 0.9555516242980957
- I-Disease 1 0.7135636210441589
Zonana I-Disease 1 0.9913575649261475
( I-Disease 0 0.07502531260251999
BZS I-Disease 1 0.9621040225028992
) I-Disease 0 0.053756412118673325
or I-Disease 0 0.05237673595547676
Ruvalcaba I-Disease 1 0.9989196062088013
- I-Disease 1 0.9856475591659546
Riley I-Disease 1 0.9918832778930664
- I-Disease 1 0.9965761303901672
Smith I-Disease 1 0.9911612272262573
syndrome I-Disease 1 0.9999988079071045
( O 0 0.21436336636543274
MIM O 1 0.9983711838722229
153480 O 1 0.7627571821212769
) O 0 0.06750039756298065
. O 0 0.048520419746637344

Constitutive O 0 0.20832228660583496
DNA O 0 0.09456545114517212
from O 0 0.032598938792943954
37 O 0 0.045080967247486115
CD B-Disease 0 0.04627496004104614
families O 0 0.0276104174554348
and O 0 0.016894293949007988
seven O 0 0.03148588538169861
BZS B-Disease 1 0.9198575615882874
families O 0 0.04472487419843674
was O 0 0.027452759444713593
screened O 0 0.07447498291730881
for O 0 0.04229212924838066
germline O 1 0.9897658228874207
PTEN O 1 0.9972694516181946
mutations O 1 0.5928168296813965
. O 0 0.07912994921207428

PTEN O 1 0.9923337697982788
mutations O 0 0.17530430853366852
were O 0 0.022236045449972153
identified O 0 0.029121074825525284
in O 0 0.014989732764661312
30 O 0 0.021932698786258698
of O 0 0.014445395208895206
37 O 0 0.04333895444869995
( O 0 0.03370700776576996
81 O 0 0.055921413004398346
% O 0 0.02970205247402191
) O 0 0.026063285768032074
CD B-Disease 0 0.036378972232341766
families O 0 0.026991799473762512
, O 0 0.017551260069012642
including O 0 0.021348081529140472
missense O 0 0.12822479009628296
and O 0 0.027787834405899048
nonsense O 0 0.0777006521821022
point O 0 0.040636736899614334
mutations O 0 0.1145002469420433
, O 0 0.024380642920732498
deletions O 0 0.08811024576425552
, O 0 0.027210209518671036
insertions O 0 0.11211922764778137
, O 0 0.02855384722352028
a O 0 0.039755094796419144
deletion O 1 0.5627143383026123
/ O 1 0.8873331546783447
insertion O 0 0.14808513224124908
and O 0 0.04056766256690025
splice O 0 0.18614071607589722
site O 0 0.07683972269296646
mutations O 0 0.1824691891670227
. O 0 0.0645638182759285

These O 0 0.038933102041482925
mutations O 0 0.09977322071790695
were O 0 0.017769232392311096
scattered O 0 0.02857423573732376
over O 0 0.014568126760423183
the O 0 0.013285484164953232
entire O 0 0.026312610134482384
length O 0 0.030291501432657242
of O 0 0.01675407961010933
PTEN O 1 0.9578449726104736
, O 0 0.012557330541312695
with O 0 0.009454822167754173
the O 0 0.009724066592752934
exception O 0 0.01787414215505123
of O 0 0.007998021319508553
the O 0 0.009384426288306713
first O 0 0.011553247459232807
, O 0 0.011938982643187046
fourth O 0 0.024120165035128593
and O 0 0.015390696935355663
last O 0 0.03241082280874252
exons O 0 0.1153978481888771
. O 0 0.045552827417850494

A O 0 0.07189805805683136
hot O 0 0.09944099932909012
spot O 0 0.06935355812311172
for O 0 0.03751639276742935
PTEN O 1 0.9876013398170471
mutation O 0 0.15329766273498535
in O 0 0.022773535922169685
CD B-Disease 0 0.042567528784275055
was O 0 0.01678508147597313
identified O 0 0.023337792605161667
in O 0 0.017429733648896217
exon O 0 0.08173247426748276
5 O 0 0.025407858192920685
that O 0 0.011012163944542408
contains O 0 0.01842367835342884
the O 0 0.01718343235552311
PTPase O 0 0.11024441570043564
core O 0 0.040236424654722214
motif O 0 0.0531301349401474
, O 0 0.013141891919076443
with O 0 0.011417945846915245
13 O 0 0.019505305215716362
of O 0 0.011855495162308216
30 O 0 0.022261761128902435
( O 0 0.026837345212697983
43 O 0 0.03757728636264801
% O 0 0.03220180794596672
) O 0 0.0280027873814106
CD B-Disease 0 0.0563085675239563
mutations O 0 0.09501267969608307
identified O 0 0.032004475593566895
in O 0 0.019884834066033363
this O 0 0.023333311080932617
exon O 0 0.13308528065681458
. O 0 0.05304638668894768

Seven O 0 0.037982743233442307
of O 0 0.019250700250267982
30 O 0 0.028863172978162766
( O 0 0.02914910390973091
23 O 0 0.02846119925379753
% O 0 0.02309100516140461
) O 0 0.015478131361305714
were O 0 0.007706272881478071
within O 0 0.011518172919750214
the O 0 0.011724029667675495
core O 0 0.030039837583899498
motif O 0 0.05000342056155205
, O 0 0.012237302958965302
the O 0 0.011999932117760181
majority O 0 0.02177448756992817
( O 0 0.01815284788608551
five O 0 0.010622650384902954
of O 0 0.008366541005671024
seven O 0 0.015320174396038055
) O 0 0.015809010714292526
of O 0 0.010190164670348167
which O 0 0.014725126326084137
were O 0 0.019814737141132355
missense O 0 0.46234217286109924
mutations O 0 0.14422667026519775
, O 0 0.0214395709335804
possibly O 0 0.0318022221326828
pointing O 0 0.02969965897500515
to O 0 0.010353288613259792
the O 0 0.010435529053211212
functional O 0 0.028135335072875023
significance O 0 0.01950058527290821
of O 0 0.012074419297277927
this O 0 0.016388367861509323
region O 0 0.04602455720305443
. O 0 0.03677711635828018

Germline O 1 0.9935474991798401
PTEN O 1 0.9946801066398621
mutations O 0 0.16520319879055023
were O 0 0.021284809336066246
identified O 0 0.022580480203032494
in O 0 0.010213276371359825
four O 0 0.011861875653266907
of O 0 0.01027613040059805
seven O 0 0.021456068381667137
( O 0 0.03268444538116455
57 O 0 0.052921656519174576
% O 0 0.03911039978265762
) O 0 0.04585639387369156
BZS B-Disease 1 0.9091305732727051
families O 0 0.058749664574861526
studied O 0 0.05259442701935768
. O 0 0.04122096300125122

Interestingly O 0 0.11305108666419983
, O 0 0.025796514004468918
none O 0 0.02584194205701351
of O 0 0.012462527491152287
these O 0 0.017257653176784515
mutations O 0 0.0832066610455513
was O 0 0.01909509301185608
observed O 0 0.031485360115766525
in O 0 0.01713930070400238
the O 0 0.02400517649948597
PTPase O 0 0.15205171704292297
core O 0 0.07087760418653488
motif O 0 0.11588622629642487
. O 0 0.051383357495069504

It O 0 0.024589015170931816
is O 0 0.017060615122318268
also O 0 0.013983671553432941
worthy O 0 0.033662889152765274
of O 0 0.011793176643550396
note O 0 0.027491871267557144
that O 0 0.011466553434729576
a O 0 0.018467258661985397
single O 0 0.02975810319185257
nonsense O 0 0.06624899059534073
point O 0 0.03767406940460205
mutation O 0 0.11167027801275253
, O 0 0.020190857350826263
R233X O 0 0.07881111651659012
, O 0 0.016268378123641014
was O 0 0.014764216728508472
observed O 0 0.025030652061104774
in O 0 0.013424642384052277
the O 0 0.02244383655488491
germline O 0 0.1775771677494049
DNA O 0 0.06260581314563751
from O 0 0.01930408738553524
two O 0 0.015924837440252304
unrelated O 0 0.04970170930027962
CD B-Disease 0 0.04847393557429314
families O 0 0.036947574466466904
and O 0 0.019558727741241455
one O 0 0.02851281687617302
BZS B-Disease 1 0.940725564956665
family O 0 0.05869881063699722
. O 0 0.04419531300663948

Genotype O 1 0.9870327711105347
- O 1 0.678900957107544
phenotype O 1 0.821845293045044
studies O 0 0.04269612208008766
were O 0 0.012538861483335495
not O 0 0.009804769419133663
performed O 0 0.015397636219859123
on O 0 0.008346104063093662
this O 0 0.008935396559536457
small O 0 0.016169574111700058
group O 0 0.02871425449848175
of O 0 0.022099951282143593
BZS B-Disease 1 0.9400272965431213
families O 0 0.06988605856895447
. O 0 0.05446162447333336

However O 0 0.05618329718708992
, O 0 0.047751497477293015
genotype O 1 0.8397278189659119
- O 0 0.18395790457725525
phenotype O 1 0.6460394263267517
analysis O 0 0.07004673779010773
inthe O 0 0.13646192848682404
group O 0 0.037052951753139496
of O 0 0.01620330475270748
CD B-Disease 0 0.044499851763248444
families O 0 0.027960870414972305
revealed O 0 0.027864942327141762
two O 0 0.015077541582286358
possible O 0 0.026203038170933723
associations O 0 0.039643630385398865
worthy O 0 0.04347996413707733
of O 0 0.015827003866434097
follow O 0 0.03273031860589981
- O 0 0.04376036301255226
up O 0 0.01751570962369442
in O 0 0.015128923580050468
independent O 0 0.029238633811473846
analyses O 0 0.06227056682109833
. O 0 0.041673995554447174

The O 0 0.026360834017395973
first O 0 0.018180403858423233
was O 0 0.014425327070057392
an O 0 0.01231196615844965
association O 0 0.027269285172224045
noted O 0 0.014797624200582504
in O 0 0.008442703634500504
the O 0 0.009971559047698975
group O 0 0.019809680059552193
of O 0 0.013843121007084846
CD B-Disease 0 0.0491977259516716
families O 0 0.044857487082481384
with O 0 0.04856998473405838
breast B-Disease 1 0.9999934434890747
disease I-Disease 1 0.9999761581420898
. O 0 0.06531424075365067

A O 0 0.06088384985923767
correlation O 0 0.07783974707126617
was O 0 0.021690303459763527
observed O 0 0.02930719591677189
between O 0 0.01687868870794773
the O 0 0.016642630100250244
presence O 0 0.045172739773988724
/ O 0 0.4659564197063446
absence O 0 0.03949257358908653
of O 0 0.017308350652456284
a O 0 0.03598498925566673
PTEN O 1 0.9966315627098083
mutation O 0 0.15008744597434998
and O 0 0.017469406127929688
the O 0 0.018640482798218727
type O 0 0.04974569007754326
of O 0 0.025616705417633057
breast O 1 0.9997696280479431
involvement O 1 0.5328710079193115
( O 0 0.07332610338926315
unaffected O 1 0.9120396971702576
versus O 1 0.8592742085456848
benign O 1 0.9991810917854309
versus O 1 0.9795657396316528
malignant O 1 0.9999271631240845
) O 0 0.06463371962308884
. O 0 0.05009220913052559

Specifically O 0 0.04006415233016014
and O 0 0.014362914487719536
more O 0 0.010919406078755856
directly O 0 0.014151779934763908
, O 0 0.010077938437461853
an O 0 0.011588340625166893
association O 0 0.025052862241864204
was O 0 0.0113249272108078
also O 0 0.011262833140790462
observed O 0 0.021289575845003128
between O 0 0.01195073314011097
the O 0 0.013153288513422012
presence O 0 0.029267003759741783
of O 0 0.016982778906822205
a O 0 0.04138763248920441
PTEN O 1 0.9996904134750366
mutation O 1 0.9975074529647827
and O 1 0.5019686222076416
malignant B-Disease 1 0.9999995231628418
breast I-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999886751174927
. O 0 0.07617007941007614

Secondly O 0 0.08966700732707977
, O 0 0.020768839865922928
there O 0 0.012500707991421223
appeared O 0 0.016824092715978622
to O 0 0.00978216715157032
be O 0 0.00975633505731821
an O 0 0.01526978611946106
interdependent O 0 0.09382541477680206
association O 0 0.05045907571911812
between O 0 0.03437654301524162
mutations O 0 0.12134812027215958
upstream O 0 0.06030447781085968
and O 0 0.015432418324053288
within O 0 0.019710080698132515
the O 0 0.020068783313035965
PTPase O 0 0.130968376994133
core O 0 0.051537517458200455
motif O 0 0.06655407696962357
, O 0 0.01587299443781376
the O 0 0.014706169255077839
core O 0 0.03383588790893555
motif O 0 0.056067757308483124
containing O 0 0.022334102541208267
the O 0 0.01527483481913805
majority O 0 0.029784562066197395
of O 0 0.021449659019708633
missense O 0 0.32509782910346985
mutations O 0 0.11319322884082794
, O 0 0.016811786219477654
and O 0 0.010740946047008038
the O 0 0.011794609017670155
involvement O 0 0.03230760991573334
of O 0 0.00972986314445734
all O 0 0.01265003252774477
major O 0 0.02531181275844574
organ O 0 0.07465967535972595
systems O 0 0.04892682656645775
( O 0 0.03854803740978241
central O 0 0.04139026254415512
nervous O 1 0.9783706665039062
system O 0 0.04424169659614563
, O 0 0.03405189514160156
thyroid O 1 0.9999934434890747
, O 0 0.08083823323249817
breast O 1 0.999993085861206
, O 0 0.13707691431045532
skin O 1 0.9999856948852539
and O 0 0.056123971939086914
gastrointestinal O 1 0.9999959468841553
tract O 1 0.9995774626731873
) O 0 0.05583362281322479
. O 0 0.04315314441919327

However O 0 0.03253164887428284
, O 0 0.01555449329316616
these O 0 0.01046541053801775
observations O 0 0.021030688658356667
would O 0 0.010216188617050648
need O 0 0.014674435369670391
to O 0 0.00928064901381731
be O 0 0.008675272576510906
confirmed O 0 0.019233234226703644
by O 0 0.010174175724387169
studying O 0 0.017197273671627045
a O 0 0.014080503024160862
larger O 0 0.019098680466413498
number O 0 0.013311474584043026
of O 0 0.014789464883506298
CD B-Disease 0 0.054964300245046616
families O 0 0.053529828786849976
. O 0 0.05107493698596954

Molecular O 0 0.1681406944990158
defects O 1 0.7901608347892761
leading O 0 0.042628925293684006
to O 0 0.02152864821255207
human O 0 0.03907683864235878
complement B-Disease 0 0.08505101501941681
component I-Disease 1 0.8406952023506165
C6 I-Disease 1 0.9999872446060181
deficiency I-Disease 1 0.9999939203262329
in O 0 0.022290388122200966
an O 0 0.020964113995432854
African O 0 0.050592899322509766
- O 0 0.07780295610427856
American O 0 0.044107645750045776
family O 0 0.05526115000247955
. O 0 0.04939301684498787

Complement B-Disease 0 0.4858579933643341
component I-Disease 1 0.9854322075843811
C6 I-Disease 1 0.9999951124191284
deficiency I-Disease 1 0.9999995231628418
( O 0 0.1069536954164505
C6D B-Disease 1 0.9696372151374817
) O 0 0.036703892052173615
was O 0 0.022405054420232773
diagnosed O 1 0.9966259002685547
in O 0 0.016405003145337105
a O 0 0.018057338893413544
16 O 0 0.029793940484523773
- O 0 0.05432810261845589
year O 0 0.028471384197473526
- O 0 0.0650269091129303
old O 0 0.03803606703877449
African O 0 0.05930282175540924
- O 0 0.0907551571726799
American O 0 0.04957505315542221
male O 0 0.09261224418878555
with O 0 0.07121947407722473
meningococcal B-Disease 1 0.9999974966049194
meningitis I-Disease 1 0.9999922513961792
. O 0 0.08864001929759979

The O 0 0.05040998384356499
patients O 1 0.9648429751396179
father O 0 0.0318053662776947
and O 0 0.01282263919711113
two O 0 0.012279259972274303
brothers O 0 0.033975157886743546
also O 0 0.01538107730448246
had O 0 0.02104041539132595
C6D B-Disease 0 0.21947041153907776
, O 0 0.014412196353077888
but O 0 0.013258019462227821
gave O 0 0.019732056185603142
no O 0 0.016249051317572594
history O 0 0.021168123930692673
of O 0 0.022278938442468643
meningitis B-Disease 1 0.9999690055847168
or O 0 0.03884012997150421
other O 0 0.0318635031580925
neisserial B-Disease 1 0.9970048069953918
infection I-Disease 1 0.99977046251297
. O 0 0.06395478546619415

By O 0 0.0448995903134346
using O 0 0.04389834776520729
exon O 0 0.14099067449569702
- O 0 0.10252964496612549
specific O 0 0.06244310364127159
polymerase O 0 0.18829013407230377
chain O 0 0.11746595799922943
reaction O 0 0.10964393615722656
( O 0 0.06337697058916092
PCR O 0 0.17059703171253204
) O 0 0.04852558299899101
/ O 0 0.16383275389671326
single O 0 0.042149558663368225
- O 0 0.09168309718370438
strand O 0 0.12351527810096741
conformation O 0 0.11461857706308365
polymorphism O 0 0.10808266699314117
as O 0 0.019410401582717896
a O 0 0.02446167916059494
screening O 0 0.06610530614852905
step O 0 0.03505183756351471
and O 0 0.01984518952667713
nucleotide O 0 0.07633012533187866
sequencing O 0 0.061649080365896225
of O 0 0.018567517399787903
target O 0 0.038029029965400696
exons O 0 0.07086032629013062
, O 0 0.015562409535050392
we O 0 0.012278045527637005
determined O 0 0.022476037964224815
that O 0 0.010855496861040592
the O 0 0.015799812972545624
proband O 0 0.08361311256885529
was O 0 0.019683385267853737
a O 0 0.026306355372071266
compound O 0 0.06973171979188919
heterozygote O 0 0.20674452185630798
for O 0 0.02638011798262596
two O 0 0.037159331142902374
C6 O 1 0.9901778101921082
gene O 0 0.18429283797740936
mutations O 0 0.22093234956264496
. O 0 0.06312849372625351

The O 0 0.030461447313427925
first O 0 0.02573547698557377
, O 0 0.022783778607845306
1195delC O 0 0.0880386233329773
located O 0 0.02674264647066593
in O 0 0.01755780726671219
exon O 0 0.0857730433344841
7 O 0 0.028886858373880386
, O 0 0.014647258445620537
is O 0 0.013276229612529278
a O 0 0.017705513164401054
novel O 0 0.03589504957199097
mutation O 0 0.09165886789560318
, O 0 0.015297063626348972
while O 0 0.012284521944820881
the O 0 0.012917516753077507
second O 0 0.020842192694544792
, O 0 0.018491225317120552
1936delG O 0 0.08218807727098465
in O 0 0.019722335040569305
exon O 0 0.08024899661540985
12 O 0 0.025667704641819
, O 0 0.014292913489043713
has O 0 0.013592004776000977
been O 0 0.01408007275313139
described O 0 0.024593783542513847
before O 0 0.016155259683728218
to O 0 0.017182769253849983
cause O 0 0.06182817742228508
C6D B-Disease 0 0.1277734935283661
in O 0 0.01495991088449955
an O 0 0.015771515667438507
unrelated O 0 0.052884191274642944
African O 0 0.05405595153570175
- O 0 0.07805836200714111
American O 0 0.04398089274764061
individual O 0 0.04861411824822426
. O 0 0.04338761419057846

Both O 0 0.06320451200008392
mutations O 0 0.17651066184043884
result O 0 0.06021968647837639
in O 0 0.040924642235040665
premature O 1 0.9095751643180847
termination O 1 0.8658770322799683
codons O 0 0.14940425753593445
and O 0 0.04918936640024185
C6 O 1 0.9906831979751587
null O 0 0.14060333371162415
alleles O 0 0.22807984054088593
. O 0 0.06610963493585587

Allele O 0 0.2665364146232605
- O 0 0.12550190091133118
specific O 0 0.05965598300099373
PCR O 0 0.14063620567321777
indicated O 0 0.04620998352766037
that O 0 0.014639615081250668
the O 0 0.01679326593875885
probands O 0 0.09269632399082184
two O 0 0.019979678094387054
brothers O 0 0.04619200900197029
also O 0 0.020984891802072525
inherited O 0 0.08069551736116409
the O 0 0.030460156500339508
1195delC O 0 0.1860717236995697
mutation O 0 0.13259558379650116
from O 0 0.022866612300276756
their O 0 0.021090328693389893
heterozygous O 0 0.09752202033996582
mother O 0 0.04253929853439331
and O 0 0.016940973699092865
the O 0 0.025969048961997032
1936delG O 0 0.15752527117729187
mutation O 0 0.1241292953491211
from O 0 0.022392982617020607
their O 0 0.021584175527095795
homozygous O 0 0.0989934653043747
father O 0 0.04767679050564766
. O 0 0.02787751518189907
. O 0 0.03989236056804657

PAX6 O 1 0.9824085831642151
mutations O 0 0.3951634466648102
reviewed O 0 0.09851013869047165
. O 0 0.060148026794195175

Mutations O 0 0.32135918736457825
in O 0 0.0448162667453289
PAX6 O 1 0.9674752354621887
are O 0 0.016466746106743813
responsible O 0 0.02634204924106598
for O 0 0.014778130687773228
human O 0 0.026953941211104393
aniridia B-Disease 1 0.7757872343063354
and O 0 0.014605332165956497
have O 0 0.011114101856946945
also O 0 0.010118751786649227
been O 0 0.011846164241433144
found O 0 0.017841417342424393
in O 0 0.01926739700138569
patients O 1 0.9962081909179688
with O 0 0.03299916163086891
Peters B-Disease 1 0.9984429478645325
anomaly I-Disease 1 0.9988681077957153
, O 0 0.029680272564291954
with O 0 0.044273484498262405
congenital B-Disease 1 0.9999994039535522
cataracts I-Disease 1 0.9999970197677612
, O 0 0.03695876523852348
with O 0 0.03757596015930176
autosomal B-Disease 1 0.9996839761734009
dominant I-Disease 1 0.9693799614906311
keratitis I-Disease 1 0.9999665021896362
, O 0 0.02619052119553089
and O 0 0.019327696412801743
with O 0 0.032122064381837845
isolated B-Disease 0 0.39078229665756226
foveal I-Disease 1 0.9983289837837219
hypoplasia I-Disease 1 0.9997598528862
. O 0 0.07522518187761307

No O 0 0.05240205302834511
locus O 0 0.11490543931722641
other O 0 0.026644814759492874
than O 0 0.029261276125907898
chromosome O 0 0.12473632395267487
11p13 O 0 0.10877493023872375
has O 0 0.02309555560350418
been O 0 0.01873553916811943
implicated O 0 0.07544902712106705
in O 0 0.024803463369607925
aniridia B-Disease 1 0.9631809592247009
, O 0 0.02175632305443287
and O 0 0.02233378030359745
PAX6 O 1 0.9829139113426208
is O 0 0.017435794696211815
clearly O 0 0.018717672675848007
the O 0 0.01202565897256136
major O 0 0.016406340524554253
, O 0 0.01060955785214901
if O 0 0.011273474432528019
not O 0 0.00813948642462492
only O 0 0.010684731416404247
, O 0 0.01743263006210327
gene O 0 0.07163763046264648
responsible O 0 0.05523311346769333
. O 0 0.041992805898189545

Twenty O 0 0.0844552144408226
- O 0 0.07447145879268646
eight O 0 0.03203968331217766
percent O 0 0.03320588916540146
of O 0 0.020359378308057785
identified O 0 0.05809168517589569
PAX6 O 1 0.9978381991386414
mutations O 0 0.41752341389656067
are O 0 0.031023526564240456
C O 0 0.3119516372680664
- O 0 0.44361191987991333
T O 1 0.8822727799415588
changes O 0 0.043281953781843185
at O 0 0.03848879784345627
CpG O 1 0.6223891377449036
dinucleotides O 0 0.13798277080059052
, O 0 0.02205711044371128
20 O 0 0.024395383894443512
% O 0 0.026334291324019432
are O 0 0.01571168564260006
splicing O 0 0.07457011938095093
errors O 0 0.03726569563150406
, O 0 0.012755535542964935
and O 0 0.009705166332423687
more O 0 0.008282897993922234
than O 0 0.012205217033624649
30 O 0 0.01867101714015007
% O 0 0.023843316361308098
are O 0 0.015790237113833427
deletion O 0 0.09966111183166504
or O 0 0.03831649571657181
insertion O 0 0.13017572462558746
events O 0 0.05929886922240257
. O 0 0.047134384512901306

There O 0 0.03125951066613197
is O 0 0.02031603269279003
a O 0 0.024714788421988487
noticeably O 0 0.07328720390796661
elevated O 0 0.06853502988815308
level O 0 0.029682880267500877
of O 0 0.016205858439207077
mutation O 0 0.08361142128705978
in O 0 0.014350755140185356
the O 0 0.014892835170030594
paired O 0 0.06431592255830765
domain O 0 0.037715110927820206
compared O 0 0.023629453033208847
with O 0 0.011082064360380173
the O 0 0.011857466772198677
rest O 0 0.02061850018799305
of O 0 0.012730988673865795
the O 0 0.021385205909609795
gene O 0 0.09951211512088776
. O 0 0.05303800106048584

Increased O 0 0.08903298527002335
mutation O 0 0.13735431432724
in O 0 0.02131718210875988
the O 0 0.02383371815085411
homeodomain O 0 0.13298341631889343
is O 0 0.02000427432358265
accounted O 0 0.034267306327819824
for O 0 0.012772559188306332
by O 0 0.017947407439351082
the O 0 0.027289675548672676
hypermutable O 0 0.37047743797302246
CpG O 1 0.8494004011154175
dinucleotide O 0 0.3143382966518402
in O 0 0.05686856061220169
codon O 0 0.15515224635601044
240 O 0 0.09852688759565353
. O 0 0.055210426449775696

Very O 0 0.04441244527697563
nearly O 0 0.038363855332136154
all O 0 0.020880160853266716
mutations O 0 0.1070842295885086
appear O 0 0.03313841670751572
to O 0 0.018252355977892876
cause O 0 0.06338296085596085
loss O 0 0.039887942373752594
of O 0 0.011487533338367939
function O 0 0.021325521171092987
of O 0 0.010970612056553364
the O 0 0.016970045864582062
mutant O 0 0.08382090926170349
allele O 0 0.0929829403758049
, O 0 0.016118859872221947
and O 0 0.010811357758939266
more O 0 0.009920088574290276
than O 0 0.011592540889978409
80 O 0 0.02717445231974125
% O 0 0.023504219949245453
of O 0 0.01890256628394127
exonic O 0 0.13766515254974365
substitutions O 0 0.07692771404981613
result O 0 0.04020491614937782
in O 0 0.025555193424224854
nonsense O 0 0.09429867565631866
codons O 0 0.1346064954996109
. O 0 0.05076848715543747

In O 0 0.03558449447154999
a O 0 0.033337175846099854
gene O 0 0.06823763996362686
with O 0 0.019245494157075882
such O 0 0.02024364471435547
extraordinarily O 0 0.06829160451889038
high O 0 0.03456125780940056
sequence O 0 0.03893843665719032
conservation O 0 0.03565060347318649
throughout O 0 0.020067067816853523
evolution O 0 0.02863895148038864
, O 0 0.013394259847700596
there O 0 0.014885545708239079
are O 0 0.016867056488990784
presumed O 0 0.0761302262544632
undiscovered O 0 0.23132309317588806
missense O 1 0.5411803126335144
mutations O 0 0.13428226113319397
, O 0 0.01972099021077156
these O 0 0.012042167596518993
are O 0 0.012538059614598751
hypothesized O 0 0.05084403604269028
to O 0 0.012856568209826946
exist O 0 0.016842253506183624
in O 0 0.011676528491079807
as O 0 0.015288728289306164
- O 0 0.055684130638837814
yet O 0 0.035258516669273376
unidentified O 0 0.07698611170053482
phenotypes O 0 0.18084052205085754
. O 0 0.03604907542467117
. O 0 0.04114605858922005

Genetic O 0 0.19171364605426788
heterogeneity O 0 0.18201158940792084
and O 0 0.03692508861422539
penetrance O 0 0.18216349184513092
analysis O 0 0.033504534512758255
of O 0 0.015688922256231308
the O 0 0.02713066153228283
BRCA1 O 1 0.989174485206604
and O 0 0.0440993458032608
BRCA2 O 1 0.9993149042129517
genes O 0 0.3384789526462555
in O 0 0.06168966367840767
breast B-Disease 1 0.999994158744812
cancer I-Disease 1 0.9999614953994751
families O 0 0.084562748670578
. O 0 0.06122890114784241

The O 0 0.1805938184261322
Breast B-Disease 1 0.9999972581863403
Cancer I-Disease 1 0.999988317489624
Linkage O 1 0.9573398232460022
Consortium O 0 0.22164730727672577
. O 0 0.06869380176067352

The O 0 0.03646168112754822
contribution O 0 0.05338788032531738
of O 0 0.03103661723434925
BRCA1 O 1 0.986530601978302
and O 0 0.04448545724153519
BRCA2 O 1 0.9995341300964355
to O 0 0.06799442321062088
inherited B-Disease 1 0.9999877214431763
breast I-Disease 1 0.999998927116394
cancer I-Disease 1 0.999994158744812
was O 0 0.034203242510557175
assessed O 0 0.058796659111976624
by O 0 0.02235991507768631
linkage O 0 0.10462101548910141
and O 0 0.02326575107872486
mutation O 0 0.10826317965984344
analysis O 0 0.02979215607047081
in O 0 0.01620754785835743
237 O 0 0.05819697305560112
families O 0 0.025285035371780396
, O 0 0.01206942554563284
each O 0 0.01125336904078722
with O 0 0.0116316182538867
at O 0 0.013492436148226261
least O 0 0.01436565537005663
four O 0 0.014463313855230808
cases O 0 0.03396023064851761
of O 0 0.0277937613427639
breast B-Disease 1 0.9999898672103882
cancer I-Disease 1 0.9998718500137329
, O 0 0.020998235791921616
collected O 0 0.020878050476312637
by O 0 0.022541673853993416
the O 0 0.04582023620605469
Breast B-Disease 1 0.9999973773956299
Cancer I-Disease 1 0.9999904632568359
Linkage O 1 0.9532997608184814
Consortium O 0 0.1754842847585678
. O 0 0.0615113265812397

Families O 0 0.05210185796022415
were O 0 0.017705190926790237
included O 0 0.017864076420664787
without O 0 0.01838974468410015
regard O 0 0.023352280259132385
to O 0 0.012009546160697937
the O 0 0.016695385798811913
occurrence O 0 0.08028548955917358
of O 0 0.029910042881965637
ovarian B-Disease 1 0.9999595880508423
or I-Disease 0 0.04123571887612343
other I-Disease 0 0.03521692007780075
cancers I-Disease 1 0.9992891550064087
. O 0 0.0547989159822464

Overall O 0 0.10923565924167633
, O 0 0.04439825937151909
disease O 1 0.9989303946495056
was O 0 0.023649416863918304
linked O 0 0.04985874518752098
to O 0 0.019638968631625175
BRCA1 O 1 0.5733402371406555
in O 0 0.01571640558540821
an O 0 0.013597535900771618
estimated O 0 0.027293916791677475
52 O 0 0.03412707895040512
% O 0 0.019528450444340706
of O 0 0.011521663516759872
families O 0 0.022896157577633858
, O 0 0.015330074355006218
to O 0 0.017555324360728264
BRCA2 O 1 0.6133499145507812
in O 0 0.020095886662602425
32 O 0 0.029899870976805687
% O 0 0.018964165821671486
of O 0 0.009493897669017315
families O 0 0.022710653021931648
, O 0 0.010531888343393803
and O 0 0.009705166332423687
to O 0 0.011655103415250778
neither O 0 0.028696734458208084
gene O 0 0.04826463386416435
in O 0 0.0165445227175951
16 O 0 0.026937777176499367
% O 0 0.027660882100462914
( O 0 0.028276963159441948
95 O 0 0.04220691695809364
% O 0 0.04026833176612854
confidence O 0 0.06487682461738586
interval O 0 0.10911031067371368
[ O 0 0.10319120436906815
CI O 1 0.9928836822509766
] O 0 0.08947975188493729
6 O 0 0.04177467152476311
% O 0 0.034721408039331436
- O 0 0.056901078671216965
28 O 0 0.03489426150918007
% O 0 0.027725251391530037
) O 0 0.02335323952138424
, O 0 0.01451500691473484
suggesting O 0 0.041697245091199875
other O 0 0.023568956181406975
predisposition O 1 0.9231878519058228
genes O 0 0.12473081797361374
. O 0 0.05906295031309128

The O 0 0.04145227000117302
majority O 0 0.04814863204956055
( O 0 0.04067115858197212
81 O 0 0.05801684036850929
% O 0 0.0286069568246603
) O 0 0.022644400596618652
of O 0 0.016167588531970978
the O 0 0.03951461985707283
breast B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999853372573853
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999977350234985
families O 0 0.04788791388273239
were O 0 0.015321397222578526
due O 0 0.02460300177335739
to O 0 0.020867101848125458
BRCA1 O 1 0.8768323063850403
, O 0 0.01743629202246666
with O 0 0.014754446223378181
most O 0 0.01372955646365881
others O 0 0.0211537666618824
( O 0 0.02477036602795124
14 O 0 0.02618412859737873
% O 0 0.026314783841371536
) O 0 0.02184934727847576
due O 0 0.025610676035284996
to O 0 0.027531994506716728
BRCA2 O 1 0.9795859456062317
. O 0 0.05690358206629753

Conversely O 0 0.09497031569480896
, O 0 0.019076991826295853
the O 0 0.013616581447422504
majority O 0 0.02061738818883896
of O 0 0.011265489272773266
families O 0 0.023704418912529945
with O 0 0.017055610194802284
male B-Disease 0 0.04708707332611084
and I-Disease 0 0.022335892543196678
female I-Disease 0 0.3839559853076935
breast I-Disease 1 0.9999921321868896
cancer I-Disease 1 0.9998950958251953
were O 0 0.01889657974243164
due O 0 0.027991855517029762
to O 0 0.024603575468063354
BRCA2 O 1 0.991424024105072
( O 0 0.05427771061658859
76 O 0 0.07329963892698288
% O 0 0.044937558472156525
) O 0 0.04285287484526634
. O 0 0.040469277650117874

The O 0 0.038361284881830215
largest O 0 0.04976268112659454
proportion O 0 0.0601220428943634
( O 0 0.03860270604491234
67 O 0 0.04810802638530731
% O 0 0.02432236261665821
) O 0 0.015907660126686096
of O 0 0.009808367118239403
families O 0 0.023304346948862076
due O 0 0.01819440722465515
to O 0 0.011704222299158573
other O 0 0.012595648877322674
genes O 0 0.03963625803589821
was O 0 0.014269493520259857
found O 0 0.013644225895404816
in O 0 0.009276501834392548
families O 0 0.016805993393063545
with O 0 0.010350855998694897
four O 0 0.012324927374720573
or O 0 0.016501642763614655
five O 0 0.015473335050046444
cases O 0 0.02755388431251049
of O 0 0.02010420151054859
female O 0 0.42730632424354553
breast B-Disease 1 0.9999856948852539
cancer I-Disease 1 0.9998161196708679
only O 0 0.03406871482729912
. O 0 0.04301012307405472

These O 0 0.028256310150027275
estimates O 0 0.03798472136259079
were O 0 0.013394966721534729
not O 0 0.014265214093029499
substantially O 0 0.03864070400595665
affected O 0 0.036140117794275284
either O 0 0.018096162006258965
by O 0 0.013448003679513931
changing O 0 0.029203113168478012
the O 0 0.018921956419944763
assumed O 0 0.05596248805522919
penetrance O 0 0.2869970202445984
model O 0 0.040546875447034836
for O 0 0.021651163697242737
BRCA1 O 1 0.8821869492530823
or O 0 0.022559931501746178
by O 0 0.01466168463230133
including O 0 0.01842297986149788
or O 0 0.02924855798482895
excluding O 0 0.06573128700256348
BRCA1 O 1 0.9929443001747131
mutation O 0 0.4711008369922638
data O 0 0.05582756549119949
. O 0 0.05048156902194023

Among O 0 0.044742126017808914
those O 0 0.024330753833055496
families O 0 0.03672390058636665
with O 0 0.028329046443104744
disease O 1 0.9997840523719788
due O 0 0.03591020032763481
to O 0 0.022809583693742752
BRCA1 O 1 0.9186170697212219
that O 0 0.014317999593913555
were O 0 0.011001553386449814
tested O 0 0.031119853258132935
by O 0 0.01039670966565609
one O 0 0.00949978269636631
of O 0 0.008847529999911785
the O 0 0.013316924683749676
standard O 0 0.03213116526603699
screening O 0 0.06228938698768616
methods O 0 0.03266844525933266
, O 0 0.021059591323137283
mutations O 0 0.0839291363954544
were O 0 0.015829041600227356
detected O 0 0.0538782924413681
in O 0 0.015538555569946766
the O 0 0.01849871315062046
coding O 0 0.08462876826524734
sequence O 0 0.04324837028980255
or O 0 0.02823207899928093
splice O 0 0.09408534318208694
sites O 0 0.022156663239002228
in O 0 0.012493164278566837
an O 0 0.013390555046498775
estimated O 0 0.031724512577056885
63 O 0 0.05680325999855995
% O 0 0.03652734309434891
( O 0 0.03522130101919174
95 O 0 0.05000321567058563
% O 0 0.05264272540807724
CI O 1 0.9773564338684082
51 O 0 0.06052817404270172
% O 0 0.042969781905412674
- O 0 0.07703641057014465
77 O 0 0.0702853724360466
% O 0 0.041525065898895264
) O 0 0.041641633957624435
. O 0 0.03881071135401726

The O 0 0.03717103600502014
estimated O 0 0.0472368448972702
sensitivity O 0 0.07211699336767197
was O 0 0.019720178097486496
identical O 0 0.025988757610321045
for O 0 0.013395609334111214
direct O 0 0.02635006792843342
sequencing O 0 0.04775359481573105
and O 0 0.01422236580401659
other O 0 0.0157528854906559
techniques O 0 0.049071699380874634
. O 0 0.03992178663611412

The O 0 0.05455043539404869
penetrance O 0 0.2791920006275177
of O 0 0.03489284962415695
BRCA2 O 1 0.9416007399559021
was O 0 0.02709953673183918
estimated O 0 0.033884771168231964
by O 0 0.02140950970351696
maximizing O 0 0.0797574371099472
the O 0 0.032072823494672775
LOD O 1 0.8783724308013916
score O 0 0.04195773974061012
in O 0 0.03583887964487076
BRCA2 O 1 0.9984476566314697
- O 1 0.6576777100563049
mutation O 0 0.33483606576919556
families O 0 0.03869416564702988
, O 0 0.015250425785779953
over O 0 0.015903785824775696
all O 0 0.015345990657806396
possible O 0 0.041032880544662476
penetrance O 0 0.19170410931110382
functions O 0 0.049667004495859146
. O 0 0.04226801544427872

The O 0 0.04480772092938423
estimated O 0 0.06575284153223038
cumulative O 0 0.3005579710006714
risk O 1 0.9410141706466675
of O 0 0.04209132120013237
breast B-Disease 1 0.9999879598617554
cancer I-Disease 1 0.9998741149902344
reached O 0 0.04423580691218376
28 O 0 0.035376667976379395
% O 0 0.031865451484918594
( O 0 0.03547575697302818
95 O 0 0.04812530055642128
% O 0 0.050036489963531494
CI O 1 0.971028208732605
9 O 0 0.042448800057172775
% O 0 0.037290312349796295
- O 0 0.058424971997737885
44 O 0 0.0391683466732502
% O 0 0.027493281289935112
) O 0 0.019604619592428207
by O 0 0.012874809093773365
age O 0 0.025127584114670753
50 O 0 0.022508013993501663
years O 0 0.017740262672305107
and O 0 0.013461257331073284
84 O 0 0.04674232751131058
% O 0 0.030894752591848373
( O 0 0.03468243405222893
95 O 0 0.0474320687353611
% O 0 0.04819093644618988
CI O 1 0.9643356204032898
43 O 0 0.05408964306116104
% O 0 0.036469608545303345
- O 0 0.06510646641254425
95 O 0 0.050945330411195755
% O 0 0.030682004988193512
) O 0 0.023443441838026047
by O 0 0.015049681067466736
age O 0 0.030398733913898468
70 O 0 0.04126015678048134
years O 0 0.03141077607870102
. O 0 0.036358483135700226

The O 0 0.07174382358789444
corresponding O 1 0.9158779978752136
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999973773956299
risks O 1 0.9259007573127747
were O 0 0.03340471535921097
0 O 0 0.07035551220178604
. O 0 0.032831043004989624

4 O 0 0.06568178534507751
% O 0 0.04726114496588707
( O 0 0.03960160166025162
95 O 0 0.05203818902373314
% O 0 0.046588409692049026
CI O 1 0.9797605872154236
0 O 0 0.0594731941819191
% O 0 0.034114640206098557
- O 0 0.05085732787847519
1 O 0 0.02675708942115307
% O 0 0.027490749955177307
) O 0 0.020090844482183456
by O 0 0.011542982421815395
age O 0 0.021472079679369926
50 O 0 0.01962164044380188
years O 0 0.01447377074509859
and O 0 0.012345748953521252
27 O 0 0.028423955664038658
% O 0 0.031380876898765564
( O 0 0.03340256214141846
95 O 0 0.050374969840049744
% O 0 0.04901069775223732
CI O 1 0.9889696836471558
0 O 0 0.0672275498509407
% O 0 0.03908640518784523
- O 0 0.05848626419901848
47 O 0 0.04231948405504227
% O 0 0.030741307884454727
) O 0 0.021405650302767754
by O 0 0.01688309945166111
age O 0 0.03242786228656769
70 O 0 0.04287370666861534
years O 0 0.0314069502055645
. O 0 0.03822004422545433

The O 0 0.05277968570590019
lifetime O 0 0.29985055327415466
risk O 1 0.9648865461349487
of O 0 0.04136607050895691
breast B-Disease 1 0.9999972581863403
cancer I-Disease 1 0.9999715089797974
appears O 0 0.04775266349315643
similar O 0 0.023393141105771065
to O 0 0.013984611257910728
the O 0 0.017957797273993492
risk O 0 0.11797215044498444
in O 0 0.02720281295478344
BRCA1 O 1 0.9960108995437622
carriers O 0 0.12663580477237701
, O 0 0.014902540482580662
but O 0 0.010925247333943844
there O 0 0.009424299001693726
was O 0 0.009869877249002457
some O 0 0.010080070234835148
suggestion O 0 0.026743188500404358
of O 0 0.012665659189224243
a O 0 0.02347506210207939
lower O 0 0.05307316780090332
risk O 0 0.28431436419487
in O 0 0.038480982184410095
BRCA2 O 1 0.9982149600982666
carriers O 1 0.6939268112182617
< O 0 0.3966476619243622
50 O 0 0.035932280123233795
years O 0 0.021966001018881798
of O 0 0.01770365610718727
age O 0 0.042635250836610794
. O 0 0.04012073203921318

Eye B-Disease 1 0.9836658835411072
movement I-Disease 0 0.11591866612434387
abnormalities I-Disease 1 0.976682186126709
correlate O 0 0.11657662689685822
with O 0 0.04209312051534653
genotype O 1 0.9236141443252563
in O 0 0.04763328656554222
autosomal O 1 0.9988620281219482
dominant O 1 0.980124831199646
cerebellar B-Disease 1 0.9999771118164062
ataxia I-Disease 1 0.9999667406082153
type I-Disease 1 0.713763952255249
I I-Disease 0 0.07013513892889023
. O 0 0.04727700352668762

We O 0 0.041945792734622955
compared O 0 0.054639607667922974
horizontal O 0 0.10865344107151031
eye O 0 0.4971977174282074
movements O 0 0.07011424750089645
( O 0 0.04996997490525246
visually O 0 0.09533090889453888
guided O 0 0.10047964751720428
saccades O 1 0.9926130771636963
, O 0 0.03532218560576439
antisaccades O 0 0.1072688102722168
, O 0 0.018010245636105537
and O 0 0.016247892752289772
smooth O 0 0.053758781403303146
pursuit O 0 0.06608155369758606
) O 0 0.02465231344103813
in O 0 0.014135239645838737
control O 0 0.033013228327035904
subjects O 0 0.04075843468308449
( O 0 0.039970848709344864
n O 0 0.06507275998592377
= O 0 0.08335332572460175
14 O 0 0.03133078292012215
) O 0 0.021756010130047798
and O 0 0.01448718924075365
patients O 1 0.5050137639045715
with O 0 0.015149128623306751
three O 0 0.016562355682253838
forms O 0 0.029551759362220764
of O 0 0.022242289036512375
autosomal O 1 0.9968074560165405
dominant O 1 0.7741268873214722
cerebellar B-Disease 1 0.9998737573623657
ataxias I-Disease 1 0.9972585439682007
type I-Disease 1 0.6767575144767761
I I-Disease 0 0.08138306438922882
spinocerebellar B-Disease 1 0.9983640313148499
ataxias I-Disease 0 0.28693586587905884
1 I-Disease 0 0.0336422324180603
and I-Disease 0 0.019238092005252838
2 I-Disease 0 0.034658174961805344
( O 0 0.039640869945287704
SCA1 B-Disease 0 0.24931210279464722
, O 0 0.02963213622570038
n O 0 0.0719209834933281
= O 0 0.0965823158621788
11 O 0 0.03994400426745415
; O 0 0.03643655776977539
SCA2 B-Disease 0 0.1652340441942215
, O 0 0.028919409960508347
n O 0 0.07429111003875732
= O 0 0.08193595707416534
10 O 0 0.026765912771224976
) O 0 0.03033011592924595
and O 0 0.027051426470279694
SCA3 B-Disease 1 0.9991809725761414
/ O 1 0.9968793392181396
Machado B-Disease 1 0.9776594042778015
- I-Disease 1 0.9769500494003296
Joseph I-Disease 1 0.7282291054725647
disease I-Disease 1 0.999920129776001
( O 0 0.07926850765943527
MJD B-Disease 1 0.9970120191574097
) O 0 0.05335737764835358
( O 0 0.05176585912704468
n O 0 0.08085186779499054
= O 0 0.09249363839626312
16 O 0 0.036922719329595566
) O 0 0.03658502921462059
. O 0 0.0350373350083828

In O 0 0.05448373034596443
SCA1 B-Disease 1 0.538533627986908
, O 0 0.04373055696487427
saccade O 1 0.5215567350387573
amplitude O 0 0.10462383180856705
was O 0 0.028574669733643532
significantly O 0 0.04859160631895065
increased O 0 0.03594553470611572
, O 0 0.02098899707198143
resulting O 0 0.05345512926578522
in O 0 0.0325341671705246
hypermetria B-Disease 0 0.21947742998600006
. O 0 0.05377814173698425

The O 0 0.05531727895140648
smooth O 0 0.09340833127498627
pursuit O 0 0.10142967104911804
gain O 0 0.05804680660367012
was O 0 0.03421434387564659
decreased O 0 0.0840991660952568
. O 0 0.04341297224164009

In O 0 0.05933766067028046
SCA2 B-Disease 0 0.3467656075954437
, O 0 0.05003464221954346
saccade O 1 0.6524378061294556
velocity O 0 0.10759380459785461
was O 0 0.03708778694272041
markedly O 0 0.10617894679307938
decreased O 0 0.10618657618761063
. O 0 0.049297790974378586

The O 0 0.03355778753757477
percentage O 0 0.04328010603785515
of O 0 0.018657464534044266
errors O 0 0.04965083673596382
in O 0 0.023082509636878967
antisaccades O 0 0.12404312938451767
was O 0 0.02424227073788643
greatly O 0 0.03862156346440315
increased O 0 0.02930976264178753
and O 0 0.01606103777885437
was O 0 0.019656619057059288
significantly O 0 0.04612082242965698
correlated O 0 0.07263652980327606
with O 0 0.024641217663884163
age O 0 0.05166000872850418
at O 0 0.06084761768579483
disease O 1 0.999976634979248
onset O 1 0.9995245933532715
. O 0 0.07098088413476944

In O 0 0.0288094449788332
addition O 0 0.02546568028628826
, O 0 0.016631286591291428
a O 0 0.021273719146847725
correlation O 0 0.05122411251068115
between O 0 0.022874733433127403
smooth O 0 0.04925559461116791
pursuit O 0 0.05751749128103256
gain O 0 0.02910296991467476
and O 0 0.011152645573019981
the O 0 0.011895562522113323
number O 0 0.013387531973421574
of O 0 0.018262004479765892
trinucleotide O 1 0.9393965005874634
repeats O 0 0.08376569300889969
was O 0 0.027341635897755623
found O 0 0.033805448561906815
. O 0 0.033674709498882294

In O 0 0.06556851416826248
SCA3 B-Disease 1 0.9942907094955444
, O 0 0.051143430173397064
gaze B-Disease 1 0.8808532953262329
- I-Disease 1 0.6731140613555908
evoked I-Disease 1 0.5776132941246033
nystagmus I-Disease 1 0.9945301413536072
was O 0 0.02581951394677162
often O 0 0.020463066175580025
present O 0 0.0168460663408041
as O 0 0.015338181518018246
was O 0 0.024505674839019775
saccade O 1 0.6956073641777039
hypometria O 0 0.13319212198257446
and O 0 0.021690580993890762
smooth O 0 0.0586116798222065
pursuit O 0 0.07468897104263306
gain O 0 0.052815113216638565
was O 0 0.028503241017460823
markedly O 0 0.09886591881513596
decreased O 0 0.10209773480892181
. O 0 0.046287987381219864

Three O 0 0.039588406682014465
major O 0 0.04548725113272667
criteria O 0 0.055595025420188904
, O 0 0.03737269714474678
saccade O 0 0.4940987527370453
amplitude O 0 0.1219228208065033
, O 0 0.03449634462594986
saccade O 0 0.29524508118629456
velocity O 0 0.07225925475358963
, O 0 0.017538323998451233
and O 0 0.015052368864417076
presence O 0 0.03540331497788429
of O 0 0.025255341082811356
gaze B-Disease 1 0.5768073201179504
- I-Disease 0 0.2710067331790924
evoked I-Disease 1 0.561863899230957
nystagmus I-Disease 1 0.9932546019554138
, O 0 0.02336830459535122
permitted O 0 0.024289913475513458
the O 0 0.01623186469078064
correct O 0 0.0411546565592289
assignment O 0 0.040313512086868286
of O 0 0.013009984977543354
90 O 0 0.029396971687674522
% O 0 0.01921369694173336
of O 0 0.011020340956747532
the O 0 0.016972171142697334
SCA1 B-Disease 0 0.12057524174451828
, O 0 0.018045740202069283
90 O 0 0.027460463345050812
% O 0 0.018234288319945335
of O 0 0.010161485522985458
the O 0 0.015258792787790298
SCA2 B-Disease 0 0.13397015631198883
, O 0 0.017138995230197906
and O 0 0.013587274588644505
93 O 0 0.040434785187244415
% O 0 0.020579000934958458
of O 0 0.012558122165501118
the O 0 0.019384412094950676
patients O 1 0.9433478713035583
with O 0 0.0238018985837698
SCA3 B-Disease 1 0.974886417388916
to O 0 0.01685715839266777
their O 0 0.017055243253707886
genetically O 0 0.058938510715961456
confirmed O 0 0.05045873671770096
patient O 0 0.48239022493362427
group O 0 0.027080094441771507
and O 0 0.012614189647138119
, O 0 0.013643442653119564
therefore O 0 0.01678072288632393
, O 0 0.014319239184260368
may O 0 0.02380354329943657
help O 0 0.03602851182222366
orient O 0 0.09249839186668396
diagnoses O 1 0.974494457244873
of O 0 0.027148734778165817
SCA1 B-Disease 1 0.8288434147834778
, O 0 0.03151557594537735
SCA2 B-Disease 0 0.4285418391227722
, O 0 0.02376631647348404
and O 0 0.022339224815368652
SCA3 B-Disease 1 0.9710921049118042
at O 0 0.028518933802843094
early O 0 0.031983088701963425
clinical O 0 0.14668531715869904
stages O 0 0.0440206378698349
of O 0 0.014744454994797707
the O 0 0.022733351215720177
diseases O 1 0.9986991882324219
. O 0 0.030610186979174614
. O 0 0.03985673934221268

Genetic O 0 0.10555409640073776
basis O 0 0.03255513310432434
and O 0 0.02405286207795143
molecular O 0 0.07798056304454803
mechanism O 0 0.12473803013563156
for O 0 0.05445730686187744
idiopathic B-Disease 1 0.9999990463256836
ventricular I-Disease 1 0.999995231628418
fibrillation I-Disease 1 0.9999971389770508
. O 0 0.0920083150267601

Ventricular B-Disease 1 0.9999384880065918
fibrillation I-Disease 1 0.9999607801437378
causes O 1 0.7093656659126282
more O 0 0.023690197616815567
than O 0 0.020739302039146423
300 O 0 0.035430360585451126
, O 0 0.02301166206598282
000 O 0 0.07511293888092041
sudden O 0 0.27375155687332153
deaths O 0 0.06740377098321915
each O 0 0.016971876844763756
year O 0 0.018200071528553963
in O 0 0.013256928883492947
the O 0 0.018359847366809845
USA O 0 0.07060983777046204
alone O 0 0.05194246396422386
. O 0 0.04110352694988251

In O 0 0.029468810185790062
approximately O 0 0.03614101931452751
5 O 0 0.03139420226216316
- O 0 0.044490404427051544
12 O 0 0.0232196357101202
% O 0 0.018460934981703758
of O 0 0.009462382644414902
these O 0 0.010568434372544289
cases O 0 0.021873731166124344
, O 0 0.011055245995521545
there O 0 0.011239245533943176
are O 0 0.01247326098382473
no O 0 0.026237452402710915
demonstrable O 1 0.9939925074577332
cardiac O 1 0.9999181032180786
or O 0 0.04222270846366882
non O 0 0.3354923129081726
- O 1 0.9920011758804321
cardiac O 1 0.9998916387557983
causes O 0 0.2840084135532379
to O 0 0.015247311443090439
account O 0 0.017316162586212158
for O 0 0.010559682734310627
the O 0 0.012060923501849174
episode O 0 0.028123294934630394
, O 0 0.012014242820441723
which O 0 0.011054599657654762
is O 0 0.013978445902466774
therefore O 0 0.023545460775494576
classified O 0 0.04500029981136322
as O 0 0.04424761235713959
idiopathic B-Disease 1 0.9999995231628418
ventricular I-Disease 1 0.9999980926513672
fibrillation I-Disease 1 0.9999995231628418
( O 1 0.8793321251869202
IVF B-Disease 1 0.999710738658905
) O 0 0.06450312584638596
. O 0 0.047402869910001755

A O 0 0.05356940999627113
distinct O 0 0.057471372187137604
group O 0 0.04297643527388573
of O 0 0.031018409878015518
IVF B-Disease 1 0.9999001026153564
patients O 1 0.9977589845657349
has O 0 0.016897475346922874
been O 0 0.011682985350489616
found O 0 0.01078599039465189
to O 0 0.008446256630122662
present O 0 0.013967080041766167
with O 0 0.014491438865661621
a O 0 0.02815011702477932
characteristic O 0 0.08145155012607574
electrocardiographic O 1 0.5857349038124084
pattern O 0 0.11597336828708649
. O 0 0.059788499027490616

Because O 0 0.030628619715571404
of O 0 0.013156735338270664
the O 0 0.01232087705284357
small O 0 0.017842119559645653
size O 0 0.01818985678255558
of O 0 0.011514941230416298
most O 0 0.015226168558001518
pedigrees O 0 0.06150791049003601
and O 0 0.013347460888326168
the O 0 0.015627311542630196
high O 0 0.03560761362314224
incidence O 1 0.9578233361244202
of O 0 0.02422107383608818
sudden B-Disease 1 0.9141333699226379
death I-Disease 0 0.04084715247154236
, O 0 0.017473386600613594
however O 0 0.017389241605997086
, O 0 0.017461616545915604
molecular O 0 0.05087592452764511
genetic O 0 0.06911734491586685
studies O 0 0.0397624634206295
of O 0 0.021216128021478653
IVF B-Disease 1 0.9966220855712891
have O 0 0.016588976606726646
not O 0 0.013041327707469463
yet O 0 0.017849355936050415
been O 0 0.015873150900006294
done O 0 0.03145618736743927
. O 0 0.03632323071360588

Because O 1 0.5303351879119873
IVF B-Disease 1 0.9999598264694214
causes O 1 0.9996885061264038
cardiac O 1 0.999982476234436
rhythm O 1 0.9628118276596069
disturbance O 1 0.8080857992172241
, O 0 0.02228950336575508
we O 0 0.016742369160056114
investigated O 0 0.04318385571241379
whether O 0 0.03061046451330185
malfunction O 0 0.16486406326293945
of O 0 0.024035226553678513
ion O 0 0.09628952294588089
channels O 0 0.04645278677344322
could O 0 0.027041317895054817
cause O 0 0.0698041021823883
the O 0 0.027634363621473312
disorder O 1 0.9988749623298645
by O 0 0.023442430421710014
studying O 0 0.04044593870639801
mutations O 0 0.10966935753822327
in O 0 0.02605154737830162
the O 0 0.03868566080927849
cardiac O 1 0.9994015693664551
sodium O 0 0.21542714536190033
channel O 0 0.09110551327466965
gene O 0 0.1482267826795578
SCN5A O 1 0.5415129065513611
. O 0 0.0671887919306755

We O 0 0.027851521968841553
have O 0 0.01891678012907505
now O 0 0.02565079554915428
identified O 0 0.03657637909054756
a O 0 0.03618922084569931
missense O 0 0.2198600172996521
mutation O 0 0.15475739538669586
, O 0 0.031360410153865814
a O 0 0.038156941533088684
splice O 0 0.3748423755168915
- O 0 0.31786563992500305
donor O 0 0.469100683927536
mutation O 0 0.22562186419963837
, O 0 0.023693839088082314
and O 0 0.01987140066921711
a O 0 0.03519519791007042
frameshift O 1 0.8574624061584473
mutation O 0 0.12387368083000183
in O 0 0.018604956567287445
the O 0 0.020780228078365326
coding O 0 0.07374054938554764
region O 0 0.03931480273604393
of O 0 0.01957526244223118
SCN5A O 0 0.22784151136875153
in O 0 0.02135622873902321
three O 0 0.03215134143829346
IVF B-Disease 1 0.9979591369628906
families O 0 0.06561149656772614
. O 0 0.049792174249887466

We O 0 0.03131285682320595
show O 0 0.028872013092041016
that O 0 0.01708149164915085
sodium O 0 0.07570144534111023
channels O 0 0.03625965118408203
with O 0 0.01898842118680477
the O 0 0.027755267918109894
missense O 1 0.5350785851478577
mutation O 1 0.6029281616210938
recover O 0 0.16248078644275665
from O 0 0.036927465349435806
inactivation O 0 0.12865638732910156
more O 0 0.019365403801202774
rapidly O 0 0.03330834582448006
than O 0 0.014493598602712154
normal O 0 0.028546296060085297
and O 0 0.012090915814042091
that O 0 0.013896065764129162
the O 0 0.025885723531246185
frameshift O 1 0.9812270402908325
mutation O 1 0.5571234822273254
causes O 0 0.11446640640497208
the O 0 0.026220778003335
sodium O 0 0.0847487524151802
channel O 0 0.033153850585222244
to O 0 0.013295239768922329
be O 0 0.012599924579262733
non O 0 0.03907902538776398
- O 0 0.07154504954814911
functional O 0 0.06651951372623444
. O 0 0.0477149672806263

Our O 0 0.0468759723007679
results O 0 0.054874811321496964
indicate O 0 0.05282378941774368
that O 0 0.025687849149107933
mutations O 0 0.13429619371891022
in O 0 0.04284906014800072
cardiac O 1 0.999380350112915
ion O 0 0.22001728415489197
- O 0 0.08991219848394394
channel O 0 0.06337643414735794
genes O 0 0.06686081737279892
contribute O 0 0.045865438878536224
to O 0 0.016828810796141624
the O 0 0.01897580921649933
risk O 0 0.07877805829048157
of O 0 0.02431453950703144
developing O 0 0.08912909030914307
IVF B-Disease 1 0.9978283047676086
. O 0 0.04199066758155823
. O 0 0.04839730262756348

Molecular O 0 0.14850753545761108
heterogeneity O 0 0.1783832162618637
in O 0 0.0463697575032711
mucopolysaccharidosis B-Disease 1 0.725557804107666
IVA I-Disease 1 0.9586005806922913
in O 0 0.024286026135087013
Australia O 0 0.02368968166410923
and O 0 0.012910175137221813
Northern O 0 0.026512090116739273
Ireland O 0 0.030391037464141846
: O 0 0.023904701694846153
nine O 0 0.02765744924545288
novel O 0 0.04004032164812088
mutations O 0 0.10230045765638351
including O 0 0.028686149045825005
T312S O 0 0.10093168169260025
, O 0 0.01872115768492222
a O 0 0.02159099280834198
common O 0 0.03875576704740524
allele O 0 0.12103958427906036
that O 0 0.02838217467069626
confers O 0 0.14673666656017303
a O 0 0.05439908057451248
mild O 1 0.9915238618850708
phenotype O 1 0.9716165661811829
. O 0 0.06896916776895523

Mucopolysaccharidosis B-Disease 1 0.9943721294403076
IVA I-Disease 1 0.9988008737564087
( O 0 0.11290457844734192
MPS B-Disease 1 0.9036184549331665
IVA I-Disease 1 0.9995391368865967
) O 0 0.04595676437020302
is O 0 0.024938292801380157
an O 0 0.031098971143364906
autosomal B-Disease 1 0.9998049139976501
recessive I-Disease 1 0.9999620914459229
lysosomal I-Disease 1 0.9999605417251587
storage I-Disease 1 0.9924266338348389
disorder I-Disease 1 0.9999725818634033
caused O 0 0.2551227807998657
by O 0 0.025412457063794136
a O 0 0.036699533462524414
genetic B-Disease 0 0.3084969222545624
defect I-Disease 1 0.9882140159606934
in O 0 0.0357639417052269
N O 0 0.12276192754507065
- O 0 0.33582523465156555
acetylgalactosamine O 1 0.9574246406555176
- O 1 0.6340534687042236
6 O 0 0.14049430191516876
- O 1 0.9878150224685669
sulfate O 1 0.9997171759605408
sulfatase O 1 0.9996771812438965
( O 0 0.09993459284305573
GALNS O 1 0.8915134072303772
) O 0 0.06178130954504013
. O 0 0.045225244015455246

Previous O 0 0.057786084711551666
studies O 0 0.04494038596749306
of O 0 0.022094573825597763
patients O 1 0.8412403464317322
from O 0 0.023402413353323936
a O 0 0.02083188109099865
British O 0 0.03658033162355423
- O 0 0.06793636083602905
Irish O 0 0.04192408546805382
population O 0 0.027804143726825714
showed O 0 0.02914750948548317
that O 0 0.013467680662870407
the O 0 0.018360724672675133
I113F O 0 0.12190548330545425
mutation O 0 0.09844357520341873
is O 0 0.016024786978960037
the O 0 0.012718264013528824
most O 0 0.01413723360747099
common O 0 0.03378200903534889
single O 0 0.04574945569038391
mutation O 1 0.5242378115653992
among O 0 0.048417117446660995
MPS B-Disease 1 0.9935198426246643
IVA I-Disease 1 0.9999898672103882
patients O 1 0.9994390606880188
and O 0 0.026944724842905998
produces O 0 0.07677075266838074
a O 0 0.049363698810338974
severe O 1 0.9988895058631897
clinical O 1 0.9956377148628235
phenotype O 1 0.9927312731742859
. O 0 0.06940804421901703

We O 0 0.03872781619429588
studied O 0 0.04981125891208649
mutations O 0 0.1019480749964714
in O 0 0.020258761942386627
the O 0 0.027883216738700867
GALNS O 0 0.4848308563232422
gene O 0 0.08724011480808258
from O 0 0.02624664083123207
23 O 0 0.038828060030937195
additional O 0 0.04435737058520317
MPS B-Disease 1 0.9749028086662292
IVA I-Disease 1 0.9999746084213257
patients O 1 0.9983615279197693
( O 0 0.037140440195798874
15 O 0 0.02245216630399227
from O 0 0.01422909926623106
Australia O 0 0.018148912116885185
, O 0 0.012221986427903175
8 O 0 0.01864112913608551
from O 0 0.012779205106198788
Northern O 0 0.021849099546670914
Ireland O 0 0.026249675080180168
) O 0 0.018568316474556923
, O 0 0.01037560123950243
with O 0 0.01363737415522337
various O 0 0.02076503075659275
clinical O 1 0.9530434012413025
phenotypes O 1 0.9901446104049683
( O 0 0.06931111216545105
severe O 1 0.9899289011955261
, O 0 0.020199304446578026
16 O 0 0.0254221074283123
cases O 0 0.027537772431969643
; O 0 0.024799995124340057
intermediate O 0 0.04038025066256523
, O 0 0.01602715626358986
4 O 0 0.027131175622344017
cases O 0 0.036214470863342285
; O 0 0.03037550300359726
mild O 1 0.9707985520362854
, O 0 0.020404307171702385
3 O 0 0.03062002919614315
cases O 0 0.03636379539966583
) O 0 0.03674359992146492
. O 0 0.039168182760477066

We O 0 0.02756175398826599
found O 0 0.021591246128082275
two O 0 0.015497295185923576
common O 0 0.02985338866710663
mutations O 0 0.07687290757894516
that O 0 0.011800152249634266
together O 0 0.013240217231214046
accounted O 0 0.029101064428687096
for O 0 0.011524217203259468
32 O 0 0.022798901423811913
% O 0 0.017168710008263588
of O 0 0.010554248467087746
the O 0 0.01551050040870905
44 O 0 0.041407860815525055
unrelated O 0 0.06445600837469101
alleles O 0 0.12377404421567917
in O 0 0.02316446602344513
these O 0 0.024481795728206635
patients O 1 0.9858410358428955
. O 0 0.04415984824299812

One O 0 0.03261187672615051
is O 0 0.021722979843616486
the O 0 0.021811338141560555
T312S O 0 0.14418742060661316
mutation O 0 0.1290019452571869
, O 0 0.019898798316717148
a O 0 0.022139795124530792
novel O 0 0.03919439762830734
mutation O 0 0.1090504378080368
found O 0 0.02537425234913826
exclusively O 0 0.03249718248844147
in O 0 0.03408188372850418
milder O 1 0.9896119236946106
patients O 1 0.998391330242157
. O 0 0.055369507521390915

The O 0 0.028331108391284943
other O 0 0.014250658452510834
is O 0 0.012545960955321789
the O 0 0.014743998646736145
previously O 0 0.02736526168882847
described O 0 0.036699384450912476
I113F O 0 0.10363668203353882
that O 0 0.020505355671048164
produces O 0 0.060415659099817276
a O 0 0.04419172927737236
severe O 1 0.9946731925010681
phenotype O 1 0.9794723987579346
. O 0 0.06470584124326706

The O 0 0.049779828637838364
I113F O 0 0.15041476488113403
and O 0 0.039813920855522156
T312S O 0 0.18019329011440277
mutations O 0 0.1401989758014679
accounted O 0 0.05659039318561554
for O 0 0.019853215664625168
8 O 0 0.03442247956991196
( O 0 0.028876930475234985
18 O 0 0.023884188383817673
% O 0 0.02594130113720894
) O 0 0.021255871281027794
and O 0 0.014534656889736652
6 O 0 0.027466868981719017
( O 0 0.02732672356069088
14 O 0 0.02703043632209301
% O 0 0.02426379919052124
) O 0 0.018734049052000046
of O 0 0.011864201165735722
44 O 0 0.03614942729473114
unrelated O 0 0.06461373716592789
alleles O 0 0.14239448308944702
, O 0 0.03053440898656845
respectively O 0 0.04685881733894348
. O 0 0.04006129130721092

The O 0 0.04405812919139862
relatively O 0 0.05478990077972412
high O 0 0.05776749551296234
residual O 0 0.2755809724330902
GALNS O 1 0.65900719165802
activity O 0 0.05975694581866264
seen O 0 0.03266918659210205
when O 0 0.023983348160982132
the O 0 0.023310266435146332
T312S O 0 0.12869447469711304
mutant O 0 0.13035981357097626
cDNA O 0 0.14079123735427856
is O 0 0.03645024448633194
overexpressed O 0 0.1442270427942276
in O 0 0.02785808965563774
mutant O 0 0.10211655497550964
cells O 0 0.0802893340587616
provides O 0 0.03524557128548622
an O 0 0.01620170846581459
explanation O 0 0.03015720099210739
for O 0 0.015655312687158585
the O 0 0.022605350241065025
mild O 1 0.9942574501037598
phenotype O 1 0.9825726747512817
in O 0 0.03278086706995964
patients O 1 0.9827663898468018
with O 0 0.02395498752593994
this O 0 0.026979509741067886
mutation O 0 0.16675437986850739
. O 0 0.047780510038137436

The O 0 0.026695625856518745
distribution O 0 0.030637893825769424
and O 0 0.015863917768001556
relative O 0 0.03559742867946625
frequencies O 0 0.03418687731027603
of O 0 0.01374614704400301
the O 0 0.020511936396360397
I113F O 0 0.11164269596338272
and O 0 0.03010541945695877
T312S O 0 0.1566888391971588
mutations O 0 0.10533611476421356
in O 0 0.01789757050573826
Australia O 0 0.022449852898716927
corresponded O 0 0.0336264967918396
to O 0 0.01145262736827135
those O 0 0.011587811633944511
observed O 0 0.01966051571071148
in O 0 0.010679071769118309
Northern O 0 0.020179711282253265
Ireland O 0 0.022557634860277176
and O 0 0.01009033340960741
are O 0 0.0074116806499660015
unique O 0 0.01209309697151184
to O 0 0.007358590606600046
these O 0 0.00816414412111044
two O 0 0.01041140966117382
populations O 0 0.0390201210975647
, O 0 0.016269978135824203
suggesting O 0 0.03133687749505043
that O 0 0.010385725647211075
both O 0 0.016202287748456
mutations O 0 0.0735677108168602
were O 0 0.012567409314215183
probably O 0 0.022771311923861504
introduced O 0 0.01799209788441658
to O 0 0.0120112095028162
Australia O 0 0.019638435915112495
by O 0 0.014563254080712795
Irish O 0 0.03529134392738342
migrants O 0 0.03871845453977585
during O 0 0.023643845692276955
the O 0 0.01748638227581978
19th O 0 0.037643201649188995
century O 0 0.04617833346128464
. O 0 0.042623892426490784

Haplotype O 1 0.7050646543502808
analysis O 0 0.064375139772892
using O 0 0.043667327612638474
6 O 0 0.05011998862028122
RFLPs O 0 0.10964473336935043
provides O 0 0.03341635689139366
additional O 0 0.02322991192340851
data O 0 0.014839369803667068
that O 0 0.010989025235176086
the O 0 0.021759916096925735
I113F O 0 0.13759878277778625
mutation O 0 0.13061752915382385
originated O 0 0.05584538355469704
from O 0 0.021619465202093124
a O 0 0.023467421531677246
common O 0 0.041173022240400314
ancestor O 0 0.08140048384666443
. O 0 0.04492972046136856

The O 0 0.029125496745109558
other O 0 0.020794972777366638
9 O 0 0.03956180438399315
novel O 0 0.04357072338461876
mutations O 0 0.09207643568515778
identified O 0 0.03043808788061142
in O 0 0.013310747221112251
these O 0 0.014174124225974083
23 O 0 0.032178208231925964
patients O 0 0.33653518557548523
were O 0 0.00972763542085886
each O 0 0.010456441901624203
limited O 0 0.016404839232563972
to O 0 0.011425203643739223
a O 0 0.016315069049596786
single O 0 0.02693879045546055
family O 0 0.04193342477083206
. O 0 0.04352607578039169

These O 0 0.02278430387377739
data O 0 0.021435437723994255
provide O 0 0.020805425941944122
further O 0 0.01702776364982128
evidence O 0 0.01812242902815342
for O 0 0.014982384629547596
extensive O 0 0.04604624956846237
allelic O 0 0.45035701990127563
heterogeneity O 0 0.13479405641555786
in O 0 0.03391067683696747
MPS B-Disease 1 0.7533021569252014
IVA I-Disease 1 0.9986827969551086
in O 0 0.029653506353497505
British O 0 0.051566336303949356
- O 0 0.2213955819606781
Irish O 0 0.06659098714590073
patients O 1 0.9690882563591003
and O 0 0.013388136401772499
provide O 0 0.015448613092303276
evidence O 0 0.014079875312745571
for O 0 0.007924569770693779
their O 0 0.010609718970954418
transmission O 0 0.04289296269416809
to O 0 0.012078060768544674
Australia O 0 0.01731744594871998
by O 0 0.01428690180182457
British O 0 0.03210073709487915
- O 0 0.06484305113554001
Irish O 0 0.04883277416229248
migrants O 0 0.05776064097881317
. O 0 0.02672702819108963
. O 0 0.034382082521915436

Identification O 0 0.06847558170557022
of O 0 0.032752662897109985
constitutional O 0 0.06148790568113327
WT1 O 1 0.995969295501709
mutations O 0 0.3040701746940613
, O 0 0.02715357206761837
in O 0 0.024437716230750084
patients O 1 0.9982713460922241
with O 0 0.04046584293246269
isolated O 1 0.9759499430656433
diffuse B-Disease 1 0.9999408721923828
mesangial I-Disease 1 0.999998927116394
sclerosis I-Disease 1 0.9999996423721313
, O 0 0.0304312314838171
and O 0 0.017446748912334442
analysis O 0 0.03274727612733841
of O 0 0.02671675942838192
genotype O 1 0.9923787117004395
/ O 1 0.9884317517280579
phenotype O 1 0.7069271206855774
correlations O 0 0.07776638120412827
by O 0 0.014917516149580479
use O 0 0.017226655036211014
of O 0 0.014334543608129025
a O 0 0.02906850166618824
computerized O 0 0.11801479756832123
mutation O 0 0.1656859666109085
database O 0 0.0716685876250267
. O 0 0.047062747180461884

Constitutional O 0 0.09574691951274872
mutations O 0 0.14094306528568268
of O 0 0.028706518933176994
the O 0 0.03587329015135765
WT1 O 1 0.9871600866317749
gene O 0 0.10669508576393127
, O 0 0.02869734726846218
encoding O 0 0.05702107772231102
a O 0 0.0362270325422287
zinc O 1 0.9065556526184082
- O 0 0.12065976113080978
finger O 0 0.14614862203598022
transcription O 0 0.11789420247077942
factor O 0 0.07245125621557236
involved O 0 0.04119405895471573
in O 0 0.03187083825469017
renal O 1 0.9999938011169434
and O 0 0.031187959015369415
gonadal O 1 0.9985706806182861
development O 0 0.03010200709104538
, O 0 0.012856204994022846
are O 0 0.009385772049427032
found O 0 0.013509849086403847
in O 0 0.0129637336358428
most O 0 0.018794875591993332
patients O 1 0.9976147413253784
with O 0 0.038346029818058014
Denys B-Disease 1 0.9998856782913208
- I-Disease 1 0.9996963739395142
Drash I-Disease 1 0.9999696016311646
syndrome I-Disease 1 0.9999998807907104
( O 1 0.7226452827453613
DDS B-Disease 1 0.999966025352478
) O 0 0.050100911408662796
, O 0 0.03135054185986519
or O 0 0.07410360872745514
diffuse B-Disease 1 0.9999098777770996
mesangial I-Disease 1 0.9999994039535522
sclerosis I-Disease 1 1.0
( O 1 0.9495425224304199
DMS B-Disease 1 0.9998430013656616
) O 0 0.04018699750304222
associated O 0 0.034391697496175766
with O 0 0.024824418127536774
pseudohermaphroditism B-Disease 1 0.9934096336364746
and O 0 0.036031417548656464
/ O 1 0.9978454113006592
or O 0 0.11504454910755157
Wilms B-Disease 1 0.9999794960021973
tumor I-Disease 1 0.9998433589935303
( O 0 0.15807084739208221
WT B-Disease 1 0.9987427592277527
) O 0 0.054718393832445145
. O 0 0.04352569952607155

Most O 0 0.06506025791168213
mutations O 0 0.3638215661048889
in O 0 0.053353045135736465
DDS B-Disease 1 0.999976396560669
patients O 1 0.9988204836845398
lie O 0 0.06059501692652702
in O 0 0.023170175030827522
exon O 0 0.11067810654640198
8 O 0 0.04142128303647041
or O 0 0.031074801459908485
exon O 0 0.10645155608654022
9 O 0 0.04347710683941841
, O 0 0.02466202713549137
encoding O 0 0.06510085612535477
zinc O 0 0.4178083837032318
finger O 0 0.11133886873722076
2 O 0 0.04580644518136978
or O 0 0.03638611361384392
zinc O 1 0.7495850920677185
finger O 0 0.0897706001996994
3 O 0 0.02812691405415535
, O 0 0.012860521674156189
respectively O 0 0.019415682181715965
, O 0 0.01102995965629816
with O 0 0.014020121656358242
a O 0 0.024796130135655403
hot O 0 0.06024949625134468
spot O 0 0.05206259712576866
( O 0 0.04082217812538147
R394W O 0 0.10762465000152588
) O 0 0.0302716176956892
in O 0 0.022222179919481277
exon O 0 0.11814505606889725
9 O 0 0.06087138131260872
. O 0 0.0442674420773983

We O 0 0.03258903697133064
analyzed O 0 0.04361710324883461
a O 0 0.02166839689016342
series O 0 0.026905061677098274
of O 0 0.01768379844725132
24 O 0 0.039470694959163666
patients O 1 0.8291311860084534
, O 0 0.01939219795167446
10 O 0 0.023964015766978264
with O 0 0.027989625930786133
isolated B-Disease 0 0.24195952713489532
DMS I-Disease 1 0.9998118281364441
( O 0 0.08268895000219345
IDMS B-Disease 1 0.9983114004135132
) O 0 0.03267882391810417
, O 0 0.015686532482504845
10 O 0 0.018814168870449066
with O 0 0.020465897396206856
DDS B-Disease 1 0.9992384910583496
, O 0 0.0180928073823452
and O 0 0.015377734787762165
4 O 0 0.03237144276499748
with O 0 0.03086608089506626
urogenital B-Disease 1 0.9991693496704102
abnormalities I-Disease 1 0.9979973435401917
and O 0 0.044516053050756454
/ O 1 0.9915068745613098
or O 0 0.06602195650339127
WT B-Disease 1 0.9980829954147339
. O 0 0.06391740590333939

We O 0 0.04896354302763939
report O 0 0.06393436342477798
WT1 O 1 0.9711480736732483
heterozygous O 0 0.20931124687194824
mutations O 0 0.15556064248085022
in O 0 0.027202526107430458
16 O 0 0.04189398139715195
patients O 1 0.8633106350898743
, O 0 0.017148759216070175
4 O 0 0.021921712905168533
of O 0 0.011690220795571804
whom O 0 0.030530115589499474
presented O 0 0.03167804703116417
with O 0 0.033994052559137344
IDMS B-Disease 1 0.9962015748023987
. O 0 0.059770774096250534

One O 0 0.037498872727155685
male O 0 0.05820649117231369
and O 0 0.020769638940691948
two O 0 0.02458447404205799
female O 0 0.08672682195901871
IDMS B-Disease 1 0.9999293088912964
patients O 1 0.9996463060379028
with O 0 0.06475839018821716
WT1 O 1 0.9994843006134033
mutations O 1 0.9747376441955566
underwent O 1 0.9869371056556702
normal O 0 0.13005100190639496
puberty O 1 0.9191471934318542
. O 0 0.061174191534519196

Two O 0 0.0574285089969635
mutations O 0 0.16936706006526947
associated O 0 0.04764985293149948
with O 0 0.02852405235171318
IDMS B-Disease 1 0.9914041757583618
are O 0 0.014592723920941353
different O 0 0.010211256332695484
from O 0 0.011830844916403294
those O 0 0.014244028367102146
described O 0 0.032774485647678375
in O 0 0.03318614885210991
DDS B-Disease 1 0.9999845027923584
patients O 1 0.9993748068809509
. O 0 0.05341172218322754

No O 0 0.09345104545354843
WT1 O 1 0.9843235611915588
mutations O 0 0.1514245867729187
were O 0 0.024594176560640335
detected O 0 0.05286765843629837
in O 0 0.012170307338237762
the O 0 0.012881705537438393
six O 0 0.023493798449635506
other O 0 0.024949589744210243
IDMS B-Disease 1 0.9999228715896606
patients O 1 0.9992882609367371
, O 0 0.030230548232793808
suggesting O 0 0.06442601978778839
genetic O 0 0.09040460735559464
heterogeneity O 0 0.11242491006851196
of O 0 0.024083571508526802
this O 0 0.030587853863835335
disease O 1 0.9997108578681946
. O 0 0.055169057101011276

We O 0 0.05196525901556015
analyzed O 0 0.11016572266817093
genotype O 1 0.9794470071792603
/ O 1 0.9810980558395386
phenotype O 1 0.7059255242347717
correlations O 0 0.08055239170789719
, O 0 0.0138953672721982
on O 0 0.007247216533869505
the O 0 0.007428970653563738
basis O 0 0.009454965591430664
of O 0 0.007217905484139919
the O 0 0.01040925644338131
constitution O 0 0.015174133703112602
of O 0 0.01632045954465866
a O 0 0.035742077976465225
WT1 O 1 0.9742476940155029
mutation O 0 0.15671731531620026
database O 0 0.048771344125270844
of O 0 0.022322475910186768
84 O 0 0.08828253298997879
germ O 1 0.9937533736228943
- O 0 0.10782259702682495
line O 0 0.05364907905459404
mutations O 0 0.09422148019075394
, O 0 0.01587015762925148
to O 0 0.014162689447402954
compare O 0 0.035327594727277756
the O 0 0.012954317033290863
distribution O 0 0.021512823179364204
and O 0 0.013696014881134033
type O 0 0.037387777119874954
of O 0 0.016927571967244148
mutations O 0 0.08712698519229889
, O 0 0.01251248735934496
according O 0 0.012865855358541012
to O 0 0.009777577593922615
the O 0 0.014468656852841377
different O 0 0.027702266350388527
symptoms O 1 0.9994328618049622
. O 0 0.05008234083652496

This O 0 0.034151364117860794
demonstrated O 0 0.058580346405506134
( O 0 0.03590923175215721
1 O 0 0.024627448990941048
) O 0 0.01857643760740757
the O 0 0.01338917575776577
association O 0 0.034383419901132584
between O 0 0.028509801253676414
mutations O 0 0.09562040865421295
in O 0 0.0235862098634243
exons O 0 0.08690282702445984
8 O 0 0.02953062392771244
and O 0 0.01559376623481512
9 O 0 0.03371386229991913
and O 0 0.02203289233148098
DMS B-Disease 1 0.9991902709007263
; O 0 0.029598766937851906
( O 0 0.02820175513625145
2 O 0 0.025940272957086563
) O 0 0.025655237957835197
among O 0 0.02546936273574829
patients O 1 0.9848992824554443
with O 0 0.02952507697045803
DMS B-Disease 1 0.9977299571037292
, O 0 0.015965135768055916
a O 0 0.01733577437698841
higher O 0 0.02680860087275505
frequency O 0 0.04462990164756775
of O 0 0.021522432565689087
exon O 0 0.11340932548046112
8 O 0 0.05720788612961769
mutations O 0 0.11337794363498688
among O 0 0.03343561664223671
46 O 0 0.057838793843984604
, O 0 0.03694919869303703
XY O 1 0.9980390667915344
patients O 1 0.9919860363006592
with O 0 0.028254175558686256
female O 0 0.06140068173408508
phenotype O 1 0.5107202529907227
than O 0 0.022484462708234787
among O 0 0.029675355181097984
46 O 0 0.05467790737748146
, O 0 0.035619549453258514
XY O 1 0.99951171875
patients O 1 0.9968690276145935
with O 0 0.029111329466104507
sexual O 0 0.055548954755067825
ambiguity O 0 0.06611485779285431
or O 0 0.035945940762758255
male O 0 0.08478937298059464
phenotype O 1 0.9827901124954224
; O 0 0.029840992763638496
and O 0 0.016099225729703903
( O 0 0.029044775292277336
3 O 0 0.02554975263774395
) O 0 0.02174489013850689
statistically O 0 0.035412129014730453
significant O 0 0.023881696164608
evidence O 0 0.022525368258357048
that O 0 0.01791100949048996
mutations O 0 0.09479179233312607
in O 0 0.025796350091695786
exons O 0 0.08980344980955124
8 O 0 0.036028020083904266
and O 0 0.017667097970843315
9 O 0 0.038755957037210464
preferentially O 0 0.09393534064292908
affect O 0 0.058993320912122726
amino O 0 0.05875864252448082
acids O 0 0.05001647025346756
with O 0 0.01627182774245739
different O 0 0.015485688112676144
functions O 0 0.02081005647778511
. O 0 0.021633721888065338
. O 0 0.032317887991666794

The O 0 0.08230933547019958
185delAG O 1 0.8213678598403931
BRCA1 O 1 0.9912459254264832
mutation O 0 0.42933863401412964
originated O 0 0.06152307987213135
before O 0 0.021497325971722603
the O 0 0.015259228646755219
dispersion O 0 0.05216987058520317
of O 0 0.01075275894254446
Jews O 0 0.017229579389095306
in O 0 0.009897241368889809
the O 0 0.012435092590749264
diaspora O 0 0.039672691375017166
and O 0 0.012199394404888153
is O 0 0.01265739742666483
not O 0 0.010846447199583054
limited O 0 0.026583464816212654
to O 0 0.023969070985913277
Ashkenazim O 0 0.26840341091156006
. O 0 0.05382127687335014

The O 0 0.06479527801275253
185delAG O 0 0.398660272359848
mutation O 0 0.20371569693088531
in O 0 0.04341548681259155
BRCA1 O 1 0.9448688626289368
is O 0 0.0370425246655941
detected O 0 0.07323300838470459
in O 0 0.022552890703082085
Ashkenazi O 0 0.10042458027601242
Jews O 0 0.03336983174085617
both O 0 0.022137118503451347
in O 0 0.030516276136040688
familial B-Disease 1 0.9999953508377075
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.977196455001831
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999945163726807
and O 0 0.01772642321884632
in O 0 0.012168106622993946
the O 0 0.013594144955277443
general O 0 0.022986898198723793
population O 0 0.03612706810235977
. O 0 0.032012198120355606

All O 0 0.04142555221915245
tested O 0 0.1142774298787117
Ashkenazi O 0 0.4928532540798187
mutation O 0 0.44732666015625
carriers O 0 0.09748511016368866
share O 0 0.03314802795648575
the O 0 0.018701612949371338
same O 0 0.028967980295419693
allelic O 0 0.2729889452457428
pattern O 0 0.07565948367118835
at O 0 0.03134280443191528
the O 0 0.03158973157405853
BRCA1 O 1 0.9441177248954773
locus O 0 0.21149176359176636
. O 0 0.06932830065488815

Our O 0 0.03839397430419922
previous O 0 0.032759860157966614
study O 0 0.03231437876820564
showed O 0 0.026983849704265594
that O 0 0.012926560826599598
this O 0 0.017603415995836258
Ashkenazi O 0 0.1620655059814453
mutation O 0 0.17902638018131256
also O 0 0.02145560272037983
occurs O 0 0.04239782318472862
in O 0 0.013369972817599773
Iraqi O 0 0.027130816131830215
Jews O 0 0.0224295761436224
with O 0 0.016043441370129585
a O 0 0.02604609727859497
similar O 0 0.050952162593603134
allelic O 1 0.5462958812713623
pattern O 0 0.13484768569469452
. O 0 0.06105303764343262

We O 0 0.028249861672520638
extended O 0 0.02910882607102394
our O 0 0.015898287296295166
analysis O 0 0.020121045410633087
to O 0 0.011500806547701359
other O 0 0.012778038159012794
non O 0 0.04533481225371361
- O 0 0.08664648234844208
Ashkenazi O 0 0.1332450807094574
subsets O 0 0.09242714941501617
354 O 0 0.09486470371484756
of O 0 0.020197927951812744
Moroccan O 0 0.06027970463037491
origin O 0 0.030039925128221512
, O 0 0.019840432330965996
200 O 0 0.039853330701589584
Yemenites O 0 0.14179092645645142
and O 0 0.01965893618762493
150 O 0 0.03723539412021637
Iranian O 0 0.03809931129217148
Jews O 0 0.04570287838578224
. O 0 0.046148452907800674

Heteroduplex O 0 0.23394843935966492
analysis O 0 0.06478500366210938
complemented O 0 0.06663953512907028
by O 0 0.02256389521062374
direct O 0 0.03432154655456543
DNA O 0 0.06208372488617897
sequencing O 0 0.07086510211229324
of O 0 0.02761865220963955
abnormally O 0 0.2513754665851593
migrating O 0 0.09384310990571976
bands O 0 0.052108556032180786
were O 0 0.022105960175395012
employed O 0 0.049692053347826004
. O 0 0.040558043867349625

Four O 0 0.036261606961488724
of O 0 0.02153082750737667
Moroccan O 0 0.06639620661735535
origin O 0 0.03554537519812584
( O 0 0.027585189789533615
1 O 0 0.024024538695812225
. O 0 0.014411491341888905
1 O 0 0.01962481625378132
% O 0 0.0203193761408329
) O 0 0.015164701268076897
and O 0 0.008580765686929226
none O 0 0.016901470720767975
of O 0 0.008709556423127651
the O 0 0.014929656870663166
Yemenites O 0 0.15912975370883942
or O 0 0.02039548195898533
Iranians O 0 0.030825670808553696
was O 0 0.013419642113149166
a O 0 0.01580062136054039
carrier O 0 0.04950679838657379
of O 0 0.017038654536008835
the O 0 0.029598580673336983
185delAG O 0 0.3269643485546112
mutation O 0 0.2653810381889343
. O 0 0.06429130584001541

BRCA1 O 1 0.9926413893699646
allelic O 1 0.7880566716194153
patterns O 0 0.06764797121286392
were O 0 0.017689233645796776
determined O 0 0.021169569343328476
for O 0 0.009138771332800388
four O 0 0.009215924888849258
of O 0 0.007547972723841667
these O 0 0.009641211479902267
individuals O 0 0.016113748773932457
and O 0 0.008776105009019375
for O 0 0.010377462022006512
12 O 0 0.02169623225927353
additional O 0 0.027965374290943146
non O 0 0.05305004492402077
- O 0 0.1514076292514801
Ashkenazi O 1 0.8349959254264832
185delAG O 1 0.9597662091255188
mutation O 1 0.957358181476593
carriers O 1 0.7824744582176208
who O 0 0.0715460404753685
had O 1 0.8652524948120117
breast B-Disease 1 0.9999997615814209
/ I-Disease 1 0.9999984502792358
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999970197677612
. O 0 0.08103582262992859

Six O 0 0.0683804303407669
non O 0 0.0702882930636406
- O 0 0.09987367689609528
Ashkenazi O 0 0.1277846246957779
individuals O 0 0.04194966331124306
shared O 0 0.034687239676713943
the O 0 0.023782486096024513
common O 0 0.04670126363635063
Ashkenazi O 1 0.6957319974899292
haplotype O 1 0.9300078749656677
, O 0 0.017967186868190765
four O 0 0.014223448932170868
had O 0 0.015320160426199436
a O 0 0.016651442274451256
closely O 0 0.02404608018696308
related O 0 0.029364490881562233
pattern O 0 0.04254734143614769
, O 0 0.013732190243899822
and O 0 0.010743096470832825
the O 0 0.012373349629342556
rest O 0 0.03417801111936569
( O 0 0.0383320115506649
n O 0 0.06879746168851852
= O 0 0.08518831431865692
6 O 0 0.03446759656071663
) O 0 0.025816768407821655
displayed O 0 0.02753603272140026
a O 0 0.028320815414190292
distinct O 0 0.07187303900718689
BRCA1 O 1 0.990806519985199
allelic O 1 0.9459677934646606
pattern O 0 0.14002126455307007
. O 0 0.06413949280977249

We O 0 0.03839690610766411
conclude O 0 0.0627540871500969
that O 0 0.021920787170529366
the O 0 0.027816426008939743
185delAG O 1 0.8237929940223694
BRCA1 O 1 0.9961179494857788
mutation O 1 0.8918964266777039
occurs O 0 0.06756127625703812
in O 0 0.016269676387310028
some O 0 0.017503799870610237
non O 0 0.04818398877978325
- O 0 0.10071387887001038
Ashkenazi O 0 0.28562131524086
populations O 0 0.08006379753351212
at O 0 0.03147723525762558
rates O 0 0.043110307306051254
comparable O 0 0.03400349244475365
with O 0 0.013968754559755325
that O 0 0.013453242368996143
of O 0 0.022377409040927887
Ashkenazim O 1 0.651327908039093
. O 0 0.05530001223087311

The O 0 0.036234691739082336
majority O 0 0.04605688154697418
of O 0 0.02601129375398159
Jewish O 0 0.0688173770904541
185delAG O 1 0.8327285647392273
mutation O 1 0.6326596140861511
carriers O 0 0.09166042506694794
have O 0 0.019491780549287796
a O 0 0.028165658935904503
common O 0 0.047052789479494095
allelic O 1 0.6474517583847046
pattern O 0 0.06359018385410309
, O 0 0.01870991289615631
supporting O 0 0.02614770084619522
the O 0 0.017999976873397827
founder O 0 0.05454844981431961
effect O 0 0.045032795518636703
notion O 0 0.03419152647256851
, O 0 0.015557182021439075
but O 0 0.01431818213313818
dating O 0 0.02758023701608181
the O 0 0.01619759015738964
mutations O 0 0.07287517189979553
origin O 0 0.021277720108628273
to O 0 0.011545450426638126
an O 0 0.010283660143613815
earlier O 0 0.016611263155937195
date O 0 0.01768702082335949
than O 0 0.015112761408090591
currently O 0 0.020654713734984398
estimated O 0 0.040124647319316864
. O 0 0.039352551102638245

However O 0 0.03769571706652641
, O 0 0.018985310569405556
the O 0 0.017084676772356033
different O 0 0.022921599447727203
allelic O 0 0.17988577485084534
pattern O 0 0.07440385967493057
at O 0 0.02923545241355896
the O 0 0.02858722396194935
BRCA1 O 1 0.885908305644989
locus O 0 0.11692466586828232
even O 0 0.023533295840024948
in O 0 0.01744946651160717
some O 0 0.018244905397295952
Jewish O 0 0.05018187686800957
mutation O 0 0.47061559557914734
carriers O 0 0.11128651350736618
, O 0 0.02074529603123665
might O 0 0.02596828155219555
suggest O 0 0.027268575504422188
that O 0 0.012519262731075287
the O 0 0.019349101930856705
mutation O 0 0.11933775991201401
arose O 0 0.059648387134075165
independently O 0 0.03978335112333298
. O 0 0.026366345584392548
. O 0 0.036730218678712845

Crystal O 0 0.11304726451635361
structure O 0 0.04365412890911102
of O 0 0.026954632252454758
the O 0 0.03998693823814392
hemochromatosis B-Disease 1 0.9999589920043945
protein O 0 0.13746269047260284
HFE O 1 0.9452140927314758
and O 0 0.02441900596022606
characterization O 0 0.0498495027422905
of O 0 0.0147187365218997
its O 0 0.020131194964051247
interaction O 0 0.05281629040837288
with O 0 0.03536684438586235
transferrin O 1 0.8632161617279053
receptor O 0 0.29107147455215454
. O 0 0.054980695247650146

HFE O 1 0.9303312301635742
is O 0 0.04184085130691528
an O 0 0.03561580181121826
MHC O 1 0.9852790832519531
- O 0 0.09145480394363403
related O 0 0.04388129711151123
protein O 0 0.04610849544405937
that O 0 0.012494505383074284
is O 0 0.016222380101680756
mutated O 0 0.07281298190355301
in O 0 0.018692346289753914
the O 0 0.02681131474673748
iron B-Disease 1 0.9984671473503113
- I-Disease 1 0.9997794032096863
overload I-Disease 1 0.9999837875366211
disease I-Disease 1 0.9999980926513672
hereditary B-Disease 1 0.9999809265136719
hemochromatosis I-Disease 1 0.9999973773956299
. O 0 0.1159791499376297

HFE O 1 0.9523282051086426
binds O 0 0.1842702478170395
to O 0 0.06588480621576309
transferrin O 1 0.9386496543884277
receptor O 0 0.4701273739337921
( O 0 0.08052262663841248
TfR O 1 0.9636016488075256
) O 0 0.03595693036913872
and O 0 0.01701650768518448
reduces O 0 0.0627172514796257
its O 0 0.019342390820384026
affinity O 0 0.06648384779691696
for O 0 0.02028580941259861
iron O 0 0.07725390791893005
- O 0 0.08112215995788574
loaded O 0 0.06953251361846924
transferrin O 1 0.6898127794265747
, O 0 0.04265294224023819
implicating O 0 0.20122292637825012
HFE O 1 0.976830005645752
in O 0 0.04547443985939026
iron O 0 0.14086315035820007
metabolism O 0 0.2981710433959961
. O 0 0.05911197513341904

The O 0 0.04684248939156532
2 O 0 0.061626680195331573
. O 0 0.050908301025629044

6 O 0 0.06687185913324356
A O 0 0.04476704075932503
crystal O 0 0.06696115434169769
structure O 0 0.03380894660949707
of O 0 0.024162549525499344
HFE O 1 0.9702901840209961
reveals O 0 0.06990568339824677
the O 0 0.021518483757972717
locations O 0 0.038860514760017395
of O 0 0.03271199390292168
hemochromatosis B-Disease 1 0.9999769926071167
mutations O 0 0.3083781898021698
and O 0 0.022632896900177002
a O 0 0.028012879192829132
patch O 0 0.2870948910713196
of O 0 0.020564137026667595
histidines O 0 0.11589109897613525
that O 0 0.015077953226864338
could O 0 0.016809839755296707
be O 0 0.010619984939694405
involved O 0 0.02574341371655464
in O 0 0.02294323593378067
pH O 1 0.5454562902450562
- O 0 0.09930576384067535
dependent O 0 0.08966407179832458
interactions O 0 0.08358234167098999
. O 0 0.05113306641578674

We O 0 0.03519927337765694
also O 0 0.022547027096152306
demonstrate O 0 0.04143035411834717
that O 0 0.023782502859830856
soluble O 0 0.14511509239673615
TfR O 1 0.9873188138008118
and O 0 0.04018059000372887
HFE O 1 0.9667923450469971
bind O 0 0.09529972821474075
tightly O 0 0.05663226172327995
at O 0 0.022050077095627785
the O 0 0.01617836207151413
basic O 0 0.029218370094895363
pH O 0 0.08924749493598938
of O 0 0.013588730245828629
the O 0 0.017704054713249207
cell O 0 0.05276712402701378
surface O 0 0.030371399596333504
, O 0 0.011203331872820854
but O 0 0.00997607409954071
not O 0 0.009117440320551395
at O 0 0.014527971856296062
the O 0 0.017646795138716698
acidic O 0 0.11983530968427658
pH O 0 0.16637557744979858
of O 0 0.03862717002630234
intracellular O 0 0.22892224788665771
vesicles O 0 0.2784668505191803
. O 0 0.07594694197177887

TfR O 1 0.9961851239204407
HFE O 1 0.9947525262832642
stoichiometry O 1 0.6640550494194031
( O 0 0.06767670810222626
2 O 0 0.04312664642930031
1 O 0 0.03774700313806534
) O 0 0.03367297723889351
differs O 0 0.05970725044608116
from O 0 0.048371002078056335
TfR O 1 0.9932624697685242
transferrin O 1 0.9746590852737427
stoichiometry O 0 0.3943108320236206
( O 0 0.04850487411022186
2 O 0 0.033556018024683
2 O 0 0.028720708563923836
) O 0 0.019663512706756592
, O 0 0.01364278793334961
implying O 0 0.040014706552028656
a O 0 0.017545586451888084
different O 0 0.014269774779677391
mode O 0 0.03674112632870674
of O 0 0.015151667408645153
binding O 0 0.04046846553683281
for O 0 0.022998115047812462
HFE O 1 0.9652422070503235
and O 0 0.030688351020216942
transferrin O 0 0.2606225311756134
to O 0 0.028561556711792946
TfR O 1 0.9330412149429321
, O 0 0.020479461178183556
consistent O 0 0.029503701254725456
with O 0 0.015854718163609505
our O 0 0.021390989422798157
demonstration O 0 0.046734780073165894
that O 0 0.02433168515563011
HFE O 1 0.9673183560371399
, O 0 0.03116697445511818
transferrin O 1 0.613101065158844
, O 0 0.020717842504382133
and O 0 0.02265099808573723
TfR O 1 0.9294465184211731
form O 0 0.036759983748197556
a O 0 0.03219063580036163
ternary O 0 0.09686744958162308
complex O 0 0.06312122941017151
. O 0 0.04615454003214836

Identification O 0 0.05504637211561203
of O 0 0.018661364912986755
three O 0 0.020672054961323738
novel O 0 0.039713285863399506
mutations O 0 0.08405955880880356
and O 0 0.015807170420885086
a O 0 0.017225082963705063
high O 0 0.02448691986501217
frequency O 0 0.037847381085157394
of O 0 0.013898267410695553
the O 0 0.023522373288869858
Arg778Leu O 1 0.7901186347007751
mutation O 0 0.3342609703540802
in O 0 0.028874140232801437
Korean O 0 0.09001932293176651
patients O 1 0.9985857009887695
with O 0 0.04693341627717018
Wilson B-Disease 1 0.973440408706665
disease I-Disease 1 0.9997894167900085
. O 0 0.06616352498531342

Four O 0 0.08520019054412842
mutations O 1 0.5583795309066772
- O 0 0.2646844983100891
- O 0 0.13754400610923767
R778L O 0 0.18209929764270782
, O 0 0.039755772799253464
A874V O 0 0.1261100471019745
, O 0 0.031195364892482758
L1083F O 0 0.0980108380317688
, O 0 0.024341823533177376
and O 0 0.020945202559232712
2304delC O 0 0.14685942232608795
- O 0 0.07595580816268921
- O 0 0.05605899542570114
in O 0 0.016081765294075012
the O 0 0.01968042366206646
copper O 0 0.06645175069570541
- O 0 0.08401424437761307
transporting O 0 0.08006073534488678
enzyme O 0 0.11153744906187057
, O 0 0.04213431850075722
P O 1 0.7126551270484924
- O 0 0.12093371152877808
type O 0 0.10601714253425598
ATPase O 1 0.9785881042480469
( O 0 0.056978512555360794
ATP7B O 0 0.3087993562221527
) O 0 0.023735692724585533
, O 0 0.010624931193888187
were O 0 0.008745941333472729
identified O 0 0.020082948729395866
in O 0 0.014903450384736061
Korean O 0 0.06755227595567703
Patients O 1 0.998907208442688
with O 0 0.03647815063595772
Wilson B-Disease 1 0.9336768984794617
disease I-Disease 1 0.9998095631599426
. O 0 0.05952952802181244

Arg778Leu O 0 0.22946462035179138
, O 0 0.025271527469158173
the O 0 0.016442274674773216
most O 0 0.01728011481463909
frequently O 0 0.030061446130275726
reported O 0 0.038590140640735626
mutation O 0 0.08961350470781326
of O 0 0.01326123345643282
this O 0 0.013356436043977737
enzyme O 0 0.05232185497879982
, O 0 0.01194657851010561
was O 0 0.009273232892155647
found O 0 0.010453063994646072
in O 0 0.00894141010940075
six O 0 0.013364878483116627
of O 0 0.010458515025675297
eight O 0 0.025036148726940155
unrelated O 0 0.0721551924943924
patients O 1 0.9810327291488647
studied O 0 0.030528970062732697
, O 0 0.015504244714975357
an O 0 0.01870863512158394
allele O 0 0.11414693295955658
frequency O 0 0.06419951468706131
of O 0 0.022444764152169228
37 O 0 0.06180541589856148
. O 0 0.04475132375955582

5 O 0 0.05153654143214226
% O 0 0.030650721862912178
, O 0 0.013750936836004257
which O 0 0.012667088769376278
is O 0 0.012917749583721161
considerably O 0 0.02733677811920643
higher O 0 0.020743386819958687
than O 0 0.009592575952410698
those O 0 0.010239319875836372
in O 0 0.009781062602996826
other O 0 0.013183229602873325
Asian O 0 0.0521487221121788
populations O 0 0.07773055881261826
. O 0 0.04090535640716553

The O 0 0.040090594440698624
novel O 0 0.05645960569381714
single O 0 0.054808296263217926
nucleotide O 0 0.1290094554424286
deletion O 0 0.14315181970596313
, O 0 0.029066603630781174
2304delC O 0 0.10309025645256042
, O 0 0.017439542338252068
was O 0 0.014129990711808205
found O 0 0.016182901337742805
in O 0 0.013907890766859055
one O 0 0.022734008729457855
patient O 0 0.3273903727531433
. O 0 0.04688240960240364

Since O 0 0.0569692999124527
a O 0 0.05286717042326927
mutation O 0 0.17443972826004028
at O 0 0.06577150523662567
cDNA O 0 0.18658447265625
nucleotide O 0 0.19606386125087738
2302 O 1 0.9732494354248047
( O 0 0.06930040568113327
2302insC O 0 0.12896661460399628
) O 0 0.028132876381278038
had O 0 0.01574757881462574
been O 0 0.012022865936160088
previously O 0 0.016799455508589745
described O 0 0.019898192957043648
, O 0 0.01029742881655693
this O 0 0.008993269875645638
region O 0 0.022993765771389008
of O 0 0.012565787881612778
the O 0 0.020628295838832855
ATP7B O 1 0.9212493300437927
gene O 0 0.09861979633569717
may O 0 0.03445609658956528
be O 0 0.018799370154738426
susceptible O 0 0.24752818048000336
to O 0 0.02843581512570381
gene O 0 0.17786793410778046
rearrangements O 1 0.7842843532562256
causing O 1 0.9773446917533875
Wilson B-Disease 1 0.9738031625747681
disease I-Disease 1 0.9998468160629272
. O 0 0.060099292546510696

Disruption O 0 0.17678239941596985
of O 0 0.04034072905778885
splicing O 0 0.13309232890605927
regulated O 0 0.06622923910617828
by O 0 0.026215093210339546
a O 0 0.039818186312913895
CUG O 1 0.7954680919647217
- O 0 0.11459363996982574
binding O 0 0.095380999147892
protein O 0 0.10640810430049896
in O 0 0.06211162358522415
myotonic B-Disease 1 0.9999921321868896
dystrophy I-Disease 1 0.9999978542327881
. O 0 0.09476859122514725

Myotonic B-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9948170781135559
DM B-Disease 1 0.9999951124191284
) O 0 0.043211743235588074
is O 0 0.020659372210502625
caused O 0 0.04564252868294716
by O 0 0.01617870293557644
a O 0 0.026177186518907547
CTG O 0 0.4534686207771301
expansion O 0 0.03673916682600975
in O 0 0.015011871233582497
the O 0 0.015667738392949104
3 O 0 0.03502083942294121
untranslated O 0 0.10448278486728668
region O 0 0.03762613981962204
of O 0 0.019143598154187202
the O 0 0.03980238363146782
DM B-Disease 1 0.9999568462371826
gene O 0 0.1547480821609497
. O 0 0.059684619307518005

One O 0 0.04288875311613083
model O 0 0.05669185891747475
of O 0 0.045860715210437775
DM B-Disease 1 0.9999927282333374
pathogenesis O 1 0.9981191754341125
suggests O 0 0.06551925092935562
that O 0 0.02369053103029728
RNAs O 0 0.08379635214805603
from O 0 0.015390627086162567
the O 0 0.015178040601313114
expanded O 0 0.03095703013241291
allele O 0 0.09714929014444351
create O 0 0.036763668060302734
a O 0 0.025343626737594604
gain O 0 0.042172182351350784
- O 0 0.05777600780129433
of O 0 0.0210417453199625
- O 0 0.07007968425750732
function O 0 0.04936657100915909
mutation O 0 0.0984223261475563
by O 0 0.017994720488786697
the O 0 0.017252538353204727
inappropriate O 0 0.0514371283352375
binding O 0 0.036015454679727554
of O 0 0.015366712585091591
proteins O 0 0.03381463512778282
to O 0 0.015774616971611977
the O 0 0.025314781814813614
CUG O 0 0.4660405218601227
repeats O 0 0.1259748786687851
. O 0 0.054388195276260376

Data O 0 0.03882461413741112
presented O 0 0.028756331652402878
here O 0 0.019877977669239044
indicate O 0 0.027066465467214584
that O 0 0.011253406293690205
the O 0 0.015652934089303017
conserved O 0 0.053333576768636703
heterogeneous O 0 0.10532303899526596
nuclear O 0 0.0800490602850914
ribonucleoprotein O 1 0.8990070819854736
, O 0 0.043071966618299484
CUG O 1 0.7676686644554138
- O 0 0.10033214092254639
binding O 0 0.07584143429994583
protein O 0 0.08451811224222183
( O 0 0.05408934876322746
CUG O 1 0.9171897172927856
- O 0 0.10561671853065491
BP O 0 0.10712742805480957
) O 0 0.02965737320482731
, O 0 0.016150623559951782
may O 0 0.0234126765280962
mediate O 0 0.06828609853982925
the O 0 0.023936597630381584
trans O 0 0.16093146800994873
- O 0 0.08158481866121292
dominant O 0 0.05962839350104332
effect O 0 0.038858942687511444
of O 0 0.014527268707752228
the O 0 0.02439776435494423
RNA O 0 0.10683674365282059
. O 0 0.04733358696103096

CUG O 1 0.9381484389305115
- O 0 0.13367938995361328
BP O 0 0.1031980812549591
was O 0 0.023661725223064423
found O 0 0.01726546511054039
to O 0 0.01453477330505848
bind O 0 0.04446221888065338
to O 0 0.015887415036559105
the O 0 0.021670915186405182
human O 0 0.06453822553157806
cardiac O 1 0.9999603033065796
troponin O 1 0.999779999256134
T O 1 0.9940290451049805
( O 0 0.06791975349187851
cTNT O 0 0.347356379032135
) O 0 0.042680419981479645
pre O 0 0.09203692525625229
- O 0 0.0923926830291748
messenger O 0 0.10785474628210068
RNA O 0 0.09149745851755142
and O 0 0.022502195090055466
regulate O 0 0.06133892759680748
its O 0 0.028164980933070183
alternative O 0 0.0698443204164505
splicing O 0 0.1329309642314911
. O 0 0.050565656274557114

Splicing O 0 0.17966605722904205
of O 0 0.039609454572200775
cTNT O 0 0.1677493304014206
was O 0 0.03789079189300537
disrupted O 0 0.12341590225696564
in O 0 0.06066238880157471
DM B-Disease 1 0.9999958276748657
striated O 1 0.9995662569999695
muscle O 1 0.9953532218933105
and O 0 0.023660175502300262
in O 0 0.02291487343609333
normal O 0 0.060302287340164185
cells O 0 0.08610177040100098
expressing O 0 0.06092473119497299
transcripts O 0 0.04854629561305046
that O 0 0.022548366338014603
contain O 0 0.053557202219963074
CUG O 0 0.4649837613105774
repeats O 0 0.12922734022140503
. O 0 0.0552455335855484

Altered O 0 0.10474999994039536
expression O 0 0.059655096381902695
of O 0 0.026150966063141823
genes O 0 0.0924464538693428
regulated O 0 0.08878818899393082
posttranscriptionally O 0 0.1711987555027008
by O 0 0.03855989873409271
CUG O 1 0.9471017718315125
- O 0 0.12460680305957794
BP O 0 0.12761744856834412
therefore O 0 0.04016438126564026
may O 0 0.03754040226340294
contribute O 0 0.05989609658718109
to O 0 0.04153325408697128
DM B-Disease 1 0.999994158744812
pathogenesis O 1 0.9975419044494629
. O 0 0.03905507177114487
. O 0 0.04487661272287369

Identification O 0 0.06088096275925636
of O 0 0.02214590460062027
a O 0 0.027336597442626953
novel O 0 0.052718281745910645
nonsense O 0 0.0836871787905693
mutation O 0 0.11890126764774323
and O 0 0.021978963166475296
a O 0 0.027711203321814537
missense O 0 0.1462772786617279
substitution O 0 0.07173258811235428
in O 0 0.02155477926135063
the O 0 0.028986573219299316
vasopressin O 1 0.9537023901939392
- O 0 0.20207782089710236
neurophysin O 1 0.569683849811554
II O 0 0.09659650921821594
gene O 0 0.07366035878658295
in O 0 0.018029822036623955
two O 0 0.019563069567084312
Spanish O 0 0.05989518016576767
kindreds O 1 0.8100607991218567
with O 0 0.06297878175973892
familial B-Disease 1 0.9998455047607422
neurohypophyseal I-Disease 1 0.9998237490653992
diabetes I-Disease 1 0.9999972581863403
insipidus I-Disease 1 0.9998904466629028
. O 0 0.08375313133001328

Familial B-Disease 1 0.9997057318687439
neurohypophyseal I-Disease 1 0.9997846484184265
diabetes I-Disease 1 0.9999988079071045
insipidus I-Disease 1 0.9999711513519287
( O 0 0.49836379289627075
FNDI B-Disease 1 0.9988343119621277
) O 0 0.04066077247262001
is O 0 0.021312998607754707
an O 0 0.030074592679739
autosomal B-Disease 1 0.9997839331626892
dominant I-Disease 1 0.9973999261856079
disease I-Disease 1 0.9999982118606567
caused O 1 0.9955997467041016
by O 0 0.04523327946662903
deficiency O 1 0.9999834299087524
in O 0 0.03372624143958092
the O 0 0.042081959545612335
antidiuretic O 1 0.997809112071991
hormone O 1 0.9936445951461792
arginine O 1 0.8395138382911682
vasopressin O 1 0.9711049199104309
( O 0 0.07469024509191513
AVP O 1 0.8100069165229797
) O 0 0.0324992872774601
encoded O 0 0.029827022925019264
by O 0 0.018030406907200813
the O 0 0.030711960047483444
AVP O 1 0.989956796169281
- O 0 0.4840971827507019
neurophysin O 1 0.9181145429611206
II O 0 0.4567856788635254
( O 0 0.0724659115076065
AVP O 1 0.9946414232254028
- O 0 0.274558424949646
NPII O 1 0.8011581897735596
) O 0 0.04946763813495636
gene O 0 0.08121270686388016
on O 0 0.03076193854212761
chromosome O 0 0.1713140606880188
20p13 O 0 0.2109985500574112
. O 0 0.05318988859653473

In O 0 0.025917120277881622
this O 0 0.01679903082549572
study O 0 0.02423536404967308
, O 0 0.012455451302230358
we O 0 0.010437991470098495
analyzed O 0 0.022240016609430313
two O 0 0.01141591090708971
families O 0 0.026734765619039536
with O 0 0.021502496674656868
FNDI B-Disease 1 0.6109676957130432
using O 0 0.03342273458838463
direct O 0 0.043977927416563034
automated O 0 0.07291106134653091
fluorescent O 0 0.0939851626753807
, O 0 0.024339422583580017
solid O 0 0.045882053673267365
phase O 0 0.06304800510406494
, O 0 0.020104337483644485
single O 0 0.03285251557826996
- O 0 0.07322291284799576
stranded O 0 0.1008613258600235
DNA O 0 0.07050962746143341
sequencing O 0 0.07517941296100616
of O 0 0.03055047057569027
PCR O 0 0.23354162275791168
- O 0 0.13565000891685486
amplified O 0 0.1692107617855072
AVP O 1 0.9827376008033752
- O 0 0.2754698693752289
NPII O 1 0.6840922832489014
DNA O 0 0.12275588512420654
. O 0 0.06301457434892654

In O 0 0.024878427386283875
one O 0 0.013196008279919624
of O 0 0.010490486398339272
the O 0 0.01376674510538578
families O 0 0.028325462713837624
, O 0 0.017144443467259407
affected O 0 0.038594458252191544
individuals O 0 0.02511429414153099
presented O 0 0.022485094144940376
a O 0 0.023493453860282898
novel O 0 0.043431948870420456
nonsense O 0 0.08263859152793884
mutation O 0 0.11814367771148682
in O 0 0.022704770788550377
exon O 0 0.09056627005338669
3 O 0 0.026783427223563194
of O 0 0.013433701358735561
the O 0 0.017154263332486153
gene O 0 0.05384349077939987
, O 0 0.013931669294834137
consisting O 0 0.023265546187758446
in O 0 0.01694708876311779
a O 0 0.02755405195057392
G O 0 0.09949036687612534
to O 0 0.028466086834669113
T O 0 0.23418419063091278
transition O 0 0.0597442090511322
at O 0 0.03882875293493271
nucleotide O 0 0.10439565777778625
2101 O 0 0.17412495613098145
, O 0 0.021279126405715942
which O 0 0.017838936299085617
produces O 0 0.03899114578962326
a O 0 0.025011897087097168
stop O 0 0.04445822536945343
signal O 0 0.05779657140374184
in O 0 0.03219914063811302
codon O 0 0.13381239771842957
82 O 0 0.0966966301202774
( O 0 0.06876718252897263
Glu O 1 0.9582919478416443
) O 0 0.04543852061033249
of O 0 0.026717117056250572
NPII O 1 0.6037889719009399
. O 0 0.05186871066689491

The O 0 0.0690479502081871
premature O 1 0.9355885982513428
termination O 1 0.6600106954574585
eliminates O 0 0.09913133084774017
part O 0 0.02296493388712406
of O 0 0.01210529450327158
the O 0 0.019759956747293472
C O 0 0.08808813989162445
- O 0 0.06967411190271378
terminal O 0 0.07191282510757446
domain O 0 0.03950437158346176
of O 0 0.019248275086283684
NPII O 0 0.15559624135494232
, O 0 0.017470847815275192
including O 0 0.015027671121060848
a O 0 0.0238569937646389
cysteine O 0 0.07607447355985641
residue O 0 0.06327737122774124
in O 0 0.016146257519721985
position O 0 0.021332353353500366
85 O 0 0.0325724221765995
, O 0 0.010954181663691998
which O 0 0.00899940449744463
could O 0 0.010526384226977825
be O 0 0.007217857055366039
involved O 0 0.014455505646765232
in O 0 0.008428449742496014
the O 0 0.012369666248559952
correct O 0 0.042002126574516296
folding O 0 0.06205068156123161
of O 0 0.020931635051965714
the O 0 0.03314795717597008
prohormone O 1 0.9479243159294128
. O 0 0.06431230157613754

In O 0 0.023100074380636215
the O 0 0.017306379973888397
second O 0 0.024564802646636963
family O 0 0.028312943875789642
, O 0 0.017177335917949677
a O 0 0.026722809299826622
G279A O 0 0.11112580448389053
substitution O 0 0.05883144959807396
at O 0 0.021324964240193367
position O 0 0.021078789606690407
- O 0 0.04313119873404503
1 O 0 0.019573524594306946
of O 0 0.011654349975287914
the O 0 0.01676342450082302
signal O 0 0.050655558705329895
peptide O 0 0.07974456250667572
was O 0 0.016921496018767357
observed O 0 0.026155345141887665
in O 0 0.011661349795758724
all O 0 0.01295397523790598
affected O 0 0.05316594988107681
individuals O 0 0.04432232677936554
. O 0 0.04386020079255104

This O 0 0.06751748919487
missense O 0 0.3456558287143707
mutation O 0 0.18653056025505066
, O 0 0.02817959524691105
which O 0 0.02297458052635193
replaces O 0 0.09948571771383286
Ala O 1 0.9069733023643494
with O 0 0.04610982537269592
Thr O 1 0.9987670183181763
, O 0 0.02601349540054798
is O 0 0.02271449565887451
frequent O 0 0.05853271484375
among O 0 0.03821713849902153
FNDI B-Disease 1 0.9997615218162537
patients O 1 0.9973587393760681
and O 0 0.014592614956200123
is O 0 0.013484746217727661
thought O 0 0.01917729526758194
to O 0 0.01152584608644247
reduce O 0 0.0320136584341526
the O 0 0.015218734741210938
efficiency O 0 0.04049332067370415
of O 0 0.020754635334014893
cleavage O 0 0.14767317473888397
by O 0 0.03384498506784439
signal O 0 0.08347053080797195
peptidases O 0 0.19490787386894226
. O 0 0.03713539242744446
. O 0 0.03869247063994408

Genetic O 0 0.18874087929725647
heterogeneity O 0 0.19001543521881104
of O 0 0.045061223208904266
Saethre B-Disease 1 0.9991464614868164
- I-Disease 1 0.9991814494132996
Chotzen I-Disease 1 0.9998455047607422
syndrome I-Disease 1 0.9999980926513672
, O 0 0.02819136157631874
due O 0 0.029203547164797783
to O 0 0.024005074054002762
TWIST O 0 0.11020850390195847
and O 0 0.03728875890374184
FGFR O 1 0.9200752973556519
mutations O 0 0.2858158051967621
. O 0 0.057857807725667953

Thirty O 0 0.08850104361772537
- O 0 0.08309315890073776
two O 0 0.027078570798039436
unrelated O 0 0.07488473504781723
patients O 1 0.9617689847946167
with O 0 0.01990796998143196
features O 0 0.03182850033044815
of O 0 0.028236880898475647
Saethre B-Disease 1 0.9986579418182373
- I-Disease 1 0.9971235394477844
Chotzen I-Disease 1 0.9996994733810425
syndrome I-Disease 1 0.9999973773956299
, O 0 0.031116284430027008
a O 0 0.03174017369747162
common O 0 0.055189747363328934
autosomal B-Disease 1 0.9986518025398254
dominant I-Disease 0 0.4221121072769165
condition I-Disease 1 0.940563440322876
of O 0 0.034595806151628494
craniosynostosis B-Disease 1 0.9999105930328369
and O 0 0.0407765731215477
limb B-Disease 1 0.999345600605011
anomalies I-Disease 1 0.6252107620239258
, O 0 0.020425189286470413
were O 0 0.01472441479563713
screened O 0 0.05160888284444809
for O 0 0.01923510991036892
mutations O 0 0.09458177536725998
in O 0 0.02561042830348015
TWIST O 0 0.11084027588367462
, O 0 0.027944181114435196
FGFR2 O 1 0.5111610889434814
, O 0 0.02480154298245907
and O 0 0.025189340114593506
FGFR3 O 1 0.5861630439758301
. O 0 0.053241658955812454

Nine O 0 0.04959019273519516
novel O 0 0.0495867058634758
and O 0 0.022305181249976158
three O 0 0.030953096225857735
recurrent O 1 0.9892087578773499
TWIST O 1 0.6271219849586487
mutations O 0 0.12607091665267944
were O 0 0.016698580235242844
found O 0 0.017934132367372513
in O 0 0.013901476748287678
12 O 0 0.0269374530762434
families O 0 0.04291927441954613
. O 0 0.0434284470975399

Seven O 0 0.043879225850105286
families O 0 0.03454078361392021
were O 0 0.014445638284087181
found O 0 0.013601066544651985
to O 0 0.010378670878708363
have O 0 0.013804636895656586
the O 0 0.021997902542352676
FGFR3 O 1 0.9660372734069824
P250R O 1 0.6605613827705383
mutation O 0 0.13580726087093353
, O 0 0.015165884047746658
and O 0 0.010414155200123787
one O 0 0.011265726760029793
individual O 0 0.014291422441601753
was O 0 0.012114541605114937
found O 0 0.014924249611794949
to O 0 0.011451148428022861
have O 0 0.014496118761599064
an O 0 0.024658657610416412
FGFR2 O 1 0.71269690990448
VV269 O 0 0.4231291711330414
- O 0 0.1362360715866089
270 O 0 0.13632845878601074
deletion O 0 0.21402914822101593
. O 0 0.0664028748869896

To O 0 0.030390864238142967
date O 0 0.02523128129541874
, O 0 0.016857614740729332
our O 0 0.020999640226364136
detection O 0 0.06780918687582016
rate O 0 0.03608750179409981
for O 0 0.017490454018115997
TWIST O 0 0.09371908754110336
or O 0 0.037002693861722946
FGFR O 1 0.9060355424880981
mutations O 0 0.12777875363826752
is O 0 0.0215624887496233
68 O 0 0.045204825699329376
% O 0 0.023435380309820175
in O 0 0.016570892184972763
our O 0 0.030325639992952347
Saethre B-Disease 1 0.9995496869087219
- I-Disease 1 0.9997881054878235
Chotzen I-Disease 1 0.9999842643737793
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9997629523277283
, O 0 0.018405497074127197
including O 0 0.015343094244599342
our O 0 0.0188754890114069
five O 0 0.026474300771951675
patients O 1 0.990088939666748
elsewhere O 0 0.04405514523386955
reported O 0 0.04397926107048988
with O 0 0.031959544867277145
TWIST O 0 0.27335235476493835
mutations O 0 0.25769317150115967
. O 0 0.05836799368262291

More O 0 0.03176968917250633
than O 0 0.02369857020676136
35 O 0 0.036316391080617905
different O 0 0.022340871393680573
TWIST O 0 0.11230961233377457
mutations O 0 0.10087992250919342
are O 0 0.014512729831039906
now O 0 0.01573803462088108
known O 0 0.016060683876276016
in O 0 0.010454562492668629
the O 0 0.015797991305589676
literature O 0 0.030199555680155754
. O 0 0.037148430943489075

The O 0 0.0299178846180439
most O 0 0.01957211270928383
common O 0 0.032993875443935394
phenotypic O 0 0.06997358053922653
features O 0 0.0246018934994936
, O 0 0.013056711293756962
present O 0 0.013088956475257874
in O 0 0.008993457071483135
more O 0 0.007950839586555958
than O 0 0.00956097524613142
a O 0 0.011996143497526646
third O 0 0.017477314919233322
of O 0 0.011177115142345428
our O 0 0.02226959727704525
patients O 1 0.9875931143760681
with O 0 0.028565069660544395
TWIST O 1 0.6367496252059937
mutations O 0 0.15966778993606567
, O 0 0.024628328159451485
are O 0 0.02390689216554165
coronal B-Disease 1 0.5242310762405396
synostosis I-Disease 0 0.42508628964424133
, O 0 0.0368228517472744
brachycephaly B-Disease 1 0.5603581070899963
, O 0 0.03374442085623741
low B-Disease 0 0.08989326655864716
frontal I-Disease 1 0.9992045760154724
hairline I-Disease 1 0.9999374151229858
, O 0 0.05836234614253044
facial B-Disease 1 0.9993452429771423
asymmetry I-Disease 1 0.989345371723175
, O 0 0.05213099718093872
ptosis B-Disease 1 0.9999148845672607
, O 0 0.049671296030282974
hypertelorism B-Disease 1 0.9950453042984009
, O 0 0.032859787344932556
broad B-Disease 0 0.05860072001814842
great I-Disease 0 0.040489356964826584
toes I-Disease 0 0.10592642426490784
, O 0 0.025156697258353233
and O 0 0.02613217383623123
clinodactyly B-Disease 0 0.16326528787612915
. O 0 0.0484565868973732

Significant O 0 0.07845953106880188
intra O 0 0.15377941727638245
- O 0 0.11422346532344818
and O 0 0.03926466777920723
interfamilial O 0 0.2247784584760666
phenotypic O 0 0.13972388207912445
variability O 0 0.10272416472434998
is O 0 0.01742279902100563
present O 0 0.018675262108445168
for O 0 0.01507199089974165
either O 0 0.034233640879392624
TWIST O 0 0.3261934816837311
mutations O 0 0.4554382562637329
or O 0 0.059342168271541595
FGFR O 1 0.980822741985321
mutations O 0 0.41041573882102966
. O 0 0.05229305103421211

The O 0 0.03437192365527153
overlap O 0 0.058257509022951126
in O 0 0.021429648622870445
clinical O 0 0.07943779230117798
features O 0 0.02099457196891308
and O 0 0.009056624956429005
the O 0 0.010480863973498344
presence O 0 0.022452112287282944
, O 0 0.00904805213212967
in O 0 0.008873329497873783
the O 0 0.01007920503616333
same O 0 0.014581824652850628
genes O 0 0.04054196551442146
, O 0 0.012756568379700184
of O 0 0.012581180781126022
mutations O 0 0.06580884009599686
for O 0 0.010928700678050518
more O 0 0.010805325582623482
than O 0 0.01463925838470459
one O 0 0.0192228015512228
craniosynostotic B-Disease 0 0.49076342582702637
condition I-Disease 0 0.16839943826198578
- O 0 0.055595725774765015
such O 0 0.019123826175928116
as O 0 0.023457786068320274
Saethre B-Disease 1 0.8763114809989929
- I-Disease 0 0.14711187779903412
Chotzen I-Disease 1 0.6465278267860413
, I-Disease 0 0.03302595764398575
Crouzon I-Disease 1 0.640245795249939
, I-Disease 0 0.025918690487742424
and I-Disease 0 0.03059888631105423
Pfeiffer I-Disease 1 0.9998818635940552
syndromes I-Disease 1 0.9999829530715942
- O 0 0.08397269248962402
support O 0 0.029244359582662582
the O 0 0.020220700651407242
hypothesis O 0 0.05519160255789757
that O 0 0.019642548635601997
TWIST O 0 0.07400905340909958
and O 0 0.016504816710948944
FGFRs O 0 0.08168035000562668
are O 0 0.010746161453425884
components O 0 0.019280387088656425
of O 0 0.008370486088097095
the O 0 0.012509823776781559
same O 0 0.018495889380574226
molecular O 0 0.05189961567521095
pathway O 0 0.07851656526327133
involved O 0 0.023038433864712715
in O 0 0.0123792365193367
the O 0 0.016292110085487366
modulation O 0 0.09445616602897644
of O 0 0.022019507363438606
craniofacial O 1 0.9998155236244202
and O 0 0.031374238431453705
limb O 1 0.9888538122177124
development O 0 0.03483130410313606
in O 0 0.02047574147582054
humans O 0 0.048632439225912094
. O 0 0.027326632291078568
. O 0 0.03753311559557915

Mutation O 0 0.2984689772129059
analysis O 0 0.0810546875
of O 0 0.04924188554286957
UBE3A O 1 0.9996562004089355
in O 1 0.8804668188095093
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.9998986721038818
. O 0 0.07342113554477692

Angelman B-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999997615814209
( O 0 0.0936945304274559
AS B-Disease 0 0.04008680209517479
) O 0 0.03110634535551071
is O 0 0.02296248823404312
caused O 0 0.06325794756412506
by O 0 0.030560018494725227
chromosome O 0 0.17346210777759552
15q11 O 0 0.40109243988990784
- O 0 0.13635872304439545
q13 O 0 0.183549702167511
deletions O 0 0.11620871722698212
of O 0 0.026544468477368355
maternal O 0 0.10283706337213516
origin O 0 0.03810106962919235
, O 0 0.02382482774555683
by O 0 0.03338250890374184
paternal O 0 0.45301324129104614
uniparental B-Disease 1 0.9990600943565369
disomy I-Disease 1 0.9834321141242981
( O 0 0.10863259434700012
UPD B-Disease 1 0.999212384223938
) O 0 0.0382244810461998
15 O 0 0.025651345029473305
, O 0 0.017786072567105293
by O 0 0.024755852296948433
imprinting O 1 0.8260868787765503
defects O 1 0.9146642684936523
, O 0 0.022163692861795425
and O 0 0.015407455153763294
by O 0 0.01861870475113392
mutations O 0 0.08763988316059113
in O 0 0.019884081557393074
the O 0 0.035064443945884705
UBE3A O 1 0.9861360788345337
gene O 0 0.1479056179523468
. O 0 0.05632093548774719

UBE3A O 1 0.7805427312850952
encodes O 0 0.1480185091495514
a O 0 0.07061848789453506
ubiquitin O 0 0.19135317206382751
- O 0 0.13684089481830597
protein O 0 0.11386536061763763
ligase O 0 0.11275666952133179
and O 0 0.027077844366431236
shows O 0 0.049818504601716995
brain O 1 0.9297131299972534
- O 0 0.08914878219366074
specific O 0 0.05225586146116257
imprinting O 0 0.422134667634964
. O 0 0.058477964252233505

Here O 0 0.05067813768982887
we O 0 0.03441740199923515
describe O 0 0.08790799975395203
UBE3A O 1 0.9626016020774841
coding O 0 0.1861037164926529
- O 0 0.14775918424129486
region O 0 0.09144530445337296
mutations O 0 0.18940795958042145
detected O 0 0.1031438559293747
by O 0 0.030962886288762093
SSCP O 0 0.20209871232509613
analysis O 0 0.0316077396273613
in O 0 0.01622878760099411
13 O 0 0.023650340735912323
AS B-Disease 0 0.021703816950321198
individuals O 0 0.026069242507219315
or O 0 0.02490822784602642
families O 0 0.03982154279947281
. O 0 0.04124307259917259

Two O 0 0.04737716540694237
identical O 0 0.07930459082126617
de O 0 0.11354699730873108
novo O 0 0.1565939486026764
5 O 0 0.056839581578969955
- O 0 0.09043246507644653
bp O 0 0.10706277936697006
duplications O 0 0.11254014819860458
in O 0 0.030988628044724464
exon O 0 0.10650898516178131
16 O 0 0.03409532085061073
were O 0 0.017693642526865005
found O 0 0.030031366273760796
. O 0 0.040601328015327454

Among O 0 0.03427774831652641
the O 0 0.01766166277229786
other O 0 0.014183142222464085
11 O 0 0.02830561250448227
unique O 0 0.03271454572677612
mutations O 0 0.09220782667398453
, O 0 0.016871830448508263
8 O 0 0.022349709644913673
were O 0 0.011348829604685307
small O 0 0.02413288503885269
deletions O 0 0.0810968205332756
or O 0 0.0334203764796257
insertions O 0 0.1264411211013794
predicted O 0 0.05367410182952881
to O 0 0.02317582257091999
cause O 0 0.07459229975938797
frameshifts O 0 0.127053365111351
, O 0 0.01924029551446438
1 O 0 0.021636907011270523
was O 0 0.01583961397409439
a O 0 0.020748769864439964
mutation O 0 0.08394984155893326
to O 0 0.017425037920475006
a O 0 0.02374555543065071
stop O 0 0.0462433360517025
codon O 0 0.08794671297073364
, O 0 0.020003395155072212
1 O 0 0.024805394932627678
was O 0 0.018627699464559555
a O 0 0.03206772357225418
missense O 0 0.17265242338180542
mutation O 0 0.12361519783735275
, O 0 0.01955525018274784
and O 0 0.01314204465597868
1 O 0 0.023533087223768234
was O 0 0.017182795330882072
predicted O 0 0.03443490341305733
to O 0 0.016229990869760513
cause O 0 0.05204557254910469
insertion O 0 0.07555680721998215
of O 0 0.015264998190104961
an O 0 0.01951957680284977
isoleucine O 0 0.09329424798488617
in O 0 0.01981368102133274
the O 0 0.019611602649092674
hect O 0 0.10198955237865448
domain O 0 0.03511092811822891
of O 0 0.01414534356445074
the O 0 0.02398051880300045
UBE3A O 1 0.7768887281417847
protein O 0 0.051611464470624924
, O 0 0.014625534415245056
which O 0 0.010222564451396465
functions O 0 0.017579946666955948
in O 0 0.01908230036497116
E2 O 0 0.2424907237291336
binding O 0 0.05071345344185829
and O 0 0.02405766025185585
ubiquitin O 0 0.10306734591722488
transfer O 0 0.04850003495812416
. O 0 0.04747507721185684

Eight O 0 0.03453486040234566
of O 0 0.016561802476644516
the O 0 0.01569417491555214
cases O 0 0.030805842950940132
were O 0 0.017458003014326096
familial O 1 0.9735605716705322
, O 0 0.017541823908686638
and O 0 0.011684316210448742
five O 0 0.01578686572611332
were O 0 0.017431538552045822
sporadic O 0 0.08120308816432953
. O 0 0.04571090638637543

In O 0 0.036980003118515015
two O 0 0.032707393169403076
familial O 1 0.986138641834259
cases O 0 0.04690733551979065
and O 0 0.017224259674549103
one O 0 0.020337823778390884
sporadic O 0 0.07334867864847183
case O 0 0.03555173799395561
, O 0 0.02951705828309059
mosaicism O 1 0.9766173958778381
for O 0 0.04310213774442673
UBE3A O 1 0.9877606630325317
mutations O 0 0.15052057802677155
was O 0 0.02780861407518387
detected O 0 0.05271786451339722
in O 0 0.011182153597474098
the O 0 0.011484500952064991
mother O 0 0.023449908941984177
of O 0 0.009931100532412529
three O 0 0.012341533787548542
AS B-Disease 0 0.016391566023230553
sons O 0 0.0325203575193882
, O 0 0.011999659240245819
in O 0 0.010611110366880894
the O 0 0.014423049986362457
maternal O 0 0.07004227489233017
grandfather O 0 0.03708084672689438
of O 0 0.010872137732803822
two O 0 0.010483385995030403
AS B-Disease 0 0.01605399139225483
first O 0 0.013965582475066185
cousins O 0 0.03888877481222153
, O 0 0.010411378927528858
and O 0 0.008135205134749413
in O 0 0.008796844631433487
the O 0 0.009694855660200119
mother O 0 0.02239375188946724
of O 0 0.009724671952426434
an O 0 0.014465353451669216
AS B-Disease 0 0.026478715240955353
daughter O 0 0.0638805627822876
. O 0 0.04346860200166702

The O 0 0.03653998672962189
frequencies O 0 0.05383175238966942
with O 0 0.020892433822155
which O 0 0.019196709617972374
we O 0 0.02192426659166813
detected O 0 0.07125706970691681
mutations O 0 0.09035072475671768
were O 0 0.016651371493935585
5 O 0 0.02606026455760002
( O 0 0.025286242365837097
14 O 0 0.02153281308710575
% O 0 0.019781002774834633
) O 0 0.016366498544812202
of O 0 0.010198136791586876
35 O 0 0.02320161461830139
in O 0 0.015237484127283096
sporadic O 0 0.04989141225814819
cases O 0 0.02947918139398098
and O 0 0.015219379216432571
8 O 0 0.028198227286338806
( O 0 0.025802811607718468
80 O 0 0.02658757008612156
% O 0 0.021602613851428032
) O 0 0.015879804268479347
of O 0 0.01023165788501501
10 O 0 0.020240388810634613
in O 0 0.0198566485196352
familial O 1 0.9955201148986816
cases O 0 0.05581333860754967
. O 0 0.028021985664963722
. O 0 0.04179409518837929

The O 0 0.09326284378767014
hemochromatosis B-Disease 1 0.9999411106109619
845 O 1 0.9946500658988953
G O 1 0.9798554182052612
- O 1 0.5866384506225586
- O 0 0.1428297460079193
> O 0 0.12448868155479431
A O 0 0.03422791510820389
and O 0 0.027747439220547676
187 O 0 0.10506477952003479
C O 0 0.4841325879096985
- O 1 0.8166183829307556
- O 1 0.7629947066307068
> O 1 0.9113286733627319
G O 1 0.6797370314598083
mutations O 0 0.2761925458908081
: O 0 0.054445780813694
prevalence O 0 0.35124000906944275
in O 0 0.02765895612537861
non O 0 0.06155179440975189
- O 0 0.14254061877727509
Caucasian O 1 0.7500917315483093
populations O 0 0.12212064862251282
. O 0 0.05391055718064308

Hemochromatosis B-Disease 1 0.9998098015785217
, O 0 0.051336705684661865
the O 0 0.04664689674973488
inherited B-Disease 1 0.9997596144676208
disorder I-Disease 1 0.9999927282333374
of I-Disease 0 0.03446987643837929
iron I-Disease 1 0.7894678711891174
metabolism I-Disease 1 0.6734596490859985
, O 0 0.026200436055660248
leads O 0 0.05214512720704079
, O 0 0.019696949049830437
if O 0 0.02277844399213791
untreated O 1 0.9720814228057861
, O 0 0.016149381175637245
to O 0 0.020770642906427383
progressive O 0 0.33503711223602295
iron B-Disease 1 0.9268092513084412
overload I-Disease 1 0.9960758090019226
and O 0 0.04281046986579895
premature B-Disease 1 0.9322769045829773
death I-Disease 0 0.07318738847970963
. O 0 0.04684733971953392

The O 0 0.09240589290857315
hemochromatosis B-Disease 1 0.9999536275863647
gene O 0 0.26482146978378296
, O 0 0.04887506365776062
HFE O 1 0.9852933287620544
, O 0 0.026800913736224174
recently O 0 0.02986794523894787
has O 0 0.015188812278211117
been O 0 0.010656098835170269
identified O 0 0.01841488666832447
, O 0 0.010896153748035431
and O 0 0.01045434083789587
characterization O 0 0.03260154649615288
of O 0 0.010076998732984066
this O 0 0.012588243931531906
gene O 0 0.04480597749352455
has O 0 0.012224595062434673
shown O 0 0.017524639144539833
that O 0 0.008239541202783585
it O 0 0.008248528465628624
contains O 0 0.014119718223810196
two O 0 0.01449778862297535
mutations O 0 0.07444674521684647
that O 0 0.013216644525527954
result O 0 0.028716731816530228
in O 0 0.022433428093791008
amino O 0 0.08036673814058304
acid O 0 0.13675810396671295
substitutions O 0 0.10932313650846481
- O 0 0.12600073218345642
cDNA O 0 0.1871275156736374
nucleotides O 0 0.15552717447280884
845 O 1 0.9533596634864807
G O 1 0.9266660213470459
- O 0 0.4518052339553833
- O 0 0.1605158895254135
> O 0 0.15097308158874512
A O 0 0.04617230221629143
( O 0 0.044575732201337814
C282Y O 0 0.10787443816661835
) O 0 0.03062085062265396
and O 0 0.02048199065029621
187 O 0 0.08751612156629562
C O 0 0.18531303107738495
- O 1 0.5404394268989563
- O 1 0.5893072485923767
> O 1 0.8203851580619812
G O 0 0.46316957473754883
( O 0 0.07414300739765167
H63D O 1 0.7559906244277954
) O 0 0.04900719225406647
. O 0 0.04435231536626816

Although O 0 0.0816168487071991
hemochromatosis B-Disease 1 0.9998279809951782
is O 0 0.02941487915813923
common O 0 0.029816467314958572
in O 0 0.022586243227124214
Caucasians O 1 0.6217573285102844
, O 0 0.032017339020967484
affecting O 0 0.11334734410047531
> O 1 0.7678185701370239
= O 0 0.12858957052230835
1 O 0 0.041765060275793076
/ O 0 0.09446055442094803
300 O 0 0.032141681760549545
individuals O 0 0.021354129537940025
of O 0 0.01282281894236803
northern O 0 0.026743952184915543
European O 0 0.02279994823038578
origin O 0 0.01961868815124035
, O 0 0.01154202502220869
it O 0 0.0087876683101058
has O 0 0.009807787835597992
not O 0 0.007654927205294371
been O 0 0.008982083760201931
recognized O 0 0.016364866867661476
in O 0 0.012097729369997978
other O 0 0.015531818382441998
populations O 0 0.07170572876930237
. O 0 0.0480675995349884

The O 0 0.029692860320210457
present O 0 0.028864296153187752
study O 0 0.03348095342516899
used O 0 0.02676939032971859
PCR O 0 0.1119716614484787
and O 0 0.021671850234270096
restriction O 0 0.06038620322942734
- O 0 0.08107533305883408
enzyme O 0 0.10294998437166214
digestion O 0 0.11160437017679214
to O 0 0.01809184066951275
analyze O 0 0.0370296835899353
the O 0 0.016684196889400482
frequency O 0 0.03448440507054329
of O 0 0.014983003959059715
the O 0 0.023966073989868164
845 O 1 0.8794935941696167
G O 1 0.7239000201225281
- O 0 0.19620735943317413
- O 0 0.11574500799179077
> O 0 0.11683041602373123
A O 0 0.032427601516246796
and O 0 0.024454232305288315
187 O 0 0.09512681514024734
C O 0 0.3057134449481964
- O 1 0.7360639572143555
- O 1 0.6621640920639038
> O 1 0.8155421018600464
G O 0 0.4217471182346344
mutations O 0 0.17047154903411865
in O 0 0.0419856496155262
HLA O 1 0.994102418422699
- O 0 0.08960827440023422
typed O 0 0.07078810781240463
samples O 0 0.05219594016671181
from O 0 0.029560893774032593
non O 0 0.05345382168889046
- O 0 0.10066520422697067
Caucasian O 1 0.5115507245063782
populations O 0 0.07539052516222
, O 0 0.02183884009718895
comprising O 0 0.03193936124444008
Australian O 0 0.03760983422398567
Aboriginal O 0 0.04830171540379524
, O 0 0.017845746129751205
Chinese O 0 0.018836768344044685
, O 0 0.014574372209608555
and O 0 0.018011780455708504
Pacific O 0 0.05842573195695877
Islanders O 0 0.1133846566081047
. O 0 0.04619460180401802

Results O 0 0.06059898063540459
showed O 0 0.03802455961704254
that O 0 0.014968344941735268
the O 0 0.022825226187705994
845 O 1 0.9757924675941467
G O 1 0.9823238849639893
- O 1 0.7874826192855835
- O 0 0.3119235336780548
> O 0 0.21078233420848846
A O 0 0.03777030110359192
mutation O 0 0.0987153872847557
was O 0 0.01772715523838997
present O 0 0.01815379038453102
in O 0 0.013510853052139282
these O 0 0.015309273265302181
populations O 0 0.054006997495889664
( O 0 0.04506518691778183
allele O 0 0.12135870009660721
frequency O 0 0.06165674328804016
0 O 0 0.04230925068259239
. O 0 0.015472432598471642
32 O 0 0.029768990352749825
% O 0 0.02353966236114502
) O 0 0.01641194149851799
, O 0 0.008308490738272667
and O 0 0.008376444689929485
, O 0 0.010087357833981514
furthermore O 0 0.019600287079811096
, O 0 0.010404160246253014
it O 0 0.008118884637951851
was O 0 0.011829022318124771
always O 0 0.017301199957728386
seen O 0 0.018640972673892975
in O 0 0.014234937727451324
conjunction O 0 0.04544377699494362
with O 0 0.02980092167854309
HLA O 1 0.999064028263092
haplotypes O 1 0.7900306582450867
common O 0 0.04264356195926666
in O 0 0.02453324757516384
Caucasians O 0 0.14817999303340912
, O 0 0.02558841183781624
suggesting O 0 0.05475306883454323
that O 0 0.02467370592057705
845 O 1 0.9836385250091553
G O 1 0.9883314967155457
- O 1 0.7557886838912964
- O 0 0.1810891479253769
> O 0 0.11875806003808975
A O 0 0.024811793118715286
may O 0 0.01939338818192482
have O 0 0.011088995262980461
been O 0 0.010095736011862755
introduced O 0 0.015662487596273422
into O 0 0.01508696936070919
these O 0 0.014549287967383862
populations O 0 0.0504765622317791
by O 0 0.034028880298137665
Caucasian O 1 0.7378690838813782
admixture O 1 0.9126863479614258
. O 0 0.06864222139120102

187 O 0 0.19164355099201202
C O 0 0.46599841117858887
- O 1 0.6183114051818848
- O 0 0.3377785086631775
> O 0 0.24132321774959564
G O 0 0.10029247403144836
was O 0 0.019630303606390953
present O 0 0.01953268237411976
at O 0 0.02156537026166916
an O 0 0.019301265478134155
allele O 0 0.09753063321113586
frequency O 0 0.0522940456867218
of O 0 0.02090868540108204
2 O 0 0.03935205191373825
. O 0 0.036324985325336456

68 O 0 0.09247460216283798
% O 0 0.03444572165608406
in O 0 0.013890557922422886
the O 0 0.013018443249166012
two O 0 0.01775253191590309
populations O 0 0.05189480632543564
analyzed O 0 0.04595479369163513
( O 0 0.029390906915068626
Australian O 0 0.03378136456012726
Aboriginal O 0 0.04480276256799698
and O 0 0.017904771491885185
Chinese O 0 0.03096807561814785
) O 0 0.038123007863759995
. O 0 0.04331709444522858

In O 0 0.025948917493224144
the O 0 0.01912287250161171
Australian O 0 0.04049709439277649
Aboriginal O 0 0.05921120569109917
samples O 0 0.05532484129071236
, O 0 0.030163463205099106
187 O 0 0.09509056806564331
C O 0 0.3187609612941742
- O 1 0.5799481868743896
- O 0 0.32908791303634644
> O 0 0.2839730978012085
G O 0 0.08593780547380447
was O 0 0.015837911516427994
found O 0 0.013530150055885315
to O 0 0.010380429215729237
be O 0 0.011364227160811424
associated O 0 0.02478121966123581
with O 0 0.029247494414448738
HLA O 1 0.9990198612213135
haplotypes O 1 0.9132668375968933
common O 0 0.04542071372270584
in O 0 0.023380033671855927
Caucasians O 0 0.3451213836669922
, O 0 0.020765960216522217
suggesting O 0 0.034375324845314026
that O 0 0.010195811279118061
it O 0 0.009321581572294235
was O 0 0.012023789808154106
introduced O 0 0.021490251645445824
by O 0 0.01808488555252552
recent O 0 0.04577837511897087
admixture O 0 0.27366122603416443
. O 0 0.058514442294836044

In O 0 0.02274920418858528
the O 0 0.017814714461565018
Chinese O 0 0.02310270443558693
samples O 0 0.03910936042666435
analyzed O 0 0.04459574818611145
, O 0 0.023137960582971573
187 O 0 0.07464154809713364
C O 0 0.2190820574760437
- O 0 0.4829085171222687
- O 0 0.35873085260391235
> O 0 0.33213791251182556
G O 0 0.09227219969034195
was O 0 0.018257997930049896
present O 0 0.01767531968653202
in O 0 0.012014876119792461
association O 0 0.025183536112308502
with O 0 0.012107932940125465
a O 0 0.01646903157234192
wide O 0 0.027364620938897133
variety O 0 0.02859080582857132
of O 0 0.026154058054089546
HLA O 1 0.9983416795730591
haplotypes O 1 0.8810291290283203
, O 0 0.026252679526805878
showing O 0 0.03431092947721481
this O 0 0.016027020290493965
mutation O 0 0.0756080374121666
to O 0 0.012425528839230537
be O 0 0.009783875197172165
widespread O 0 0.025124192237854004
and O 0 0.010630440898239613
likely O 0 0.02299102209508419
to O 0 0.01323656551539898
predate O 0 0.053724516183137894
the O 0 0.013602345250546932
more O 0 0.017123498022556305
genetically O 0 0.059613414108753204
restricted O 0 0.06762586534023285
845 O 1 0.9861389994621277
G O 1 0.9835200905799866
- O 1 0.8617169857025146
- O 0 0.4846275746822357
> O 0 0.40693485736846924
A O 0 0.06463304162025452
mutation O 0 0.19830046594142914
. O 0 0.053482428193092346

Genotype O 1 0.981502890586853
- O 1 0.9172321557998657
phenotype O 1 0.9663842916488647
correlations O 0 0.28403088450431824
in O 0 0.08635362982749939
attenuated B-Disease 1 0.9995682835578918
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999984502792358
coli I-Disease 1 0.9998993873596191
. O 0 0.12069608271121979

Germ O 1 0.9943898320198059
- O 0 0.15472379326820374
line O 0 0.06402952969074249
mutations O 0 0.11934245377779007
of O 0 0.02869556099176407
the O 0 0.044702671468257904
tumor B-Disease 1 0.9991990923881531
suppressor O 1 0.9849485754966736
APC O 1 0.8283196091651917
are O 0 0.0350009985268116
implicated O 1 0.5135877728462219
in O 0 0.06388860195875168
attenuated B-Disease 1 0.9998635053634644
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999915361404419
( O 1 0.7935323119163513
AAPC B-Disease 1 0.9998912811279297
) O 0 0.04050206393003464
, O 0 0.02088610641658306
a O 0 0.028493739664554596
variant O 0 0.13710807263851166
of O 0 0.052267760038375854
familial B-Disease 1 0.9999977350234985
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999997615814209
( O 1 0.977547287940979
FAP B-Disease 1 0.9998855590820312
) O 0 0.07573792338371277
. O 0 0.056081537157297134

AAPC B-Disease 1 0.9953423738479614
is O 0 0.03808015212416649
recognized O 0 0.034266021102666855
by O 0 0.018083347007632256
the O 0 0.021059658378362656
occurrence O 0 0.08184739947319031
of O 0 0.028940921649336815
< O 1 0.5562175512313843
100 O 0 0.06761021912097931
colonic B-Disease 1 0.9957799911499023
adenomas I-Disease 1 0.9980664849281311
and O 0 0.023139534518122673
a O 0 0.030315769836306572
later O 0 0.03714749589562416
onset O 1 0.9998989105224609
of O 0 0.13910046219825745
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
( O 0 0.09223216772079468
age O 0 0.05640444532036781
> O 0 0.1680099219083786
40 O 0 0.03595636785030365
years O 0 0.02961151674389839
) O 0 0.037820469588041306
. O 0 0.03516167402267456

The O 0 0.02907348982989788
aim O 0 0.04002318158745766
of O 0 0.013220668770372868
this O 0 0.01249511819332838
study O 0 0.023249920457601547
was O 0 0.01620027981698513
to O 0 0.02090708538889885
assess O 0 0.09408783912658691
genotype O 1 0.9495934844017029
- O 0 0.4939759075641632
phenotype O 1 0.9101464748382568
correlations O 0 0.14827197790145874
in O 0 0.04987876117229462
AAPC B-Disease 1 0.9991796612739563
families O 0 0.0894310250878334
. O 0 0.0629640743136406

By O 0 0.05408034846186638
protein O 0 0.10618311166763306
- O 0 0.11572059988975525
truncation O 0 0.15458953380584717
test O 0 0.07537388056516647
( O 0 0.053828828036785126
PTT O 0 0.10799077153205872
) O 0 0.03352566063404083
assay O 0 0.0645190104842186
, O 0 0.012984214350581169
the O 0 0.012376928701996803
entire O 0 0.028433160856366158
coding O 0 0.07294794917106628
region O 0 0.03503885492682457
of O 0 0.015730736777186394
the O 0 0.023110397160053253
APC B-Disease 0 0.32225921750068665
gene O 0 0.08649750053882599
was O 0 0.02298532985150814
screened O 0 0.05263156443834305
in O 0 0.018571197986602783
affected O 0 0.04440764710307121
individuals O 0 0.032012939453125
from O 0 0.02530156634747982
11 O 0 0.056051433086395264
AAPC B-Disease 1 0.9998519420623779
kindreds O 1 0.8735928535461426
, O 0 0.021571438759565353
and O 0 0.013615965843200684
their O 0 0.014875921420753002
phenotypic O 0 0.0704793632030487
differences O 0 0.04007415100932121
were O 0 0.02214876562356949
examined O 0 0.07805846631526947
. O 0 0.0453936830163002

Five O 0 0.059861067682504654
novel O 0 0.08301311731338501
germ O 1 0.9901919364929199
- O 0 0.18966849148273468
line O 0 0.07468097656965256
APC B-Disease 1 0.9075085520744324
mutations O 0 0.13409751653671265
were O 0 0.020764034241437912
identified O 0 0.03133626654744148
in O 0 0.02177789993584156
seven O 0 0.04168727248907089
kindreds O 1 0.6080148816108704
. O 0 0.05575760826468468

Mutations O 0 0.1427926868200302
were O 0 0.01995059661567211
located O 0 0.01982750929892063
in O 0 0.009363667108118534
three O 0 0.008300033397972584
different O 0 0.009088815189898014
regions O 0 0.0226880069822073
of O 0 0.012500266544520855
the O 0 0.022390468046069145
APC B-Disease 1 0.5825632810592651
gene O 0 0.09872979670763016
( O 0 0.034783605486154556
1 O 0 0.025141842663288116
) O 0 0.018320856615900993
at O 0 0.013170716352760792
the O 0 0.012318717315793037
5 O 0 0.026732970029115677
end O 0 0.026524823158979416
spanning O 0 0.04902800917625427
exons O 0 0.08365385234355927
4 O 0 0.02926945686340332
and O 0 0.016285283491015434
5 O 0 0.027194790542125702
, O 0 0.015071749687194824
( O 0 0.02315622568130493
2 O 0 0.02466338686645031
) O 0 0.022516116499900818
within O 0 0.02107936516404152
exon O 0 0.07969383150339127
9 O 0 0.0301531869918108
, O 0 0.014636430889368057
and O 0 0.012344736605882645
( O 0 0.024708613753318787
3 O 0 0.022280720993876457
) O 0 0.016156593337655067
at O 0 0.014789090491831303
the O 0 0.015282210893929005
3 O 0 0.03306727856397629
distal O 0 0.24979998171329498
end O 0 0.026959922164678574
of O 0 0.014227387495338917
the O 0 0.024253161624073982
gene O 0 0.09848087280988693
. O 0 0.05108620598912239

Variability O 0 0.1368716061115265
in O 0 0.021010905504226685
the O 0 0.016855664551258087
number O 0 0.02137310430407524
of O 0 0.030003128573298454
colorectal B-Disease 1 0.9999990463256836
adenomas I-Disease 1 0.9999681711196899
was O 0 0.02743351273238659
most O 0 0.016901975497603416
apparent O 0 0.043513111770153046
in O 0 0.014496984891593456
individuals O 0 0.02439057268202305
with O 0 0.020065991207957268
mutations O 0 0.08295010775327682
in O 0 0.01920207403600216
region O 0 0.034101810306310654
1 O 0 0.02417627163231373
, O 0 0.015420902520418167
and O 0 0.017819387838244438
upper O 1 0.91336590051651
- O 1 0.996560275554657
gastrointestinal O 1 0.9999698400497437
manifestations O 1 0.8094556927680969
were O 0 0.01763151027262211
more O 0 0.017378123477101326
severe O 1 0.7488588690757751
in O 0 0.01653914712369442
them O 0 0.01997114159166813
. O 0 0.035749029368162155

In O 0 0.033666759729385376
individuals O 0 0.035660237073898315
with O 0 0.025287272408604622
mutations O 0 0.08801799267530441
in O 0 0.018025802448391914
either O 0 0.02220991998910904
region O 0 0.03358827531337738
2 O 0 0.02532128617167473
or O 0 0.018025685101747513
region O 0 0.029109736904501915
3 O 0 0.02104884944856167
, O 0 0.010842672549188137
the O 0 0.011487193405628204
average O 0 0.02526329830288887
number O 0 0.01578601263463497
of O 0 0.01816837303340435
adenomas B-Disease 1 0.9959282279014587
tended O 0 0.04593006148934364
to O 0 0.012523037381470203
be O 0 0.009493421763181686
lower O 0 0.020494583994150162
than O 0 0.010264672338962555
those O 0 0.009510745294392109
in O 0 0.010873532854020596
individuals O 0 0.0171872079372406
with O 0 0.015327051281929016
mutations O 0 0.07938620448112488
in O 0 0.015350962057709694
region O 0 0.031111745163798332
1 O 0 0.023745201528072357
, O 0 0.014226577244699001
although O 0 0.019308356568217278
age O 0 0.030775561928749084
at O 0 0.030858393758535385
diagnosis O 1 0.9860252737998962
was O 0 0.026952803134918213
similar O 0 0.03764835372567177
. O 0 0.03896421194076538

In O 0 0.040437910705804825
all O 0 0.03968064859509468
AAPC B-Disease 1 0.9991588592529297
kindreds O 0 0.47882500290870667
, O 0 0.026293935254216194
a O 0 0.02629818581044674
predominance O 0 0.09416714310646057
of O 0 0.020848607644438744
right O 0 0.13080304861068726
- O 1 0.9973505735397339
sided O 1 0.9997531771659851
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.999997615814209
and O 1 0.6347140669822693
rectal B-Disease 1 0.9999935626983643
polyp I-Disease 1 0.9999558925628662
sparing O 1 0.9263002276420593
was O 0 0.04399038851261139
observed O 0 0.06937870383262634
. O 0 0.040727753192186356

No O 0 0.07979093492031097
desmoid B-Disease 1 0.9883652925491333
tumors I-Disease 1 0.9992857575416565
were O 0 0.022087005898356438
found O 0 0.022139009088277817
in O 0 0.016211669892072678
these O 0 0.02154858410358429
kindreds O 0 0.41320136189460754
. O 0 0.05341431125998497

Our O 0 0.03997672349214554
data O 0 0.026333196088671684
suggest O 0 0.030716080218553543
that O 0 0.012766937725245953
, O 0 0.014080033637583256
in O 0 0.02103264443576336
AAPC B-Disease 1 0.9992644190788269
families O 0 0.03203698992729187
, O 0 0.012945734895765781
the O 0 0.011140850372612476
location O 0 0.017578495666384697
of O 0 0.012095211073756218
the O 0 0.02483782172203064
APC B-Disease 1 0.9551125168800354
mutation O 1 0.7142359018325806
may O 0 0.05064449459314346
partially O 0 0.08186384290456772
predict O 0 0.07000194489955902
specific O 0 0.038299545645713806
phenotypic O 0 0.11043071746826172
expression O 0 0.08424309641122818
. O 0 0.05229109898209572

This O 0 0.02430415153503418
should O 0 0.01831645704805851
help O 0 0.021482352167367935
in O 0 0.00972921121865511
the O 0 0.00948556512594223
design O 0 0.02066071704030037
of O 0 0.015424905344843864
tailored O 0 0.09017808735370636
clinical O 1 0.9675368070602417
- O 0 0.09780813753604889
management O 0 0.05433650687336922
protocols O 0 0.041152436286211014
in O 0 0.014925084076821804
this O 0 0.014132595621049404
subset O 0 0.06366880238056183
of O 0 0.03672748804092407
FAP B-Disease 1 0.9999215602874756
patients O 1 0.9989339709281921
. O 0 0.03816166892647743
. O 0 0.04646503925323486

Wilms B-Disease 1 0.999697208404541
' I-Disease 1 0.756260871887207
tumor I-Disease 1 0.9940248131752014
1 O 0 0.04480494558811188
and O 0 0.028491750359535217
Dax O 1 0.6207507848739624
- O 0 0.08700727671384811
1 O 0 0.04701395332813263
modulate O 0 0.13089671730995178
the O 0 0.0363970547914505
orphan O 1 0.9097781777381897
nuclear O 0 0.10154864192008972
receptor O 1 0.6763706207275391
SF O 1 0.9873294830322266
- O 0 0.08260189741849899
1 O 0 0.03231494501233101
in O 0 0.019943969324231148
sex O 0 0.05396924167871475
- O 0 0.07727958261966705
specific O 0 0.04359065741300583
gene O 0 0.1106024980545044
expression O 0 0.0756521001458168
. O 0 0.045619141310453415

Products O 0 0.0696568489074707
of O 0 0.043946702033281326
steroidogenic O 1 0.9850155115127563
factor O 0 0.11446775496006012
1 O 0 0.05721394345164299
( O 0 0.06013274937868118
SF O 1 0.9911218881607056
- O 0 0.10036027431488037
1 O 0 0.044528596103191376
) O 0 0.03645574301481247
and O 0 0.035429056733846664
Wilms B-Disease 1 0.9998723268508911
tumor I-Disease 1 0.9985626339912415
1 O 0 0.061884813010692596
( O 0 0.059179868549108505
WT1 O 1 0.9771078824996948
) O 0 0.036711446940898895
genes O 0 0.053290966898202896
are O 0 0.014627568423748016
essential O 0 0.026061544194817543
for O 0 0.018165957182645798
mammalian O 0 0.10239563137292862
gonadogenesis O 0 0.12045112997293472
prior O 0 0.02943241037428379
to O 0 0.01963864266872406
sexual O 0 0.054468750953674316
differentiation O 0 0.11157062649726868
. O 0 0.05298633873462677

In O 0 0.04779721051454544
males O 0 0.09104982763528824
, O 0 0.045090481638908386
SF O 1 0.991298496723175
- O 0 0.08602531254291534
1 O 0 0.0389598049223423
participates O 0 0.05897246673703194
in O 0 0.02043190784752369
sexual O 0 0.03627688065171242
development O 0 0.026000721380114555
by O 0 0.01792450249195099
regulating O 0 0.056497201323509216
expression O 0 0.03940439969301224
of O 0 0.018624616786837578
the O 0 0.03364110365509987
polypeptide O 1 0.5724018216133118
hormone O 1 0.9971946477890015
Mullerian O 1 0.9989620447158813
inhibiting O 1 0.986417293548584
substance O 1 0.9542485475540161
( O 0 0.09250631928443909
MIS O 1 0.9913008809089661
) O 0 0.05627875402569771
. O 0 0.04189429432153702

Here O 0 0.03506650775671005
, O 0 0.022888649255037308
we O 0 0.017481770366430283
show O 0 0.030822675675153732
that O 0 0.029473675414919853
WT1 O 1 0.9952268600463867
- O 0 0.430083692073822
KTS O 1 0.9810633659362793
isoforms O 0 0.11723338812589645
associate O 0 0.06304220855236053
and O 0 0.028430065140128136
synergize O 1 0.6776900291442871
with O 0 0.045935679227113724
SF O 1 0.9926859140396118
- O 0 0.08314365148544312
1 O 0 0.03506913781166077
to O 0 0.022653788328170776
promote O 0 0.05767456814646721
MIS O 1 0.8261871933937073
expression O 0 0.0962965115904808
. O 0 0.0542813315987587

In O 0 0.04885152727365494
contrast O 0 0.08036832511425018
, O 0 0.057531096041202545
WT1 O 1 0.9942396879196167
missense O 1 0.8888566493988037
mutations O 0 0.20420661568641663
, O 0 0.029787447303533554
associated O 0 0.03378469496965408
with O 0 0.023738248273730278
male B-Disease 0 0.0720956102013588
pseudohermaphroditism I-Disease 1 0.9945294260978699
in O 0 0.0420185886323452
Denys B-Disease 1 0.999745786190033
- I-Disease 1 0.9988073110580444
Drash I-Disease 1 0.9998388290405273
syndrome I-Disease 1 0.9999980926513672
, O 0 0.03570811450481415
fail O 0 0.08067034184932709
to O 0 0.027227014303207397
synergize O 1 0.8911303877830505
with O 0 0.04402496665716171
SF O 1 0.9959278702735901
- O 0 0.10958325117826462
1 O 0 0.05481265112757683
. O 0 0.04545941576361656

Additionally O 0 0.069793701171875
, O 0 0.024434227496385574
the O 0 0.02155965566635132
X O 0 0.09070321172475815
- O 0 0.08094153553247452
linked O 0 0.06163307651877403
, O 0 0.02155597135424614
candidate O 0 0.042171526700258255
dosage O 1 0.9317826628684998
- O 0 0.11626153439283371
sensitive O 0 0.06174929440021515
sex O 0 0.07530300319194794
- O 0 0.28103554248809814
reversal O 0 0.29252684116363525
gene O 0 0.10319633781909943
, O 0 0.03440557047724724
Dax O 1 0.746810257434845
- O 0 0.08653491735458374
1 O 0 0.04106537252664566
, O 0 0.030771778896450996
antagonizes O 1 0.808588445186615
synergy O 0 0.2801952362060547
between O 0 0.054350513964891434
SF O 1 0.994956910610199
- O 0 0.09506857395172119
1 O 0 0.04189101979136467
and O 0 0.024933699518442154
WT1 O 1 0.9321572780609131
, O 0 0.019112080335617065
most O 0 0.012604006566107273
likely O 0 0.025287549942731857
through O 0 0.01752896048128605
a O 0 0.01741449348628521
direct O 0 0.031212765723466873
interaction O 0 0.0423441082239151
with O 0 0.03062714822590351
SF O 1 0.992352306842804
- O 0 0.1044042631983757
1 O 0 0.0566968135535717
. O 0 0.042934682220220566

We O 0 0.04480641335248947
propose O 0 0.08038762956857681
that O 0 0.03187823295593262
WT1 O 1 0.9794365763664246
and O 0 0.03177044913172722
Dax O 1 0.5294759273529053
- O 0 0.07795993238687515
1 O 0 0.040733933448791504
functionally O 0 0.08095607161521912
oppose O 0 0.04215897619724274
each O 0 0.014684931375086308
other O 0 0.012468809261918068
in O 0 0.020589208230376244
testis O 0 0.20720872282981873
development O 0 0.04042776674032211
by O 0 0.03247341886162758
modulating O 1 0.9299054145812988
SF O 1 0.9967712759971619
- O 0 0.1526864469051361
1 O 0 0.05805224925279617
- O 0 0.11982998996973038
mediated O 0 0.2920350432395935
transactivation O 1 0.8206455111503601
. O 0 0.03897315636277199
. O 0 0.04844820499420166

A O 0 0.08376561850309372
mouse O 0 0.1458055078983307
model O 0 0.07260459661483765
for O 0 0.05544528365135193
Prader B-Disease 1 0.999997615814209
- I-Disease 1 0.9998899698257446
Willi I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999996423721313
imprinting O 1 0.9963891506195068
- O 1 0.8461905717849731
centre O 0 0.11205732077360153
mutations O 0 0.34235242009162903
. O 0 0.06085487827658653

Imprinting O 0 0.23107010126113892
in O 0 0.03578832373023033
the O 0 0.030611056834459305
15q11 O 0 0.29031166434288025
- O 0 0.11031694710254669
q13 O 0 0.15391100943088531
region O 0 0.06680405884981155
involves O 0 0.06326751410961151
an O 0 0.03025738336145878
imprinting O 0 0.31569400429725647
centre O 0 0.06938717514276505
( O 0 0.049279894679784775
IC O 1 0.711928129196167
) O 0 0.026614101603627205
, O 0 0.012628450058400631
mapping O 0 0.02971513196825981
in O 0 0.010446170344948769
part O 0 0.012625268660485744
to O 0 0.010311268270015717
the O 0 0.012668199837207794
promoter O 0 0.058917753398418427
and O 0 0.016285497695207596
first O 0 0.020836444571614265
exon O 0 0.10009106993675232
of O 0 0.032033149152994156
SNRPN O 1 0.6997097730636597
. O 0 0.06419318914413452

Deletion O 0 0.20476384460926056
of O 0 0.03668148070573807
this O 0 0.03935050591826439
IC O 1 0.5398954153060913
abolishes O 0 0.19797398149967194
local O 0 0.04957857355475426
paternally O 0 0.15919414162635803
derived O 0 0.06376644223928452
gene O 0 0.08928755670785904
expression O 0 0.049481574445962906
and O 0 0.019107164815068245
results O 0 0.046782780438661575
in O 0 0.05259709060192108
Prader B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999748468399048
Willi I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9398560523986816
PWS B-Disease 1 0.9999563694000244
) O 0 0.07399198412895203
. O 0 0.04921199381351471

We O 0 0.0298739206045866
have O 0 0.019724613055586815
created O 0 0.033281613141298294
two O 0 0.026420896872878075
deletion O 0 0.1575765162706375
mutations O 0 0.14392751455307007
in O 0 0.03069145791232586
mice O 0 0.12782125174999237
to O 0 0.026089487597346306
understand O 0 0.05307980999350548
PWS B-Disease 1 0.9997110962867737
and O 0 0.016880106180906296
the O 0 0.018549654632806778
mechanism O 0 0.04796178638935089
of O 0 0.016452210023999214
this O 0 0.023789057508111
IC O 1 0.6625375747680664
. O 0 0.045492708683013916

Mice O 1 0.8438377380371094
harbouring O 1 0.8265920877456665
an O 0 0.051045339554548264
intragenic O 1 0.6546384692192078
deletion O 0 0.1527772694826126
in O 0 0.035103604197502136
Snrpn O 0 0.19648700952529907
are O 0 0.02684035897254944
phenotypically O 0 0.13492606580257416
normal O 0 0.04884706810116768
, O 0 0.01917186751961708
suggesting O 0 0.03706750273704529
that O 0 0.017614206299185753
mutations O 0 0.0887661799788475
of O 0 0.019071239978075027
SNRPN O 0 0.18289422988891602
are O 0 0.01438098307698965
not O 0 0.014951173216104507
sufficient O 0 0.03804426267743111
to O 0 0.03688796982169151
induce O 1 0.9267607927322388
PWS B-Disease 1 0.9997941851615906
. O 0 0.07192207127809525

Mice O 0 0.16904261708259583
with O 0 0.03340129926800728
a O 0 0.03311145305633545
larger O 0 0.04377113655209541
deletion O 0 0.11971555650234222
involving O 0 0.047486335039138794
both O 0 0.02325667440891266
Snrpn O 0 0.16118566691875458
and O 0 0.02202499471604824
the O 0 0.034347958862781525
putative O 1 0.9851527214050293
PWS O 1 0.9999940395355225
- O 1 0.9620617628097534
IC O 1 0.9650619626045227
lack O 0 0.04766565188765526
expression O 0 0.03809310868382454
of O 0 0.015056462027132511
the O 0 0.02210197038948536
imprinted O 0 0.13568489253520966
genes O 0 0.11552413552999496
Zfp127 O 0 0.46998628973960876
( O 0 0.057313378900289536
mouse O 0 0.12934359908103943
homologue O 0 0.158667653799057
of O 0 0.03506326302886009
ZNF127 O 1 0.7512280941009521
) O 0 0.04083307087421417
, O 0 0.02935539372265339
Ndn O 1 0.9565941095352173
and O 0 0.02887209691107273
Ipw O 0 0.12361099570989609
, O 0 0.01846582442522049
and O 0 0.015137429349124432
manifest O 0 0.04940551519393921
several O 0 0.024213658645749092
phenotypes O 0 0.25267523527145386
common O 0 0.058807872235774994
to O 0 0.05156877636909485
PWS B-Disease 1 0.999981164932251
infants O 1 0.9928287863731384
. O 0 0.060563355684280396

These O 0 0.023875100538134575
data O 0 0.024312753230333328
demonstrate O 0 0.028287887573242188
that O 0 0.008138831704854965
both O 0 0.008356228470802307
the O 0 0.008205583319067955
position O 0 0.011205481365323067
of O 0 0.007868549786508083
the O 0 0.01386643759906292
IC O 0 0.0993657261133194
and O 0 0.011156520806252956
its O 0 0.009480607695877552
role O 0 0.016364840790629387
in O 0 0.010142171755433083
the O 0 0.012430683709681034
coordinate O 0 0.04658309370279312
expression O 0 0.03405005484819412
of O 0 0.013214798644185066
genes O 0 0.04619385674595833
is O 0 0.016020186245441437
conserved O 0 0.03347911685705185
between O 0 0.019101811572909355
mouse O 0 0.06027765944600105
and O 0 0.012950464151799679
human O 0 0.01840764842927456
, O 0 0.010877813212573528
and O 0 0.009329264052212238
indicate O 0 0.0199957937002182
that O 0 0.007577384356409311
the O 0 0.01241288986057043
mouse O 0 0.058221232146024704
is O 0 0.01435669232159853
a O 0 0.01287022139877081
suitable O 0 0.023518823087215424
model O 0 0.024505464360117912
system O 0 0.020614363253116608
in O 0 0.009771331213414669
which O 0 0.008770523592829704
to O 0 0.00873046275228262
investigate O 0 0.02841934561729431
the O 0 0.015646658837795258
molecular O 0 0.047445137053728104
mechanisms O 0 0.045217547565698624
of O 0 0.01489601843059063
imprinting O 0 0.10039936751127243
in O 0 0.014071867801249027
this O 0 0.011468573473393917
region O 0 0.0246011670678854
of O 0 0.010663391090929508
the O 0 0.018040573224425316
genome O 0 0.07195236533880234
. O 0 0.028376994654536247
. O 0 0.038504816591739655

Mutations O 0 0.1615597903728485
of O 0 0.026488671079277992
the O 0 0.031137801706790924
ATM O 0 0.13781514763832092
gene O 0 0.11685167253017426
detected O 0 0.09156198799610138
in O 0 0.029901599511504173
Japanese O 1 0.6425710320472717
ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.9998341798782349
telangiectasia I-Disease 1 0.9999916553497314
patients O 1 0.9997871518135071
: O 0 0.03814456984400749
possible O 0 0.03122860938310623
preponderance O 0 0.07363994419574738
of O 0 0.011673870496451855
the O 0 0.013800691813230515
two O 0 0.02176915667951107
founder O 0 0.07554610818624496
mutations O 0 0.17677775025367737
4612del165 O 0 0.16918343305587769
and O 0 0.04026385024189949
7883del5 O 0 0.17332607507705688
. O 0 0.058510079979896545

The O 0 0.052651211619377136
ATM O 0 0.16600683331489563
( O 0 0.05754958093166351
A O 0 0.061483584344387054
- O 1 0.8217662572860718
T O 1 0.9946331977844238
, O 0 0.03589028865098953
mutated O 0 0.13019412755966187
) O 0 0.042238395661115646
gene O 0 0.07220123708248138
on O 0 0.020401358604431152
human O 0 0.04951448366045952
chromosome O 0 0.1806982457637787
11q22 O 0 0.18618595600128174
. O 0 0.058630820363759995

3 O 0 0.05445163697004318
has O 0 0.02258937992155552
recently O 0 0.026873966678977013
been O 0 0.01402980275452137
identified O 0 0.01998661831021309
as O 0 0.00908766407519579
the O 0 0.0116596519947052
gene O 0 0.051380421966314316
responsible O 0 0.02653508633375168
for O 0 0.012913505546748638
the O 0 0.020326046273112297
human O 0 0.16881167888641357
recessive B-Disease 1 0.9999926090240479
disease I-Disease 1 0.9999998807907104
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9996899366378784
telangiectasia I-Disease 1 0.999961256980896
( O 0 0.1567065268754959
A B-Disease 0 0.14388278126716614
- I-Disease 1 0.9655148983001709
T I-Disease 1 0.9965051412582397
) O 0 0.047933246940374374
. O 0 0.040944699198007584

In O 0 0.02450725995004177
order O 0 0.02130316197872162
to O 0 0.017165731638669968
define O 0 0.032125115394592285
the O 0 0.018170490860939026
types O 0 0.03795282915234566
of O 0 0.028797078877687454
disease O 1 0.9999749660491943
- O 1 0.941115140914917
causing O 1 0.8037955164909363
ATM O 0 0.4251765012741089
mutations O 0 0.12705029547214508
in O 0 0.02224770188331604
Japanese O 0 0.04281948506832123
A B-Disease 0 0.07232559472322464
- I-Disease 1 0.9910712242126465
T I-Disease 1 0.9997521042823792
patients O 1 0.9900035262107849
as O 0 0.012700637802481651
well O 0 0.010458017699420452
as O 0 0.008546414785087109
to O 0 0.011024384759366512
look O 0 0.021967343986034393
for O 0 0.015702353790402412
possible O 0 0.045546676963567734
mutational O 1 0.9319403171539307
hotspots O 0 0.18687981367111206
, O 0 0.03117731213569641
reverse O 0 0.08272792398929596
- O 0 0.09278959780931473
transcribed O 0 0.08964373171329498
RNA O 0 0.08892983198165894
derived O 0 0.04266069456934929
from O 0 0.020861390978097916
ten O 0 0.02988477237522602
patients O 0 0.46388715505599976
belonging O 0 0.03407464548945427
to O 0 0.01596200466156006
eight O 0 0.023749880492687225
unrelated O 0 0.05350395664572716
Japanese O 0 0.04213905707001686
A B-Disease 0 0.05876832827925682
- I-Disease 1 0.7169014811515808
T I-Disease 1 0.9933053851127625
families O 0 0.042237162590026855
was O 0 0.020843468606472015
analyzed O 0 0.03954966366291046
for O 0 0.017893489450216293
mutations O 0 0.08028856664896011
by O 0 0.017684495076537132
the O 0 0.024296261370182037
restriction O 0 0.07976354658603668
endonuclease O 1 0.5399301052093506
fingerprinting O 0 0.13212832808494568
method O 0 0.06954322010278702
. O 0 0.04660957306623459

As O 0 0.028752755373716354
has O 0 0.02237880416214466
been O 0 0.01640225201845169
reported O 0 0.027154622599482536
by O 0 0.01541855651885271
others O 0 0.021578244864940643
, O 0 0.017640341073274612
mutations O 0 0.0760849341750145
that O 0 0.016489017754793167
lead O 0 0.03345739096403122
to O 0 0.022587325423955917
exon O 0 0.11693191528320312
skipping O 0 0.11509193480014801
or O 0 0.052002131938934326
premature O 1 0.5854861736297607
protein O 0 0.08522145450115204
truncation O 0 0.10081013292074203
were O 0 0.018023261800408363
also O 0 0.01594359055161476
predominant O 0 0.04581274092197418
in O 0 0.01626250147819519
our O 0 0.030705919489264488
mutants O 0 0.11691117286682129
. O 0 0.050630200654268265

Six O 0 0.050328921526670456
different O 0 0.029866443946957588
mutations O 0 0.09298574924468994
were O 0 0.014651382341980934
identified O 0 0.02194707654416561
on O 0 0.011172214522957802
12 O 0 0.016055431216955185
of O 0 0.010536197572946548
the O 0 0.016902705654501915
16 O 0 0.041289299726486206
alleles O 0 0.16239528357982635
examined O 0 0.09699393063783646
. O 0 0.05232523754239082

Four O 0 0.03561621531844139
were O 0 0.023140233010053635
deletions O 0 0.08462543040513992
involving O 0 0.043112099170684814
a O 0 0.02652832679450512
loss O 0 0.04341355711221695
of O 0 0.015603145584464073
a O 0 0.02266646735370159
single O 0 0.038756582885980606
exon O 0 0.12697573006153107
exon O 0 0.12888534367084503
7 O 0 0.045227449387311935
, O 0 0.024283016100525856
exon O 0 0.10701633244752884
16 O 0 0.039432547986507416
, O 0 0.02700636349618435
exon O 0 0.1173599511384964
33 O 0 0.05907201021909714
or O 0 0.040708549320697784
exon O 0 0.1366288959980011
35 O 0 0.07201192528009415
. O 0 0.050212204456329346

The O 0 0.03170371055603027
others O 0 0.027882428839802742
were O 0 0.017880406230688095
minute O 0 0.0405871719121933
deletions O 0 0.0909636840224266
, O 0 0.02816137857735157
4649delA O 0 0.10082085430622101
in O 0 0.025164542719721794
exon O 0 0.10730649530887604
33 O 0 0.05142790451645851
and O 0 0.02463744953274727
7883del5 O 0 0.10033256560564041
in O 0 0.03303514048457146
exon O 0 0.13355569541454315
55 O 0 0.08313331753015518
. O 0 0.04815954342484474

The O 0 0.06527344882488251
mutations O 0 0.21319548785686493
4612del165 O 0 0.15451094508171082
and O 0 0.025731408968567848
7883del5 O 0 0.08547501266002655
were O 0 0.012867985293269157
found O 0 0.012675304897129536
in O 0 0.00881162565201521
more O 0 0.007712685037404299
than O 0 0.00925371516495943
two O 0 0.01102039311081171
unrelated O 0 0.04557552561163902
families O 0 0.036648742854595184
; O 0 0.02645057439804077
44 O 0 0.036673933267593384
% O 0 0.031076638028025627
( O 0 0.024332817643880844
7 O 0 0.021213186904788017
of O 0 0.011955766938626766
16 O 0 0.021924395114183426
) O 0 0.01790790632367134
of O 0 0.011088264174759388
the O 0 0.01772303692996502
mutant O 0 0.0821295976638794
alleles O 0 0.10562584549188614
had O 0 0.020769432187080383
one O 0 0.011188303120434284
of O 0 0.010050243698060513
the O 0 0.014017288573086262
two O 0 0.02287166938185692
mutations O 0 0.1424054354429245
. O 0 0.053403835743665695

The O 0 0.05578630790114403
4612del165 O 0 0.17972566187381744
mutations O 0 0.09663192182779312
in O 0 0.01531628891825676
three O 0 0.012613137252628803
different O 0 0.010084148496389389
families O 0 0.01890377514064312
were O 0 0.008900146931409836
all O 0 0.008690803311765194
ascribed O 0 0.03936755284667015
to O 0 0.01153347548097372
the O 0 0.013978932052850723
same O 0 0.027650078758597374
T O 1 0.9904098510742188
- O 0 0.3711395263671875
- O 0 0.1245870441198349
> O 0 0.13122038543224335
A O 0 0.037342630326747894
substitution O 0 0.061797838658094406
at O 0 0.024519676342606544
the O 0 0.02239539660513401
splice O 0 0.1370570957660675
donor O 0 0.10753370076417923
site O 0 0.04556220397353172
in O 0 0.0313858687877655
intron O 1 0.5419455766677856
33 O 0 0.09285515546798706
. O 0 0.05537464842200279

Microsatellite O 1 0.5550915598869324
genotyping O 0 0.2178143411874771
around O 0 0.04294430464506149
the O 0 0.03038499318063259
ATM O 0 0.11135643720626831
locus O 0 0.10458847880363464
also O 0 0.020244721323251724
indicated O 0 0.03329258784651756
that O 0 0.012271014973521233
a O 0 0.019262664020061493
common O 0 0.03501663729548454
haplotype O 0 0.2760526239871979
was O 0 0.017330162227153778
shared O 0 0.022081928327679634
by O 0 0.014674157835543156
the O 0 0.019019924104213715
mutant O 0 0.08923300355672836
alleles O 0 0.13115283846855164
in O 0 0.02657221630215645
both O 0 0.03431644290685654
mutations O 0 0.16153953969478607
. O 0 0.049861591309309006

This O 0 0.0314541831612587
suggests O 0 0.03963388502597809
that O 0 0.011645462363958359
these O 0 0.011371150612831116
two O 0 0.017573827877640724
founder O 0 0.05282852426171303
mutations O 0 0.1115548238158226
may O 0 0.0288194939494133
be O 0 0.01372424978762865
predominant O 0 0.052616048604249954
among O 0 0.029679100960493088
Japanese O 0 0.054831746965646744
ATM O 0 0.15256792306900024
mutant O 0 0.1610795557498932
alleles O 0 0.23727498948574066
. O 0 0.06876981258392334

W474C O 0 0.3381696343421936
amino O 0 0.16567762196063995
acid O 0 0.2752096951007843
substitution O 0 0.12851689755916595
affects O 0 0.103168785572052
early O 0 0.027904804795980453
processing O 0 0.0232143085449934
of O 0 0.011302297934889793
the O 0 0.01594952493906021
alpha O 0 0.056453876197338104
- O 0 0.06432441622018814
subunit O 0 0.07583615183830261
of O 0 0.023201756179332733
beta O 0 0.07836402207612991
- O 0 0.07901252061128616
hexosaminidase O 0 0.10677773505449295
A O 0 0.024093490093946457
and O 0 0.015042572282254696
is O 0 0.01792655885219574
associated O 0 0.03175242617726326
with O 0 0.03526301681995392
subacute O 1 0.9998955726623535
G B-Disease 1 0.9475314021110535
( I-Disease 0 0.0627785474061966
M2 I-Disease 0 0.3420131504535675
) I-Disease 0 0.06472647190093994
gangliosidosis I-Disease 0 0.17904895544052124
. O 0 0.053625427186489105

Mutations O 0 0.19411994516849518
in O 0 0.0354992114007473
the O 0 0.04472838714718819
HEXA O 1 0.9788051843643188
gene O 0 0.1033448725938797
, O 0 0.024823466315865517
encoding O 0 0.042812932282686234
the O 0 0.019910968840122223
alpha O 0 0.06648566573858261
- O 0 0.07745105028152466
subunit O 0 0.08477934449911118
of O 0 0.025680696591734886
beta O 0 0.07556590437889099
- O 0 0.08598136156797409
hexosaminidase O 0 0.13210462033748627
A O 0 0.03560411185026169
( O 0 0.038137540221214294
Hex O 0 0.07092300057411194
A O 0 0.025866949930787086
) O 0 0.021751798689365387
, O 0 0.013070834800601006
that O 0 0.014503988437354565
abolish O 0 0.0645001083612442
Hex O 0 0.08631865680217743
A O 0 0.046639520674943924
enzyme O 0 0.2154819816350937
activity O 0 0.4574694335460663
cause O 1 0.9997425675392151
Tay B-Disease 1 0.9999995231628418
- I-Disease 1 0.9998836517333984
Sachs I-Disease 1 0.9999887943267822
disease I-Disease 1 0.9999955892562866
( O 0 0.40387648344039917
TSD B-Disease 1 0.9996298551559448
) O 0 0.03921636566519737
, O 0 0.02016562782227993
the O 0 0.027145376428961754
fatal O 1 0.9977397918701172
infantile B-Disease 1 0.9987723231315613
form I-Disease 0 0.04472580552101135
of I-Disease 0 0.027656223624944687
G I-Disease 0 0.44621139764785767
( I-Disease 0 0.054021887481212616
M2 I-Disease 0 0.22547219693660736
) I-Disease 0 0.04787193983793259
gangliosidosis I-Disease 0 0.13626158237457275
, I-Disease 0 0.0268910713493824
Type I-Disease 0 0.06330408155918121
1 I-Disease 0 0.0460064560174942
. O 0 0.03666774928569794

Less O 0 0.0890774130821228
severe O 1 0.999090313911438
, O 0 0.06101417914032936
subacute O 1 0.9999833106994629
( O 1 0.7894916534423828
juvenile O 1 0.9994097948074341
- O 1 0.9980888962745667
onset O 1 0.9998754262924194
) O 0 0.046958956867456436
and O 0 0.031918786466121674
chronic O 1 0.9999939203262329
( O 0 0.07174361497163773
adult O 0 0.15930315852165222
- O 1 0.972527265548706
onset O 1 0.9991963505744934
) O 0 0.038531094789505005
variants O 0 0.04590100795030594
are O 0 0.015394853428006172
characterized O 0 0.047123268246650696
by O 0 0.015489332377910614
a O 0 0.019845597445964813
broad O 0 0.04630887135863304
spectrum O 0 0.05953823775053024
of O 0 0.02170051634311676
clinical O 1 0.8978609442710876
manifestations O 0 0.1761551797389984
and O 0 0.013763056136667728
are O 0 0.010932644829154015
associated O 0 0.02201010473072529
with O 0 0.017497960478067398
residual O 0 0.07652776688337326
levels O 0 0.04310140013694763
of O 0 0.01987416483461857
Hex O 0 0.09083229303359985
A O 0 0.04504512995481491
enzyme O 0 0.12566828727722168
activity O 0 0.07550669461488724
. O 0 0.052586257457733154

We O 0 0.0343819223344326
identified O 0 0.05026457458734512
a O 0 0.052470989525318146
1422 O 1 0.9952303767204285
G O 1 0.9671392440795898
- O 1 0.8460310697555542
- O 1 0.623222827911377
> O 1 0.6344025135040283
C O 0 0.1377406269311905
( O 0 0.06463485956192017
amino O 0 0.09265721589326859
acid O 0 0.144612118601799
W474C O 0 0.14055678248405457
) O 0 0.033396296203136444
substitution O 0 0.04038717970252037
in O 0 0.010706250555813313
the O 0 0.010976351797580719
first O 0 0.013369808904826641
position O 0 0.01763373799622059
of O 0 0.013991584070026875
exon O 0 0.08812747895717621
13 O 0 0.030910396948456764
of O 0 0.020970910787582397
HEXA O 1 0.8822307586669922
of O 0 0.018551938235759735
a O 0 0.026336172595620155
non O 0 0.0516882948577404
- O 0 0.08371680974960327
Jewish O 0 0.06726672500371933
proband O 0 0.34259119629859924
who O 0 0.04206324368715286
manifested O 0 0.15391691029071808
a O 0 0.052056122571229935
subacute O 1 0.9991868138313293
variant O 0 0.15675891935825348
of O 0 0.03858253359794617
G B-Disease 0 0.4734888970851898
( I-Disease 0 0.06736117601394653
M2 I-Disease 0 0.39225196838378906
) I-Disease 0 0.05794879421591759
gangliosidosis I-Disease 0 0.18419252336025238
. O 0 0.055537622421979904

On O 0 0.0301286019384861
the O 0 0.029332155361771584
second O 0 0.04800090566277504
maternally O 0 0.17365989089012146
inherited O 0 0.20612798631191254
allele O 0 0.13572002947330475
, O 0 0.023108020424842834
we O 0 0.014423896558582783
identified O 0 0.02407720498740673
the O 0 0.020188668742775917
common O 0 0.27844297885894775
infantile O 1 0.9999970197677612
disease O 1 0.9999978542327881
- O 1 0.977220892906189
causing O 1 0.7294949889183044
4 O 0 0.05921012908220291
- O 0 0.11907157301902771
bp O 0 0.14214617013931274
insertion O 0 0.15525799989700317
, O 0 0.04024495556950569
+ O 0 0.3454909920692444
TATC O 1 0.8675915002822876
1278 O 1 0.7055984735488892
, O 0 0.027656277641654015
in O 0 0.02377857267856598
exon O 0 0.12105706334114075
11 O 0 0.05551159009337425
. O 0 0.04452361911535263

Pulse O 1 0.5495915412902832
- O 0 0.15863041579723358
chase O 0 0.1436648666858673
analysis O 0 0.06176058202981949
using O 0 0.04297468811273575
proband O 0 0.34279176592826843
fibroblasts O 0 0.46540775895118713
revealed O 0 0.044361717998981476
that O 0 0.015728214755654335
the O 0 0.0222135279327631
W474C O 0 0.12015828490257263
- O 0 0.07446438074111938
containing O 0 0.04260316863656044
alpha O 0 0.08941762894392014
- O 0 0.09843844175338745
subunit O 0 0.11519855260848999
precursor O 0 0.09041150659322739
was O 0 0.02605200931429863
normally O 0 0.03952692076563835
synthesized O 0 0.05900224298238754
, O 0 0.015874944627285004
but O 0 0.01325308158993721
not O 0 0.013720092363655567
phosphorylated O 0 0.06372477859258652
or O 0 0.026151178404688835
secreted O 0 0.05756671354174614
, O 0 0.01303413137793541
and O 0 0.011081302538514137
the O 0 0.018233729526400566
mature O 0 0.08264151215553284
lysosomal O 1 0.8829615712165833
alpha O 0 0.09583874046802521
- O 0 0.09774298220872879
subunit O 0 0.0967307910323143
was O 0 0.025005562230944633
not O 0 0.024797460064291954
detected O 0 0.09517627954483032
. O 0 0.043803416192531586

When O 0 0.04679932817816734
the O 0 0.03467606380581856
W474C O 0 0.13326159119606018
- O 0 0.08288313448429108
containing O 0 0.052283965051174164
alpha O 0 0.08363652229309082
- O 0 0.09030625224113464
subunit O 0 0.11105558276176453
was O 0 0.0368444062769413
transiently O 0 0.42148610949516296
co O 0 0.08698650449514389
- O 0 0.06468155980110168
expressed O 0 0.032330527901649475
with O 0 0.016384394839406013
the O 0 0.018917221575975418
beta O 0 0.06459324061870575
- O 0 0.06077943742275238
subunit O 0 0.07091327756643295
to O 0 0.01892227679491043
produce O 0 0.031446848064661026
Hex O 0 0.06968226283788681
A O 0 0.031043315306305885
( O 0 0.043390531092882156
alphabeta O 0 0.12006589770317078
) O 0 0.03248655050992966
in O 0 0.02468712069094181
COS O 1 0.9919360876083374
- O 0 0.08434245735406876
7 O 0 0.044132743030786514
cells O 0 0.06521280109882355
, O 0 0.01831376925110817
the O 0 0.0186166949570179
mature O 0 0.05899371951818466
alpha O 0 0.0655023455619812
- O 0 0.06426320225000381
subunit O 0 0.06742357462644577
was O 0 0.01627166010439396
present O 0 0.015668243169784546
, O 0 0.010141702368855476
but O 0 0.008564178831875324
its O 0 0.008647361770272255
level O 0 0.01732376590371132
was O 0 0.01109209656715393
much O 0 0.013097187504172325
lower O 0 0.023378949612379074
than O 0 0.012412101961672306
that O 0 0.010443844832479954
from O 0 0.0170600563287735
normal O 0 0.04713185504078865
alpha O 0 0.0721166804432869
- O 0 0.08876857161521912
subunit O 0 0.11174775660037994
transfections O 0 0.11986888200044632
, O 0 0.01916959136724472
although O 0 0.01789739541709423
higher O 0 0.018815642222762108
than O 0 0.01114385575056076
in O 0 0.011049611493945122
those O 0 0.01795283704996109
cells O 0 0.0785611942410469
transfected O 0 0.16211026906967163
with O 0 0.023073427379131317
an O 0 0.021678730845451355
alpha O 0 0.06987268477678299
- O 0 0.08914092183113098
subunit O 0 0.11517544835805893
associated O 0 0.05518835410475731
with O 0 0.05467410013079643
infantile O 1 0.9995399713516235
TSD B-Disease 1 0.9985421895980835
. O 0 0.06946997344493866

Furthermore O 0 0.06777048856019974
, O 0 0.021443074569106102
the O 0 0.01959189772605896
precursor O 0 0.05688299238681793
level O 0 0.026350483298301697
of O 0 0.013380644842982292
the O 0 0.023490555584430695
W474C O 0 0.12186996638774872
alpha O 0 0.07821034640073776
- O 0 0.07768893986940384
subunit O 0 0.0756012499332428
was O 0 0.018258094787597656
found O 0 0.01755731925368309
to O 0 0.01484634354710579
accumulate O 0 0.057537682354450226
in O 0 0.013883596286177635
comparison O 0 0.02552833780646324
to O 0 0.012742661871016026
the O 0 0.01713481917977333
normal O 0 0.0536644421517849
alpha O 0 0.0791098028421402
- O 0 0.10446660965681076
subunit O 0 0.1355346441268921
precursor O 0 0.11712909489870071
levels O 0 0.08534299582242966
. O 0 0.05382457748055458

We O 0 0.036609869450330734
conclude O 0 0.058271877467632294
that O 0 0.020244931802153587
the O 0 0.028797078877687454
1422 O 1 0.9966462254524231
G O 1 0.9840213656425476
- O 1 0.9033825397491455
- O 1 0.7147025465965271
> O 1 0.7790000438690186
C O 0 0.14316141605377197
mutation O 0 0.12104985862970352
is O 0 0.019036345183849335
the O 0 0.01910788007080555
cause O 0 0.0505923256278038
of O 0 0.020871834829449654
Hex B-Disease 0 0.10272037982940674
A I-Disease 0 0.058515336364507675
enzyme I-Disease 1 0.9929060935974121
deficiency I-Disease 1 0.99998939037323
in O 0 0.032168786972761154
the O 0 0.031521379947662354
proband O 0 0.39052343368530273
. O 0 0.05828050523996353

The O 0 0.051828932017087936
resulting O 0 0.10329476743936539
W474C O 0 0.18605957925319672
substitution O 0 0.11132359504699707
clearly O 0 0.05744218826293945
interferes O 0 0.10363853722810745
with O 0 0.03045136295258999
alpha O 0 0.07373641431331635
- O 0 0.07960651814937592
subunit O 0 0.07793357968330383
processing O 0 0.028637338429689407
, O 0 0.01271742582321167
but O 0 0.011491556651890278
because O 0 0.01410636305809021
the O 0 0.014271734282374382
base O 0 0.03416641801595688
substitution O 0 0.056058693677186966
falls O 0 0.04786964878439903
at O 0 0.014062991365790367
the O 0 0.010037061758339405
first O 0 0.013698166236281395
position O 0 0.019152309745550156
of O 0 0.01747315563261509
exon O 0 0.10651910305023193
13 O 0 0.04041343554854393
, O 0 0.03130526840686798
aberrant O 0 0.14442481100559235
splicing O 0 0.12239862978458405
may O 0 0.03441284969449043
also O 0 0.0180232934653759
contribute O 0 0.04151828587055206
to O 0 0.0211472287774086
Hex B-Disease 0 0.08843450993299484
A I-Disease 0 0.045530229806900024
deficiency I-Disease 1 0.9998811483383179
in O 0 0.022625762969255447
this O 0 0.022024836391210556
proband O 0 0.12027256935834885
. O 0 0.025846272706985474
. O 0 0.0360945463180542

Two O 0 0.060919102281332016
frequent O 0 0.14577621221542358
missense O 1 0.9414170980453491
mutations O 1 0.9535213708877563
in O 0 0.06762538850307465
Pendred B-Disease 1 0.9999399185180664
syndrome I-Disease 1 0.9999995231628418
. O 0 0.0861089900135994

Pendred B-Disease 1 0.9999760389328003
syndrome I-Disease 1 0.9999998807907104
is O 0 0.06770309060811996
an O 0 0.09801267832517624
autosomal B-Disease 1 0.9999988079071045
recessive I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
characterized O 1 0.9954354166984558
by O 0 0.04178366810083389
early O 0 0.07204693555831909
childhood O 1 0.9988822340965271
deafness B-Disease 1 0.9999953508377075
and O 0 0.07909463346004486
goiter B-Disease 1 0.9999645948410034
. O 0 0.07685494422912598

A O 0 0.03757384046912193
century O 0 0.028560195118188858
after O 0 0.023350192233920097
its O 0 0.015903407707810402
recognition O 0 0.03149658814072609
as O 0 0.020082073286175728
a O 0 0.04069244861602783
syndrome O 1 0.9999902248382568
by O 0 0.039091747254133224
Vaughan O 0 0.12386340647935867
Pendred O 1 0.6982434988021851
, O 0 0.0283989068120718
the O 0 0.034216225147247314
disease O 1 0.9998036026954651
gene O 0 0.17659436166286469
( O 0 0.05938783288002014
PDS O 1 0.9687895178794861
) O 0 0.02792513370513916
was O 0 0.01990073174238205
mapped O 0 0.05730023980140686
to O 0 0.03224087879061699
chromosome O 0 0.16119541227817535
7q22 O 0 0.3120838403701782
- O 0 0.16108563542366028
q31 O 0 0.21143057942390442
. O 0 0.0691661685705185

1 O 0 0.04336629435420036
and O 0 0.01762072555720806
, O 0 0.015357205644249916
recently O 0 0.021823333576321602
, O 0 0.013049044646322727
found O 0 0.01609865017235279
to O 0 0.015887614339590073
encode O 0 0.04842258617281914
a O 0 0.041665446013212204
putative O 0 0.2981502115726471
sulfate O 1 0.9942746758460999
transporter O 1 0.7737016081809998
. O 0 0.06379286199808121

We O 0 0.04749355837702751
performed O 0 0.05705861747264862
mutation O 0 0.11823266744613647
analysis O 0 0.03134553134441376
of O 0 0.014629741199314594
the O 0 0.022864030674099922
PDS B-Disease 1 0.9932872653007507
gene O 0 0.09762726724147797
in O 0 0.028770633041858673
patients O 1 0.9542201161384583
from O 0 0.025166014209389687
14 O 0 0.03441896662116051
Pendred B-Disease 0 0.18628638982772827
families O 0 0.03676494210958481
originating O 0 0.044909220188856125
from O 0 0.013894503004848957
seven O 0 0.017582038417458534
countries O 0 0.014345670118927956
and O 0 0.013649936765432358
identified O 0 0.030090510845184326
all O 0 0.021751221269369125
mutations O 0 0.1481286734342575
. O 0 0.05272621661424637

The O 0 0.05086246505379677
mutations O 0 0.1234249621629715
include O 0 0.03057655692100525
three O 0 0.018622729927301407
single O 0 0.02897476591169834
base O 0 0.041357383131980896
deletions O 0 0.07729310542345047
, O 0 0.02069026604294777
one O 0 0.02363518998026848
splice O 0 0.12777654826641083
site O 0 0.04859297350049019
mutation O 0 0.11853736639022827
and O 0 0.02600325644016266
10 O 0 0.05056258663535118
missense O 0 0.4127616286277771
mutations O 0 0.2539311647415161
. O 0 0.0661013275384903

One O 0 0.0822664350271225
missense O 1 0.6571332216262817
mutation O 1 0.6171020865440369
( O 0 0.07240970432758331
L236P O 0 0.13914896547794342
) O 0 0.028016770258545876
was O 0 0.014256072230637074
found O 0 0.016383880749344826
in O 0 0.011808480136096478
a O 0 0.018163954839110374
homozygous O 0 0.06284947693347931
state O 0 0.015278881415724754
in O 0 0.013715539127588272
two O 0 0.016389604657888412
consanguineous O 0 0.40007534623146057
families O 0 0.029871612787246704
and O 0 0.011054741218686104
in O 0 0.01201310008764267
a O 0 0.016574373468756676
heterozygous O 0 0.0640343576669693
state O 0 0.01622583530843258
in O 0 0.01164887472987175
five O 0 0.01617438532412052
additional O 0 0.02730371803045273
non O 0 0.05281950533390045
- O 0 0.12784411013126373
consanguineous O 1 0.84562748670578
families O 0 0.07800057530403137
. O 0 0.06071483716368675

Another O 0 0.12381486594676971
missense O 1 0.8080258965492249
mutation O 1 0.5398585796356201
( O 0 0.06342294067144394
T416P O 0 0.13300514221191406
) O 0 0.028189031407237053
was O 0 0.014347342774271965
found O 0 0.015490401536226273
in O 0 0.011117300018668175
a O 0 0.016512326896190643
homozygous O 0 0.05796472728252411
state O 0 0.013289685361087322
in O 0 0.009758803993463516
one O 0 0.01067623682320118
family O 0 0.016811605542898178
and O 0 0.009218045510351658
in O 0 0.010466646403074265
a O 0 0.016261907294392586
heterozygous O 0 0.06309964507818222
state O 0 0.015495026484131813
in O 0 0.012887990102171898
four O 0 0.017896102741360664
families O 0 0.03608007729053497
. O 0 0.040891360491514206

Pendred B-Disease 1 0.9788728952407837
patients O 1 0.9799553751945496
in O 0 0.023560481145977974
three O 0 0.02173067443072796
non O 0 0.0515015684068203
- O 0 0.10734532028436661
consanguineous O 1 0.6358815431594849
families O 0 0.03619469702243805
were O 0 0.01421155221760273
shown O 0 0.022906513884663582
to O 0 0.01301040779799223
be O 0 0.015320468693971634
compound O 0 0.06620881706476212
heterozygotes O 0 0.47759804129600525
for O 0 0.027869654819369316
L236P O 0 0.12743720412254333
and O 0 0.03202419728040695
T416P O 0 0.1563216745853424
. O 0 0.051707882434129715

In O 0 0.02750791423022747
total O 0 0.021068695932626724
, O 0 0.011657091788947582
one O 0 0.009742285124957561
or O 0 0.010920601896941662
both O 0 0.008670910261571407
of O 0 0.008407248184084892
these O 0 0.012716780416667461
mutations O 0 0.06147384271025658
were O 0 0.010835673660039902
found O 0 0.013561658561229706
in O 0 0.008951163850724697
nine O 0 0.013234635815024376
of O 0 0.008908340707421303
the O 0 0.013663710094988346
14 O 0 0.02958221361041069
families O 0 0.04302702471613884
analyzed O 0 0.06226533278822899
. O 0 0.0436258390545845

The O 0 0.029942478984594345
identification O 0 0.03715106099843979
of O 0 0.014993788674473763
two O 0 0.0217813141644001
frequent O 0 0.09214455634355545
PDS B-Disease 1 0.9941375255584717
mutations O 0 0.14372429251670837
will O 0 0.020724529400467873
facilitate O 0 0.03767341002821922
the O 0 0.024494800716638565
molecular O 0 0.10029121488332748
diagnosis O 1 0.9993903636932373
of O 0 0.05236738920211792
Pendred B-Disease 1 0.9999423027038574
syndrome I-Disease 1 0.9999992847442627
. O 0 0.09333629906177521

Insertional O 1 0.8223766088485718
mutation O 0 0.22593975067138672
by O 0 0.049170877784490585
transposable O 0 0.413446843624115
element O 0 0.0722445696592331
, O 0 0.03262157738208771
L1 O 1 0.501461923122406
, O 0 0.02106757089495659
in O 0 0.017191721126437187
the O 0 0.03140099346637726
DMD B-Disease 1 0.9999548196792603
gene O 0 0.10360970348119736
results O 0 0.04305145516991615
in O 0 0.02732405997812748
X B-Disease 1 0.6603438258171082
- I-Disease 1 0.8992202281951904
linked I-Disease 1 0.9521046876907349
dilated I-Disease 1 0.9998354911804199
cardiomyopathy I-Disease 1 0.9999971389770508
. O 0 0.08506081253290176

X B-Disease 1 0.9648506045341492
- I-Disease 1 0.984126627445221
linked I-Disease 1 0.9879001379013062
dilated I-Disease 1 0.9999200105667114
cardiomyopathy I-Disease 1 0.9999985694885254
( O 0 0.1480562388896942
XLDCM B-Disease 1 0.9828603863716125
) O 0 0.034559495747089386
is O 0 0.0192396380007267
a O 0 0.0266875009983778
clinical O 1 0.5921540260314941
phenotype O 1 0.8810624480247498
of O 0 0.024483205750584602
dystrophinopathy B-Disease 0 0.19732056558132172
which O 0 0.02086687460541725
is O 0 0.020677847787737846
characterized O 0 0.07304331660270691
by O 0 0.031695879995822906
preferential O 1 0.944159209728241
myocardial B-Disease 1 0.999953031539917
involvement I-Disease 0 0.08782327175140381
without O 0 0.031094003468751907
any O 0 0.025386659428477287
overt O 0 0.1005326360464096
clinical O 1 0.9760052561759949
signs O 0 0.07761837542057037
of O 0 0.036216821521520615
skeletal B-Disease 1 0.999843955039978
myopathy I-Disease 1 0.9999822378158569
. O 0 0.0857064425945282

To O 0 0.026732733473181725
date O 0 0.025710880756378174
, O 0 0.015587766654789448
several O 0 0.019402533769607544
mutations O 0 0.09876346588134766
in O 0 0.026095418259501457
the O 0 0.0459158830344677
Duchenne B-Disease 1 0.9999951124191284
muscular I-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.9999995231628418
gene O 1 0.9871805310249329
, O 0 0.06710121035575867
DMD O 1 0.9999878406524658
, O 0 0.02213844284415245
have O 0 0.013979930430650711
been O 0 0.013750577345490456
identified O 0 0.026372646912932396
in O 0 0.01919889822602272
patients O 1 0.9819266200065613
with O 0 0.023937828838825226
XLDCM B-Disease 1 0.6821079850196838
, O 0 0.016988476738333702
but O 0 0.014017420820891857
a O 0 0.022135648876428604
pathogenic O 0 0.09133302420377731
correlation O 0 0.0640314593911171
of O 0 0.01866156980395317
these O 0 0.02316012978553772
cardiospecific O 1 0.8625872135162354
mutations O 0 0.42662644386291504
in O 0 0.03627394884824753
DMD O 1 0.9999725818634033
with O 0 0.032776929438114166
the O 0 0.033837199211120605
XLDCM B-Disease 1 0.9585285782814026
phenotype O 1 0.8522741198539734
has O 0 0.023803425952792168
remained O 0 0.022488204762339592
to O 0 0.01606711931526661
be O 0 0.01856999658048153
elucidated O 0 0.10772868245840073
. O 0 0.044862356036901474

We O 0 0.026129666715860367
report O 0 0.019483257085084915
here O 0 0.01285059005022049
the O 0 0.009343810379505157
identification O 0 0.019308505579829216
of O 0 0.010345947928726673
a O 0 0.019414322450757027
unique O 0 0.036334890872240067
de O 0 0.09344436973333359
novo O 0 0.1768578290939331
L1 O 1 0.8492305278778076
insertion O 0 0.13175688683986664
in O 0 0.026302635669708252
the O 0 0.03222275897860527
muscle O 1 0.9118279218673706
exon O 0 0.14274121820926666
1 O 0 0.05089167132973671
in O 0 0.03464056923985481
DMD O 1 0.9999393224716187
in O 0 0.02439747005701065
three O 0 0.0288448054343462
XLDCM B-Disease 1 0.9892482161521912
patients O 1 0.9758360981941223
from O 0 0.019157689064741135
two O 0 0.017303282395005226
unrelated O 0 0.05732055380940437
Japanese O 0 0.04913971945643425
families O 0 0.04981906712055206
. O 0 0.048910144716501236

The O 0 0.04868968948721886
insertion O 0 0.11976068466901779
was O 0 0.02395634911954403
a O 0 0.02556193619966507
5 O 0 0.03771374002099037
- O 0 0.06455150991678238
truncated O 0 0.07785192877054214
form O 0 0.03620174899697304
of O 0 0.0192379392683506
human O 0 0.039737798273563385
L1 O 0 0.4863610565662384
inversely O 0 0.09376224130392075
integrated O 0 0.04506322741508484
in O 0 0.01605537161231041
the O 0 0.018005583435297012
5 O 0 0.036250364035367966
- O 0 0.07334666699171066
untranslated O 0 0.12473973631858826
region O 0 0.040327735245227814
in O 0 0.018549779430031776
the O 0 0.02414882741868496
muscle O 1 0.9333216547966003
exon O 0 0.1221282109618187
1 O 0 0.02891699969768524
, O 0 0.015212876722216606
which O 0 0.012947439216077328
affected O 0 0.030082376673817635
the O 0 0.013809462077915668
transcription O 0 0.0449162982404232
or O 0 0.01642770692706108
the O 0 0.01123612280935049
stability O 0 0.02836996503174305
of O 0 0.012889919802546501
the O 0 0.020196039229631424
muscle O 1 0.8388441205024719
form O 0 0.03317795693874359
of O 0 0.020119253545999527
dystrophin O 1 0.7796021699905396
transcripts O 0 0.04266716167330742
but O 0 0.011255580931901932
not O 0 0.008103333413600922
that O 0 0.006861350033432245
of O 0 0.009052110835909843
the O 0 0.01964762806892395
brain O 1 0.9666792750358582
or O 0 0.043851468712091446
Purkinje O 1 0.998944103717804
cell O 0 0.07353416085243225
form O 0 0.02894032746553421
, O 0 0.015507259406149387
probably O 0 0.019539525732398033
due O 0 0.014301575720310211
to O 0 0.00955889280885458
its O 0 0.009981147944927216
unique O 0 0.019998082891106606
site O 0 0.020279545336961746
of O 0 0.01645633950829506
integration O 0 0.0522574856877327
. O 0 0.03633381426334381

We O 0 0.036393966525793076
speculate O 0 0.057051099836826324
that O 0 0.013311939314007759
this O 0 0.014282404445111752
insertion O 0 0.06884092092514038
of O 0 0.01725372113287449
an O 0 0.02452375367283821
L1 O 1 0.6520528793334961
sequence O 0 0.06033627316355705
in O 0 0.03212839365005493
DMD O 1 0.9998804330825806
is O 0 0.01913924142718315
responsible O 0 0.02169940434396267
for O 0 0.008704572916030884
some O 0 0.007972275838255882
of O 0 0.007821670733392239
the O 0 0.010341553948819637
population O 0 0.0210722666233778
of O 0 0.01567903719842434
Japanese O 0 0.040822628885507584
patients O 1 0.9870453476905823
with O 0 0.03085491620004177
XLDCM B-Disease 1 0.8664756417274475
. O 0 0.03301810473203659
. O 0 0.03893531486392021

Severe O 1 0.9995622038841248
early O 1 0.5016306042671204
- O 1 0.999671459197998
onset O 1 0.9999926090240479
obesity B-Disease 1 0.9999972581863403
, O 1 0.7530844211578369
adrenal B-Disease 1 0.9999978542327881
insufficiency I-Disease 1 0.9999961853027344
and O 0 0.03865006938576698
red O 1 0.9872300028800964
hair O 1 0.9987940788269043
pigmentation O 1 0.9999394416809082
caused O 1 0.9521502256393433
by O 0 0.05067960545420647
POMC O 1 0.9992425441741943
mutations O 0 0.44246840476989746
in O 0 0.03488626331090927
humans O 0 0.07945313304662704
. O 0 0.05228687450289726

Sequential O 0 0.13332657516002655
cleavage O 0 0.15532900393009186
of O 0 0.02465922012925148
the O 0 0.025830967351794243
precursor O 0 0.09414970129728317
protein O 0 0.0761600062251091
pre O 0 0.09507222473621368
- O 0 0.11438970267772675
pro O 0 0.08824358880519867
- O 0 0.18193680047988892
opiomelanocortin O 1 0.7651979923248291
( O 0 0.08469513803720474
POMC O 1 0.9879446029663086
) O 0 0.051034167408943176
generates O 0 0.08027235418558121
the O 0 0.04531397670507431
melanocortin O 1 0.9842779040336609
peptides O 0 0.25703659653663635
adrenocorticotrophin O 1 0.8614294528961182
( O 0 0.09210982918739319
ACTH O 1 0.9947414398193359
) O 0 0.05475175753235817
, O 0 0.03741170093417168
melanocyte O 1 0.997793436050415
- O 1 0.8208848834037781
stimulating O 1 0.9257451295852661
hormones O 1 0.9493972063064575
( O 0 0.0895443931221962
MSH O 1 0.9984252452850342
) O 0 0.04387803375720978
alpha O 0 0.052233241498470306
, O 0 0.018147435039281845
beta O 0 0.042094599455595016
and O 0 0.01467127725481987
gamma O 0 0.0544678159058094
as O 0 0.009850987233221531
well O 0 0.011594902724027634
as O 0 0.01340863574296236
the O 0 0.027122313156723976
opioid O 1 0.9859344363212585
- O 1 0.52036452293396
receptor O 1 0.5643355846405029
ligand O 0 0.41022926568984985
beta O 0 0.16014200448989868
- O 0 0.32337191700935364
endorphin O 1 0.9577473998069763
. O 0 0.07399911433458328

While O 0 0.03325900435447693
a O 0 0.025334876030683517
few O 0 0.023719608783721924
cases O 0 0.031693633645772934
of O 0 0.02515551447868347
isolated O 1 0.9120609760284424
ACTH B-Disease 1 0.9999843835830688
deficiency I-Disease 1 0.9999922513961792
have O 0 0.02926579676568508
been O 0 0.024252772331237793
reported O 0 0.04769601672887802
( O 0 0.06396203488111496
OMIM O 1 0.9991269707679749
201400 O 1 0.6680149435997009
) O 0 0.03336598724126816
, O 0 0.018161054700613022
an O 0 0.026014043018221855
inherited O 1 0.9857139587402344
POMC O 1 0.9997755885124207
defect O 1 0.9609144330024719
has O 0 0.018867023289203644
not O 0 0.0111047038808465
been O 0 0.013013487681746483
described O 0 0.02318977192044258
so O 0 0.019152319058775902
far O 0 0.029240600764751434
. O 0 0.032873596996068954

Recent O 0 0.06789681315422058
studies O 0 0.04499751701951027
in O 0 0.020926186814904213
animal O 0 0.04290219396352768
models O 0 0.044032901525497437
elucidated O 0 0.0768297016620636
a O 0 0.022222811356186867
central O 0 0.02332446351647377
role O 0 0.02837063930928707
of O 0 0.019876139238476753
alpha O 0 0.0760783925652504
- O 0 0.11238553375005722
MSH O 1 0.9855688214302063
in O 0 0.017947323620319366
the O 0 0.016154669225215912
regulation O 0 0.03687570244073868
of O 0 0.014397477731108665
food O 0 0.037460993975400925
intake O 0 0.08275458961725235
by O 0 0.02391197346150875
activation O 0 0.08521930128335953
of O 0 0.018307076767086983
the O 0 0.02927960455417633
brain O 1 0.9870365858078003
melanocortin O 1 0.9973968267440796
- O 0 0.252954363822937
4 O 0 0.07065233588218689
- O 0 0.3743681311607361
receptor O 1 0.6117375493049622
( O 0 0.0953773707151413
MC4 O 1 0.9991006851196289
- O 0 0.43884462118148804
R O 0 0.17135676741600037
; O 0 0.05118485540151596
refs O 0 0.13115127384662628
3 O 0 0.044024329632520676
- O 0 0.05818629264831543
5 O 0 0.0291666928678751
) O 0 0.019693901762366295
and O 0 0.010934763588011265
the O 0 0.01334653701633215
linkage O 0 0.07110599428415298
of O 0 0.018170690163969994
human O 0 0.044269125908613205
obesity B-Disease 1 0.9991307854652405
to O 0 0.02725854143500328
chromosome O 0 0.09442545473575592
2 O 0 0.026355193927884102
in O 0 0.013000492006540298
close O 0 0.02578231319785118
proximity O 0 0.03709973394870758
to O 0 0.016017217189073563
the O 0 0.025140229612588882
POMC O 1 0.974558413028717
locus O 0 0.10152685642242432
, O 0 0.018588589504361153
led O 0 0.021439051255583763
to O 0 0.00922459363937378
the O 0 0.009950351901352406
proposal O 0 0.0206215288490057
of O 0 0.010017797350883484
an O 0 0.015310480259358883
association O 0 0.03644273802638054
of O 0 0.026735233142971992
POMC O 1 0.9978025555610657
with O 0 0.03838282451033592
human O 0 0.07597357779741287
obesity B-Disease 1 0.9997033476829529
. O 0 0.05798255652189255

The O 0 0.03525170311331749
dual O 0 0.06403915584087372
role O 0 0.039578311145305634
of O 0 0.027039309963583946
alpha O 0 0.098195381462574
- O 0 0.18737547099590302
MSH O 1 0.9919933080673218
in O 0 0.03603401780128479
regulating O 0 0.08117476850748062
food O 0 0.05784383788704872
intake O 0 0.14035838842391968
and O 0 0.03281019628047943
influencing O 0 0.12059071660041809
hair O 1 0.9821054935455322
pigmentation O 1 0.9990035891532898
predicts O 0 0.11724947392940521
that O 0 0.01897413097321987
the O 0 0.02226695977151394
phenotype O 0 0.43695780634880066
associated O 0 0.03453025966882706
with O 0 0.01904239133000374
a O 0 0.02740866132080555
defect O 1 0.7390938997268677
in O 0 0.033136479556560516
POMC O 1 0.9930443167686462
function O 0 0.04521435126662254
would O 0 0.02347242645919323
include O 0 0.03731358423829079
obesity B-Disease 1 0.9994090795516968
, O 0 0.033666204661130905
alteration O 0 0.10245154798030853
in O 0 0.03780234232544899
pigmentation O 1 0.9997236132621765
and O 0 0.0854450911283493
ACTH B-Disease 1 0.9999711513519287
deficiency I-Disease 1 0.9999880790710449
. O 0 0.07363249361515045

The O 0 0.03765324130654335
observation O 0 0.06573173403739929
of O 0 0.019669249653816223
these O 0 0.020611615851521492
symptoms O 1 0.9982653260231018
in O 0 0.019010165706276894
two O 0 0.018898580223321915
probands O 0 0.40167081356048584
prompted O 0 0.05366155877709389
us O 0 0.025093192234635353
to O 0 0.0150150703266263
search O 0 0.02894638478755951
for O 0 0.020549418404698372
mutations O 0 0.0914301723241806
within O 0 0.026969391852617264
their O 0 0.032954756170511246
POMC O 1 0.9889882206916809
genes O 0 0.12656091153621674
. O 0 0.060279879719018936

Patient O 1 0.589622437953949
1 O 0 0.03692691773176193
was O 0 0.015826424583792686
found O 0 0.013874604366719723
to O 0 0.009496696293354034
be O 0 0.009807010181248188
a O 0 0.019266005605459213
compound O 0 0.06119155511260033
heterozygote O 0 0.17366284132003784
for O 0 0.020877424627542496
two O 0 0.022534415125846863
mutations O 0 0.1025359034538269
in O 0 0.027142174541950226
exon O 0 0.12367284297943115
3 O 0 0.050239384174346924
( O 0 0.045330263674259186
G7013T O 0 0.11395405232906342
, O 0 0.026458466425538063
C7133delta O 0 0.11304726451635361
) O 0 0.023022759705781937
which O 0 0.014084546826779842
interfere O 0 0.03941633924841881
with O 0 0.018322572112083435
appropriate O 0 0.035730987787246704
synthesis O 0 0.055747441947460175
of O 0 0.024535181000828743
ACTH O 1 0.9438655376434326
and O 0 0.032069217413663864
alpha O 0 0.10227212309837341
- O 0 0.4240231513977051
MSH O 1 0.9953705668449402
. O 0 0.07706838846206665

Patient O 1 0.7074965834617615
2 O 0 0.04391789436340332
was O 0 0.024617016315460205
homozygous O 0 0.07445134222507477
for O 0 0.017976071685552597
a O 0 0.02755976840853691
mutation O 0 0.1112934947013855
in O 0 0.026371875777840614
exon O 0 0.11859792470932007
2 O 0 0.049581605941057205
( O 0 0.05209508538246155
C3804A O 0 0.1315690577030182
) O 0 0.04075568541884422
which O 0 0.03479209542274475
abolishes O 1 0.6061153411865234
POMC O 1 0.9784888029098511
translation O 0 0.07999315857887268
. O 0 0.05528949946165085

These O 0 0.02794332429766655
findings O 0 0.037989404052495956
represent O 0 0.019523020833730698
the O 0 0.011472770012915134
first O 0 0.014126085676252842
examples O 0 0.01912464015185833
of O 0 0.013242757879197598
a O 0 0.030151790007948875
genetic B-Disease 0 0.3818306624889374
defect I-Disease 1 0.9835440516471863
within O 0 0.03787773847579956
the O 0 0.03707437589764595
POMC O 1 0.9925416707992554
gene O 0 0.086171954870224
and O 0 0.019482901319861412
define O 0 0.04202729091048241
a O 0 0.02789747714996338
new O 0 0.04731619730591774
monogenic B-Disease 1 0.9998263716697693
endocrine I-Disease 1 0.9999828338623047
disorder I-Disease 1 0.9999805688858032
resulting O 0 0.09258773922920227
in O 0 0.02583134174346924
early O 0 0.06372278928756714
- O 1 0.999518871307373
onset O 1 0.999993085861206
obesity B-Disease 1 0.9999980926513672
, O 1 0.5563616156578064
adrenal B-Disease 1 0.9999877214431763
insufficiency I-Disease 1 0.9999790191650391
and O 0 0.04369765520095825
red O 1 0.906848669052124
hair O 1 0.9917068481445312
pigmentation O 1 0.9992656111717224
. O 0 0.04033323749899864
. O 0 0.05204351246356964

A O 0 0.05873855948448181
European O 0 0.06900978088378906
multicenter O 1 0.9675703048706055
study O 0 0.06441961973905563
of O 0 0.045999277383089066
phenylalanine B-Disease 1 0.9978138208389282
hydroxylase I-Disease 1 0.9998548030853271
deficiency I-Disease 1 0.9999986886978149
: O 0 0.052663110196590424
classification O 0 0.06645671278238297
of O 0 0.022371578961610794
105 O 0 0.06709644943475723
mutations O 0 0.08827748149633408
and O 0 0.013846968300640583
a O 0 0.014331337995827198
general O 0 0.019946329295635223
system O 0 0.026169048622250557
for O 0 0.01988345757126808
genotype O 1 0.5168634653091431
- O 0 0.08410786092281342
based O 0 0.036000799387693405
prediction O 0 0.08304877579212189
of O 0 0.03843384608626366
metabolic O 1 0.9801944494247437
phenotype O 1 0.9684528708457947
. O 0 0.06290944665670395

Phenylketonuria B-Disease 1 0.9998582601547241
( O 1 0.6029872298240662
PKU B-Disease 1 0.9998906850814819
) O 0 0.056414246559143066
and O 0 0.0334908664226532
mild B-Disease 1 0.9995712637901306
hyperphenylalaninemia I-Disease 1 0.9997510313987732
( O 1 0.5330758094787598
MHP B-Disease 1 0.9999436140060425
) O 0 0.04468574374914169
are O 0 0.02872151881456375
allelic B-Disease 1 0.9989728927612305
disorders I-Disease 1 0.9999804496765137
caused O 0 0.4065978229045868
by O 0 0.027635183185338974
mutations O 0 0.08943676948547363
in O 0 0.01830614171922207
the O 0 0.023777682334184647
gene O 0 0.0937226414680481
encoding O 0 0.10161122679710388
phenylalanine O 1 0.6716808080673218
hydroxylase O 1 0.9899356961250305
( O 0 0.15931934118270874
PAH O 1 0.9997408986091614
) O 0 0.06262435764074326
. O 0 0.047778233885765076

Previous O 0 0.054419972002506256
studies O 0 0.037838809192180634
have O 0 0.016903609037399292
suggested O 0 0.026484375819563866
that O 0 0.012491906061768532
the O 0 0.01768394000828266
highly O 0 0.04807000234723091
variable O 0 0.13885469734668732
metabolic O 1 0.9967328310012817
phenotypes O 1 0.994144856929779
of O 0 0.15354777872562408
PAH B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999979734420776
correlate O 1 0.9100292921066284
with O 0 0.08760100603103638
PAH O 1 0.9999560117721558
genotypes O 1 0.9730103015899658
. O 0 0.07747559994459152

We O 0 0.03704259917140007
identified O 0 0.042176488786935806
both O 0 0.03251936659216881
causative O 1 0.9394034743309021
mutations O 0 0.29649481177330017
in O 0 0.03927893564105034
686 O 1 0.9869982004165649
patients O 1 0.9834433794021606
from O 0 0.025136442855000496
seven O 0 0.02802910842001438
European O 0 0.037559106945991516
centers O 0 0.061416931450366974
. O 0 0.04171109199523926

On O 0 0.021852530539035797
the O 0 0.014431416988372803
basis O 0 0.014333526603877544
of O 0 0.011403605341911316
the O 0 0.01715988479554653
phenotypic O 0 0.07783277332782745
characteristics O 0 0.044961120933294296
of O 0 0.0263021569699049
297 O 0 0.31764644384384155
functionally O 0 0.45531395077705383
hemizygous O 1 0.9878939986228943
patients O 1 0.9944379329681396
, O 0 0.021265605464577675
105 O 0 0.04011726751923561
of O 0 0.011956162750720978
the O 0 0.014821082353591919
mutations O 0 0.060768011957407
were O 0 0.010222322307527065
assigned O 0 0.019478168338537216
to O 0 0.008738281205296516
one O 0 0.008846393786370754
of O 0 0.00867999717593193
four O 0 0.01647345721721649
arbitrary O 0 0.04348868876695633
phenotype O 0 0.30576977133750916
categories O 0 0.05479612201452255
. O 0 0.04461576044559479

We O 0 0.03409654647111893
proposed O 0 0.03140583634376526
and O 0 0.015076755546033382
tested O 0 0.043905116617679596
a O 0 0.018052250146865845
simple O 0 0.025048047304153442
model O 0 0.024430520832538605
for O 0 0.015546056441962719
correlation O 0 0.058415766805410385
between O 0 0.027219822630286217
genotype O 0 0.22940579056739807
and O 0 0.027900446206331253
phenotypic O 0 0.1086503341794014
outcome O 0 0.07725387811660767
. O 0 0.04729820787906647

The O 0 0.0547737255692482
observed O 0 0.09248962253332138
phenotype O 1 0.5398385524749756
matched O 0 0.07988583296537399
the O 0 0.029586613178253174
predicted O 0 0.0701470896601677
phenotype O 0 0.15893420577049255
in O 0 0.02039221115410328
79 O 0 0.046756207942962646
% O 0 0.018317312002182007
of O 0 0.008518547751009464
the O 0 0.010188913904130459
cases O 0 0.019148828461766243
, O 0 0.00960481632500887
and O 0 0.007374041248112917
in O 0 0.008185177110135555
only O 0 0.010402745567262173
5 O 0 0.019811972975730896
of O 0 0.013236640952527523
184 O 0 0.07076750695705414
patients O 1 0.9119216799736023
was O 0 0.018085936084389687
the O 0 0.017102375626564026
observed O 0 0.04277662932872772
phenotype O 0 0.12619782984256744
more O 0 0.0138001199811697
than O 0 0.01181731279939413
one O 0 0.011046460829675198
category O 0 0.025845980271697044
away O 0 0.018724922090768814
from O 0 0.013482285663485527
that O 0 0.012707826681435108
expected O 0 0.030796051025390625
. O 0 0.03710034117102623

Among O 0 0.03733190894126892
the O 0 0.020972516387701035
seven O 0 0.025525163859128952
contributing O 0 0.042001236230134964
centers O 0 0.03371059149503708
, O 0 0.011706496588885784
the O 0 0.011670377105474472
proportion O 0 0.03128238767385483
of O 0 0.01585366204380989
patients O 1 0.9053364992141724
for O 0 0.01506138313561678
whom O 0 0.028751496225595474
the O 0 0.020896758884191513
observed O 0 0.04682884365320206
phenotype O 0 0.30049368739128113
did O 0 0.02240658737719059
not O 0 0.012345853261649609
match O 0 0.02503778040409088
the O 0 0.017870184034109116
predicted O 0 0.055562566965818405
phenotype O 0 0.14108750224113464
was O 0 0.02145993895828724
4 O 0 0.02833789587020874
% O 0 0.030865903943777084
- O 0 0.06075890362262726
23 O 0 0.03929140791296959
% O 0 0.04235915094614029
( O 0 0.055573202669620514
P O 1 0.8148455023765564
< O 1 0.5045809149742126
. O 0 0.03316279128193855
0001 O 1 0.5443610548973083
) O 0 0.02668027952313423
, O 0 0.013207251206040382
suggesting O 0 0.024862032383680344
that O 0 0.009180658496916294
differences O 0 0.01749001257121563
in O 0 0.010832847096025944
methods O 0 0.020227354019880295
used O 0 0.017361339181661606
for O 0 0.02326478622853756
mutation O 0 0.35789647698402405
detection O 0 0.18610836565494537
or O 0 0.04491320997476578
phenotype O 1 0.9829962849617004
classification O 0 0.10051119327545166
may O 0 0.0271234679967165
account O 0 0.017744051292538643
for O 0 0.011708293110132217
a O 0 0.0188426710665226
considerable O 0 0.03569061681628227
proportion O 0 0.04650037735700607
of O 0 0.03225070983171463
genotype O 1 0.9788316488265991
- O 1 0.8017243146896362
phenotype O 1 0.9651116728782654
inconsistencies O 0 0.1245896965265274
. O 0 0.057315316051244736

Our O 0 0.036296434700489044
data O 0 0.02785126306116581
indicate O 0 0.034951794892549515
that O 0 0.01633494906127453
the O 0 0.032464731484651566
PAH O 1 0.9999761581420898
- O 1 0.6965063214302063
mutation O 0 0.4236209988594055
genotype O 0 0.22862885892391205
is O 0 0.019681399688124657
the O 0 0.014955554157495499
main O 0 0.024756645783782005
determinant O 0 0.08138824999332428
of O 0 0.027717141434550285
metabolic O 1 0.9850260615348816
phenotype O 1 0.9624118804931641
in O 0 0.027747126296162605
most O 0 0.03099619783461094
patients O 1 0.9998443126678467
with O 1 0.647052526473999
PAH B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999961853027344
. O 0 0.08325839042663574

In O 0 0.023507963865995407
the O 0 0.017021428793668747
present O 0 0.01972411572933197
study O 0 0.024425679817795753
, O 0 0.012526752427220345
the O 0 0.014103299006819725
classification O 0 0.05488727614283562
of O 0 0.024690955877304077
105 O 1 0.6653993725776672
PAH O 1 0.9999504089355469
mutations O 0 0.3814258575439453
may O 0 0.034592583775520325
allow O 0 0.022522279992699623
the O 0 0.01721840724349022
prediction O 0 0.04330528527498245
of O 0 0.01346820592880249
the O 0 0.021383289247751236
biochemical O 0 0.10790316760540009
phenotype O 1 0.7040392756462097
in O 0 0.032399967312812805
> O 0 0.11629799008369446
10 O 0 0.027926376089453697
, O 0 0.02077423222362995
000 O 0 0.05929939076304436
genotypes O 0 0.13934628665447235
, O 0 0.017660852521657944
which O 0 0.01256587728857994
may O 0 0.015805300325155258
be O 0 0.007259732577949762
useful O 0 0.014375914819538593
for O 0 0.008885025978088379
the O 0 0.012511048465967178
management O 0 0.03454267978668213
of O 0 0.02088615484535694
hyperphenylalaninemia B-Disease 1 0.9737750887870789
in O 0 0.03419478237628937
newborns O 1 0.9575391411781311
. O 0 0.04946857690811157

Somatic O 1 0.5956266522407532
instability O 0 0.1337483674287796
of O 0 0.02404719963669777
the O 0 0.035801324993371964
CTG O 1 0.9069200754165649
repeat O 0 0.09999999403953552
in O 0 0.02999376691877842
mice O 0 0.14376553893089294
transgenic O 0 0.08794904500246048
for O 0 0.02726108580827713
the O 0 0.05022100359201431
myotonic B-Disease 1 0.9999978542327881
dystrophy I-Disease 1 0.9999996423721313
region O 0 0.08456330746412277
is O 0 0.02648969367146492
age O 0 0.032725803554058075
dependent O 0 0.04050774872303009
but O 0 0.012777111493051052
not O 0 0.012001264840364456
correlated O 0 0.05241731181740761
to O 0 0.014043117873370647
the O 0 0.01745581068098545
relative O 0 0.0569424107670784
intertissue O 0 0.2317403107881546
transcription O 0 0.11380989104509354
levels O 0 0.06706651300191879
and O 0 0.03611467406153679
proliferative O 1 0.9989381432533264
capacities O 0 0.10782700031995773
. O 0 0.05651631951332092

A O 0 0.0804007276892662
( O 0 0.0779627114534378
CTG O 1 0.8244264125823975
) O 0 0.046091146767139435
nexpansion O 0 0.10223058611154556
in O 0 0.01833243854343891
the O 0 0.01992415264248848
3 O 0 0.04422915726900101
- O 0 0.091023750603199
untranslated O 0 0.18302689492702484
region O 0 0.07155947387218475
( O 0 0.05390772968530655
UTR O 0 0.16123135387897491
) O 0 0.02925112284719944
of O 0 0.018586063757538795
the O 0 0.037022024393081665
DM O 1 0.9999209642410278
protein O 0 0.15777787566184998
kinase O 1 0.763674795627594
gene O 0 0.1321418583393097
( O 0 0.05860969051718712
DMPK O 0 0.3231816291809082
) O 0 0.031621526926755905
is O 0 0.019955987110733986
responsible O 0 0.03513916954398155
for O 0 0.0314180888235569
causing O 1 0.9989485144615173
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 1.0
( O 1 0.993108868598938
DM B-Disease 1 0.9999926090240479
) O 0 0.07455229014158249
. O 0 0.053759705275297165

Major O 0 0.06397755444049835
instability O 0 0.09901666641235352
, O 0 0.016706004738807678
with O 0 0.013131784275174141
very O 0 0.015230187214910984
large O 0 0.01938793994486332
expansions O 0 0.047142237424850464
between O 0 0.01897856779396534
generations O 0 0.030844997614622116
and O 0 0.014939314685761929
high O 0 0.030761880800127983
levels O 0 0.042380135506391525
of O 0 0.02547169290482998
somatic O 1 0.7462839484214783
mosaicism O 1 0.989446759223938
, O 0 0.024723628535866737
is O 0 0.021434985101222992
observed O 0 0.036021701991558075
in O 0 0.02654360607266426
patients O 1 0.9879013299942017
. O 0 0.048114027827978134

There O 0 0.025994637981057167
is O 0 0.018076535314321518
a O 0 0.02019965462386608
good O 0 0.03011668287217617
correlation O 0 0.05501449480652809
between O 0 0.02443252131342888
repeat O 0 0.06728441268205643
size O 0 0.033301062881946564
( O 0 0.026700198650360107
at O 0 0.0178076084703207
least O 0 0.01774412766098976
in O 0 0.017072631046175957
leucocytes O 0 0.308603972196579
) O 0 0.03239067271351814
, O 0 0.024223318323493004
clinical O 1 0.8215675354003906
severity O 1 0.9368804097175598
and O 0 0.021545670926570892
age O 0 0.03733957186341286
of O 0 0.028977783396840096
onset O 1 0.9983567595481873
. O 0 0.05986875668168068

The O 0 0.07669141888618469
trinucleotide O 1 0.9913508892059326
repeat O 0 0.3189544379711151
instability O 0 0.36236435174942017
mechanisms O 0 0.07531844079494476
involved O 0 0.03856069594621658
in O 0 0.029338067397475243
DM B-Disease 1 0.9999915361404419
and O 0 0.017429005354642868
other O 0 0.01672341674566269
human O 0 0.05064929649233818
genetic B-Disease 1 0.9943161606788635
diseases I-Disease 1 0.9999278783798218
are O 0 0.026528703048825264
unknown O 0 0.05461347475647926
. O 0 0.04006857052445412

We O 0 0.05446174740791321
studied O 0 0.06666679680347443
somatic O 0 0.17364928126335144
instability O 0 0.11851348727941513
by O 0 0.029336564242839813
measuring O 0 0.057499583810567856
the O 0 0.0316532738506794
CTG O 1 0.7504680752754211
repeat O 0 0.08444905281066895
length O 0 0.033615972846746445
at O 0 0.01712229661643505
several O 0 0.012669684365391731
ages O 0 0.029910854995250702
in O 0 0.011706274002790451
various O 0 0.01582479290664196
tissues O 0 0.06653793156147003
of O 0 0.021776435896754265
transgenic O 0 0.10193167626857758
mice O 0 0.11621472984552383
carrying O 0 0.04284718260169029
a O 0 0.03430372104048729
( O 0 0.05541878938674927
CTG O 1 0.9008616209030151
) O 0 0.047678105533123016
55expansion O 0 0.11753345280885696
surrounded O 0 0.04830721765756607
by O 0 0.02064274065196514
45 O 0 0.03482023626565933
kb O 0 0.07084180414676666
of O 0 0.01712695136666298
the O 0 0.021801896393299103
human O 0 0.053300414234399796
DM B-Disease 1 0.9999561309814453
region O 0 0.0511711984872818
, O 0 0.019331593066453934
using O 0 0.023485863581299782
small O 0 0.035603322088718414
- O 0 0.09921219944953918
pool O 0 0.12648335099220276
PCR O 0 0.2104000747203827
. O 0 0.05876218155026436

These O 0 0.03944936767220497
mice O 0 0.10069525986909866
have O 0 0.017957555130124092
been O 0 0.013891387730836868
shown O 0 0.022067736834287643
to O 0 0.013069702312350273
reproduce O 0 0.041914328932762146
the O 0 0.019713090732693672
intergenerational O 0 0.12929794192314148
and O 0 0.026476606726646423
somatic O 0 0.13730062544345856
instability O 0 0.08528716117143631
of O 0 0.017070597037672997
the O 0 0.023695483803749084
55 O 0 0.06865954399108887
CTG O 1 0.9738450646400452
repeat O 0 0.10107988119125366
suggesting O 0 0.053718168288469315
that O 0 0.01747988536953926
surrounding O 0 0.034020330756902695
sequences O 0 0.035743217915296555
and O 0 0.014630942605435848
the O 0 0.018031088635325432
chromatin O 0 0.07200662046670914
environment O 0 0.02976679801940918
are O 0 0.01157889049500227
involved O 0 0.023451101034879684
in O 0 0.018985342234373093
instability O 0 0.1994878649711609
mechanisms O 0 0.08388485014438629
. O 0 0.04482714459300041

As O 0 0.02984391339123249
observed O 0 0.03252466768026352
in O 0 0.012592730112373829
some O 0 0.01001707836985588
of O 0 0.00948245171457529
the O 0 0.018325895071029663
tissues O 0 0.31247678399086
of O 0 0.03615512698888779
DM B-Disease 1 0.9999992847442627
patients O 1 0.9993512034416199
, O 0 0.017017066478729248
there O 0 0.012644692324101925
is O 0 0.012412333860993385
a O 0 0.01590467430651188
tendency O 0 0.04819277301430702
for O 0 0.016731150448322296
repeat O 0 0.06295415759086609
length O 0 0.03677063807845116
and O 0 0.021733667701482773
somatic O 0 0.14822791516780853
mosaicism O 1 0.8541735410690308
to O 0 0.017629319801926613
increase O 0 0.020118430256843567
with O 0 0.010178733617067337
the O 0 0.010710225440561771
age O 0 0.02172757126390934
of O 0 0.012658052146434784
the O 0 0.023463638499379158
mouse O 0 0.11256597936153412
. O 0 0.04688900336623192

Furthermore O 0 0.07339327037334442
, O 0 0.021707309409976006
we O 0 0.016611691564321518
observed O 0 0.027632199227809906
no O 0 0.017096634954214096
correlation O 0 0.047798097133636475
between O 0 0.021366126835346222
the O 0 0.025142479687929153
somatic O 0 0.27865153551101685
mutation O 0 0.4668208956718445
rate O 0 0.05888121575117111
and O 0 0.0273943729698658
tissue O 1 0.8366467952728271
proliferation O 0 0.1273498833179474
capacity O 0 0.04779451712965965
. O 0 0.03941402584314346

The O 0 0.06236301362514496
somatic O 0 0.29536333680152893
mutation O 0 0.28381744027137756
rates O 0 0.05972724035382271
in O 0 0.017598619684576988
different O 0 0.015298091806471348
tissues O 0 0.04941628500819206
were O 0 0.011456460691988468
also O 0 0.011680138297379017
not O 0 0.01125538069754839
correlated O 0 0.04498032480478287
to O 0 0.012418367899954319
the O 0 0.014262143522500992
relative O 0 0.03914007544517517
inter O 0 0.0772719606757164
- O 0 0.1344749927520752
tissue O 0 0.20865774154663086
difference O 0 0.04316035285592079
in O 0 0.02073693834245205
transcriptional O 0 0.08165279775857925
levels O 0 0.03360627591609955
of O 0 0.011305446736514568
the O 0 0.014400914311408997
three O 0 0.023579128086566925
genes O 0 0.07153573632240295
( O 0 0.04924166202545166
DMAHP O 1 0.662865936756134
, O 0 0.02678092196583748
DMPK O 0 0.15537628531455994
and O 0 0.02192501723766327
59 O 0 0.04298557713627815
) O 0 0.02574860490858555
surrounding O 0 0.030238503590226173
the O 0 0.018372900784015656
repeat O 0 0.07455617189407349
. O 0 0.02897404320538044
. O 0 0.037566959857940674

A O 0 0.08283048868179321
novel O 0 0.09730324894189835
missense O 1 0.725906252861023
mutation O 1 0.5590958595275879
in O 0 0.04110147804021835
patients O 1 0.9884257316589355
from O 0 0.026277363300323486
a O 0 0.04232337325811386
retinoblastoma B-Disease 1 0.99662846326828
pedigree O 0 0.13679568469524384
showing O 0 0.049350518733263016
only O 0 0.025187533348798752
mild O 1 0.6317393779754639
expression O 0 0.04344691336154938
of O 0 0.01954304799437523
the O 0 0.038782861083745956
tumor B-Disease 1 0.9983465671539307
phenotype O 1 0.9792650938034058
. O 0 0.07132325321435928

We O 0 0.0267049428075552
have O 0 0.016646765172481537
used O 0 0.020769132301211357
single O 0 0.03610115870833397
strand O 0 0.09074332565069199
conformation O 0 0.10214335471391678
polymorphism O 0 0.09779337048530579
analysis O 0 0.033686719834804535
to O 0 0.01606273278594017
study O 0 0.02306462451815605
the O 0 0.01489981822669506
27 O 0 0.03129281848669052
exons O 0 0.06966859102249146
of O 0 0.018229879438877106
the O 0 0.027656305581331253
RB1 O 1 0.9956918358802795
gene O 0 0.07542244344949722
in O 0 0.015561300329864025
individuals O 0 0.021093172952532768
from O 0 0.01596638560295105
a O 0 0.02054644376039505
family O 0 0.03539910167455673
showing O 0 0.05399944633245468
mild O 1 0.7464150190353394
expression O 0 0.046411264687776566
of O 0 0.021380562335252762
the O 0 0.03906770795583725
retinoblastoma B-Disease 1 0.9967314004898071
phenotype O 1 0.9812681078910828
. O 0 0.0670732706785202

In O 0 0.03124784491956234
this O 0 0.018743081018328667
family O 0 0.03933900594711304
affected O 0 0.05813005194067955
individuals O 0 0.039131272584199905
developed O 0 0.05972481891512871
unilateral B-Disease 1 0.8202721476554871
tumors I-Disease 1 0.9998185038566589
and O 0 0.018165603280067444
, O 0 0.012700052000582218
as O 0 0.009901601821184158
a O 0 0.014917529188096523
result O 0 0.02196515165269375
of O 0 0.016216078773140907
linkage O 0 0.11005629599094391
analysis O 0 0.046848852187395096
, O 0 0.030374620109796524
unaffected O 0 0.4682803153991699
mutation O 0 0.25401026010513306
carriers O 0 0.07510558515787125
were O 0 0.016046304255723953
also O 0 0.0135577991604805
identified O 0 0.025990374386310577
within O 0 0.021163858473300934
the O 0 0.021719830110669136
pedigree O 0 0.11650034040212631
. O 0 0.04825170710682869

A O 0 0.053418584167957306
single O 0 0.049882836639881134
band O 0 0.057436030358076096
shift O 0 0.060805004090070724
using O 0 0.031306393444538116
SSCP O 0 0.12526175379753113
was O 0 0.02249923162162304
identified O 0 0.03047938272356987
in O 0 0.01828094571828842
exon O 0 0.08705844730138779
21 O 0 0.03192596137523651
which O 0 0.015920765697956085
resulted O 0 0.03693828731775284
in O 0 0.019882120192050934
a O 0 0.0380869098007679
missense O 0 0.20442870259284973
mutation O 0 0.1757141649723053
converting O 0 0.07626895606517792
a O 0 0.055806633085012436
cys O 1 0.9992234706878662
- O 1 0.9538818001747131
- O 1 0.7966416478157043
> O 1 0.836455762386322
arg O 1 0.879321813583374
at O 0 0.041222356259822845
nucleotide O 0 0.07762805372476578
position O 0 0.025430602952837944
28 O 0 0.026159193366765976
in O 0 0.013706091791391373
the O 0 0.022072874009609222
exon O 0 0.1358996033668518
. O 0 0.05745411664247513

The O 0 0.06484849005937576
mutation O 0 0.17111380398273468
destroyed O 0 0.07136731594800949
an O 0 0.03980462625622749
NdeI O 0 0.20590625703334808
restriction O 0 0.09599882364273071
enzyme O 0 0.1269637644290924
site O 0 0.059910379350185394
. O 0 0.04877939075231552

Analysis O 0 0.046690430492162704
of O 0 0.014903507195413113
all O 0 0.0111393379047513
family O 0 0.022884806618094444
members O 0 0.018950074911117554
demonstrated O 0 0.031076522544026375
that O 0 0.014697852544486523
the O 0 0.027177147567272186
missense O 1 0.6757609248161316
mutation O 1 0.9271560907363892
co O 1 0.6467081308364868
- O 0 0.13912948966026306
segregated O 0 0.10595759004354477
with O 0 0.03630439192056656
patients O 1 0.999415397644043
with O 0 0.0335179902613163
tumors B-Disease 1 0.9999527931213379
or O 0 0.02045305445790291
who O 0 0.013785234652459621
, O 0 0.010007012635469437
as O 0 0.008094844408333302
a O 0 0.012818209826946259
result O 0 0.021077647805213928
of O 0 0.012962757609784603
linkage O 0 0.0728008821606636
analysis O 0 0.025687921792268753
had O 0 0.015841184183955193
been O 0 0.01308817882090807
predicted O 0 0.028148576617240906
to O 0 0.013518698513507843
carry O 0 0.029077671468257904
the O 0 0.030187785625457764
predisposing O 0 0.3247724175453186
mutation O 0 0.33670830726623535
. O 0 0.06458849459886551

These O 0 0.02357516996562481
observations O 0 0.03414636477828026
point O 0 0.01878318376839161
to O 0 0.011774446815252304
another O 0 0.018409639596939087
region O 0 0.030788948759436607
of O 0 0.015978476032614708
the O 0 0.029369179159402847
RB1 O 1 0.9976645708084106
gene O 0 0.10610532015562057
where O 0 0.03032650798559189
mutations O 0 0.08075592666864395
only O 0 0.013703621923923492
modify O 0 0.03792482614517212
the O 0 0.014421693980693817
function O 0 0.022108031436800957
of O 0 0.010870067402720451
the O 0 0.015346841886639595
gene O 0 0.054988980293273926
and O 0 0.013994121924042702
raise O 0 0.0336737185716629
important O 0 0.017179686576128006
questions O 0 0.024211058393120766
for O 0 0.017017750069499016
genetic O 0 0.0656203031539917
counseling O 0 0.15465021133422852
in O 0 0.016145484521985054
families O 0 0.027360444888472557
with O 0 0.016345739364624023
these O 0 0.018454229459166527
distinctive O 0 0.06699929386377335
phenotypes O 0 0.3636308014392853
. O 0 0.034015998244285583
. O 0 0.04396550729870796

Maternal B-Disease 1 0.9456907510757446
disomy I-Disease 1 0.9918448328971863
and O 0 0.3905208706855774
Prader B-Disease 1 0.999998927116394
- I-Disease 1 0.999941349029541
Willi I-Disease 1 0.9999983310699463
syndrome I-Disease 1 0.9999980926513672
consistent O 0 0.08793022483587265
with O 0 0.04256627708673477
gamete O 1 0.9420033097267151
complementation O 1 0.9867652654647827
in O 0 0.022691970691084862
a O 0 0.02395583502948284
case O 0 0.028329046443104744
of O 0 0.022949114441871643
familial O 1 0.995652437210083
translocation O 1 0.7363678216934204
( O 0 0.04513522982597351
3 O 0 0.03194127604365349
; O 0 0.023846957832574844
15 O 0 0.027039794251322746
) O 0 0.032301779836416245
( O 0 0.04707010090351105
p25 O 1 0.78331059217453
; O 0 0.03881489858031273
q11 O 0 0.10469979047775269
. O 0 0.02224021404981613
2 O 0 0.03509039804339409
) O 0 0.03575495257973671
. O 0 0.03733079507946968

Maternal B-Disease 1 0.9851827025413513
uniparental I-Disease 1 0.9989748001098633
disomy I-Disease 1 0.9821957945823669
( I-Disease 0 0.10069190710783005
UPD I-Disease 1 0.9991280436515808
) I-Disease 0 0.03585711494088173
for I-Disease 0 0.017703764140605927
chromosome I-Disease 0 0.08756954967975616
15 I-Disease 0 0.021843651309609413
is O 0 0.011188477277755737
responsible O 0 0.016465434804558754
for O 0 0.009269073605537415
an O 0 0.011204899288713932
estimated O 0 0.023074934259057045
30 O 0 0.01905420422554016
% O 0 0.018731024116277695
of O 0 0.012257244437932968
cases O 0 0.039326123893260956
of O 0 0.047364167869091034
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999823570251465
Willi I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9459130167961121
PWS B-Disease 1 0.9999600648880005
) O 0 0.07405546307563782
. O 0 0.05230982229113579

We O 0 0.024713706225156784
report O 0 0.01987755484879017
on O 0 0.01242993026971817
an O 0 0.01258095633238554
unusual O 0 0.027020154520869255
case O 0 0.024770285934209824
of O 0 0.020472772419452667
maternal B-Disease 0 0.17037878930568695
disomy I-Disease 0 0.48332542181015015
15 I-Disease 0 0.03442792966961861
in O 0 0.02413831278681755
PWS B-Disease 1 0.9997504353523254
that O 0 0.015760954469442368
is O 0 0.012751597911119461
most O 0 0.010770677588880062
consistent O 0 0.02421792969107628
with O 0 0.014358023181557655
adjacent O 0 0.0333964005112648
- O 0 0.055931802839040756
1 O 0 0.03512537479400635
segregation O 0 0.060326069593429565
of O 0 0.017577987164258957
a O 0 0.03126407042145729
paternal O 0 0.13809476792812347
t O 1 0.6610370874404907
( O 0 0.04255765676498413
3 O 0 0.03698006272315979
; O 0 0.025273416191339493
15 O 0 0.03080062009394169
) O 0 0.03190312534570694
( O 0 0.04319733753800392
p25 O 1 0.8212988972663879
; O 0 0.03491007164120674
q11 O 0 0.0962316244840622
. O 0 0.0197425726801157
2 O 0 0.026021843776106834
) O 0 0.020932897925376892
with O 0 0.01845729537308216
simultaneous O 0 0.06354265660047531
maternal O 0 0.22769616544246674
meiotic O 1 0.9762516021728516
nondisjunction O 0 0.38346174359321594
for O 0 0.039410945028066635
chromosome O 0 0.1544407457113266
15 O 0 0.0639846995472908
. O 0 0.04818055406212807

The O 0 0.05986803397536278
patient O 1 0.9335499405860901
( O 0 0.06161236763000488
J O 1 0.7776426672935486
. O 0 0.02303219772875309
B O 0 0.053422246128320694
. O 0 0.014489561319351196
) O 0 0.015601101331412792
, O 0 0.009969253093004227
a O 0 0.014858602546155453
17 O 0 0.026488782837986946
- O 0 0.05342893302440643
year O 0 0.026334108784794807
- O 0 0.06396784633398056
old O 0 0.03796825930476189
white O 0 0.05314565822482109
male O 0 0.06377366185188293
with O 0 0.034701451659202576
PWS B-Disease 1 0.9999473094940186
, O 0 0.01939086616039276
was O 0 0.013995728455483913
found O 0 0.013651972636580467
to O 0 0.01069623976945877
have O 0 0.014061524532735348
47 O 0 0.03564373776316643
chromosomes O 0 0.05183981731534004
with O 0 0.01869550161063671
a O 0 0.026835201308131218
supernumerary O 0 0.12351875007152557
, O 0 0.032048072665929794
paternal O 0 0.13647611439228058
der O 0 0.37725839018821716
( O 0 0.0347408726811409
15 O 0 0.022009344771504402
) O 0 0.015700679272413254
consisting O 0 0.015856904909014702
of O 0 0.00962832197546959
the O 0 0.012777045369148254
short O 0 0.028750384226441383
arm O 0 0.055275071412324905
and O 0 0.014488102868199348
the O 0 0.018343083560466766
proximal O 1 0.8137819766998291
long O 0 0.05050394684076309
arm O 0 0.0772714838385582
of O 0 0.023290107026696205
chromosome O 0 0.10276613384485245
15 O 0 0.028644952923059464
, O 0 0.01889633946120739
and O 0 0.024128146469593048
distal O 1 0.9879647493362427
chromosome O 1 0.6875422596931458
arm O 1 0.8357043266296387
3p O 1 0.9722687005996704
. O 0 0.06600150465965271

The O 0 0.05409909784793854
t O 0 0.276574969291687
( O 0 0.04324840009212494
3 O 0 0.02817472442984581
; O 0 0.01940225437283516
15 O 0 0.019598860293626785
) O 0 0.01480621937662363
was O 0 0.009845815598964691
present O 0 0.01165988389402628
in O 0 0.007879621349275112
the O 0 0.009708746336400509
balanced O 0 0.028690263628959656
state O 0 0.013287559151649475
in O 0 0.012616642750799656
the O 0 0.01733480952680111
patients O 1 0.9512069821357727
father O 0 0.02776937186717987
and O 0 0.01648765616118908
a O 0 0.02587498165667057
sister O 0 0.059757791459560394
. O 0 0.042597487568855286

Fluorescent O 0 0.16738787293434143
in O 0 0.043590717017650604
situ O 0 0.15705159306526184
hybridization O 0 0.11519352346658707
analysis O 0 0.04623252898454666
demonstrated O 0 0.042118802666664124
that O 0 0.016816312447190285
the O 0 0.027726372703909874
PWS B-Disease 1 0.9998039603233337
critical O 0 0.051558561623096466
region O 0 0.04196007177233696
resided O 0 0.04832514375448227
on O 0 0.01404552161693573
the O 0 0.018510520458221436
derivative O 0 0.07727763801813126
chromosome O 0 0.0932588130235672
3 O 0 0.023215828463435173
and O 0 0.00876574870198965
that O 0 0.008055907674133778
there O 0 0.009733924642205238
was O 0 0.011104485020041466
no O 0 0.014964591711759567
deletion O 0 0.0676710307598114
of O 0 0.015084213577210903
the O 0 0.024245191365480423
PWS B-Disease 1 0.9996089339256287
region O 0 0.03751320764422417
on O 0 0.012173737399280071
the O 0 0.013857567682862282
normal O 0 0.03485359624028206
pair O 0 0.03477872908115387
of O 0 0.017715517431497574
15s O 0 0.11540394276380539
present O 0 0.034928057342767715
in O 0 0.03509598225355148
J O 1 0.7919459342956543
. O 0 0.05751318857073784

B O 0 0.19236847758293152
. O 0 0.07358774542808533

Methylation O 0 0.15025821328163147
analysis O 0 0.05272461101412773
at O 0 0.03228745609521866
exon O 0 0.08847212791442871
alpha O 0 0.04612910747528076
of O 0 0.013050243258476257
the O 0 0.01834181696176529
small O 0 0.03308848664164543
nuclear O 0 0.07048355787992477
ribonucleoprotein O 1 0.9739015102386475
- O 0 0.12258642166852951
associated O 0 0.06958461552858353
polypeptide O 0 0.16094298660755157
N O 0 0.1257435381412506
( O 0 0.0715990886092186
SNRPN O 1 0.6979357004165649
) O 0 0.043035876005887985
gene O 0 0.07054616510868073
showed O 0 0.03364696353673935
a O 0 0.02337145060300827
pattern O 0 0.05272858962416649
characteristic O 0 0.03757010027766228
of O 0 0.01248905248939991
only O 0 0.015956373885273933
the O 0 0.01998196542263031
maternal O 0 0.12344574928283691
chromosome O 0 0.1326458901166916
15 O 0 0.037666503340005875
in O 0 0.031594790518283844
J O 1 0.8989905118942261
. O 0 0.050714749842882156

B O 0 0.2097432017326355
. O 0 0.07503820955753326

Maternal B-Disease 0 0.3976867198944092
disomy I-Disease 0 0.20845024287700653
was O 0 0.03640450909733772
confirmed O 0 0.049888502806425095
by O 0 0.034181173890829086
polymerase O 0 0.1532914787530899
chain O 0 0.09549097716808319
reaction O 0 0.07500281184911728
analysis O 0 0.0344214104115963
of O 0 0.023881569504737854
microsatellite O 0 0.17659246921539307
repeats O 0 0.08957670629024506
at O 0 0.03235548734664917
the O 0 0.03126702085137367
gamma O 0 0.15303057432174683
- O 0 0.18133945763111115
aminobutyric O 1 0.7834864258766174
acid O 1 0.6246558427810669
receptor O 0 0.457390159368515
beta3 O 0 0.2710677683353424
subunit O 0 0.17028844356536865
( O 0 0.08075614273548126
GABRB3 O 0 0.4119791090488434
) O 0 0.05810987204313278
locus O 0 0.14133623242378235
. O 0 0.057330090552568436

A O 0 0.06888297200202942
niece O 0 0.14267732203006744
( O 0 0.059143275022506714
B O 0 0.07969118654727936
. O 0 0.02082841843366623
B O 0 0.054731689393520355
. O 0 0.013638541102409363
) O 0 0.017422359436750412
with O 0 0.013179679401218891
45 O 0 0.027757981792092323
chromosomes O 0 0.044527776539325714
and O 0 0.013366159982979298
the O 0 0.015684468671679497
derivative O 0 0.05660998448729515
3 O 0 0.02315467596054077
but O 0 0.011864470317959785
without O 0 0.015383531339466572
the O 0 0.017415780574083328
der O 0 0.13232775032520294
( O 0 0.028360828757286072
15 O 0 0.0224909745156765
) O 0 0.02323513850569725
demonstrated O 0 0.03536061570048332
a O 0 0.023976348340511322
phenotype O 0 0.17385540902614594
consistent O 0 0.0339033342897892
with O 0 0.013240933418273926
that O 0 0.010965408757328987
reported O 0 0.02630111761391163
for O 0 0.017239205539226532
haploinsufficiency O 0 0.11771315336227417
of O 0 0.02807316742837429
distal O 1 0.9706618189811707
3 O 0 0.07280970364809036
p O 0 0.14257264137268066
. O 0 0.048658885061740875

Uniparental B-Disease 1 0.9995654225349426
disomy I-Disease 1 0.9578055143356323
associated O 0 0.057063404470682144
with O 0 0.029780475422739983
unbalanced O 0 0.11962224543094635
segregation O 0 0.08234913647174835
of O 0 0.02398820035159588
non O 0 0.05832705646753311
- O 0 0.282661110162735
Robertsonian O 1 0.875044584274292
translocations O 0 0.30981096625328064
has O 0 0.02027679793536663
been O 0 0.015654416754841805
reported O 0 0.022417167201638222
previously O 0 0.014748083427548409
but O 0 0.009485125541687012
has O 0 0.009472021833062172
not O 0 0.0067607443779706955
, O 0 0.007159391883760691
to O 0 0.006708748172968626
our O 0 0.009631468914449215
knowledge O 0 0.01424538716673851
, O 0 0.009434091858565807
been O 0 0.010852137580513954
observed O 0 0.020064303651452065
in O 0 0.010614865459501743
a O 0 0.01801932044327259
case O 0 0.02970028668642044
of O 0 0.03072251006960869
PWS B-Disease 1 0.9998394250869751
. O 0 0.06567353010177612

Furthermore O 0 0.06772277504205704
, O 0 0.02062920108437538
our O 0 0.018437879160046577
findings O 0 0.028767000883817673
are O 0 0.011168211698532104
best O 0 0.017940526828169823
interpreted O 0 0.02536041848361492
as O 0 0.016401246190071106
true O 0 0.04535380005836487
gamete O 1 0.8865059018135071
complementation O 1 0.9934780597686768
resulting O 0 0.08800768852233887
in O 0 0.040743909776210785
maternal B-Disease 1 0.8415618538856506
UPD I-Disease 1 0.9991394281387329
15 I-Disease 0 0.07383985072374344
and O 0 0.063706174492836
PWS B-Disease 1 0.999833345413208

Schwartz B-Disease 1 0.9920791983604431
- I-Disease 1 0.9918796420097351
Jampel I-Disease 1 0.9988371729850769
syndrome I-Disease 1 0.9999948740005493
type I-Disease 0 0.12210038304328918
2 I-Disease 0 0.04661603644490242
and O 0 0.031064363196492195
Stuve B-Disease 1 0.9994909763336182
- I-Disease 1 0.9991558790206909
Wiedemann I-Disease 1 0.9999504089355469
syndrome I-Disease 1 0.9999969005584717
: O 0 0.03468736261129379
a O 0 0.018904874101281166
case O 0 0.020859766751527786
for O 0 0.015143126249313354
" O 0 0.024074673652648926
lumping O 0 0.09957043826580048
" O 0 0.03526505455374718
. O 0 0.0377078652381897

Recent O 0 0.06831027567386627
studies O 0 0.048803187906742096
demonstrated O 0 0.038330044597387314
the O 0 0.015051646158099174
existence O 0 0.02105126716196537
of O 0 0.011822625994682312
a O 0 0.019631844013929367
genetically O 0 0.047492995858192444
distinct O 0 0.04134581610560417
, O 0 0.020291157066822052
usually O 0 0.026790978386998177
lethal O 0 0.06776297837495804
form O 0 0.024704813957214355
of O 0 0.015600224956870079
the O 0 0.02932845614850521
Schwartz B-Disease 1 0.9942929744720459
- I-Disease 1 0.9980214834213257
Jampel I-Disease 1 0.9998505115509033
syndrome I-Disease 1 0.9999996423721313
( O 1 0.8710800409317017
SJS B-Disease 1 0.9999547004699707
) O 0 0.05324363335967064
of O 0 0.030281441286206245
myotonia B-Disease 1 0.9999217987060547
and O 0 0.04610928148031235
skeletal B-Disease 1 0.9991356730461121
dysplasia I-Disease 1 0.9999558925628662
, O 0 0.02653496339917183
which O 0 0.0207591000944376
we O 0 0.022701915353536606
called O 0 0.048122067004442215
SJS B-Disease 1 0.9997758269309998
type I-Disease 0 0.09131330996751785
2 I-Disease 0 0.05158400908112526
. O 0 0.04518338292837143

This O 0 0.05464275926351547
disorder O 1 0.9989857077598572
is O 0 0.025399448350071907
reminiscent O 0 0.053007882088422775
of O 0 0.014838834293186665
another O 0 0.024571696296334267
rare O 0 0.04620278626680374
condition O 0 0.07921002060174942
, O 0 0.019900839775800705
the O 0 0.029753699898719788
Stuve B-Disease 1 0.99953293800354
- I-Disease 1 0.999561607837677
Wiedemann I-Disease 1 0.9999508857727051
syndrome I-Disease 1 0.9999992847442627
( O 0 0.17397768795490265
SWS B-Disease 1 0.9977647066116333
) O 0 0.031723324209451675
, O 0 0.015184669755399227
which O 0 0.014729015529155731
comprises O 0 0.032126203179359436
campomelia B-Disease 0 0.13101311028003693
at O 0 0.034092824906110764
birth O 0 0.058686502277851105
with O 0 0.036459583789110184
skeletal B-Disease 1 0.9997819066047668
dysplasia I-Disease 1 0.999996542930603
, O 0 0.04717855155467987
contractures B-Disease 1 0.999337375164032
, O 0 0.02148299105465412
and O 0 0.016247602179646492
early B-Disease 0 0.031003538519144058
death I-Disease 0 0.05025199055671692
. O 0 0.0403742715716362

To O 0 0.029830152168869972
test O 0 0.04337623342871666
for O 0 0.01675388403236866
possible O 0 0.031905509531497955
nosologic O 0 0.1134943887591362
identity O 0 0.03429336100816727
between O 0 0.02080971747636795
these O 0 0.01967702992260456
disorders O 1 0.9995858073234558
, O 0 0.01657254807651043
we O 0 0.011098286136984825
reviewed O 0 0.017938291653990746
the O 0 0.009746959432959557
literature O 0 0.01468873955309391
and O 0 0.00871849525719881
obtained O 0 0.01594267599284649
a O 0 0.014411909505724907
follow O 0 0.021983113139867783
- O 0 0.029767757281661034
up O 0 0.010979220271110535
of O 0 0.007857115939259529
the O 0 0.008965171873569489
only O 0 0.010766655206680298
two O 0 0.012826206162571907
surviving O 0 0.04645060747861862
patients O 1 0.9671409130096436
, O 0 0.017697056755423546
one O 0 0.017717251554131508
with O 0 0.03061523102223873
SJS B-Disease 1 0.9998465776443481
type I-Disease 0 0.06326717883348465
2 I-Disease 0 0.027005312964320183
at O 0 0.018076330423355103
age O 0 0.019489159807562828
10 O 0 0.016029080376029015
years O 0 0.013601488433778286
and O 0 0.011007599532604218
another O 0 0.0191683080047369
with O 0 0.021206507459282875
SWS B-Disease 1 0.9783927202224731
at O 0 0.03038731776177883
age O 0 0.03536739945411682
7 O 0 0.03571682795882225
years O 0 0.02749970182776451
. O 0 0.032667119055986404

Patients O 1 0.9975626468658447
reported O 0 0.058275382965803146
as O 0 0.024237897247076035
having O 0 0.043069031089544296
either O 0 0.07004395127296448
neonatal O 1 0.9999762773513794
SJS B-Disease 1 0.9999327659606934
or O 0 0.06648692488670349
SWS B-Disease 1 0.9889931082725525
presented O 0 0.0369538888335228
a O 0 0.02353447675704956
combination O 0 0.051339879631996155
of O 0 0.018603824079036713
a O 0 0.03157148137688637
severe O 1 0.9994031190872192
, O 0 0.07460517436265945
prenatal O 1 0.9999825954437256
- O 1 0.9999457597732544
onset O 1 0.999998927116394
neuromuscular B-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999991655349731
( O 1 0.707575798034668
with O 0 0.09559600055217743
congenital B-Disease 1 0.9999996423721313
joint I-Disease 1 0.9989383816719055
contractures I-Disease 1 0.9999922513961792
, O 0 0.18421301245689392
respiratory O 1 0.999994158744812
and O 0 0.027712566778063774
feeding O 0 0.08447425067424774
difficulties O 0 0.07495356351137161
, O 0 0.023397548124194145
tendency O 0 0.07210715115070343
to O 0 0.02808471769094467
hyperthermia B-Disease 1 0.9996746778488159
, O 0 0.018410366028547287
and O 0 0.016073526814579964
frequent O 0 0.05508230999112129
death O 0 0.03964164853096008
in O 0 0.02002047374844551
infancy O 0 0.08480654656887054
) O 0 0.024749591946601868
with O 0 0.015336237847805023
a O 0 0.02788856253027916
distinct O 0 0.06975255906581879
campomelic B-Disease 1 0.9843308329582214
- I-Disease 1 0.9620652794837952
metaphyseal I-Disease 1 0.9944427609443665
skeletal I-Disease 1 0.99898761510849
dysplasia I-Disease 1 0.9999581575393677
. O 0 0.08008960634469986

The O 0 0.031460437923669815
similarity O 0 0.049566712230443954
of O 0 0.015206104144454002
the O 0 0.019456224516034126
clinical O 0 0.1756635308265686
and O 0 0.023704132065176964
radiographic O 1 0.9568449258804321
findings O 0 0.046253643929958344
is O 0 0.01696689799427986
so O 0 0.015557182021439075
extensive O 0 0.027780046686530113
that O 0 0.01356420386582613
these O 0 0.01705188676714897
disorders O 1 0.9989579916000366
appear O 0 0.025016244500875473
to O 0 0.0092239398509264
be O 0 0.009191378951072693
a O 0 0.016242818906903267
single O 0 0.030292268842458725
entity O 0 0.05918586999177933
. O 0 0.04227635636925697

The O 0 0.036916956305503845
follow O 0 0.04537013918161392
- O 0 0.05834376811981201
up O 0 0.021488329395651817
observation O 0 0.03714242950081825
of O 0 0.010397136211395264
an O 0 0.011648327112197876
identical O 0 0.024845361709594727
and O 0 0.01414535753428936
unique O 0 0.029780574142932892
pattern O 0 0.05089643597602844
of O 0 0.02550535462796688
progressive O 1 0.9716286063194275
bone B-Disease 1 0.9998393058776855
dysplasia I-Disease 1 0.999962329864502
in O 0 0.02149703912436962
the O 0 0.014061518013477325
two O 0 0.01881355606019497
patients O 1 0.9868740439414978
( O 0 0.030129985883831978
one O 0 0.016736706718802452
with O 0 0.02751246653497219
SJS B-Disease 1 0.9998026490211487
type I-Disease 0 0.060556091368198395
2 I-Disease 0 0.024956710636615753
, O 0 0.013283971697092056
one O 0 0.015694689005613327
with O 0 0.025887461379170418
SWS B-Disease 1 0.9954883456230164
) O 0 0.03965919464826584
surviving O 0 0.05506991222500801
beyond O 0 0.04902750626206398
infancy O 0 0.09326547384262085
adds O 0 0.042686909437179565
to O 0 0.011130964383482933
the O 0 0.01080307923257351
evidence O 0 0.015553266741335392
in O 0 0.012639056891202927
favor O 0 0.02115490287542343
of O 0 0.015973107889294624
identity O 0 0.04624443128705025
. O 0 0.03984266147017479

The O 0 0.0448850616812706
hypothesis O 0 0.097188800573349
that O 0 0.03770768642425537
SWS B-Disease 1 0.99729984998703
and O 0 0.05138538405299187
SJS B-Disease 1 0.9997854828834534
type I-Disease 0 0.06659743189811707
2 I-Disease 0 0.02765556611120701
are O 0 0.0107258390635252
the O 0 0.01425844430923462
same O 0 0.02337087132036686
disorder O 1 0.9989234805107117
should O 0 0.02068742737174034
be O 0 0.013285070657730103
testable O 0 0.050665583461523056
by O 0 0.018714861944317818
molecular O 0 0.04978124052286148
methods O 0 0.03363357111811638
. O 0 0.02453051134943962
. O 0 0.03791552037000656

A O 0 0.07451679557561874
mouse O 0 0.13372501730918884
model O 0 0.06276165693998337
of O 0 0.03776862099766731
severe O 1 0.9999840259552002
von B-Disease 1 0.9999946355819702
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999997615814209
: O 0 0.3403576910495758
defects O 1 0.9968558549880981
in O 0 0.04555146396160126
hemostasis O 1 0.9996163845062256
and O 0 0.06689099222421646
thrombosis B-Disease 1 0.9999864101409912
. O 0 0.06793361157178879

von B-Disease 1 0.9932977557182312
Willebrand I-Disease 1 0.999826967716217
factor I-Disease 1 0.9285706877708435
( I-Disease 1 0.8088680505752563
vWf I-Disease 1 0.999901294708252
) I-Disease 1 0.9983909130096436
deficiency I-Disease 1 0.9999998807907104
causes O 1 0.99998939037323
severe O 1 0.9999983310699463
von B-Disease 1 0.9999972581863403
Willebrand I-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999984502792358
in O 0 0.04236306622624397
humans O 0 0.08774477243423462
. O 0 0.048083312809467316

We O 0 0.03507115691900253
generated O 0 0.04458967223763466
a O 0 0.02864832431077957
mouse O 0 0.07980068027973175
model O 0 0.034034837037324905
for O 0 0.016156047582626343
this O 0 0.021525664255023003
disease O 1 0.9905105233192444
by O 0 0.02297203056514263
using O 0 0.033586952835321426
gene O 0 0.10775410383939743
targeting O 0 0.09797459840774536
. O 0 0.05487651377916336

vWf B-Disease 1 0.9952768087387085
- I-Disease 1 0.9548548460006714
deficient I-Disease 1 0.9838610887527466
mice O 1 0.50766921043396
appeared O 0 0.04843944311141968
normal O 0 0.045569103211164474
at O 0 0.024855107069015503
birth O 0 0.04221400246024132
; O 0 0.020082993432879448
they O 0 0.011871839873492718
were O 0 0.012247845530509949
viable O 0 0.04260721430182457
and O 0 0.02347096987068653
fertile O 0 0.0888424813747406
. O 0 0.04781303182244301

Neither O 0 0.16889958083629608
vWf O 1 0.962039589881897
nor O 0 0.17054398357868195
vWf O 1 0.990818440914154
propolypeptide O 1 0.9846962690353394
( O 0 0.15182679891586304
von B-Disease 1 0.9947296380996704
Willebrand I-Disease 1 0.9999014139175415
antigen O 1 0.9976880550384521
II O 0 0.12908776104450226
) O 0 0.028179720044136047
were O 0 0.017500324174761772
detectable O 0 0.07520730048418045
in O 0 0.021939976140856743
plasma O 0 0.08558067679405212
, O 0 0.02501012571156025
platelets O 1 0.8644424080848694
, O 0 0.023279376327991486
or O 0 0.032148443162441254
endothelial O 1 0.9851605892181396
cells O 0 0.06580803543329239
of O 0 0.016202475875616074
the O 0 0.024965206161141396
homozygous O 0 0.1500886082649231
mutant O 0 0.16227512061595917
mice O 0 0.35258713364601135
. O 0 0.062284842133522034

The O 0 0.06620826572179794
mutant O 0 0.19432432949543
mice O 1 0.8690499663352966
exhibited O 0 0.14172273874282837
defects O 1 0.9813965559005737
in O 0 0.035238321870565414
hemostasis O 1 0.9967362284660339
with O 0 0.023884814232587814
a O 0 0.02944786846637726
highly O 0 0.05907629802823067
prolonged O 1 0.9982013702392578
bleeding O 1 0.999555766582489
time O 0 0.03499969094991684
and O 0 0.0266471765935421
spontaneous O 0 0.1354171186685562
bleeding O 1 0.995083749294281
events O 0 0.03152736648917198
in O 0 0.015184298157691956
approximately O 0 0.024613626301288605
10 O 0 0.022197894752025604
% O 0 0.02644125185906887
of O 0 0.02475079707801342
neonates O 1 0.9500160813331604
. O 0 0.05433334782719612

As O 0 0.023836757987737656
in O 0 0.017888737842440605
the O 0 0.020002838224172592
human O 0 0.04238387942314148
disease O 1 0.9994990825653076
, O 0 0.017718598246574402
the O 0 0.019224092364311218
factor O 0 0.05831286311149597
VIII O 0 0.13404342532157898
level O 0 0.027684178203344345
in O 0 0.013516834937036037
these O 0 0.014921852387487888
mice O 0 0.07362404465675354
was O 0 0.018100680783391
reduced O 0 0.028424520045518875
strongly O 0 0.019813042134046555
as O 0 0.008648928254842758
a O 0 0.01225019060075283
result O 0 0.018164997920393944
of O 0 0.009718714281916618
the O 0 0.011691069230437279
lack O 0 0.027283448725938797
of O 0 0.015192743390798569
protection O 0 0.03880960866808891
provided O 0 0.0351778008043766
by O 0 0.03818538784980774
vWf O 1 0.7327426075935364
. O 0 0.06646409630775452

Defective O 1 0.9976335763931274
thrombosis B-Disease 1 0.9999678134918213
in O 0 0.05617675930261612
mutant O 0 0.13374261558055878
mice O 0 0.12517327070236206
was O 0 0.022519370540976524
also O 0 0.014232069253921509
evident O 0 0.028166456148028374
in O 0 0.0104602612555027
an O 0 0.012375494465231895
in O 0 0.01782965660095215
vivo O 0 0.10721946507692337
model O 0 0.04893165081739426
of O 0 0.03368073329329491
vascular B-Disease 1 0.9999855756759644
injury I-Disease 1 0.9978916049003601
. O 0 0.05980722978711128

In O 0 0.027918191626667976
this O 0 0.016514478251338005
model O 0 0.02942688949406147
, O 0 0.016603123396635056
the O 0 0.02359190583229065
exteriorized O 0 0.25478944182395935
mesentery O 1 0.7403225302696228
was O 0 0.03760397434234619
superfused O 1 0.515751302242279
with O 0 0.037623338401317596
ferric O 1 0.996008038520813
chloride O 1 0.7031441330909729
and O 0 0.021148042753338814
the O 0 0.022015245631337166
accumulation O 0 0.09576945006847382
of O 0 0.028877215459942818
fluorescently O 1 0.7394453883171082
labeled O 0 0.10810873657464981
platelets O 1 0.7301598787307739
was O 0 0.032056424766778946
observed O 0 0.045924268662929535
by O 0 0.02892877161502838
intravital O 0 0.18182392418384552
microscopy O 0 0.14618243277072906
. O 0 0.05668168514966965

We O 0 0.03246593102812767
conclude O 0 0.04983782768249512
that O 0 0.013937361538410187
these O 0 0.01635381393134594
mice O 0 0.09387940168380737
very O 0 0.029181236401200294
closely O 0 0.0526919923722744
mimic O 1 0.994904637336731
severe O 1 0.9999305009841919
human O 1 0.9175537824630737
von B-Disease 1 0.9999855756759644
Willebrand I-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999943971633911
and O 0 0.019625505432486534
will O 0 0.012999383732676506
be O 0 0.008718930184841156
very O 0 0.012121585197746754
useful O 0 0.016063615679740906
for O 0 0.010516008362174034
investigating O 0 0.026482388377189636
the O 0 0.012384251691401005
role O 0 0.024477491155266762
of O 0 0.01844542846083641
vWf O 0 0.2619771659374237
in O 0 0.023679273203015327
normal O 0 0.04743477702140808
physiology O 0 0.07657254487276077
and O 0 0.018190795555710793
in O 0 0.023757170885801315
disease O 1 0.9994968175888062
models O 0 0.04904380440711975
. O 0 0.027764778584241867
. O 0 0.03455587476491928

Oral O 0 0.19449399411678314
contraceptives O 0 0.3514271378517151
and O 0 0.024460166692733765
the O 0 0.02652411349117756
risk O 1 0.9369294047355652
of O 0 0.04509701207280159
hereditary B-Disease 1 0.9999791383743286
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999971389770508
. O 0 0.0891125500202179

Hereditary B-Disease 1 0.9999703168869019
Ovarian I-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999946355819702
Clinical O 1 0.9941617846488953
Study O 0 0.06728501617908478
Group O 0 0.055109284818172455
. O 0 0.04474097117781639

BACKGROUND O 0 0.09618150442838669
Women O 0 0.05021639168262482
with O 0 0.0268909502774477
mutations O 0 0.09463804215192795
in O 0 0.01852860487997532
either O 0 0.02228669822216034
the O 0 0.021352337673306465
BRCA1 O 1 0.9625860452651978
or O 0 0.03382919356226921
the O 0 0.02972269244492054
BRCA2 O 1 0.9933784604072571
gene O 0 0.09338656067848206
have O 0 0.018830785527825356
a O 0 0.02288590744137764
high O 0 0.03650717809796333
lifetime O 0 0.2980027496814728
risk O 1 0.9916270971298218
of O 0 0.0659191757440567
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999955892562866
. O 0 0.0748116597533226

Oral O 1 0.8306803703308105
contraceptives O 1 0.9911971092224121
protect O 1 0.699230968952179
against O 1 0.8912227153778076
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999995231628418
in O 0 0.01903466507792473
general O 0 0.017405176535248756
, O 0 0.010320045053958893
but O 0 0.008195914328098297
it O 0 0.006425535771995783
is O 0 0.007163683418184519
not O 0 0.006434808950871229
known O 0 0.01260965783149004
whether O 0 0.011124887503683567
they O 0 0.008713130839169025
also O 0 0.011126870289444923
protect O 0 0.03199451416730881
against O 0 0.02744404599070549
hereditary B-Disease 1 0.9520331621170044
forms I-Disease 0 0.058637697249650955
of I-Disease 0 0.060173191130161285
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999996542930603
. O 0 0.07697125524282455

METHODS O 0 0.07661276310682297
We O 0 0.03518389165401459
enrolled O 0 0.07703162729740143
207 O 0 0.1927601397037506
women O 0 0.07024319469928741
with O 0 0.049907512962818146
hereditary B-Disease 1 0.9999682903289795
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999901056289673
and O 0 0.026502130553126335
161 O 0 0.049157414585351944
of O 0 0.010932252742350101
their O 0 0.012555474415421486
sisters O 0 0.03000422939658165
as O 0 0.011747400276362896
controls O 0 0.026791321113705635
in O 0 0.013438631780445576
a O 0 0.016865583136677742
case O 0 0.024853911250829697
- O 0 0.06202567368745804
control O 0 0.04729290306568146
study O 0 0.04417720064520836
. O 0 0.03931073844432831

All O 0 0.028034167364239693
the O 0 0.029479365795850754
patients O 1 0.8448488116264343
carried O 0 0.0388178788125515
a O 0 0.03653303533792496
pathogenic O 0 0.1535922735929489
mutation O 0 0.16094538569450378
in O 0 0.02931729145348072
either O 0 0.04494008049368858
BRCA1 O 1 0.9825199842453003
( O 0 0.05800771340727806
179 O 0 0.08817139267921448
women O 0 0.049241065979003906
) O 0 0.035375989973545074
or O 0 0.03523518890142441
BRCA2 O 1 0.9936745166778564
( O 0 0.0509868748486042
28 O 0 0.04015118628740311
women O 0 0.0436098650097847
) O 0 0.03841520473361015
. O 0 0.03699326515197754

The O 0 0.03530555218458176
control O 0 0.043906375765800476
women O 0 0.03323241323232651
were O 0 0.01584683358669281
enrolled O 0 0.03913191705942154
regardless O 0 0.02630286104977131
of O 0 0.010421446524560452
whether O 0 0.014380834996700287
or O 0 0.013816924765706062
not O 0 0.010097991675138474
they O 0 0.010408446192741394
had O 0 0.01982939802110195
either O 0 0.03511011227965355
mutation O 0 0.16034869849681854
. O 0 0.05167067050933838

Lifetime O 0 0.13823473453521729
histories O 0 0.08596479147672653
of O 0 0.025362463667988777
oral O 0 0.2003694772720337
- O 0 0.1443260759115219
contraceptive O 1 0.8055813312530518
use O 0 0.02147589437663555
were O 0 0.010746298357844353
obtained O 0 0.015584801323711872
by O 0 0.01189012173563242
interview O 0 0.023407090455293655
or O 0 0.013856779783964157
by O 0 0.01146651990711689
written O 0 0.013901796191930771
questionnaire O 0 0.040965478867292404
and O 0 0.01235147099941969
were O 0 0.012445627711713314
compared O 0 0.026134245097637177
between O 0 0.022781522944569588
patients O 1 0.9705231189727783
and O 0 0.01552360225468874
control O 0 0.03036702424287796
women O 0 0.02783237025141716
, O 0 0.016088495030999184
after O 0 0.022190280258655548
adjustment O 0 0.04028934985399246
for O 0 0.012126782909035683
year O 0 0.014368842355906963
of O 0 0.013180244714021683
birth O 0 0.04842968285083771
and O 0 0.02441069856286049
parity O 0 0.09633713215589523
. O 0 0.05130130052566528

RESULTS O 0 0.06901205331087112
The O 0 0.028610244393348694
adjusted O 0 0.06593047082424164
odds O 0 0.10603480786085129
ratio O 0 0.19315318763256073
for O 0 0.05332311987876892
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999892711639404
associated O 0 0.03496604785323143
with O 0 0.013625473715364933
any O 0 0.011321191675961018
past O 0 0.015662966296076775
use O 0 0.01506013236939907
of O 0 0.015240561217069626
oral O 0 0.07035662978887558
contraceptives O 0 0.1617312878370285
was O 0 0.03669944033026695
0 O 0 0.07799075543880463
. O 0 0.04290209710597992

5 O 0 0.07088535279035568
( O 0 0.043700575828552246
95 O 0 0.04452574625611305
percent O 0 0.03302163630723953
confidence O 0 0.051688432693481445
interval O 0 0.06298848241567612
, O 0 0.017789287492632866
0 O 0 0.03536367416381836
. O 0 0.012137812562286854
3 O 0 0.018904022872447968
to O 0 0.013839535415172577
0 O 0 0.03412714973092079
. O 0 0.014291689731180668
8 O 0 0.030938096344470978
) O 0 0.029946336522698402
. O 0 0.032888587564229965

The O 0 0.05533711612224579
risk O 0 0.4132806062698364
decreased O 0 0.075372613966465
with O 0 0.02387545257806778
increasing O 0 0.036249157041311264
duration O 0 0.05698028951883316
of O 0 0.015921803191304207
use O 0 0.023383351042866707
( O 0 0.03431546315550804
P O 0 0.0864662304520607
for O 0 0.0193399079144001
trend O 0 0.051979705691337585
, O 0 0.02852165699005127
< O 0 0.1445019543170929
0 O 0 0.05566059798002243
. O 0 0.026006070896983147
001 O 0 0.12287404388189316
) O 0 0.021199315786361694
; O 0 0.01309596560895443
use O 0 0.00973694957792759
for O 0 0.007480241358280182
six O 0 0.012765268795192242
or O 0 0.011673595756292343
more O 0 0.009219701401889324
years O 0 0.012201315723359585
was O 0 0.011318737640976906
associated O 0 0.015631912276148796
with O 0 0.011384806595742702
a O 0 0.016969982534646988
60 O 0 0.03245066851377487
percent O 0 0.034677233546972275
reduction O 0 0.063981793820858
in O 0 0.028747308999300003
risk O 0 0.29194292426109314
. O 0 0.0500391386449337

Oral O 1 0.673001229763031
- O 1 0.7214781641960144
contraceptive O 1 0.9792914986610413
use O 0 0.04531983286142349
protected O 0 0.07986652106046677
against O 0 0.37049198150634766
ovarian B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999666213989258
both O 0 0.022383736446499825
for O 0 0.015994887799024582
carriers O 0 0.0538993738591671
of O 0 0.01752620004117489
the O 0 0.03099737875163555
BRCA1 O 1 0.994948148727417
mutation O 1 0.8743504881858826
( O 0 0.057347267866134644
odds O 0 0.08673131465911865
ratio O 0 0.06659159064292908
, O 0 0.02309415675699711
0 O 0 0.044449351727962494
. O 0 0.01789730228483677
5 O 0 0.025081461295485497
; O 0 0.020294195041060448
95 O 0 0.03683992102742195
percent O 0 0.030346442013978958
confidence O 0 0.04491042718291283
interval O 0 0.0585009939968586
, O 0 0.01929342746734619
0 O 0 0.03499152883887291
. O 0 0.014699634164571762
3 O 0 0.02094210870563984
to O 0 0.013445074670016766
0 O 0 0.033542390912771225
. O 0 0.013440691865980625
9 O 0 0.021286843344569206
) O 0 0.014908604323863983
and O 0 0.009637865237891674
for O 0 0.010872137732803822
carriers O 0 0.04725215584039688
of O 0 0.016692083328962326
the O 0 0.031573712825775146
BRCA2 O 1 0.997398853302002
mutation O 1 0.8413973450660706
( O 0 0.06273723393678665
odds O 0 0.08203999698162079
ratio O 0 0.0591183565557003
, O 0 0.01923294924199581
0 O 0 0.038764018565416336
. O 0 0.013240273110568523
4 O 0 0.0219134371727705
; O 0 0.019573213532567024
95 O 0 0.03267786651849747
percent O 0 0.02847748063504696
confidence O 0 0.03685620427131653
interval O 0 0.05532218888401985
, O 0 0.01544866431504488
0 O 0 0.03205451741814613
. O 0 0.011286732740700245
2 O 0 0.016645468771457672
to O 0 0.011077800765633583
1 O 0 0.019044041633605957
. O 0 0.01584794372320175
1 O 0 0.028624068945646286
) O 0 0.034351885318756104
. O 0 0.03609100729227066

CONCLUSIONS O 0 0.11725363880395889
Oral O 0 0.35400626063346863
- O 0 0.4571744501590729
contraceptive O 1 0.9702147841453552
use O 0 0.03180200979113579
may O 0 0.02990155853331089
reduce O 0 0.04572081193327904
the O 0 0.0226722564548254
risk O 1 0.9924720525741577
of O 0 0.05199681222438812
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999974966049194
in O 0 0.02473195642232895
women O 0 0.03940389305353165
with O 0 0.029039813205599785
pathogenic O 1 0.5183858275413513
mutations O 0 0.15135394036769867
in O 0 0.024996181949973106
the O 0 0.03796445205807686
BRCA1 O 1 0.9900570511817932
or O 0 0.1038481667637825
BRCA2 O 1 0.9948965907096863
gene O 0 0.46244898438453674

A O 0 0.056487489491701126
Japanese O 0 0.04823807626962662
family O 0 0.04481137916445732
with O 0 0.040572524070739746
adrenoleukodystrophy B-Disease 1 0.9998514652252197
with O 0 0.036405619233846664
a O 0 0.043048467487096786
codon O 0 0.15524087846279144
291 O 0 0.15968535840511322
deletion O 0 0.17535577714443207
: O 0 0.039713822305202484
a O 0 0.032024793326854706
clinical O 0 0.45389577746391296
, O 0 0.027818400412797928
biochemical O 0 0.08796270191669464
, O 0 0.023663688451051712
pathological O 0 0.11115705966949463
, O 0 0.019647499546408653
and O 0 0.018689237534999847
genetic O 0 0.06952660530805588
report O 0 0.03780331462621689
. O 0 0.038151711225509644

We O 0 0.032387010753154755
report O 0 0.02985919453203678
a O 0 0.024147773161530495
Japanese O 0 0.036760516464710236
family O 0 0.04061952605843544
with O 0 0.04537799954414368
adrenoleukodystrophy B-Disease 1 0.9999974966049194
( O 1 0.5056232213973999
ALD B-Disease 1 0.999984860420227
) O 0 0.030782276764512062
with O 0 0.014061497524380684
a O 0 0.01626526564359665
three O 0 0.01689603552222252
base O 0 0.040151745080947876
pair O 0 0.0587366558611393
deletion O 0 0.15074004232883453
( O 0 0.05984760820865631
delGAG O 0 0.4267851710319519
291 O 0 0.11940955370664597
) O 0 0.03150319308042526
in O 0 0.02290109358727932
the O 0 0.03984463959932327
ALD B-Disease 1 0.9999628067016602
gene O 0 0.1762199103832245
. O 0 0.06124710664153099

A O 0 0.04731468856334686
variety O 0 0.03185844421386719
of O 0 0.021142203360795975
phenotypes O 0 0.12287423759698868
were O 0 0.018602143973112106
observed O 0 0.03415984287858009
within O 0 0.021286696195602417
this O 0 0.01682792790234089
family O 0 0.03871212527155876
. O 0 0.0404813326895237

While O 0 0.04347218573093414
the O 0 0.037779174745082855
proband O 1 0.5742192268371582
( O 0 0.05467141792178154
patient O 0 0.24591940641403198
1 O 0 0.02902991510927677
) O 0 0.019776754081249237
was O 0 0.01230002660304308
classified O 0 0.02243727631866932
as O 0 0.011987787671387196
having O 0 0.01913795992732048
a O 0 0.01990424282848835
rare O 0 0.04351256787776947
intermediate O 0 0.051588255912065506
type O 0 0.04856771603226662
of O 0 0.020972834900021553
adult O 0 0.06862399727106094
cerebral O 1 0.9995476603507996
and O 0 0.030492283403873444
cerebello O 1 0.9985722303390503
- O 1 0.9827986359596252
brain O 1 0.9910619258880615
stem O 0 0.09469202905893326
forms O 0 0.03376065194606781
, O 0 0.01759403385221958
his O 0 0.020136047154664993
younger O 0 0.05043967813253403
brother O 0 0.05037696287035942
( O 0 0.04390402510762215
patient O 0 0.3273111879825592
2 O 0 0.030724285170435905
) O 0 0.021611683070659637
and O 0 0.015206576324999332
nephew O 0 0.08064138144254684
( O 0 0.04758114740252495
patient O 1 0.538495659828186
3 O 0 0.038209594786167145
) O 0 0.02730785682797432
had O 0 0.02515483647584915
a O 0 0.04214152693748474
childhood O 1 0.9819208979606628
ALD B-Disease 1 0.9999747276306152
type O 0 0.16405680775642395
. O 0 0.058731768280267715

Another O 0 0.08776959031820297
nephew O 0 0.15072666108608246
( O 0 0.07028333842754364
patient O 1 0.5004460215568542
4 O 0 0.03347845375537872
) O 0 0.021733010187745094
of O 0 0.014402654953300953
patient O 0 0.10623150318861008
1 O 0 0.02236028201878071
was O 0 0.014144200831651688
classified O 0 0.022056499496102333
as O 0 0.011197135783731937
having O 0 0.01926272176206112
an O 0 0.019371137022972107
adolescent O 0 0.425997793674469
form O 0 0.04835536703467369
. O 0 0.046096161007881165

The O 0 0.04644399881362915
tau O 0 0.1163923367857933
level O 0 0.03697782754898071
in O 0 0.020274637266993523
the O 0 0.031621117144823074
cerebrospinal O 1 0.9938334226608276
fluid O 1 0.6873626708984375
( O 0 0.07138609886169434
CSF O 1 0.9846333265304565
) O 0 0.03646887466311455
in O 0 0.021182358264923096
patient O 0 0.09770743548870087
1 O 0 0.02054731920361519
was O 0 0.011693290434777737
as O 0 0.009188847616314888
high O 0 0.016886264085769653
as O 0 0.008589313365519047
that O 0 0.009374041110277176
of O 0 0.016359392553567886
patients O 1 0.9997559189796448
with O 0 0.30968955159187317
Alzheimers B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999946355819702
( O 0 0.07780429720878601
AD B-Disease 0 0.127240389585495
) O 0 0.04449569433927536
. O 0 0.03796941414475441

His O 0 0.07587867975234985
brain O 1 0.5554455518722534
magnetic O 0 0.10856060683727264
resonance O 0 0.12323617190122604
image O 0 0.08007333427667618
( O 0 0.05845749005675316
MRI O 1 0.885089099407196
) O 0 0.03740554302930832
showed O 0 0.04183366149663925
abnormalities B-Disease 0 0.4827299118041992
in I-Disease 0 0.016633594408631325
the I-Disease 0 0.016721190884709358
bilateral I-Disease 0 0.05750054866075516
cerebellar I-Disease 1 0.9993301630020142
hemispheres I-Disease 1 0.7314192652702332
and O 0 0.03313271701335907
brain O 1 0.9931550621986389
stem O 0 0.08569612354040146
, O 0 0.01513986848294735
but O 0 0.01004765834659338
not O 0 0.009324607439339161
in O 0 0.011541067622601986
the O 0 0.018227405846118927
cerebral O 1 0.9982448816299438
white O 0 0.045786336064338684
matter O 0 0.02374960482120514
, O 0 0.013840106315910816
where O 0 0.01633361726999283
marked O 0 0.03249812126159668
reductions O 0 0.048353660851716995
of O 0 0.015491272322833538
the O 0 0.025194142013788223
cerebral O 1 0.9996009469032288
blood O 1 0.8748589754104614
flow O 0 0.07059137523174286
and O 0 0.026759741827845573
oxygen O 0 0.14080379903316498
metabolism O 0 0.10263550281524658
were O 0 0.019662808626890182
clearly O 0 0.03796268627047539
demonstrated O 0 0.04836394637823105
by O 0 0.02855311706662178
positron O 0 0.3049355745315552
emission O 0 0.15201064944267273
tomography O 0 0.27986305952072144
( O 0 0.06118558347225189
PET O 0 0.14297287166118622
) O 0 0.04823441803455353
. O 0 0.03915957361459732

In O 0 0.05078568309545517
patients O 1 0.9250456094741821
2 O 0 0.031849976629018784
and O 0 0.014362617395818233
3 O 0 0.02455633133649826
, O 0 0.01311761699616909
the O 0 0.01832680217921734
autopsy O 0 0.08570488542318344
findings O 0 0.05571397766470909
showed O 0 0.05474216118454933
massive O 0 0.09870080649852753
demyelination B-Disease 1 0.9984026551246643
of I-Disease 0 0.024384183809161186
the I-Disease 0 0.029587142169475555
cerebral I-Disease 1 0.9976850748062134
white I-Disease 0 0.047308262437582016
matter I-Disease 0 0.022306745871901512
with O 0 0.01716272346675396
sparing O 0 0.06748583912849426
of O 0 0.014872496947646141
the O 0 0.02188950963318348
U O 0 0.12501227855682373
- O 0 0.08591394871473312
fibers O 0 0.08401384949684143
, O 0 0.017258282750844955
compatible O 0 0.02669859677553177
with O 0 0.012094401754438877
the O 0 0.01482478715479374
findings O 0 0.03990790620446205
of O 0 0.02982182614505291
childhood O 1 0.9858377575874329
ALD B-Disease 1 0.9999904632568359
. O 0 0.07638150453567505

Oleic O 1 0.5474205017089844
and O 0 0.06912742555141449
erucic O 1 0.9618212580680847
acids O 0 0.1281224489212036
( O 0 0.06043750420212746
Lorenzos O 0 0.1421245038509369
Oil O 0 0.04303961992263794
) O 0 0.023597965016961098
were O 0 0.013077737763524055
administered O 0 0.04492681100964546
to O 0 0.017321281135082245
patients O 1 0.6315554976463318
1 O 0 0.022076070308685303
and O 0 0.011725742369890213
4 O 0 0.02171405404806137
, O 0 0.012888764962553978
but O 0 0.011406288482248783
sufficient O 0 0.027850721031427383
effectiveness O 0 0.05025811493396759
was O 0 0.015786129981279373
not O 0 0.0133909210562706
obtained O 0 0.02856600098311901
. O 0 0.03257003054022789

The O 0 0.03004865162074566
findings O 0 0.03853074088692665
in O 0 0.014293658547103405
this O 0 0.011573090218007565
family O 0 0.022937433794140816
suggest O 0 0.028486479073762894
that O 0 0.013673519715666771
delGAG291 O 0 0.06981244683265686
is O 0 0.011587347835302353
part O 0 0.011945757083594799
of O 0 0.0092161251232028
the O 0 0.015756739303469658
cause O 0 0.05712093785405159
of O 0 0.021954631432890892
Japanese O 0 0.06808167695999146
ALD B-Disease 1 0.9999407529830933
with O 0 0.04478917270898819
phenotypic O 0 0.14253345131874084
variations O 0 0.09836801141500473
. O 0 0.05449296534061432

Moreover O 0 0.06985398381948471
, O 0 0.018441133201122284
although O 0 0.01564386859536171
the O 0 0.01187735702842474
scale O 0 0.025769110769033432
of O 0 0.009655044414103031
the O 0 0.012047410011291504
study O 0 0.01903671771287918
is O 0 0.011750434525310993
limited O 0 0.01715497113764286
, O 0 0.010994624346494675
there O 0 0.00883695762604475
is O 0 0.011012516915798187
a O 0 0.015011277981102467
possibility O 0 0.029977187514305115
that O 0 0.018258817493915558
PET O 0 0.08741001039743423
can O 0 0.029366562142968178
detect O 0 0.07779792696237564
an O 0 0.03338293731212616
insidious B-Disease 1 0.948934018611908
lesion I-Disease 1 0.9983476400375366
which O 0 0.02762729302048683
is O 0 0.025725847110152245
undetectable O 0 0.15107570588588715
by O 0 0.036116279661655426
computed O 0 0.1078481450676918
tomogram O 1 0.6969773173332214
( O 0 0.07004766911268234
CT O 1 0.9982613921165466
) O 0 0.03521335497498512
or O 0 0.027084238827228546
MRI O 0 0.16183407604694366
analysis O 0 0.023761428892612457
, O 0 0.010266431607306004
and O 0 0.007918179966509342
that O 0 0.007810122333467007
the O 0 0.009817554615437984
higher O 0 0.019375229254364967
level O 0 0.02114180661737919
of O 0 0.013694306835532188
tau O 0 0.06472760438919067
reflects O 0 0.03236452862620354
the O 0 0.013847489841282368
process O 0 0.024055825546383858
of O 0 0.028275247663259506
neuronal B-Disease 1 0.991856575012207
degeneration I-Disease 1 0.999930739402771
in O 0 0.06692643463611603
ALD B-Disease 1 0.9999837875366211
. O 0 0.06933364272117615

Lorenzos O 0 0.223361074924469
Oil O 0 0.05106228590011597
should O 0 0.020544160157442093
be O 0 0.009080440737307072
given O 0 0.010805138386785984
in O 0 0.009616793133318424
the O 0 0.012104324996471405
early O 0 0.025325847789645195
stage O 0 0.0456971675157547
. O 0 0.022709332406520844
. O 0 0.03580604866147041

Nonsense O 0 0.1802106350660324
mutation O 0 0.1665564477443695
in O 0 0.027401449158787727
exon O 0 0.09474965184926987
4 O 0 0.0314701683819294
of O 0 0.016300706192851067
human O 0 0.03379052132368088
complement O 0 0.07710123807191849
C9 O 1 0.9890992641448975
gene O 0 0.07967820763587952
is O 0 0.01489222515374422
the O 0 0.013938719406723976
major O 0 0.026675965636968613
cause O 0 0.0502670519053936
of O 0 0.01889880932867527
Japanese O 0 0.056168749928474426
complement B-Disease 0 0.3502195477485657
C9 I-Disease 1 0.9999023675918579
deficiency I-Disease 1 0.9999805688858032
. O 0 0.08243481814861298

Deficiency B-Disease 1 0.9998098015785217
of I-Disease 0 0.02766403555870056
the I-Disease 0 0.022744514048099518
ninth I-Disease 0 0.05884012207388878
component I-Disease 0 0.051946304738521576
of I-Disease 0 0.01844233274459839
human I-Disease 0 0.036801569163799286
complement I-Disease 0 0.07185839116573334
( O 0 0.04898807778954506
C9 O 1 0.9597814679145813
) O 0 0.02863900549709797
is O 0 0.013850284740328789
the O 0 0.013278002850711346
most O 0 0.016820792108774185
common O 0 0.044447243213653564
complement B-Disease 1 0.9734558463096619
deficiency I-Disease 1 0.9999951124191284
in O 0 0.02010473422706127
Japan O 0 0.0246194526553154
but O 0 0.011483580805361271
is O 0 0.013076087459921837
rare O 0 0.027274738997220993
in O 0 0.011108580976724625
other O 0 0.010537500493228436
countries O 0 0.020399032160639763
. O 0 0.031381089240312576

We O 0 0.03134303539991379
studied O 0 0.029230432584881783
the O 0 0.015947556123137474
molecular O 0 0.04291733726859093
basis O 0 0.025546999648213387
of O 0 0.028994467109441757
C9 B-Disease 1 0.9997492432594299
deficiency I-Disease 1 0.9999375343322754
in O 0 0.028925932943820953
four O 0 0.02896210364997387
Japanese O 0 0.07654403895139694
C9 B-Disease 1 0.9999164342880249
- I-Disease 1 0.9977117776870728
deficient I-Disease 1 0.9995336532592773
patients O 1 0.9996998310089111
who O 0 0.037684760987758636
had O 0 0.04094969108700752
suffered O 1 0.9998573064804077
from O 0 0.3034203052520752
meningococcal B-Disease 1 0.999998927116394
meningitis I-Disease 1 0.9999961853027344
. O 0 0.08298862725496292

Direct O 0 0.08645389974117279
sequencing O 0 0.09458822757005692
of O 0 0.03285032510757446
amplified O 0 0.14132478833198547
C9 O 1 0.8646503686904907
cDNA O 0 0.14418765902519226
and O 0 0.027965078130364418
DNA O 0 0.05981491506099701
revealed O 0 0.03952605277299881
a O 0 0.02811364084482193
nonsense O 0 0.07732048630714417
substitution O 0 0.0893445536494255
( O 0 0.05670573189854622
CGA O 1 0.7944932579994202
- O 1 0.768662691116333
- O 1 0.7221737504005432
> O 1 0.8663890957832336
TGA O 1 0.9815743565559387
) O 0 0.0476686991751194
at O 0 0.03628531098365784
codon O 0 0.09227508306503296
95 O 0 0.04159129783511162
in O 0 0.019358471035957336
exon O 0 0.08878479152917862
4 O 0 0.029571250081062317
in O 0 0.013799387961626053
the O 0 0.01591302827000618
four O 0 0.031565483659505844
C9 B-Disease 1 0.9990285634994507
- I-Disease 1 0.6340590715408325
deficient I-Disease 1 0.8914235234260559
individuals O 0 0.06389552354812622
. O 0 0.044586971402168274

An O 0 0.05602701008319855
allele O 0 0.1886977255344391
- O 0 0.12012080103158951
specific O 0 0.06079784780740738
polymerase O 0 0.17042894661426544
chain O 0 0.09251661598682404
reaction O 0 0.06339029222726822
system O 0 0.031325530260801315
designed O 0 0.02797526679933071
to O 0 0.013874088414013386
detect O 0 0.046865932643413544
exclusively O 0 0.016263067722320557
only O 0 0.008283588103950024
one O 0 0.00885763019323349
of O 0 0.008431430906057358
the O 0 0.014746137894690037
normal O 0 0.03632548078894615
and O 0 0.02053048647940159
mutant O 0 0.09243089705705643
alleles O 0 0.12899398803710938
indicated O 0 0.039969030767679214
that O 0 0.010529065504670143
all O 0 0.00855310820043087
the O 0 0.012522423639893532
four O 0 0.019785510376095772
patients O 1 0.5246961116790771
were O 0 0.017061350867152214
homozygous O 0 0.0674155205488205
for O 0 0.016116835176944733
the O 0 0.019846897572278976
mutation O 0 0.09579593688249588
in O 0 0.02213229425251484
exon O 0 0.0949990302324295
4 O 0 0.027518220245838165
and O 0 0.011240155436098576
that O 0 0.008592420257627964
the O 0 0.011766232550144196
parents O 0 0.0307187270373106
of O 0 0.018914654850959778
patient O 0 0.16740643978118896
2 O 0 0.032773200422525406
were O 0 0.021315747871994972
heterozygous O 0 0.10484671592712402
. O 0 0.044876303523778915

The O 0 0.04052521660923958
common O 0 0.05827009305357933
mutation O 0 0.13929277658462524
at O 0 0.03854728490114212
codon O 0 0.10388047993183136
95 O 0 0.042747944593429565
in O 0 0.021430328488349915
exon O 0 0.08698402345180511
4 O 0 0.029723823070526123
might O 0 0.023875735700130463
be O 0 0.01148180104792118
responsible O 0 0.020795652642846107
for O 0 0.011742043308913708
most O 0 0.01864219456911087
Japanese O 0 0.07042106240987778
C9 B-Disease 1 0.9999086856842041
deficiency I-Disease 1 0.9999850988388062
. O 0 0.04570885747671127
. O 0 0.04951810836791992

BRCA1 O 1 0.7680048942565918
required O 0 0.058069877326488495
for O 0 0.032770786434412
transcription O 0 0.10634537041187286
- O 0 0.1379547119140625
coupled O 0 0.11782514303922653
repair O 0 0.39650896191596985
of O 0 0.03688756003975868
oxidative O 1 0.9290984869003296
DNA O 0 0.12486772984266281
damage O 0 0.173363596200943
. O 0 0.049691226333379745

The O 0 0.08370641618967056
breast B-Disease 1 0.9999895095825195
and I-Disease 1 0.9383930563926697
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
susceptibility O 1 0.9995906949043274
gene O 1 0.8157110214233398
BRCA1 O 1 0.9904588460922241
encodes O 0 0.11717600375413895
a O 0 0.04891103506088257
zinc O 1 0.6133095622062683
finger O 0 0.11379435658454895
protein O 0 0.058982547372579575
of O 0 0.018484458327293396
unknown O 0 0.044403888285160065
function O 0 0.05609515681862831
. O 0 0.041989244520664215

Association O 0 0.06794780492782593
of O 0 0.02224891632795334
the O 0 0.02867189794778824
BRCA1 O 1 0.8275946974754333
protein O 0 0.06457150727510452
with O 0 0.021357214078307152
the O 0 0.021566910669207573
DNA O 0 0.07452413439750671
repair O 0 0.4461423456668854
protein O 0 0.0881454199552536
Rad51 O 1 0.9453451633453369
and O 0 0.019319700077176094
changes O 0 0.020757701247930527
in O 0 0.010881711728870869
the O 0 0.013662732206285
phosphorylation O 0 0.04981367662549019
and O 0 0.014337783679366112
cellular O 0 0.04965034872293472
localization O 0 0.04887184128165245
of O 0 0.011991350911557674
the O 0 0.01645367033779621
protein O 0 0.049025557935237885
after O 0 0.029667984694242477
exposure O 0 0.2476215809583664
to O 0 0.02139737457036972
DNA O 0 0.06524775922298431
- O 0 0.08076498657464981
damaging O 0 0.08088479191064835
agents O 0 0.04307987168431282
are O 0 0.013214983977377415
consistent O 0 0.024911193177103996
with O 0 0.01451157033443451
a O 0 0.018176725134253502
role O 0 0.02992730401456356
for O 0 0.024775037541985512
BRCA1 O 1 0.9131739139556885
in O 0 0.03383825346827507
DNA O 0 0.08673141896724701
repair O 0 0.42329612374305725
. O 0 0.05458024889230728

Here O 0 0.029564613476395607
, O 0 0.016503654420375824
it O 0 0.012069018557667732
is O 0 0.01374104805290699
shown O 0 0.025381775572896004
that O 0 0.020591285079717636
mouse O 0 0.1352372020483017
embryonic O 0 0.4176490306854248
stem O 1 0.5832950472831726
cells O 0 0.4477391839027405
deficient B-Disease 1 0.9065153002738953
in I-Disease 0 0.030355209484696388
BRCA1 I-Disease 1 0.9471027851104736
are O 0 0.021059801802039146
defective O 0 0.07533515244722366
in O 0 0.01443527638912201
the O 0 0.011972915381193161
ability O 0 0.021275313571095467
to O 0 0.011730782687664032
carry O 0 0.023819290101528168
out O 0 0.024548286572098732
transcription O 0 0.08813688904047012
- O 0 0.09961822628974915
coupled O 0 0.09659890085458755
repair O 0 0.4335309565067291
of O 0 0.030059194192290306
oxidative O 1 0.920599639415741
DNA O 0 0.08469164371490479
damage O 0 0.07428722828626633
, O 0 0.016790952533483505
and O 0 0.014084230177104473
are O 0 0.01706920750439167
hypersensitive O 0 0.20510871708393097
to O 0 0.034581687301397324
ionizing O 1 0.8453564047813416
radiation O 1 0.6857228875160217
and O 0 0.03089032880961895
hydrogen O 0 0.1105952039361
peroxide O 1 0.5532566905021667
. O 0 0.062408529222011566

These O 0 0.0363590233027935
results O 0 0.05470585078001022
suggest O 0 0.05341024696826935
that O 0 0.027512773871421814
BRCA1 O 1 0.8201608061790466
participates O 0 0.07000421732664108
, O 0 0.018355615437030792
directly O 0 0.022132840007543564
or O 0 0.020922521129250526
indirectly O 0 0.050652794539928436
, O 0 0.016558634117245674
in O 0 0.01947411336004734
transcription O 0 0.08101821690797806
- O 0 0.12653885781764984
coupled O 0 0.1315121054649353
repair O 0 0.47850191593170166
of O 0 0.033865731209516525
oxidative O 1 0.9460851550102234
DNA O 0 0.09877241402864456
damage O 0 0.11067935079336166
. O 0 0.03039867989718914
. O 0 0.041764289140701294

Truncation O 0 0.41652899980545044
mutations O 0 0.1656438410282135
in O 0 0.03002115711569786
the O 0 0.026393067091703415
transactivation O 0 0.23968014121055603
region O 0 0.05242323875427246
of O 0 0.030163155868649483
PAX6 O 1 0.9895305633544922
result O 0 0.04563517868518829
in O 0 0.024387076497077942
dominant O 0 0.06618092209100723
- O 0 0.1041359156370163
negative O 0 0.08864732831716537
mutants O 0 0.1341792643070221
. O 0 0.05427723377943039

PAX6 O 1 0.9288698434829712
is O 0 0.043802786618471146
a O 0 0.03500046581029892
transcription O 0 0.08311281353235245
factor O 0 0.05046205222606659
with O 0 0.018091540783643723
two O 0 0.018559636548161507
DNA O 0 0.06039898842573166
- O 0 0.06934013962745667
binding O 0 0.05558843910694122
domains O 0 0.06168089061975479
( O 0 0.04406646639108658
paired O 0 0.08097422122955322
box O 0 0.05690488591790199
and O 0 0.024452276527881622
homeobox O 1 0.6512854099273682
) O 0 0.029034093022346497
and O 0 0.016711143776774406
a O 0 0.02993515320122242
proline O 0 0.20064835250377655
- O 0 0.13730086386203766
serine O 0 0.2213386446237564
- O 0 0.17031259834766388
threonine O 0 0.2692836821079254
( O 0 0.07406628876924515
PST O 1 0.9780945181846619
) O 0 0.04531961679458618
- O 0 0.08662492781877518
rich O 0 0.0780152678489685
transactivation O 0 0.25148069858551025
domain O 0 0.08819644898176193
. O 0 0.05717458948493004

PAX6 O 1 0.9915870428085327
regulates O 0 0.2481030970811844
eye O 1 0.6773694157600403
development O 0 0.04657519608736038
in O 0 0.02308967337012291
animals O 0 0.038666922599077225
ranging O 0 0.03947550058364868
from O 0 0.025887932628393173
jellyfish O 0 0.09659713506698608
to O 0 0.024316314607858658
Drosophila O 0 0.087873175740242
to O 0 0.02716628834605217
humans O 0 0.06830409914255142
. O 0 0.04922650754451752

Heterozygous O 0 0.24889269471168518
mutations O 0 0.17659074068069458
in O 0 0.028177183121442795
the O 0 0.027606170624494553
human O 0 0.052272532135248184
PAX6 O 1 0.9961649179458618
gene O 0 0.0913819819688797
result O 0 0.03041684627532959
in O 0 0.01542085874825716
various O 0 0.01886758767068386
phenotypes O 0 0.13097317516803741
, O 0 0.024989362806081772
including O 0 0.028248973190784454
aniridia B-Disease 1 0.9919793605804443
, O 0 0.035426490008831024
Peters B-Disease 1 0.9914587140083313
anomaly I-Disease 1 0.9959690570831299
, O 0 0.03976913169026375
autosomal B-Disease 1 0.9985504746437073
dominant I-Disease 1 0.9440745115280151
keratitis I-Disease 1 0.9999825954437256
, O 0 0.04010244458913803
and O 0 0.040950480848550797
familial B-Disease 1 0.9997168183326721
foveal I-Disease 1 0.999190628528595
dysplasia I-Disease 1 0.9999775886535645
. O 0 0.08327659219503403

It O 0 0.02837420627474785
is O 0 0.020213639363646507
believed O 0 0.02616899460554123
that O 0 0.013203312642872334
the O 0 0.020411184057593346
mutated O 0 0.12117118388414383
allele O 0 0.14288361370563507
of O 0 0.03680829331278801
PAX6 O 1 0.975618839263916
produces O 0 0.07493716478347778
an O 0 0.02964317798614502
inactive O 0 0.09578034281730652
protein O 0 0.07223735749721527
and O 0 0.026982346549630165
aniridia B-Disease 1 0.9546728134155273
is O 0 0.026169056072831154
caused O 0 0.05854529142379761
due O 0 0.033703502267599106
to O 0 0.026805242523550987
genetic O 0 0.10055658221244812
haploinsufficiency O 0 0.3264506161212921
. O 0 0.0525754950940609

However O 0 0.03693610802292824
, O 0 0.023853356018662453
several O 0 0.02336125448346138
truncation O 0 0.12295585870742798
mutations O 0 0.09670116752386093
have O 0 0.015060203149914742
been O 0 0.012361829169094563
found O 0 0.014452598989009857
to O 0 0.013030407950282097
occur O 0 0.026396693661808968
in O 0 0.011607532389461994
the O 0 0.016804717481136322
C O 0 0.0786220133304596
- O 0 0.07171794772148132
terminal O 0 0.06496841460466385
half O 0 0.03018645942211151
of O 0 0.0231835525482893
PAX6 O 1 0.9965110421180725
in O 0 0.033286597579717636
patients O 1 0.9954856038093567
with O 0 0.03108341060578823
Aniridia B-Disease 1 0.9827430248260498
resulting O 0 0.0511346310377121
in O 0 0.018976563587784767
mutant O 0 0.07400545477867126
proteins O 0 0.03991222009062767
that O 0 0.014071007259190083
retain O 0 0.037099916487932205
the O 0 0.01890815980732441
DNA O 0 0.05916844680905342
- O 0 0.06570594757795334
binding O 0 0.0491548515856266
domains O 0 0.04457667097449303
but O 0 0.01378678996115923
have O 0 0.01167301181703806
lost O 0 0.019675612449645996
most O 0 0.010010726749897003
of O 0 0.011815408244729042
the O 0 0.02375013194978237
transactivation O 0 0.20297610759735107
domain O 0 0.07816645503044128
. O 0 0.04784826561808586

It O 0 0.022976599633693695
is O 0 0.014324636198580265
not O 0 0.010154567658901215
clear O 0 0.01845255121588707
whether O 0 0.017000267282128334
such O 0 0.014576590619981289
mutants O 0 0.0807233676314354
really O 0 0.03363532945513725
behave O 0 0.0440821498632431
as O 0 0.015061420388519764
loss O 0 0.04839281365275383
- O 0 0.05040080472826958
of O 0 0.019215282052755356
- O 0 0.07392731308937073
function O 0 0.04651261493563652
mutants O 0 0.0830148234963417
as O 0 0.022300075739622116
predicted O 0 0.049484558403491974
by O 0 0.02906794100999832
haploinsufficiency O 0 0.174532949924469
. O 0 0.051592499017715454

Contrary O 0 0.050104714930057526
to O 0 0.015000708401203156
this O 0 0.013583471067249775
theory O 0 0.021327128633856773
, O 0 0.01151624508202076
our O 0 0.011767412535846233
data O 0 0.01463368721306324
showed O 0 0.018848810344934464
that O 0 0.009291045367717743
these O 0 0.011444209143519402
mutants O 0 0.05992485582828522
are O 0 0.017974060028791428
dominant O 0 0.06174793094396591
- O 0 0.08383471518754959
negative O 0 0.06507814675569534
in O 0 0.03316834941506386
transient O 1 0.9705003499984741
transfection O 1 0.9862194657325745
assays O 0 0.0909823402762413
when O 0 0.022383863106369972
they O 0 0.013615421950817108
are O 0 0.014709644950926304
coexpressed O 0 0.08904467523097992
with O 0 0.025527479127049446
wild O 0 0.06492996960878372
- O 0 0.13984298706054688
type O 0 0.11904295533895493
PAX6 O 1 0.9909535646438599
. O 0 0.06697993725538254

We O 0 0.02747693471610546
found O 0 0.021742772310972214
that O 0 0.012845153920352459
the O 0 0.018541835248470306
dominant O 0 0.06668683141469955
- O 0 0.10988674312829971
negative O 0 0.06758840382099152
effects O 0 0.07258979231119156
result O 0 0.026804044842720032
from O 0 0.015761064365506172
the O 0 0.015354466624557972
enhanced O 0 0.052657902240753174
DNA O 0 0.05158648267388344
binding O 0 0.038495372980833054
ability O 0 0.03192943334579468
of O 0 0.015378390438854694
these O 0 0.020159658044576645
mutants O 0 0.1214822307229042
. O 0 0.05226866155862808

Kinetic O 0 0.11767103523015976
studies O 0 0.04421090707182884
of O 0 0.01923998072743416
binding O 0 0.04671638086438179
and O 0 0.025173010304570198
dissociation O 0 0.1399252563714981
revealed O 0 0.03731759637594223
that O 0 0.014616657979786396
various O 0 0.021421046927571297
truncation O 0 0.11995714157819748
mutants O 0 0.09006062895059586
have O 0 0.026112649589776993
3 O 0 0.03836263343691826
- O 0 0.0704033300280571
5 O 0 0.037867333739995956
- O 0 0.06061005964875221
fold O 0 0.06093991920351982
higher O 0 0.037979353219270706
affinity O 0 0.05262325704097748
to O 0 0.014865897595882416
various O 0 0.01599702052772045
DNA O 0 0.05736812204122543
- O 0 0.0630946084856987
binding O 0 0.04252283275127411
sites O 0 0.021895816549658775
when O 0 0.017044680193066597
compared O 0 0.022197548300027847
with O 0 0.012538106180727482
the O 0 0.018796702846884727
wild O 0 0.06163666024804115
- O 0 0.13806425034999847
type O 0 0.1198846623301506
PAX6 O 1 0.9911212921142578
. O 0 0.0693703442811966

These O 0 0.024280762299895287
results O 0 0.031055070459842682
provide O 0 0.021494457498192787
a O 0 0.015075813047587872
new O 0 0.016933731734752655
insight O 0 0.043344661593437195
into O 0 0.01370651088654995
the O 0 0.012780697084963322
role O 0 0.024935554713010788
of O 0 0.020203547552227974
mutant O 0 0.1321798861026764
PAX6 O 1 0.9952574372291565
in O 0 0.040358398109674454
causing O 0 0.31514841318130493
aniridia B-Disease 1 0.9761326909065247
. O 0 0.0400054007768631
. O 0 0.04535596817731857

Reversal O 1 0.9471201300621033
of O 0 0.061685774475336075
severe O 1 0.9999680519104004
hypertrophic B-Disease 1 0.9999991655349731
cardiomyopathy I-Disease 1 0.9999990463256836
and O 0 0.040484264492988586
excellent O 0 0.0626475065946579
neuropsychologic O 0 0.28425708413124084
outcome O 0 0.040204789489507675
in O 0 0.01675041951239109
very B-Disease 0 0.022517269477248192
- I-Disease 0 0.08047125488519669
long I-Disease 0 0.053422581404447556
- I-Disease 0 0.46302005648612976
chain I-Disease 0 0.26773473620414734
acyl I-Disease 1 0.9961819648742676
- I-Disease 1 0.8832248449325562
coenzyme I-Disease 1 0.9711568355560303
A I-Disease 0 0.1518423855304718
dehydrogenase I-Disease 1 0.9995236396789551
deficiency I-Disease 1 0.9999747276306152
. O 0 0.08567214012145996

Very B-Disease 0 0.05669768527150154
- I-Disease 0 0.12949499487876892
long I-Disease 0 0.06987610459327698
- I-Disease 0 0.38264089822769165
chain I-Disease 0 0.21704328060150146
acyl I-Disease 1 0.985673725605011
- I-Disease 1 0.6140021085739136
coenzyme I-Disease 1 0.7357030510902405
A I-Disease 0 0.09983986616134644
dehydrogenase I-Disease 1 0.9955744743347168
( I-Disease 0 0.12963318824768066
VLCAD I-Disease 1 0.9977765679359436
) I-Disease 0 0.22836951911449432
deficiency I-Disease 1 0.9999788999557495
is O 0 0.031171107664704323
a O 0 0.04011790081858635
disorder O 1 0.9997431635856628
of O 0 0.032375138252973557
fatty O 1 0.9318219423294067
acid O 1 0.7692399621009827
beta O 0 0.11585723608732224
oxidation O 0 0.10064582526683807
that O 0 0.01624862290918827
reportedly O 0 0.037959977984428406
has O 0 0.019288131967186928
high O 0 0.028842240571975708
rates O 0 0.046368181705474854
of O 0 0.02162313461303711
morbidity O 1 0.9820854067802429
and O 0 0.03411885350942612
mortality O 1 0.7875245809555054
. O 0 0.04907669499516487

We O 0 0.029907062649726868
describe O 0 0.034115128219127655
the O 0 0.014818397350609303
outcome O 0 0.029707029461860657
of O 0 0.011503354646265507
a O 0 0.018893543630838394
5 O 0 0.030286287888884544
- O 0 0.0587538480758667
year O 0 0.027381185442209244
- O 0 0.07413651049137115
old O 0 0.04657375067472458
girl O 0 0.10129126161336899
with O 0 0.04186759144067764
VLCAD B-Disease 1 0.9999586343765259
deficiency I-Disease 1 0.9999966621398926
who O 0 0.030718427151441574
was O 0 0.01492450200021267
first O 0 0.014148734509944916
seen O 0 0.02259172312915325
at O 0 0.014707565307617188
5 O 0 0.018404165282845497
months O 0 0.017299307510256767
of O 0 0.012628396973013878
age O 0 0.03544527292251587
with O 0 0.04926353320479393
severe O 1 0.999994158744812
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
, O 1 0.9698955416679382
hepatomegaly B-Disease 1 0.9999984502792358
, O 0 0.35918596386909485
encephalopathy B-Disease 1 0.9999915361404419
, O 0 0.03671664372086525
and O 0 0.03417535871267319
hypotonia B-Disease 1 0.996299684047699
. O 0 0.05798095092177391

Biochemical O 1 0.7567048072814941
studies O 0 0.12513597309589386
indicated O 1 0.954530656337738
VLCAD B-Disease 1 0.9999814033508301
deficiency I-Disease 1 0.9999992847442627
caused O 0 0.31843703985214233
by O 0 0.026990095153450966
a O 0 0.02879679948091507
stable O 0 0.07172109186649323
yet O 0 0.04929886385798454
inactive O 0 0.11984504759311676
enzyme O 0 0.1379597783088684
. O 0 0.04940967634320259

Molecular O 0 0.14240767061710358
genetic O 0 0.10447341203689575
analysis O 0 0.0444147102534771
of O 0 0.020564958453178406
her O 0 0.03786797821521759
VLCAD O 1 0.8646965622901917
gene O 0 0.10039444267749786
revealed O 0 0.056895237416028976
a O 0 0.04066542163491249
T1372C O 0 0.1548416167497635
( O 0 0.0623493455350399
F458L O 0 0.23310421407222748
) O 0 0.06346292048692703
missense O 0 0.28294745087623596
mutation O 0 0.1704847663640976
and O 0 0.03240762650966644
a O 0 0.05332481488585472
1668 O 1 0.8507570028305054
ACAG O 1 0.9459694027900696
1669 O 1 0.7515978217124939
splice O 0 0.2718167006969452
site O 0 0.0931442454457283
mutation O 0 0.2068127691745758
. O 0 0.06616415083408356

After O 0 0.07213032245635986
initial O 0 0.0820457860827446
treatment O 1 0.8884317278862
with O 0 0.03713411092758179
intravenous O 1 0.9830477833747864
glucose O 0 0.41269996762275696
and O 0 0.03224348649382591
carnitine O 1 0.9936798810958862
, O 0 0.022943472489714622
the O 0 0.019619202241301537
patient O 0 0.2717772424221039
has O 0 0.020413070917129517
thrived O 0 0.05475311726331711
on O 0 0.014018579386174679
a O 0 0.024349955841898918
low O 0 0.05762012302875519
- O 0 0.0917239710688591
fat O 0 0.09034828096628189
diet O 0 0.08690356463193893
supplemented O 0 0.060845997184515
with O 0 0.025651754811406136
medium O 0 0.06259117275476456
- O 0 0.09966026991605759
chain O 0 0.10072026401758194
triglyceride O 0 0.3453153967857361
oil O 0 0.05727604031562805
and O 0 0.03175549954175949
carnitine O 1 0.9923906922340393
and O 0 0.029029564931988716
avoidance O 1 0.8616697192192078
of O 0 0.03296400606632233
fasting O 0 0.14281797409057617
. O 0 0.051260821521282196

Her O 0 0.1468350887298584
ventricular O 1 0.9999247789382935
hypertrophy O 1 0.9997557997703552
resolved O 0 0.07303362339735031
significantly O 0 0.052224766463041306
over O 0 0.019662732258439064
1 O 0 0.023865168914198875
year O 0 0.017840180546045303
, O 0 0.013119115494191647
and O 0 0.013993524014949799
cognitively O 0 0.09130216389894485
, O 0 0.013598155230283737
she O 0 0.01154416799545288
is O 0 0.009183102287352085
in O 0 0.00845231395214796
the O 0 0.00988802220672369
superior O 0 0.03272257000207901
range O 0 0.027792122215032578
for O 0 0.01671777293086052
age O 0 0.0448455736041069
. O 0 0.03526344522833824

Clinical O 1 0.7161479592323303
recognition O 0 0.08204850554466248
of O 0 0.04473637789487839
VLCAD B-Disease 1 0.9999253749847412
deficiency I-Disease 1 0.9999959468841553
is O 0 0.02387075498700142
important O 0 0.013517427258193493
because O 0 0.013103685341775417
it O 0 0.007466895505785942
is O 0 0.007795426063239574
one O 0 0.007164104375988245
of O 0 0.0070104338228702545
the O 0 0.011490121483802795
few O 0 0.02577594853937626
directly O 0 0.041676945984363556
treatable O 1 0.9998779296875
causes O 1 0.9929732084274292
of O 0 0.036432329565286636
cardiomyopathy B-Disease 1 0.9999973773956299
in O 0 0.027461277320981026
children O 0 0.038102682679891586
. O 0 0.02467009238898754
. O 0 0.040011197328567505

Cloning O 0 0.10041456669569016
of O 0 0.020216267555952072
a O 0 0.019625049084424973
novel O 0 0.025523120537400246
member O 0 0.0159276332706213
of O 0 0.010027761571109295
the O 0 0.01847626455128193
low O 0 0.06144855543971062
- O 0 0.12615512311458588
density O 0 0.14190879464149475
lipoprotein O 1 0.9883872866630554
receptor O 0 0.4014301896095276
family O 0 0.08093658834695816
. O 0 0.05745721608400345

A O 0 0.06731866300106049
gene O 0 0.10387958586215973
encoding O 0 0.07024458795785904
a O 0 0.03230377659201622
novel O 0 0.049343131482601166
transmembrane O 0 0.13072317838668823
protein O 0 0.05860116705298424
was O 0 0.019746042788028717
identified O 0 0.02876807563006878
by O 0 0.017105387523770332
DNA O 0 0.04841698333621025
sequence O 0 0.035228487104177475
analysis O 0 0.02902035601437092
within O 0 0.023709187284111977
the O 0 0.027286939322948456
insulin B-Disease 1 0.9976589679718018
- I-Disease 1 0.9919316172599792
dependent I-Disease 1 0.989617645740509
diabetes I-Disease 1 0.9999996423721313
mellitus I-Disease 1 0.9999910593032837
( O 0 0.17565828561782837
IDDM B-Disease 1 0.9771471619606018
) O 0 0.06967703998088837
locus O 0 0.15721271932125092
IDDM4 O 0 0.274656742811203
on O 0 0.0476677231490612
chromosome O 0 0.1958518922328949
11q13 O 0 0.19759440422058105
. O 0 0.06679803133010864

Based O 0 0.03329848870635033
on O 0 0.014701456762850285
its O 0 0.019298119470477104
chromosomal O 0 0.10255104303359985
position O 0 0.023381073027849197
, O 0 0.013732519000768661
this O 0 0.013722294010221958
gene O 0 0.04309482127428055
is O 0 0.01426385436207056
a O 0 0.01603919081389904
candidate O 0 0.026781806722283363
for O 0 0.019683532416820526
conferring O 0 0.10213765501976013
susceptibility O 1 0.9823285937309265
to O 0 0.0486462339758873
diabetes B-Disease 1 0.9999239444732666
. O 0 0.06840471178293228

The O 0 0.044126205146312714
gene O 0 0.0999455451965332
, O 0 0.031288452446460724
termed O 0 0.09509726613759995
low O 0 0.08897434920072556
- O 0 0.15207000076770782
density O 0 0.1400844305753708
lipoprotein O 1 0.990222692489624
receptor O 0 0.3429758548736572
related O 0 0.07742507755756378
protein O 0 0.07620953023433685
5 O 0 0.04719553887844086
( O 0 0.048591144382953644
LRP5 O 0 0.2213359773159027
) O 0 0.028960684314370155
, O 0 0.017599787563085556
encodes O 0 0.05166489630937576
a O 0 0.027223296463489532
protein O 0 0.052103206515312195
of O 0 0.021770669147372246
1615 O 0 0.11503865569829941
amino O 0 0.0665033832192421
acids O 0 0.05283971503376961
that O 0 0.014457246288657188
contains O 0 0.02271292917430401
conserved O 0 0.03790254890918732
modules O 0 0.0372004397213459
which O 0 0.011763516813516617
are O 0 0.010105005465447903
characteristic O 0 0.029937317594885826
of O 0 0.0124601349234581
the O 0 0.017351923510432243
low O 0 0.05687994882464409
- O 0 0.15319781005382538
density O 0 0.12301994860172272
lipoprotein O 1 0.9972692131996155
( O 0 0.1135152205824852
LDL O 1 0.9986311793327332
) O 0 0.07244115322828293
receptor O 0 0.18093448877334595
family O 0 0.06354302912950516
. O 0 0.047722313553094864

These O 0 0.033766645938158035
modules O 0 0.05436278134584427
include O 0 0.028845660388469696
a O 0 0.03022175468504429
putative O 0 0.11200267821550369
signal O 0 0.07539842277765274
peptide O 0 0.09067700058221817
for O 0 0.021441511809825897
protein O 0 0.047246042639017105
export O 0 0.025976847857236862
, O 0 0.020474214106798172
four O 0 0.031154809519648552
epidermal O 1 0.9976156949996948
growth O 0 0.09346819669008255
factor O 0 0.10429961234331131
( O 0 0.06553459912538528
EGF O 1 0.9886743426322937
) O 0 0.04459347203373909
repeats O 0 0.070341557264328
with O 0 0.022766882553696632
associated O 0 0.04383084923028946
spacer O 0 0.169085294008255
domains O 0 0.0764557346701622
, O 0 0.02972046658396721
three O 0 0.039609361439943314
LDL O 1 0.999484658241272
- O 1 0.6894389390945435
receptor O 1 0.552952229976654
( O 0 0.06590018421411514
LDLR O 1 0.5075799822807312
) O 0 0.039132170379161835
repeats O 0 0.061219483613967896
, O 0 0.016201527789235115
a O 0 0.020160403102636337
single O 0 0.03300106152892113
transmembrane O 0 0.10489168018102646
spanning O 0 0.048034556210041046
domain O 0 0.0337531752884388
, O 0 0.013456408865749836
and O 0 0.012039002031087875
a O 0 0.02330917678773403
cytoplasmic O 0 0.11030587553977966
domain O 0 0.06854314357042313
. O 0 0.04382472112774849

The O 0 0.03731461241841316
encoded O 0 0.04634053632616997
protein O 0 0.0504879467189312
has O 0 0.017605725675821304
a O 0 0.016858572140336037
unique O 0 0.027227241545915604
organization O 0 0.030896121636033058
of O 0 0.023284191265702248
EGF O 1 0.9811016917228699
and O 0 0.0328746922314167
LDLR O 1 0.7112114429473877
repeats O 0 0.0882342979311943
; O 0 0.026857605203986168
therefore O 0 0.023596176877617836
, O 0 0.020743049681186676
LRP5 O 0 0.16349467635154724
likely O 0 0.03414571285247803
represents O 0 0.02750871703028679
a O 0 0.015738647431135178
new O 0 0.01441181544214487
category O 0 0.024371493607759476
of O 0 0.012554634362459183
the O 0 0.02164958231151104
LDLR O 0 0.4090656638145447
family O 0 0.06226317957043648
. O 0 0.04770304635167122

Both O 0 0.03358568251132965
human O 0 0.03980497270822525
and O 0 0.027990590780973434
mouse O 0 0.15195998549461365
LRP5 O 1 0.9518303871154785
cDNAs O 0 0.26054680347442627
have O 0 0.018432555720210075
been O 0 0.015421278774738312
isolated O 0 0.04241320863366127
and O 0 0.013022413477301598
the O 0 0.015520754270255566
encoded O 0 0.03682837262749672
mature O 0 0.05884141847491264
proteins O 0 0.03591382876038551
are O 0 0.013648525811731815
95 O 0 0.03321908786892891
% O 0 0.024380112066864967
identical O 0 0.031708505004644394
, O 0 0.015192601829767227
indicating O 0 0.0351056233048439
a O 0 0.01938020996749401
high O 0 0.02460738830268383
degree O 0 0.028739644214510918
of O 0 0.013796310871839523
evolutionary O 0 0.043809328228235245
conservation O 0 0.047711580991744995
. O 0 0.023004330694675446
. O 0 0.031179029494524002

The O 0 0.07093306630849838
APC B-Disease 0 0.4805960953235626
variants O 0 0.12665697932243347
I1307K O 0 0.15798312425613403
and O 0 0.03165551275014877
E1317Q O 0 0.11861136555671692
are O 0 0.021736133843660355
associated O 0 0.03932954743504524
with O 0 0.05469531938433647
colorectal B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999972581863403
, O 0 0.024588866159319878
but O 0 0.012816930189728737
not O 0 0.010111359879374504
always O 0 0.015735935419797897
with O 0 0.011547128669917583
a O 0 0.016422322019934654
family O 0 0.02938087284564972
history O 0 0.03292692080140114
. O 0 0.037175003439188004

Classical O 0 0.3083406686782837
familial B-Disease 1 0.9999816417694092
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999995231628418
( O 1 0.918819785118103
FAP B-Disease 1 0.9995991587638855
) O 0 0.036024224013090134
is O 0 0.017772763967514038
a O 0 0.02429915964603424
high O 0 0.05014282092452049
- O 1 0.9437640309333801
penetrance O 1 0.9985164999961853
autosomal B-Disease 1 0.9998413324356079
dominant I-Disease 1 0.9883449077606201
disease I-Disease 1 0.9999716281890869
that O 0 0.03196127340197563
predisposes O 1 0.9751285910606384
to O 0 0.022804824635386467
hundreds O 0 0.030687667429447174
or O 0 0.026745164766907692
thousands O 0 0.040562424808740616
of O 0 0.044787824153900146
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999977350234985
and I-Disease 0 0.12724311649799347
carcinoma I-Disease 1 0.9999961853027344
and O 0 0.020131422206759453
that O 0 0.01705210842192173
results O 0 0.034362342208623886
from O 0 0.02531244419515133
truncating O 0 0.41424527764320374
mutations O 0 0.13261985778808594
in O 0 0.026300504803657532
the O 0 0.030105501413345337
APC B-Disease 1 0.7423688769340515
gene O 0 0.13935419917106628
. O 0 0.057139791548252106

A O 0 0.07233670353889465
variant O 0 0.14085297286510468
of O 0 0.05036142095923424
FAP B-Disease 1 0.9998533725738525
is O 0 0.112909696996212
attenuated B-Disease 1 0.9995912909507751
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999983310699463
coli I-Disease 1 0.9998050332069397
, O 0 0.040106985718011856
which O 0 0.023106250911951065
results O 0 0.03911299258470535
from O 0 0.03176504001021385
germ O 1 0.9896739721298218
- O 0 0.07884378731250763
line O 0 0.043470315635204315
mutations O 0 0.07455585896968842
in O 0 0.012363046407699585
the O 0 0.012695281766355038
5 O 0 0.018789969384670258
and O 0 0.012261742725968361
3 O 0 0.022135592997074127
regions O 0 0.02698620967566967
of O 0 0.015013167634606361
the O 0 0.02489161491394043
APC B-Disease 1 0.5360129475593567
gene O 0 0.12951838970184326
. O 0 0.057311050593853

Attenuated B-Disease 1 0.9999240636825562
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999973773956299
patients O 1 0.9998434782028198
have O 0 0.03973693400621414
" O 0 0.03763517737388611
multiple O 0 0.062106262892484665
" O 0 0.2252856343984604
colorectal B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999861717224121
( O 0 0.053283508867025375
typically O 0 0.038879700005054474
fewer O 0 0.028061039745807648
than O 0 0.015743395313620567
100 O 0 0.023970121517777443
) O 0 0.02004230208694935
without O 0 0.01727401092648506
the O 0 0.023983344435691833
florid O 0 0.2813093960285187
phenotype O 0 0.4419113099575043
of O 0 0.036302607506513596
classical O 0 0.0830615982413292
FAP B-Disease 1 0.9972368478775024
. O 0 0.06650529056787491

Another O 0 0.054732441902160645
group O 0 0.04540659859776497
of O 0 0.02400820329785347
patients O 1 0.9709081053733826
with O 0 0.026912754401564598
multiple O 0 0.06527905911207199
adenomas B-Disease 1 0.9986680746078491
has O 0 0.024273114278912544
no O 0 0.02435951866209507
mutations O 0 0.07717370986938477
in O 0 0.016213495284318924
the O 0 0.021413937211036682
APC B-Disease 1 0.8236687779426575
gene O 0 0.07972310483455658
, O 0 0.01723240502178669
and O 0 0.013712119311094284
their O 0 0.019936898723244667
phenotype O 1 0.7059926986694336
probably O 0 0.03736835718154907
results O 0 0.027968421578407288
from O 0 0.017466740682721138
variation O 0 0.031759317964315414
at O 0 0.018179545179009438
a O 0 0.01964586414396763
locus O 0 0.07552998512983322
, O 0 0.02008381485939026
or O 0 0.027011921629309654
loci O 0 0.0993158221244812
, O 0 0.01633499562740326
elsewhere O 0 0.02392343245446682
in O 0 0.014573754742741585
the O 0 0.021275997161865234
genome O 0 0.09595377743244171
. O 0 0.04846186190843582

Recently O 0 0.0558793768286705
, O 0 0.023483699187636375
however O 0 0.021612053737044334
, O 0 0.018258007243275642
a O 0 0.03492005169391632
missense O 0 0.18523095548152924
variant O 0 0.12349068373441696
of O 0 0.038069408386945724
APC B-Disease 1 0.8765650391578674
( O 0 0.060660846531391144
I1307K O 0 0.13005399703979492
) O 0 0.02606891468167305
was O 0 0.015122330747544765
described O 0 0.02213730663061142
that O 0 0.012559979222714901
confers O 0 0.062889963388443
an O 0 0.019124850630760193
increased O 0 0.04640459641814232
risk O 1 0.9936443567276001
of O 0 0.051728639751672745
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999979734420776
, O 0 0.030124058946967125
including O 0 0.026769179850816727
multiple O 0 0.06149953231215477
adenomas B-Disease 1 0.998971700668335
, O 0 0.029025064781308174
in O 0 0.03224058821797371
Ashkenazim O 1 0.6896348595619202
. O 0 0.05946214124560356

We O 0 0.026296159252524376
have O 0 0.015135880559682846
studied O 0 0.020772496238350868
a O 0 0.015278107486665249
set O 0 0.01484747976064682
of O 0 0.015483565628528595
164 O 0 0.10241485387086868
patients O 1 0.9981733560562134
with O 0 0.038663461804389954
multiple O 1 0.9384698867797852
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.999995231628418
and I-Disease 0 0.07977168262004852
/ I-Disease 1 0.9991357922554016
or I-Disease 0 0.055295880883932114
carcinoma I-Disease 1 0.9999899864196777
and O 0 0.03674595057964325
analyzed O 0 0.08877590298652649
codons O 0 0.17658217251300812
1263 O 1 0.9859040379524231
- O 0 0.4489777088165283
1377 O 1 0.8026157021522522
( O 0 0.07770831137895584
exon O 0 0.15228621661663055
15G O 0 0.178028404712677
) O 0 0.03158368915319443
of O 0 0.016453854739665985
the O 0 0.02451319806277752
APC B-Disease 0 0.42952027916908264
gene O 0 0.09896238148212433
for O 0 0.03288983553647995
germ O 1 0.9780699610710144
- O 0 0.1019032672047615
line O 0 0.05209299549460411
variants O 0 0.09026220440864563
. O 0 0.04896552488207817

Three O 0 0.05174506828188896
patients O 1 0.9124582409858704
with O 0 0.025691257789731026
the O 0 0.030049093067646027
I1307K O 0 0.1516704261302948
allele O 0 0.116740882396698
were O 0 0.021172840148210526
detected O 0 0.05312062427401543
, O 0 0.014064658433198929
each O 0 0.014073831960558891
of O 0 0.017736822366714478
Ashkenazi O 0 0.13217245042324066
descent O 0 0.09983188658952713
. O 0 0.05118437856435776

Four O 0 0.06038989499211311
patients O 1 0.9748595356941223
had O 0 0.035382725298404694
a O 0 0.0378897562623024
germ O 1 0.9695289731025696
- O 0 0.12366675585508347
line O 0 0.06910142302513123
E1317Q O 0 0.4653113782405853
missense O 0 0.2808001935482025
variant O 0 0.10266877710819244
of O 0 0.02272571250796318
APC O 0 0.13838911056518555
that O 0 0.01114585343748331
was O 0 0.009828203357756138
not O 0 0.007721288129687309
present O 0 0.011092929169535637
in O 0 0.009323440492153168
controls O 0 0.024247072637081146
; O 0 0.013386864215135574
one O 0 0.0074312700890004635
of O 0 0.0067303902469575405
these O 0 0.008454887196421623
individuals O 0 0.015538403764367104
had O 0 0.012229541316628456
an O 0 0.01376394834369421
unusually O 0 0.0415591336786747
large O 0 0.018233340233564377
number O 0 0.014801669865846634
of O 0 0.017967132851481438
metaplastic B-Disease 1 0.6832246780395508
polyps I-Disease 1 0.9763041138648987
of I-Disease 0 0.021754447370767593
the I-Disease 0 0.02752254717051983
colorectum I-Disease 0 0.3784855902194977
. O 0 0.05349365249276161

There O 0 0.02826155535876751
is O 0 0.01692992076277733
increasing O 0 0.022688649594783783
evidence O 0 0.015549266710877419
that O 0 0.011208129115402699
there O 0 0.013551653362810612
exist O 0 0.025519954040646553
germ O 1 0.9014085531234741
- O 0 0.06468480825424194
line O 0 0.032834216952323914
variants O 0 0.04141997545957565
of O 0 0.01633467897772789
the O 0 0.023111416026949883
APC B-Disease 0 0.36563220620155334
gene O 0 0.08377030491828918
that O 0 0.019484616816043854
predispose O 0 0.11259789764881134
to O 0 0.015315369702875614
the O 0 0.015173478983342648
development O 0 0.02581898681819439
of O 0 0.02191951870918274
multiple O 1 0.9673318266868591
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999995231628418
and I-Disease 0 0.28803277015686035
carcinoma I-Disease 1 0.999998927116394
, O 0 0.023572701960802078
but O 0 0.015433975495398045
without O 0 0.01772925816476345
the O 0 0.022767014801502228
florid O 1 0.5811256170272827
phenotype O 1 0.5079396367073059
of O 0 0.028477024286985397
classical O 0 0.05135821923613548
FAP B-Disease 1 0.9968068599700928
, O 0 0.018819652497768402
and O 0 0.01338051725178957
possibly O 0 0.029142141342163086
with O 0 0.01646609790623188
importance O 0 0.03078315779566765
for O 0 0.05872255191206932
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
risk O 1 0.9778105020523071
in O 0 0.015001761727035046
the O 0 0.013625385239720345
general O 0 0.02140008844435215
population O 0 0.028165742754936218
. O 0 0.022700423374772072
. O 0 0.03594406694173813

Genomic O 0 0.14366722106933594
structure O 0 0.03878075256943703
of O 0 0.01636323146522045
the O 0 0.02726641856133938
human O 1 0.7686220407485962
congenital B-Disease 1 0.9999997615814209
chloride I-Disease 1 0.9999967813491821
diarrhea I-Disease 1 1.0
( O 1 0.9545274972915649
CLD B-Disease 1 0.9999191761016846
) O 0 0.07907208055257797
gene O 0 0.13994000852108002
. O 0 0.05845458060503006

Congenital B-Disease 1 0.9999998807907104
chloride I-Disease 1 0.9999947547912598
diarrhea I-Disease 1 0.9999998807907104
( O 1 0.9581460356712341
CLD B-Disease 1 0.999934196472168
) O 0 0.042978908866643906
is O 0 0.021060854196548462
caused O 0 0.05366390943527222
by O 0 0.019916219636797905
mutations O 0 0.07713320851325989
in O 0 0.01861003413796425
a O 0 0.02296697162091732
gene O 0 0.07067257165908813
which O 0 0.025398626923561096
encodes O 0 0.08156194537878036
an O 0 0.04833613708615303
intestinal O 1 0.999639630317688
anion O 1 0.9710240960121155
transporter O 1 0.8545507192611694
. O 0 0.0631914883852005

We O 0 0.024451078847050667
report O 0 0.022500494495034218
here O 0 0.013182142749428749
the O 0 0.014799709431827068
complete O 0 0.028854239732027054
genomic O 0 0.0703035220503807
organization O 0 0.0271393284201622
of O 0 0.012811186723411083
the O 0 0.020212313160300255
human O 0 0.04865306615829468
CLD B-Disease 1 0.9994919300079346
gene O 0 0.09975040704011917
which O 0 0.023055706173181534
spans O 0 0.06145969405770302
approximately O 0 0.03394770249724388
39kb O 0 0.09661177545785904
, O 0 0.020067961886525154
and O 0 0.0165261160582304
comprises O 0 0.03593776002526283
21 O 0 0.04877758026123047
exons O 0 0.1293008178472519
. O 0 0.051089487969875336

All O 0 0.04873810335993767
exon O 0 0.1928025186061859
/ O 0 0.26619094610214233
intron O 0 0.2131749838590622
boundaries O 0 0.04369980841875076
conform O 0 0.05137135088443756
to O 0 0.02239779755473137
the O 0 0.033892106264829636
GT O 1 0.9908343553543091
/ O 1 0.9928191304206848
AG O 1 0.9819314479827881
rule O 0 0.07078129798173904
. O 0 0.05212046205997467

An O 0 0.03344419226050377
analysis O 0 0.03255796432495117
of O 0 0.01532738283276558
the O 0 0.026040896773338318
putative O 0 0.11239879578351974
promoter O 0 0.11478624492883682
region O 0 0.05540842562913895
sequence O 0 0.04554426670074463
shows O 0 0.034326620399951935
a O 0 0.032144781202077866
putative O 0 0.11181121319532394
TATA O 0 0.1600656360387802
box O 0 0.06713248789310455
and O 0 0.026676800101995468
predicts O 0 0.08929625898599625
multiple O 0 0.06325648725032806
transcription O 0 0.10331124812364578
factor O 0 0.0727580264210701
binding O 0 0.05660800263285637
sites O 0 0.04429851844906807
. O 0 0.042629703879356384

The O 0 0.046344198286533356
genomic O 0 0.10962303727865219
structure O 0 0.03701157867908478
was O 0 0.01917945221066475
determined O 0 0.025799743831157684
using O 0 0.018965091556310654
DNA O 0 0.03352640941739082
from O 0 0.012111174874007702
several O 0 0.01054181158542633
sources O 0 0.017776276916265488
including O 0 0.015431593172252178
multiple O 0 0.0357077419757843
large O 0 0.032182157039642334
- O 0 0.08578784018754959
insert O 0 0.11768009513616562
libaries O 0 0.14896157383918762
and O 0 0.03198191523551941
genomic O 0 0.12024934589862823
DNA O 0 0.08103252947330475
from O 0 0.04061353951692581
Finnish O 0 0.23734807968139648
CLD B-Disease 1 0.9999351501464844
patients O 1 0.9971535205841064
and O 0 0.02993365004658699
controls O 0 0.06750747561454773
. O 0 0.04012858867645264

Exon O 0 0.2174963802099228
- O 0 0.11968768388032913
specific O 0 0.04677668958902359
primers O 0 0.108340784907341
developed O 0 0.035752467811107635
in O 0 0.015157326124608517
this O 0 0.012339831329882145
study O 0 0.02419872209429741
will O 0 0.01741241291165352
facilitate O 0 0.047851186245679855
mutation O 0 0.1660519391298294
screening O 0 0.08459634333848953
studies O 0 0.03546517342329025
of O 0 0.017513412982225418
patients O 1 0.9974175691604614
with O 0 0.02237718552350998
the O 0 0.029603229835629463
disease O 1 0.9997859597206116
. O 0 0.05568324029445648

Genomic O 0 0.19704289734363556
sequencing O 0 0.10953215509653091
of O 0 0.03643077611923218
a O 0 0.058984845876693726
BAC O 1 0.9872176051139832
clone O 1 0.935768723487854
H O 1 0.9931723475456238
_ O 0 0.05838095396757126
RG364P16 O 0 0.10710383951663971
revealed O 0 0.034307464957237244
the O 0 0.01311654131859541
presence O 0 0.02665448747575283
of O 0 0.01071595586836338
another O 0 0.019688570871949196
, O 0 0.016216635704040527
highly O 0 0.033537592738866806
homologous O 0 0.10456077754497528
gene O 0 0.07557429373264313
3 O 0 0.026117775589227676
of O 0 0.012813118286430836
the O 0 0.024911273270845413
CLD B-Disease 1 0.9995182752609253
gene O 0 0.07736622542142868
, O 0 0.014450146816670895
with O 0 0.012824327684938908
a O 0 0.016176296398043633
similar O 0 0.026199914515018463
genomic O 0 0.07144353538751602
structure O 0 0.028874671086668968
, O 0 0.015491527505218983
recently O 0 0.027647141367197037
identified O 0 0.026944011449813843
as O 0 0.020306101068854332
the O 0 0.03663914278149605
Pendred B-Disease 1 0.999907374382019
syndrome I-Disease 1 0.9999997615814209
gene O 1 0.8313411474227905
( O 0 0.08433680236339569
PDS B-Disease 1 0.9934491515159607
) O 0 0.04113653674721718
. O 0 0.02590371109545231
. O 0 0.03589920699596405

The O 0 0.07244106382131577
APCI1307K O 1 0.9047117829322815
allele O 0 0.3351461589336395
and O 0 0.04317455366253853
cancer B-Disease 1 0.9997496008872986
risk O 0 0.4782748222351074
in O 0 0.017470454797148705
a O 0 0.019619230180978775
community O 0 0.028300395235419273
- O 0 0.04462769627571106
based O 0 0.022315137088298798
study O 0 0.028662225231528282
of O 0 0.02071368508040905
Ashkenazi O 0 0.12732507288455963
Jews O 0 0.06294107437133789
. O 0 0.04697916656732559

Mutations O 0 0.22589457035064697
in O 0 0.048703424632549286
APC O 1 0.5057686567306519
are O 0 0.03487612307071686
classically O 1 0.5007463097572327
associated O 0 0.06223790720105171
with O 0 0.06859337538480759
familial B-Disease 1 0.9999963045120239
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
( O 1 0.9700794816017151
FAP B-Disease 1 0.9999146461486816
) O 0 0.0470493882894516
, O 0 0.023202834650874138
a O 0 0.03564480319619179
highly O 0 0.08844417333602905
penetrant O 1 0.9997937083244324
autosomal B-Disease 1 0.999984622001648
dominant I-Disease 1 0.9991061091423035
disorder I-Disease 1 0.9999992847442627
characterized O 1 0.9923793077468872
by O 0 0.043218858540058136
multiple O 1 0.7546670436859131
intestinal O 1 0.9999924898147583
polyps B-Disease 1 0.9996975660324097
and O 0 0.023040106520056725
, O 0 0.01743326708674431
without O 0 0.02178710512816906
surgical O 1 0.9921104311943054
intervention O 0 0.07510022073984146
, O 0 0.014689575880765915
the O 0 0.014772521331906319
development O 0 0.03105844184756279
of O 0 0.03767301142215729
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
( O 0 0.13282211124897003
CRC B-Disease 1 0.9840853214263916
) O 0 0.05383764207363129
. O 0 0.04370092228055

APC B-Disease 1 0.7754406332969666
is O 0 0.052594143897295
a O 0 0.06067125126719475
tumour O 1 0.9999111890792847
- O 1 0.9633572101593018
suppressor O 1 0.9513429403305054
gene O 0 0.10387910157442093
, O 0 0.022723989561200142
and O 0 0.02427649311721325
somatic O 1 0.7548283338546753
loss O 0 0.4872204065322876
occurs O 0 0.0928327813744545
in O 0 0.0386447012424469
tumours B-Disease 1 0.999518871307373
. O 0 0.06072017922997475

The O 0 0.07760597765445709
germline O 1 0.9912064671516418
T O 1 0.9797612428665161
- O 0 0.0878504067659378
to O 0 0.024617111310362816
- O 0 0.0607532300055027
A O 0 0.03362966328859329
transversion O 0 0.10864969342947006
responsible O 0 0.04131459444761276
for O 0 0.01655331626534462
the O 0 0.02842009626328945
APC O 0 0.2425229400396347
I1307K O 0 0.1684897392988205
allele O 0 0.14448274672031403
converts O 0 0.059143997728824615
the O 0 0.023262906819581985
wild O 0 0.056447844952344894
- O 0 0.07314839214086533
type O 0 0.05863505229353905
sequence O 0 0.03893947973847389
to O 0 0.01963953673839569
a O 0 0.03621547669172287
homopolymer O 1 0.9391502141952515
tract O 1 0.9931660294532776
( O 0 0.06154057756066322
A8 O 1 0.8562765121459961
) O 0 0.028355993330478668
that O 0 0.013683800585567951
is O 0 0.01778205670416355
genetically O 0 0.05582530051469803
unstable O 0 0.2175493836402893
and O 0 0.02547181211411953
prone O 0 0.1810746043920517
to O 0 0.038046155124902725
somatic O 0 0.31976667046546936
mutation O 0 0.41106492280960083
. O 0 0.06240306794643402

The O 0 0.0546700544655323
I1307K O 0 0.17171913385391235
allele O 0 0.13348117470741272
was O 0 0.02848057448863983
found O 0 0.026228582486510277
in O 0 0.021797403693199158
6 O 0 0.045295313000679016
. O 0 0.03803690895438194

1 O 0 0.06020074337720871
% O 0 0.039757970720529556
of O 0 0.025260675698518753
unselected O 0 0.1562681943178177
Ashkenazi O 0 0.12156470119953156
Jews O 0 0.03649519011378288
and O 0 0.01621495559811592
higher O 0 0.032612286508083344
proportions O 0 0.07339992374181747
of O 0 0.021841825917363167
Ashkenazim O 0 0.16612571477890015
with O 0 0.02116614766418934
family O 0 0.0292009636759758
or O 0 0.022403810173273087
personal O 0 0.03221920132637024
histories O 0 0.0630037859082222
of O 0 0.02784251980483532
CRC B-Disease 1 0.945947527885437
( O 0 0.06143653392791748
ref O 0 0.15037308633327484
. O 0 0.026793424040079117
2 O 0 0.03938017040491104
) O 0 0.03486699238419533
. O 0 0.035419803112745285

To O 0 0.03301383927464485
evaluate O 0 0.05054577440023422
the O 0 0.017560305073857307
role O 0 0.028126956894993782
of O 0 0.020922256633639336
I1307K O 0 0.20627418160438538
in O 0 0.03045603260397911
cancer B-Disease 1 0.9990591406822205
, O 0 0.02050010859966278
we O 0 0.02195996791124344
genotyped O 0 0.12454633414745331
5 O 0 0.04235527291893959
, O 0 0.028480051085352898
081 O 1 0.7517181634902954
Ashkenazi O 0 0.12389043718576431
volunteers O 0 0.058345917612314224
in O 0 0.017083322629332542
a O 0 0.021563660353422165
community O 0 0.03419502079486847
survey O 0 0.04788626357913017
. O 0 0.039546359330415726

Risk O 1 0.9438353180885315
of O 0 0.04445737227797508
developing O 1 0.9311432242393494
colorectal B-Disease 1 0.9999985694885254
, I-Disease 0 0.05252956598997116
breast I-Disease 1 0.9998389482498169
and I-Disease 0 0.019655490294098854
other I-Disease 0 0.019101351499557495
cancers I-Disease 1 0.9965774416923523
were O 0 0.017663832753896713
compared O 0 0.0327608622610569
between O 0 0.03372952714562416
genotyped O 1 0.7715110778808594
I1307K O 0 0.3737166225910187
carriers O 0 0.09145537763834
and O 0 0.020072052255272865
non O 0 0.04219428077340126
- O 0 0.06483174860477448
carriers O 0 0.05966614559292793
and O 0 0.011992697604000568
their O 0 0.012083171866834164
first O 0 0.020352261140942574
- O 0 0.06409794092178345
degree O 0 0.049149248749017715
relatives O 0 0.06903734803199768
. O 0 0.04931268095970154

Sperm O 0 0.16362398862838745
DNA O 0 0.09367319196462631
analysis O 0 0.04654914140701294
in O 0 0.02704165130853653
a O 0 0.0522310696542263
Friedreich B-Disease 1 0.999007523059845
ataxia I-Disease 1 0.9997771382331848
premutation O 1 0.9645370841026306
carrier O 0 0.2108495980501175
suggests O 0 0.06055228412151337
both O 0 0.026932816952466965
meiotic O 1 0.6948356628417969
and O 0 0.02811160869896412
mitotic O 0 0.13514183461666107
expansion O 0 0.046129945665597916
in O 0 0.01984822191298008
the O 0 0.02841648831963539
FRDA B-Disease 1 0.7854552865028381
gene O 0 0.1385607123374939
. O 0 0.0575394481420517

Friedreich B-Disease 1 0.9995311498641968
ataxia I-Disease 1 0.9995880722999573
is O 0 0.03812599554657936
usually O 0 0.03288104385137558
caused O 0 0.04487587511539459
by O 0 0.01375054381787777
an O 0 0.014081912115216255
expansion O 0 0.03181164711713791
of O 0 0.015349723398685455
a O 0 0.03108866699039936
GAA O 0 0.12713845074176788
trinucleotide O 1 0.9746638536453247
repeat O 0 0.12281912565231323
in O 0 0.035165075212717056
intron O 0 0.24667780101299286
1 O 0 0.04111253842711449
of O 0 0.017962895333766937
the O 0 0.03176366165280342
FRDA B-Disease 1 0.5422700643539429
gene O 0 0.14486081898212433
. O 0 0.06163901835680008

Occasionally O 0 0.0648437887430191
, O 0 0.020670020952820778
a O 0 0.01945030875504017
fully O 0 0.029907528311014175
expanded O 0 0.03077160194516182
allele O 0 0.08471498638391495
has O 0 0.016807720065116882
been O 0 0.011396211571991444
found O 0 0.014460711739957333
to O 0 0.011045340448617935
arise O 0 0.035875167697668076
from O 0 0.015232140198349953
a O 0 0.01708970032632351
premutation O 0 0.07216298580169678
of O 0 0.014416528865695
100 O 0 0.026104265823960304
or O 0 0.027137773111462593
less O 0 0.035900264978408813
triplet O 0 0.25548040866851807
repeats O 0 0.13970430195331573
. O 0 0.06034748628735542

We O 0 0.031024515628814697
have O 0 0.019917543977499008
examined O 0 0.04254645109176636
the O 0 0.01997709460556507
sperm O 0 0.06879614293575287
DNA O 0 0.04596841335296631
of O 0 0.01683303341269493
a O 0 0.032691843807697296
premutation O 0 0.18711501359939575
carrier O 0 0.13149316608905792
. O 0 0.0513928160071373

This O 0 0.048070184886455536
mans O 0 0.14506526291370392
leucocyte O 0 0.18480248749256134
DNA O 0 0.0831197202205658
showed O 0 0.04540419951081276
one O 0 0.021562596783041954
normal O 0 0.047406651079654694
allele O 0 0.09174074977636337
and O 0 0.01737317256629467
one O 0 0.01881086826324463
allele O 0 0.07687706500291824
of O 0 0.018839390948414803
approximately O 0 0.03700300678610802
100 O 0 0.04484804719686508
repeats O 0 0.0977080836892128
. O 0 0.04131007194519043

His O 0 0.050578903406858444
sperm O 0 0.10621276497840881
showed O 0 0.04385261610150337
an O 0 0.01866873726248741
expanded O 0 0.031196752563118935
allele O 0 0.08791682869195938
in O 0 0.019509252160787582
a O 0 0.0216370839625597
tight O 0 0.038071293383836746
range O 0 0.030361445620656013
centering O 0 0.04805630445480347
on O 0 0.013467807322740555
a O 0 0.017237963154911995
size O 0 0.023837018758058548
of O 0 0.015823572874069214
approximately O 0 0.04467962682247162
320 O 0 0.1291218400001526
trinucleotide O 1 0.9502202272415161
repeats O 0 0.15559953451156616
. O 0 0.060524050146341324

His O 0 0.05750073119997978
affected O 0 0.08378811180591583
son O 0 0.0680302157998085
has O 0 0.030863605439662933
repeat O 0 0.08285866677761078
sizes O 0 0.05225342512130737
of O 0 0.023074448108673096
1040 O 0 0.15691395103931427
and O 0 0.02759159915149212
540 O 0 0.12363261729478836
. O 0 0.048522572964429855

These O 0 0.027973337098956108
data O 0 0.025478793308138847
suggest O 0 0.03100717067718506
that O 0 0.013053233735263348
expansion O 0 0.03154281899333
occurs O 0 0.03060760535299778
in O 0 0.010532877407968044
two O 0 0.010697097517549992
stages O 0 0.03032500669360161
, O 0 0.009885967709124088
the O 0 0.010206010192632675
first O 0 0.01447922084480524
during O 0 0.025521820411086082
meiosis O 0 0.08509837836027145
followed O 0 0.026118500158190727
by O 0 0.01545694749802351
a O 0 0.023586124181747437
second O 0 0.03700793534517288
mitotic O 0 0.17821094393730164
expansion O 0 0.07764292508363724
. O 0 0.051791850477457047

We O 0 0.024357618764042854
also O 0 0.014277021400630474
show O 0 0.01660890318453312
that O 0 0.008360233157873154
in O 0 0.009390181861817837
all O 0 0.0111829349771142
informative O 0 0.037079207599163055
carrier O 0 0.05503443256020546
father O 0 0.027090653777122498
to O 0 0.016956336796283722
affected O 0 0.04373877868056297
child O 0 0.04312831163406372
transmissions O 0 0.05035364255309105
, O 0 0.012021931819617748
with O 0 0.010667053051292896
the O 0 0.011901427060365677
notable O 0 0.01983794756233692
exception O 0 0.02312956564128399
of O 0 0.012187105603516102
the O 0 0.018179671838879585
premutation O 0 0.12178325653076172
carrier O 0 0.06663872301578522
, O 0 0.016990501433610916
the O 0 0.015483377501368523
expansion O 0 0.041479405015707016
size O 0 0.03769927844405174
decreases O 0 0.07868976145982742
. O 0 0.02742578089237213
. O 0 0.03562274947762489

The O 0 0.060788433998823166
R496H O 0 0.19783036410808563
mutation O 0 0.16156005859375
of O 0 0.027372043579816818
arylsulfatase O 0 0.1797409951686859
A O 0 0.0317763015627861
does O 0 0.026716524735093117
not O 0 0.02494708076119423
cause O 1 0.7300541400909424
metachromatic B-Disease 1 0.9983586668968201
leukodystrophy I-Disease 1 0.9999068975448608
. O 0 0.08144894987344742

Deficiency B-Disease 1 0.9999039173126221
of I-Disease 0 0.05064331367611885
arylsulfatase I-Disease 1 0.7014058828353882
A I-Disease 0 0.061872027814388275
( O 0 0.08623009920120239
ARSA O 1 0.993999719619751
) O 0 0.07011152058839798
enzyme O 0 0.18780115246772766
activity O 0 0.11903690546751022
causes O 1 0.9965028762817383
metachromatic B-Disease 1 0.9997768998146057
leukodystrophy I-Disease 1 0.9999939203262329
( O 1 0.7214826345443726
MLD B-Disease 1 0.9998131394386292
) O 0 0.06791849434375763
. O 0 0.04799101874232292

A O 0 0.0447549931704998
number O 0 0.029527248814702034
of O 0 0.03588610887527466
ARSA O 1 0.9937362670898438
gene O 0 0.18710993230342865
mutations O 0 0.1797800362110138
responsible O 0 0.06092589348554611
for O 0 0.034469638019800186
MLD B-Disease 1 0.9989410042762756
have O 0 0.02959250845015049
been O 0 0.025071166455745697
identified O 0 0.0462765097618103
. O 0 0.041755009442567825

Recently O 0 0.06859291344881058
, O 0 0.026988398283720016
the O 0 0.030865274369716644
R496H O 0 0.1621638983488083
mutation O 0 0.15436118841171265
of O 0 0.0302816741168499
ARSA O 1 0.965451717376709
was O 0 0.02346622571349144
proposed O 0 0.021305587142705917
to O 0 0.01064533181488514
be O 0 0.010991545394062996
a O 0 0.02217782475054264
cause O 0 0.06187134236097336
of O 0 0.03410724550485611
MLD B-Disease 1 0.9998346567153931
( O 0 0.07261209934949875
Draghia O 1 0.8195073008537292
et O 0 0.1235356330871582
al O 0 0.06084197014570236
. O 0 0.019520046189427376
, O 0 0.02044227346777916
1997 O 0 0.04100874811410904
) O 0 0.03740501031279564
. O 0 0.037969205528497696

We O 0 0.032801706343889236
have O 0 0.021815549582242966
investigated O 0 0.047634419053792953
the O 0 0.024287890642881393
R496H O 0 0.16002969443798065
mutation O 0 0.11877048760652542
and O 0 0.016587357968091965
found O 0 0.02016047015786171
this O 0 0.014849726110696793
mutation O 0 0.08488199859857559
at O 0 0.01778997853398323
a O 0 0.016645751893520355
relatively O 0 0.025781702250242233
high O 0 0.023502733558416367
frequency O 0 0.03427280858159065
in O 0 0.01126408763229847
an O 0 0.012774993665516376
African O 0 0.03518172353506088
American O 0 0.03057999722659588
population O 0 0.03630071505904198
( O 0 0.04900486767292023
f O 0 0.09661377966403961
= O 0 0.106780506670475
0 O 0 0.05554500222206116
. O 0 0.021172037348151207
09 O 0 0.08061641454696655
, O 0 0.02792467176914215
n O 0 0.07541494816541672
= O 0 0.10391616076231003
61 O 0 0.062284793704748154
subjects O 0 0.04754282906651497
) O 0 0.04058896750211716
. O 0 0.03931008651852608

The O 0 0.06951030343770981
ARSA O 1 0.9763610363006592
enzyme O 0 0.1409827470779419
activity O 0 0.04807291552424431
in O 0 0.01543834712356329
subjects O 0 0.021576864644885063
with O 0 0.011281359009444714
and O 0 0.011427820660173893
without O 0 0.01678835228085518
the O 0 0.01808561384677887
R496H O 0 0.18687553703784943
mutation O 0 0.10216081887483597
was O 0 0.01787058636546135
determined O 0 0.024152839556336403
and O 0 0.011016568168997765
found O 0 0.014433858916163445
to O 0 0.011520576663315296
be O 0 0.014175517484545708
normal O 0 0.05011105537414551
. O 0 0.039537928998470306

It O 0 0.02919611521065235
is O 0 0.018309567123651505
therefore O 0 0.021896347403526306
concluded O 0 0.032557275146245956
that O 0 0.013379385694861412
the O 0 0.02049064077436924
R496H O 0 0.16107521951198578
mutation O 0 0.16065269708633423
of O 0 0.03093242272734642
ARSA O 1 0.9884451627731323
does O 0 0.03188065066933632
not O 0 0.01431351900100708
negatively O 0 0.038817472755908966
influence O 0 0.02475624345242977
the O 0 0.015196568332612514
activity O 0 0.03359316289424896
of O 0 0.018064264208078384
ARSA O 1 0.9581089615821838
and O 0 0.014673660509288311
is O 0 0.013056717813014984
not O 0 0.011982892639935017
a O 0 0.021714886650443077
cause O 0 0.07917296141386032
of O 0 0.043750450015068054
MLD B-Disease 1 0.9995827078819275

Down O 0 0.08430361747741699
- O 0 0.10622674971818924
regulation O 0 0.08050869405269623
of O 0 0.035337939858436584
transmembrane O 1 0.9123750329017639
carbonic O 1 0.9973211884498596
anhydrases O 1 0.9909929633140564
in O 0 0.09586691111326218
renal B-Disease 1 0.9999994039535522
cell I-Disease 1 0.9987083673477173
carcinoma I-Disease 1 0.9999966621398926
cell O 0 0.26415741443634033
lines O 0 0.04960291460156441
by O 0 0.0296146459877491
wild O 0 0.07566825300455093
- O 0 0.45179301500320435
type O 0 0.3832414150238037
von B-Disease 1 0.982544481754303
Hippel I-Disease 1 0.9976029992103577
- I-Disease 1 0.9397422075271606
Lindau I-Disease 1 0.9932095408439636
transgenes O 1 0.9039069414138794
. O 0 0.08226125687360764

To O 0 0.04473389685153961
discover O 0 0.09486313909292221
genes O 0 0.08806478977203369
involved O 0 0.046264391392469406
in O 0 0.04042508453130722
von B-Disease 1 0.9812869429588318
Hippel I-Disease 1 0.9989547729492188
- I-Disease 1 0.9724038243293762
Lindau I-Disease 1 0.9983609318733215
( O 0 0.147139772772789
VHL B-Disease 1 0.9989737272262573
) O 0 0.0670633539557457
- O 0 0.2375417798757553
mediated O 1 0.8397511839866638
carcinogenesis O 1 0.9953474402427673
, O 0 0.027809040620923042
we O 0 0.02520384080708027
used O 0 0.0448518842458725
renal B-Disease 1 0.9999980926513672
cell I-Disease 1 0.9968434572219849
carcinoma I-Disease 1 0.9999955892562866
cell O 0 0.3325948715209961
lines O 0 0.06985057145357132
stably O 0 0.18455269932746887
transfected O 1 0.8882710337638855
with O 0 0.04505494609475136
wild O 0 0.08879899233579636
- O 1 0.520623505115509
type O 0 0.4670355021953583
VHL O 1 0.9986294507980347
- O 0 0.4023829400539398
expressing O 0 0.14175160229206085
transgenes O 1 0.6768255233764648
. O 0 0.07623955607414246

Large O 0 0.0719902291893959
- O 0 0.10216735303401947
scale O 0 0.0878191590309143
RNA O 0 0.10107892006635666
differential O 0 0.07789851725101471
display O 0 0.03531013801693916
technology O 0 0.025859089568257332
applied O 0 0.018785174936056137
to O 0 0.012413902208209038
these O 0 0.012858831323683262
cell O 0 0.049972690641880035
lines O 0 0.032876189798116684
identified O 0 0.029162539169192314
several O 0 0.01916114054620266
differentially O 0 0.1005096510052681
expressed O 0 0.03871869668364525
genes O 0 0.05619385465979576
, O 0 0.017941037192940712
including O 0 0.018431106582283974
an O 0 0.03078928403556347
alpha O 0 0.11845782399177551
carbonic O 1 0.9809033274650574
anhydrase O 1 0.9780054688453674
gene O 0 0.14334306120872498
, O 0 0.04597863182425499
termed O 0 0.12158340960741043
CA12 O 1 0.8741220235824585
. O 0 0.06259337812662125

The O 0 0.04656122997403145
deduced O 0 0.08880987763404846
protein O 0 0.0645553395152092
sequence O 0 0.03633280470967293
was O 0 0.016806332394480705
classified O 0 0.02198992483317852
as O 0 0.010617239400744438
a O 0 0.016849180683493614
one O 0 0.017707953229546547
- O 0 0.06924830377101898
pass O 0 0.059924960136413574
transmembrane O 0 0.1506354659795761
CA O 0 0.06451912969350815
possessing O 0 0.0377165749669075
an O 0 0.02098376676440239
apparently O 0 0.04535190016031265
intact O 0 0.06125933304429054
catalytic O 0 0.07949286699295044
domain O 0 0.03665393590927124
in O 0 0.017691636458039284
the O 0 0.024770615622401237
extracellular O 0 0.1140681579709053
CA O 0 0.0900457501411438
module O 0 0.09105396270751953
. O 0 0.047626979649066925

Reintroduced O 0 0.18653084337711334
wild O 0 0.13061901926994324
- O 0 0.43966543674468994
type O 0 0.1481664925813675
VHL B-Disease 1 0.9951844811439514
strongly O 0 0.06237739697098732
inhibited O 0 0.1101110652089119
the O 0 0.02753523550927639
overexpression O 0 0.11517880856990814
of O 0 0.017109541222453117
the O 0 0.025698723271489143
CA12 O 1 0.587111234664917
gene O 0 0.08333572745323181
in O 0 0.02214871160686016
the O 0 0.029966138303279877
parental O 1 0.9983354210853577
renal B-Disease 1 0.9999996423721313
cell I-Disease 1 0.9993230104446411
carcinoma I-Disease 1 0.9999982118606567
cell O 1 0.5929113626480103
lines O 0 0.07252565771341324
. O 0 0.045949291437864304

Similar O 0 0.05318346247076988
results O 0 0.037373725324869156
were O 0 0.013696832582354546
obtained O 0 0.021804051473736763
with O 0 0.023173240944743156
CA9 O 1 0.9910191893577576
, O 0 0.027727577835321426
encoding O 0 0.05019610375165939
another O 0 0.03432299196720123
transmembrane O 0 0.10250965505838394
CA O 0 0.05328737571835518
with O 0 0.017598073929548264
an O 0 0.023160217329859734
intact O 0 0.07232418656349182
catalytic O 0 0.11913547664880753
domain O 0 0.07108096778392792
. O 0 0.050806932151317596

Although O 0 0.03746756911277771
both O 0 0.02048526145517826
domains O 0 0.04558210447430611
of O 0 0.019996995106339455
the O 0 0.02971152402460575
VHL B-Disease 1 0.9893662333488464
protein O 0 0.075564906001091
contribute O 0 0.04399736970663071
to O 0 0.018488099798560143
regulation O 0 0.04006373882293701
of O 0 0.018572917208075523
CA12 O 0 0.2878134846687317
expression O 0 0.045291900634765625
, O 0 0.015723157674074173
the O 0 0.019450407475233078
elongin O 0 0.11584661155939102
binding O 0 0.053471751511096954
domain O 0 0.05065625533461571
alone O 0 0.039914313703775406
could O 0 0.02678419090807438
effectively O 0 0.05662493035197258
regulate O 0 0.12100859731435776
CA9 O 1 0.9958427548408508
expression O 0 0.09998078644275665
. O 0 0.047320861369371414

We O 0 0.06379614025354385
mapped O 0 0.11885406076908112
CA12 O 0 0.2839769423007965
and O 0 0.0562540702521801
CA9 O 1 0.987356424331665
loci O 0 0.20440000295639038
to O 0 0.04279683157801628
chromosome O 0 0.15227989852428436
bands O 0 0.07275328785181046
15q22 O 0 0.12930342555046082
and O 0 0.033490151166915894
17q21 O 0 0.15451687574386597
. O 0 0.05486264452338219

2 O 0 0.04898204281926155
respectively O 0 0.03868424519896507
, O 0 0.02292000874876976
regions O 0 0.04671643674373627
prone O 0 0.09925111383199692
to O 0 0.024957071989774704
amplification O 0 0.09544447064399719
in O 0 0.019415156915783882
some O 0 0.01990997977554798
human O 0 0.0468258298933506
cancers B-Disease 1 0.9984563589096069
. O 0 0.05231783911585808

Additional O 0 0.05706401541829109
experiments O 0 0.04908706992864609
are O 0 0.014181282371282578
needed O 0 0.022789157927036285
to O 0 0.010610991157591343
define O 0 0.024126576259732246
the O 0 0.01180212665349245
role O 0 0.021827884018421173
of O 0 0.01697300560772419
CA O 0 0.07468260079622269
IX O 0 0.32121118903160095
and O 0 0.02580660581588745
CA O 0 0.07797901332378387
XII O 0 0.1302568018436432
enzymes O 0 0.05071105435490608
in O 0 0.014226951636373997
the O 0 0.01422915793955326
regulation O 0 0.03681344911456108
of O 0 0.018121708184480667
pH O 0 0.09869648516178131
in O 0 0.018174314871430397
the O 0 0.021093733608722687
extracellular O 0 0.09533987939357758
microenvironment O 0 0.3004165291786194
and O 0 0.01837986148893833
its O 0 0.020208396017551422
potential O 0 0.041158515959978104
impact O 0 0.04750228300690651
on O 0 0.025890937075018883
cancer B-Disease 1 0.9997277855873108
cell O 0 0.16106072068214417
growth O 0 0.07274901866912842
. O 0 0.04772770032286644

A O 0 0.0697605088353157
gene O 0 0.11438722163438797
encoding O 0 0.07557244598865509
a O 0 0.043548375368118286
transmembrane O 0 0.14222949743270874
protein O 0 0.06753896176815033
is O 0 0.02357136830687523
mutated O 0 0.11423490196466446
in O 0 0.03198700025677681
patients O 1 0.9998915195465088
with O 1 0.5631856322288513
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999995231628418
and O 1 0.9197268486022949
optic B-Disease 1 0.9999988079071045
atrophy I-Disease 1 0.9999973773956299
( O 1 0.9976660013198853
Wolfram B-Disease 1 0.9999872446060181
syndrome I-Disease 1 0.9999997615814209
) O 0 0.07101719826459885
. O 0 0.05465374514460564

Wolfram B-Disease 1 0.9999806880950928
syndrome I-Disease 1 0.9999998807907104
( O 1 0.8701828718185425
WFS B-Disease 1 0.9999028444290161
; O 0 0.11795306205749512
OMIM O 1 0.9991918206214905
222300 O 1 0.6834975481033325
) O 0 0.04011659696698189
is O 0 0.02504214458167553
an O 0 0.03987294062972069
autosomal B-Disease 1 0.9998575448989868
recessive I-Disease 1 0.9999806880950928
neurodegenerative I-Disease 1 0.9999970197677612
disorder I-Disease 1 0.9999724626541138
defined O 0 0.06107122451066971
by O 0 0.03157798573374748
young O 0 0.14275728166103363
- O 1 0.9905458688735962
onset O 1 0.9998974800109863
non O 1 0.9312335848808289
- O 1 0.9988870024681091
immune O 1 0.9999637603759766
insulin B-Disease 1 0.9999520778656006
- I-Disease 1 0.9989780187606812
dependent I-Disease 1 0.9977948665618896
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999938011169434
and O 0 0.06965790688991547
progressive O 1 0.9939020872116089
optic B-Disease 1 0.9999099969863892
atrophy I-Disease 1 0.999460756778717
. O 0 0.07050202041864395

Linkage O 0 0.16770121455192566
to O 0 0.03433006629347801
markers O 0 0.08954041451215744
on O 0 0.03401743993163109
chromosome O 0 0.18645168840885162
4p O 1 0.95808345079422
was O 0 0.024480296298861504
confirmed O 0 0.031533580273389816
in O 0 0.014903100207448006
five O 0 0.021589048206806183
families O 0 0.043788451701402664
. O 0 0.04447110742330551

On O 0 0.02141425386071205
the O 0 0.016473913565278053
basis O 0 0.02131529524922371
of O 0 0.02413908764719963
meiotic O 1 0.9957455992698669
recombinants O 1 0.9963983297348022
and O 0 0.04170437529683113
disease O 1 0.9999734163284302
- O 0 0.44015219807624817
associated O 0 0.05830961838364601
haplotypes O 1 0.8154808282852173
, O 0 0.029432065784931183
the O 0 0.03164747357368469
WFS B-Disease 1 0.9962009787559509
gene O 0 0.10753341019153595
was O 0 0.033317647874355316
localized O 0 0.08572923392057419
to O 0 0.0253137219697237
a O 0 0.03893551975488663
BAC O 1 0.9891651272773743
/ O 1 0.9669876098632812
P1 O 1 0.7599055767059326
contig O 0 0.12028688192367554
of O 0 0.0176977701485157
less O 0 0.023740587756037712
than O 0 0.023046087473630905
250 O 0 0.059881873428821564
kb O 0 0.145255908370018
. O 0 0.05264310911297798

Mutations O 0 0.1768895536661148
in O 0 0.028949031606316566
a O 0 0.02889407053589821
novel O 0 0.055523842573165894
gene O 0 0.1003904789686203
( O 0 0.05591558665037155
WFS1 O 0 0.4058402478694916
) O 0 0.0349055714905262
encoding O 0 0.05005967617034912
a O 0 0.03268905356526375
putative O 0 0.1250220388174057
transmembrane O 0 0.1289236694574356
protein O 0 0.0536189042031765
were O 0 0.012693595141172409
found O 0 0.01332569308578968
in O 0 0.010425990447402
all O 0 0.01007921528071165
affected O 0 0.033890530467033386
individuals O 0 0.024051696062088013
in O 0 0.01497641857713461
six O 0 0.02856370247900486
WFS B-Disease 1 0.9988786578178406
families O 0 0.03171803802251816
, O 0 0.01529096718877554
and O 0 0.011451316997408867
these O 0 0.015035917982459068
mutations O 0 0.07777733355760574
were O 0 0.013952534645795822
associated O 0 0.02322414517402649
with O 0 0.018652373924851418
the O 0 0.03224560618400574
disease O 1 0.999944806098938
phenotype O 1 0.9932528138160706
. O 0 0.06422393769025803

WFS1 O 1 0.5531343817710876
appears O 0 0.04914560541510582
to O 0 0.017032794654369354
function O 0 0.02631893754005432
in O 0 0.01636318303644657
survival O 0 0.06586220115423203
of O 0 0.023750536143779755
islet O 0 0.14588448405265808
beta O 0 0.12064776569604874
- O 0 0.1395772248506546
cells O 0 0.09934385865926743
and O 0 0.028000393882393837
neurons O 0 0.1377251148223877
. O 0 0.02895832434296608
. O 0 0.038245148956775665

Stable O 0 0.10103446990251541
interaction O 0 0.048857588320970535
between O 0 0.020653583109378815
the O 0 0.01607612892985344
products O 0 0.02378740720450878
of O 0 0.01577809453010559
the O 0 0.03006650134921074
BRCA1 O 1 0.986101508140564
and O 0 0.06146933138370514
BRCA2 O 1 0.9997556805610657
tumor B-Disease 1 0.9995890259742737
suppressor O 1 0.9159643650054932
genes O 0 0.11791396141052246
in O 0 0.03831717371940613
mitotic O 0 0.40100303292274475
and O 0 0.04079004377126694
meiotic O 1 0.9819197058677673
cells O 0 0.2143351286649704
. O 0 0.05907097086310387

BRCA1 O 1 0.9736713171005249
and O 0 0.05932966619729996
BRCA2 O 1 0.9571022391319275
account O 0 0.034964412450790405
for O 0 0.015195246785879135
most O 0 0.015233212150633335
cases O 0 0.02872367575764656
of O 0 0.020401043817400932
familial O 1 0.9992964267730713
, O 0 0.029811367392539978
early O 0 0.06832967698574066
onset O 1 0.9999867677688599
breast B-Disease 1 0.9999929666519165
and I-Disease 0 0.15220507979393005
/ I-Disease 1 0.9999338388442993
or I-Disease 1 0.939280092716217
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999864101409912
and O 0 0.023167088627815247
encode O 0 0.04094618931412697
products O 0 0.023820053786039352
that O 0 0.012517707422375679
each O 0 0.017993971705436707
interact O 0 0.04623132944107056
with O 0 0.031185569241642952
hRAD51 O 0 0.15787702798843384
. O 0 0.056581370532512665

Results O 0 0.06016559898853302
presented O 0 0.03307716175913811
here O 0 0.022980796173214912
show O 0 0.02867153286933899
that O 0 0.021014703437685966
BRCA1 O 1 0.9421391487121582
and O 0 0.02920091338455677
BRCA2 O 1 0.9888366460800171
coexist O 0 0.07208499312400818
in O 0 0.01936408318579197
a O 0 0.025715749710798264
biochemical O 0 0.07572151720523834
complex O 0 0.036279357969760895
and O 0 0.01989567279815674
colocalize O 0 0.11735700815916061
in O 0 0.029220322147011757
subnuclear O 0 0.28468647599220276
foci O 0 0.25061583518981934
in O 0 0.02992456778883934
somatic O 0 0.14931122958660126
cells O 0 0.06950639188289642
and O 0 0.013836528174579144
on O 0 0.01113266870379448
the O 0 0.016883336007595062
axial O 0 0.09491755813360214
elements O 0 0.03093539923429489
of O 0 0.020614642649888992
developing O 0 0.07492084801197052
synaptonemal O 1 0.7363982200622559
complexes O 0 0.15662063658237457
. O 0 0.05473873391747475

Like O 0 0.09537015110254288
BRCA1 O 1 0.9777463674545288
and O 0 0.0575803779065609
RAD51 O 1 0.9933645725250244
, O 0 0.059889744967222214
BRCA2 O 1 0.9799455404281616
relocates O 0 0.3451691269874573
to O 0 0.04965110868215561
PCNA O 1 0.9867697954177856
+ O 0 0.240868479013443
replication O 0 0.12134450674057007
sites O 0 0.03855243697762489
following O 0 0.03360458090901375
exposure O 0 0.15836980938911438
of O 0 0.022863544523715973
S O 0 0.4036646783351898
phase O 0 0.09599844366312027
cells O 0 0.09672030806541443
to O 0 0.03633271902799606
hydroxyurea O 1 0.9905154705047607
or O 0 0.07489550858736038
UV O 1 0.9967880249023438
irradiation O 0 0.29963186383247375
. O 0 0.059444256126880646

Thus O 0 0.06287509948015213
, O 0 0.0395028330385685
BRCA1 O 1 0.9072972536087036
and O 0 0.03021802380681038
BRCA2 O 1 0.9698588848114014
participate O 0 0.034401219338178635
, O 0 0.014854960143566132
together O 0 0.013850915245711803
, O 0 0.011684813536703587
in O 0 0.011918795295059681
a O 0 0.023741498589515686
pathway O 0 0.12431671470403671
( O 0 0.03887120261788368
s O 0 0.06323003768920898
) O 0 0.021711476147174835
associated O 0 0.01970602013170719
with O 0 0.012219736352562904
the O 0 0.014366276562213898
activation O 0 0.07193194329738617
of O 0 0.01718134619295597
double O 0 0.06507483869791031
- O 0 0.10641781240701675
strand O 0 0.11617482453584671
break O 0 0.07584385573863983
repair O 1 0.5123488903045654
and O 0 0.03330209478735924
/ O 1 0.5750269889831543
or O 0 0.04467190429568291
homologous O 0 0.16521774232387543
recombination O 0 0.24901677668094635
. O 0 0.06601457297801971

Dysfunction O 1 0.9982744455337524
of O 0 0.02713138423860073
this O 0 0.02129392698407173
pathway O 0 0.08746666461229324
may O 0 0.022682612761855125
be O 0 0.008620314300060272
a O 0 0.011908061802387238
general O 0 0.014871234074234962
phenomenon O 0 0.03517170622944832
in O 0 0.008365859277546406
the O 0 0.00954109150916338
majority O 0 0.016288062557578087
of O 0 0.010139673948287964
cases O 0 0.027685126289725304
of O 0 0.020113801583647728
hereditary B-Disease 1 0.9996836185455322
breast I-Disease 1 0.9999951124191284
and I-Disease 0 0.39672860503196716
/ I-Disease 1 0.9999775886535645
or I-Disease 1 0.9950672388076782
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
. O 0 0.03768150135874748
. O 0 0.039782825857400894

A O 0 0.06979483366012573
novel O 0 0.08978185802698135
Arg362Ser O 0 0.29279768466949463
mutation O 0 0.14448069036006927
in O 0 0.028818417340517044
the O 0 0.033507321029901505
sterol O 1 0.8468546867370605
27 O 0 0.08591872453689575
- O 0 0.458657443523407
hydroxylase O 1 0.9188067317008972
gene O 0 0.13756263256072998
( O 0 0.06018708273768425
CYP27 O 1 0.515731155872345
) O 0 0.028728457167744637
: O 0 0.018308300524950027
its O 0 0.01510927639901638
effects O 0 0.04874831438064575
on O 0 0.017752937972545624
pre O 0 0.0788760557770729
- O 0 0.08779235184192657
mRNA O 0 0.0919143408536911
splicing O 0 0.12003956735134125
and O 0 0.03194547817111015
enzyme O 0 0.11928429454565048
activity O 0 0.08230093121528625
. O 0 0.04613252356648445

A O 0 0.05432014539837837
novel O 0 0.05183405056595802
C O 0 0.07195404171943665
to O 0 0.021624855697155
A O 0 0.030337749049067497
mutation O 0 0.09427984803915024
in O 0 0.019329803064465523
the O 0 0.030170045793056488
sterol O 1 0.7859851717948914
27 O 0 0.0771745890378952
- O 0 0.45186954736709595
hydroxylase O 1 0.9390293955802917
gene O 0 0.138495534658432
( O 0 0.05748875439167023
CYP27 O 1 0.5113781690597534
) O 0 0.028959957882761955
was O 0 0.017737438902258873
identified O 0 0.02851250022649765
by O 0 0.02416248619556427
sequencing O 0 0.08710819482803345
amplified O 0 0.12344279140233994
CYP27 O 0 0.3499443531036377
gene O 0 0.10516848415136337
products O 0 0.03461422771215439
from O 0 0.021301373839378357
a O 0 0.028427591547369957
patient O 1 0.636994481086731
with O 0 0.03894796594977379
cerebrotendinous B-Disease 1 0.9976804256439209
xanthomatosis I-Disease 1 0.9977433681488037
( O 0 0.10364687442779541
CTX B-Disease 1 0.9988730549812317
) O 0 0.06233811751008034
. O 0 0.04804331064224243

The O 0 0.056358203291893005
mutation O 0 0.1696871817111969
changed O 0 0.04726557433605194
the O 0 0.03524480387568474
adrenodoxin O 0 0.19700784981250763
cofactor O 0 0.1884438693523407
binding O 0 0.08796181529760361
residue O 0 0.12280610203742981
362Arg O 0 0.1375228613615036
to O 0 0.032849520444869995
362Ser O 0 0.20289647579193115
( O 0 0.06693024188280106
CGT O 1 0.8648302555084229
362Arg O 0 0.355097234249115
to O 0 0.051183268427848816
AGT O 1 0.9995404481887817
362Ser O 0 0.2600608766078949
) O 0 0.02766474336385727
, O 0 0.011189938522875309
and O 0 0.009641275741159916
was O 0 0.013981534168124199
responsible O 0 0.027382340282201767
for O 0 0.022298576310276985
deficiency O 1 0.9998296499252319
in O 0 0.02224196121096611
the O 0 0.028453202918171883
sterol O 1 0.9480956196784973
27 O 0 0.06437136232852936
- O 0 0.26194247603416443
hydroxylase O 1 0.7037553787231445
activity O 0 0.03850257396697998
, O 0 0.012650176882743835
as O 0 0.010470252484083176
confirmed O 0 0.024537913501262665
by O 0 0.015239788219332695
expression O 0 0.03627194091677666
of O 0 0.019189994782209396
mutant O 0 0.10660526901483536
cDNA O 0 0.1286875605583191
into O 0 0.050244320183992386
COS O 1 0.986732542514801
- O 0 0.13915058970451355
1 O 0 0.0647478774189949
cells O 0 0.10807950794696808
. O 0 0.04746246710419655

Quantitative O 0 0.10757097601890564
analysis O 0 0.042488135397434235
showed O 0 0.030287878587841988
that O 0 0.010725787840783596
the O 0 0.013865681365132332
expression O 0 0.03609984740614891
of O 0 0.018534520640969276
CYP27 O 1 0.5418595671653748
gene O 0 0.08238253742456436
mRNA O 0 0.05836796388030052
in O 0 0.017324397340416908
the O 0 0.02093043364584446
patient O 0 0.11111633479595184
represented O 0 0.04144061729311943
52 O 0 0.0694550946354866
. O 0 0.04377969354391098

5 O 0 0.05080302432179451
% O 0 0.028157375752925873
of O 0 0.013659480959177017
the O 0 0.01835642196238041
normal O 0 0.05095186457037926
level O 0 0.04878320172429085
. O 0 0.04248490557074547

As O 0 0.03190295025706291
the O 0 0.030478646978735924
mutation O 0 0.13183431327342987
occurred O 0 0.04660210385918617
at O 0 0.022054798901081085
the O 0 0.01978314481675625
penultimate O 0 0.10673586279153824
nucleotide O 0 0.08994979411363602
of O 0 0.024686560034751892
exon O 0 0.11129448562860489
6 O 0 0.05178830400109291
( O 0 0.035322800278663635
- O 0 0.05035306140780449
2 O 0 0.027247164398431778
position O 0 0.022627195343375206
of O 0 0.018107611685991287
exon O 0 0.11279504746198654
6 O 0 0.06299211084842682
- O 0 0.10974732041358948
intron O 0 0.44590264558792114
6 O 0 0.07006284594535828
splice O 0 0.132812961935997
site O 0 0.03668086975812912
) O 0 0.020288536325097084
of O 0 0.01105658058077097
the O 0 0.01644536852836609
gene O 0 0.06296990811824799
, O 0 0.017373759299516678
we O 0 0.016390236094594002
hypothesized O 0 0.05613863840699196
that O 0 0.014835027977824211
the O 0 0.018158862367272377
mutation O 0 0.1310785710811615
may O 0 0.03388258442282677
partially O 0 0.05298732593655586
affect O 0 0.04250779002904892
the O 0 0.01817348226904869
normal O 0 0.04968835785984993
splicing O 0 0.10782637447118759
efficiency O 0 0.05353955551981926
in O 0 0.023332100361585617
exon O 0 0.11178489029407501
6 O 0 0.04117433726787567
and O 0 0.02292552962899208
cause O 0 0.0739063173532486
alternative O 0 0.048874109983444214
splicing O 0 0.09482259303331375
elsewhere O 0 0.03581121191382408
, O 0 0.01436716876924038
which O 0 0.01270835381001234
resulted O 0 0.030997728928923607
in O 0 0.01796768791973591
decreased O 0 0.060068611055612564
transcript O 0 0.05184440314769745
in O 0 0.018150128424167633
the O 0 0.02420087344944477
patient O 1 0.5995672941207886
. O 0 0.04791192337870598

Transfection O 1 0.7695713043212891
of O 0 0.03320431709289551
constructed O 0 0.04635435342788696
minigenes O 0 0.10140356421470642
, O 0 0.01635907031595707
with O 0 0.012630406767129898
or O 0 0.016295986250042915
without O 0 0.014806093648076057
the O 0 0.01821451634168625
mutation O 0 0.09582214057445526
, O 0 0.021231967955827713
into O 0 0.02789289504289627
COS O 1 0.9960589408874512
- O 0 0.10720408707857132
1 O 0 0.04277169704437256
cells O 0 0.06449935585260391
confirmed O 0 0.031465619802474976
that O 0 0.013133724220097065
the O 0 0.01866798661649227
mutant O 0 0.08623671531677246
minigene O 0 0.10841672122478485
was O 0 0.01979176513850689
responsible O 0 0.026566999033093452
for O 0 0.013297229073941708
a O 0 0.021491993218660355
mRNA O 0 0.057709332555532455
species O 0 0.03710930421948433
alternatively O 0 0.07521559298038483
spliced O 0 0.09646833688020706
at O 0 0.029736407101154327
an O 0 0.028407327830791473
activated O 0 0.12338905036449432
cryptic O 0 0.12313156574964523
5 O 0 0.05760129541158676
splice O 0 0.14255088567733765
site O 0 0.05203178524971008
88 O 0 0.0788302943110466
bp O 0 0.09138407558202744
upstream O 0 0.05032757297158241
from O 0 0.01694897934794426
the O 0 0.014680171385407448
3 O 0 0.026131216436624527
end O 0 0.023496976122260094
of O 0 0.018071256577968597
exon O 0 0.12287584692239761
6 O 0 0.06838638335466385
. O 0 0.04404902458190918

Our O 0 0.03327716141939163
data O 0 0.02498042955994606
suggest O 0 0.02878309041261673
that O 0 0.01003924198448658
the O 0 0.013112814165651798
C O 0 0.04749114438891411
to O 0 0.014346770010888577
A O 0 0.024894479662179947
mutation O 0 0.08871185034513474
at O 0 0.02248423919081688
the O 0 0.021531088277697563
penultimate O 0 0.09917277097702026
nucleotide O 0 0.07430372387170792
of O 0 0.021197441965341568
exon O 0 0.08819616585969925
6 O 0 0.03152425214648247
of O 0 0.015317785553634167
the O 0 0.022293854504823685
CYP27 O 1 0.7144414186477661
gene O 0 0.07124097645282745
not O 0 0.015101118944585323
only O 0 0.01498335599899292
causes O 0 0.3162655830383301
the O 0 0.027968628332018852
deficiency B-Disease 1 0.9999406337738037
in I-Disease 0 0.02566337212920189
the I-Disease 0 0.02802642434835434
sterol I-Disease 1 0.9016343951225281
27 I-Disease 0 0.06715619564056396
- I-Disease 0 0.14860136806964874
hydroxylase I-Disease 1 0.5730586647987366
activity I-Disease 0 0.04560430347919464
, O 0 0.015986740589141846
but O 0 0.013390820473432541
also O 0 0.013349738903343678
partially O 0 0.04264901950955391
leads O 0 0.045000527054071426
to O 0 0.019764086231589317
alternative O 0 0.044454172253608704
pre O 0 0.0776284784078598
- O 0 0.08644935488700867
mRNA O 0 0.08089802414178848
splicing O 0 0.08588682115077972
of O 0 0.02009231597185135
the O 0 0.031110916286706924
gene O 0 0.11238210648298264
. O 0 0.05012212321162224

To O 0 0.025046352297067642
our O 0 0.01908288151025772
knowledge O 0 0.01855032704770565
, O 0 0.009731531143188477
this O 0 0.007346326485276222
is O 0 0.00795796513557434
the O 0 0.008923874236643314
first O 0 0.013256298378109932
report O 0 0.020339401438832283
regarding O 0 0.028404079377651215
effects O 0 0.05862901732325554
on O 0 0.018932901322841644
pre O 0 0.07066059112548828
- O 0 0.07138928025960922
mRNA O 0 0.07785172760486603
splicing O 0 0.08524134755134583
of O 0 0.01816989853978157
a O 0 0.02601432055234909
mutation O 0 0.0898585319519043
at O 0 0.021877337247133255
the O 0 0.016159066930413246
- O 0 0.049625713378190994
2 O 0 0.022625165060162544
position O 0 0.0174671970307827
of O 0 0.012804700061678886
a O 0 0.023259267210960388
5 O 0 0.04331494867801666
splice O 0 0.13104405999183655
site O 0 0.047205276787281036
. O 0 0.04393710568547249

ATM O 1 0.7690339088439941
germline O 1 0.9549502730369568
mutations O 0 0.24729874730110168
in O 0 0.04907951131463051
classical O 0 0.10171528160572052
ataxia B-Disease 1 0.999996542930603
- I-Disease 1 0.9992535710334778
telangiectasia I-Disease 1 0.9999713897705078
patients O 1 0.9979946613311768
in O 0 0.023730577901005745
the O 0 0.02464202605187893
Dutch O 0 0.06102477386593819
population O 0 0.049000710248947144
. O 0 0.04230845347046852

Germline O 1 0.9196091890335083
mutations O 0 0.18362092971801758
in O 0 0.029697200283408165
the O 0 0.030644571408629417
ATM O 0 0.10631071031093597
gene O 0 0.07539013028144836
are O 0 0.01622997596859932
responsible O 0 0.029791127890348434
for O 0 0.0219059269875288
the O 0 0.05296748876571655
autosomal B-Disease 1 0.9999969005584717
recessive I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999210834503174
telangiectasia I-Disease 1 0.9999887943267822
( O 0 0.29429635405540466
A B-Disease 0 0.19121208786964417
- I-Disease 1 0.941922664642334
T I-Disease 1 0.9955958724021912
) O 0 0.06337639689445496
. O 0 0.04493694007396698

In O 0 0.026745522394776344
our O 0 0.021245354786515236
study O 0 0.023806937038898468
, O 0 0.011654735542833805
we O 0 0.010603033006191254
have O 0 0.010972837917506695
determined O 0 0.02694237045943737
the O 0 0.021444549784064293
ATM O 0 0.1075381189584732
mutation O 0 0.12475942820310593
spectrum O 0 0.059016935527324677
in O 0 0.01784699037671089
19 O 0 0.03338593989610672
classical O 0 0.036972954869270325
A B-Disease 0 0.09325351566076279
- I-Disease 1 0.9962871074676514
T I-Disease 1 0.9999043941497803
patients O 1 0.9976891279220581
, O 0 0.016919851303100586
including O 0 0.014252602122724056
some O 0 0.013630460947751999
immigrant O 0 0.04910709336400032
populations O 0 0.04242955893278122
, O 0 0.011650249361991882
as O 0 0.008559576235711575
well O 0 0.009284578263759613
as O 0 0.008035539649426937
12 O 0 0.016187306493520737
of O 0 0.010103011503815651
Dutch O 0 0.03798120468854904
ethnic O 0 0.03525831550359726
origin O 0 0.0509677529335022
. O 0 0.04841197282075882

Both O 0 0.0374554879963398
the O 0 0.035103507339954376
protein O 0 0.08172943443059921
truncation O 0 0.13127082586288452
test O 0 0.0639737993478775
( O 0 0.04171772301197052
PTT O 0 0.09245089441537857
) O 0 0.026118986308574677
and O 0 0.013957717455923557
the O 0 0.02195005491375923
restriction O 0 0.08331480622291565
endonuclease O 1 0.5696976780891418
fingerprinting O 0 0.1481410562992096
( O 0 0.059281956404447556
REF O 0 0.16676436364650726
) O 0 0.025040779262781143
method O 0 0.020535757765173912
were O 0 0.00846126303076744
used O 0 0.009702527895569801
and O 0 0.0091483099386096
compared O 0 0.018253128975629807
for O 0 0.008750560693442822
their O 0 0.01370750367641449
detection O 0 0.06400377303361893
efficiency O 0 0.04667651280760765
, O 0 0.018146874383091927
identifying O 0 0.041039396077394485
76 O 0 0.047440458089113235
% O 0 0.022079862654209137
and O 0 0.012036007829010487
60 O 0 0.020943425595760345
% O 0 0.017826249822974205
of O 0 0.010726374574005604
the O 0 0.018571536988019943
mutations O 0 0.10915476083755493
, O 0 0.02513044886291027
respectively O 0 0.04357869178056717
. O 0 0.041305527091026306

Most O 0 0.04831176996231079
patients O 1 0.8890111446380615
were O 0 0.017815817147493362
found O 0 0.020030736923217773
to O 0 0.01529722847044468
be O 0 0.02003624476492405
compound O 0 0.08772607892751694
heterozygote O 1 0.8632926940917969
. O 0 0.06344524025917053

Seventeen O 0 0.11097705364227295
mutations O 0 0.1331375241279602
were O 0 0.021144265308976173
distinct O 0 0.030550220981240273
, O 0 0.013418366201221943
of O 0 0.010107466951012611
which O 0 0.010987399145960808
10 O 0 0.015711095184087753
were O 0 0.01069759763777256
not O 0 0.01311636995524168
reported O 0 0.03353976830840111
previously O 0 0.0335838720202446
. O 0 0.036598920822143555

Mutations O 0 0.20529623329639435
are O 0 0.028188960626721382
small O 0 0.035065073519945145
deletions O 0 0.09959590435028076
or O 0 0.03806189075112343
point O 0 0.0457267127931118
mutations O 0 0.1393161118030548
frequently O 0 0.055909961462020874
affecting O 0 0.09263938665390015
splice O 0 0.17908446490764618
sites O 0 0.06653381884098053
. O 0 0.05234519764780998

Moreover O 0 0.07357294112443924
, O 0 0.025218060240149498
a O 0 0.02749931812286377
16 O 0 0.04127263277769089
. O 0 0.04268898069858551

7 O 0 0.09718255698680878
- O 0 0.12756343185901642
kb O 0 0.15330572426319122
genomic O 0 0.13677005469799042
deletion O 0 0.11266110092401505
of O 0 0.016783585771918297
the O 0 0.015917137265205383
3 O 0 0.02021619863808155
end O 0 0.01620090939104557
of O 0 0.010350508615374565
the O 0 0.013690353371202946
gene O 0 0.05093717947602272
, O 0 0.014229882508516312
most O 0 0.01328722108155489
likely O 0 0.02050800807774067
a O 0 0.016362430527806282
result O 0 0.022781480103731155
of O 0 0.013510650023818016
recombination O 0 0.07438281178474426
between O 0 0.01684769243001938
two O 0 0.011875285767018795
LINE O 0 0.027146916836500168
elements O 0 0.020397907122969627
, O 0 0.014858336187899113
was O 0 0.0196518711745739
identified O 0 0.037750743329524994
. O 0 0.037583258002996445

The O 0 0.029025079682469368
most O 0 0.022657429799437523
frequently O 0 0.03747569024562836
found O 0 0.027087390422821045
mutation O 0 0.0907781794667244
, O 0 0.015066534280776978
identified O 0 0.018973521888256073
in O 0 0.010913172736763954
three O 0 0.013174640946090221
unrelated O 0 0.04587622731924057
Turkish O 0 0.045487578958272934
A B-Disease 0 0.05559234321117401
- I-Disease 1 0.7956846952438354
T I-Disease 1 0.9915122389793396
individuals O 0 0.02837260253727436
, O 0 0.012751754373311996
was O 0 0.011765905655920506
previously O 0 0.016802961006760597
described O 0 0.017355946823954582
to O 0 0.00927956122905016
be O 0 0.009479871951043606
a O 0 0.016565360128879547
Turkish O 0 0.03853845223784447
A B-Disease 0 0.06046615540981293
- I-Disease 1 0.7294268012046814
T I-Disease 1 0.9955497980117798
founder O 0 0.1318172812461853
mutation O 0 0.2490765005350113
. O 0 0.0697520300745964

The O 0 0.03026794269680977
presence O 0 0.04143718630075455
of O 0 0.0160082895308733
a O 0 0.027490917593240738
founder O 0 0.062103625386953354
mutation O 0 0.11863411217927933
among O 0 0.02696945331990719
relatively O 0 0.02854255400598049
small O 0 0.01888556405901909
ethnic O 0 0.02350439503788948
population O 0 0.0274833794683218
groups O 0 0.021446319296956062
in O 0 0.015434911474585533
Western O 0 0.02893989346921444
Europe O 0 0.03018803708255291
could O 0 0.02199367806315422
indicate O 0 0.03116612322628498
a O 0 0.020156599581241608
high O 0 0.0314834825694561
carrier O 0 0.06425168365240097
frequency O 0 0.04568987712264061
in O 0 0.014648285694420338
such O 0 0.016131039708852768
communities O 0 0.044586360454559326
. O 0 0.0403711274266243

In O 0 0.0439029335975647
patients O 1 0.8516877889633179
of O 0 0.019510546699166298
Dutch O 0 0.040824901312589645
ethnic O 0 0.025480711832642555
origin O 0 0.02601860649883747
, O 0 0.014046684838831425
however O 0 0.013967566192150116
, O 0 0.0114930784329772
no O 0 0.015565026551485062
significant O 0 0.023181820288300514
founder O 0 0.041260506957769394
effect O 0 0.0346732959151268
could O 0 0.017703060060739517
be O 0 0.014348812401294708
identified O 0 0.034690868109464645
. O 0 0.035783566534519196

The O 0 0.04357261583209038
observed O 0 0.06234438344836235
genetic O 0 0.0814540684223175
heterogeneity O 0 0.08469174057245255
including O 0 0.018629001453518867
the O 0 0.015154167078435421
relative O 0 0.03349148482084274
high O 0 0.031012404710054398
percentage O 0 0.033378515392541885
of O 0 0.021221451461315155
splice O 0 0.15575924515724182
- O 0 0.09049321711063385
site O 0 0.047820694744586945
mutations O 0 0.10246822237968445
had O 0 0.02313910238444805
no O 0 0.020709659904241562
reflection O 0 0.04703743755817413
on O 0 0.017198005691170692
the O 0 0.02885577641427517
phenotype O 1 0.8091826438903809
. O 0 0.053289882838726044

All O 0 0.0490189790725708
patients O 1 0.9824814200401306
manifested O 0 0.13590185344219208
classical O 0 0.052570536732673645
A B-Disease 0 0.05648563802242279
- I-Disease 1 0.6211305856704712
T I-Disease 1 0.9847465753555298
and O 0 0.02392999269068241
increased O 0 0.050140030682086945
cellular O 0 0.09927931427955627
radioresistant O 0 0.1866932362318039
DNA O 0 0.11387969553470612
synthesis O 0 0.11591673642396927
. O 0 0.05073734372854233

Determination O 0 0.06695621460676193
of O 0 0.018978305160999298
the O 0 0.0183540228754282
genomic O 0 0.07440456002950668
structure O 0 0.026468783617019653
of O 0 0.013918141834437847
the O 0 0.02126368321478367
COL4A4 O 0 0.47190046310424805
gene O 0 0.0739179253578186
and O 0 0.01835743337869644
of O 0 0.02010198123753071
novel O 0 0.07208696752786636
mutations O 1 0.9877462387084961
causing O 1 0.9981210827827454
autosomal B-Disease 1 0.999981164932251
recessive I-Disease 1 0.9999977350234985
Alport I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999995231628418
. O 0 0.10461778938770294

Autosomal B-Disease 1 0.9999628067016602
recessive I-Disease 1 0.9999945163726807
Alport I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999992847442627
is O 0 0.05584605410695076
a O 0 0.05364566668868065
progressive O 1 0.8816383481025696
hematuric B-Disease 1 0.9983221888542175
glomerulonephritis I-Disease 1 0.9999834299087524
characterized O 1 0.9080191850662231
by O 0 0.05198482796549797
glomerular B-Disease 1 0.9996535778045654
basement I-Disease 1 0.9298830628395081
membrane I-Disease 1 0.5782470703125
abnormalities I-Disease 1 0.979681134223938
and O 0 0.02120751515030861
associated O 0 0.028887875378131866
with O 0 0.02031170390546322
mutations O 0 0.08068759739398956
in O 0 0.013896927237510681
either O 0 0.017671287059783936
the O 0 0.017464326694607735
COL4A3 O 0 0.22205036878585815
or O 0 0.025182802230119705
the O 0 0.02222614735364914
COL4A4 O 0 0.4024467468261719
gene O 0 0.0735507681965828
, O 0 0.016907300800085068
which O 0 0.01472089346498251
encode O 0 0.03769749775528908
the O 0 0.02162923850119114
alpha3 O 0 0.1271900236606598
and O 0 0.03322562575340271
alpha4 O 1 0.8787866234779358
type O 1 0.5128260850906372
IV O 1 0.9942808151245117
collagen O 1 0.9924679398536682
chains O 0 0.09108488261699677
, O 0 0.03154252469539642
respectively O 0 0.04574789106845856
. O 0 0.043069686740636826

To O 0 0.033683400601148605
date O 0 0.03478242829442024
, O 0 0.02450602874159813
mutation O 0 0.11569333076477051
screening O 0 0.05405384302139282
in O 0 0.012181779369711876
the O 0 0.01278957910835743
two O 0 0.012238818220794201
genes O 0 0.04523519426584244
has O 0 0.01647789403796196
been O 0 0.01658392883837223
hampered O 0 0.057687245309352875
by O 0 0.013627852313220501
the O 0 0.014601626433432102
lack O 0 0.03003782220184803
of O 0 0.01677343063056469
genomic O 0 0.09077540785074234
structure O 0 0.04043194651603699
information O 0 0.031190598383545876
. O 0 0.035768188536167145

We O 0 0.026646621525287628
report O 0 0.020473582670092583
here O 0 0.01271958276629448
the O 0 0.011673287488520145
complete O 0 0.022544531151652336
characterization O 0 0.03949255496263504
of O 0 0.010946177877485752
the O 0 0.015107842162251472
48 O 0 0.03623375669121742
exons O 0 0.06363445520401001
of O 0 0.014815332368016243
the O 0 0.023389289155602455
COL4A4 O 1 0.6050897240638733
gene O 0 0.07751429826021194
, O 0 0.016567567363381386
a O 0 0.020634548738598824
comprehensive O 0 0.04714687913656235
gene O 0 0.06764962524175644
screen O 0 0.031082209199666977
, O 0 0.012266774661839008
and O 0 0.010260817594826221
the O 0 0.013178514316678047
subsequent O 0 0.03358948603272438
detection O 0 0.0599450059235096
of O 0 0.014155134558677673
10 O 0 0.02487958036363125
novel O 0 0.04064316675066948
mutations O 0 0.11060739308595657
in O 0 0.027186691761016846
eight O 0 0.053675327450037
patients O 1 0.9999785423278809
diagnosed O 1 0.9999969005584717
with O 0 0.457112580537796
autosomal B-Disease 1 0.9999946355819702
recessive I-Disease 1 0.9999980926513672
Alport I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999997615814209
. O 0 0.09067364782094955

Furthermore O 0 0.07310952246189117
, O 0 0.02439550682902336
we O 0 0.017836932092905045
identified O 0 0.029240211471915245
a O 0 0.027073584496974945
glycine O 0 0.10228784382343292
to O 0 0.024712083861231804
alanine O 0 0.11666306108236313
substitution O 0 0.06038820371031761
in O 0 0.019330482929944992
the O 0 0.021610930562019348
collagenous O 1 0.7470102906227112
domain O 0 0.037676986306905746
that O 0 0.014249867759644985
is O 0 0.016839150339365005
apparently O 0 0.03553052246570587
silent O 0 0.04113426432013512
in O 0 0.015393748879432678
the O 0 0.021238887682557106
heterozygous O 0 0.10473006218671799
carriers O 0 0.0879925787448883
, O 0 0.02476954460144043
in O 0 0.021085873246192932
11 O 0 0.04197271913290024
. O 0 0.040472351014614105

5 O 0 0.04762382432818413
% O 0 0.027138736099004745
of O 0 0.010413846001029015
all O 0 0.009761404246091843
control O 0 0.023482101038098335
individuals O 0 0.017429087311029434
, O 0 0.009646003134548664
and O 0 0.00829688087105751
in O 0 0.00994502566754818
one O 0 0.013986833393573761
control O 0 0.029819048941135406
individual O 0 0.027115479111671448
homozygous O 0 0.07948034256696701
for O 0 0.01905941218137741
this O 0 0.025000110268592834
glycine O 0 0.13504476845264435
substitution O 0 0.11088345944881439
. O 0 0.05269112065434456

There O 0 0.031763460487127304
has O 0 0.018652351573109627
been O 0 0.013693270273506641
no O 0 0.013675795868039131
previous O 0 0.01512102410197258
finding O 0 0.02288237027823925
of O 0 0.012472530826926231
a O 0 0.024286681786179543
glycine O 0 0.100472591817379
substitution O 0 0.05951059237122536
that O 0 0.014328313060104847
is O 0 0.010951557196676731
not O 0 0.009777692146599293
associated O 0 0.01910983771085739
with O 0 0.012979644350707531
any O 0 0.02049793303012848
obvious O 0 0.061642836779356
phenotype O 1 0.6062132716178894
in O 0 0.03533182293176651
homozygous O 0 0.12846006453037262
individuals O 0 0.05354868620634079
. O 0 0.04616615176200867

Founder O 0 0.20257338881492615
BRCA1 O 1 0.9760503172874451
and O 0 0.061950210481882095
BRCA2 O 1 0.9950700998306274
mutations O 1 0.5004837512969971
in O 0 0.037818387150764465
French O 0 0.08138304948806763
Canadian O 1 0.6915173530578613
breast B-Disease 1 0.9999938011169434
and I-Disease 1 0.8816824555397034
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999967813491821
families O 0 0.1026836559176445
. O 0 0.058463986963033676

We O 0 0.02930048666894436
have O 0 0.017903706058859825
identified O 0 0.026628028601408005
four O 0 0.017631756141781807
mutations O 0 0.06666763871908188
in O 0 0.012707671150565147
each O 0 0.013428925536572933
of O 0 0.01733560673892498
the O 0 0.034038033336400986
breast B-Disease 1 0.999995231628418
cancer I-Disease 1 0.9999959468841553
- O 1 0.9868690371513367
susceptibility O 1 0.9893871545791626
genes O 0 0.11210443079471588
, O 0 0.03825179487466812
BRCA1 O 1 0.9836395382881165
and O 0 0.029823672026395798
BRCA2 O 1 0.9890241622924805
, O 0 0.022129345685243607
in O 0 0.02061345987021923
French O 0 0.06807789206504822
Canadian O 1 0.9507549405097961
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999995231628418
and O 1 0.9920145273208618
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
families O 0 0.06058457866311073
from O 0 0.03460387885570526
Quebec O 0 0.09787560999393463
. O 0 0.044937390834093094

To O 0 0.038621533662080765
identify O 0 0.05912744626402855
founder O 0 0.0723140612244606
effects O 0 0.08531256765127182
, O 0 0.019892744719982147
we O 0 0.01760917343199253
examined O 0 0.04456954821944237
independently O 0 0.040005892515182495
ascertained O 0 0.087528757750988
French O 0 0.05890050530433655
Canadian O 0 0.06992258131504059
cancer B-Disease 1 0.9987536668777466
families O 0 0.028962835669517517
for O 0 0.011112299747765064
the O 0 0.011984620243310928
distribution O 0 0.018820252269506454
of O 0 0.010757213458418846
these O 0 0.016399787738919258
eight O 0 0.04032079875469208
mutations O 0 0.17108649015426636
. O 0 0.0560549721121788

Mutations O 0 0.15986298024654388
were O 0 0.022433502599596977
found O 0 0.02311304397881031
in O 0 0.017940601333975792
41 O 0 0.04425211250782013
of O 0 0.021325821056962013
97 O 0 0.08423103392124176
families O 0 0.056645285338163376
. O 0 0.044835254549980164

Six O 0 0.04185469076037407
of O 0 0.022435154765844345
eight O 0 0.03916501998901367
mutations O 0 0.10435739159584045
were O 0 0.01835920475423336
observed O 0 0.03625690937042236
at O 0 0.023084349930286407
least O 0 0.024935515597462654
twice O 0 0.03732207417488098
. O 0 0.03850649297237396

The O 0 0.07989968359470367
BRCA1 O 1 0.9886096715927124
C4446T O 1 0.63303142786026
mutation O 0 0.16472454369068146
was O 0 0.0205340925604105
the O 0 0.014931492507457733
most O 0 0.016160307452082634
common O 0 0.035068415105342865
mutation O 0 0.11320628970861435
found O 0 0.021862976253032684
, O 0 0.014167316257953644
followed O 0 0.023499520495533943
by O 0 0.018065575510263443
the O 0 0.03368838131427765
BRCA2 O 1 0.9928444027900696
8765delAG O 1 0.8258982300758362
mutation O 1 0.5192005634307861
. O 0 0.06290006637573242

Together O 0 0.03389078006148338
, O 0 0.019915033131837845
these O 0 0.016468260437250137
mutations O 0 0.07037197798490524
were O 0 0.012132473289966583
found O 0 0.014744759537279606
in O 0 0.011581581085920334
28 O 0 0.019711554050445557
of O 0 0.0111226262524724
41 O 0 0.03162736818194389
families O 0 0.024469567462801933
identified O 0 0.023089176043868065
to O 0 0.012817660346627235
have O 0 0.017831776291131973
a O 0 0.03030923195183277
mutation O 0 0.15973304212093353
. O 0 0.053950753062963486

The O 0 0.035196252167224884
odds O 0 0.06728757172822952
of O 0 0.019534872844815254
detection O 0 0.055468667298555374
of O 0 0.010420521721243858
any O 0 0.010513816960155964
of O 0 0.009807094000279903
the O 0 0.015221680514514446
four O 0 0.02962612733244896
BRCA1 O 1 0.9621397852897644
mutations O 0 0.1784370392560959
was O 0 0.03180474415421486
18 O 0 0.04119287058711052
. O 0 0.041069597005844116

7x O 1 0.9191518425941467
greater O 0 0.04996732622385025
if O 0 0.020446080714464188
one O 0 0.014406600967049599
or O 0 0.01602163538336754
more O 0 0.013234206475317478
cases O 0 0.038947876542806625
of O 0 0.034521374851465225
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999991774559021
were O 0 0.01626143418252468
also O 0 0.012372161261737347
present O 0 0.014896528795361519
in O 0 0.012629799544811249
the O 0 0.017567895352840424
family O 0 0.04112010449171066
. O 0 0.040230706334114075

The O 0 0.03119850903749466
odds O 0 0.061714012175798416
of O 0 0.01757342368364334
detection O 0 0.04824317991733551
of O 0 0.010014870204031467
any O 0 0.009095843881368637
of O 0 0.009083547629415989
the O 0 0.015624437481164932
four O 0 0.031966082751750946
BRCA2 O 1 0.9880591034889221
mutations O 0 0.18042585253715515
was O 0 0.036317288875579834
5 O 0 0.04642851650714874
. O 0 0.042532552033662796

3x O 0 0.22763806581497192
greater O 0 0.048188257962465286
if O 0 0.01706773228943348
there O 0 0.010671121068298817
were O 0 0.008979808539152145
at O 0 0.012577377259731293
least O 0 0.01607591100037098
five O 0 0.01594342477619648
cases O 0 0.030677344650030136
of O 0 0.02796332538127899
breast B-Disease 1 0.9999792575836182
cancer I-Disease 1 0.9998337030410767
in O 0 0.025256343185901642
the O 0 0.02193043939769268
family O 0 0.04146520048379898
. O 0 0.040019385516643524

Interestingly O 0 0.08873157203197479
, O 0 0.018539749085903168
the O 0 0.014481568709015846
presence O 0 0.029592659324407578
of O 0 0.016945339739322662
a O 0 0.04327067732810974
breast B-Disease 1 0.9999927282333374
cancer I-Disease 1 0.999981164932251
case O 0 0.0703919380903244
< O 0 0.4166294038295746
36 O 0 0.037224628031253815
years O 0 0.01684638299047947
of O 0 0.013082895427942276
age O 0 0.025664526969194412
was O 0 0.017558086663484573
strongly O 0 0.028417717665433884
predictive O 0 0.04660367965698242
of O 0 0.00939425453543663
the O 0 0.010708881542086601
presence O 0 0.0183892659842968
of O 0 0.007142268121242523
any O 0 0.00931178592145443
of O 0 0.010001742281019688
the O 0 0.017501061782240868
eight O 0 0.04281041398644447
mutations O 0 0.1623591035604477
screened O 0 0.12717634439468384
. O 0 0.05211983621120453

Carriers O 0 0.10126012563705444
of O 0 0.020989811047911644
the O 0 0.019402585923671722
same O 0 0.024438029155135155
mutation O 0 0.09720277786254883
, O 0 0.015089583583176136
from O 0 0.012309473939239979
different O 0 0.013047713786363602
families O 0 0.023298168554902077
, O 0 0.015467743389308453
shared O 0 0.02795846201479435
similar O 0 0.03403797000646591
haplotypes O 1 0.5261351466178894
, O 0 0.020502878352999687
indicating O 0 0.038133036345243454
that O 0 0.013950159773230553
the O 0 0.018152005970478058
mutant O 0 0.08341584354639053
alleles O 0 0.10725023597478867
were O 0 0.01694585010409355
likely O 0 0.022193633019924164
to O 0 0.010228789411485195
be O 0 0.009517216123640537
identical O 0 0.021832836791872978
by O 0 0.013203099370002747
descent O 0 0.04128750041127205
for O 0 0.014643282629549503
a O 0 0.022432906553149223
mutation O 0 0.07966814190149307
in O 0 0.013987202197313309
the O 0 0.016611192375421524
founder O 0 0.04979582130908966
population O 0 0.04293026402592659
. O 0 0.03956606239080429

The O 0 0.03664962574839592
identification O 0 0.044454243034124374
of O 0 0.021739307790994644
common O 0 0.061295799911022186
BRCA1 O 1 0.9864257574081421
and O 0 0.044050104916095734
BRCA2 O 1 0.9971805810928345
mutations O 0 0.2971349358558655
will O 0 0.027545657008886337
facilitate O 0 0.053607892245054245
carrier O 0 0.09736718237400055
detection O 0 0.09554562717676163
in O 0 0.029082326218485832
French O 0 0.08260843902826309
Canadian O 1 0.9753265380859375
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999997615814209
and O 1 0.9910333752632141
breast B-Disease 1 1.0
/ I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
families O 0 0.12988285720348358
. O 0 0.0628754049539566

Are O 0 0.04868222773075104
Dp71 O 0 0.20766106247901917
and O 0 0.045517634600400925
Dp140 O 1 0.9216592311859131
brain O 1 0.9922264814376831
dystrophin O 1 0.9797719120979309
isoforms O 0 0.11402326077222824
related O 0 0.054173413664102554
to O 0 0.03438326716423035
cognitive B-Disease 1 0.9585675597190857
impairment I-Disease 1 0.999659538269043
in O 0 0.09881750494241714
Duchenne B-Disease 1 0.9999960660934448
muscular I-Disease 1 0.9999918937683105
dystrophy I-Disease 1 0.9999978542327881
? O 1 0.8696562051773071

Molecular O 0 0.11804857850074768
study O 0 0.04919377714395523
and O 0 0.02643618732690811
neuropsychological O 0 0.15670904517173767
analysis O 0 0.029317039996385574
were O 0 0.011848983354866505
performed O 0 0.02312423475086689
concurrently O 0 0.02858005464076996
on O 0 0.019405357539653778
49 O 0 0.0706709697842598
patients O 1 0.9993531107902527
with O 0 0.08382447808980942
Duchenne B-Disease 1 0.999997615814209
muscular I-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9896659851074219
DMD B-Disease 1 0.9999946355819702
) O 0 0.02837573178112507
in O 0 0.011039461009204388
order O 0 0.01249966025352478
to O 0 0.010444090701639652
find O 0 0.018989017233252525
a O 0 0.018221935257315636
molecular O 0 0.03807772323489189
explanation O 0 0.03185468167066574
for O 0 0.01515292003750801
the O 0 0.021576493978500366
cognitive B-Disease 0 0.27663519978523254
impairment I-Disease 1 0.995763897895813
observed O 0 0.048460476100444794
in O 0 0.024854114279150963
most O 0 0.04319898039102554
DMD B-Disease 1 0.9999984502792358
patients O 1 0.9995430707931519
. O 0 0.06280022859573364

Complete O 0 0.04971890151500702
analysis O 0 0.03217455744743347
of O 0 0.014529937878251076
the O 0 0.02373955026268959
dystrophin O 1 0.7191559076309204
gene O 0 0.0804290622472763
was O 0 0.02039780281484127
performed O 0 0.024628276005387306
to O 0 0.011827207170426846
define O 0 0.02770576998591423
the O 0 0.01624446175992489
localization O 0 0.05300407111644745
of O 0 0.016345832496881485
deletions O 0 0.06834349781274796
and O 0 0.015850061550736427
duplications O 0 0.06521698832511902
in O 0 0.015733182430267334
relation O 0 0.02648671716451645
to O 0 0.013353664427995682
the O 0 0.01787842996418476
different O 0 0.03806111589074135
DMD B-Disease 1 0.9999797344207764
promoters O 1 0.7779867053031921
. O 0 0.053632110357284546

Qualitative O 0 0.09277620166540146
analysis O 0 0.03568432480096817
of O 0 0.015724308788776398
the O 0 0.0200961884111166
Dp71 O 0 0.12838214635849
transcript O 0 0.052207477390766144
and O 0 0.013031591661274433
testing O 0 0.025645678862929344
for O 0 0.009986831806600094
the O 0 0.010997170582413673
specific O 0 0.01903590001165867
first O 0 0.018405769020318985
exon O 0 0.07696899026632309
of O 0 0.018707435578107834
Dp140 O 0 0.07791906595230103
were O 0 0.013490196317434311
also O 0 0.013214723207056522
carried O 0 0.023895852267742157
out O 0 0.02407914027571678
. O 0 0.03314376622438431

Neuropsychological O 1 0.6443920731544495
analysis O 0 0.07457967102527618
assessed O 0 0.08143553137779236
verbal O 0 0.08814304322004318
and O 0 0.029492277652025223
visuospatial O 1 0.9184444546699524
intelligence O 0 0.04686794802546501
, O 0 0.021294016391038895
verbal O 0 0.06475156545639038
memory O 0 0.04449917748570442
, O 0 0.0139953987672925
and O 0 0.013630691915750504
reading O 0 0.02837516739964485
skills O 0 0.05121421813964844
. O 0 0.04096723347902298

Comparison O 0 0.07273876667022705
of O 0 0.0265642199665308
molecular O 0 0.06182948499917984
and O 0 0.024228716269135475
psychometric O 0 0.185165137052536
findings O 0 0.05266036093235016
demonstrated O 0 0.04494547098875046
that O 0 0.018599262461066246
deletions O 0 0.0782616138458252
and O 0 0.019666070118546486
duplications O 0 0.07346266508102417
that O 0 0.014377394691109657
were O 0 0.014044307172298431
localized O 0 0.06121910363435745
in O 0 0.01486295647919178
the O 0 0.017503799870610237
distal O 0 0.41847389936447144
part O 0 0.020520910620689392
of O 0 0.01133149117231369
the O 0 0.01666979119181633
gene O 0 0.06597289443016052
seemed O 0 0.036896709352731705
to O 0 0.01423805020749569
be O 0 0.0148435328155756
preferentially O 0 0.07659360766410828
associated O 0 0.03904995694756508
with O 0 0.030853481963276863
cognitive B-Disease 0 0.38969340920448303
impairment I-Disease 1 0.9957095384597778
. O 0 0.05861459672451019

Two O 0 0.042315851897001266
altered O 0 0.07715754956007004
Dp71 O 0 0.1336425393819809
transcripts O 0 0.054499197751283646
and O 0 0.015897898003458977
two O 0 0.017911406233906746
deleted O 0 0.060713086277246475
Dp140 O 0 0.1135425940155983
DNA O 0 0.05659327656030655
sequences O 0 0.03624333068728447
were O 0 0.01163928396999836
found O 0 0.014915482141077518
in O 0 0.012844712473452091
four O 0 0.024931568652391434
patients O 1 0.9994145631790161
with O 0 0.048476025462150574
severe O 1 0.9999713897705078
cerebral B-Disease 1 0.999992847442627
dysfunction I-Disease 1 0.9999709129333496
. O 0 0.07139763236045837

These O 0 0.030870355665683746
findings O 0 0.03973899036645889
suggest O 0 0.030519219115376472
that O 0 0.010843255557119846
some O 0 0.011131745763123035
sequences O 0 0.028217095881700516
located O 0 0.020300734788179398
in O 0 0.011056841351091862
the O 0 0.014273503795266151
distal O 0 0.11073673516511917
part O 0 0.02191878855228424
of O 0 0.011857662349939346
the O 0 0.014921937137842178
gene O 0 0.05018312484025955
and O 0 0.010818141512572765
, O 0 0.010343155823647976
in O 0 0.010703488253057003
particular O 0 0.018688645213842392
, O 0 0.015060740523040295
some O 0 0.022265488281846046
DMD B-Disease 1 0.999962568283081
isoforms O 0 0.07820075005292892
expressed O 0 0.03167540952563286
in O 0 0.01539449393749237
the O 0 0.019460203126072884
brain O 1 0.6850481033325195
may O 0 0.022646617144346237
be O 0 0.010055026970803738
related O 0 0.02290118858218193
to O 0 0.013809513300657272
the O 0 0.02078184112906456
cognitive B-Disease 1 0.6081011295318604
impairment I-Disease 1 0.9976315498352051
associated O 0 0.05293339490890503
with O 0 0.04469608888030052
DMD B-Disease 1 0.9999721050262451
. O 0 0.04263005778193474
. O 0 0.04363849014043808

I1307K O 1 0.5462164282798767
APC O 1 0.5967789888381958
and O 0 0.04447794705629349
hMLH1 O 0 0.19957435131072998
mutations O 0 0.11542049050331116
in O 0 0.020413821563124657
a O 0 0.023603057488799095
non O 0 0.03936950862407684
- O 0 0.06058189272880554
Jewish O 0 0.03842559829354286
family O 0 0.03360156714916229
with O 0 0.030771324411034584
hereditary B-Disease 1 0.9991440773010254
non I-Disease 1 0.998256266117096
- I-Disease 1 0.999976396560669
polyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
. O 0 0.09580741822719574

We O 0 0.03596629947423935
describe O 0 0.049281395971775055
a O 0 0.032582275569438934
French O 0 0.056953612715005875
Canadian O 0 0.07030146569013596
hereditary B-Disease 1 0.9981957077980042
non I-Disease 1 0.9958968162536621
- I-Disease 1 0.999975323677063
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 1 0.9726762771606445
HNPCC B-Disease 1 0.9999736547470093
) O 0 0.0640299916267395
kindred O 1 0.6069754958152771
which O 0 0.02295037731528282
carries O 0 0.03811471164226532
a O 0 0.029795290902256966
novel O 0 0.052943240851163864
truncating O 0 0.3032006621360779
mutation O 0 0.1862536072731018
in O 0 0.04389436915516853
hMLH1 O 0 0.18280580639839172
. O 0 0.05839576572179794

Interestingly O 0 0.1264095902442932
, O 0 0.03412536159157753
the O 0 0.03145377337932587
I1307K O 0 0.18047845363616943
APC O 0 0.3712754547595978
polymorphism O 0 0.11467106640338898
, O 0 0.02098306454718113
associated O 0 0.023758672177791595
with O 0 0.013954791240394115
an O 0 0.015911998227238655
increased O 0 0.04593928903341293
risk O 1 0.996428906917572
of O 0 0.07764623314142227
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
, O 0 0.018734076991677284
is O 0 0.011153538711369038
also O 0 0.009071245789527893
present O 0 0.012104080058634281
in O 0 0.010231097228825092
this O 0 0.013287033885717392
family O 0 0.03590074181556702
. O 0 0.034586161375045776

The O 0 0.05439693480730057
I1307K O 0 0.15674643218517303
polymorphism O 0 0.10687819868326187
has O 0 0.0200412068516016
previously O 0 0.017515357583761215
only O 0 0.010703456588089466
been O 0 0.011764585971832275
identified O 0 0.018145358189940453
in O 0 0.012210213579237461
individuals O 0 0.01865026168525219
of O 0 0.014751022681593895
self O 0 0.056749846786260605
- O 0 0.09120729565620422
reported O 0 0.06238840892910957
Ashkenazi O 0 0.15240693092346191
Jewish O 0 0.07294955849647522
origins O 0 0.09061136096715927
. O 0 0.054382145404815674

In O 0 0.029991429299116135
addition O 0 0.02483968250453472
, O 0 0.01382414624094963
in O 0 0.011389024555683136
this O 0 0.010362512432038784
family O 0 0.02019358240067959
, O 0 0.011572791263461113
there O 0 0.010679339058697224
appears O 0 0.020862078294157982
to O 0 0.009260574355721474
be O 0 0.008419758640229702
no O 0 0.01300328690558672
relationship O 0 0.023328781127929688
between O 0 0.015907270833849907
the O 0 0.018020927906036377
I1307K O 0 0.104054294526577
polymorphism O 0 0.07829030603170395
and O 0 0.013301882892847061
the O 0 0.014948236756026745
presence O 0 0.033404044806957245
or O 0 0.024377115070819855
absence O 0 0.049285415560007095
of O 0 0.02811560034751892
cancer B-Disease 1 0.9995537400245667
. O 0 0.03205942362546921
. O 0 0.037447620183229446

Identification O 0 0.05513899400830269
of O 0 0.01711582951247692
a O 0 0.024092650040984154
novel O 0 0.04039192572236061
mutation O 0 0.09290080517530441
of O 0 0.017597157508134842
the O 0 0.022485187277197838
CPO O 0 0.102206751704216
gene O 0 0.0676322802901268
in O 0 0.017881734296679497
a O 0 0.022574570029973984
Japanese O 0 0.04417333006858826
hereditary B-Disease 1 0.7010009288787842
coproporphyria I-Disease 1 0.5882730484008789
family O 0 0.06815745681524277
. O 0 0.05289531499147415

Hereditary B-Disease 1 0.975885808467865
coproporphyria I-Disease 1 0.9725023508071899
( O 0 0.10363008081912994
HCP B-Disease 1 0.9922937154769897
) O 0 0.04018747806549072
is O 0 0.01994648575782776
an O 0 0.02614767476916313
autosomal B-Disease 1 0.99947589635849
dominant I-Disease 1 0.9879183173179626
disease I-Disease 1 0.9999891519546509
characterized O 1 0.7437027096748352
by O 0 0.034847062081098557
a O 0 0.05080486088991165
deficiency B-Disease 1 0.9999699592590332
of I-Disease 0 0.04611876234412193
coproporphyrinogen I-Disease 1 0.960127592086792
oxidase I-Disease 1 0.9452306032180786
( O 0 0.06790053844451904
CPO O 0 0.1891373246908188
) O 0 0.0358007587492466
caused O 0 0.053684961050748825
by O 0 0.018396206200122833
a O 0 0.02432367019355297
mutation O 0 0.08786961436271667
in O 0 0.019599681720137596
the O 0 0.02698173187673092
CPO O 0 0.13393494486808777
gene O 0 0.11677926033735275
. O 0 0.054252199828624725

Only O 0 0.03315077722072601
11 O 0 0.04595004394650459
mutations O 0 0.08494291454553604
of O 0 0.014550503343343735
the O 0 0.019196398556232452
gene O 0 0.06122065335512161
have O 0 0.015113881789147854
been O 0 0.016336718574166298
reported O 0 0.0372500866651535
in O 0 0.03093300387263298
HCP B-Disease 1 0.9994314312934875
patients O 1 0.9981620907783508
. O 0 0.05076950788497925

We O 0 0.033573903143405914
report O 0 0.030091900378465652
another O 0 0.03262339159846306
mutation O 0 0.09038244187831879
in O 0 0.017739813774824142
a O 0 0.023859446868300438
Japanese O 0 0.039624933153390884
family O 0 0.04796452447772026
. O 0 0.0453619547188282

Polymerase O 1 0.557790219783783
chain O 0 0.14898812770843506
reaction O 0 0.10983848571777344
- O 0 0.0896252989768982
single O 0 0.05825395882129669
strand O 0 0.12947456538677216
conformational O 0 0.14188551902770996
polymorphism O 0 0.10458879172801971
and O 0 0.0218344833701849
direct O 0 0.033048730343580246
sequence O 0 0.03876296058297157
analyses O 0 0.04424310848116875
demonstrated O 0 0.03841506689786911
a O 0 0.022475922480225563
C O 0 0.061412494629621506
to O 0 0.020944591611623764
T O 0 0.20382024347782135
substitution O 0 0.05812662094831467
in O 0 0.020297884941101074
exon O 0 0.08076439052820206
1 O 0 0.02647274360060692
of O 0 0.013588109984993935
the O 0 0.0206292774528265
CPO O 0 0.10759007185697556
gene O 0 0.08400113135576248
at O 0 0.03071349672973156
nucleotide O 0 0.063332200050354
position O 0 0.025520553812384605
85 O 0 0.0385957770049572
, O 0 0.01201655250042677
which O 0 0.010861293412744999
lies O 0 0.025783652439713478
in O 0 0.012501142919063568
the O 0 0.019483381882309914
putative O 0 0.09645476192235947
presequence O 0 0.11213456094264984
for O 0 0.023254355415701866
targeting O 0 0.06407962739467621
to O 0 0.02734798565506935
mitochondria O 0 0.11676544696092606
. O 0 0.050333332270383835

This O 0 0.049528658390045166
mutation O 0 0.15635356307029724
changes O 0 0.0446087121963501
the O 0 0.026084866374731064
codon O 0 0.09728796035051346
for O 0 0.024620898067951202
glutamine O 0 0.10605184733867645
to O 0 0.02583373710513115
a O 0 0.03587724640965462
termination O 0 0.16823329031467438
codon O 0 0.1373884677886963
at O 0 0.047691166400909424
amino O 0 0.0821724534034729
acid O 0 0.1046781986951828
position O 0 0.04251886159181595
29 O 0 0.053343046456575394
. O 0 0.04514944925904274

MaeI O 0 0.3887978792190552
restriction O 0 0.08316272497177124
analysis O 0 0.03894265741109848
showed O 0 0.02973841316998005
two O 0 0.011752737686038017
other O 0 0.011800185777246952
carriers O 0 0.04936522617936134
in O 0 0.01485142856836319
the O 0 0.019387274980545044
family O 0 0.04330027848482132
. O 0 0.038702983409166336

The O 0 0.06466284394264221
C O 0 0.4639679789543152
- O 1 0.8045238256454468
T O 1 0.9548152685165405
mutation O 0 0.12789177894592285
is O 0 0.018201010301709175
located O 0 0.021555710583925247
within O 0 0.017027894034981728
a O 0 0.018319396302103996
recently O 0 0.03540927916765213
proposed O 0 0.039876874536275864
putative O 0 0.10923004895448685
alternative O 0 0.06152615696191788
translation O 0 0.05185705050826073
initiation O 0 0.11774291843175888
codon O 0 0.15035657584667206
( O 0 0.06635648012161255
TIC O 1 0.9962038397789001
- O 0 0.07919825613498688
1 O 0 0.03187921643257141
) O 0 0.022374209016561508
, O 0 0.013303493149578571
supporting O 0 0.02512275241315365
that O 0 0.019744616001844406
TIC O 1 0.9948872923851013
- O 0 0.06496947258710861
1 O 0 0.023933768272399902
is O 0 0.013951629400253296
the O 0 0.015953468158841133
real O 0 0.04110519215464592
TIC O 1 0.9646344780921936
rather O 0 0.03641649708151817
than O 0 0.0293122585862875
TIC O 1 0.9961920976638794
- O 0 0.08726215362548828
2 O 0 0.03734174743294716
. O 0 0.026014668866991997
. O 0 0.036843813955783844

Human B-Disease 0 0.10624942928552628
complement I-Disease 0 0.2873922884464264
factor I-Disease 1 0.9901750087738037
H I-Disease 1 0.999977707862854
deficiency I-Disease 1 0.9999992847442627
associated O 1 0.8779815435409546
with O 1 0.9751017093658447
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
. O 0 0.10463204979896545

This O 0 0.027129802852869034
study O 0 0.02808264084160328
reports O 0 0.019544364884495735
on O 0 0.010929097421467304
six O 0 0.019537700340151787
cases O 0 0.029353108257055283
of O 0 0.021037163212895393
deficiency B-Disease 1 0.9999066591262817
in I-Disease 0 0.017552988603711128
the I-Disease 0 0.01787841133773327
human I-Disease 0 0.031126942485570908
complement I-Disease 0 0.06713458895683289
regulatory I-Disease 0 0.10089237987995148
protein I-Disease 0 0.10762422531843185
Factor I-Disease 0 0.1881549060344696
H I-Disease 1 0.9934251308441162
( O 0 0.06413145363330841
FH O 1 0.9972872734069824
) O 0 0.0202438123524189
in O 0 0.00934799574315548
the O 0 0.010917666368186474
context O 0 0.0228834580630064
of O 0 0.017101621255278587
an O 0 0.057293713092803955
acute B-Disease 1 0.9999996423721313
renal I-Disease 1 1.0
disease I-Disease 1 0.9999988079071045
. O 0 0.0842934101819992

Five O 0 0.02739431895315647
of O 0 0.013658955693244934
the O 0 0.01417552400380373
cases O 0 0.02365627884864807
were O 0 0.012455112300813198
observed O 0 0.026286868378520012
in O 0 0.0144234299659729
children O 0 0.03287778049707413
presenting O 0 0.07804079353809357
with O 1 0.8467623591423035
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9906570911407471
HUS B-Disease 1 0.9999191761016846
) O 0 0.06754477322101593
. O 0 0.04599836841225624

Two O 0 0.02472156472504139
of O 0 0.016524938866496086
the O 0 0.017577312886714935
children O 0 0.035356614738702774
exhibited O 0 0.05841789022088051
a O 0 0.04245273396372795
homozygous O 1 0.9820538759231567
deficiency O 1 0.99998939037323
characterized O 0 0.10113675147294998
by O 0 0.01680799573659897
the O 0 0.014759909361600876
absence O 0 0.029881523922085762
of O 0 0.011951848864555359
the O 0 0.015898674726486206
150 O 0 0.043712541460990906
- O 0 0.09306029975414276
kD O 0 0.47565218806266785
form O 0 0.03578832373023033
of O 0 0.020881593227386475
Factor O 0 0.0686744973063469
H O 0 0.4063422679901123
and O 0 0.014080907218158245
the O 0 0.01331914309412241
presence O 0 0.026823436841368675
, O 0 0.012586720287799835
upon O 0 0.015938226133584976
immunoblotting O 0 0.06815376877784729
, O 0 0.014461887069046497
of O 0 0.011809714138507843
the O 0 0.01840553618967533
42 O 0 0.06320638954639435
- O 0 0.19061049818992615
kD O 1 0.981789767742157
Factor O 0 0.1509675234556198
H O 1 0.9722719788551331
- O 0 0.09137226641178131
like O 0 0.03789014741778374
protein O 0 0.06237421929836273
1 O 0 0.04053706303238869
( O 0 0.050181712955236435
FHL O 1 0.9931085109710693
- O 0 0.0795113667845726
1 O 0 0.03375038132071495
) O 0 0.02376442588865757
and O 0 0.0147069301456213
other O 0 0.020875316113233566
FH O 1 0.9995793700218201
- O 0 0.11101774871349335
related O 0 0.06590268760919571
protein O 0 0.08763650059700012
( O 0 0.053133394569158554
FHR O 1 0.7106490731239319
) O 0 0.03897522762417793
bands O 0 0.05987352877855301
. O 0 0.039326269179582596

Southern O 0 0.09404278546571732
blot O 0 0.1664419174194336
and O 0 0.03442142903804779
PCR O 0 0.11185263842344284
analysis O 0 0.0323559045791626
of O 0 0.01410831231623888
DNA O 0 0.03626229241490364
of O 0 0.014502081088721752
one O 0 0.020634489133954048
patient O 1 0.8661317229270935
with O 0 0.03633129596710205
homozygous O 1 0.9902685880661011
deficiency O 1 0.9999887943267822
ruled O 0 0.05332866311073303
out O 0 0.01574786938726902
the O 0 0.011421293020248413
presence O 0 0.021899087354540825
of O 0 0.01007015909999609
a O 0 0.016643892973661423
large O 0 0.023718073964118958
deletion O 0 0.08487240970134735
of O 0 0.01881953328847885
the O 0 0.032135214656591415
FH O 1 0.99769127368927
gene O 0 0.07714279741048813
as O 0 0.017354711890220642
the O 0 0.01913226582109928
underlying O 0 0.06994286924600601
defect O 1 0.9191851615905762
for O 0 0.02359270304441452
the O 0 0.038550954312086105
deficiency O 1 0.9999620914459229
. O 0 0.059049468487501144

The O 0 0.02243904583156109
other O 0 0.013422342948615551
four O 0 0.0173492394387722
children O 0 0.029151612892746925
presented O 0 0.027407677844166756
with O 0 0.032256945967674255
heterozygous O 1 0.9517344236373901
deficiency O 1 0.9999713897705078
and O 0 0.027820024639368057
exhibited O 0 0.05452845245599747
a O 0 0.0287946704775095
normal O 0 0.058868251740932465
immunoblotting O 0 0.13267123699188232
pattern O 0 0.05801726505160332
of O 0 0.01759837195277214
proteins O 0 0.0409725084900856
of O 0 0.019113101065158844
the O 0 0.035030707716941833
FH O 1 0.9967790246009827
family O 0 0.06882375478744507
. O 0 0.05692629516124725

Factor B-Disease 1 0.9845106601715088
H I-Disease 1 0.9997732043266296
deficiency I-Disease 1 0.9999619722366333
is O 0 0.02638918161392212
the O 0 0.02252253144979477
only O 0 0.027369827032089233
complement B-Disease 1 0.9716705679893494
deficiency I-Disease 1 0.9999971389770508
associated O 0 0.07546549290418625
with O 0 0.05011049658060074
HUS B-Disease 1 0.999466598033905
. O 0 0.0654291957616806

These O 0 0.033107686787843704
observations O 0 0.04540669173002243
suggest O 0 0.03618193790316582
a O 0 0.022672099992632866
role O 0 0.030508115887641907
for O 0 0.02800755389034748
FH O 1 0.9990463852882385
and O 0 0.038205116987228394
/ O 1 0.9756861329078674
or O 0 0.04604938253760338
FH O 1 0.9990229606628418
receptors O 0 0.13595321774482727
in O 0 0.023347502574324608
the O 0 0.025329623371362686
pathogenesis O 1 0.9952280521392822
of O 0 0.0434044748544693
idiopathic O 1 0.9999877214431763
HUS B-Disease 1 0.9999141693115234
. O 0 0.04740329459309578
. O 0 0.046781640499830246

Further O 0 0.04005102440714836
evidence O 0 0.026418231427669525
for O 0 0.015002749860286713
a O 0 0.02080160565674305
major O 0 0.03267614543437958
ancient O 0 0.04832687973976135
mutation O 1 0.9915571212768555
underlying O 1 0.9957354068756104
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999995231628418
from O 0 0.07500572502613068
linkage O 1 0.8989439606666565
disequilibrium O 1 0.9499572515487671
studies O 0 0.0454743318259716
in O 0 0.01734834536910057
the O 0 0.01799178682267666
Japanese O 0 0.03902696818113327
population O 0 0.046420153230428696
. O 0 0.043951500207185745

The O 0 0.1816316843032837
myotonic B-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9907264709472656
DM B-Disease 1 0.9999943971633911
) O 0 0.06538781523704529
mutation O 0 0.15107537806034088
is O 0 0.02621529996395111
an O 0 0.024277305230498314
unstable O 1 0.6946738958358765
( O 0 0.05925518274307251
CTG O 1 0.9769377708435059
) O 0 0.045652586966753006
n O 0 0.06156587973237038
repeat O 0 0.06462646275758743
, O 0 0.015775376930832863
present O 0 0.01667989231646061
at O 0 0.017024477943778038
a O 0 0.013319519348442554
copy O 0 0.02180599607527256
number O 0 0.011868181638419628
of O 0 0.010887021198868752
5 O 0 0.02981700375676155
- O 0 0.05594462901353836
37 O 0 0.04339774698019028
repeats O 0 0.060483742505311966
on O 0 0.01660945452749729
normal O 0 0.04216666519641876
chromosomes O 0 0.06173684820532799
but O 0 0.018660973757505417
amplified O 0 0.05524149909615517
to O 0 0.018631912767887115
50 O 0 0.03491758182644844
- O 0 0.06523413956165314
3000 O 0 0.09829405695199966
copies O 0 0.04238615185022354
on O 0 0.04082971066236496
DM B-Disease 1 0.9995641112327576
chromosomes O 0 0.13942012190818787
. O 0 0.06257320940494537

Previous O 0 0.05060159042477608
findings O 0 0.056268516927957535
in O 0 0.028648078441619873
Caucasian O 0 0.17269599437713623
populations O 0 0.0659361481666565
of O 0 0.022300569340586662
a O 0 0.04936935752630234
DM B-Disease 1 0.9999560117721558
founder O 0 0.10189580917358398
chromosome O 0 0.12465377897024155
raise O 0 0.04709737002849579
a O 0 0.02125551365315914
question O 0 0.01874532550573349
about O 0 0.011976255103945732
the O 0 0.012522105127573013
molecular O 0 0.037921205163002014
events O 0 0.025146769359707832
involved O 0 0.024883121252059937
in O 0 0.013686606660485268
the O 0 0.01994135044515133
expansion O 0 0.06101555749773979
mutation O 0 0.17132790386676788
. O 0 0.0499696359038353

To O 0 0.0333431139588356
investigate O 0 0.0495138093829155
whether O 0 0.02644481137394905
a O 0 0.02389451675117016
founder O 0 0.054155245423316956
chromosome O 0 0.09689853340387344
for O 0 0.021816637367010117
the O 0 0.03758694604039192
DM B-Disease 1 0.9999783039093018
mutation O 0 0.47011351585388184
exists O 0 0.04075958579778671
in O 0 0.012344899587333202
the O 0 0.01250330451875925
Japanese O 0 0.02454075776040554
population O 0 0.02252814546227455
, O 0 0.014305179007351398
we O 0 0.01614907756447792
genotyped O 0 0.09878542274236679
families O 0 0.04286591708660126
using O 0 0.03814837709069252
polymorphic O 0 0.16984227299690247
markers O 0 0.0875014066696167
near O 0 0.04388810321688652
the O 0 0.024735473096370697
( O 0 0.05595545843243599
CTG O 1 0.84135901927948
) O 0 0.04789028689265251
n O 0 0.08010460436344147
repeat O 0 0.0792693942785263
region O 0 0.04647180065512657
and O 0 0.02609800361096859
constructed O 0 0.061684612184762955
haplotypes O 0 0.40944337844848633
. O 0 0.06898194551467896

Six O 0 0.04755455628037453
different O 0 0.03079965151846409
haplotypes O 0 0.15052121877670288
were O 0 0.02168247289955616
found O 0 0.027847878634929657
and O 0 0.0321786068379879
DM B-Disease 1 0.9999761581420898
alleles O 0 0.22848311066627502
were O 0 0.030456624925136566
always O 0 0.04874524474143982
haplotype O 1 0.5567632913589478
A O 0 0.05428162217140198
. O 0 0.04578099399805069

To O 0 0.026754209771752357
find O 0 0.024146148934960365
an O 0 0.013082304038107395
origin O 0 0.01974051631987095
of O 0 0.014054393395781517
the O 0 0.02030377835035324
( O 0 0.04706992954015732
CTG O 1 0.9635651111602783
) O 0 0.04441254585981369
n O 0 0.07704509794712067
repeat O 0 0.09466090798377991
mutation O 0 0.10194440186023712
and O 0 0.014366783201694489
to O 0 0.011096036061644554
investigate O 0 0.026760809123516083
the O 0 0.01128087006509304
mechanism O 0 0.03178611025214195
of O 0 0.010896504856646061
the O 0 0.014868278056383133
expansion O 0 0.043457578867673874
mutation O 0 0.08683745563030243
in O 0 0.013123641721904278
the O 0 0.011664428748190403
Japanese O 0 0.02341887354850769
population O 0 0.0210738405585289
we O 0 0.011224813759326935
have O 0 0.01359222736209631
studied O 0 0.025434043258428574
90 O 0 0.04223766177892685
Japanese O 0 0.056038640439510345
DM B-Disease 1 0.9998828172683716
families O 0 0.04940791800618172
comprising O 0 0.04477175325155258
190 O 0 0.07143310457468033
affected O 0 0.056795429438352585
and O 0 0.022817160934209824
130 O 0 0.05980938673019409
unaffected O 0 0.11222884058952332
members O 0 0.04225220903754234
. O 0 0.045806609094142914

The O 0 0.03602960705757141
results O 0 0.04257979989051819
suggest O 0 0.03353177011013031
that O 0 0.0109611377120018
a O 0 0.014594423584640026
few O 0 0.01854255422949791
common O 0 0.028878767043352127
ancestral O 0 0.06447862088680267
mutations O 0 0.0985175296664238
in O 0 0.016683584079146385
both O 0 0.018895328044891357
Caucasian O 0 0.1194767951965332
and O 0 0.01641983538866043
Japanese O 0 0.029225429520010948
populations O 0 0.039403244853019714
have O 0 0.013917847536504269
originated O 0 0.028962381184101105
by O 0 0.012637877836823463
expansion O 0 0.02816188521683216
of O 0 0.012703920714557171
an O 0 0.018911292776465416
ancestral O 0 0.07114116102457047
n O 0 0.08820484578609467
= O 0 0.10181370377540588
5 O 0 0.039187099784612656
repeat O 0 0.06258923560380936
to O 0 0.023309312760829926
n O 0 0.06730498373508453
= O 0 0.09512538462877274
19 O 0 0.043817248195409775
- O 0 0.06419434398412704
37 O 0 0.050930436700582504
copies O 0 0.04058987647294998
. O 0 0.04612979665398598

These O 0 0.028574366122484207
data O 0 0.02882583811879158
support O 0 0.03396562486886978
multistep O 0 0.116620734333992
models O 0 0.04512055963277817
of O 0 0.023900333791971207
triplet O 0 0.32552415132522583
repeat O 0 0.08466722816228867
expansion O 0 0.036215126514434814
that O 0 0.010739123448729515
have O 0 0.010375404730439186
been O 0 0.011010636575520039
proposed O 0 0.01828550547361374
for O 0 0.014789339154958725
both O 0 0.029718834906816483
DM B-Disease 1 0.9999783039093018
and O 0 0.04146227985620499
Friedreichs B-Disease 1 0.9911824464797974
ataxia I-Disease 1 0.9993902444839478
. O 0 0.0431654192507267
. O 0 0.04549267515540123

The O 0 0.04100264608860016
molecular O 0 0.06768372654914856
basis O 0 0.035061221569776535
of O 0 0.04086145758628845
C6 B-Disease 1 0.9999852180480957
deficiency I-Disease 1 0.9999921321868896
in O 0 0.019834185019135475
the O 0 0.01651320606470108
western O 0 0.030933506786823273
Cape O 0 0.062396757304668427
, O 0 0.018981967121362686
South O 0 0.03497589752078056
Africa O 0 0.06153305992484093
. O 0 0.04076973348855972

Deficiency B-Disease 1 0.9997102618217468
of I-Disease 0 0.025514787063002586
the I-Disease 0 0.023379778489470482
sixth I-Disease 0 0.04751347377896309
component I-Disease 0 0.04838557913899422
of I-Disease 0 0.01789274252951145
human I-Disease 0 0.0347076952457428
complement I-Disease 0 0.06647510081529617
( O 0 0.0532284677028656
C6 O 1 0.9928004741668701
) O 0 0.02149161510169506
has O 0 0.011113299988210201
been O 0 0.009644308127462864
reported O 0 0.01875993423163891
in O 0 0.009637757204473019
a O 0 0.010095675475895405
number O 0 0.008604037575423717
of O 0 0.008117049932479858
families O 0 0.021148983389139175
from O 0 0.013777827844023705
the O 0 0.013204331509768963
western O 0 0.030824044719338417
Cape O 0 0.06161618232727051
, O 0 0.02202739007771015
South O 0 0.036974530667066574
Africa O 0 0.058943986892700195
. O 0 0.043167129158973694

Meningococcal B-Disease 1 0.9999923706054688
disease I-Disease 1 0.9999581575393677
is O 0 0.0342802070081234
endemic O 0 0.07988116145133972
in O 0 0.016749875620007515
the O 0 0.016129102557897568
Cape O 0 0.04496800899505615
and O 0 0.011394250206649303
almost O 0 0.014409920200705528
all O 0 0.012885953299701214
pedigrees O 0 0.07406370341777802
of O 0 0.024356894195079803
total O 0 0.07552380114793777
C6 B-Disease 1 0.9999947547912598
deficiency I-Disease 1 0.9999994039535522
( O 0 0.08599290251731873
C6Q0 O 1 0.9728946685791016
) O 0 0.027662629261612892
have O 0 0.014908085577189922
been O 0 0.017957942560315132
ascertained O 0 0.06093273311853409
because O 0 0.02701733447611332
of O 0 0.02876732498407364
recurrent O 1 0.9997480511665344
disease O 1 0.9999523162841797
. O 0 0.06679419428110123

We O 0 0.029700271785259247
have O 0 0.019869429990649223
sequenced O 0 0.05694535747170448
the O 0 0.019017629325389862
expressed O 0 0.03191395848989487
exons O 0 0.07368382811546326
of O 0 0.01972045563161373
the O 0 0.024084025993943214
C6 O 1 0.971126914024353
gene O 0 0.07404562085866928
from O 0 0.01775195077061653
selected O 0 0.016845231875777245
cases O 0 0.02111141011118889
and O 0 0.009952757507562637
have O 0 0.010834616608917713
found O 0 0.016310058534145355
three O 0 0.017496969550848007
molecular O 0 0.06363791227340698
defects O 1 0.7766000032424927
leading O 0 0.03537691384553909
to O 0 0.02101796865463257
total O 0 0.044359080493450165
deficiency O 1 0.9999754428863525
879delG O 0 0.23660176992416382
, O 0 0.017201438546180725
which O 0 0.010885007679462433
is O 0 0.00989115983247757
the O 0 0.011302398517727852
common O 0 0.030339227989315987
defect O 0 0.2179330289363861
in O 0 0.014518937095999718
the O 0 0.01544144842773676
Cape O 0 0.057972993701696396
and O 0 0.01900121197104454
hitherto O 0 0.06986493617296219
unreported O 0 0.07579146325588226
, O 0 0.018490852788090706
and O 0 0.017185138538479805
1195delC O 0 0.09633931517601013
and O 0 0.017098689451813698
1936delG O 0 0.08318421989679337
, O 0 0.01281093992292881
which O 0 0.009821287356317043
have O 0 0.008448407053947449
been O 0 0.010198978707194328
previously O 0 0.016270482912659645
reported O 0 0.025890763849020004
in O 0 0.014501446858048439
African O 0 0.04589293524622917
- O 0 0.08457806706428528
Americans O 0 0.06282074004411697
. O 0 0.04343800991773605

We O 0 0.026358963921666145
also O 0 0.01598014123737812
show O 0 0.02025269716978073
that O 0 0.01151195727288723
the O 0 0.017314497381448746
879delG O 0 0.11338961869478226
and O 0 0.027456045150756836
1195delC O 1 0.7774451375007629
defects O 1 0.9056504368782043
are O 0 0.019659988582134247
associated O 0 0.03276733681559563
with O 0 0.03198390081524849
characteristic O 0 0.3533552587032318
C6 O 1 0.9998308420181274
/ O 1 0.995891809463501
C7 O 1 0.9911733269691467
region O 0 0.08944831043481827
DNA O 0 0.10417446494102478
marker O 0 0.11905086040496826
haplotypes O 0 0.47796064615249634
, O 0 0.022766729816794395
although O 0 0.02197273075580597
small O 0 0.024452660232782364
variations O 0 0.039182476699352264
were O 0 0.020310495048761368
observed O 0 0.05058682709932327
. O 0 0.03960280865430832

The O 0 0.0657465010881424
1936delG O 1 0.5876379609107971
defect O 1 0.6218236684799194
was O 0 0.026485182344913483
observed O 0 0.028993001207709312
only O 0 0.011807778850197792
once O 0 0.01626633293926716
in O 0 0.010945919901132584
the O 0 0.014003283344209194
Cape O 0 0.04838196560740471
, O 0 0.013263411819934845
but O 0 0.01248036976903677
its O 0 0.014633742161095142
associated O 0 0.035926979035139084
haplotype O 1 0.6243074536323547
could O 0 0.02400142326951027
be O 0 0.018785402178764343
deduced O 0 0.07553379237651825
. O 0 0.04119492322206497

The O 0 0.02633238211274147
data O 0 0.02279885858297348
from O 0 0.017570776864886284
the O 0 0.01896093599498272
haplotypes O 0 0.23401887714862823
indicate O 0 0.03189055994153023
that O 0 0.009754160419106483
these O 0 0.010380092076957226
three O 0 0.015612040646374226
molecular O 0 0.05012161284685135
defects O 0 0.2943600118160248
account O 0 0.022942883893847466
for O 0 0.011434362269937992
the O 0 0.01567060500383377
defects O 0 0.09711502492427826
in O 0 0.010986932553350925
all O 0 0.009807570837438107
the O 0 0.013861171901226044
38 O 0 0.04207848384976387
unrelated O 0 0.06481760740280151
C6Q0 O 1 0.506356418132782
individuals O 0 0.032202962785959244
we O 0 0.01382294949144125
have O 0 0.013426043093204498
studied O 0 0.019792724400758743
from O 0 0.01585587114095688
the O 0 0.02016841061413288
Cape O 0 0.0851052775979042
. O 0 0.040011756122112274

We O 0 0.02750239707529545
have O 0 0.017795953899621964
also O 0 0.015492552891373634
observed O 0 0.03089790605008602
the O 0 0.021909447386860847
879delG O 0 0.17351576685905457
defect O 0 0.3071672320365906
in O 0 0.02373185008764267
two O 0 0.027319811284542084
Dutch O 0 0.136427640914917
C6 B-Disease 1 0.9999512434005737
- I-Disease 1 0.9766016602516174
deficient I-Disease 1 0.9981566071510315
kindreds O 1 0.8945928812026978
, O 0 0.023265989497303963
but O 0 0.014966124668717384
the O 0 0.01899629831314087
879delG O 0 0.1523846685886383
defect O 0 0.2417328655719757
in O 0 0.017186323180794716
the O 0 0.016948232427239418
Cape O 0 0.05320600047707558
probably O 0 0.02925861068069935
did O 0 0.016251444816589355
not O 0 0.008877243846654892
come O 0 0.01458988431841135
from O 0 0.01218061987310648
The O 0 0.013853221200406551
Netherlands O 0 0.0361374206840992
. O 0 0.02023988775908947
. O 0 0.032863423228263855

Complement B-Disease 1 0.9674458503723145
C7 I-Disease 1 0.9999759197235107
deficiency I-Disease 1 0.9999966621398926
: O 0 0.05177437141537666
seven O 0 0.03609410300850868
further O 0 0.03356808423995972
molecular O 0 0.07392255961894989
defects O 0 0.46261361241340637
and O 0 0.017728615552186966
their O 0 0.022935668006539345
associated O 0 0.05770666152238846
marker O 0 0.12295997887849808
haplotypes O 1 0.8246089220046997
. O 0 0.058935534209012985

Seven O 0 0.05211374908685684
further O 0 0.040436118841171265
molecular O 0 0.06899295002222061
bases O 0 0.05247314274311066
of O 0 0.03819885849952698
C7 B-Disease 1 0.999976634979248
deficiency I-Disease 1 0.9999959468841553
are O 0 0.03360486403107643
described O 0 0.0571967177093029
. O 0 0.04888007789850235

All O 0 0.02273082546889782
these O 0 0.018505098298192024
new O 0 0.028611863031983376
molecular O 0 0.07941220700740814
defects O 1 0.6032136678695679
involve O 0 0.055134255439043045
single O 0 0.041999123990535736
- O 0 0.0796641930937767
nucleotide O 0 0.08420238643884659
events O 0 0.03636257350444794
, O 0 0.019822517409920692
deletions O 0 0.06110076233744621
and O 0 0.016966912895441055
substitutions O 0 0.04086829721927643
, O 0 0.012626269832253456
some O 0 0.008890041150152683
of O 0 0.009451821446418762
which O 0 0.01621999591588974
alter O 0 0.06184837222099304
splice O 0 0.1107993870973587
sites O 0 0.030435308814048767
, O 0 0.018059469759464264
and O 0 0.018242739140987396
others O 0 0.03486872836947441
codons O 0 0.11813852190971375
. O 0 0.047488901764154434

They O 0 0.02614297717809677
are O 0 0.015469085425138474
distributed O 0 0.023343930020928383
along O 0 0.02392783761024475
the O 0 0.026226332411170006
C7 O 1 0.8494069576263428
gene O 0 0.0803452879190445
, O 0 0.016227858141064644
but O 0 0.013353118672966957
predominantly O 0 0.026304541155695915
towards O 0 0.024021100252866745
the O 0 0.019151415675878525
3 O 0 0.04010722413659096
end O 0 0.04140608012676239
. O 0 0.03808112069964409

All O 0 0.02096380479633808
were O 0 0.015883149579167366
found O 0 0.023269707337021828
in O 0 0.022131452336907387
compound O 0 0.07723841071128845
heterozygous O 0 0.1260424703359604
individuals O 0 0.054508522152900696
. O 0 0.05099453777074814

The O 0 0.09654358774423599
C6 O 1 0.9990596175193787
/ O 1 0.9973875880241394
C7 O 1 0.9957999587059021
marker O 0 0.1781759262084961
haplotypes O 1 0.8528621792793274
associated O 0 0.04256366938352585
with O 0 0.022837277501821518
most O 0 0.028738845139741898
C7 B-Disease 1 0.9974724650382996
defects I-Disease 1 0.8478429913520813
are O 0 0.019869498908519745
tabulated O 0 0.04940960928797722
. O 0 0.027354760095477104
. O 0 0.041031546890735626

A O 0 0.06642775982618332
genome O 0 0.1127065122127533
- O 0 0.0831531286239624
wide O 0 0.04819059744477272
search O 0 0.042308591306209564
for O 0 0.031014742329716682
chromosomal O 0 0.3413371741771698
loci O 0 0.4962822198867798
linked O 0 0.0860244631767273
to O 0 0.028454989194869995
mental O 1 0.9976375102996826
health O 1 0.9325731992721558
wellness O 1 0.9623915553092957
in O 0 0.021924251690506935
relatives O 0 0.04455651342868805
at O 0 0.02957434393465519
high O 0 0.04090357944369316
risk O 1 0.9534608721733093
for O 0 0.04870589077472687
bipolar B-Disease 1 0.9999995231628418
affective I-Disease 1 0.9999669790267944
disorder I-Disease 1 0.9999579191207886
among O 0 0.029394719749689102
the O 0 0.018594885244965553
Old O 0 0.03620116412639618
Order O 0 0.03629928454756737
Amish O 0 0.12226176261901855
. O 0 0.053858060389757156

Bipolar B-Disease 1 0.9999994039535522
affective I-Disease 1 0.9999911785125732
disorder I-Disease 1 0.9999982118606567
( O 1 0.9940798282623291
BPAD B-Disease 1 0.999984860420227
; O 1 0.9948908090591431
manic B-Disease 1 0.999998927116394
- I-Disease 1 0.9999490976333618
depressive I-Disease 1 0.9999990463256836
illness I-Disease 1 0.9999357461929321
) O 0 0.04195259511470795
is O 0 0.01966838538646698
characterized O 0 0.05425050109624863
by O 0 0.020065927878022194
episodes O 0 0.048205990344285965
of O 0 0.02760075032711029
mania B-Disease 1 0.9996013045310974
and O 0 0.035186100751161575
/ O 1 0.9956111311912537
or O 0 0.04651203006505966
hypomania B-Disease 1 0.999835729598999
interspersed O 0 0.08186834305524826
with O 0 0.02622387371957302
periods O 0 0.059443604201078415
of O 0 0.030425425618886948
depression B-Disease 1 0.9969152212142944
. O 0 0.052415791898965836

Compelling O 0 0.06975886970758438
evidence O 0 0.033467452973127365
supports O 0 0.03951806575059891
a O 0 0.023109229281544685
significant O 0 0.028114134445786476
genetic O 0 0.05828271433711052
component O 0 0.04179636761546135
in O 0 0.01752611994743347
the O 0 0.02264351211488247
susceptibility O 0 0.3345789313316345
to O 0 0.026811176910996437
develop O 0 0.08572655916213989
BPAD B-Disease 1 0.9918210506439209
. O 0 0.059242893010377884

To O 0 0.02856222726404667
date O 0 0.03148075193166733
, O 0 0.017109235748648643
however O 0 0.016489699482917786
, O 0 0.018562808632850647
linkage O 0 0.0736861601471901
studies O 0 0.029795510694384575
have O 0 0.0128121767193079
attempted O 0 0.02455035224556923
only O 0 0.011373230256140232
to O 0 0.01482565887272358
identify O 0 0.04703914746642113
chromosomal O 0 0.29401227831840515
loci O 0 0.16558890044689178
that O 0 0.020268505439162254
cause O 0 0.06363905966281891
or O 0 0.01989673264324665
increase O 0 0.02414698526263237
the O 0 0.01738358661532402
risk O 0 0.08167240768671036
of O 0 0.022377343848347664
developing O 0 0.07531612366437912
BPAD B-Disease 1 0.995222270488739
. O 0 0.05798650160431862

To O 0 0.027000360190868378
determine O 0 0.03375810384750366
whether O 0 0.02198532409965992
there O 0 0.014164506457746029
could O 0 0.01719500683248043
be O 0 0.01523875817656517
protective O 0 0.10150957852602005
alleles O 0 0.12793996930122375
that O 0 0.01843711920082569
prevent O 0 0.04627120867371559
or O 0 0.023743145167827606
reduce O 0 0.04310419037938118
the O 0 0.019513869658112526
risk O 0 0.09643197059631348
of O 0 0.017743537202477455
developing O 0 0.05491282045841217
BPAD B-Disease 1 0.9932094216346741
, O 0 0.017983902245759964
similar O 0 0.017513234168291092
to O 0 0.010162622667849064
what O 0 0.012297339737415314
is O 0 0.01240476779639721
observed O 0 0.025014307349920273
in O 0 0.013363883830606937
other O 0 0.018629707396030426
genetic B-Disease 1 0.9942626357078552
disorders I-Disease 1 0.9999905824661255
, O 0 0.02130846120417118
we O 0 0.016826879233121872
used O 0 0.02371383085846901
mental O 1 0.9995598196983337
health O 1 0.9798062443733215
wellness O 1 0.9952077269554138
( O 0 0.038209427148103714
absence O 0 0.038161564618349075
of O 0 0.015455150045454502
any O 0 0.028940929099917412
psychiatric B-Disease 1 0.9999829530715942
disorder I-Disease 1 0.9999383687973022
) O 0 0.025432473048567772
as O 0 0.012848438695073128
the O 0 0.01709689199924469
phenotype O 0 0.20219741761684418
in O 0 0.02039242535829544
our O 0 0.02417224645614624
genome O 0 0.07634279876947403
- O 0 0.07869484275579453
wide O 0 0.04855743795633316
linkage O 0 0.11824502050876617
scan O 0 0.08508463948965073
of O 0 0.014861631207168102
several O 0 0.015022887848317623
large O 0 0.024252399802207947
multigeneration O 0 0.11491426825523376
Old O 0 0.04169182479381561
Order O 0 0.03381111100316048
Amish O 0 0.1222875565290451
pedigrees O 0 0.13424070179462433
exhibiting O 0 0.08362014591693878
an O 0 0.030355866998434067
extremely O 0 0.05804765969514847
high O 0 0.059396833181381226
incidence O 1 0.8752984404563904
of O 0 0.0374344177544117
BPAD B-Disease 1 0.9958051443099976
. O 0 0.062106646597385406

We O 0 0.0257863849401474
have O 0 0.016037791967391968
found O 0 0.016508113592863083
strong O 0 0.02002047374844551
evidence O 0 0.018496356904506683
for O 0 0.013477941043674946
a O 0 0.024025024846196175
locus O 0 0.10371014475822449
on O 0 0.030008012428879738
chromosome O 0 0.19244058430194855
4p O 1 0.9416593909263611
at O 0 0.056114330887794495
D4S2949 O 0 0.1493406444787979
( O 0 0.05172513797879219
maximum O 0 0.06482221186161041
GENEHUNTER O 1 0.734541654586792
- O 0 0.10508660972118378
PLUS O 0 0.09270086884498596
nonparametric O 0 0.17493678629398346
linkage O 0 0.14281436800956726
score O 0 0.05087670311331749
= O 0 0.09123433381319046
4 O 0 0.033447276800870895
. O 0 0.020723216235637665
05 O 0 0.09227613359689713
, O 0 0.026766281574964523
P O 0 0.11487407237291336
= O 0 0.07896523922681808
5 O 0 0.025766266509890556
. O 0 0.015448961406946182
22 O 0 0.025964315980672836
x O 0 0.047585345804691315
10 O 0 0.02505532093346119
( O 0 0.031108180060982704
- O 0 0.05934529006481171
4 O 0 0.0373343788087368
) O 0 0.03428562358021736
; O 0 0.03561161085963249
SIBPAL O 0 0.37702056765556335
Pempirical O 0 0.1833650916814804
value O 0 0.04485824331641197
< O 0 0.13380353152751923
3 O 0 0.04054846614599228
x O 0 0.06173954904079437
10 O 0 0.03081831894814968
( O 0 0.03432604297995567
- O 0 0.06036700680851936
5 O 0 0.032489217817783356
) O 0 0.023600054904818535
) O 0 0.01988239213824272
and O 0 0.014076936058700085
suggestive O 0 0.057409826666116714
evidence O 0 0.02213284745812416
for O 0 0.014242099598050117
a O 0 0.022160615772008896
locus O 0 0.09826651215553284
on O 0 0.031164757907390594
chromosome O 0 0.19801338016986847
4q O 1 0.990120530128479
at O 0 0.04983238875865936
D4S397 O 0 0.1385103315114975
( O 0 0.053402919322252274
maximum O 0 0.06626620143651962
GENEHUNTER O 1 0.6646320223808289
- O 0 0.11969596892595291
PLUS O 0 0.10347926616668701
nonparametric O 0 0.17192572355270386
linkage O 0 0.13945527374744415
score O 0 0.0533471442759037
= O 0 0.08677857369184494
3 O 0 0.029090169817209244
. O 0 0.017647158354520798
29 O 0 0.031186765059828758
, O 0 0.022408638149499893
P O 0 0.10565917193889618
= O 0 0.08401982486248016
2 O 0 0.030207600444555283
. O 0 0.018138069659471512
57 O 0 0.04097536578774452
x O 0 0.05381918326020241
10 O 0 0.0282683614641428
( O 0 0.035636939108371735
- O 0 0.06142116338014603
3 O 0 0.03907710686326027
) O 0 0.035075411200523376
; O 0 0.03820516914129257
SIBPAL O 0 0.3901492953300476
Pempirical O 0 0.1496204435825348
value O 0 0.042292434722185135
< O 0 0.12009713798761368
1 O 0 0.03347070887684822
x O 0 0.05459919944405556
10 O 0 0.026117665693163872
( O 0 0.029989168047904968
- O 0 0.05347442626953125
3 O 0 0.030084246769547462
) O 0 0.022189700976014137
) O 0 0.016285227611660957
that O 0 0.009133522398769855
are O 0 0.011309145949780941
linked O 0 0.04553845897316933
to O 0 0.024475034326314926
mental O 1 0.9952163696289062
health O 1 0.92931067943573
wellness O 1 0.990365743637085
. O 0 0.06126139312982559

These O 0 0.029648028314113617
findings O 0 0.03725871816277504
are O 0 0.011992521584033966
consistent O 0 0.025974266231060028
with O 0 0.013084170408546925
the O 0 0.0144879799336195
hypothesis O 0 0.04417051374912262
that O 0 0.01491942722350359
certain O 0 0.02504623867571354
alleles O 0 0.11887218803167343
could O 0 0.029089221730828285
prevent O 0 0.05109856277704239
or O 0 0.025168847292661667
modify O 0 0.05404239147901535
the O 0 0.024882951751351357
clinical O 1 0.7191355228424072
manifestations O 0 0.3985917568206787
of O 0 0.02420148253440857
BPAD B-Disease 1 0.9951850771903992
and O 0 0.018939757719635963
perhaps O 0 0.030314721167087555
other O 0 0.020571840927004814
related O 0 0.13886821269989014
affective B-Disease 1 0.9998152852058411
disorders I-Disease 1 0.9999681711196899
. O 0 0.06364506483078003

Segregation O 1 0.6463273763656616
distortion O 1 0.8689369559288025
in O 0 0.11383625864982605
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999990463256836
. O 0 0.08865217864513397

Myotonic B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 0.9999998807907104
( O 1 0.9923253059387207
DM B-Disease 1 0.9999911785125732
) O 0 0.04530298709869385
is O 0 0.022309191524982452
an O 0 0.02954929694533348
autosomal B-Disease 1 0.9990277290344238
dominant I-Disease 1 0.8796133995056152
disease I-Disease 1 0.9999021291732788
which O 0 0.020834289491176605
, O 0 0.013104338198900223
in O 0 0.011274617165327072
the O 0 0.01415230706334114
typical O 0 0.043361734598875046
pedigree O 0 0.0692693293094635
, O 0 0.015354746021330357
shows O 0 0.019533347338438034
a O 0 0.01669386774301529
three O 0 0.02116166427731514
generation O 0 0.06754092872142792
anticipation O 0 0.10612807422876358
cascade O 0 0.19511298835277557
. O 0 0.06220822036266327

This O 0 0.03680713102221489
results O 0 0.05136881023645401
in O 0 0.0404132679104805
infertility B-Disease 1 0.9999905824661255
and O 1 0.9011786580085754
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7311012148857117
CDM B-Disease 1 0.9972936511039734
) O 0 0.028434675186872482
with O 0 0.01563004031777382
the O 0 0.01723642647266388
disappearance O 0 0.058079008013010025
of O 0 0.02796461060643196
DM B-Disease 1 0.9998992681503296
in O 0 0.028904948383569717
that O 0 0.023974411189556122
pedigree O 0 0.11352559924125671
. O 0 0.04742175713181496

The O 0 0.03786589950323105
concept O 0 0.04830431565642357
of O 0 0.024311397224664688
segregation O 0 0.09684913605451584
distortion O 0 0.09605161100625992
, O 0 0.017868192866444588
where O 0 0.014658074826002121
there O 0 0.010821744799613953
is O 0 0.013853689655661583
preferential O 0 0.055144648998975754
transmission O 0 0.05220578983426094
of O 0 0.01324412226676941
the O 0 0.016699785366654396
larger O 0 0.03739236295223236
allele O 0 0.11042987555265427
at O 0 0.0312497541308403
the O 0 0.030818233266472816
DM B-Disease 1 0.9998340606689453
locus O 0 0.11834894865751266
, O 0 0.021549412980675697
has O 0 0.013166161254048347
been O 0 0.012590473517775536
put O 0 0.018811002373695374
forward O 0 0.019270481541752815
to O 0 0.012060573324561119
explain O 0 0.02837827056646347
partially O 0 0.03926490619778633
the O 0 0.01702575385570526
maintenance O 0 0.0503312312066555
of O 0 0.026702143251895905
DM B-Disease 1 0.9998672008514404
in O 0 0.022595485672354698
the O 0 0.019993800669908524
population O 0 0.03931887447834015
. O 0 0.041795216500759125

In O 0 0.03020627424120903
a O 0 0.029407434165477753
survey O 0 0.047827400267124176
of O 0 0.025960635393857956
DM B-Disease 1 0.9997050166130066
in O 0 0.02371109649538994
Northern O 0 0.03402760997414589
Ireland O 0 0.03563361242413521
, O 0 0.023004217073321342
59 O 0 0.05797360837459564
pedigrees O 0 0.10324808955192566
were O 0 0.02959032543003559
ascertained O 0 0.10690123587846756
. O 0 0.0485144667327404

Sibships O 0 0.18455015122890472
where O 0 0.024539334699511528
the O 0 0.01230118703097105
status O 0 0.01631747931241989
of O 0 0.007049492094665766
all O 0 0.00682775629684329
the O 0 0.008625742979347706
members O 0 0.011978794820606709
had O 0 0.013157212175428867
been O 0 0.009988727979362011
identified O 0 0.017737817019224167
were O 0 0.00878818891942501
examined O 0 0.028126072138547897
to O 0 0.011517210863530636
determine O 0 0.022336851805448532
the O 0 0.015345234423875809
transmission O 0 0.05298689380288124
of O 0 0.01515719760209322
the O 0 0.025976205244660378
DM B-Disease 1 0.9999804496765137
expansion O 0 0.050176601856946945
from O 0 0.018638452515006065
affected O 0 0.03945041447877884
parents O 0 0.029747430235147476
to O 0 0.014986790716648102
their O 0 0.018885983154177666
offspring O 0 0.09230223298072815
. O 0 0.05011601746082306

Where O 0 0.0443144366145134
the O 0 0.029563555493950844
transmitting O 0 0.09993303567171097
parent O 0 0.07905798405408859
was O 0 0.026050109416246414
male O 0 0.0570075586438179
, O 0 0.02489604242146015
58 O 0 0.06323137134313583
. O 0 0.041122302412986755

3 O 0 0.048706721514463425
% O 0 0.028137976303696632
of O 0 0.011286945082247257
the O 0 0.014910439029335976
offspring O 0 0.05524593964219093
were O 0 0.015198808163404465
affected O 0 0.03582119569182396
, O 0 0.010856919921934605
and O 0 0.008066622540354729
in O 0 0.00882931798696518
the O 0 0.010560579597949982
case O 0 0.01770106889307499
of O 0 0.012360000982880592
a O 0 0.021307822316884995
female O 0 0.048816241323947906
transmitting O 0 0.09375113993883133
parent O 0 0.09010214358568192
, O 0 0.03307509422302246
68 O 0 0.08280791342258453
. O 0 0.051210060715675354

7 O 0 0.07486648112535477
% O 0 0.04504025727510452
were O 0 0.025806253775954247
affected O 0 0.07597260922193527
. O 0 0.047812338918447495

Studies O 0 0.07534129917621613
on O 0 0.03463026508688927
meiotic O 1 0.7761484980583191
drive O 0 0.07830644398927689
in O 0 0.03782331570982933
DM B-Disease 1 0.9999288320541382
have O 0 0.022636735811829567
shown O 0 0.03008362092077732
increased O 0 0.02803739160299301
transmission O 0 0.047011565417051315
of O 0 0.011255216784775257
the O 0 0.015671420842409134
larger O 0 0.031345050781965256
allele O 0 0.10182482749223709
at O 0 0.03295542672276497
the O 0 0.03422035276889801
DM B-Disease 1 0.9997772574424744
locus O 0 0.14738744497299194
in O 0 0.03616829216480255
non O 0 0.11641260981559753
- O 1 0.9899886250495911
DM O 1 0.9999771118164062
heterozygotes O 1 0.9734300971031189
for O 0 0.047432031482458115
CTGn O 1 0.5185325741767883
. O 0 0.05879320576786995

This O 0 0.03023354522883892
study O 0 0.03338702395558357
provides O 0 0.03291161730885506
further O 0 0.01981346867978573
evidence O 0 0.01790105737745762
that O 0 0.015494151972234249
the O 0 0.0290952417999506
DM B-Disease 1 0.9999310970306396
expansion O 0 0.06705781817436218
tends O 0 0.057639144361019135
to O 0 0.018798645585775375
be O 0 0.02326626516878605
transmitted O 0 0.09293864667415619
preferentially O 0 0.14593975245952606
. O 0 0.05741124227643013

Diagnosis O 1 0.9992427825927734
of O 0 0.0793052464723587
hemochromatosis B-Disease 1 0.9999523162841797
. O 0 0.0807720348238945

If O 0 0.09375955164432526
untreated O 1 0.9997060894966125
, O 0 0.3863065540790558
hemochromatosis B-Disease 1 0.9999995231628418
can O 0 0.1985282301902771
cause O 1 0.994929313659668
serious O 1 0.9765892624855042
illness O 1 0.9998539686203003
and O 0 0.017853587865829468
early B-Disease 0 0.02599678561091423
death I-Disease 0 0.029567968100309372
, O 0 0.01186460256576538
but O 0 0.012238265946507454
the O 0 0.017966991290450096
disease O 1 0.9993450045585632
is O 0 0.019679604098200798
still O 0 0.022536348551511765
substantially O 0 0.049111124128103256
under O 0 0.03376762568950653
- O 1 0.9560431241989136
diagnosed O 1 0.9998592138290405
. O 0 0.05900310352444649

The O 0 0.03610074520111084
cornerstone O 0 0.07070351392030716
of O 0 0.02066630870103836
screening O 0 0.06450396031141281
and O 0 0.018561137840151787
case O 0 0.02849435806274414
detection O 0 0.06275097280740738
is O 0 0.01327270083129406
the O 0 0.015817100182175636
measurement O 0 0.0445311963558197
of O 0 0.02785518206655979
serum O 1 0.9217127561569214
transferrin O 1 0.8662194609642029
saturation O 0 0.15110957622528076
and O 0 0.026295360177755356
the O 0 0.03787694871425629
serum O 1 0.8011740446090698
ferritin O 1 0.5916993618011475
level O 0 0.07768354564905167
. O 0 0.0478961206972599

Once O 0 0.06404799222946167
the O 0 0.038434773683547974
diagnosis O 1 0.9938198924064636
is O 0 0.027348019182682037
suspected O 0 0.06120740622282028
, O 0 0.024336937814950943
physicians O 0 0.1012272983789444
must O 0 0.028759529814124107
use O 0 0.03724224865436554
serum O 1 0.9666799902915955
ferritin O 1 0.9431260228157043
levels O 0 0.08327357470989227
and O 0 0.03502071276307106
hepatic O 1 0.9999598264694214
iron O 0 0.27703219652175903
stores O 0 0.042910486459732056
on O 0 0.03089294396340847
liver O 1 0.9996892213821411
biopsy O 1 0.9946954846382141
specimens O 0 0.054308582097291946
to O 0 0.02368933893740177
assess O 0 0.08466357737779617
patients O 1 0.8169130682945251
for O 0 0.014314083382487297
the O 0 0.0158339012414217
presence O 0 0.03711703419685364
of O 0 0.023679548874497414
iron B-Disease 0 0.37948670983314514
overload I-Disease 1 0.9701380133628845
. O 0 0.05764514207839966

Liver O 1 0.9997830986976624
biopsy O 1 0.9868341088294983
is O 0 0.02359425090253353
also O 0 0.013167308643460274
used O 0 0.011797772720456123
to O 0 0.010051882825791836
establish O 0 0.021986624225974083
the O 0 0.012792144902050495
presence O 0 0.028494546189904213
or O 0 0.02125747874379158
absence O 0 0.03994575887918472
of O 0 0.02382824942469597
cirrhosis B-Disease 1 0.9992637038230896
, O 0 0.022546691820025444
which O 0 0.018148941919207573
can O 0 0.023922128602862358
affect O 0 0.062083158642053604
prognosis O 1 0.9993293285369873
and O 0 0.028016556054353714
management O 0 0.06961546093225479
. O 0 0.041475579142570496

A O 0 0.062482453882694244
DNA O 0 0.07347345352172852
- O 0 0.06746038049459457
based O 0 0.028126325458288193
test O 0 0.033881306648254395
for O 0 0.014385946094989777
the O 0 0.024005180224776268
HFE O 1 0.9506879448890686
gene O 0 0.08026400208473206
is O 0 0.01719260774552822
commercially O 0 0.023759258911013603
available O 0 0.012345805764198303
, O 0 0.00865013338625431
but O 0 0.0075629763305187225
its O 0 0.007596305571496487
place O 0 0.011513108387589455
in O 0 0.011024988256394863
the O 0 0.019646551460027695
diagnosis O 1 0.9992449283599854
of O 0 0.03240261971950531
hemochromatosis B-Disease 1 0.9999862909317017
is O 0 0.02447359636425972
still O 0 0.022708717733621597
being O 0 0.022074468433856964
evaluated O 0 0.07353146374225616
. O 0 0.04003317281603813

Currently O 0 0.03263601288199425
, O 0 0.01666649430990219
the O 0 0.01180517952889204
most O 0 0.010984663851559162
useful O 0 0.01647692732512951
role O 0 0.014478234574198723
for O 0 0.007684985175728798
this O 0 0.009673230350017548
test O 0 0.019842738285660744
is O 0 0.009868629276752472
in O 0 0.009580334648489952
the O 0 0.014259153977036476
detection O 0 0.06313297897577286
of O 0 0.02284366451203823
hemochromatosis B-Disease 1 0.9998812675476074
in O 0 0.016771582886576653
the O 0 0.01429403480142355
family O 0 0.020988475531339645
members O 0 0.015222009271383286
of O 0 0.01313849724829197
patients O 1 0.8892298936843872
with O 0 0.013750608079135418
a O 0 0.019393324851989746
proven O 0 0.040396738797426224
case O 0 0.021457843482494354
of O 0 0.014475199393928051
the O 0 0.028123842552304268
disease O 1 0.9993757605552673
. O 0 0.05532672256231308

It O 0 0.026886530220508575
is O 0 0.020533742383122444
crucial O 0 0.04279168322682381
to O 0 0.036037880927324295
diagnose O 1 0.9999151229858398
hemochromatosis B-Disease 1 0.999998927116394
before O 1 0.8169832229614258
hepatic B-Disease 1 0.9999990463256836
cirrhosis I-Disease 1 0.9999973773956299
develops O 1 0.9991187453269958
because O 0 0.4429868757724762
phlebotomy O 1 0.9999778270721436
therapy O 1 0.999984860420227
can O 1 0.6073141694068909
avert O 1 0.9997144341468811
serious O 1 0.9998687505722046
chronic O 1 0.9999998807907104
disease O 1 0.9999887943267822
and O 0 0.0204106867313385
can O 0 0.017834916710853577
even O 0 0.015276758000254631
lead O 0 0.02493453584611416
to O 0 0.015109745785593987
normal O 0 0.041668135672807693
life O 0 0.034006256610155106
expectancy O 0 0.07855753600597382
. O 0 0.02912949025630951
. O 0 0.03870977833867073

Prevalence O 1 0.6341090202331543
of O 0 0.03441430255770683
the O 0 0.037146590650081635
I1307K O 1 0.5574930310249329
APC B-Disease 1 0.8870224952697754
gene O 0 0.12112530320882797
variant O 0 0.10087209194898605
in O 0 0.024292808026075363
Israeli O 0 0.034612350165843964
Jews O 0 0.02311263605952263
of O 0 0.011473890393972397
differing O 0 0.030668260529637337
ethnic O 0 0.030387137085199356
origin O 0 0.03441343829035759
and O 0 0.02684279903769493
risk O 1 0.9973049163818359
for O 0 0.12465646862983704
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999997615814209
. O 0 0.07414060086011887

BACKGROUND O 0 0.11530204862356186
& O 0 0.08882500231266022
AIMS O 0 0.07708416134119034
Israeli O 0 0.03967990353703499
Jews O 0 0.02646598406136036
of O 0 0.014513717964291573
European O 0 0.025665923953056335
birth O 0 0.04285424202680588
, O 0 0.01645609363913536
i O 0 0.01950293779373169
. O 0 0.016201937571167946
e O 0 0.04049243405461311
. O 0 0.012968352064490318
, O 0 0.016063576564192772
Ashkenazim O 0 0.10644453018903732
, O 0 0.016840634867548943
have O 0 0.014302745461463928
the O 0 0.01965354196727276
highest O 1 0.8966257572174072
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
incidence O 1 0.9979189038276672
of O 0 0.019592486321926117
any O 0 0.019953841343522072
Israeli O 0 0.03513425588607788
ethnic O 0 0.03483616188168526
group O 0 0.05357616767287254
. O 0 0.04426752030849457

The O 0 0.073384590446949
I1307K O 0 0.41350093483924866
APC B-Disease 1 0.8828515410423279
gene O 0 0.13876977562904358
variant O 0 0.1098400354385376
was O 0 0.02562965266406536
found O 0 0.024123990908265114
in O 0 0.0197348203510046
6 O 0 0.04922909662127495
. O 0 0.039785001426935196

1 O 0 0.051815424114465714
% O 0 0.03070865571498871
of O 0 0.014259322546422482
American O 0 0.024104967713356018
Jews O 0 0.025168847292661667
, O 0 0.015180163085460663
28 O 0 0.02445676177740097
% O 0 0.021829593926668167
of O 0 0.016705581918358803
their O 0 0.03941391408443451
familial O 1 0.999998927116394
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cases O 0 0.11980403959751129
, O 0 0.015211940743029118
but O 0 0.010273076593875885
not O 0 0.008594894781708717
in O 0 0.011761536821722984
non O 0 0.035086166113615036
- O 0 0.06714816391468048
Jews O 0 0.04538366198539734
. O 0 0.04391282796859741

We O 0 0.040531743317842484
assessed O 0 0.06579897552728653
the O 0 0.032934192568063736
I1307K O 0 0.21915404498577118
prevalence O 1 0.6044625639915466
in O 0 0.02184213697910309
Israeli O 0 0.032746050506830215
Jews O 0 0.02288123406469822
of O 0 0.012304662726819515
differing O 0 0.030587755143642426
ethnic O 0 0.027447927743196487
origin O 0 0.03494881093502045
and O 0 0.029541660100221634
risk O 1 0.99623042345047
for O 0 0.10292761027812958
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999973773956299
. O 0 0.07864222675561905

METHODS O 0 0.08758082985877991
DNA O 0 0.08324849605560303
samples O 0 0.05674055963754654
from O 0 0.023469340056180954
500 O 0 0.04118848219513893
unrelated O 0 0.05065874382853508
Jews O 0 0.028240922838449478
of O 0 0.012871147133409977
European O 0 0.02641117013990879
or O 0 0.022671829909086227
non O 0 0.033074751496315
- O 0 0.04598694294691086
European O 0 0.02435840107500553
origin O 0 0.02083982340991497
, O 0 0.011567117646336555
with O 0 0.011292481794953346
or O 0 0.014551536180078983
without O 0 0.013686221092939377
a O 0 0.015833735466003418
personal O 0 0.021500620990991592
and O 0 0.017070645466446877
/ O 0 0.43212777376174927
or O 0 0.01905100792646408
family O 0 0.024678749963641167
history O 0 0.024613646790385246
of O 0 0.02172739990055561
neoplasia B-Disease 1 0.9966921806335449
, O 0 0.01896519586443901
were O 0 0.011904224753379822
examined O 0 0.034816861152648926
for O 0 0.014452049508690834
the O 0 0.021549053490161896
I1307K O 0 0.10615632683038712
variant O 0 0.0814998522400856
by O 0 0.02134001813828945
the O 0 0.02643992379307747
allele O 0 0.1425333172082901
- O 0 0.09980122745037079
specific O 0 0.057271260768175125
oligonucleotide O 0 0.29419073462486267
( O 0 0.06692538410425186
ASO O 1 0.7158332467079163
) O 0 0.044762060046195984
method O 0 0.048284657299518585
. O 0 0.04275300353765488

RESULTS O 0 0.06731757521629333
In O 0 0.023191768676042557
persons O 0 0.033877696841955185
at O 0 0.027004610747098923
average O 0 0.04999992251396179
risk O 1 0.992398202419281
for O 0 0.05943789333105087
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999973773956299
, O 0 0.033266883343458176
I1307K O 0 0.14476121962070465
was O 0 0.020267968997359276
found O 0 0.020644716918468475
in O 0 0.017582565546035767
5 O 0 0.03643375262618065
. O 0 0.035432036966085434

0 O 0 0.07553844153881073
% O 0 0.03396918252110481
of O 0 0.01499511394649744
120 O 0 0.0320311114192009
European O 0 0.025187909603118896
and O 0 0.017782039940357208
1 O 0 0.038690198212862015
. O 0 0.036743197590112686

6 O 0 0.066859669983387
% O 0 0.03611750900745392
of O 0 0.01985970139503479
188 O 0 0.07564245909452438
non O 0 0.05703005939722061
- O 0 0.0823400616645813
European O 0 0.043868862092494965
Jews O 0 0.05105625465512276
( O 0 0.05871186405420303
P O 0 0.30499428510665894
= O 0 0.11317563056945801
0 O 0 0.060469236224889755
. O 0 0.025355609133839607
08 O 0 0.08893918246030807
) O 0 0.044802334159612656
. O 0 0.04108206927776337

It O 0 0.035268716514110565
occurred O 0 0.0552256777882576
in O 0 0.02339964546263218
15 O 0 0.039850231260061264
. O 0 0.03972838446497917

4 O 0 0.05947443097829819
% O 0 0.039186712354421616
of O 0 0.021508945152163506
52 O 0 0.0585104264318943
Ashkenazi O 0 0.15374645590782166
Israelis O 0 0.08912187069654465
with O 0 0.04698586463928223
familial O 1 0.9999628067016602
cancer B-Disease 1 0.9999905824661255
( O 0 0.18691585958003998
P O 1 0.9313691258430481
= O 0 0.1349990963935852
0 O 0 0.05643041431903839
. O 0 0.021365048363804817
02 O 0 0.20383194088935852
) O 0 0.021553194150328636
and O 0 0.010605845600366592
was O 0 0.011869993060827255
not O 0 0.012415602803230286
detected O 0 0.039677128195762634
in O 0 0.013137445785105228
51 O 0 0.04167764633893967
non O 0 0.0450441800057888
- O 0 0.05643879249691963
European O 0 0.038256462663412094
Jews O 0 0.03844365105032921
at O 0 0.032841168344020844
increased O 0 0.10035068541765213
cancer B-Disease 1 0.9999397993087769
risk O 1 0.9457627534866333
. O 0 0.05589775741100311

Colorectal B-Disease 1 0.9999722242355347
neoplasia I-Disease 1 0.9996427297592163
occurred O 0 0.09134086966514587
personally O 0 0.0516304075717926
or O 0 0.018443185836076736
in O 0 0.01073744148015976
the O 0 0.010832867585122585
families O 0 0.02017470821738243
of O 0 0.012274540960788727
13 O 0 0.02297092229127884
of O 0 0.017023831605911255
20 O 0 0.036712758243083954
Ashkenazi O 0 0.16104307770729065
I1307K O 0 0.348883718252182
carriers O 0 0.0749065950512886
, O 0 0.01659747213125229
8 O 0 0.01923159696161747
of O 0 0.008661012165248394
whom O 0 0.020736029371619225
also O 0 0.01029184553772211
had O 0 0.012110271491110325
a O 0 0.013404371216893196
personal O 0 0.017758352681994438
or O 0 0.017860010266304016
family O 0 0.026905639097094536
history O 0 0.026186641305685043
of O 0 0.028381530195474625
noncolonic O 1 0.9576095342636108
neoplasia B-Disease 1 0.9987618923187256
. O 0 0.07242035120725632

CONCLUSIONS O 0 0.10735739022493362
The O 0 0.04920007660984993
I1307K O 0 0.3516959249973297
APC O 1 0.8884491324424744
variant O 0 0.1354987621307373
may O 0 0.0369621142745018
represent O 0 0.02992124669253826
a O 0 0.03668210282921791
susceptibility O 1 0.9790600538253784
gene O 0 0.12811005115509033
for O 0 0.03197789192199707
colorectal B-Disease 1 0.9999809265136719
, I-Disease 0 0.019845090806484222
or I-Disease 0 0.01902603544294834
other I-Disease 0 0.013703365810215473
, I-Disease 0 0.0189803633838892
cancers I-Disease 1 0.997000515460968
in O 0 0.02002144791185856
Ashkenazi O 0 0.08910238742828369
Jews O 0 0.028208421543240547
, O 0 0.014941195957362652
and O 0 0.014562118798494339
partially O 0 0.04590132087469101
explains O 0 0.043371111154556274
the O 0 0.020484713837504387
higher O 0 0.05135036259889603
incidence O 1 0.9991618394851685
of O 0 0.07159746438264847
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999904632568359
in O 0 0.032282572239637375
European O 0 0.045063238590955734
Israelis O 0 0.08267556875944138
. O 0 0.04771476238965988

Systematic O 0 0.1311064213514328
analysis O 0 0.06197066232562065
of O 0 0.03854626789689064
coproporphyrinogen O 1 0.948251485824585
oxidase O 1 0.9669939875602722
gene O 0 0.33215251564979553
defects O 1 0.9609441161155701
in O 0 0.033750563859939575
hereditary B-Disease 1 0.9411923289299011
coproporphyria I-Disease 1 0.8981379270553589
and O 0 0.036110419780015945
mutation O 0 0.45163023471832275
update O 0 0.11569257080554962
. O 0 0.05046215280890465

Hereditary B-Disease 1 0.9795798063278198
coproporphyria I-Disease 1 0.9778044819831848
( O 0 0.09237263351678848
HC B-Disease 1 0.9980981945991516
) O 0 0.04281488433480263
is O 0 0.025834668427705765
an O 0 0.04133037105202675
acute O 1 0.9999940395355225
hepatic B-Disease 1 0.9999984502792358
porphyria I-Disease 1 0.999991774559021
with O 0 0.07459187507629395
autosomal O 1 0.9991681575775146
dominant O 1 0.5838162302970886
inheritance O 1 0.8439761400222778
caused O 1 0.5116608738899231
by O 0 0.04027499258518219
deficient B-Disease 1 0.6447915434837341
activity I-Disease 0 0.06454509496688843
of I-Disease 0 0.032278165221214294
coproporphyrinogen I-Disease 1 0.9698873162269592
III I-Disease 1 0.8347637057304382
oxidase I-Disease 1 0.7425371408462524
( O 0 0.06424129009246826
CPO O 0 0.14070524275302887
) O 0 0.04894790053367615
. O 0 0.039150357246398926

Clinical O 1 0.961760401725769
manifestations O 0 0.26915737986564636
of O 0 0.021640758961439133
the O 0 0.02724537067115307
disease O 1 0.9998905658721924
are O 0 0.02313314378261566
characterized O 0 0.42492517828941345
by O 0 0.03183009475469589
acute O 1 0.9999679327011108
attacks O 1 0.5300385355949402
of O 0 0.03945121169090271
neurological B-Disease 1 0.9999974966049194
dysfunction I-Disease 1 0.9999874830245972
often O 0 0.05349759757518768
precipitated O 1 0.8769579529762268
by O 0 0.028406426310539246
drugs O 0 0.1209002137184143
, O 0 0.029282717034220695
fasting O 0 0.2096710056066513
, O 0 0.03643826022744179
cyclical O 1 0.9905999302864075
hormonal O 1 0.9953944683074951
changes O 0 0.05384569615125656
, O 0 0.03358602151274681
or O 0 0.12414289265871048
infectious B-Disease 1 0.9999712705612183
diseases I-Disease 1 0.9999469518661499
. O 0 0.06342361122369766

Skin O 1 0.9999593496322632
photosensitivity O 1 0.9995262622833252
may O 0 0.04524571821093559
also O 0 0.01795658841729164
be O 0 0.014393080025911331
present O 0 0.028248146176338196
. O 0 0.03564423695206642

The O 0 0.034268561750650406
seven O 0 0.03786870464682579
exons O 0 0.09576988965272903
, O 0 0.024886932224035263
the O 0 0.02764206752181053
exon O 0 0.16157083213329315
/ O 0 0.3956998288631439
intron O 0 0.1735616773366928
boundaries O 0 0.030190501362085342
and O 0 0.01285028737038374
part O 0 0.01889844425022602
of O 0 0.014060460031032562
3 O 0 0.03526480868458748
noncoding O 0 0.11210528761148453
sequence O 0 0.03713954612612724
of O 0 0.013880059123039246
the O 0 0.019692672416567802
CPO O 0 0.0932547003030777
gene O 0 0.06758639961481094
were O 0 0.01634948141872883
systematically O 0 0.048675138503313065
analyzed O 0 0.04110061004757881
by O 0 0.017018796876072884
an O 0 0.02247108519077301
exon O 0 0.11072126775979996
- O 0 0.08955124020576477
by O 0 0.03628319501876831
- O 0 0.1363617330789566
exon O 0 0.22528508305549622
denaturing O 1 0.9409787058830261
gradient O 1 0.7375815510749817
gel O 1 0.9767424464225769
electrophoresis O 1 0.8174938559532166
( O 0 0.07420756667852402
DGGE O 1 0.590290367603302
) O 0 0.03445979580283165
strategy O 0 0.04257660731673241
followed O 0 0.025704434141516685
by O 0 0.01377962063997984
direct O 0 0.03366175666451454
sequencing O 0 0.05294966325163841
in O 0 0.01994900219142437
seven O 0 0.031606562435626984
unrelated O 0 0.0933241993188858
heterozygous O 1 0.7355788350105286
HC B-Disease 1 0.9998363256454468
patients O 1 0.998831570148468
from O 0 0.029200349003076553
France O 0 0.04501846060156822
, O 0 0.02072848193347454
Holland O 0 0.05618438497185707
, O 0 0.01469789445400238
and O 0 0.015295950695872307
Czech O 0 0.04675669968128204
Republic O 0 0.03968309611082077
. O 0 0.03953416272997856

Seven O 0 0.0657287985086441
novel O 0 0.0702425092458725
mutations O 0 0.10975116491317749
and O 0 0.01762147806584835
two O 0 0.016268469393253326
new O 0 0.027303284034132957
polymorphisms O 0 0.12016093730926514
were O 0 0.027819398790597916
detected O 0 0.10099504142999649
. O 0 0.04538564383983612

Among O 0 0.05092061683535576
these O 0 0.027879953384399414
mutations O 0 0.10124870389699936
two O 0 0.023000279441475868
are O 0 0.026572860777378082
missense O 0 0.1826367825269699
( O 0 0.04815627261996269
G197W O 0 0.12463823705911636
, O 0 0.027068667113780975
W427R O 0 0.09718979895114899
) O 0 0.022656720131635666
, O 0 0.011351238004863262
two O 0 0.011405997909605503
are O 0 0.014300904236733913
nonsense O 0 0.06435131281614304
( O 0 0.04474327340722084
Q306X O 0 0.10373517870903015
, O 0 0.0265472624450922
Q385X O 0 0.09096579998731613
) O 0 0.0202776025980711
, O 0 0.009872497990727425
two O 0 0.009559860453009605
are O 0 0.011163020506501198
small O 0 0.026458967477083206
deletions O 0 0.09336652606725693
( O 0 0.053606871515512466
662de14bp O 0 0.1670900285243988
; O 0 0.042720191180706024
1168del3bp O 0 0.12510745227336884
removing O 0 0.056645140051841736
a O 0 0.03515324741601944
glycine O 0 0.09741698950529099
at O 0 0.025133587419986725
position O 0 0.022659391164779663
390 O 0 0.059159327298402786
) O 0 0.019590524956583977
, O 0 0.009903375059366226
and O 0 0.008240516297519207
one O 0 0.011699226684868336
is O 0 0.01503060944378376
a O 0 0.02525109052658081
splicing O 0 0.12381643056869507
mutation O 0 0.30307987332344055
( O 0 0.06841680407524109
IVS1 O 1 0.9912306070327759
- O 1 0.7868437170982361
15c O 1 0.9865459203720093
- O 1 0.853627622127533
- O 1 0.6283543109893799
> O 0 0.4980422556400299
g O 0 0.09803923964500427
) O 0 0.027118802070617676
which O 0 0.015382825396955013
creates O 0 0.044711094349622726
a O 0 0.024121610447764397
new O 0 0.03307553753256798
acceptor O 0 0.1486665904521942
splice O 0 0.1826547086238861
site O 0 0.06552072614431381
. O 0 0.047695308923721313

The O 0 0.04055006057024002
pathological O 0 0.10203609615564346
significance O 0 0.035144004970788956
of O 0 0.01472537498921156
the O 0 0.021630210801959038
point O 0 0.03799908235669136
mutations O 0 0.13632410764694214
G197W O 0 0.1260712891817093
, O 0 0.024919290095567703
W427R O 0 0.08026747405529022
, O 0 0.013447017408907413
and O 0 0.009237519465386868
the O 0 0.012121014297008514
in O 0 0.017985299229621887
- O 0 0.08155832439661026
frame O 0 0.07856715470552444
deletion O 0 0.14491955935955048
390delGly O 0 0.11698100715875626
were O 0 0.017727205529808998
assessed O 0 0.03563013672828674
by O 0 0.012761445716023445
their O 0 0.01162080280482769
respective O 0 0.025734184309840202
expression O 0 0.030854742974042892
in O 0 0.012402448803186417
a O 0 0.01751633547246456
prokaryotic O 0 0.05445089936256409
system O 0 0.034820158034563065
using O 0 0.02341480925679207
site O 0 0.03545728325843811
- O 0 0.07528986036777496
directed O 0 0.05985773727297783
mutagenesis O 0 0.1949257254600525
. O 0 0.05981654301285744

These O 0 0.04695584997534752
mutations O 0 0.1387508064508438
resulted O 0 0.04652069881558418
in O 0 0.015250683762133121
the O 0 0.015655651688575745
absence O 0 0.037774331867694855
or O 0 0.020868105813860893
a O 0 0.0204271599650383
dramatic O 0 0.05400887504220009
decrease O 0 0.058499403297901154
of O 0 0.020512035116553307
CPO O 0 0.11984467506408691
activity O 0 0.06695237755775452
. O 0 0.04353366047143936

The O 0 0.03410075232386589
two O 0 0.02638559229671955
polymorphisms O 0 0.11682973057031631
were O 0 0.021352019160985947
localized O 0 0.08570542931556702
in O 0 0.022186074405908585
noncoding O 0 0.10484156757593155
part O 0 0.021989265456795692
of O 0 0.014064406976103783
the O 0 0.01821391098201275
gene O 0 0.07258343696594238
1 O 0 0.03189138323068619
) O 0 0.027529152110219002
a O 0 0.030268635600805283
C O 0 0.1187654659152031
/ O 0 0.4410502314567566
G O 0 0.10928530991077423
polymorphism O 0 0.08240313082933426
in O 0 0.01997188851237297
the O 0 0.025336837396025658
promotor O 0 0.46356692910194397
region O 0 0.05190261825919151
, O 0 0.02588881552219391
142 O 0 0.0774427279829979
bp O 0 0.09250390529632568
upstream O 0 0.0657273456454277
from O 0 0.025314936414361
the O 0 0.02580241672694683
transcriptional O 0 0.12220034748315811
initiation O 0 0.09888888895511627
site O 0 0.047675274312496185
( O 0 0.0535832904279232
- O 0 0.17267414927482605
142C O 1 0.8562600016593933
/ O 1 0.9035969376564026
G O 0 0.11157886683940887
) O 0 0.025143582373857498
, O 0 0.013113913126289845
and O 0 0.012653505429625511
2 O 0 0.024931659922003746
) O 0 0.02204020880162716
a O 0 0.020565582439303398
6 O 0 0.04186636582016945
bp O 0 0.08960580825805664
deletion O 0 0.12287072837352753
polymorphism O 0 0.08401670306921005
in O 0 0.01620594970881939
the O 0 0.015773415565490723
3 O 0 0.03381066769361496
noncoding O 0 0.10355320572853088
part O 0 0.02178175002336502
of O 0 0.013350493274629116
the O 0 0.02191193401813507
CPO O 0 0.1278151273727417
gene O 0 0.09418530762195587
, O 0 0.03199990466237068
574 O 0 0.137105330824852
bp O 0 0.0849308893084526
downstream O 0 0.0524146743118763
of O 0 0.01219162903726101
the O 0 0.012863820418715477
last O 0 0.017250552773475647
base O 0 0.02346305176615715
of O 0 0.012752803973853588
the O 0 0.021570395678281784
normal O 0 0.07529293745756149
termination O 1 0.717192530632019
codon O 0 0.1795298457145691
( O 0 0.07936148345470428
+ O 0 0.3690522313117981
574 O 0 0.48225000500679016
delATTCTT O 0 0.3494069576263428
) O 0 0.0597413145005703
. O 0 0.04269104450941086

Five O 0 0.05988983064889908
intragenic O 0 0.19213180243968964
dimorphisms O 0 0.12871479988098145
are O 0 0.017845511436462402
now O 0 0.016226153820753098
well O 0 0.013414565473794937
characterized O 0 0.03640783950686455
and O 0 0.009863599203526974
the O 0 0.011526340618729591
high O 0 0.021782996132969856
degree O 0 0.02901633270084858
of O 0 0.01773958094418049
allelic O 0 0.4954145848751068
heterogeneity O 0 0.13095307350158691
in O 0 0.02956053800880909
HC B-Disease 1 0.9897721409797668
is O 0 0.02058287151157856
demonstrated O 0 0.028755897656083107
with O 0 0.011050669476389885
seven O 0 0.015756303444504738
new O 0 0.016448266804218292
different O 0 0.015974337235093117
mutations O 0 0.07115612924098969
making O 0 0.016199976205825806
a O 0 0.014317239634692669
total O 0 0.01807071454823017
of O 0 0.01610652357339859
nineteen O 0 0.06492570042610168
CPO O 1 0.6808809041976929
gene B-Disease 0 0.2501874268054962
defects I-Disease 1 0.9569511413574219
reported O 0 0.0431603379547596
so O 0 0.02252349629998207
far O 0 0.023757148534059525
. O 0 0.02107037603855133
. O 0 0.03347022086381912

Coincidence O 0 0.09110260754823685
of O 0 0.01967947743833065
two O 0 0.021830664947628975
novel O 0 0.055660177022218704
arylsulfatase O 0 0.14634720981121063
A O 0 0.05397412180900574
alleles O 0 0.1725858449935913
and O 0 0.046499624848365784
mutation O 1 0.53274005651474
459 O 1 0.9037091732025146
+ O 1 0.7213331460952759
1G O 1 0.7922086715698242
> O 0 0.13079573214054108
A O 0 0.029337389394640923
within O 0 0.01958470605313778
a O 0 0.022547941654920578
family O 0 0.03690331429243088
with O 0 0.03542150929570198
metachromatic B-Disease 1 0.9974259734153748
leukodystrophy I-Disease 1 0.9998480081558228
: O 0 0.048844486474990845
molecular O 0 0.05234984681010246
basis O 0 0.023106036707758904
of O 0 0.024204310029745102
phenotypic O 0 0.11608165502548218
heterogeneity O 0 0.17920462787151337
. O 0 0.05798209831118584

In O 0 0.030483750626444817
a O 0 0.024603677913546562
family O 0 0.025720374658703804
with O 0 0.015338268131017685
three O 0 0.018065189942717552
siblings O 0 0.05622356757521629
, O 0 0.015336007811129093
one O 0 0.01736895553767681
developed O 0 0.03781640902161598
classical O 0 0.04893578961491585
late O 0 0.07276329398155212
infantile O 1 0.9999209642410278
metachromatic B-Disease 1 0.9998737573623657
leukodystrophy I-Disease 1 0.9999932050704956
( O 1 0.8805903792381287
MLD B-Disease 1 0.9999563694000244
) O 0 0.047905899584293365
, O 0 0.03129947930574417
fatal O 1 0.9564688801765442
at O 0 0.030295154079794884
age O 0 0.03303069621324539
5 O 0 0.026448793709278107
years O 0 0.017498519271612167
, O 0 0.014783850871026516
with O 0 0.02007432095706463
deficient O 1 0.8554509282112122
arylsulfatase O 0 0.38116568326950073
A O 0 0.044848065823316574
( O 0 0.054662395268678665
ARSA O 1 0.989619791507721
) O 0 0.03576897457242012
activity O 0 0.03448738530278206
and O 0 0.017530135810375214
increased O 0 0.04958753660321236
galactosylsulfatide O 1 0.9147783517837524
( O 0 0.08408155292272568
GS O 1 0.9994295239448547
) O 0 0.06686265766620636
excretion O 0 0.18196657299995422
. O 0 0.059349097311496735

The O 0 0.02511691302061081
two O 0 0.01801980286836624
other O 0 0.014620368368923664
siblings O 0 0.05789981409907341
, O 0 0.021525312215089798
apparently O 0 0.0417797677218914
healthy O 0 0.05848971754312515
at O 0 0.022870022803544998
12 O 0 0.02885924093425274
( O 0 0.03195333853363991
1 O 0 0.03195812925696373
/ O 0 0.09260064363479614
2 O 0 0.024694185703992844
) O 0 0.017348850145936012
and O 0 0.009320041164755821
15 O 0 0.015111157670617104
years O 0 0.011385150253772736
, O 0 0.008960030041635036
respectively O 0 0.014528858475387096
, O 0 0.00914104375988245
and O 0 0.008382814936339855
their O 0 0.009776819497346878
father O 0 0.02020327001810074
, O 0 0.015461004339158535
apparently O 0 0.036740683019161224
healthy O 0 0.0500117689371109
as O 0 0.013827486895024776
well O 0 0.015498654916882515
, O 0 0.019430136308073997
presented O 0 0.03862299025058746
ARSA O 1 0.9856247901916504
and O 0 0.0326552651822567
GS O 1 0.9777466654777527
values O 0 0.028935275971889496
within O 0 0.020015442743897438
the O 0 0.01507310289889574
range O 0 0.03975546732544899
of O 0 0.035211775451898575
MLD B-Disease 1 0.9999383687973022
patients O 1 0.9988335967063904
. O 0 0.06078376993536949

Mutation O 0 0.49126216769218445
screening O 0 0.11493444442749023
and O 0 0.02526787295937538
sequence O 0 0.046980876475572586
analysis O 0 0.03396002948284149
disclosed O 0 0.03993900492787361
the O 0 0.015855759382247925
involvement O 0 0.038390181958675385
of O 0 0.012965870089828968
three O 0 0.01806901954114437
different O 0 0.026681646704673767
ARSA O 1 0.9922389984130859
mutations O 0 0.1175282821059227
being O 0 0.018684769049286842
the O 0 0.016944512724876404
molecular O 0 0.04642532393336296
basis O 0 0.02390757016837597
of O 0 0.028115853667259216
intrafamilial O 0 0.197127103805542
phenotypic O 0 0.15885530412197113
heterogeneity O 0 0.21116162836551666
. O 0 0.06867431849241257

The O 0 0.05654431879520416
late O 0 0.08747284859418869
infantile O 1 0.9996705055236816
patient O 1 0.994691789150238
inherited O 0 0.26766595244407654
from O 0 0.02302059717476368
his O 0 0.022658158093690872
mother O 0 0.04114716872572899
the O 0 0.023376088589429855
frequent O 0 0.07743275910615921
0 O 0 0.08843883126974106
- O 0 0.13844315707683563
type O 0 0.12266206741333008
mutation O 1 0.726552426815033
459 O 1 0.9514268636703491
+ O 1 0.8128408789634705
1G O 1 0.920383870601654
> O 0 0.13008251786231995
A O 0 0.024683507159352303
, O 0 0.01182676013559103
and O 0 0.00983541738241911
from O 0 0.012311380356550217
his O 0 0.013896739110350609
father O 0 0.02518230304121971
a O 0 0.019040528684854507
novel O 0 0.02810233272612095
, O 0 0.017451060935854912
single O 0 0.034187059849500656
basepair O 0 0.13247829675674438
microdeletion O 0 0.1255156546831131
of O 0 0.02925090864300728
guanine O 0 0.10542316734790802
at O 0 0.042431946843862534
nucleotide O 0 0.08708078414201736
7 O 0 0.038558416068553925
in O 0 0.023228105157613754
exon O 0 0.12287171930074692
1 O 0 0.05256129056215286
( O 0 0.05735050514340401
7delG O 0 0.15583108365535736
) O 0 0.053354259580373764
. O 0 0.049221646040678024

The O 0 0.0380062460899353
two O 0 0.03400629758834839
clinically O 0 0.49457141757011414
unaffected O 0 0.14791664481163025
siblings O 0 0.09070126712322235
carried O 0 0.039180826395750046
the O 0 0.033657800406217575
maternal O 0 0.4086568355560303
mutation O 1 0.9287590980529785
459 O 1 0.9803227186203003
+ O 1 0.9436712265014648
1G O 1 0.9396229386329651
> O 0 0.12131386995315552
A O 0 0.021237671375274658
and O 0 0.01056010089814663
, O 0 0.010094992816448212
on O 0 0.010035011917352676
their O 0 0.016285518184304237
paternal O 0 0.07980156689882278
allele O 0 0.10246475040912628
, O 0 0.020376870408654213
a O 0 0.02165643312036991
novel O 0 0.04195390269160271
cytosine O 0 0.11197318881750107
to O 0 0.030613550916314125
thymidine O 0 0.16256147623062134
transition O 0 0.07269003987312317
at O 0 0.041246090084314346
nucleotide O 0 0.1229395866394043
2435 O 0 0.40197938680648804
in O 0 0.03308996558189392
exon O 0 0.10998675972223282
8 O 0 0.037411365658044815
, O 0 0.019459454342722893
resulting O 0 0.04045679420232773
in O 0 0.017484178766608238
substitution O 0 0.056268543004989624
of O 0 0.022877929732203484
alanine O 0 0.16430622339248657
464 O 0 0.18400363624095917
by O 0 0.04776008799672127
valine O 0 0.22546304762363434
( O 0 0.06832271814346313
A464V O 0 0.17137670516967773
) O 0 0.05908435210585594
. O 0 0.046642087399959564

The O 0 0.047549374401569366
fathers O 0 0.09916854649782181
genotype O 0 0.24983841180801392
thus O 0 0.04672852158546448
was O 0 0.045456767082214355
7delG O 1 0.7845857739448547
/ O 1 0.9345257878303528
A464V O 0 0.2172408103942871
. O 0 0.056820113211870193

Mutation O 1 0.5933907628059387
A464V O 0 0.1573796421289444
was O 0 0.02702883817255497
not O 0 0.014185141772031784
found O 0 0.018288075923919678
in O 0 0.017453227192163467
18 O 0 0.0367538258433342
unrelated O 0 0.4192972779273987
MLD B-Disease 1 0.999981164932251
patients O 1 0.9975662231445312
and O 0 0.023653622716665268
50 O 0 0.037388138473033905
controls O 0 0.06073283031582832
. O 0 0.04116787388920784

A464V O 0 0.19272346794605255
, O 0 0.03501047194004059
although O 0 0.03360870108008385
clearly O 0 0.051294274628162384
modifying O 0 0.13127753138542175
ARSA O 1 0.9979251623153687
and O 0 0.04527721554040909
GS O 1 0.9996401071548462
levels O 0 0.057234760373830795
, O 0 0.01859956793487072
apparently O 0 0.0372275710105896
bears O 0 0.043630313128232956
little O 0 0.02915407158434391
significance O 0 0.03041256219148636
for O 0 0.0194731205701828
clinical O 0 0.44189029932022095
manifestation O 0 0.1799449324607849
of O 0 0.04001055657863617
MLD B-Disease 1 0.9996812343597412
, O 0 0.04257367178797722
mimicking O 0 0.13315191864967346
the O 0 0.04045543074607849
frequent O 0 0.1416742503643036
ARSA O 1 0.9922577738761902
pseudodeficiency O 1 0.7864850163459778
allele O 0 0.25241997838020325
. O 0 0.0687788650393486

Our O 0 0.04213402792811394
results O 0 0.03994009271264076
demonstrate O 0 0.03514007478952408
that O 0 0.013292673975229263
in O 0 0.014625148847699165
certain O 0 0.02773689292371273
genetic O 0 0.12687000632286072
conditions O 1 0.8063126802444458
MLD B-Disease 1 0.999969482421875
- O 1 0.6135338544845581
like O 0 0.06536298990249634
ARSA O 1 0.9934980869293213
and O 0 0.0354846753180027
GS O 1 0.9933964014053345
values O 0 0.031113319098949432
need O 0 0.020708799362182617
not O 0 0.010866029188036919
be O 0 0.011999355629086494
paralleled O 0 0.06732767075300217
by O 0 0.028487563133239746
clinical O 1 0.9972328543663025
disease O 1 0.9998610019683838
, O 0 0.018800854682922363
a O 0 0.017933234572410583
finding O 0 0.02916688099503517
with O 0 0.020337805151939392
serious O 0 0.07751847803592682
diagnostic O 0 0.34628719091415405
and O 0 0.038647159934043884
prognostic O 1 0.9849050641059875
implications O 0 0.12752339243888855
. O 0 0.053991738706827164

Moreover O 0 0.09258680790662766
, O 0 0.039775554090738297
further O 0 0.055073853582143784
ARSA O 1 0.9852519035339355
alleles O 0 0.2036382108926773
functionally O 0 0.11277763545513153
similar O 0 0.03775481507182121
to O 0 0.022251809015870094
A464V O 0 0.10113293677568436
might O 0 0.02715054713189602
exist O 0 0.01585971936583519
which O 0 0.009420724585652351
, O 0 0.009601564146578312
together O 0 0.013093304820358753
with O 0 0.018393978476524353
0 O 0 0.061210859566926956
- O 0 0.13094565272331238
type O 0 0.09170227497816086
mutations O 0 0.38143637776374817
, O 0 0.02701035887002945
may O 0 0.04656132683157921
cause O 1 0.6285302042961121
pathological O 1 0.9932029247283936
ARSA O 1 0.9992907047271729
and O 0 0.04189341515302658
GS O 1 0.9997817873954773
levels O 0 0.05043625086545944
, O 0 0.017640555277466774
but O 0 0.01434460561722517
not O 0 0.017476709559559822
clinical O 1 0.8959836363792419
outbreak O 1 0.9725741744041443
of O 0 0.018081579357385635
the O 0 0.027865326032042503
disease O 1 0.9996616840362549
. O 0 0.03118961676955223
. O 0 0.04131869226694107

Human O 1 0.817939043045044
MLH1 O 1 0.9999374151229858
deficiency O 1 0.9999984502792358
predisposes O 1 0.9988534450531006
to O 0 0.08557910472154617
hematological B-Disease 1 0.9997237324714661
malignancy I-Disease 1 0.9998078942298889
and O 0 0.06808780133724213
neurofibromatosis B-Disease 1 0.9998977184295654
type I-Disease 0 0.11437880992889404
1 I-Disease 0 0.05133172497153282
. O 0 0.04741137847304344

Heterozygous O 0 0.476366251707077
germ O 1 0.9832534193992615
- O 0 0.1506912261247635
line O 0 0.0656203031539917
mutations O 0 0.11475619673728943
in O 0 0.023014985024929047
the O 0 0.026064883917570114
DNA O 0 0.08805237710475922
mismatch O 1 0.9190428853034973
repair O 1 0.620050311088562
genes O 0 0.10396435856819153
lead O 0 0.07161291688680649
to O 0 0.043452899903059006
hereditary B-Disease 1 0.9992185831069946
nonpolyposis I-Disease 1 0.9999518394470215
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999955892562866
. O 0 0.08897524327039719

The O 0 0.07126986235380173
disease O 1 0.9997953772544861
susceptibility O 1 0.8892037868499756
of O 0 0.02309710532426834
individuals O 0 0.03280271962285042
who O 0 0.02405162900686264
constitutionally O 0 0.045537982136011124
lack O 0 0.03194968029856682
both O 0 0.019754137843847275
wild O 0 0.054171882569789886
- O 0 0.08685510605573654
type O 0 0.08145882934331894
alleles O 0 0.15284501016139984
is O 0 0.033778805285692215
unknown O 0 0.0545385517179966
. O 0 0.04080711677670479

We O 0 0.027591733261942863
have O 0 0.01666310243308544
identified O 0 0.026134327054023743
three O 0 0.017573747783899307
offspring O 0 0.059366948902606964
in O 0 0.02357851341366768
a O 0 0.04517114907503128
hereditary B-Disease 1 0.9995425939559937
nonpolyposis I-Disease 1 0.9999841451644897
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
family O 0 0.08873122185468674
who O 0 0.04529585689306259
developed O 0 0.16847467422485352
hematological B-Disease 1 0.9998935461044312
malignancy I-Disease 1 0.9996709823608398
at O 0 0.02964259870350361
a O 0 0.017696360126137733
very O 0 0.014323155395686626
early O 0 0.01817178912460804
age O 0 0.019296687096357346
, O 0 0.0095614492893219
and O 0 0.007959719747304916
at O 0 0.010059640742838383
least O 0 0.010814988985657692
two O 0 0.006789420731365681
of O 0 0.007978199049830437
them O 0 0.00950703676789999
displayed O 0 0.026934079825878143
signs O 0 0.046207692474126816
of O 0 0.028729038313031197
neurofibromatosis B-Disease 1 0.9997995495796204
type I-Disease 0 0.0983356237411499
1 I-Disease 0 0.05276740714907646
( O 0 0.06166176497936249
NF1 B-Disease 1 0.9906851649284363
) O 0 0.050375938415527344
. O 0 0.044221267104148865

DNA O 0 0.11462122201919556
sequence O 0 0.06486577540636063
analysis O 0 0.04556962102651596
and O 0 0.025639835745096207
allele O 0 0.13167428970336914
- O 0 0.08372073620557785
specific O 0 0.03867170587182045
amplification O 0 0.08952966332435608
in O 0 0.017879199236631393
two O 0 0.01758887618780136
siblings O 0 0.07604757696390152
revealed O 0 0.0583084374666214
a O 0 0.05349350720643997
homozygous O 0 0.21574875712394714
MLH1 O 1 0.9969881176948547
mutation O 1 0.9440543055534363
( O 0 0.09461261332035065
C676T O 1 0.9215761423110962
- O 1 0.8771507143974304
- O 1 0.80157071352005
> O 1 0.7931720018386841
Arg226Stop O 1 0.5087288022041321
) O 0 0.060822874307632446
. O 0 0.0466979444026947

Thus O 0 0.045688092708587646
, O 0 0.02625587210059166
a O 0 0.03702455759048462
homozygous O 0 0.2912753224372864
germ O 1 0.9966731071472168
- O 0 0.2864907383918762
line O 0 0.07997157424688339
MLH1 O 1 0.998630166053772
mutation O 1 0.9407867789268494
and O 0 0.05038207769393921
consequent O 1 0.9953970313072205
mismatch O 1 0.9994397759437561
repair O 1 0.9996868371963501
deficiency O 1 0.9999896287918091
results O 0 0.05653929337859154
in O 0 0.027611667290329933
a O 0 0.04679209738969803
mutator O 1 0.9983720183372498
phenotype O 1 0.9980006814002991
characterized O 1 0.9629849195480347
by O 0 0.05140727758407593
leukemia B-Disease 1 0.9999991655349731
and O 0 0.06480719149112701
/ O 1 0.9998565912246704
or O 1 0.7467494010925293
lymphoma B-Disease 1 0.9999997615814209
associated O 0 0.06816340237855911
with O 0 0.04485699161887169
neurofibromatosis B-Disease 1 0.9998880624771118
type I-Disease 0 0.08254901319742203
1 I-Disease 0 0.03904147446155548
. O 0 0.024385659024119377
. O 0 0.03688940033316612

Missense O 1 0.7320009469985962
mutations O 0 0.1501360982656479
in O 0 0.021309491246938705
the O 0 0.014751431532204151
most O 0 0.014255334623157978
ancient O 0 0.023666488006711006
residues O 0 0.04426204785704613
of O 0 0.017224524170160294
the O 0 0.025327583774924278
PAX6 O 1 0.9868919253349304
paired O 0 0.09706268459558487
domain O 0 0.06672464311122894
underlie O 0 0.10921899229288101
a O 0 0.02810974419116974
spectrum O 0 0.055519409477710724
of O 0 0.02271421067416668
human O 0 0.27867045998573303
congenital B-Disease 1 0.9999990463256836
eye I-Disease 1 0.999880313873291
malformations I-Disease 1 0.9998399019241333
. O 0 0.06521892547607422

Mutations O 0 0.16851674020290375
of O 0 0.026526743546128273
the O 0 0.030892767012119293
human O 0 0.07471754401922226
PAX6 O 1 0.9988521337509155
gene O 1 0.9322123527526855
underlie O 1 0.9974143505096436
aniridia B-Disease 1 0.9997699856758118
( O 1 0.6360880136489868
congenital B-Disease 1 0.9999805688858032
absence I-Disease 0 0.05986780300736427
of I-Disease 0 0.016200600191950798
the I-Disease 0 0.02025616727769375
iris I-Disease 1 0.632527768611908
) O 0 0.0221540667116642
, O 0 0.013667425140738487
a O 0 0.019486641511321068
rare O 0 0.04487987980246544
dominant O 0 0.07214140146970749
malformation B-Disease 1 0.9959583878517151
of I-Disease 0 0.021460801362991333
the I-Disease 0 0.028615646064281464
eye I-Disease 1 0.8510318994522095
. O 0 0.051327742636203766

The O 0 0.04599500074982643
spectrum O 0 0.09267029166221619
of O 0 0.03877067565917969
PAX6 O 1 0.9987194538116455
mutations O 1 0.8349348306655884
in O 0 0.04328349977731705
aniridia B-Disease 1 0.9988110065460205
patients O 1 0.9958589673042297
is O 0 0.02312668226659298
highly O 0 0.02968568354845047
biased O 0 0.04532330483198166
, O 0 0.013889878988265991
with O 0 0.01537526398897171
92 O 0 0.0413459949195385
% O 0 0.02108195796608925
of O 0 0.009668590500950813
all O 0 0.011129929684102535
reported O 0 0.03835071623325348
mutations O 0 0.09811042249202728
leading O 0 0.029644835740327835
to O 0 0.022026563063263893
premature O 0 0.20024248957633972
truncation O 0 0.09441063553094864
of O 0 0.016232458874583244
the O 0 0.02130833826959133
protein O 0 0.06147143989801407
( O 0 0.04272681102156639
nonsense O 0 0.06283440440893173
, O 0 0.021910110488533974
splicing O 0 0.08801940083503723
, O 0 0.022574085742235184
insertions O 0 0.09102371335029602
and O 0 0.022797314450144768
deletions O 0 0.08190009742975235
) O 0 0.023306258022785187
and O 0 0.012382815591990948
just O 0 0.017760805785655975
2 O 0 0.021098649129271507
% O 0 0.019402990117669106
leading O 0 0.02094937488436699
to O 0 0.012173530645668507
substitution O 0 0.037853047251701355
of O 0 0.012800795026123524
one O 0 0.01820334792137146
amino O 0 0.05528319627046585
acid O 0 0.08870250731706619
by O 0 0.024535708129405975
another O 0 0.0416877306997776
( O 0 0.05701287090778351
missense O 0 0.19983787834644318
) O 0 0.05768216773867607
. O 0 0.045183006674051285

The O 0 0.038372378796339035
extraordinary O 0 0.058136917650699615
conservation O 0 0.04547015577554703
of O 0 0.016215963289141655
the O 0 0.029868710786104202
PAX6 O 1 0.9545741081237793
protein O 0 0.0704423189163208
at O 0 0.024039510637521744
the O 0 0.01825292780995369
amino O 0 0.06343565881252289
acid O 0 0.10018489509820938
level O 0 0.041396383196115494
amongst O 0 0.04418625310063362
vertebrates O 0 0.08868391066789627
predicts O 0 0.1027827113866806
that O 0 0.032203227281570435
pathological O 1 0.8332882523536682
missense O 1 0.9348217248916626
mutations O 0 0.18746572732925415
should O 0 0.01957876980304718
in O 0 0.011460058391094208
fact O 0 0.01534290798008442
be O 0 0.00936559122055769
common O 0 0.018847806379199028
even O 0 0.014036161825060844
though O 0 0.014319333247840405
they O 0 0.009537482634186745
are O 0 0.01182785164564848
hardly O 0 0.039931949228048325
ever O 0 0.022994523867964745
seen O 0 0.03479713946580887
in O 0 0.02988876774907112
aniridia B-Disease 1 0.997833788394928
patients O 1 0.9974433183670044
. O 0 0.05489616468548775

This O 0 0.02926214039325714
indicates O 0 0.03836680203676224
that O 0 0.011157120577991009
there O 0 0.011737627908587456
is O 0 0.013924785889685154
a O 0 0.023110385984182358
heavy O 0 0.07090108841657639
ascertainment O 1 0.645430862903595
bias O 0 0.0735359638929367
in O 0 0.01588604226708412
the O 0 0.012929926626384258
selection O 0 0.02702888287603855
of O 0 0.019671382382512093
patients O 1 0.9920209050178528
for O 0 0.033664099872112274
PAX6 O 1 0.9979792237281799
mutation O 0 0.1948101967573166
analysis O 0 0.03541326895356178
and O 0 0.014244912192225456
that O 0 0.012655150145292282
the O 0 0.024090180173516273
missing O 0 0.08364377915859222
PAX6 O 1 0.9983558058738708
missense O 1 0.9728953242301941
mutations O 1 0.7006592154502869
frequently O 0 0.0701286643743515
may O 0 0.058122724294662476
underlie O 1 0.8278512954711914
phenotypes O 0 0.38935866951942444
distinct O 0 0.061176929622888565
from O 0 0.040529780089855194
textbook O 0 0.11048033088445663
aniridia B-Disease 1 0.9700750708580017
. O 0 0.06947352737188339

Here O 0 0.032739680260419846
we O 0 0.018427934497594833
present O 0 0.02224251627922058
four O 0 0.028610948473215103
novel O 0 0.07512025535106659
PAX6 O 1 0.9948855042457581
missense O 1 0.812340259552002
mutations O 0 0.13434866070747375
, O 0 0.01860973611474037
two O 0 0.012094811536371708
in O 0 0.015081181190907955
association O 0 0.040682390332221985
with O 0 0.03136925399303436
atypical O 1 0.9958893656730652
phenotypes O 1 0.9850132465362549
ectopia B-Disease 1 0.9796491265296936
pupillae I-Disease 1 0.9590821266174316
( O 0 0.05698392912745476
displaced B-Disease 0 0.09106763452291489
pupils I-Disease 0 0.08056459575891495
) O 0 0.048295121639966965
and O 0 0.0422685369849205
congenital B-Disease 1 0.9999951124191284
nystagmus I-Disease 1 0.9997851252555847
( O 0 0.057613957673311234
searching B-Disease 0 0.06034716218709946
gaze I-Disease 0 0.09697028994560242
) O 0 0.021505076438188553
, O 0 0.00993235781788826
and O 0 0.007684352807700634
two O 0 0.007723392453044653
in O 0 0.010987512767314911
association O 0 0.028857404366135597
with O 0 0.01748272217810154
more O 0 0.023353809490799904
recognizable O 0 0.1085791066288948
aniridia B-Disease 1 0.9790827631950378
phenotypes O 1 0.6799450516700745
. O 0 0.06919704377651215

Strikingly O 0 0.11915712058544159
, O 0 0.024423744529485703
all O 0 0.015284951776266098
four O 0 0.020652035251259804
mutations O 0 0.0836154893040657
are O 0 0.014215948060154915
located O 0 0.024980660527944565
within O 0 0.020998146384954453
the O 0 0.024679748341441154
PAX6 O 1 0.9471303224563599
paired O 0 0.09297440946102142
domain O 0 0.04679320380091667
and O 0 0.02036377601325512
affect O 0 0.0517038032412529
amino O 0 0.05252014473080635
acids O 0 0.0432313047349453
which O 0 0.01258841436356306
are O 0 0.009543709456920624
highly O 0 0.021574493497610092
conserved O 0 0.026711391285061836
in O 0 0.012356532737612724
all O 0 0.012554019689559937
known O 0 0.026971394196152687
paired O 0 0.0766075998544693
domain O 0 0.05621584504842758
proteins O 0 0.07139363139867783
. O 0 0.049812909215688705

Our O 0 0.03571578487753868
results O 0 0.03275378420948982
support O 0 0.019911158829927444
the O 0 0.01279634889215231
hypothesis O 0 0.035652510821819305
that O 0 0.009957804344594479
the O 0 0.01072189211845398
under O 0 0.017405454069375992
- O 0 0.05117832496762276
representation O 0 0.03165534511208534
of O 0 0.02787410095334053
missense O 1 0.8408597111701965
mutations O 0 0.428628146648407
is O 0 0.029282845556735992
caused O 0 0.07218070328235626
by O 0 0.027475029230117798
ascertainment O 1 0.9524399042129517
bias O 0 0.08481865376234055
and O 0 0.018360774964094162
suggest O 0 0.029292212799191475
that O 0 0.012748735025525093
a O 0 0.019190983846783638
substantial O 0 0.040834568440914154
burden O 0 0.12114071846008301
of O 0 0.03216055780649185
PAX6 B-Disease 1 0.9999737739562988
- I-Disease 1 0.9933885335922241
related I-Disease 0 0.46481889486312866
disease I-Disease 1 0.9998766183853149
remains O 0 0.030218694359064102
to O 0 0.014552515000104904
be O 0 0.012850717641413212
uncovered O 0 0.049859948456287384
. O 0 0.0240961704403162
. O 0 0.03353559970855713

The O 0 0.04532153904438019
chromosomal O 0 0.13797786831855774
order O 0 0.029593590646982193
of O 0 0.019854003563523293
genes O 0 0.06281762570142746
controlling O 0 0.06278780847787857
the O 0 0.025311175733804703
major O 0 0.04582275450229645
histocompatibility O 1 0.9880481958389282
complex O 0 0.05526651814579964
, O 0 0.027712952345609665
properdin O 0 0.4404606819152832
factor O 0 0.0731872022151947
B O 0 0.07996297627687454
, O 0 0.01652486063539982
and O 0 0.016764352098107338
deficiency B-Disease 1 0.9997385144233704
of I-Disease 0 0.014601913280785084
the I-Disease 0 0.014282080344855785
second I-Disease 0 0.023006584495306015
component I-Disease 0 0.042803339660167694
of I-Disease 0 0.020833492279052734
complement I-Disease 0 0.06236869469285011
. O 0 0.0445299856364727

The O 0 0.03249216824769974
relationship O 0 0.03915831819176674
of O 0 0.015360580757260323
the O 0 0.022078176960349083
genes O 0 0.07211663573980331
coding O 0 0.08828966319561005
for O 0 0.023311853408813477
HLA O 1 0.9576716423034668
to O 0 0.018877968192100525
those O 0 0.019972071051597595
coding O 0 0.0813995897769928
for O 0 0.02522176504135132
properdin O 1 0.518419086933136
Factor O 0 0.09622079133987427
B O 0 0.10364832729101181
allotypes O 0 0.2192085087299347
and O 0 0.019120018929243088
for O 0 0.019873879849910736
deficiency B-Disease 1 0.9997426867485046
of I-Disease 0 0.013493211008608341
the I-Disease 0 0.013332170434296131
second I-Disease 0 0.023234859108924866
component I-Disease 0 0.03795500472187996
of I-Disease 0 0.017114752903580666
complement I-Disease 0 0.0609884187579155
( O 0 0.04941876232624054
C2 O 1 0.9831142425537109
) O 0 0.02884279564023018
was O 0 0.014768787659704685
studied O 0 0.020217308774590492
in O 0 0.013992221094667912
families O 0 0.027149276807904243
of O 0 0.021476998925209045
patients O 1 0.9993357062339783
with O 0 0.05433318018913269
connective O 1 0.9999549388885498
tissue O 1 0.9998676776885986
disorders O 1 0.9999814033508301
. O 0 0.06990069150924683

Patients O 1 0.9507066607475281
were O 0 0.019522693008184433
selected O 0 0.023747384548187256
because O 0 0.017050815746188164
they O 0 0.010221184231340885
were O 0 0.013757736422121525
heterozygous O 0 0.08547471463680267
or O 0 0.037274930626153946
homozygous O 0 0.17659133672714233
for O 0 0.05144374817609787
C2 B-Disease 1 0.9999974966049194
deficiency I-Disease 1 0.9999990463256836
. O 0 0.08591220527887344

12 O 0 0.05054658278822899
families O 0 0.043255843222141266
with O 0 0.026407405734062195
15 O 0 0.04059508070349693
matings O 0 0.1985611766576767
informative O 0 0.09373423457145691
for O 0 0.049700651317834854
C2 B-Disease 1 0.9999947547912598
deficiency I-Disease 1 0.9999961853027344
were O 0 0.039086099714040756
found O 0 0.03894229978322983
. O 0 0.03845232352614403

Of O 0 0.04062686488032341
57 O 0 0.07602161914110184
informative O 0 0.07494495809078217
meioses O 0 0.10780350863933563
, O 0 0.02000392973423004
two O 0 0.01706225611269474
crossovers O 0 0.058062586933374405
were O 0 0.0153576098382473
noted O 0 0.024377085268497467
between O 0 0.028439322486519814
the O 0 0.04254230111837387
C2 B-Disease 1 0.9999977350234985
deficiency I-Disease 1 0.9999984502792358
gene O 0 0.12608613073825836
and O 0 0.022937336936593056
the O 0 0.028471171855926514
HLA O 1 0.9995037317276001
- O 0 0.19287332892417908
B O 0 0.10809341073036194
gene O 0 0.06555347889661789
, O 0 0.014367256313562393
with O 0 0.01525048166513443
a O 0 0.023542992770671844
recombinant O 0 0.09777089208364487
fraction O 0 0.05359729379415512
of O 0 0.023534566164016724
0 O 0 0.06508012115955353
. O 0 0.03917916491627693

035 O 1 0.8867002129554749
. O 0 0.09905650466680527

A O 0 0.0748383179306984
lod O 0 0.2039620578289032
score O 0 0.03313823416829109
of O 0 0.013615294359624386
13 O 0 0.025520337745547295
was O 0 0.019120529294013977
calculated O 0 0.03289907053112984
for O 0 0.02405383437871933
linkage O 0 0.3727628290653229
between O 0 0.07504566013813019
C2 B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999997615814209
and O 0 0.05844809487462044
HLA O 1 0.9997835755348206
- O 0 0.1319265514612198
B O 0 0.08221655339002609
at O 0 0.024091528728604317
a O 0 0.018803324550390244
maximum O 0 0.031537845730781555
likelihood O 0 0.04584496468305588
value O 0 0.013640946708619595
of O 0 0.009978532791137695
the O 0 0.016220873221755028
recombinant O 0 0.07949758321046829
fraction O 0 0.05184206739068031
of O 0 0.020669205114245415
0 O 0 0.06730133295059204
. O 0 0.04262164607644081

04 O 1 0.7978726625442505
. O 0 0.08503862470388412

18 O 0 0.058387160301208496
families O 0 0.047410253435373306
with O 0 0.024664733558893204
21 O 0 0.043824974447488785
informative O 0 0.06385765969753265
matings O 0 0.12467247992753983
for O 0 0.02266118675470352
both O 0 0.0297000240534544
properdin O 0 0.3173304796218872
Factor O 0 0.10672872513532639
B O 0 0.1303779035806656
allotype O 1 0.5771191716194153
and O 0 0.04121993109583855
HLA O 1 0.9989826083183289
- O 0 0.11220738291740417
B O 0 0.0848490446805954
were O 0 0.019358456134796143
found O 0 0.030575377866625786
. O 0 0.03534558787941933

Of O 0 0.042344480752944946
72 O 0 0.08240219950675964
informative O 0 0.07265833020210266
meioses O 0 0.11861984431743622
, O 0 0.017716646194458008
three O 0 0.018271135166287422
recombinants O 0 0.07940458506345749
were O 0 0.013371141627430916
found O 0 0.016561493277549744
, O 0 0.011674508452415466
giving O 0 0.023333637043833733
a O 0 0.02089308388531208
recombinant O 0 0.09157340973615646
fraction O 0 0.04907703027129173
of O 0 0.023558231070637703
0 O 0 0.0726509839296341
. O 0 0.04063541814684868

042 O 0 0.3721967935562134
. O 0 0.08894791454076767

A O 0 0.0709514245390892
lod O 0 0.1847175508737564
score O 0 0.031275127083063126
of O 0 0.016279470175504684
16 O 0 0.029156871140003204
between O 0 0.032251350581645966
HLA O 1 0.9989859461784363
- O 0 0.11397441476583481
B O 0 0.09027815610170364
and O 0 0.025714226067066193
Factor O 0 0.06998761743307114
B O 0 0.09074581414461136
allotypes O 0 0.10480085015296936
was O 0 0.020837638527154922
calculated O 0 0.030711187049746513
at O 0 0.017651408910751343
a O 0 0.01712542399764061
maximum O 0 0.028520386666059494
likelihood O 0 0.040880344808101654
value O 0 0.015688017010688782
of O 0 0.010531441308557987
the O 0 0.016948653385043144
recombinant O 0 0.08928297460079193
fraction O 0 0.05309661105275154
of O 0 0.02448013424873352
0 O 0 0.06938645988702774
. O 0 0.04024510830640793

04 O 1 0.7036006450653076
. O 0 0.08991186320781708

A O 0 0.0559549443423748
crossover O 0 0.07454909384250641
was O 0 0.018383169546723366
shown O 0 0.023858947679400444
to O 0 0.011606061831116676
have O 0 0.012451358139514923
occurred O 0 0.03054369054734707
between O 0 0.01912534609436989
genes O 0 0.04801363870501518
for O 0 0.020229537039995193
Factor O 0 0.06187615171074867
B O 0 0.0990196093916893
and O 0 0.03056143969297409
HLA O 1 0.9994358420372009
- O 0 0.252679705619812
D O 0 0.19539597630500793
, O 0 0.01910574547946453
in O 0 0.016063900664448738
which O 0 0.025207139551639557
HLA O 1 0.9994640946388245
- O 1 0.6605122089385986
D O 1 0.930314838886261
segregared O 1 0.6748778820037842
with O 0 0.039617154747247696
HLA O 1 0.9976293444633484
- O 0 0.08996451646089554
A O 0 0.03891859948635101
and O 0 0.03061225637793541
B O 0 0.11368484795093536
. O 0 0.04855978488922119

These O 0 0.02969266101717949
studies O 0 0.04053044319152832
suggest O 0 0.0312329288572073
that O 0 0.01226368360221386
the O 0 0.015627583488821983
genes O 0 0.051602039486169815
for O 0 0.02031233161687851
Factor O 0 0.07730447500944138
B O 0 0.4718056917190552
and O 0 0.043333329260349274
C2 B-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999963045120239
are O 0 0.01881188526749611
located O 0 0.022543953731656075
outside O 0 0.016264118254184723
those O 0 0.01178954727947712
for O 0 0.015500861220061779
HLA O 1 0.9473246335983276
, O 0 0.014090867713093758
that O 0 0.009004021063446999
the O 0 0.009953001514077187
order O 0 0.013443385250866413
of O 0 0.01614856906235218
genese O 0 0.18138551712036133
is O 0 0.02857440896332264
HLA O 1 0.9965143799781799
- O 0 0.07446122914552689
A O 0 0.03125704824924469
, O 0 0.02279650606215
- O 0 0.08311460167169571
B O 0 0.08773478120565414
, O 0 0.026548216119408607
- O 0 0.10884100943803787
D O 0 0.4643608331680298
, O 0 0.03667615354061127
Factor O 0 0.10422748327255249
B O 0 0.33052316308021545
allotype O 1 0.98920738697052
, O 0 0.08565182983875275
C2 B-Disease 1 0.9999966621398926
deficiency I-Disease 1 0.9999959468841553
, O 0 0.025616830214858055
that O 0 0.014684074558317661
the O 0 0.021874696016311646
genes O 0 0.07917553931474686
coding O 0 0.13954253494739532
for O 0 0.05201738700270653
C2 B-Disease 1 0.9999973773956299
deficiency I-Disease 1 0.9999982118606567
and O 0 0.04162327200174332
Factor O 0 0.09494083374738693
B O 0 0.10209633409976959
allotypes O 0 0.11384498327970505
are O 0 0.016728248447179794
approximately O 0 0.028405774384737015
3 O 0 0.03851650655269623
- O 0 0.07062559574842453
- O 0 0.07662328332662582
5 O 0 0.04398468881845474
centimorgans O 0 0.0996357798576355
from O 0 0.02247040532529354
the O 0 0.025436576455831528
HLA O 1 0.9976086616516113
- O 0 0.08128513395786285
A O 0 0.032804325222969055
and O 0 0.03229479119181633
HLA O 1 0.9995027780532837
- O 0 0.21201707422733307
B O 0 0.11888877302408218
loci O 0 0.10232163220643997
, O 0 0.013530442491173744
and O 0 0.010042190551757812
that O 0 0.00974875409156084
the O 0 0.014087634161114693
apparent O 0 0.046447742730379105
lack O 0 0.03102421946823597
of O 0 0.0168694369494915
recombinants O 0 0.09454246610403061
between O 0 0.023567408323287964
the O 0 0.026118658483028412
Factor O 0 0.09601365029811859
B O 0 0.4354158937931061
gene O 0 0.4593092203140259
and O 0 0.07727338373661041
C2 B-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999995231628418
gene O 0 0.34787189960479736
suggests O 0 0.04131172224879265
that O 0 0.012208075262606144
these O 0 0.009266183711588383
two O 0 0.011298530735075474
genes O 0 0.042697686702013016
lie O 0 0.0358186811208725
in O 0 0.014603910967707634
close O 0 0.024170365184545517
proximity O 0 0.03337755426764488
to O 0 0.012552033178508282
one O 0 0.014446726068854332
another O 0 0.027591388672590256
. O 0 0.033142488449811935

Distribution O 0 0.05978802219033241
of O 0 0.027330715209245682
emerin O 0 0.12696518003940582
and O 0 0.026337604969739914
lamins O 1 0.777778148651123
in O 0 0.01725408434867859
the O 0 0.019697654992341995
heart O 0 0.22962714731693268
and O 0 0.01816994696855545
implications O 0 0.0634203851222992
for O 0 0.027921494096517563
Emery B-Disease 1 0.9976033568382263
- I-Disease 1 0.9969756603240967
Dreifuss I-Disease 1 0.9999240636825562
muscular I-Disease 1 0.9999741315841675
dystrophy I-Disease 1 0.9999942779541016
. O 0 0.09441621601581573

Emerin O 0 0.18040762841701508
is O 0 0.029141323640942574
a O 0 0.028032654896378517
nuclear O 0 0.04898587986826897
membrane O 0 0.0718013271689415
protein O 0 0.04740303009748459
which O 0 0.014675096608698368
is O 0 0.014408375136554241
missing O 0 0.03405076265335083
or O 0 0.028871707618236542
defective O 0 0.3293149769306183
in O 0 0.037624161690473557
Emery B-Disease 1 0.9972724318504333
- I-Disease 1 0.9986770749092102
Dreifuss I-Disease 1 0.9999301433563232
muscular I-Disease 1 0.9999935626983643
dystrophy I-Disease 1 0.9999991655349731
( O 1 0.6033775210380554
EDMD B-Disease 1 0.9987284541130066
) O 0 0.058018963783979416
. O 0 0.04580129683017731

It O 0 0.022940445691347122
is O 0 0.013919115997850895
one O 0 0.011771317571401596
member O 0 0.0154415937140584
of O 0 0.009712052531540394
a O 0 0.01610712893307209
family O 0 0.02793300151824951
of O 0 0.0211004801094532
lamina O 1 0.9959774613380432
- O 0 0.08896113187074661
associated O 0 0.04018092527985573
proteins O 0 0.04325246810913086
which O 0 0.01809754967689514
includes O 0 0.030942320823669434
LAP1 O 0 0.36601054668426514
, O 0 0.030812526121735573
LAP2 O 1 0.5095075964927673
and O 0 0.04349812492728233
lamin O 1 0.967173159122467
B O 1 0.6258671879768372
receptor O 1 0.8444498181343079
( O 0 0.09532042592763901
LBR O 1 0.9977797865867615
) O 0 0.06704426556825638
. O 0 0.05302749574184418

A O 0 0.04707682505249977
panel O 0 0.055046096444129944
of O 0 0.028536535799503326
16 O 0 0.062174320220947266
monoclonal O 1 0.8395615220069885
antibodies O 1 0.8473321795463562
( O 0 0.07033118605613708
mAbs O 1 0.827577531337738
) O 0 0.025669869035482407
has O 0 0.012393089942634106
been O 0 0.01188238337635994
mapped O 0 0.03135237470269203
to O 0 0.011235921643674374
six O 0 0.015481188893318176
specific O 0 0.018066922202706337
sites O 0 0.0178390946239233
throughout O 0 0.020989712327718735
the O 0 0.022982969880104065
emerin O 0 0.13567164540290833
molecule O 0 0.10088726878166199
using O 0 0.04471803829073906
phage O 1 0.9781349897384644
- O 0 0.09299126267433167
displayed O 0 0.05466848239302635
peptide O 0 0.09090688824653625
libraries O 0 0.02669215388596058
and O 0 0.010767071507871151
has O 0 0.010223056189715862
been O 0 0.008636115118861198
used O 0 0.01345399022102356
to O 0 0.01806020550429821
localize O 0 0.1257523000240326
emerin O 0 0.11098463088274002
in O 0 0.023453351110219955
human O 0 0.0335705503821373
and O 0 0.030048761516809464
rabbit O 1 0.9411073327064514
heart O 1 0.9552128911018372
. O 0 0.05320471525192261

Several O 0 0.05884525924921036
mAbs O 0 0.41130927205085754
against O 0 0.046718306839466095
different O 0 0.037517983466386795
emerin O 0 0.29328495264053345
epitopes O 0 0.23546111583709717
did O 0 0.03040100820362568
not O 0 0.01850612461566925
recognize O 0 0.04757922887802124
intercalated O 0 0.14771224558353424
discs O 0 0.05042069032788277
in O 0 0.016222449019551277
the O 0 0.01738644577562809
heart O 0 0.2338109016418457
, O 0 0.017408521845936775
though O 0 0.01796003431081772
they O 0 0.015160885639488697
recognized O 0 0.03179984167218208
cardiomyocyte O 0 0.15202629566192627
nuclei O 0 0.07524104416370392
strongly O 0 0.02936697192490101
, O 0 0.012494305148720741
both O 0 0.012558733113110065
at O 0 0.015900570899248123
the O 0 0.013146869838237762
rim O 0 0.06331949681043625
and O 0 0.01664665713906288
in O 0 0.021454768255352974
intranuclear O 0 0.13440735638141632
spots O 0 0.0721617043018341
or O 0 0.03619955852627754
channels O 0 0.06168713793158531
. O 0 0.04422510787844658

A O 0 0.10837928205728531
polyclonal O 1 0.950745165348053
rabbit O 1 0.8418328166007996
antiserum O 1 0.7953696846961975
against O 0 0.0543852373957634
emerin O 0 0.15474562346935272
did O 0 0.029317965731024742
recognize O 0 0.0368306003510952
both O 0 0.01712314784526825
nuclear O 0 0.03846104070544243
membrane O 0 0.05923875793814659
and O 0 0.020796602591872215
intercalated O 0 0.25651589035987854
discs O 0 0.05068149417638779
but O 0 0.015518538653850555
, O 0 0.013287934474647045
after O 0 0.02533852867782116
affinity O 0 0.07066409289836884
purification O 0 0.061915844678878784
against O 0 0.024227339774370193
a O 0 0.026208193972706795
pure O 0 0.05534277483820915
- O 0 0.08568207919597626
emerin O 0 0.11644869297742844
band O 0 0.03899659588932991
on O 0 0.014038603752851486
a O 0 0.019546592608094215
western O 0 0.03351182863116264
blot O 0 0.10729087889194489
, O 0 0.021700231358408928
it O 0 0.015664268285036087
stained O 0 0.07543476670980453
only O 0 0.016066350042819977
the O 0 0.02127082459628582
nuclear O 0 0.05694275349378586
membrane O 0 0.10155433416366577
. O 0 0.051951754838228226

These O 0 0.027898050844669342
results O 0 0.026799945160746574
would O 0 0.013669827952980995
not O 0 0.010118053294718266
be O 0 0.008413462899625301
expected O 0 0.018989475443959236
if O 0 0.021087655797600746
immunostaining O 0 0.10551942884922028
at O 0 0.02597903460264206
intercalated O 0 0.14935138821601868
discs O 0 0.04023398086428642
were O 0 0.010697194375097752
due O 0 0.014980961568653584
to O 0 0.008192403241991997
a O 0 0.011706572957336903
product O 0 0.01661677099764347
of O 0 0.011310160160064697
the O 0 0.020201511681079865
emerin O 0 0.2809661030769348
gene O 0 0.0632539764046669
and O 0 0.013793508522212505
, O 0 0.012175600975751877
therefore O 0 0.015019544400274754
, O 0 0.010582019574940205
cast O 0 0.017847375944256783
some O 0 0.010545537807047367
doubt O 0 0.02809612639248371
upon O 0 0.017682025209069252
the O 0 0.018104374408721924
hypothesis O 0 0.06965283304452896
that O 0 0.033007360994815826
cardiac B-Disease 1 0.9999675750732422
defects I-Disease 1 0.9983878135681152
in O 0 0.02993043139576912
EDMD B-Disease 1 0.9985244870185852
are O 0 0.02083336003124714
caused O 0 0.05602910742163658
by O 0 0.017763759940862656
absence O 0 0.041715107858181
of O 0 0.020931586623191833
emerin O 0 0.17112979292869568
from O 0 0.034884028136730194
intercalated O 1 0.6602887511253357
discs O 0 0.1024046391248703
. O 0 0.04769415408372879

Although O 0 0.06480926275253296
emerin O 0 0.132560133934021
was O 0 0.024357154965400696
abundant O 0 0.031953249126672745
in O 0 0.013518545776605606
the O 0 0.01732795313000679
membranes O 0 0.06292939186096191
of O 0 0.018526295199990273
cardiomyocyte O 0 0.3530484437942505
nuclei O 0 0.07090454548597336
, O 0 0.014849155209958553
it O 0 0.01193927600979805
was O 0 0.014156877994537354
absent O 0 0.03834296762943268
from O 0 0.016397155821323395
many O 0 0.016243480145931244
non O 0 0.0483953058719635
- O 0 0.3637721538543701
myocyte O 1 0.9953140020370483
cells O 0 0.09543537348508835
in O 0 0.020564788952469826
the O 0 0.028225557878613472
heart O 1 0.7276237607002258
. O 0 0.046607181429862976

This O 0 0.03071865253150463
distribution O 0 0.0319850817322731
of O 0 0.018802812322974205
emerin O 0 0.09664618968963623
was O 0 0.019353562965989113
similar O 0 0.017182715237140656
to O 0 0.009566724300384521
that O 0 0.009070046246051788
of O 0 0.012728039175271988
lamin O 0 0.11733811348676682
A O 0 0.023214813321828842
, O 0 0.01390755083411932
a O 0 0.016148796305060387
candidate O 0 0.026279266923666
gene O 0 0.05348469316959381
for O 0 0.014042683877050877
an O 0 0.020548345521092415
autosomal O 1 0.9481902718544006
form O 0 0.04244004562497139
of O 0 0.034883949905633926
EDMD B-Disease 1 0.9944614171981812
. O 0 0.060371033847332

In O 0 0.0440400056540966
contrast O 0 0.06899456679821014
, O 0 0.04183176904916763
lamin O 1 0.9880433082580566
B1 O 1 0.9988056421279907
was O 0 0.04035879299044609
absent O 0 0.08196675777435303
from O 0 0.03816773369908333
cardiomyocyte O 0 0.30004048347473145
nuclei O 0 0.08268062025308609
, O 0 0.02138020284473896
showing O 0 0.0372304730117321
that O 0 0.025037970393896103
lamin O 1 0.9910030364990234
B1 O 1 0.9979227185249329
is O 0 0.018906032666563988
not O 0 0.011331955902278423
essential O 0 0.020530924201011658
for O 0 0.013519754633307457
localization O 0 0.05214658007025719
of O 0 0.01488542091101408
emerin O 0 0.07974442094564438
to O 0 0.01755058579146862
the O 0 0.02251141518354416
nuclear O 0 0.06827400624752045
lamina O 1 0.9442979097366333
. O 0 0.058287132531404495

Lamin O 1 0.9910440444946289
B1 O 1 0.9943846464157104
is O 0 0.032088976353406906
also O 0 0.02051001600921154
almost O 0 0.023202624171972275
completely O 0 0.03842027485370636
absent O 0 0.06723220646381378
from O 0 0.0421183705329895
skeletal O 1 0.9955658316612244
muscle O 1 0.9983400106430054
nuclei O 0 0.2807379961013794
. O 0 0.06002764776349068

In O 0 0.0511823333799839
EDMD B-Disease 1 0.8561973571777344
, O 0 0.019060632213950157
the O 0 0.014940081164240837
additional O 0 0.028081633150577545
absence O 0 0.045669544488191605
of O 0 0.032475795596838
lamin O 1 0.9953910112380981
B1 O 1 0.9998393058776855
from O 0 0.0426357164978981
heart O 1 0.9898592829704285
and O 0 0.03182338550686836
skeletal O 1 0.9980873465538025
muscle O 1 0.9985567927360535
nuclei O 0 0.10393259674310684
which O 0 0.021160433068871498
already O 0 0.02949170209467411
lack O 0 0.041661590337753296
emerin O 0 0.34145280718803406
may O 0 0.025019366294145584
offer O 0 0.020686674863100052
an O 0 0.012931904755532742
alternative O 0 0.02994544990360737
explanation O 0 0.027858393266797066
of O 0 0.010888433083891869
why O 0 0.021831870079040527
these O 0 0.012885999865829945
tissues O 0 0.05975256487727165
are O 0 0.015411971136927605
particularly O 0 0.03426404297351837
affected O 0 0.05357850342988968
. O 0 0.02627483569085598
. O 0 0.03492796793580055

Genetic O 0 0.12520639598369598
mapping O 0 0.071698397397995
of O 0 0.019806096330285072
the O 0 0.02832643687725067
copper B-Disease 0 0.13544687628746033
toxicosis I-Disease 1 0.9932970404624939
locus O 0 0.16523683071136475
in O 0 0.049105510115623474
Bedlington O 1 0.9357359409332275
terriers O 0 0.19082699716091156
to O 0 0.035110753029584885
dog O 0 0.09712638705968857
chromosome O 0 0.10363137722015381
10 O 0 0.02351665496826172
, O 0 0.013090945780277252
in O 0 0.012473784387111664
a O 0 0.02046850137412548
region O 0 0.04183125123381615
syntenic O 0 0.1017555296421051
to O 0 0.02322952076792717
human O 0 0.0420428030192852
chromosome O 0 0.15400901436805725
region O 0 0.0904369205236435
2p13 O 1 0.8956177234649658
- O 0 0.4512455463409424
p16 O 1 0.9120515584945679
. O 0 0.06956726312637329

Abnormal O 1 0.9992210865020752
hepatic B-Disease 1 0.9999781847000122
copper I-Disease 1 0.800260066986084
accumulation I-Disease 0 0.44174331426620483
is O 0 0.022403160110116005
recognized O 0 0.026458587497472763
as O 0 0.01672307401895523
an O 0 0.02860882878303528
inherited B-Disease 1 0.9996976852416992
disorder I-Disease 1 0.9999886751174927
in O 0 0.026982592418789864
man O 0 0.04457031935453415
, O 0 0.025679973885416985
mouse O 0 0.10284724831581116
, O 0 0.03151784464716911
rat O 1 0.5235075354576111
and O 0 0.030267292633652687
dog O 0 0.11845685541629791
. O 0 0.05480092763900757

The O 0 0.04410938546061516
major O 0 0.053384024649858475
cause O 0 0.12157981097698212
of O 0 0.033827174454927444
hepatic B-Disease 1 0.9999731779098511
copper I-Disease 0 0.4880402088165283
accumulation I-Disease 0 0.18536977469921112
in O 0 0.018987981602549553
man O 0 0.03292986750602722
is O 0 0.018595339730381966
a O 0 0.030775634571909904
dysfunctional O 1 0.9503033757209778
ATP7B O 1 0.9947702288627625
gene O 0 0.31570446491241455
, O 0 0.04183192178606987
causing O 1 0.986855149269104
Wilson B-Disease 1 0.993030846118927
disease I-Disease 1 0.9999849796295166
( O 1 0.57283616065979
WD B-Disease 1 0.9998502731323242
) O 0 0.057443130761384964
. O 0 0.043120793998241425

Mutations O 0 0.18373703956604004
in O 0 0.02785208448767662
the O 0 0.030676303431391716
ATP7B O 0 0.4294573664665222
genes O 0 0.06236666813492775
have O 0 0.016653401777148247
also O 0 0.01412893459200859
been O 0 0.015960581600666046
demonstrated O 0 0.03501586243510246
in O 0 0.019273752346634865
mouse O 0 0.08580182492733002
and O 0 0.03254472091794014
rat O 1 0.5468382835388184
. O 0 0.049674827605485916

The O 0 0.06158067286014557
ATP7B O 1 0.6417393684387207
gene O 0 0.08426008373498917
has O 0 0.019287969917058945
been O 0 0.013902593404054642
excluded O 0 0.02984647825360298
in O 0 0.010765314102172852
the O 0 0.01312704011797905
much O 0 0.023922070860862732
rarer O 0 0.4925566613674164
human O 0 0.06523240357637405
copper B-Disease 1 0.9925097227096558
overload I-Disease 1 0.9999204874038696
disease O 1 0.9999794960021973
non B-Disease 0 0.21545766294002533
- I-Disease 1 0.7794156074523926
Indian I-Disease 0 0.07649142295122147
childhood I-Disease 1 0.9965707063674927
cirrhosis I-Disease 1 0.999906063079834
, O 0 0.049781907349824905
indicating O 0 0.09177067130804062
genetic O 0 0.13663536310195923
heterogeneity O 0 0.22657249867916107
. O 0 0.05913834273815155

By O 0 0.038591418415308
investigating O 0 0.06357695907354355
the O 0 0.036032505333423615
common O 0 0.08565019816160202
autosomal O 1 0.999559223651886
recessive O 1 0.9998071789741516
copper B-Disease 1 0.9978162050247192
toxicosis I-Disease 1 0.9998494386672974
( O 0 0.2756066918373108
CT B-Disease 1 0.9989027976989746
) O 0 0.03901137784123421
in O 0 0.027520066127181053
Bedlington O 1 0.9799106121063232
terriers O 0 0.2747911214828491
, O 0 0.016374023631215096
we O 0 0.009907321073114872
have O 0 0.010415988974273205
identified O 0 0.020589377731084824
a O 0 0.016267308965325356
new O 0 0.022536441683769226
locus O 0 0.09547371417284012
involved O 0 0.04070611298084259
in O 0 0.03465208038687706
progressive O 1 0.9992853999137878
liver B-Disease 1 0.9999994039535522
disease I-Disease 1 0.999996542930603
. O 0 0.07359269261360168

We O 0 0.03727433830499649
examined O 0 0.06333208829164505
whether O 0 0.03840479999780655
the O 0 0.03541705012321472
WD B-Disease 1 0.9993178844451904
gene O 0 0.14197881519794464
ATP7B O 0 0.3569914996623993
was O 0 0.026659483090043068
also O 0 0.02288719452917576
causative O 0 0.14358855783939362
for O 0 0.026796216145157814
CT B-Disease 1 0.9704399108886719
by O 0 0.021610865369439125
investigating O 0 0.04434029757976532
the O 0 0.027310414239764214
chromosomal O 0 0.4926019310951233
co O 0 0.16113406419754028
- O 0 0.09663433581590652
localization O 0 0.0886603519320488
of O 0 0.023235127329826355
ATP7B O 0 0.2877541184425354
and O 0 0.02311478927731514
C04107 O 0 0.0982385203242302
, O 0 0.018852056935429573
using O 0 0.02604507841169834
fluorescence O 0 0.10762665420770645
in O 0 0.030763033777475357
situ O 0 0.14809584617614746
hybridization O 0 0.12482039630413055
( O 0 0.050179727375507355
FISH O 0 0.05809988081455231
) O 0 0.0462019108235836
. O 0 0.037226662039756775

C04107 O 0 0.1922246217727661
is O 0 0.03425806015729904
an O 0 0.027576975524425507
anonymous O 0 0.07501964271068573
microsatellite O 0 0.2813098132610321
marker O 0 0.1058732345700264
closely O 0 0.04368162527680397
linked O 0 0.06906622648239136
to O 0 0.03692829608917236
CT B-Disease 1 0.9875267148017883
. O 0 0.05455049127340317

However O 0 0.06001626327633858
, O 0 0.04381550848484039
BAC O 1 0.8738203644752502
clones O 0 0.12851224839687347
containing O 0 0.053537145256996155
ATP7B O 0 0.18634767830371857
and O 0 0.02956882305443287
C04107 O 0 0.10218993574380875
mapped O 0 0.05429551750421524
to O 0 0.02025521919131279
the O 0 0.025822695344686508
canine O 1 0.6024521589279175
chromosome O 0 0.17443731427192688
regions O 0 0.0820404589176178
CFA22q11 O 0 0.24707657098770142
and O 0 0.025675762444734573
CFA10q26 O 0 0.13101918995380402
, O 0 0.017273882403969765
respectively O 0 0.02538624219596386
, O 0 0.0174435805529356
demonstrating O 0 0.04352952912449837
that O 0 0.028288360685110092
WD B-Disease 1 0.9954639077186584
cannot O 0 0.03779102861881256
be O 0 0.020550228655338287
homologous O 0 0.10083208978176117
to O 0 0.037862155586481094
CT B-Disease 1 0.9908214807510376
. O 0 0.0557229220867157

The O 0 0.04410458728671074
copper O 0 0.08874285221099854
transport O 0 0.06913020461797714
genes O 0 0.09978874772787094
CTR1 O 1 0.5445197820663452
and O 0 0.025111326947808266
CTR2 O 0 0.1277281492948532
were O 0 0.013401337899267673
also O 0 0.01389735285192728
excluded O 0 0.03194304183125496
as O 0 0.012749701738357544
candidate O 0 0.03145129978656769
genes O 0 0.05510764196515083
for O 0 0.02132030762732029
CT B-Disease 1 0.9723533391952515
since O 0 0.02159796468913555
they O 0 0.011638076044619083
both O 0 0.0133506553247571
mapped O 0 0.046714115887880325
to O 0 0.024830155074596405
canine O 1 0.604092538356781
chromosome O 0 0.18930551409721375
region O 0 0.08623237162828445
CFA11q22 O 1 0.5518587827682495
. O 0 0.05613502860069275

2 O 0 0.09003089368343353
- O 0 0.12026102095842361
22 O 0 0.07097043842077255
. O 0 0.05299483984708786

5 O 0 0.10549475997686386
. O 0 0.062252551317214966

A O 0 0.06679321080446243
transcribed O 0 0.08560870587825775
sequence O 0 0.05118902772665024
identified O 0 0.032894399017095566
from O 0 0.020664934068918228
the O 0 0.022679094225168228
C04107 O 0 0.13833394646644592
- O 0 0.07584875077009201
containing O 0 0.04225676506757736
BAC O 0 0.35480985045433044
was O 0 0.022428464144468307
found O 0 0.017717652022838593
to O 0 0.010615001432597637
be O 0 0.010261577554047108
homologous O 0 0.06298241019248962
to O 0 0.017375940456986427
a O 0 0.026373950764536858
gene O 0 0.06976234167814255
expressed O 0 0.035664524883031845
from O 0 0.024524055421352386
human O 0 0.046561699360609055
chromosome O 0 0.27013760805130005
2p13 O 1 0.8646256923675537
- O 0 0.16600283980369568
p16 O 1 0.6095155477523804
, O 0 0.021313142031431198
a O 0 0.021560775116086006
region O 0 0.03581451252102852
devoid O 0 0.04753418266773224
of O 0 0.014888770878314972
any O 0 0.021337708458304405
positional O 0 0.08545172959566116
candidate O 0 0.052740562707185745
genes O 0 0.09089876711368561
. O 0 0.045441124588251114

Molecular O 0 0.08815757185220718
analysis O 0 0.03649885579943657
of O 0 0.01532082911580801
the O 0 0.023906392976641655
APC B-Disease 0 0.2669435441493988
gene O 0 0.08450108021497726
in O 0 0.023648083209991455
205 O 0 0.08136732131242752
families O 0 0.04869253560900688
: O 0 0.04280988126993179
extended O 0 0.05905608832836151
genotype O 1 0.9665799140930176
- O 0 0.40990719199180603
phenotype O 1 0.9370969533920288
correlations O 0 0.10740406066179276
in O 0 0.02617773599922657
FAP B-Disease 1 0.9978577494621277
and O 0 0.014658390544354916
evidence O 0 0.014786213636398315
for O 0 0.009246955625712872
the O 0 0.011283609084784985
role O 0 0.022884417325258255
of O 0 0.019829828292131424
APC B-Disease 1 0.8349457383155823
amino O 0 0.10851289331912994
acid O 1 0.6532034873962402
changes O 0 0.05624411255121231
in O 0 0.07915006577968597
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
predisposition O 1 0.9994388222694397
. O 0 0.07213743031024933

BACKGROUND O 0 0.13104462623596191
/ O 0 0.3847041130065918
AIMS O 0 0.0641397088766098
The O 0 0.02277872897684574
development O 0 0.03744116052985191
of O 0 0.03848685324192047
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999839067459106
and O 0 0.023061472922563553
a O 0 0.023900160565972328
variable O 0 0.064862459897995
range O 0 0.036420900374650955
of O 0 0.02396717667579651
extracolonic O 1 0.9532871842384338
manifestations O 1 0.9694793224334717
in O 0 0.0710824504494667
familial B-Disease 1 0.9999980926513672
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.9519622921943665
FAP B-Disease 1 0.9997459053993225
) O 0 0.0313783697783947
is O 0 0.012015900574624538
the O 0 0.010417857207357883
result O 0 0.016062423586845398
of O 0 0.009811494499444962
the O 0 0.016914991661906242
dominant O 0 0.06694942712783813
inheritance O 1 0.5504313111305237
of O 0 0.08171772211790085
adenomatous B-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999854564666748
( O 1 0.5298583507537842
APC B-Disease 1 0.9924581050872803
) O 0 0.0775439515709877
gene O 0 0.164475217461586
mutations O 0 0.2743118703365326
. O 0 0.05564744770526886

In O 0 0.027008680626749992
this O 0 0.01633504033088684
study O 0 0.02722826413810253
, O 0 0.01787717454135418
direct O 0 0.035424888134002686
mutation O 0 0.0985373854637146
analysis O 0 0.03292665630578995
of O 0 0.014490894973278046
the O 0 0.02370956353843212
APC B-Disease 0 0.2804996073246002
gene O 0 0.08223936706781387
was O 0 0.02360861375927925
performed O 0 0.030854742974042892
to O 0 0.017288895323872566
determine O 0 0.044009242206811905
genotype O 1 0.9000928401947021
- O 0 0.16746068000793457
phenotype O 1 0.6910972595214844
correlations O 0 0.0924021452665329
for O 0 0.02074926346540451
nine O 0 0.03410036116838455
extracolonic O 0 0.4255884289741516
manifestations O 0 0.07486504316329956
and O 0 0.012363669462502003
to O 0 0.011936119757592678
investigate O 0 0.03417353332042694
the O 0 0.019414717331528664
incidence O 0 0.472828209400177
of O 0 0.02914218232035637
APC B-Disease 1 0.9752280116081238
mutations O 0 0.46778351068496704
in O 0 0.03773684799671173
non O 1 0.9147877097129822
- O 1 0.9998365640640259
FAP O 1 0.9999991655349731
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999974966049194
. O 0 0.08435514569282532

METHODS O 0 0.07776085287332535
The O 0 0.04109904170036316
APC B-Disease 0 0.21944499015808105
gene O 0 0.0927983820438385
was O 0 0.028673527762293816
analysed O 0 0.058665454387664795
in O 0 0.024056654423475266
190 O 0 0.07516206055879593
unrelated O 0 0.09473604708909988
FAP B-Disease 1 0.9985962510108948
and O 0 0.031034300103783607
15 O 0 0.04843120276927948
non O 1 0.919600248336792
- O 1 0.9998645782470703
FAP O 1 0.9999994039535522
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
patients O 1 0.9996287822723389
using O 0 0.08037885278463364
denaturing O 1 0.9850897789001465
gradient O 1 0.8544469475746155
gel O 1 0.9548593163490295
electrophoresis O 0 0.24253322184085846
, O 0 0.02847035974264145
the O 0 0.025136098265647888
protein O 0 0.0672854408621788
truncation O 0 0.1130218356847763
test O 0 0.040526773780584335
, O 0 0.015588379465043545
and O 0 0.015123900026082993
direct O 0 0.03596756234765053
sequencing O 0 0.07621011883020401
. O 0 0.0425778366625309

RESULTS O 0 0.11873520910739899
Chain O 0 0.11268075555562973
terminating O 0 0.1045820340514183
signals O 0 0.049807045608758926
were O 0 0.013326332904398441
only O 0 0.01273412350565195
identified O 0 0.02692699059844017
in O 0 0.01743789203464985
patients O 1 0.7011866569519043
belonging O 0 0.03540271148085594
to O 0 0.017842769622802734
the O 0 0.02624526247382164
FAP B-Disease 1 0.9996411800384521
group O 0 0.06437195837497711
( O 0 0.05755608156323433
105 O 0 0.10431026667356491
patients O 1 0.9881789684295654
) O 0 0.05147242546081543
. O 0 0.039567433297634125

Amino O 0 0.14892368018627167
acid O 0 0.13901051878929138
changes O 0 0.03559112921357155
were O 0 0.01385247241705656
identified O 0 0.023867301642894745
in O 0 0.013830270618200302
four O 0 0.017281420528888702
patients O 1 0.8251979947090149
, O 0 0.01141657866537571
three O 0 0.009224414825439453
of O 0 0.009457346983253956
whom O 0 0.02252425067126751
belonged O 0 0.02732887864112854
to O 0 0.012594610452651978
the O 0 0.018445448949933052
non O 0 0.06254002451896667
- O 1 0.9775857925415039
FAP O 1 0.9998970031738281
group O 0 0.4358363747596741
of O 0 0.16756755113601685
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9999499320983887
. O 0 0.06330765038728714

Genotype O 1 0.9884170889854431
- O 1 0.8184899687767029
phenotype O 1 0.9334498047828674
correlations O 0 0.1250237673521042
identified O 0 0.04253363236784935
significant O 0 0.026431774720549583
differences O 0 0.024611223489046097
in O 0 0.011992589570581913
the O 0 0.012477895244956017
nature O 0 0.023135079070925713
of O 0 0.013369781896471977
certain O 0 0.026906205341219902
extracolonic O 1 0.92912757396698
manifestations O 1 0.8428430557250977
in O 0 0.03525746986269951
FAP B-Disease 1 0.9999483823776245
patients O 1 0.9963666200637817
belonging O 0 0.04864120855927467
to O 0 0.02106313407421112
three O 0 0.026073014363646507
mutation O 0 0.16189180314540863
subgroups O 0 0.13053415715694427
. O 0 0.06339111179113388

CONCLUSIONS O 0 0.1182050034403801
Extended O 0 0.11429721117019653
genotype O 1 0.969496488571167
- O 0 0.42229387164115906
phenotype O 1 0.8165804743766785
correlations O 0 0.08202125877141953
made O 0 0.014630580320954323
in O 0 0.012123658321797848
this O 0 0.010225338861346245
study O 0 0.018012473359704018
may O 0 0.01528562605381012
have O 0 0.009225753135979176
the O 0 0.010555298067629337
potential O 0 0.022331925109028816
to O 0 0.009734919294714928
determine O 0 0.015861988067626953
the O 0 0.009472004137933254
most O 0 0.01259208470582962
appropriate O 0 0.028249016031622887
surveillance O 0 0.05064241588115692
and O 0 0.027516895905137062
prophylactic O 1 0.9996373653411865
treatment O 1 0.9996237754821777
regimens O 1 0.9986044764518738
for O 0 0.020575156435370445
those O 0 0.021605290472507477
patients O 1 0.9982247948646545
with O 0 0.023985955864191055
mutations O 0 0.4192955493927002
associated O 0 0.03443434089422226
with O 0 0.021094201132655144
life O 0 0.0423407144844532
threatening O 0 0.37714266777038574
conditions O 0 0.08418618887662888
. O 0 0.052771393209695816

This O 0 0.025097165256738663
study O 0 0.028128864243626595
also O 0 0.013914366252720356
provided O 0 0.019035693258047104
evidence O 0 0.01660589501261711
for O 0 0.01059536263346672
the O 0 0.017171412706375122
pathological O 0 0.08137945085763931
nature O 0 0.032587893307209015
of O 0 0.019255787134170532
amino O 0 0.06907376646995544
acid O 0 0.08979885280132294
changes O 0 0.032275035977363586
in O 0 0.018891043961048126
APC O 0 0.135816290974617
associated O 0 0.026195157319307327
with O 0 0.01723540760576725
both O 0 0.022637713700532913
FAP B-Disease 1 0.999901533126831
and O 0 0.03401361405849457
non O 1 0.9880091547966003
- O 1 0.9999537467956543
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9999022483825684
. O 0 0.04132221266627312
. O 0 0.03911123424768448

Inherited B-Disease 1 0.9999192953109741
colorectal I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999988079071045
and O 0 0.24926814436912537
cancer B-Disease 1 0.9999864101409912
risk O 1 0.7293791770935059
of O 0 0.02115274965763092
the O 0 0.03384590148925781
APC O 1 0.921171247959137
I1307K O 1 0.5574647188186646
polymorphism O 0 0.18241585791110992
. O 0 0.059946950525045395

Germ O 1 0.9768825769424438
- O 0 0.13155123591423035
line O 0 0.05842934921383858
and O 0 0.03450271487236023
somatic O 0 0.18898905813694
truncating O 0 0.2929301857948303
mutations O 0 0.14081548154354095
of O 0 0.020622987300157547
the O 0 0.024799831211566925
APC B-Disease 1 0.548174262046814
gene O 0 0.08015242218971252
are O 0 0.01660594344139099
thought O 0 0.02932785078883171
to O 0 0.026772119104862213
initiate O 1 0.9309918284416199
colorectal B-Disease 1 0.9999990463256836
tumor I-Disease 1 0.9999679327011108
formation O 1 0.9702220559120178
in O 0 0.40824151039123535
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.3892199993133545
sporadic O 1 0.9987758994102478
colorectal O 1 0.9999990463256836
carcinogenesis O 1 0.9994938373565674
, O 0 0.03672807663679123
respectively O 0 0.0458376407623291
. O 0 0.04055934399366379

Recently O 0 0.07012799382209778
, O 0 0.034137606620788574
an O 0 0.03734279051423073
isoleucine O 1 0.7094869613647461
- O 1 0.7575883865356445
- O 0 0.4964827001094818
> O 1 0.5558717846870422
lysine O 0 0.21024008095264435
polymorphism O 0 0.17332500219345093
at O 0 0.066482312977314
codon O 0 0.17976826429367065
1307 O 1 0.7309585809707642
( O 0 0.06056637316942215
I1307K O 0 0.11704636365175247
) O 0 0.025509821251034737
of O 0 0.014814206399023533
the O 0 0.022050512954592705
APC B-Disease 0 0.24198190867900848
gene O 0 0.07015959173440933
has O 0 0.017070628702640533
been O 0 0.013413039967417717
identified O 0 0.021454954519867897
in O 0 0.014495921321213245
6 O 0 0.028916697949171066
% O 0 0.029974745586514473
- O 0 0.048067010939121246
7 O 0 0.031629953533411026
% O 0 0.021821776404976845
of O 0 0.011314542964100838
the O 0 0.01808736100792885
Ashkenazi O 0 0.10851661115884781
Jewish O 0 0.05087976157665253
population O 0 0.045980535447597504
. O 0 0.04119929298758507

To O 0 0.03312737122178078
assess O 0 0.06652369350194931
the O 0 0.02517055533826351
risk O 0 0.07205584645271301
of O 0 0.017108917236328125
this O 0 0.01888994872570038
common O 0 0.053967591375112534
APC B-Disease 1 0.9813162088394165
allelic O 1 0.9836007952690125
variant O 1 0.7924898266792297
in O 0 0.06272153556346893
colorectal O 1 0.9999953508377075
carcinogenesis O 1 0.9978038668632507
, O 0 0.02619318664073944
we O 0 0.015802884474396706
have O 0 0.0131954001262784
analyzed O 0 0.029253561049699783
a O 0 0.0211443193256855
large O 0 0.030004583299160004
cohort O 0 0.10682477802038193
of O 0 0.027638541534543037
unselected O 0 0.16988277435302734
Ashkenazi O 0 0.17986349761486053
Jewish O 0 0.05597253516316414
subjects O 0 0.05263090878725052
with O 0 0.05181071534752846
adenomatous B-Disease 1 0.9999973773956299
polyps I-Disease 1 0.9999094009399414
and O 0 0.030180441215634346
. O 0 0.03043527901172638
or O 1 0.8805487155914307
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999940395355225
, I-Disease 0 0.027224982157349586
for O 0 0.016751587390899658
the O 0 0.030077273026108742
APC O 1 0.82451993227005
I1307K O 0 0.39648813009262085
polymorphism O 0 0.18620219826698303
. O 0 0.06333804875612259

The O 0 0.06557036191225052
APC O 1 0.5462186336517334
I1307K O 0 0.19886228442192078
allele O 0 0.1331462562084198
was O 0 0.025733914226293564
identified O 0 0.02950125001370907
in O 0 0.014481949619948864
48 O 0 0.030634582042694092
( O 0 0.021880747750401497
10 O 0 0.016975663602352142
. O 0 0.014712085016071796
1 O 0 0.022937679663300514
% O 0 0.02727334015071392
) O 0 0.024230720475316048
of O 0 0.02024819515645504
476 O 1 0.8926066160202026
patients O 1 0.9967689514160156
. O 0 0.05709318444132805

Compared O 0 0.04682158678770065
with O 0 0.014650474302470684
the O 0 0.013781928457319736
frequency O 0 0.028729530051350594
in O 0 0.009908170439302921
two O 0 0.009789660573005676
separate O 0 0.018281718716025352
population O 0 0.022456258535385132
control O 0 0.030942372977733612
groups O 0 0.02156740427017212
, O 0 0.01555662415921688
the O 0 0.0253120269626379
APC O 1 0.6644676923751831
I1307K O 0 0.16927948594093323
allele O 0 0.12137974053621292
is O 0 0.019139356911182404
associated O 0 0.022135354578495026
with O 0 0.013073306530714035
an O 0 0.01627223938703537
estimated O 0 0.033990148454904556
relative O 0 0.042587585747241974
risk O 0 0.07050676643848419
of O 0 0.018707454204559326
1 O 0 0.04066767171025276
. O 0 0.03783454746007919

5 O 0 0.08773208409547806
- O 0 0.10093886405229568
1 O 0 0.05453723296523094
. O 0 0.048386458307504654

7 O 0 0.0939827486872673
for O 0 0.05543758347630501
colorectal B-Disease 1 0.9999895095825195
neoplasia I-Disease 1 0.9997715353965759
( O 0 0.05864795297384262
both O 0 0.03203725442290306
P O 1 0.6805784106254578
= O 0 0.11635195463895798
. O 0 0.031190475448966026
01 O 1 0.5317375659942627
) O 0 0.045472949743270874
. O 0 0.03947868198156357

Furthermore O 0 0.07274498045444489
, O 0 0.02980179898440838
compared O 0 0.03585141897201538
with O 0 0.024964524433016777
noncarriers O 0 0.21313504874706268
, O 0 0.03335176780819893
APC O 1 0.844907820224762
I1307K O 0 0.3092694580554962
carriers O 0 0.08749713748693466
had O 0 0.023948902264237404
increased O 0 0.03247372433543205
numbers O 0 0.02765832655131817
of O 0 0.024248644709587097
adenomas B-Disease 1 0.9998867511749268
and O 0 0.08449659496545792
colorectal B-Disease 1 0.9999991655349731
cancers I-Disease 1 0.9999481439590454
per O 0 0.07196448743343353
patient O 1 0.9949126243591309
( O 0 0.07250932604074478
P O 1 0.7953234910964966
= O 0 0.10358092188835144
. O 0 0.02142379991710186
03 O 0 0.1672745943069458
) O 0 0.019024737179279327
, O 0 0.009980719536542892
as O 0 0.008854398503899574
well O 0 0.010100903920829296
as O 0 0.010009515099227428
a O 0 0.017667677253484726
younger O 0 0.04245619475841522
age O 0 0.039555199444293976
at O 0 0.04246825352311134
diagnosis O 1 0.9955560564994812
. O 0 0.056081924587488174

We O 0 0.03675448149442673
conclude O 0 0.058689046651124954
that O 0 0.01959758624434471
the O 0 0.03249656409025192
APC O 1 0.7324585318565369
I1307K O 0 0.4238872230052948
variant O 0 0.14985010027885437
leads O 0 0.07519271969795227
to O 0 0.028440289199352264
increased O 0 0.06150432676076889
adenoma B-Disease 1 0.9999362230300903
formation O 0 0.06741451472043991
and O 0 0.01667040027678013
directly O 0 0.02293737791478634
contributes O 0 0.054472874850034714
to O 0 0.017158765345811844
3 O 0 0.02782331220805645
% O 0 0.027650296688079834
- O 0 0.050137780606746674
4 O 0 0.027231112122535706
% O 0 0.021526839584112167
of O 0 0.013031721115112305
all O 0 0.021751977503299713
Ashkenazi O 1 0.9751273393630981
Jewish O 1 0.9709600210189819
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999971389770508
. O 0 0.08209347724914551

The O 0 0.03791611269116402
estimated O 0 0.054297421127557755
relative O 0 0.05757536366581917
risk O 0 0.18660208582878113
for O 0 0.020986413583159447
carriers O 0 0.09220940619707108
may O 0 0.03482837975025177
justify O 0 0.047134917229413986
specific O 0 0.03002641536295414
clinical O 0 0.2135539948940277
screening O 0 0.05271480605006218
for O 0 0.013248654082417488
the O 0 0.013433347456157207
360 O 0 0.041590843349695206
, O 0 0.01548114512115717
000 O 0 0.0379953496158123
Americans O 0 0.029306450858712196
expected O 0 0.02114039659500122
to O 0 0.015316317789256573
harbor O 0 0.048070281744003296
this O 0 0.01657562516629696
allele O 0 0.08197321742773056
, O 0 0.015223023481667042
and O 0 0.01425157766789198
genetic O 0 0.04803963378071785
testing O 0 0.03277641162276268
in O 0 0.010074951685965061
the O 0 0.01108244527131319
setting O 0 0.02256389521062374
of O 0 0.01482133287936449
long O 0 0.03834550082683563
- O 0 0.07421129196882248
term O 0 0.04541477560997009
- O 0 0.07458636164665222
outcome O 0 0.04858580231666565
studies O 0 0.03769655525684357
may O 0 0.03589892387390137
impact O 0 0.05122242867946625
significantly O 0 0.06564538180828094
on O 0 0.054058972746133804
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
prevention O 1 0.9988312125205994
in O 0 0.021434009075164795
this O 0 0.01669865846633911
population O 0 0.038031864911317825
. O 0 0.039761561900377274

Localization O 0 0.11854210495948792
of O 0 0.025558704510331154
human O 0 0.04173427075147629
BRCA1 O 1 0.6775606870651245
and O 0 0.01863737404346466
its O 0 0.017223766073584557
loss O 0 0.04055606946349144
in O 0 0.014869878999888897
high O 0 0.028884679079055786
- O 0 0.06345197558403015
grade O 0 0.05159156396985054
, O 0 0.026082389056682587
non B-Disease 0 0.07186637073755264
- I-Disease 1 0.9802870154380798
inherited I-Disease 1 0.9985707998275757
breast I-Disease 1 0.9999837875366211
carcinomas I-Disease 1 0.9999040365219116
. O 0 0.08686761558055878

Although O 0 0.036618854850530624
the O 0 0.022442083805799484
link O 0 0.0548836924135685
between O 0 0.03428606316447258
the O 0 0.046068839728832245
BRCA1 O 1 0.9999240636825562
tumour B-Disease 1 0.9999971389770508
- O 1 0.995835542678833
suppressor O 1 0.9949682354927063
gene O 0 0.2577817142009735
and O 0 0.042723990976810455
hereditary B-Disease 1 0.9998329877853394
breast I-Disease 1 0.9999978542327881
and I-Disease 1 0.9452558755874634
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999885559082031
is O 0 0.02215188555419445
established O 0 0.01671493425965309
, O 0 0.010073940269649029
the O 0 0.009101334027945995
role O 0 0.015351368114352226
, O 0 0.011120287701487541
if O 0 0.011247498914599419
any O 0 0.010393134318292141
, O 0 0.011553121730685234
of O 0 0.014598689042031765
BRCA1 O 1 0.9173909425735474
in O 0 0.028775285929441452
non B-Disease 0 0.0886453241109848
- I-Disease 1 0.9912522435188293
familial I-Disease 1 0.9999101161956787
cancers I-Disease 1 0.9998550415039062
is O 0 0.038386572152376175
unclear O 0 0.056240152567625046
. O 0 0.0387541726231575

BRCA1 O 1 0.9962204098701477
mutations O 1 0.5631682276725769
are O 0 0.027593007311224937
rare O 0 0.05121346563100815
in O 0 0.027942156419157982
sporadic B-Disease 1 0.7659170031547546
cancers I-Disease 1 0.9997515082359314
, O 0 0.02266823872923851
but O 0 0.019329054281115532
loss O 0 0.057482246309518814
of O 0 0.02363279089331627
BRCA1 O 1 0.9919313788414001
resulting O 0 0.06508714705705643
from O 0 0.026061933487653732
reduced O 0 0.05029037222266197
expression O 0 0.049576081335544586
or O 0 0.03048674575984478
incorrect O 0 0.0640810951590538
subcellular O 0 0.10188142955303192
localization O 0 0.07144065946340561
is O 0 0.01726805604994297
postulated O 0 0.04465639218688011
to O 0 0.010269924998283386
be O 0 0.008347738534212112
important O 0 0.013094056397676468
in O 0 0.017005344852805138
non B-Disease 0 0.16368351876735687
- I-Disease 1 0.9974664449691772
familial I-Disease 1 0.9999929666519165
breast I-Disease 1 0.999998927116394
and I-Disease 1 0.9590674638748169
ovarian I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.999992847442627
. O 0 0.0822722315788269

Epigenetic O 1 0.7157541513442993
loss O 0 0.09990111738443375
, O 0 0.01879894733428955
however O 0 0.012750037014484406
, O 0 0.009721283800899982
has O 0 0.009865042753517628
not O 0 0.008959902450442314
received O 0 0.017142504453659058
general O 0 0.01795690692961216
acceptance O 0 0.04046518728137016
due O 0 0.02195836417376995
to O 0 0.013356768526136875
controversy O 0 0.03169581666588783
regarding O 0 0.02448316290974617
the O 0 0.02069101482629776
subcellular O 0 0.08965376019477844
localization O 0 0.07942932099103928
of O 0 0.025847751647233963
BRCA1 O 1 0.9537639617919922
proteins O 0 0.04723414406180382
, O 0 0.015189461410045624
reports O 0 0.017218440771102905
of O 0 0.008639741688966751
which O 0 0.009867501445114613
have O 0 0.012119746766984463
ranged O 0 0.032989051192998886
from O 0 0.014238117262721062
exclusively O 0 0.022029072046279907
nuclear O 0 0.02736130729317665
, O 0 0.01239786483347416
to O 0 0.012013585306704044
conditionally O 0 0.0625985786318779
nuclear O 0 0.03198367357254028
, O 0 0.01374034397304058
to O 0 0.01381068304181099
the O 0 0.024737518280744553
ER O 1 0.9969576597213745
/ O 1 0.8736922740936279
golgi O 0 0.3740547001361847
, O 0 0.023372124880552292
to O 0 0.020623641088604927
cytoplasmic O 0 0.10609089583158493
invaginations O 0 0.10589581727981567
into O 0 0.02515232190489769
the O 0 0.02543971687555313
nucleus O 0 0.10161242634057999
. O 0 0.046685487031936646

In O 0 0.02696860581636429
an O 0 0.017712099477648735
attempt O 0 0.03072873130440712
to O 0 0.012554931454360485
resolve O 0 0.031502578407526016
this O 0 0.010633286088705063
issue O 0 0.015974560752511024
, O 0 0.01165733952075243
we O 0 0.012327499687671661
have O 0 0.015123063698410988
comprehensively O 0 0.06846056878566742
characterized O 0 0.08931083977222443
19 O 0 0.05836094170808792
anti O 0 0.13883566856384277
- O 1 0.6739562749862671
BRCA1 O 1 0.9947903156280518
antibodies O 1 0.8550280332565308
. O 0 0.06887029111385345

These O 0 0.05058852955698967
reagents O 0 0.14062833786010742
detect O 0 0.10133880376815796
a O 0 0.03941170126199722
220 O 0 0.08717767149209976
- O 0 0.1386788934469223
kD O 1 0.6483756899833679
protein O 0 0.09897235035896301
localized O 0 0.10474812984466553
in O 0 0.025088218972086906
discrete O 0 0.05997902527451515
nuclear O 0 0.046820562332868576
foci O 0 0.11138525605201721
in O 0 0.016080202534794807
all O 0 0.01632382720708847
epithelial O 1 0.947178304195404
cell O 0 0.06418885290622711
lines O 0 0.03114074282348156
, O 0 0.01196256373077631
including O 0 0.011903260834515095
those O 0 0.013726823963224888
derived O 0 0.04080985486507416
from O 0 0.038626935333013535
breast B-Disease 1 0.9997897744178772
malignancies I-Disease 1 0.997161865234375
. O 0 0.061370428651571274

Immunohistochemical O 1 0.9748859405517578
staining O 1 0.7305104732513428
of O 0 0.03915361687541008
human O 0 0.06938730180263519
breast O 1 0.9991881251335144
specimens O 0 0.07367487251758575
also O 0 0.03270770609378815
revealed O 0 0.06696780771017075
BRCA1 O 1 0.9933555126190186
nuclear O 0 0.09574522078037262
foci O 1 0.9732004404067993
in O 0 0.044408559799194336
benign O 1 0.999936580657959
breast O 1 0.9999910593032837
, O 0 0.09106652438640594
invasive B-Disease 1 0.9998716115951538
lobular I-Disease 1 0.9999970197677612
cancers I-Disease 1 0.999961256980896
and O 0 0.04070642963051796
low B-Disease 0 0.20817530155181885
- I-Disease 1 0.9437751770019531
grade I-Disease 1 0.7743039727210999
ductal I-Disease 1 0.9999574422836304
carcinomas I-Disease 1 0.999876856803894
. O 0 0.08256785571575165

Conversely O 0 0.18147864937782288
, O 0 0.05062378570437431
BRCA1 O 1 0.9257689118385315
expression O 0 0.0611446388065815
was O 0 0.022520199418067932
reduced O 0 0.03947820886969566
or O 0 0.02414168231189251
undetectable O 0 0.09813480824232101
in O 0 0.013147389516234398
the O 0 0.011100096628069878
majority O 0 0.018663346767425537
of O 0 0.014621192589402199
high O 0 0.034272827208042145
- O 0 0.10119202733039856
grade O 0 0.07438693940639496
, O 0 0.04237932339310646
ductal B-Disease 1 0.9999651908874512
carcinomas I-Disease 1 0.9999312162399292
, O 0 0.026862772181630135
suggesting O 0 0.04054804518818855
that O 0 0.014134062454104424
absence O 0 0.03594351187348366
of O 0 0.020089924335479736
BRCA1 O 1 0.9948805570602417
may O 0 0.03500993922352791
contribute O 0 0.03757718205451965
to O 0 0.013602434657514095
the O 0 0.0158934835344553
pathogenesis O 0 0.35414084792137146
of O 0 0.014507089741528034
a O 0 0.018274903297424316
significant O 0 0.026170294731855392
percentage O 0 0.03966638445854187
of O 0 0.026311179623007774
sporadic B-Disease 1 0.9821138978004456
breast I-Disease 1 0.9999895095825195
cancers I-Disease 1 0.9999209642410278
. O 0 0.04101233556866646
. O 0 0.043553415685892105

